FN Clarivate Analytics Web of Science
VR 1.0
PT B
AU Scavuzzo, JM
   Trucco, FC
   Tauro, CB
   German, A
   Espinosa, M
   Abril, M
AF Scavuzzo, Juan M.
   Trucco, Francisco C.
   Tauro, Carolina B.
   German, Alba
   Espinosa, Manuel
   Abril, Marcelo
GP IEEE
TI Modeling the temporal pattern of Dengue, Chicungunya and Zika vector
   using satellite data and Neural Networks
SO 2017 XVII WORKSHOP ON INFORMATION PROCESSING AND CONTROL (RPIC)
LA English
DT Proceedings Paper
CT 17th Workshop on Information Processing and Control (RPIC)
CY OCT 20-22, 2017
CL Mar del Plata, ARGENTINA
SP IEEE
DE mosquito; machine learning; artificial neural network; remote sensing;
   zika; chikungunya; dengue; Argentina; Aedes aegypti
ID AEDES-AEGYPTI; IMAGE CLASSIFICATION; EPIDEMIOLOGY; DYNAMICS; OUTBREAK;
   NDVI; CITY
AB The present work includes the temporal modeling of the oviposition activity of the Aedes aegypti mosquito, a vector of viral diseases such as Dengue, Chicungunya and Zika, based on time series of data extracted from earth observation satellite images. Unlike previous works, Machine Learning techniques that are capable of capturing nonlinear relationships between variables, such as artificial neural networks, are used to build a predictive model of the oviposition activity. The results of this model show a significant increase in performance compared to linear models trained with similar data sets.
C1 [Scavuzzo, Juan M.; Trucco, Francisco C.] Univ Nacl Cordoba, FAMAF, Cordoba, Argentina.
   [Tauro, Carolina B.] CONAE, Inst Gulich, Cordoba, Argentina.
   [German, Alba; Espinosa, Manuel; Abril, Marcelo] Fdn Mundo Sano, Cordoba, Argentina.
RP Scavuzzo, JM (corresponding author), Univ Nacl Cordoba, FAMAF, Cordoba, Argentina.
EM juansca1229@gmail.com; franciscoctrucco@gmail.com;
   carolina.tauro@conae.gov.ar; albagerman@gmail.com;
   mespinosa@mundosano.org; mabril@mundosano.org
CR Atkinson P. M., 1997, INT J REMOTE SENSING, V18
   Azamathulla HM, 2012, APPL SOFT COMPUT, V12, P1227, DOI 10.1016/j.asoc.2011.12.003
   Bose P, 2016, IEEE T GEOSCI REMOTE, V54, P6563, DOI 10.1109/TGRS.2016.2586602
   Brown ME, 2008, INT J REMOTE SENS, V29, P7141, DOI 10.1080/01431160802238435
   Juri MJD, 2015, J VECTOR ECOL, V40, P36, DOI 10.1111/jvec.12130
   Espinosa M., 2017, SATELITE BASED TEMPO
   Espinosa M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004621
   Espinosa MO, 2016, GEOSPATIAL HEALTH, V11, P307, DOI 10.4081/gh.2016.471
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Estallo E. L., 2011, REV SAUDE PUBLICA
   Estallo E. L., 2016, IEEE J SELECTED TOPI
   Foody GM, 2004, INT J REMOTE SENS, V25, P3091, DOI 10.1080/01431160310001648019
   Goldarag YJ, 2016, J INDIAN SOC REMOTE, V44, P885, DOI 10.1007/s12524-016-0557-6
   GOMES AC, 1998, INF EPIDEMIOL SUS, V7, P49
   Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3
   Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116
   Kimes DS, 1998, INT J REMOTE SENS, V19, P2639, DOI 10.1080/014311698214433
   Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2
   Lary DJ, 2009, IEEE GEOSCI REMOTE S, V6, P694, DOI 10.1109/LGRS.2009.2023605
   Lary D. J., 2015, GEOSCIENCE FRONTIERS, V1
   Estallo EL, 2012, INT J REMOTE SENS, V33, P4254, DOI 10.1080/01431161.2011.640962
   Madadi M. R., 2015, EARTH SCI INFORM
   Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009
   Pavlovsky EN, 1966, NATURAL NIDALITY TRA
   Pena JM, 2014, REMOTE SENS-BASEL, V6, P5019, DOI 10.3390/rs6065019
   Polop F, 2008, ECOL RES, V23, P217, DOI 10.1007/s11284-007-0371-2
   Porcasi X, 2012, GEOSPATIAL HEALTH, V6, pS31
   RITCHIE SA, 1984, MOSQ NEWS, V44, P77
   Rotela C, 2007, ACTA TROP, V103, P1, DOI 10.1016/j.actatropica.2007.05.003
   Wang DC, 2016, INT GEOSCI REMOTE SE, P5852, DOI 10.1109/IGARSS.2016.7730529
   Wegmuller M., 2000, P ECOC 00, P109
   Yi JS, 1996, ENVIRON POLLUT, V92, P349, DOI 10.1016/0269-7491(95)00078-X
   Zahabiyoun B, 2013, CLEAN-SOIL AIR WATER, V41, P601, DOI 10.1002/clen.201100652
   Zhang GP, 2005, EUR J OPER RES, V160, P501, DOI 10.1016/j.ejor.2003.08.037
NR 34
TC 1
Z9 1
U1 1
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-987-544-754-7
PY 2017
PG 6
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA BJ7ES
UT WOS:000427184900035
DA 2020-07-08
ER

PT B
AU Vadrucci, M
   Borgognoni, F
   Calvitti, M
   Moretti, R
   Picardi, L
AF Vadrucci, M.
   Borgognoni, F.
   Calvitti, M.
   Moretti, R.
   Picardi, L.
BE Wriggers, P
   Bischoff, M
   Onate, E
   Owen, DRJ
   Zohdi, T
TI TREATMENT VOLUME OF AEDES ALBOPICTUS WITH X RAYS GENERATED FROM
   ELECTRONS
SO V INTERNATIONAL CONFERENCE ON PARTICLE-BASED METHODS - FUNDAMENTALS AND
   APPLICATIONS (PARTICLES 2017)
LA English
DT Proceedings Paper
CT 5th International Conference on Particle-Based Methods - Fundamentals
   and Applications (PARTICLES)
CY SEP 26-28, 2017
CL Hannover, GERMANY
SP European Community on Computat Methods Appl Sci, Int Assoc Computat Mech
DE electron accelerator; X Rays irradiation; Aedes albopictus; Sterile
   Insect Technique; sterilization technologies
AB Irradiation is a common method used for sterilizing objects in several fields. In the entomology sector, insects are sterilized through irradiation and released in to the wild to sexually compete with the population at large reducing the chance for reproduction. This practice is the Sterile Insect Technique (SIT). Traditionally irradiation sources for SIT purpose are radioisotopes but many reasons compelled to getting efforts to develop other radiative technologies. Since gamma rays and electrons have similar sterilizing effects, the choice of source for SIT irradiation is based on considerations about penetration and environmental factors.
   Gamma irradiators are usually simpler to operate, and less expensive, than electron accelerators, at least within the range of power required for SIT applications. Currently, the increased difficulties to manage and ship radioisotopes is being successfully resolved by the introduction of novel X-ray irradiators that enable a safer use of irradiator machines and procedures for SIT applications.
   In the ENEA Frascati research center we developed irradiators for clinical radiotherapy consisting in a radiation converter from electrons to X-rays. Since X-rays penetrate deeper than the electrons from which they are generated, we used this technology in a configuration that delivers a uniform dose on large targets to irradiate insects for SIT aim.
   In this topic, we gained practical experience working with Aedes albopictus, a mosquito vector of various tropical diseases such as dengue and zika. Several dosimetric studies have been conducted to achieve male sterility without affecting male mating competitiveness in comparison with untreated males. Lower doses have been also tested on an Ae. albopictus strain modified with the bacterium Wolbachia, which also determines male sterility, to sterilize the females eventually escaping the sexing procedures preliminary to the releases of the males.
C1 [Vadrucci, M.; Borgognoni, F.; Picardi, L.] ENEA, Dev Particle Accelerators & Med Applicat Lab, Via E Fermi 45, I-00044 Frascati, RM, Italy.
   [Calvitti, M.; Moretti, R.] ENEA, Biotechnol & Agroind Div, Via Anguillarese 30, I-00123 Santa Maria Di Galeria, RM, Italy.
RP Vadrucci, M (corresponding author), ENEA, Dev Particle Accelerators & Med Applicat Lab, Via E Fermi 45, I-00044 Frascati, RM, Italy.
EM monia.vadrucci@enea.it
CR Borgognoni F, 2017, NUCL INSTRUM METH B, V406, P309, DOI 10.1016/j.nimb.2017.03.033
   Borgognoni F., 2017, EUROMAT 2017 C UNPUB
   Mariotti F., 2017, AIRP 2017 UNPUB
   Vadrucci M., 2015, BIOPHYSICS BIOENG LE, V8
   Vadrucci M., 2017, RAD APPL J IN PRESS
NR 5
TC 2
Z9 2
U1 0
U2 1
PU INT CENTER NUMERICAL METHODS ENGINEERING
PI 08034 BARCELONA
PA GRAN CAPITAN, S-N, CAMPUS NORTE UPC, MODULO C1, 08034 BARCELONA, SPAIN
BN 978-84-946909-7-6
PY 2017
BP 795
EP 801
PG 7
WC Mathematics, Applied; Mechanics; Physics, Fluids & Plasmas
SC Mathematics; Mechanics; Physics
GA BJ6NL
UT WOS:000426873800072
DA 2020-07-08
ER

PT J
AU Buchwalter, RA
   Chen, JV
   Hammack, C
   Ogden, SC
   Tang, H
   Megraw, TL
AF Buchwalter, R. A.
   Chen, J. V.
   Hammack, C.
   Ogden, S. C.
   Tang, H.
   Megraw, T. L.
TI Activation of the centrosome's microtubule-assembly activity by the Zika
   virus (ZIKV).
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT Annual Joint Meeting of the American-Society-for-Cell-Biology and the
   European-Molecular-Biology-Organization (ASCB/EMBO)
CY DEC 02-06, 2017
CL Philadelphia, PA
SP Amer Soc Cell Biol, European Mol Biol Org
C1 [Buchwalter, R. A.; Chen, J. V.; Megraw, T. L.] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.
   [Hammack, C.; Ogden, S. C.; Tang, H.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2017
VL 28
MA P2969
PG 1
WC Cell Biology
SC Cell Biology
GA FY2RT
UT WOS:000426664303042
DA 2020-07-08
ER

PT S
AU Parks, JW
   Stambaugh, A
   Stott, MA
   Meena, GM
   Hawkins, AR
   Schmidt, H
AF Parks, J. W.
   Stambaugh, A.
   Stott, M. A.
   Meena, G. M.
   Hawkins, A. R.
   Schmidt, H.
GP IEEE Photon Soc
TI Dual Detection of Zika Virus Nucleic Acid and Protein Using a Multi-Mode
   Interference Waveguide Platform
SO 30TH ANNUAL CONFERENCE OF THE IEEE PHOTONICS SOCIETY (IPC)
SE IEEE Photonics Conference
LA English
DT Proceedings Paper
CT 30th Annual Conference of the IEEE-Photonics-Society (IPC)
CY OCT 01-05, 2017
CL Orlando, FL
SP IEEE, IEEE Photon Soc
AB We report a novel technique for simultaneous detection of nucleic acid and protein biomarkers using multimode interference (MMI) waveguides on an optofluidic chip. Multiplex detection of Zika virus nucleic acids and proteins using two-color multi-spot excitation is demonstrated with excellent specificity.
C1 [Parks, J. W.; Stambaugh, A.; Meena, G. M.; Schmidt, H.] Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
   [Stott, M. A.; Hawkins, A. R.] Brigham Young Univ, ECEn Dept, 459 Clyde Bldg, Provo, UT 84602 USA.
RP Stambaugh, A (corresponding author), Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
EM amstamba@ucsc.edu
FU W.M. Keck Center for Nanoscale Optofluidics at UC Santa Cruz; National
   Science Foundation (NSF)National Science Foundation (NSF) [CBET-1159423,
   CBET-1159453]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [4R33AI100229,
   1R21AI1002299]
FX This work is supported by the W.M. Keck Center for Nanoscale
   Optofluidics at UC Santa Cruz, the NIH under grants 4R33AI100229 and
   1R21AI1002299, and the National Science Foundation (NSF) under grants
   CBET-1159453 and CBET-1159423.
CR Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023
   Laniotti R. S., 2008, EMERG INFECT DIS, V14, P1232
   Moerener W. E., 1989, PHYS REV LETT, V62, P21
   Osterholm MT, 2016, SCIENCE, V353, P1073, DOI 10.1126/science.aai9078
   Ozcelik D., 2015, PNAS, V112, P42
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Watzinger F., 2006, Molecular Aspects of Medicine, V27, P254, DOI 10.1016/j.mam.2005.12.001
NR 7
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2374-0140
BN 978-1-5090-6578-3
J9 IEEE PHOTON CONF
PY 2017
BP 489
EP 490
PG 2
WC Optics; Physics, Applied
SC Optics; Physics
GA BJ6KM
UT WOS:000426792600214
DA 2020-07-08
ER

PT B
AU Susymary, J
   Lawrance, R
AF Susymary, J.
   Lawrance, R.
GP IEEE
TI Graph Theory Analysis of Protein-Protein Interaction Network and Graph
   based Clustering of Proteins linked with Zika Virus using MCL Algorithm
SO PROCEEDINGS OF 2017 IEEE INTERNATIONAL CONFERENCE ON CIRCUIT ,POWER AND
   COMPUTING TECHNOLOGIES (ICCPCT)
LA English
DT Proceedings Paper
CT IEEE International Conference on Circuit ,Power and Computing
   Technologies (ICCPCT)
CY APR 20-21, 2017
CL Kollam, INDIA
SP Baselios Mathews II Coll Engn, IEEE
DE graph mining; clustering; MCL algorithm; graph theory; protein-protein
   interaction; zika virus
AB Graph mining is an advancing region notably to dig up unique and intuitiveness facts from data that is pictured as a graph. Graph data like protein-protein interaction network is pervasive in actuality so that graph theory means of analysis to network can advantage supplementary findings of proteins associated with positive topological characteristic have precise biological function. Distinct graph mining techniques such as frequent subgraph mining, clustering, classification is feasible to figure out the protein-protein interaction networks. Clustering is one of the well-known technique to boast a class of proteins with related biological function. Some of the graph based clustering methods include local neighborhood density search method, flow simulation method and population based stochastic search method. MCL algorithm based on flow simulation method over protein-protein interaction network of proteins related zika virus has been analytically gauged and indicated how interesting clusters are raised.
C1 [Susymary, J.] AyyaNadar Janaki Ammal Coll, Dept Comp Sci, Sivakasi, Tamil Nadu, India.
   [Lawrance, R.] AyyaNadar Janaki Ammal Coll, Dept Comp Applicat, Sivakasi, Tamil Nadu, India.
RP Susymary, J (corresponding author), AyyaNadar Janaki Ammal Coll, Dept Comp Sci, Sivakasi, Tamil Nadu, India.
EM susymarybijudasan@gmail.com; lawrancer@yahoo.com
RI R, Lawrance/AAI-5738-2020
CR Alagukumar S, 2015, PROCEDIA COMPUT SCI, V47, P3, DOI 10.1016/j.procs.2015.03.177
   Alagukumar S, 2015, INT J COMPUTER APPL, P9
   PRZULJ N, 2004, OXFORD J, V20, P340, DOI DOI 10.1093/BIOINFORMATICS/BTG415
   Schaeffer SE, 2007, COMPUT SCI REV, V1, P27, DOI 10.1016/j.cosrev.2007.05.001
   Thomas A, 2003, BIOCHEM SOC T, V31, P1491
   Ucar D, 2006, LECT NOTES ARTIF INT, V4213, P371
   Van Dongen S., 2000, THESIS
   Wu XK, 2015, IEEE T INTELL TRANSP, V16, P2786, DOI [10.1109/MWSYM.2015.7166900, 10.1109/TITS.2015.2422778]
   WU XR, 2005, INT J INFORM TECHNOL, V11, P125
NR 9
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-4967-7
PY 2017
PG 7
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BJ6ER
UT WOS:000426597600216
DA 2020-07-08
ER

PT S
AU Moser, N
   Rodriguez-Manzano, J
   Yu, LS
   Kalofonou, M
   de Mateo, S
   Li, XX
   Lande, TS
   Toumazou, C
   Georgiou, P
AF Moser, Nicolas
   Rodriguez-Manzano, Jesus
   Yu, Ling-Shan
   Kalofonou, Melpomeni
   de Mateo, Sara
   Li, Xiaoxiang
   Lande, Tor Sverre
   Toumazou, Christofer
   Georgiou, Pantelis
GP IEEE
TI Live Demonstration: A CMOS-Based ISFET Array for Rapid Diagnosis of the
   Zika Virus
SO 2017 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS (ISCAS)
SE IEEE International Symposium on Circuits and Systems
LA English
DT Proceedings Paper
CT IEEE International Symposium on Circuits and Systems (ISCAS)
CY MAY 28-31, 2017
CL Baltimore, MD
SP IEEE, IEEE Circuits & Syst Soc
AB We demonstrate a diagnostics platform which integrates an ISFET array and a temperature control loop for isothermal DNA detection. The controller maintains a temperature of 63 degrees C to perform nucleic acid amplification which is detected by the on-chip sensors. The 32x32 ISFET array is first calibrated to cancel trapped charge and then measures the change in the pH of the reaction. The sensor data is sent to a microcontroller and the reaction is monitored in real-time using a MATLAB interface. Experiments confirm a change of 0.9 pH when tested for the presence of RNA associated with the Zika virus.
C1 [Moser, Nicolas] Imperial Coll London, Dept Elect & Elect Engn, London SW7 2BT, England.
   Imperial Coll London, Inst Biomed Engn, Ctr Bioinspired Technol, London SW7 2AZ, England.
RP Moser, N (corresponding author), Imperial Coll London, Dept Elect & Elect Engn, London SW7 2BT, England.
EM n.moser@imperial.ac.uk
OI Georgiou, Pantelis/0000-0003-2476-3857
CR Moser Neil A., 2016, 2016 74th Annual Device Research Conference (DRC), P1, DOI 10.1109/DRC.2016.7548419
   Moser N, 2016, IEEE SENS J, V16, P6496, DOI 10.1109/JSEN.2016.2585920
   Tian B., 2016, BIOSENS BIOELECTRON
NR 3
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0271-4302
BN 978-1-4673-6853-7
J9 IEEE INT SYMP CIRC S
PY 2017
PG 1
WC Engineering, Electrical & Electronic
SC Engineering
GA BJ4DH
UT WOS:000424890101211
DA 2020-07-08
ER

PT J
AU Slavov, S
   Matsuno, A
   Yamamoto, A
   Otaguiri, K
   Cervi, M
   Covas, D
   Kashima, S
AF Slavov, Svetoslav
   Matsuno, Alessandra
   Yamamoto, Aparecida
   Otaguiri, Katia
   Cervi, Maria
   Covas, Dimas
   Kashima, Simone
TI Zika virus infection in a pediatric patient with acute gastrointestinal
   involvement
SO PEDIATRIC REPORTS
LA English
DT Article
DE Zika virus; ZIKV; abdominal pain; viral load
ID DENGUE; DIAGNOSIS
AB Zika virus (ZIKV) is a mosquito-borne flavivirus, which has been related to severe neurological complications in neonates. However, many clinical aspects of the infection remain unclear, especially in pediatric patients. In this case report we describe the uncommon presentation of ZIKV infection in a pediatric patient with acute gastrointestinal involvement hospitalized in a Brazilian Emergency Unit. Dengue hemorrhagic fever was initially suspected, however, the molecular result for Dengue was negative. Molecular testing for other arboviruses (ZIKV and Chikungunya), revealed positive for ZIKV RNA result in both blood and saliva. The ZIKV load in saliva (6.947 copies/mL) was higher than the vetected ZIKV RNA in plasma (1.945 copies/mL). Additionally, the performed abdominal ultrasound revealed mesenteric lymphadenitis without abdominal retention of fluids. The presentation of this case demonstrates that ZIKV can be involved in a broader range of clinical conditions than currently assumed, including pediatric emergencies, especially in regions with extensive ZIKV outbreaks.
C1 [Slavov, Svetoslav; Otaguiri, Katia; Covas, Dimas; Kashima, Simone] Univ Sao Paulo, Blood Ctr Ribeirao Preto, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Slavov, Svetoslav; Covas, Dimas] Univ Sao Paulo, Dept Internal Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Matsuno, Alessandra; Yamamoto, Aparecida; Cervi, Maria] Univ Sao Paulo, Dept Pediat, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Otaguiri, Katia; Kashima, Simone] Univ Sao Paulo, Dept Clin Toxicol & Bromatol Anal, Fac Pharmaceut Sci Ribeirao Preto, Sao Paulo, Brazil.
RP Slavov, S (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Mol Biol Lab, Blood Ctr Ribeirao Preto, Sao Paulo, Brazil.
EM svetoslav.slavov@hemocentro.fmrp.usp.br
RI Covas, Dimas T/C-5431-2013; Matsuno, Alessandra K/H-9507-2012; Kashima,
   Simone/G-4876-2012
OI Covas, Dimas T/0000-0002-7364-2595; Matsuno, Alessandra
   K/0000-0002-3491-1641; Kashima, Simone/0000-0002-1487-0141
FU Sao Paulo Research Foundation (FAPESP), BrazilFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2009/16623-1, 13/08135-2];
   Conselho Nacional do Desenvolvimento Cientifico e Tecnologico, Brazil
   [INCTC-465539/2014]; Financiadora de Estudos e ProjetosCiencia
   Tecnologia e Inovacao (FINEP) [0245/2016]; PPSUS [2016/150493]
FX the Sao Paulo Research Foundation (FAPESP), Brazil (Grants No
   2009/16623-1, 13/08135-2), the Conselho Nacional do Desenvolvimento
   Cientifico e Tecnologico, Brazil (INCTC-465539/2014), the Financiadora
   de Estudos e Projetos (0245/2016) and the PPSUS, 2016/150493.
CR Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Khor BS, 2006, AM J TROP MED HYG, V74, P901, DOI 10.4269/ajtmh.2006.74.901
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Macari M, 2002, AM J ROENTGENOL, V178, P853, DOI 10.2214/ajr.178.4.1780853
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Patel NB, 2015, RADIOL CLIN N AM, V53, P1159, DOI 10.1016/j.rcl.2015.06.004
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Trunfio M, 2017, INFECTION, V45, P1, DOI 10.1007/s15010-016-0927-6
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 1
Z9 1
U1 0
U2 0
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 2036-749X
EI 2036-7503
J9 PEDIATRIC REP
JI Pediatric Rep.
PY 2017
VL 9
IS 4
BP 78
EP 80
AR 7341
DI 10.4081/pr.2017.7341
PG 3
WC Pediatrics
SC Pediatrics
GA FU9SI
UT WOS:000424196700006
PM 29383222
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Arabo, A
AF Arabo, Abdullahi
BE Bryant, AR
   Lopez, J
   Mills, RF
TI CyberMix: A Roadmap of SDN-Based Intelligent Cybersecurity Immune System
SO PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON CYBER WARFARE AND
   SECURITY (ICCWS 2017)
SE International Conference on Cyber Warfare and Security
LA English
DT Proceedings Paper
CT 12th International Conference on Cyber Warfare and Security (ICCWS)
CY MAR 02-03, 2017
CL Wright State Univ, Dayton, OH
SP Air Force Inst Technol, Ctr Cyberspace Res
HO Wright State Univ
DE cybersecurity; software define network; immune systems; agent based
   defence; device security
ID NETWORKS; DEFENSE
AB Cybersecurity is a prerequisite to ongoing developments concerning the interaction of a myriad of networked components ranging from PCs and portable devices through to households white goods. The resulting ecosystem in many ways resembles the human immune ecosystem. However, the cybersecurity community lacks insights into the stability, controllability and observability of the ecosystem, as well as being able to dynamically protect it so that it is immune to unknown vulnerabilities. Today's approach relies on security experts to identify new flaws, threats and remediate these issues by hand. This process takes time and provides advantage for malicious users to breach and compromise critical systems. Hence, this re-active and slow reaction cycle has created a permanent offensive advantage. CyberMix seeks to automate this cyber defence process, by fielding a system that discover, prove and fix threats and flaws in real-time with or without any assistance. The paper proposed CyberMix, an architecture that will provide an immune cybersecurity ecosystem by utilising two main principles: Software-Defined Networking (SDN) and an immune agent based on how the Human Immune System (HIS) works against unknown viruses and disease like the Zika disease. This will be complemented by a dynamic automated cause of action (ACoA), allowing human input to enhance threat signature detection leading to a more secure ecosystem. The cyber research community especially lacks insight into networks that are very large and complex multi-genre in nature. It can also be stated that little is understood about the impact of social-cognitive links and informationelement links on the overall network complexity and the various elements that make-up the complex network. Hence, it is of paramount importance to have a solution that enables dynamic, on-demand segmentation of a potentially unstable network into subnets with limited and strictly controlled connectivity between subnets. To facilitate these new and future challenges, there is a need for a system that is self-evolving with the capabilities of the HIS, along with means to predict systems security properties and create self-signatures from known and unknown patterns and behaviours within individual network element within the ecosystem. The paper investigates and identifies suitable methods for creating self-learning/organisation/healing rules that lead to the desired emergent properties.
C1 [Arabo, Abdullahi] UWE, Dept Comp Sci & Creat Technol, Ctr Complex & Cooperat Syst, Cybersecur Res Unit,Fac Environm & Technol, Bristol, Avon, England.
RP Arabo, A (corresponding author), UWE, Dept Comp Sci & Creat Technol, Ctr Complex & Cooperat Syst, Cybersecur Res Unit,Fac Environm & Technol, Bristol, Avon, England.
EM Abdullahi.arabo@uwe.ac.uk
CR Al-Shaer E, 2011, ADV INFORM SECUR, V54, P153
   Bent G., 2008, P 2 ANN C INT TECHN
   Carvalho M, 2014, IEEE SECUR PRIV, V12, P73, DOI 10.1109/MSP.2014.30
   Dasgupta D., 1998, ARTIFICIAL IMMUNE SY, P242
   DHS, 2011, EN DISTR SEC CYB BUI
   Kephart J., 2002, P 1991 IEEE COMP SOC, P343
   Kott A, 2014, COMPUTER, V47, P104, DOI 10.1109/MC.2014.366
   McKeown N, 2008, ACM SIGCOMM COMP COM, V38, P69, DOI 10.1145/1355734.1355746
   Rui Zhuang, 2013, 2013 6th International Symposium on Resilient Control Systems (ISRCS), P162, DOI 10.1109/ISRCS.2013.6623770
   Samdanis K, 2016, COMPUTER COMMUNICATI
   Swimmer M, 2007, COMPUT NETW, V51, P1315, DOI 10.1016/j.comnet.2006.09.015
   Zimmerman M., 2014, OPENFLOW ENABLED SDN
NR 12
TC 1
Z9 1
U1 0
U2 2
PU ACAD  CONFERENCES LTD
PI NR READING
PA CURTIS FARM, KIDMORE END, NR READING, RG4 9AY, ENGLAND
SN 2048-9870
EI 2048-9889
BN 978-1-911218-26-5
J9 INT C CYBER WARFARE
PY 2017
BP 10
EP 14
PG 5
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
SC Computer Science
GA BJ3MU
UT WOS:000423998600002
DA 2020-07-08
ER

PT J
AU Costa, ALFD
   Martins, TGD
   Martins, DGD
AF Fontes de Azevedo Costa, Ana Luiza
   dos Santos Martins, Thiago Goncalves
   dos Santos Martins, Diogo Goncalves
TI Third Cranial Nerve Palsy after a Chikungunya Virus Infection
SO STRABISMUS
LA English
DT Article
DE Chikungunya; strabismus; third nerve palsy
AB Chikungunya fever is a disease caused by a virus from the same family as dengue and Zika. It is endemic in several parts of the world and has recently spread to Latin America. We report the case of a patient, aged 58 years, from Rio de Janeiro, Brazil, who in 2013 developed an acute bilateral third cranial nerve palsy sparing the pupil. After extensive investigation, it was diagnosed as caused by chikungunya infection. The patient was treated with pulse therapy and after 5 months of the onset of the condition, the patient showed improvement.
C1 [Fontes de Azevedo Costa, Ana Luiza; dos Santos Martins, Thiago Goncalves] Univ Fed Sao Paulo, Ophthalmol Dept, Sao Paulo, Brazil.
   [dos Santos Martins, Diogo Goncalves] Hosp Serv, Ophthalmol Dept, Rio De Janeiro, Brazil.
RP Costa, ALFD (corresponding author), Botucatu St,821 Vila Clementino, BR-04023062 Sao Paulo, Brazil.
EM luizafacosta@hotmail.com
OI Martins, Thiago/0000-0002-3878-8564
CR Benzekri R, 2016, AM J TROP MED HYG, V95, P180, DOI 10.4269/ajtmh.15-0547
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002
   Magurano F, 2015, VECTOR-BORNE ZOONOT, V15, P258, DOI 10.1089/vbz.2014.1724
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Nair AG, 2012, J OPHTHALMIC INFLAMM, V2, P39, DOI 10.1007/s12348-011-0038-6
   Norwood PF, 2015, REV SCI TECH OIE, V34, P479, DOI 10.20506/rst.34.2.2373
   Thurtell MJ, 2014, J NEURO-OPHTHALMOL, V34, P243, DOI 10.1097/WNO.0000000000000116
   Van Aalst M, 2017, TRAVEL MED INFECT DI
   Wadia R. S., 2007, Annals of the Indian Academy of Neurology, V10, P198
NR 10
TC 3
Z9 3
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3972
EI 1744-5132
J9 STRABISMUS
JI Strabismus
PY 2017
VL 25
IS 4
BP 172
EP 175
DI 10.1080/09273972.2017.1391851
PG 4
WC Ophthalmology
SC Ophthalmology
GA FV1BJ
UT WOS:000424295700002
PM 29135313
DA 2020-07-08
ER

PT J
AU Schneider, AD
   Damodaran, L
   Witter, Z
   Janies, D
AF Schneider, Adriano de Bernardi
   Damodaran, Lambodhar
   Witter, Zachary
   Janies, Daniel
TI IN THE SEARCH OF THE HIDDEN PATH: THE SOURCE AND SPREAD OF CHIKUNGUNYA
   AND ZIKA VIRUSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Schneider, Adriano de Bernardi; Damodaran, Lambodhar; Witter, Zachary; Janies, Daniel] Univ North Carolina Charlotte, Charlotte, NC USA.
RI de Bernardi Schneider, Adriano/E-6252-2017
OI de Bernardi Schneider, Adriano/0000-0001-7487-266X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 4
BP 1
EP 2
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202004
DA 2020-07-08
ER

PT J
AU MacLeod, HJ
   Anglero-Rodriguez, YI
   Guo, XX
   Zhao, TY
   Dimopoulos, G
AF MacLeod, Hannah J.
   Anglero-Rodriguez, Yesseinia I.
   Guo, Xiao-Xia
   Zhao, Tong-Yan
   Dimopoulos, George
TI INVESTIGATING THE VECTOR COMPETENCE OF CULEX QUINQUEFASCIATUS FOR ZIKA
   VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [MacLeod, Hannah J.; Anglero-Rodriguez, Yesseinia I.; Dimopoulos, George] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Guo, Xiao-Xia; Zhao, Tong-Yan] Inst Microbiol & Epidemiol, Beijing, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 62
BP 21
EP 21
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202062
DA 2020-07-08
ER

PT J
AU Adam, A
   Woda, M
   Rothman, AL
   Mathew, A
AF Adam, Awadalkareem
   Woda, Marcia
   Rothman, Alan L.
   Mathew, Anuja
TI MODIFIED ELISPOT FOR THE ANALYSIS OF SPECIFIC AND CROSS-REACTIVE DENGUE
   VIRUS AND ZIKA VIRUS MEMORY B CELLS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Adam, Awadalkareem; Woda, Marcia; Rothman, Alan L.; Mathew, Anuja] Univ Rhode Isl, Inst Immunol & Informat, 825 Chalkstone Ave, Providence, RI 02908 USA.
RI Mathew, Anuja/V-6711-2019
OI Mathew, Anuja/0000-0002-6752-009X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 121
BP 39
EP 39
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202121
DA 2020-07-08
ER

PT J
AU Read, JS
   Torres-Velasquez, B
   Santiago, G
   Lorenzi, O
   Rivera, A
   Torres-Torres, S
   Capre, S
   Garcia-Gubern, C
   Rivera, L
   Perez-Padilla, J
   Munoz-Jordan, J
   Alvarado, L
AF Read, Jennifer S.
   Torres-Velasquez, Brenda
   Santiago, Gilberto
   Lorenzi, Olga
   Rivera, Aidsa
   Torres-Torres, Sanet
   Capre, Sheila
   Garcia-Gubern, Carlos
   Rivera, Lillian
   Perez-Padilla, Janice
   Munoz-Jordan, Jorge
   Alvarado, Luisa
TI ZIKA VIRUS QUANTITATIVE PCR RESULTS AMONG SYMPTOMATIC PEDIATRIC PATIENTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Read, Jennifer S.; Torres-Velasquez, Brenda; Santiago, Gilberto; Lorenzi, Olga; Rivera, Aidsa; Perez-Padilla, Janice; Munoz-Jordan, Jorge] Ctr Dis Control & Prevent, San Juan, PR USA.
   [Torres-Torres, Sanet; Capre, Sheila; Rivera, Lillian; Alvarado, Luisa] St Lukes Episcopal Hosp Ponce Hlth Sci Univ Conso, Dept Pediat, Ponce, PR USA.
   [Garcia-Gubern, Carlos] St Lukes Episcopal Hosp Ponce Hlth Sci Univ Conso, Dept Emergency Med, Ponce, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 132
BP 42
EP 42
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202132
DA 2020-07-08
ER

PT J
AU Terzian, AC
   Estofolete, CF
   da Silva, RA
   Vaz-Oliani, DC
   Oliani, AH
   Mattos, CC
   Mattos, LC
   Rahal, P
   Nogueira, ML
AF Terzian, Ana C.
   Estofolete, Cassia F.
   da Silva, Rafael A.
   Vaz-Oliani, Denise C.
   Oliani, Antonio H.
   Mattos, Cinara C.
   Mattos, Luiz C.
   Rahal, Paula
   Nogueira, Mauricio L.
TI INTERVALS OF POSITIVE AND NEGATIVE DETECTION OF THE ZIKV RNA IN THE
   URINE OF ZIKA-INFECTED PREGNANT WOMEN
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Terzian, Ana C.; Estofolete, Cassia F.; da Silva, Rafael A.; Nogueira, Mauricio L.] Sao Jose do Rio Preto Sch Med FAMERP, Sao Jose Do Rio Preto, Brazil.
   [Vaz-Oliani, Denise C.; Oliani, Antonio H.; Mattos, Cinara C.; Mattos, Luiz C.] Sao Jose do Rio Preto Sch Med Fdn FUNFARME, Sao Jose Do Rio Preto, Brazil.
   [Rahal, Paula] Sao Paulo State Univ IBILCE UNESP, Sao Jose Do Rio Preto, Brazil.
RI Estofolete, Cassia/N-6673-2019; OLIANI, ANTONIO/O-1673-2019
OI Estofolete, Cassia/0000-0001-7324-1591; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 136
BP 43
EP 44
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202136
DA 2020-07-08
ER

PT J
AU Tsegaye, MM
   Moltotal, WA
   Mentaye, BB
   Tadesse, AA
   Sall, AA
   Yactayo, SD
   Tareke, I
   Eshetu, MS
   Belay, D
   Lilay, A
   Alemu, A
   Alemu, E
   Staples, E
   Tefera, M
   Bekele, A
   Jima, D
   Kebede, A
AF Tsegaye, Mesfin M.
   Moltotal, Workenesh A.
   Mentaye, Berhane B.
   Tadesse, Almaz A.
   Sall, Amadou A.
   Yactayo, Sergio D.
   Tareke, Israel
   Eshetu, Messeret S.
   Belay, Desalegn
   Lilay, Abrham
   Alemu, Abebe
   Alemu, Emana
   Staples, Erin
   Tefera, Mesfin
   Bekele, Abyot
   Jima, Daddi
   Kebede, Amha
TI THE FIRST SEROLOGICAL EVIDENCE OF PREVIOUS ZIKA VIRUS TRANSMISSION IN
   ETHIOPIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Tsegaye, Mesfin M.; Moltotal, Workenesh A.; Mentaye, Berhane B.; Tadesse, Almaz A.; Belay, Desalegn; Lilay, Abrham; Alemu, Abebe; Alemu, Emana; Tefera, Mesfin; Bekele, Abyot; Jima, Daddi; Kebede, Amha] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.
   [Sall, Amadou A.] Inst Pasteur, Dakar, Senegal.
   [Yactayo, Sergio D.] World Hlth Org, Geneva, Switzerland.
   [Tareke, Israel] World Hlth Org, Addis Ababa, Ethiopia.
   [Eshetu, Messeret S.] World Hlth Org, Harare, Zimbabwe.
   [Staples, Erin] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 134
BP 43
EP 43
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202134
DA 2020-07-08
ER

PT J
AU Foronda, JLM
   Sy, AKD
   Tomas, DEZ
   Tandoc, AO
AF Foronda, Janiza Lianne M.
   Sy, Ava Kristy D.
   Tomas, Dominic Edward Z.
   Tandoc, Amado O., III
TI LOW DENSITY CIRCULATION OF ZIKA VIRUS IN THE PHILIPPINES, 2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Foronda, Janiza Lianne M.; Sy, Ava Kristy D.; Tomas, Dominic Edward Z.; Tandoc, Amado O., III] Res Inst Trop Med, Muntinlupa, Philippines.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 138
BP 44
EP 44
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202138
DA 2020-07-08
ER

PT J
AU Doyle, K
   Rosenberg, ES
   Paz-Bailey, G
   Little, E
   Klein, L
   Munoz-Jordan, J
   Adams, L
   Lozier, M
   Sharp, TM
AF Doyle, Kate
   Rosenberg, Eli S.
   Paz-Bailey, Gabriela
   Little, Emma
   Klein, Liore
   Munoz-Jordan, Jorge
   Adams, Laura
   Lozier, Matt
   Sharp, Tyler M.
TI DYNAMICS OF ANTI-ZIKA VIRUS IGM ANTIBODY IN A PROSPECTIVE COHORT STUDY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Doyle, Kate; Paz-Bailey, Gabriela; Little, Emma; Munoz-Jordan, Jorge; Adams, Laura; Lozier, Matt; Sharp, Tyler M.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Rosenberg, Eli S.] Emory Univ, Atlanta, GA 30322 USA.
   [Klein, Liore] Caduceus Healthcare Inc, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 143
BP 45
EP 46
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202143
DA 2020-07-08
ER

PT J
AU Faria, NR
   Quick, J
   Morales, I
   Theze, J
   Jesus, J
   Giovanetti, M
   Nunes, MR
   Sabino, EC
   Alcantara, LC
   Loman, N
   Pybus, OG
AF Faria, Nuno R.
   Quick, Josh
   Morales, Ingra
   Theze, Julien
   Jesus, Jaqueline
   Giovanetti, Marta
   Nunes, Marcio R.
   Sabino, Ester C.
   Alcantara, Luis C.
   Loman, Nick
   Pybus, Oliver G.
TI PORTABLE GENOMIC SURVEILLANCE OF ZIKA VIRUS IN BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Faria, Nuno R.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Oxford, England.
   [Quick, Josh; Loman, Nick] Univ Birmingham, Birmingham, W Midlands, England.
   [Morales, Ingra; Sabino, Ester C.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Jesus, Jaqueline; Giovanetti, Marta; Alcantara, Luis C.] FioCruz Bahia, Salvador, BA, Brazil.
   [Nunes, Marcio R.] Evandro Chagas Inst, Ananindeua, Brazil.
RI Giovanetti, Marta/AAK-7408-2020; Pybus, Oliver g/B-2640-2012; Loman,
   Nicholas/Z-1573-2019; Sabino, Ester Cerdeira/F-7750-2010
OI Pybus, Oliver g/0000-0002-8797-2667; Sabino, Ester
   Cerdeira/0000-0003-2623-5126
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 142
BP 45
EP 45
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202142
DA 2020-07-08
ER

PT J
AU Ramsauer, K
   Schrauf, S
   Vielnascher, R
   Kort, A
   Mullner, M
   Tauber, E
AF Ramsauer, Katrin
   Schrauf, Sabrina
   Vielnascher, Raimund
   Kort, Alexander
   Muellner, Matthias
   Tauber, Erich
TI PHASE 1 STUDY OF MV-ZIKA, A LIVE RECOMBINANT MEASLES VIRUS VACCINE TO
   PREVENT ZIKA VIRUS INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Ramsauer, Katrin; Schrauf, Sabrina; Vielnascher, Raimund; Kort, Alexander; Muellner, Matthias; Tauber, Erich] Themis Biosci GmbH, Vienna, Austria.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 140
BP 45
EP 45
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202140
DA 2020-07-08
ER

PT J
AU Cordero, E
   Kopel, KB
   Vargas, L
   Iriarte, I
   Alvarado, LI
AF Cordero, Eduardo
   Kopel, Kathleen B.
   Vargas, Luzeida
   Iriarte, Ivan
   Alvarado, Luisa I.
TI CHARACTERISTICS OF RASH IN PATIENTS WITH ZIKA VIRUS INFECTION, PUERTO
   RICO, 2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Cordero, Eduardo; Kopel, Kathleen B.; Vargas, Luzeida; Iriarte, Ivan; Alvarado, Luisa I.] Ponce Hlth Sci Univ, St Lukes Episcopal Hosp, Ponce, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 144
BP 46
EP 46
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202144
DA 2020-07-08
ER

PT J
AU Hunsawong, T
   Lohachanakul, J
   Chusri, S
   Thaisomboonsuk, B
   Anderson, KB
   Weg, AL
   Macareo, LR
   Ellison, DW
AF Hunsawong, Taweewun
   Lohachanakul, Jindarat
   Chusri, Sarunyou
   Thaisomboonsuk, Butsaya
   Anderson, Kathryn B.
   Weg, Alden L.
   Macareo, Louis R.
   Ellison, Damon W.
TI IVERMECTIN INHIBITORY EFFECTS ON ZIKA VIRUS AND CHIKUNGUNYA VIRUS
   INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Hunsawong, Taweewun; Lohachanakul, Jindarat; Thaisomboonsuk, Butsaya; Anderson, Kathryn B.; Weg, Alden L.; Macareo, Louis R.; Ellison, Damon W.] Armed Forces Res Inst Med Sci, US Army Med Directorate, Bangkok, Thailand.
   [Chusri, Sarunyou] Prince Songkla Univ, Fac Med, Hat Yai, Thailand.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 145
BP 46
EP 46
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202145
DA 2020-07-08
ER

PT J
AU Bowman, NM
   Bucardo, F
   Reyes, Y
   Collins, M
   Centeno, E
   de Silva, A
   Becker-Dreps, S
AF Bowman, Natalie M.
   Bucardo, Filemon
   Reyes, Yaoska
   Collins, Matthew
   Centeno, Edwing
   de Silva, Aravinda
   Becker-Dreps, Sylvia
TI CLINICAL AND EPIDEMIOLOGICAL FACTORS ASSOCIATED WITH ZIKA VIRUS
   INFECTION IN LEON, NICARAGUA, 2016-2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Bowman, Natalie M.; Collins, Matthew; de Silva, Aravinda; Becker-Dreps, Sylvia] Univ North Carolina Chapel Hill, Chapel Hill, NC USA.
   [Bucardo, Filemon; Reyes, Yaoska; Centeno, Edwing] Univ Nacl Autonoma Nicaragua Leon, Leon, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 149
BP 47
EP 48
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202149
DA 2020-07-08
ER

PT J
AU Simons, MP
   Widjaja, S
   Sugiharto, VA
   Myers, TE
   Williams, M
AF Simons, Mark P.
   Widjaja, Susana
   Sugiharto, Victor A.
   Myers, Todd E.
   Williams, Maya
TI EVALUATION OF ZIKA CASES IN ACTIVE DUTY US MILITARY AND DEPENDENTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Simons, Mark P.; Widjaja, Susana; Sugiharto, Victor A.; Myers, Todd E.; Williams, Maya] Naval Med Res Ctr, Silver Spring, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 148
BP 47
EP 47
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202148
DA 2020-07-08
ER

PT J
AU Tsai, WY
   Ha, HHH
   Brites, C
   Tsai, JJ
   Tyson, J
   Pedroso, C
   Drexler, JF
   Balmaseda, A
   Harris, E
   Wang, WK
AF Tsai, Wen-Yang
   Ha, Han Ha Han
   Brites, Carlos
   Tsai, Jih-Jin
   Tyson, Jasmine
   Pedroso, Celia
   Drexler, Jan Felix
   Balmaseda, Angel
   Harris, Eva
   Wang, Wei-Kung
TI DISTINGUISHING SECONDARY DENGUE VIRUS INFECTION FROM ZIKA VIRUS
   INFECTION WITH PREVIOUS DENGUE BY A COMBINATION OF THREE SEROLOGICAL
   TESTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Tsai, Wen-Yang; Ha, Han Ha Han; Tyson, Jasmine; Wang, Wei-Kung] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Brites, Carlos; Pedroso, Celia] Univ Fed Bahia, Sch Med, LAPI Lab Pesquisa Infectol, Salvador, BA, Brazil.
   [Tsai, Jih-Jin] Kaohsiung Med Univer, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univer, Kaohsiung Med Univ Hosp, Trop Med Ctr, Dept Med,Coll Med, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univer, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan.
   [Drexler, Jan Felix] Univ Bonn, Med Ctr, Inst Virol, German Ctr Infect Res, Bonn, Germany.
   [Balmaseda, Angel] Minist Hlth, Natl Ctr Diag & Reference, Natl Virol Lab, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 147
BP 47
EP 47
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202147
DA 2020-07-08
ER

PT J
AU Baldwin, W
   Giebler, H
   Sonnberg, S
   Bohning, K
   Stovall, J
   Patel, H
   Ong, YT
   Rindfleisch, T
   Livengood, J
   Huang, C
   Dean, H
AF Baldwin, Whitney
   Giebler, Holli
   Sonnberg, Stephanie
   Bohning, Kelly
   Stovall, Janae
   Patel, Hetal
   Ong, Yee Tsuey
   Rindfleisch, Timothy
   Livengood, Jill
   Huang, Claire
   Dean, Hansi
TI DEVELOPMENT, CHARACTERIZATION, AND PRE-CLINICAL IMMUNOGENICITY AND
   EFFICACY OF A PURIFIED, INACTIVATED ZIKA VIRUS VACCINE (PIZV) CANDIDATE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Baldwin, Whitney; Giebler, Holli; Livengood, Jill] Takeda Vaccines Inc, Ft Collins, CO USA.
   [Baldwin, Whitney; Giebler, Holli; Stovall, Janae; Ong, Yee Tsuey; Livengood, Jill; Huang, Claire] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Sonnberg, Stephanie; Bohning, Kelly; Patel, Hetal; Rindfleisch, Timothy; Dean, Hansi] Takeda Vaccines Inc, Cambridge, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 150
BP 48
EP 48
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202150
DA 2020-07-08
ER

PT J
AU Giang, H
   Ghozy, S
   Elabd, S
   Sassy, A
   Elhadad, H
   Nguyen, D
   Hassan, M
   AbdElsalam, E
   Linh, L
   Anh, T
   Turk, T
   Onyeudo, O
   Nasef, S
   Dang, N
   Aly, S
   Hirayama, K
   Huy, N
AF Giang, H.
   Ghozy, S.
   Elabd, S.
   Sassy, A.
   Elhadad, H.
   Nguyen, D.
   Hassan, M.
   AbdElsalam, E.
   Linh, L.
   Anh, T.
   Turk, T.
   Onyeudo, O.
   Nasef, S.
   Dang, N.
   Aly, S.
   Hirayama, K.
   Huy, N.
TI ZIKA VIRUS: A SYSTEMATIC REVIEW AND META-ANALYSIS IN EPIDEMIOLOGY,
   CLINICAL MANIFESTATIONS, AND OUTCOMES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Giang, H.] Univ Danang, Danang, Vietnam.
   [Ghozy, S.] Mansoura Univ, Mansoura, Egypt.
   [Elabd, S.] Benha Univ, Banha, Egypt.
   [Sassy, A.] Cairo Univ, Cairo, Egypt.
   [Elhadad, H.] Alexandria Univ, Alexandria, Egypt.
   [Nguyen, D.; Anh, T.; Dang, N.] Univ Med & Pharm Ho Chi Minh City, Ho Chi Minh, Vietnam.
   [Hassan, M.] Al Azhar Univ, Cairo, Egypt.
   [AbdElsalam, E.] Menia Univ, Al Minya, Egypt.
   [Linh, L.] Thai Binh Univ Med & Pharm, Thai Binh, Vietnam.
   [Turk, T.] Damascus Univ, Damascus, Syria.
   [Onyeudo, O.] Kharkov Natl Med Univ, Kharkov, Ukraine.
   [Nasef, S.] Matern & Children Hosp, Mecca, Saudi Arabia.
   [Aly, S.] Ain Shams Univ, Cairo, Egypt.
   [Hirayama, K.; Huy, N.] Nagasaki Univ, Nagasaki, Japan.
RI Huy, Nguyen Tien/B-2573-2010
OI Huy, Nguyen Tien/0000-0002-9543-9440
NR 0
TC 0
Z9 0
U1 1
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 152
BP 48
EP 48
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202152
DA 2020-07-08
ER

PT J
AU Veiga, AB
   Gregianini, TS
   Ranieri, T
   Favreto, C
   Tumioto-Giannini, G
AF Veiga, Ana B.
   Gregianini, Tatiana S.
   Ranieri, Tani
   Favreto, Catia
   Tumioto-Giannini, Gabriela
TI ZIKA VIRUS INFECTION AND CHIKUNGUNYA FEVER OUTBREAKS IN RIO GRANDE DO
   SUL, BRAZIL, 2014-2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Veiga, Ana B.] UFCSPA, Porto Alegre, RS, Brazil.
   [Gregianini, Tatiana S.; Tumioto-Giannini, Gabriela] Secretaria Saude Estado Rio Grande do Sul SES RS, IPB LACEN RS, Lab Cent Saude Publ Estado Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Ranieri, Tani; Favreto, Catia] Secretaria Saude Estado Rio Grande do Sul SES RS, CEVS, Porto Alegre, RS, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 156
BP 49
EP 49
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202156
DA 2020-07-08
ER

PT J
AU Munoz, AG
   Thomson, MC
   Stewart-Ibarra, AM
   Chourio, X
   Najera, P
   Moran, Z
   Yang, XS
AF Munoz, Angel G.
   Thomson, Madeleine C.
   Stewart-Ibarra, Anna M.
   Chourio, Xandre
   Najera, Patricia
   Moran, Zelda
   Yang, Xiaosong
TI COULD THE RECENT ZIKA EPIDEMIC HAVE BEEN PREDICTED?
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Munoz, Angel G.] Princeton Univ, Princeton, NJ 08544 USA.
   [Thomson, Madeleine C.; Moran, Zelda] Columbia Univ, New York, NY USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Chourio, Xandre] Univ Zulia, CMC, Maracaibo, Venezuela.
   [Najera, Patricia] Pan Amer Hlth Org, Washington, DC USA.
   [Yang, Xiaosong] Princeton Univ, NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08544 USA.
RI Yang, Xiaosong/C-7260-2009
OI Yang, Xiaosong/0000-0003-3154-605X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 210
BP 65
EP 65
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202210
DA 2020-07-08
ER

PT J
AU Siraj, AS
   Perkins, A
AF Siraj, Amir S.
   Perkins, Alex
TI ESTIMATING THE POPULATION AT RISK OF ZIKA IN THE ASIAN REGION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Siraj, Amir S.; Perkins, Alex] Univ Notre Dame, Notre Dame, IN 46556 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 208
BP 65
EP 65
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202208
DA 2020-07-08
ER

PT J
AU Ryken, KO
   Valverde, JG
   Barreto, SM
   Pereira, FV
   Wilson, ME
   Jeronimo, S
AF Ryken, Katherine O.
   Valverde, Joanna G.
   Barreto, Sonia M.
   Pereira, Flavio V.
   Wilson, Mary E.
   Jeronimo, Selma
TI EMOTIONAL PERCEPTIONS DURING PREGNANCY WITH POTENTIAL EXPOSURE TO ZIKA
   VIRUS: A PILOT STUDY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Ryken, Katherine O.; Wilson, Mary E.] Univ Iowa, Carver Coll Med, Iowa City, IA USA.
   [Valverde, Joanna G.; Barreto, Sonia M.; Pereira, Flavio V.; Jeronimo, Selma] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
RI Valverde, Joanna G/C-1284-2014
OI Valverde, Joanna G/0000-0001-8064-6255
NR 0
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 244
BP 76
EP 76
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202244
DA 2020-07-08
ER

PT J
AU Anglero-Rodriguez, YI
   MacLeod, H
   Kang, S
   Carlson, J
   Jupatanakul, N
   Dimopoulos, G
AF Anglero-Rodriguez, Yesseinia I.
   MacLeod, Hannah
   Kang, Seokyoung
   Carlson, Jenny
   Jupatanakul, Natapong
   Dimopoulos, George
TI ZIKA-AEDES MOLECULAR INTERACTIONS AND MOSQUITO IMMUNITY-MEDIATED VIRAL
   SUPPRESSION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Anglero-Rodriguez, Yesseinia I.; MacLeod, Hannah; Kang, Seokyoung; Carlson, Jenny; Jupatanakul, Natapong; Dimopoulos, George] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 674
BP 211
EP 211
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203045
DA 2020-07-08
ER

PT J
AU Kim, D
   Kang, S
   Gripping, C
   Figueroa-Lozano, M
   Colpitts, TM
   Dimopoulos, G
   Park, Y
   Londono-Renteria, BL
AF Kim, Donghun
   Kang, Seokyoung
   Gripping, Crystal
   Figueroa-Lozano, Mauricio
   Colpitts, Tonya M.
   Dimopoulos, George
   Park, Yoonseong
   Londono-Renteria, Berlin L.
TI EFFECT OF HUMAN C5A PROTEIN ON MOSQUITO CELLS AND ITS IMPLICATIONS IN
   ZIKA VIRUS TRANSMISSION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Kim, Donghun; Park, Yoonseong; Londono-Renteria, Berlin L.] Kansas State Univ, Manhattan, KS 66506 USA.
   [Kang, Seokyoung; Dimopoulos, George] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD USA.
   [Gripping, Crystal] Tulane Univ, Dept Trop Med, New Orleans, LA 70118 USA.
   [Figueroa-Lozano, Mauricio] Univ Pamplona, Pamplona, Colombia.
   [Colpitts, Tonya M.] Univ South Carolina, Columbia, SC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 673
BP 211
EP 211
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203044
DA 2020-07-08
ER

PT J
AU Andrade, P
   Coloma, J
   Michlmayr, D
   Balmaseda, A
   Harris, E
AF Andrade, Paulina
   Coloma, Josefina
   Michlmayr, Daniela
   Balmaseda, Angel
   Harris, Eva
TI ZIKA AND DENGUE VIRUS-SPECIFIC AND CROSS-REACTIVE MEMORY B CELL
   RESPONSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Andrade, Paulina; Coloma, Josefina; Michlmayr, Daniela; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
RI Michlmayr, Daniela/Q-1216-2018
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 795
BP 248
EP 249
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203165
DA 2020-07-08
ER

PT J
AU Chavez, C
   Katzelnick, L
   Escoto, AC
   McElvany, B
   Luo, WS
   Salje, H
   Rodriguez-Barraquer, I
   Jarman, R
   Diehl, S
   Durbin, A
   Smith, D
   Cummings, D
   Whitehead, S
AF Chavez, Christian
   Katzelnick, Leah
   Escoto, Ana Coello
   McElvany, Benjamin
   Luo, Wensheng
   Salje, Henrik
   Rodriguez-Barraquer, Isabel
   Jarman, Richard
   Diehl, Sean
   Durbin, Anna
   Smith, Derek
   Cummings, Derek
   Whitehead, Stephen
TI FLAVIDOT: AN AUTOMATED VIRUS PLAQUE COUNTER FOR MEASUREMENT OF THE
   SEROLOGICAL NEUTRALIZATION RESPONSE AGAINST ZIKA AND DENGUE VIRUSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Chavez, Christian; Katzelnick, Leah; Escoto, Ana Coello; Cummings, Derek] Univ Florida, Gainesville, FL USA.
   [McElvany, Benjamin; Diehl, Sean] Univ Vermont, Burlington, VT USA.
   [Luo, Wensheng; Salje, Henrik; Rodriguez-Barraquer, Isabel; Durbin, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Jarman, Richard] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Smith, Derek] Univ Cambridge, Cambridge, England.
   [Whitehead, Stephen] NIH, Bldg 10, Bethesda, MD 20892 USA.
RI Whitehead, Stephen/AAG-2787-2019; Diehl, Sean/AAE-2779-2020
OI Diehl, Sean/0000-0001-9700-235X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 802
BP 251
EP 251
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203172
DA 2020-07-08
ER

PT J
AU Lecouturier, VM
   Mantel, N
   Fourlinnie, C
   Marion, E
   Boudet, F
   Bonaparte, M
   Guy, B
AF Lecouturier, Valerie Martine
   Mantel, Nathalie
   Fourlinnie, Claire
   marion, Elisabeth
   Boudet, Florence
   Bonaparte, Matthew
   Guy, Bruno
TI DEVELOPMENT OF NOVEL SEROLOGICAL ASSAYS TO DISCRIMINATE BETWEEN DENGUE
   VIRUS AND ZIKA VIRUS ANTIBODY RESPONSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Lecouturier, Valerie Martine; Mantel, Nathalie; Fourlinnie, Claire; marion, Elisabeth; Boudet, Florence; Bonaparte, Matthew; Guy, Bruno] Sanofi Pasteur, Marcy Letoile, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 806
BP 252
EP 252
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203176
DA 2020-07-08
ER

PT J
AU Dudley, DM
   Nguyen, SM
   Antony, KM
   Mohr, EL
   O'Connor, DH
   Golos, TG
AF Dudley, Dawn M.
   Nguyen, Sydney M.
   Antony, Kathleen M.
   Mohr, Emma L.
   O'Connor, David H.
   Golos, Thaddeus G.
CA Project ZEST
TI CONGENITAL OCULAR PATHOLOGY IN RHESUS MACAQUES INFECTED WITH ZIKA VIRUS
   IN UTERO
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Dudley, Dawn M.; Nguyen, Sydney M.; Antony, Kathleen M.; Mohr, Emma L.; O'Connor, David H.; Golos, Thaddeus G.; Project ZEST] Univ Wisconsin Madison, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 811
BP 253
EP 253
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203181
DA 2020-07-08
ER

PT J
AU Romo, HE
   Kenney, JL
   Brault, AC
AF Romo, Hannah E.
   Kenney, Joan L.
   Brault, Aaron C.
TI DECREASED TRANSMISSION OF ZIKA VIRUS IN AEDES AEGYPTI MOSQUITOES
   CO-INOCULATED WITH AN INSECTSPECIFIC FLAVIVIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Romo, Hannah E.; Kenney, Joan L.; Brault, Aaron C.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RI Kenney, Joan L./AAE-7416-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 812
BP 253
EP 254
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203182
DA 2020-07-08
ER

PT J
AU Malmlov, A
   Miedema, K
   Aboellail, T
   Rosenberg, C
   Eckley, M
   Chotiwan, N
   Gullberg, R
   Perera, R
   Schountz, T
AF Malmlov, Ashley
   Miedema, Kaitlyn
   Aboellail, Tawfik
   Rosenberg, Corey
   Eckley, Miles
   Chotiwan, Nunya
   Gullberg, Rebekah
   Perera, Rushika
   Schountz, Tony
TI EXPERIMENTAL INFECTION OF JAMAICAN FRUIT BATS (ARTIBEUS JAMAICENSIS)
   WITH ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Malmlov, Ashley; Miedema, Kaitlyn; Aboellail, Tawfik; Rosenberg, Corey; Eckley, Miles; Chotiwan, Nunya; Gullberg, Rebekah; Perera, Rushika; Schountz, Tony] Colorado State Univ, Ft Collins, CO 80523 USA.
RI Aboellail, Tawfik/AAB-8990-2019
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 815
BP 254
EP 255
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203185
DA 2020-07-08
ER

PT J
AU Pascale, JM
   Calvo, A
   Gonzalez, R
   Hess-Holtz, M
   Hills, S
   Kaydos-Daniels, S
   Azziz-Baumgartner, E
   Sosa, N
AF Pascale, Juan M.
   Calvo, Arlene
   Gonzalez, Rosalba
   Hess-Holtz, Morgan
   Hills, Susan
   Kaydos-Daniels, Susan
   Azziz-Baumgartner, Eduardo
   Sosa, Nestor
TI ZIKA VIRUS INFECTION AMONG A POPULATION-BASED AMONG A POPULATION BASED
   COHORT OF PREGNANT WOMEN IN PANAMA CITY, PANAMA, 2016-2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Pascale, Juan M.; Gonzalez, Rosalba; Sosa, Nestor] Gorgas Mem Inst Hlth Studies, Panama City, Panama.
   [Calvo, Arlene; Hess-Holtz, Morgan] Univ S Florida, USF Hlth Panama Program, City Knowledge, Panama City, Panama.
   [Hills, Susan] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Kaydos-Daniels, Susan] Ctr Dis Control & Prevent, Guatemala City, Guatemala.
   [Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 813
BP 254
EP 254
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203183
DA 2020-07-08
ER

PT J
AU Santiago, GA
   Vazquez, J
   Munoz-Jordan, JL
AF Santiago, Gilberto A.
   Vazquez, Jesus
   Munoz-Jordan, Jorge L.
TI PERFORMANCE OF THE CDC TRIOPLEX REAL TIME RT-PCR DURING THE 2016 ZIKA
   EPIDEMIC IN PUERTO RICO
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Santiago, Gilberto A.; Vazquez, Jesus; Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 814
BP 254
EP 254
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203184
DA 2020-07-08
ER

PT J
AU Gajewski, A
   Burger-Calderon, R
   Llufrio, L
   Petitt, M
   Videa, E
   Kuan, G
   Elizondo, D
   Mercado, JC
   Zambrana, JV
   Urbina, A
   Barrera, J
   Saenz, C
   Pereira, L
   Pavon, N
   Balmaseda, A
   Harris, E
AF Gajewski, Anna
   Burger-Calderon, Raquel
   Llufrio, Liliam
   Petitt, Matthew
   Videa, Elsa
   Kuan, Guillermina
   Elizondo, Douglas
   Carlos Mercado, Juan
   Victor Zambrana, Jose
   Urbina, Anna
   Barrera, Jesslie
   Saenz, Carlos
   Pereira, Lenore
   Pavon, Nestor
   Balmaseda, Angel
   Harris, Eva
TI ANALYSIS OF THE EFFECT OF ZIKA VIRUS INFECTION DURING PREGNANCY ON
   PLACENTAL DEVELOPMENT AND BIRTH OUTCOMES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Gajewski, Anna; Llufrio, Liliam; Videa, Elsa; Elizondo, Douglas; Victor Zambrana, Jose; Urbina, Anna; Barrera, Jesslie] Sustainable Sci Inst, Managua, Nicaragua.
   [Burger-Calderon, Raquel; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Petitt, Matthew; Pereira, Lenore] Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA USA.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
   [Carlos Mercado, Juan; Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Saenz, Carlos] Minist Salud, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Pavon, Nestor] Hosp Mujer Bertha Calderon Roque, Minist Hlth, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 816
BP 255
EP 255
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203186
DA 2020-07-08
ER

PT J
AU Michlmayr, D
   Andrade, P
   Gonzalez, K
   Wang, CL
   Balmaseda, A
   Harris, E
AF Michlmayr, Daniela
   Andrade, Paulina
   Gonzalez, Karla
   Wang, Chunling
   Balmaseda, Angel
   Harris, Eva
TI INFLAMMATORY MONOCYTES ARE THE MAIN TARGET OF ZIKA VIRUS INFECTION IN
   PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PEDIATRIC PATIENTS IN NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Michlmayr, Daniela; Andrade, Paulina; Wang, Chunling; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Gonzalez, Karla; Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
RI Michlmayr, Daniela/Q-1216-2018
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 817
BP 255
EP 255
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203187
DA 2020-07-08
ER

PT J
AU Montoya, M
   Puerta-Guardo, H
   Katzelnick, L
   Schildhauer, S
   Balmaseda, A
   Harris, E
AF Montoya, Magelda
   Puerta-Guardo, Henry
   Katzelnick, Leah
   Schildhauer, Samuel
   Balmaseda, Angel
   Harris, Eva
TI LONGITUDINAL ANALYSIS OF CROSS-NEUTRALIZATION BETWEEN DENGUE AND ZIKA
   VIRUSES IN TWO PEDIATRIC STUDIES IN NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Montoya, Magelda; Puerta-Guardo, Henry; Katzelnick, Leah; Schildhauer, Samuel; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 818
BP 255
EP 256
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203188
DA 2020-07-08
ER

PT J
AU Alexander, J
   Espinosa, D
   Manayani, D
   Vang, L
   Farness, P
   Richard, T
   Aruri, J
   Guenther, B
   Avanzini, J
   Garduno, F
   Smith, J
   Harris, E
   Mendy, J
AF Alexander, Jeffery
   Espinosa, Diego
   Manayani, Darly
   Vang, Lo
   Farness, Peggy
   Richard, Tiffany
   Aruri, Jayavani
   Guenther, Ben
   Avanzini, Jenny
   Garduno, Fermin
   Smith, Jonathan
   Harris, Eva
   Mendy, Jason
TI PASSIVE TRANSFER OF ZIKA VIRUS-LIKE-PARTICLE-INDUCED IMMUNE SERA TO
   AG129 MICE PROTECTS AGAINST LETHAL ZIKA VIRUS CHALLENGE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Alexander, Jeffery; Manayani, Darly; Vang, Lo; Farness, Peggy; Richard, Tiffany; Aruri, Jayavani; Guenther, Ben; Avanzini, Jenny; Garduno, Fermin; Smith, Jonathan; Mendy, Jason] PaxVax, San Diego, CA USA.
   [Espinosa, Diego; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 820
BP 256
EP 256
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203190
DA 2020-07-08
ER

PT J
AU Balmaseda, A
   Stettler, K
   Carrera, RM
   Collado, D
   Jin, X
   Zambrana, JV
   Jaconi, S
   Saborio, S
   Percivalle, E
   Ushiro-Lumb, I
   Barzon, L
   Siqueira, P
   Brown, DW
   Baldanti, F
   Zambon, M
   de Filippis, AMB
   Harris, E
   Corti, D
AF Balmaseda, Angel
   Stettler, Karin
   Carrera, Raquel Medialdea
   Collado, Damaris
   Jin, Xia
   Victor Zambrana, Jose
   Jaconi, Stefano
   Saborio, Saira
   Percivalle, Elena
   Ushiro-Lumb, Ines
   Barzon, Luisa
   Siqueira, Patricia
   Brown, David W.
   Baldanti, Fausto
   Zambon, Maria
   Bispo de Filippis, Ana Maria
   Harris, Eva
   Corti, Davide
TI A NOVEL ANTIBODY-BASED ASSAY DISCRIMINATES ZIKA VIRUS INFECTION FROM
   OTHER FLAVIVIRUSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Balmaseda, Angel; Collado, Damaris; Victor Zambrana, Jose] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Stettler, Karin; Jin, Xia; Jaconi, Stefano; Corti, Davide] Humabs BioMed SA, Bellinzona, Switzerland.
   [Carrera, Raquel Medialdea] Univ Liverpool, Natl Inst Hlth Res Hlth Protect Res Unit Emerging, Liverpool, Merseyside, England.
   [Percivalle, Elena; Baldanti, Fausto] Policlin San Matteo, Mol Virol Unit, Microbiol & Virol Dept, Fdn Ist Ricovero & Cura Carattere Sci, Pavia, Italy.
   [Ushiro-Lumb, Ines] Natl Hlth Serv Blood & Transplant, Transfus Microbiol, London, England.
   [Barzon, Luisa] Univ Padua, Dept Mol Med, Padua, Italy.
   [Siqueira, Patricia; Brown, David W.; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Zambon, Maria] Publ Hlth England, Microbiol Serv Colindale, London, England.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RI percivalle, elena/K-7994-2016; Barzon, Luisa/K-7961-2016; Baldanti,
   Fausto/J-4924-2018
OI percivalle, elena/0000-0002-3355-1410; Barzon,
   Luisa/0000-0003-0720-8456; Baldanti, Fausto/0000-0002-3358-8969
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 819
BP 256
EP 256
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203189
DA 2020-07-08
ER

PT J
AU Luna, EJ
   Romano, CM
   Araujo, ES
   Levi, JE
   Oliveira, ON
   Fernandes, LR
   Felix, AC
   Souza, NS
   Fernandes, JH
   Campos, SR
   Fragoso, DB
   Pannuti, CS
AF Luna, Expedito J.
   Romano, Camila M.
   Araujo, Evaldo S.
   Levi, Jose E.
   Oliveira, Olimpia N.
   Fernandes, Luis R.
   Felix, Alvina C.
   Souza, Nathalia S.
   Fernandes, Joao H.
   Campos, Sergio R.
   Fragoso, Danielli B.
   Pannuti, Claudio S.
TI A COHORT STUDY TO DETERMINE THE INCIDENCE OF ZIKA VIRUS INFECTION AMONG
   NEWBORNS, SANTOS, BRAZIL, 2016-2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Luna, Expedito J.; Romano, Camila M.; Levi, Jose E.; Felix, Alvina C.; Souza, Nathalia S.; Campos, Sergio R.; Pannuti, Claudio S.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Araujo, Evaldo S.; Oliveira, Olimpia N.; Fernandes, Luis R.; Fernandes, Joao H.; Fragoso, Danielli B.] Hosp Ana Costa, Santos, Brazil.
RI Luna, Expedito J A/B-7948-2012
OI Luna, Expedito J A/0000-0002-1145-9672
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 824
BP 257
EP 258
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203194
DA 2020-07-08
ER

PT J
AU Collins, M
   Tu, H
   Liou, A
   Jadi, R
   Diehl, S
   de Silva, A
AF Collins, Matthew
   Tu, Huy
   Liou, Alice
   Jadi, Ramesh
   Diehl, Sean
   de Silva, Aravinda
TI DECIPHERING DURABLE NEUTRALIZING ANTIBODY RESPONSES TO ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Collins, Matthew; Liou, Alice; Jadi, Ramesh; de Silva, Aravinda] Univ N Carolina, Chapel Hill, NC USA.
   [Tu, Huy; Diehl, Sean] Univ Vermont, Burlington, VT USA.
RI Diehl, Sean/AAE-2779-2020
OI Diehl, Sean/0000-0001-9700-235X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 828
BP 258
EP 259
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203198
DA 2020-07-08
ER

PT J
AU Huits, R
   Jess, N
   Dickson, D
   Makee-Sookram, S
   Eggermont, K
   Michiels, J
   Arien, K
   Ramsewak, S
   Van Esbroeck, M
   Bottieau, E
   Minto-Bain, C
   Cnops, L
AF Huits, Ralph
   Jess, Natalie
   Dickson, Devon
   Makee-Sookram, Sonja
   Eggermont, Kaat
   Michiels, Johan
   Arien, Kevin
   Ramsewak, Samuel
   Van Esbroeck, Marjan
   Bottieau, Emmanuel
   Minto-Bain, Catherine
   Cnops, Lieselotte
TI PERSISTENCE OF ZIKA VIRUS IN SEMEN OF MEN LIVING IN AN ENDEMIC AREA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Huits, Ralph; Eggermont, Kaat; Michiels, Johan; Arien, Kevin; Van Esbroeck, Marjan; Bottieau, Emmanuel; Cnops, Lieselotte] Inst Trop Med, Antwerp, Belgium.
   [Jess, Natalie; Dickson, Devon; Makee-Sookram, Sonja; Ramsewak, Samuel; Minto-Bain, Catherine] Trinidad IVF Fertil Ctr, Trinidad, West Indies, Trinidad Tobago.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 825
BP 258
EP 258
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203195
DA 2020-07-08
ER

PT J
AU Newman, CM
   Dudley, DM
   Aliota, MT
   Mohr, EL
   Breitbach, ME
   Stewart, LM
   Weiler, AM
   Barry, GL
   Koenig, M
   Schultz-Darken, N
   Peterson, E
   Newton, W
   Capuano, S
   Friedrich, TC
   O'Connor, DH
AF Newman, Christina M.
   Dudley, Dawn M.
   Aliota, Matthew T.
   Mohr, Emma L.
   Breitbach, Meghan E.
   Stewart, Laurel M.
   Weiler, Andrea M.
   Barry, Gabrielle L.
   Koenig, Michelle
   Schultz-Darken, Nancy
   Peterson, Eric
   Newton, Wendy
   Capuano, Saverio, III
   Friedrich, Thomas C.
   O'Connor, David H.
TI PRIOR INFECTION WITH DENGUE VIRUS SEROTYPE 3 DOES NOT ENHANCE SUBSEQUENT
   ZIKA VIRUS INFECTION IN RHESUS MACAQUES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Newman, Christina M.; Dudley, Dawn M.; Aliota, Matthew T.; Mohr, Emma L.; Breitbach, Meghan E.; Stewart, Laurel M.; Koenig, Michelle; Friedrich, Thomas C.; O'Connor, David H.] Univ Wisconsin, Madison, WI USA.
   [Weiler, Andrea M.; Barry, Gabrielle L.; Schultz-Darken, Nancy; Peterson, Eric; Newton, Wendy; Capuano, Saverio, III] Wisconsin Natl Primate Res Ctr, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 826
BP 258
EP 258
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203196
DA 2020-07-08
ER

PT J
AU Rosales, AC
AF Rosales, Alfonso C.
TI GAPS ON RISK COMMUNICATIONS APPROACH OF NATIONAL ZIKA VIRUS OUTBREAK
   RESPONSE IN COLOMBIA, BRAZIL, EL SALVADOR, GUATEMALA, HONDURAS AND
   DOMINICAN REPUBLIC
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Rosales, Alfonso C.] World Vis US, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 827
BP 258
EP 258
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203197
DA 2020-07-08
ER

PT J
AU Aliota, MT
   Dudley, DM
   Newman, CM
   Osorio, JE
   O'Connor, SL
   Friedrich, TC
   O'Connor, DH
AF Aliota, Matthew T.
   Dudley, Dawn M.
   Newman, Christina M.
   Osorio, Jorge E.
   O'Connor, Shelby L.
   Friedrich, Thomas C.
   O'Connor, David H.
CA Zika Expt Sci Team
TI ZIKA VIRUS INFECTION OF RHESUS MACAQUES VIA MOSQUITO BITE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Aliota, Matthew T.; Dudley, Dawn M.; Newman, Christina M.; Osorio, Jorge E.; O'Connor, Shelby L.; Friedrich, Thomas C.; O'Connor, David H.; Zika Expt Sci Team] Univ Wisconsin, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 829
BP 259
EP 259
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203199
DA 2020-07-08
ER

PT J
AU Martin, EM
   Borucki, M
   Badillo-Vargas, I
   Bueno, R
   Medeiros, M
   Frank, M
   Hamer, GL
AF Martin, Estelle M.
   Borucki, Monica
   Badillo-Vargas, Ismael
   Bueno, Rudy
   Medeiros, Matthew
   Frank, Matthias
   Hamer, Gabriel L.
TI SOCIAL-ECOLOGICAL FACTORS INFLUENCING RECEPTIVITY TO ZIKA VIRUS AND THE
   EFFFICACY OF INTERVENTIONS IN COMMUNITIES ALONG THE TEXAS-MEXICO BORDER
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Martin, Estelle M.; Bueno, Rudy; Hamer, Gabriel L.] Texas A&M, College Stn, TX USA.
   [Borucki, Monica; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA USA.
   [Badillo-Vargas, Ismael] Texas A&M, Weslaco, TX USA.
   [Medeiros, Matthew] Univ Hawaii, Oahu, HI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 876
BP 273
EP 273
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203246
DA 2020-07-08
ER

PT J
AU Duggal, N
   Mead, P
   Hinckley, A
   Hook, S
   McDonald, E
   Delorey, M
   Becksted, H
   Anishchenko, M
   Max, R
   Schwartz, A
   Brault, A
AF Duggal, Nisha
   Mead, Paul
   Hinckley, Alison
   Hook, Sarah
   McDonald, Erin
   Delorey, Mark
   Becksted, Heidi
   Anishchenko, Michael
   Max, Ryan
   Schwartz, Amy
   Brault, Aaron
TI LABORATORY IDENTIFICATION OF PERSISTENT ZIKA VIRAL RNA IN SEMEN OF A US
   COHORT
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Duggal, Nisha; Mead, Paul; Hinckley, Alison; Hook, Sarah; McDonald, Erin; Delorey, Mark; Becksted, Heidi; Anishchenko, Michael; Max, Ryan; Schwartz, Amy; Brault, Aaron] Ctr Dis Control & Prevent, Ft Collins, CO USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1330
BP 413
EP 414
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204046
DA 2020-07-08
ER

PT J
AU Michlmayr, D
   Pak, T
   Rahman, A
   Kim, EY
   Kim-Schulze, S
   Gresh, L
   Kuan, G
   Kasarskis, A
   Wolinksy, S
   Balmaseda, A
   Harris, E
AF Michlmayr, Daniela
   Pak, Theodore
   Rahman, Adeeb
   Kim, Eun-Young
   Kim-Schulze, Seunghee
   Gresh, Lionel
   Kuan, Guillermina
   Kasarskis, Andrew
   Wolinksy, Steven
   Balmaseda, Angel
   Harris, Eva
TI IMMUNE PROFILING AND NETWORK MODELING OF ZIKA VIRUS INFECTION IN
   CHILDREN WITH OR WITHOUT PRIOR EXPOSURE TO DENGUE VIRUS IN A COHORT
   STUDY IN NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Michlmayr, Daniela; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Pak, Theodore; Kasarskis, Andrew] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.
   [Rahman, Adeeb; Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA.
   [Rahman, Adeeb; Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.
   [Kim, Eun-Young; Wolinksy, Steven] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA.
   [Gresh, Lionel] Sustainable Sci Inst, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1329
BP 413
EP 413
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204045
DA 2020-07-08
ER

PT J
AU Grifoni, A
   Pham, J
   O'Rourke, PH
   Peters, B
   de Silva, AD
   Ricciardi, MJ
   Silveira, CG
   Maestri, A
   de Oliveira-Pinto, LM
   Damasco, PV
   Collins, M
   de Silva, AM
   Diehl, SA
   Durbin, AP
   Cerpas, C
   Balmaseda, A
   Kuan, G
   Coloma, J
   Harris, E
   Crowe, JE
   Stone, M
   Norris, PJ
   Busch, M
   Vivanco-Cid, H
   Graham, B
   Ledgerwood, JE
   Watkins, DI
   Kallas, EG
   Sette, A
   Weiskopf, D
AF Grifoni, Alba
   Pham, John
   O'Rourke, Patrick H.
   Peters, Bjoern
   de Silva, Aruna D.
   Ricciardi, Michael J.
   Silveira, Cassia G.
   Maestri, Alvino
   de Oliveira-Pinto, Luzia M.
   Damasco, Paulo Vieira
   Collins, Mathew
   de Silva, Aravinda M.
   Diehl, Sean A.
   Durbin, Anna P.
   Cerpas, Cristhiam
   Balmaseda, Angel
   Kuan, Guillermina
   Coloma, Josefina
   Harris, Eva
   Crowe, James E., Jr.
   Stone, Mars
   Norris, Phillip J.
   Busch, Michael
   Vivanco-Cid, Hector
   Graham, Barney
   Ledgerwood, Julie E.
   Watkins, David I.
   Kallas, Esper G.
   Sette, Alessandro
   Weiskopf, Daniela
TI PRIOR DENGUE VIRUS EXPOSE SHAPES T CELL IMMUNITY TO ZIKA VIRUS IN HUMANS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Grifoni, Alba; Pham, John; O'Rourke, Patrick H.; Peters, Bjoern; Sette, Alessandro; Weiskopf, Daniela] La Jolla Inst Allergy & Immunol, La Jolla, CA USA.
   [de Silva, Aruna D.] Genetech Res Inst, Colombo, Sri Lanka.
   [Ricciardi, Michael J.; Watkins, David I.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Silveira, Cassia G.; Maestri, Alvino; Kallas, Esper G.] Univ Sao Paulo, Sao Paulo, Brazil.
   [de Oliveira-Pinto, Luzia M.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Damasco, Paulo Vieira] Fed Univ State Rio de Janeiro UNIRIO, Rio De Janeiro, Brazil.
   [Collins, Mathew; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Chapel Hill, NC USA.
   [Diehl, Sean A.] Univ Vermont, Coll Med, Burlington, VT USA.
   [Diehl, Sean A.] Univ Vermont, Vaccine Testing Ctr, Burlington, VT USA.
   [Durbin, Anna P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Cerpas, Cristhiam; Balmaseda, Angel] Minist Hlth, Natl Ctr Diag & Reference, Natl Virol Lab, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
   [Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Nashville, TN USA.
   [Stone, Mars; Norris, Phillip J.; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA.
   [Vivanco-Cid, Hector] Univ Veracruzana, Xalapa, Veracruz, Mexico.
   [Graham, Barney; Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RI Graham, Barney S./AAC-5898-2019; Diehl, Sean/AAE-2779-2020; Crowe, James
   E./B-5549-2009; /AAD-2097-2020
OI Graham, Barney S./0000-0001-8112-0853; Diehl, Sean/0000-0001-9700-235X;
   Crowe, James E./0000-0002-0049-1079; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1332
BP 414
EP 414
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204048
DA 2020-07-08
ER

PT J
AU Simmons, G
   Stone, M
   Lu, K
   Bakkour, S
   Williamson, PC
   Brambilla, DJ
   Busch, MP
AF Simmons, Graham
   Stone, Mars
   Lu, Kai
   Bakkour, Sonia
   Williamson, Phillip C.
   Brambilla, Donald J.
   Busch, Michael P.
CA NHLBI Recipient Epidemiology Donor
TI STAGING EARLY AND LATE EVENTS IN ACUTE ZIKA VIRUS INFECTION USING RNA
   plus PUERTO RICAN AND CONTINENTAL US BLOOD DONORS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Simmons, Graham; Stone, Mars; Lu, Kai; Bakkour, Sonia; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA.
   [Williamson, Phillip C.] Creat Testing Solut, Tempe, AZ USA.
   [Brambilla, Donald J.] RTI Int, Rockville, MD USA.
   [NHLBI Recipient Epidemiology Donor] NHLBI, Rockville, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1331
BP 414
EP 414
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204047
DA 2020-07-08
ER

PT J
AU Burger-Calderon, R
   Gonzalez, K
   Sanchez, N
   Zambrana, JV
   Ojeda, S
   Cerpas, C
   Laguna, HS
   Bustos, F
   Coloma, J
   Kuan, G
   Balmaseda, A
   Harris, E
AF Burger-Calderon, Raquel
   Gonzalez, Karla
   Sanchez, Nery
   Zambrana, Jose Victor
   Ojeda, Sergio
   Cerpas, Cristhiam
   Laguna, Harold Suazo
   Bustos, Fausto
   Coloma, Josefina
   Kuan, Guillermina
   Balmaseda, Angel
   Harris, Eva
TI INDEX CLUSTER STUDY OF ZIKA VIRUS INFECTION IN MANAGUA, NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Burger-Calderon, Raquel; Bustos, Fausto; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Gonzalez, Karla; Cerpas, Cristhiam; Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Sanchez, Nery; Zambrana, Jose Victor; Ojeda, Sergio; Laguna, Harold Suazo] Sustainable Sci Inst, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1333
BP 415
EP 415
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204049
DA 2020-07-08
ER

PT J
AU Rosenberg, E
   Doyle, K
   Munoz-Jordan, JL
   Klein, L
   Adams, L
   Lozier, M
   Sharp, TM
   Paz-Bailey, G
AF Rosenberg, Eli
   Doyle, Katherine
   Munoz-Jordan, Jorge L.
   Klein, Liore
   Adams, Laura
   Lozier, Matthew
   Sharp, Tyler M.
   Paz-Bailey, Gabriela
TI PREVALENCE AND INCIDENCE OF ZIKA VIRUS INFECTION AMONG HOUSEHOLD
   CONTACTS OF ZIKA PATIENTS, PUERTO RICO, 2016-2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Rosenberg, Eli] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Doyle, Katherine; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA.
   [Munoz-Jordan, Jorge L.; Adams, Laura; Lozier, Matthew; Sharp, Tyler M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [Klein, Liore] Caduceus Healthcare, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1334
BP 415
EP 415
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204050
DA 2020-07-08
ER

PT J
AU Terzian, A
   Schanoski, A
   Mota, M
   Silva, R
   Estofolete, C
   Colombo, T
   Hanley, KA
   Vasilakis, N
   Kalil, J
   Nogueira, ML
AF Terzian, Ana
   Schanoski, Alessandra
   Mota, Manlio
   Silva, Rafael
   Estofolete, Cassia
   Colombo, Tatiana
   Hanley, Kathryn A.
   Vasilakis, Nikos
   Kalil, Jorge
   Nogueira, Mauricio L.
TI VIRAL LOAD DOES NOT SUPPORT ADE HYPOTHESIS IN DENGUE-PRIMED
   ZIKA-INFECTED PATIENTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Terzian, Ana; Schanoski, Alessandra; Mota, Manlio; Silva, Rafael; Estofolete, Cassia; Colombo, Tatiana; Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil.
   [Hanley, Kathryn A.] New Mexico State Univ, Las Cruces, NM 88003 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kalil, Jorge] Univ Sao Paulo, Sao Paulo, Brazil.
RI Estofolete, Cassia/N-6673-2019; de Oliveira Mota, Manlio
   Tasso/E-2619-2013; KALIL, JORGE/C-8029-2012
OI Estofolete, Cassia/0000-0001-7324-1591; KALIL, JORGE/0000-0001-8415-4274
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1335
BP 415
EP 415
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204051
DA 2020-07-08
ER

PT J
AU Erasmus, J
   Khandhar, AP
   Granger, B
   Archer, J
   Fox, C
   Reed, SG
   Coler, R
   Stinchcomb, D
   Van Hoeven, N
AF Erasmus, Jesse
   Khandhar, Amit P.
   Granger, Brian
   Archer, Jacob
   Fox, Christopher
   Reed, Steven G.
   Coler, Rhea
   Stinchcomb, Dan
   Van Hoeven, Neal
TI RAPID DEVELOPMENT OF A REPLICATING VIRAL RNA VACCINE FOR ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Erasmus, Jesse; Khandhar, Amit P.; Granger, Brian; Archer, Jacob; Fox, Christopher; Reed, Steven G.; Coler, Rhea; Stinchcomb, Dan; Van Hoeven, Neal] Infect Dis Res Inst, Seattle, WA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1349
BP 419
EP 419
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204065
DA 2020-07-08
ER

PT J
AU Lozier, MJ
   Burke, R
   Lopez, J
   Acevedo, V
   Amador, M
   Read, JS
   Jara, A
   Waterman, SH
   Barrera, R
   Munoz-Jordan, J
   Garcia-Rivera, B
   Sharp, TM
AF Lozier, Matthew J.
   Burke, Rachel
   Lopez, Juan
   Acevedo, Veronica
   Amador, Manuel
   Read, Jennifer S.
   Jara, Amanda
   Waterman, Stephen H.
   Barrera, Roberto
   Munoz-Jordan, Jorge
   Garcia-Rivera, Brenda
   Sharp, Tyler M.
TI DIFFERENCES IN PREVALENCE OF SYMPTOMATIC ZIKA VIRUS INFECTION BY AGE AND
   SEX
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Lozier, Matthew J.; Acevedo, Veronica; Amador, Manuel; Read, Jennifer S.; Waterman, Stephen H.; Barrera, Roberto; Munoz-Jordan, Jorge; Sharp, Tyler M.] Ctr Dis Control & Prevent, San Juan, PR USA.
   [Burke, Rachel] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Lopez, Juan] Florida State Univ, Tallahassee, FL 32306 USA.
   [Jara, Amanda] Univ Georgia, Athens, GA 30602 USA.
   [Garcia-Rivera, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1350
BP 419
EP 420
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204066
DA 2020-07-08
ER

PT J
AU Petitt, M
   Tabata, T
   Michlmayr, D
   Puerta-Guardo, H
   Harris, E
   Pereira, L
AF Petitt, Matthew
   Tabata, Takako
   Michlmayr, Daniela
   Puerta-Guardo, Henry
   Harris, Eva
   Pereira, Lenore
TI POTENTIAL FOR ZIKA VIRUS TRANSMISSION FROM MATERNAL CIRCULATION TO FETAL
   BLOOD STREAM BY A PARAPLACENTAL ROUTE ACROSS AMNIOCHORIONIC MEMBRANE AND
   FETAL SKIN
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Petitt, Matthew; Tabata, Takako; Pereira, Lenore] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Michlmayr, Daniela; Puerta-Guardo, Henry; Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1348
BP 419
EP 419
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204064
DA 2020-07-08
ER

PT J
AU Balmaseda, A
   Collado, D
   Mercado, JC
   Zambrana, JV
   Ojeda, S
   Sanchez, N
   Elizondo, D
   Coloma, J
   Gresh, L
   Katzelnick, L
   Burger-Calderon, R
   Gordon, A
   Kuan, G
   Harris, E
AF Balmaseda, Angel
   Collado, Damaris
   Carlos Mercado, Juan
   Victor Zambrana, Jose
   Ojeda, Sergio
   Sanchez, Nery
   Elizondo, Douglas
   Coloma, Josefina
   Gresh, Lionel
   Katzelnick, Leah
   Burger-Calderon, Raquel
   Gordon, Aubree
   Kuan, Guillermina
   Harris, Eva
TI INCIDENCE OF ZIKA VIRUS INFECTION AND EFFECT OF PRE-EXISTING DENGUE
   VIRUS EXPOSURE ON ZIKA VIRUS INFECTION AND DISEASE IN A PEDIATRIC COHORT
   IN NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Balmaseda, Angel; Carlos Mercado, Juan] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Collado, Damaris; Victor Zambrana, Jose; Ojeda, Sergio; Sanchez, Nery; Elizondo, Douglas; Gresh, Lionel] Sustainable Sci Inst, Managua, Nicaragua.
   [Coloma, Josefina; Katzelnick, Leah; Burger-Calderon, Raquel; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Gordon, Aubree; Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Berkeley, CA USA.
RI Gordon, Aubree/X-1113-2019
OI Gordon, Aubree/0000-0002-9352-7877
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1351
BP 420
EP 420
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204067
DA 2020-07-08
ER

PT J
AU Spencer, JL
   Lahon, A
   Tran, LL
   Arya, RP
   Vogt, MB
   Rowley, DR
   Kimata, JT
   Rico-Hesse, RR
AF Spencer, Jennifer L.
   Lahon, Anismrita
   Tran, Linda L.
   Arya, Ravi P.
   Vogt, Megan B.
   Rowley, David R.
   Kimata, Jason T.
   Rico-Hesse, Rebecca R.
TI ZIKA VIRUS CLINICAL ISOLATES REPLICATE IN HUMAN PROSTATE CELLS AND
   ORGANOIDS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Spencer, Jennifer L.; Lahon, Anismrita; Tran, Linda L.; Arya, Ravi P.; Vogt, Megan B.; Rowley, David R.; Kimata, Jason T.; Rico-Hesse, Rebecca R.] Baylor Coll Med, Houston, TX 77030 USA.
RI ARYA, RAVI/AAF-4108-2020
OI ARYA, RAVI/0000-0001-9255-610X
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1353
BP 420
EP 421
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204069
DA 2020-07-08
ER

PT J
AU Whitbeck, C
   Thomas, A
   Bryan, A
   Stafford, LJ
   Chambers, R
   Sapparapu, G
   Crowe, JE
   Davidson, E
   Doranz, BJ
AF Whitbeck, Chuck
   Thomas, Anu
   Bryan, Aubrey
   Stafford, Lewis J.
   Chambers, Ross
   Sapparapu, Gopal
   Crowe, James E., Jr.
   Davidson, Edgar
   Doranz, Benjamin J.
TI ANALYZING THE IMMUNE RESPONSE TO ZIKA VIRUS USING REPORTER VIRUS
   PARTICLES, ANTI-ZIKV ANTIBODIES AND EPITOPE MAPPING
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Whitbeck, Chuck; Thomas, Anu; Bryan, Aubrey; Stafford, Lewis J.; Chambers, Ross; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA.
   [Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.
RI Crowe, James E./B-5549-2009
OI Crowe, James E./0000-0002-0049-1079
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1352
BP 420
EP 420
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204068
DA 2020-07-08
ER

PT J
AU Pereira, L
   Tabata, T
   Petitt, M
   Puerta-Guardo, H
   Michlmayr, D
   Harris, E
AF Pereira, Lenore
   Tabata, Takako
   Petitt, Matthew
   Puerta-Guardo, Henry
   Michlmayr, Daniela
   Harris, Eva
TI REPLICATION OF ZIKA VIRUS AND CYTOMEGALOVIRUS IN FIRST-TRIMESTER HUMAN
   PLACENTAS SHOWS DIVERGENT PATTERNS OF INFECTION AND PATHOGENESIS THAT
   COULD AFFECT TRANSMISSION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Pereira, Lenore; Tabata, Takako; Petitt, Matthew] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Puerta-Guardo, Henry; Michlmayr, Daniela; Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
RI Michlmayr, Daniela/Q-1216-2018
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1354
BP 421
EP 421
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204070
DA 2020-07-08
ER

PT J
AU Perera, R
   Gullberg, RC
   Andre, BG
   Anderson, K
   Gresh, L
   Burger-Calderon, R
   Hopf-Jannasch, A
   Balmaseda, A
   Beaty, B
   Harris, E
   Blair, CD
AF Perera, Rushika
   Gullberg, Rebekah C.
   Andre, Barbara G.
   Anderson, Kimberly
   Gresh, Lionel
   Burger-Calderon, Raquel
   Hopf-Jannasch, Amber
   Balmaseda, Angel
   Beaty, Barry
   Harris, Eva
   Blair, Carol D.
TI METABOLIC BIOSIGNATURES OF INFECTION: HOW DENGUE, CHIKUNGUNYA AND ZIKA
   VIRUSES DIFFERENTIALLY PERTURB HOST METABOLIC HOMEOSTASES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Perera, Rushika; Gullberg, Rebekah C.; Andre, Barbara G.; Anderson, Kimberly; Beaty, Barry; Blair, Carol D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Gresh, Lionel] Sustainable Sci Inst, Managua, Nicaragua.
   [Burger-Calderon, Raquel; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Hopf-Jannasch, Amber] Purdue Univ, Bindley Biosci Ctr, Metabolite Profiling Facil, W Lafayette, IN 47907 USA.
   [Balmaseda, Angel] Ctr Nacl Diagnost & Referencia, Minist Hlth, Lab Nacl Virol, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1406
BP 437
EP 437
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204122
DA 2020-07-08
ER

PT J
AU Balmaseda, A
   Zambrana, JV
   Collado, D
   Gonzalez, K
   Garcia, N
   Saborio, S
   Cerpas, C
   Nunez, A
   Elizondo, D
   Waggoner, JJ
   Corti, D
   Burger-Calderon, R
   Kuan, G
   Harris, E
AF Balmaseda, Angel
   Victor Zambrana, Jose
   Collado, Damaris
   Gonzalez, Karla
   Garcia, Nadezna
   Saborio, Saira
   Cerpas, Cristhiam
   Nunez, Andrea
   Elizondo, Douglas
   Waggoner, Jesse J.
   Corti, Davide
   Burger-Calderon, Raquel
   Kuan, Guillermina
   Harris, Eva
TI A COMPARISON OF FOUR SEROLOGICAL METHODS AND TWO RT-PCR ASSAYS FOR
   DIAGNOSIS AND SURVEILLANCE OF ZIKA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Balmaseda, Angel; Gonzalez, Karla; Garcia, Nadezna; Saborio, Saira; Cerpas, Cristhiam; Nunez, Andrea] Ctr Nacl Diagnost & Referencia, Minist Salud, Lab Nacl Virol, Managua, Nicaragua.
   [Victor Zambrana, Jose; Collado, Damaris; Elizondo, Douglas] Sustainable Sci Inst, Managua, Nicaragua.
   [Waggoner, Jesse J.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Corti, Davide] Humabs BioMed SA, Bellinzona, Switzerland.
   [Burger-Calderon, Raquel; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1413
BP 439
EP 440
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204129
DA 2020-07-08
ER

PT J
AU Mohr, EL
   Tan, JC
   Bailey, A
   Ericson, A
   Buechler, CR
   Dudley, DM
   Newman, CM
   Mohns, MS
   Breitbach, ME
   Stewart, LM
   Barilovits, SJ
   Patel, J
   O'Connor, DH
AF Mohr, Emma L.
   Tan, John C.
   Bailey, Adam
   Ericson, Adam
   Buechler, Connor R.
   Dudley, Dawn M.
   Newman, Christina M.
   Mohns, Mariel S.
   Breitbach, Meghan E.
   Stewart, Laurel M.
   Barilovits, Sarah J.
   Patel, Jigar
   O'Connor, David H.
TI DIFFERENTIATING ZIKA AND DENGUE VIRUS INFECTIONS WITH A LINEAR PEPTIDE
   ARRAY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Mohr, Emma L.; Bailey, Adam; Ericson, Adam; Buechler, Connor R.; Dudley, Dawn M.; Newman, Christina M.; Mohns, Mariel S.; Breitbach, Meghan E.; Stewart, Laurel M.; O'Connor, David H.] Univ Wisconsin Madison, Madison, WI USA.
   [Tan, John C.; Barilovits, Sarah J.; Patel, Jigar] Roche Sequencing Solut, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1414
BP 440
EP 440
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204130
DA 2020-07-08
ER

PT J
AU Reyes, Y
   Bowman, N
   Centeno, E
   Collins, M
   Becker-Dreps, S
   de Silva, A
   Bucardo, F
AF Reyes, Yaoska
   Bowman, Natalie
   Centeno, Edwing
   Collins, Matthew
   Becker-Dreps, Sylvia
   de Silva, Aravinda
   Bucardo, Filemon
TI LONG TERM ASYMPTOMATIC DETECTION OF VIRAL RNA IN URINE AND SALIVA
   FOLLOWING ACUTE ZIKA INFECTION IN NICARAGUA 2016-2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Reyes, Yaoska; Centeno, Edwing; Bucardo, Filemon] Natl Autonomous Univ Leon, Nicaragua, Leon, Nicaragua.
   [Bowman, Natalie; Collins, Matthew; Becker-Dreps, Sylvia; de Silva, Aravinda] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1416
BP 440
EP 440
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204132
DA 2020-07-08
ER

PT J
AU Sergeev, N
AF Sergeev, Nikolay
TI A NOVEL MOLECULAR ASSAY FOR THE DETECTION OF ZIKA RNA IN WHOLE BLOOD AND
   URINE SAMPLES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Sergeev, Nikolay] Theranos, Palo Alto, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1417
BP 440
EP 441
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204133
DA 2020-07-08
ER

PT J
AU Ramjag, AT
   Mamchak, A
   Lu, K
   Nguyen, N
   Davidson, E
   Doranz, BJ
   Cavet, G
   Carrington, CV
   Simmons, G
AF Ramjag, Anushka T.
   Mamchak, Alusha
   Lu, Kai
   Ngan Nguyen
   Davidson, Edgar
   Doranz, Benjamin J.
   Cavet, Guy
   Carrington, Christine V.
   Simmons, Graham
TI POTENT AND BROADLY NEUTRALIZING DOMAIN II ANTIBODIES INDUCED DURING
   ACUTE ZIKA VIRUS INFECTION OF A PREVIOUSLY DENGUE-EXPOSED INDIVIDUAL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Ramjag, Anushka T.; Carrington, Christine V.] Univ West Indies, St Augustine Campus, St Augustine, Trinidad Tobago.
   [Mamchak, Alusha; Ngan Nguyen; Cavet, Guy] Atreca Inc, Redwood City, CA USA.
   [Lu, Kai; Simmons, Graham] Blood Syst Res Inst, San Francisco, CA USA.
   [Davidson, Edgar; Doranz, Benjamin J.] Integral Mol, Philadelphia, PA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1418
BP 441
EP 441
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204134
DA 2020-07-08
ER

PT J
AU Verma, S
   Siemann, DN
   Strange, DP
   Shi, PY
AF Verma, Saguna
   Siemann, David N.
   Strange, Daniel P.
   Shi, Pei-Yong
TI ZIKA VIRUS INFECTION IN HUMAN SERTOLI CELLS INDUCES ROBUST ANTIVIRAL
   DEFENSE RESPONSE AND COMPROMISES BLOOD-TESTES BARRIER INTEGRITY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Verma, Saguna; Siemann, David N.; Strange, Daniel P.] Univ Hawaii, Honolulu, HI 96822 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Galveston, TX 77555 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1420
BP 441
EP 442
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204136
DA 2020-07-08
ER

PT J
AU Arunkumar, G
   Robin, S
   Aswathyraj, S
   D'Souza, G
   Sabeena, SP
   Santhosh, D
   Jazeel, A
   Anup, J
   Prabhu, S
   Bhaskar, R
   Aithal, A
   Maity, H
   Jagadesh, A
   Sudheesh, N
   Chhabra, M
   Khasnobis, P
   Venkatesh, S
   Prasad, J
   Laserson, KF
AF Arunkumar, Govindakarnavar
   Robin, S.
   Aswathyraj, Sushama
   D'Souza, Giselle
   Sabeena, Sasidharan Pillai
   Santhosh, Devadiga
   Jazeel, Abdulmajeed
   Anup, Jayaram
   Prabhu, Suresh
   Bhaskar, Revti
   Aithal, Anjali
   Maity, Hindol
   Jagadesh, Anitha
   Sudheesh, Nittur
   Chhabra, Mala
   Khasnobis, Pradeep
   Venkatesh, Srinivas
   Prasad, Jagdish
   Laserson, Kayla F.
TI SEARCHING FOR ZIKA VIRUS IN INDIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Arunkumar, Govindakarnavar; Robin, S.; Aswathyraj, Sushama; D'Souza, Giselle; Sabeena, Sasidharan Pillai; Santhosh, Devadiga; Jazeel, Abdulmajeed; Anup, Jayaram; Prabhu, Suresh; Bhaskar, Revti; Aithal, Anjali; Maity, Hindol; Jagadesh, Anitha; Sudheesh, Nittur] Manipal Univ, UDUPI, Manipal, Karnataka, India.
   [Chhabra, Mala; Khasnobis, Pradeep; Venkatesh, Srinivas] Govt India, Minist Hlth & Family Welf, Natl Ctr Dis Control, Delhi, India.
   [Prasad, Jagdish] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, New Delhi, India.
   [Laserson, Kayla F.] India Off, US Ctr Dis Control & Prevent, New Delhi, India.
RI Arunkumar, Govindakarnavar/Q-7517-2019
OI Jayaram, Anup/0000-0002-4557-0555; Sudandiradas,
   Robin/0000-0002-4340-9434
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1421
BP 442
EP 442
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204137
DA 2020-07-08
ER

PT J
AU Cavalcanti, MG
   Cabral-Castro, MJ
   Pimenta, ES
   Santana, LS
   Goncalves, JL
   Peralta, JM
AF Cavalcanti, Marta G.
   Cabral-Castro, Mauro J.
   Pimenta, Eduardo Scarlatelli
   Santana, Larissa S.
   Goncalves, Jorge L.
   Peralta, Jose Mauro
TI PROLONGED RNA SHEDDING OF ZIKA VIRUS (ZIKV) AND CHIKUNGUNYA VIRUS
   (CHIKV) DURING ZIKV AND CHIK CO-INFECTION IN DIFFERENT COMPARTMENTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Cavalcanti, Marta G.; Cabral-Castro, Mauro J.; Pimenta, Eduardo Scarlatelli; Santana, Larissa S.; Goncalves, Jorge L.; Peralta, Jose Mauro] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1422
BP 442
EP 442
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204138
DA 2020-07-08
ER

PT J
AU Ravi, V
   Debnath, M
   Nagappa, M
   Taly, AB
   Desai, A
   Mani, RS
   Reddy, V
   Sharma, R
   Sudershan, S
   Wahatule, R
   Pandarisamy, S
   Dutta, D
   Hameed, SS
   Velayudhan, A
   Laserson, K
   Srikantiah, P
AF Ravi, Vasanthapuram
   Debnath, Monojit
   Nagappa, Madhu
   Taly, Arun B.
   Desai, Anita
   Mani, Reeta S.
   Reddy, Vijayalakshmi
   Sharma, Rakhi
   Sudershan, Sampada
   Wahatule, Rahul
   Pandarisamy, Sundaravadivel
   Dutta, Debprasad
   Hameed, Shafeeq Shahul
   Velayudhan, Anoop
   Laserson, Kayla
   Srikantiah, Padmini
TI LACK OF EVIDENCE OF ANTECEDENT ZIKA VIRUS INFECTION IN GUILLAIN-BARRE
   SYNDROME PATIENTS HOSPITALIZED IN A REFERRAL HOSPITAL IN SOUTH INDIA,
   2014-2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Ravi, Vasanthapuram; Debnath, Monojit; Nagappa, Madhu; Taly, Arun B.; Desai, Anita; Mani, Reeta S.; Reddy, Vijayalakshmi; Sharma, Rakhi; Sudershan, Sampada; Wahatule, Rahul; Pandarisamy, Sundaravadivel; Dutta, Debprasad; Hameed, Shafeeq Shahul] Natl Inst Mental Hlth & Neurosci, Bengaluru, India.
   [Velayudhan, Anoop; Laserson, Kayla; Srikantiah, Padmini] US Ctr Dis Control & Prevent, New Delhi, India.
RI Vasanthapuram, Ravi/AAD-5555-2019; DUTTA, DEBPRASAD/M-2140-2019
OI DUTTA, DEBPRASAD/0000-0001-5698-3067
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1423
BP 442
EP 443
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204139
DA 2020-07-08
ER

PT J
AU Campos, M
   Poventud, Y
   Nieves, J
   Noriega, J
   Hernandez, R
   Benitez, A
   Ramos, L
   Cubero, W
   Romaguera, J
   Nerurkar, V
AF Campos, Maribel
   Poventud, Yolymar
   Nieves, Jose
   Noriega, Javier
   Hernandez, Rey
   Benitez, Alexandra
   Ramos, Lizzie
   Cubero, Wanda
   Romaguera, Josefina
   Nerurkar, Vivek
TI GROWTH OUTCOMES OF NEWBORNS BORN TO WOMEN BORN TO WOMEN WITH POSITIVE
   ZIKA SCREENS DURING PREGNANCY, HIMA SAN PABLO BAYAMON CASE SERIES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Campos, Maribel] Puerto Rico Clin & Translat Res Consortium, HIMA San Pablo Bayamon, San Juan, PR USA.
   [Poventud, Yolymar] Univ Puerto Rico, Med Sci Campus, San Juan, PR 00936 USA.
   [Nieves, Jose; Noriega, Javier; Ramos, Lizzie; Romaguera, Josefina] Puerto Rico Clin & Translat Res Consortium, San Juan, PR USA.
   [Hernandez, Rey; Benitez, Alexandra; Cubero, Wanda] Univ Puerto Rico, Rio Piedras Campus, San Juan, PR 00936 USA.
   [Nerurkar, Vivek] Univ Hawaii, Manoa, HI USA.
RI Nerurkar, Vivek R/F-5533-2011
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1427
BP 443
EP 444
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204143
DA 2020-07-08
ER

PT J
AU Mendelson, T
AF Mendelson, Tina
TI PUBLIC HEALTH AT THE FOREFRONT: BUILDING LOCAL HEALTH DEPARTMENT
   CAPACITY TO IMPROVE ZIKA PREGNANCY AND BIRTH DEFECTS SURVEILLANCE AND
   REFERRAL TO SERVICE IN UNITED STATES (US)
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Mendelson, Tina] Deloitte, Arlington, VA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1425
BP 443
EP 443
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204141
DA 2020-07-08
ER

PT J
AU Oliveira, JV
   Pessoa, L
   Magalhaes, C
   Lima, JG
   Carvalho, DA
   Xavier, TC
   Pellegrini, R
   Bessa, G
   Figueiredo, EM
   Calgano, JI
   Romero, F
   dos Santos, D
   Oliveira, A
   Silva, P
   Giovanetti, M
   Goes, J
   Lima, B
   Carneiro, MW
   Duarte, A
   Lima, FW
   Alcantara, LC
   de Siqueira, IC
AF Oliveira, Joao V.
   Pessoa, Lorena
   Magalhaes, Claudio
   Lima, Jessica G.
   Carvalho, Daniel A.
   Xavier, Tereza C.
   Pellegrini, Rosana
   Bessa, Gloryane
   Figueiredo, Eduardo M.
   Calgano, Juan I.
   Romero, Fernando
   dos Santos, Daiana
   Oliveira, Aline
   Silva, Paloma
   Giovanetti, Marta
   Goes, Jaqueline
   Lima, Breno
   Carneiro, Marcia W.
   Duarte, Alan
   Lima, Fernanda W.
   Alcantara, Luiz C.
   de Siqueira, Isadora C.
TI PREVALENCE OF PREVIOUS AND RECENT INFECTIONS BY ZIKA VIRUS, DENGUE VIRUS
   AND CHIKUNGUNYA VIRUS IN PREGNANT WOMEN AND SURVEILLANCE FOR CONGENITAL
   ZIKA INFECTIONS IN SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Oliveira, Joao V.; Pessoa, Lorena; Magalhaes, Claudio; Lima, Jessica G.; Carvalho, Daniel A.; dos Santos, Daiana; Oliveira, Aline; Silva, Paloma; Giovanetti, Marta; Goes, Jaqueline; Lima, Breno; Carneiro, Marcia W.; Alcantara, Luiz C.; de Siqueira, Isadora C.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Xavier, Tereza C.; Pellegrini, Rosana; Bessa, Gloryane; Figueiredo, Eduardo M.; Calgano, Juan I.; Romero, Fernando] Secretaria Saude Estado Bahia, Salvador, BA, Brazil.
   [Duarte, Alan; Lima, Fernanda W.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI amsalu, ribka/G-8780-2019; de Siqueira, Isadora Cristina/R-9953-2016;
   Giovanetti, Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1426
BP 443
EP 443
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204142
DA 2020-07-08
ER

PT J
AU Sivaraman, S
   Hu, R
   Joshi, N
   Zamora, S
AF Sivaraman, Sharada
   Hu, Ran
   Joshi, Netra
   Zamora, Samantha
TI SCREENING OF RECOMBINANT ZIKA VIRUS PROTEINS AS ANTIGENS TO DEVELOP AN
   ELISA FOR THE SERODIAGNOSIS OF ZIKA VIRUS INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Sivaraman, Sharada; Hu, Ran; Joshi, Netra; Zamora, Samantha] Theranos Inc, Palo Alto, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1424
BP 443
EP 443
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204140
DA 2020-07-08
ER

PT J
AU Buathong, R
   Wacharapluesadee, S
   Ruchiseesarod, C
   Joyjinda, Y
   Sae-Liang, N
   Kanjanasombut, H
   Suwanchairob, O
   Siriarayapon, P
   Hemachudha, T
AF Buathong, Rome
   Wacharapluesadee, Supaporn
   Ruchiseesarod, Chanida
   Joyjinda, Yutthana
   Sae-Liang, Nutchanart
   Kanjanasombut, Hataya
   Suwanchairob, Orathai
   Siriarayapon, Potjaman
   Hemachudha, Thiravat
TI BREAST MILK AND ZIKA VIRUS INFECTION IN PREGNANCY, THAILAND 2016-2017
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Buathong, Rome; Kanjanasombut, Hataya; Suwanchairob, Orathai; Siriarayapon, Potjaman] Minist Publ Hlth, Bur Epidemiol, Nonthaburi, Thailand.
   [Wacharapluesadee, Supaporn; Ruchiseesarod, Chanida; Joyjinda, Yutthana] Thai Red Cross Soc, Emerging Infect Dis Ctr, Bangkok, Thailand.
   [Sae-Liang, Nutchanart] Thai Red Cross Soc, Emerging Infect Dis Ctr, Nonthaburi, Thailand.
   [Hemachudha, Thiravat] Thai Red Cross, Emerging Infect Dis, Bangkok, Thailand.
   [Hemachudha, Thiravat] Chulalongkorn Univ, Bangkok, Thailand.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1428
BP 444
EP 444
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204144
DA 2020-07-08
ER

PT J
AU Tabata, T
   Petitt, M
   Puerta-Guardo, H
   Michlmayr, D
   Harris, E
   Pereira, L
AF Tabata, Takako
   Petitt, Matthew
   Puerta-Guardo, Henry
   Michlmayr, Daniela
   Harris, Eva
   Pereira, Lenore
TI FUNCTIONAL DIFFERENCES AND HOST ANTIVIRAL RESPONSES TO NICARAGUAN ZIKA
   VIRUS AND PROTOTYPE STRAINS REVEALED IN FIRST-TRIMESTER VILLUS EXPLANTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Tabata, Takako; Petitt, Matthew; Pereira, Lenore] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Puerta-Guardo, Henry; Michlmayr, Daniela; Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
RI Michlmayr, Daniela/Q-1216-2018
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1429
BP 444
EP 444
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204145
DA 2020-07-08
ER

PT J
AU Redmond, SN
   Sharakhova, MV
   Sharakhov, IV
   Tu, ZJ
   McBride, CS
   Powell, JR
   Birren, B
   Neafsey, DE
AF Redmond, Seth N.
   Sharakhova, Maria V.
   Sharakhov, Igor V.
   Tu, Zhijian
   McBride, Carolyn S.
   Powell, Jefrrey R.
   Birren, Bruce
   Neafsey, Daniel E.
TI 6 STRUCTURAL VARIANT DETECTION BY READ-CLOUD SEQUENCING IN THE ZIKA
   VECTOR AEDES AEGYPTI
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Redmond, Seth N.; Birren, Bruce; Neafsey, Daniel E.] Broad Inst, Cambridge, MA USA.
   [Sharakhova, Maria V.; Sharakhov, Igor V.; Tu, Zhijian] Virginia Tech, Blacksburg, VA USA.
   [McBride, Carolyn S.] Princeton Univ, Princeton, NJ 08544 USA.
   [Powell, Jefrrey R.] Yale Univ, New Haven, CT USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1483
BP 460
EP 460
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204198
DA 2020-07-08
ER

PT J
AU Diaz, AR
   Stewart, A
   Hargrave, A
   Kenneson-Adams, A
   Molina, JP
   Gonzales, A
   Romero, M
   Madden, D
   Garcia, R
   Domachowske, E
AF Diaz, Avriel R.
   Stewart, Anna
   Hargrave, Anita
   Kenneson-Adams, Aileen
   Pablo Molina, Juan
   Gonzales, Angelica
   Romero, Moory
   Madden, David
   Garcia, Reese
   Domachowske, Elizabeth
TI PSYCHOLOGICAL DISTRESS AND ZIKA, DENGUE, AND CHIKUNGUNYA INFECTIONS
   FOLLOWING 2016 EARTHQUAKE IN COASTAL ECUADOR
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Diaz, Avriel R.] Columbia Univ, New York, NY USA.
   [Stewart, Anna; Kenneson-Adams, Aileen; Romero, Moory; Madden, David; Domachowske, Elizabeth] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Hargrave, Anita] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Pablo Molina, Juan; Gonzales, Angelica] Minist Salud Publ, San Vicente, Ecuador.
   [Garcia, Reese] Univ Colorado, Denver, CO 80202 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1508
BP 468
EP 468
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204223
DA 2020-07-08
ER

PT J
AU Pech-Cervantes, CH
   Lara-Romero, EG
   Haas-Solis, EG
   Guillermo-Duran, JP
   Gomez-Carro, S
   Mendez-Dominguez, N
AF Pech-Cervantes, Claudio H.
   Lara-Romero, Emily G.
   Haas-Solis, Emy G.
   Guillermo-Duran, Juan-Pablo
   Gomez-Carro, Salvador
   Mendez-Dominguez, Nina
TI GUILLAIN-BARRE SYNDROME IN PATIENTS WITH ZIKA: CLINICAL SERIES WITH
   LABORATORY CONFIRMATION IN THE STATE OF YUCATAN
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Pech-Cervantes, Claudio H.; Lara-Romero, Emily G.; Haas-Solis, Emy G.; Guillermo-Duran, Juan-Pablo; Mendez-Dominguez, Nina] Univ Marista Merida, Merida, Yucatan, Mexico.
   [Gomez-Carro, Salvador] OHoran Gen Hosp, Merida, Yucatan, Mexico.
RI Mendez-Dominguez, Nina/J-3879-2019
OI Mendez-Dominguez, Nina/0000-0002-0230-0731
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1785
BP 555
EP 555
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204501
DA 2020-07-08
ER

PT J
AU Esposito, DL
   Ferreira, AA
   Moraes, FM
   Persona, MR
   dos Ribeiro, B
   Fabio, SV
   Passos, LMR
   Silva, AAMCE
   Fonseca, BA
AF Esposito, Danillo L.
   Ferreira, Adriana A.
   Moraes, Flavia M.
   Persona, Michelli R.
   dos Ribeiro, Beatriz
   Fabio, Suzi V.
   Passos, Luzia Marcia R.
   Castro e Silva, Ana Alice M.
   Fonseca, Benedito A.
TI ABORTION RATE IS MUCH HIGHER THAN MICROCEPHALY RATE IN ZIKA VIRUS
   INFECTIONS OCCURRING IN THE FIRST TRIMESTER OF PREGNANCY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Esposito, Danillo L.; Ferreira, Adriana A.; Moraes, Flavia M.; Persona, Michelli R.; dos Ribeiro, Beatriz; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
   [Fabio, Suzi V.; Passos, Luzia Marcia R.; Castro e Silva, Ana Alice M.] Ribeirao Preto Hlth Dept, Ribeirao Preto, SP, Brazil.
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
NR 0
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1959
BP 610
EP 610
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204675
DA 2020-07-08
ER

PT J
AU Castro, M
   Perez, D
   Guzman, MG
   Barrington, C
AF Castro, Marta
   Perez, Dennis
   Guzman, Maria G.
   Barrington, Clare
TI Why Did Zika Not Explode in Cuba? The Role of Active Community
   Participation to Sustain Control of Vector-Borne Diseases
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PREVENTION; VIRUS
AB As the global public health community develops strategies for sustainable Zika prevention and control, assessment of the Cuban response to Zika provides critical lessons learned. Cuba's early and successful response to Zika, grounded in the country's long-standing dengue prevention and control program, serves as a model of rapid mobilization of intersectoral efforts. Sustaining this response requires applying the evidence generated within the Cuban dengue programthat active community participation improves outcomes and is sustainable and cost-effective. There is also a need for implementation science efforts to assess the transferability of lessons learned from Zika prevention and control to other pathogens and from one context to another in addition to how to take these efforts to scale.
C1 [Castro, Marta; Perez, Dennis; Guzman, Maria G.] Pedro Kouri Trop Med Inst, Havana, Cuba.
   [Barrington, Clare] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
RP Castro, M (corresponding author), Inst Med Trop Pedro Kouri, Km 6 1-2,POB 601,Marianao 13, Havana, Cuba.
EM martac@ipk.sld.cu; dennis@ipk.sld.cu; lupe@ipk.sld.cu;
   cbarring@email.unc.edu
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Gorry C, 2016, MEDICC REV, V18, P6
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   PAHO, 2017, ZIK EP REP CUB
   PAHO, 2016, ZIK SUSP CONF CAS RE
   Pan American Health Organization (PAHO), 2016, ZIK VIR INF STEP STE
   Perez D, 2016, REV PANAM SALUD PUBL, V39, P93
   Reardon S, 2016, NATURE, V536, P257, DOI 10.1038/536257a
   Stamm LV, 2016, JAMA DERMATOL, V152, P621, DOI 10.1001/jamadermatol.2016.1499
   Toledo M, 2014, DENGUE
NR 10
TC 9
Z9 9
U1 0
U2 6
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 2
BP 311
EP 312
DI 10.4269/ajtmh.16-0906
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5MI
UT WOS:000423197200003
PM 28722613
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Fauver, JR
   Gendernalik, A
   Weger-Lucarelli, J
   Grubaugh, ND
   Brackney, DE
   Foy, BD
   Ebel, GD
AF Fauver, Joseph R.
   Gendernalik, Alex
   Weger-Lucarelli, James
   Grubaugh, Nathan D.
   Brackney, Doug E.
   Foy, Brian D.
   Ebel, Gregory D.
TI The Use of Xenosurveillance to Detect Human Bacteria, Parasites, and
   Viruses in Mosquito Bloodmeals
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID ANOPHELES-GAMBIAE; DIPTERA; IDENTIFICATION; CULICIDAE; AEGYPTI; AEDES;
   MEAL
AB Infectious disease surveillance is hindered by several factors, including limited infrastructure and geographic isolation of many resource-poor regions. In addition, the complexities of sample acquisition, processing, and analysis, even in developed regions, can be rate limiting. Therefore, new strategies to survey human populations for emerging pathogens are necessary. Xenosurveillance is a method that utilizes mosquitoes as sampling devices to search for genetic signatures of pathogens in vertebrates. Previously we demonstrated that xenosurveillance can detect viral RNA in both laboratory and field settings. However, its ability to detect bacteria and parasites remains to be assessed. Accordingly, we fed Anopheles gambiae mosquitoes blood that contained Trypanosoma brucei gambiense and Bacillus anthracis. In addition, we determined whether two additional emerging viruses, Middle East Respiratory Syndrome Coronavirus and Zika virus could be detected by this method. Pathogen-specific real-time reverse transcription polymerase chain reaction was used to evaluate the sensitivity of xenosurveillance across multiple pathogen taxa and over time. We detected RNA from all pathogens at clinically relevant concentrations from mosquitoes processed up to 1 day postbloodfeeding. These results demonstrate that xenosurveillance may be used as a tool to expand surveillance for viral, parasitic, and bacterial pathogens in resource-limited areas.
C1 [Fauver, Joseph R.; Gendernalik, Alex; Weger-Lucarelli, James; Grubaugh, Nathan D.; Foy, Brian D.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, 1692 Campus Delivery, Ft Collins, CO 80523 USA.
   [Grubaugh, Nathan D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
   [Brackney, Doug E.] Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06504 USA.
RP Ebel, GD (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, 1692 Campus Delivery, Ft Collins, CO 80523 USA.
EM joseph.fauver@colostate.edu; alghobbes@gmail.com;
   james.weger@colostate.edu; nathan.grubaugh@yahoo.com;
   doug.brackney@ct.gov; brian.foy@colostate.edu;
   gregory.ebel@colostate.edu
RI Foy, Brian/E-6230-2017
OI Foy, Brian/0000-0002-9117-203X; Grubaugh, Nathan/0000-0003-2031-1933;
   Weger-Lucarelli, James/0000-0002-9483-1694
FU CSU Infectious Disease Supercluster Grant; Armed Forces Health
   Surveillance Center grant
FX The projected was supported in part by the CSU Infectious Disease
   Supercluster Grant "Xenosurveillance: A novel approach for interrogating
   the human-pathogen landscape in sub-Saharan Africa" awarded to DEB, BDF,
   and GDE. This project was also supported in part by an Armed Forces
   Health Surveillance Center grant awarded to the Walter Reed Army
   Institute (subcontract DEB).
CR Barbazan P, 2008, VECTOR-BORNE ZOONOT, V8, P105, DOI 10.1089/vbz.2007.0142
   Bayoh MN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-380
   Breman JG, 2001, AM J TROP MED HYG, V64, P1
   Brugman VA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1034-8
   CDC, 2014, BIOSENSE NAT SYNDR S
   CDC, 2014, NAT NOT DIS SURV SYS
   Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X
   Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951
   Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324
   de Marco MF, 2016, VET PARASITOL, V229, P31, DOI 10.1016/j.vetpar.2016.09.012
   Department of Defense, 2016, GLOB EM INF SURV RES
   DOWNE A. E. R., 1963, J KANS ENTOMOL SOC, V36, P200
   Espino J, 2014, RODS REAL TIME OUTBR
   Grubaugh ND, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003628
   Harbison JE, 2006, J MED ENTOMOL, V43, P473, DOI 10.1603/0022-2585(2006)43[473:ASMFSI]2.0.CO;2
   HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883
   Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001
   IRBY WS, 1989, J MED ENTOMOL, V26, P284, DOI 10.1093/jmedent/26.4.284
   Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kading RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099342
   Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13
   Martinez-de la Puente J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-109
   Meyers JI, 2015, J EXP BIOL, V218, P1478, DOI 10.1242/jeb.118570
   Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146
   Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579
   Niare S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1152-6
   Organization WH, 2014, GOARN GLOV OUTBR AL
   Pappa V, 2011, AM J TROP MED HYG, V84, P298, DOI 10.4269/ajtmh.2011.10-0463
   Qi YA, 2001, APPL ENVIRON MICROB, V67, P3720, DOI 10.1128/AEM.67.8.3720-3727.2001
   Quinones ML, 1997, MED VET ENTOMOL, V11, P71, DOI 10.1111/j.1365-2915.1997.tb00292.x
   Ross R, 1910, BRIT MED J, V1910, P1544, DOI 10.1136/bmj.1.2582.1544
   SMITH CE, 1957, AM J PUBLIC HEALTH N, V47, P249, DOI 10.2105/AJPH.47.2.249-b
   TURELL MJ, 1987, INFECT IMMUN, V55, P1859, DOI 10.1128/IAI.55.8.1859-1861.1987
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   West A. S., 1952, Canadian Journal of Zoology, V30, P267, DOI 10.1139/z52-025
   Wolfe N, 2014, GLOBAL VIRAL FORECAS
   Yang Y, 2015, AM J TROP MED HYG, V93, P1377, DOI 10.4269/ajtmh.15-0440
NR 41
TC 4
Z9 4
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 2
BP 324
EP 329
DI 10.4269/ajtmh.17-0063
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5MI
UT WOS:000423197200006
PM 28722623
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Pradhan, F
   Burns, JD
   Agameya, A
   Patel, A
   Alfaqih, M
   Small, JE
   Ooi, W
AF Pradhan, Faruq
   Burns, Joseph D.
   Agameya, Ahmed
   Patel, Avignat
   Alfaqih, Mohammad
   Small, Juan E.
   Ooi, Winnie
TI Case Report: Zika Virus Meningoencephalitis and Myelitis and Associated
   Magnetic Resonance Imaging Findings
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID INFECTION
AB Zika virus (ZIKV) has a wide clinical spectrum of associated neurologic disease including microcephaly and Guillain-Barre syndrome but, despite its known neurotropism, ZIKV meningoencephalitis and myelitis have been rare complications. We describe a case of ZIKV meningoencephalitis and probable myelitis and its associated magnetic resonance imaging findings that rapidly resolved during recovery in a previously healthy adult.
C1 [Pradhan, Faruq; Agameya, Ahmed] Lahey Hosp & Med Ctr, Dept Internal Med, 41 Mall Rd, Burlington, MA 01805 USA.
   [Burns, Joseph D.] Lahey Hosp & Med Ctr, Dept Neurol, Burlington, MA USA.
   [Patel, Avignat] Lahey Hosp & Med Ctr, Dept Pulm & Crit Care Med, Burlington, MA USA.
   [Alfaqih, Mohammad; Small, Juan E.] Lahey Hosp & Med Ctr, Dept Radiol, Burlington, MA USA.
   [Ooi, Winnie] Lahey Hosp & Med Ctr, Dept Infect Dis, Travel & Trop Med Clin, Burlington, MA USA.
RP Pradhan, F (corresponding author), Lahey Hosp & Med Ctr, Dept Internal Med, 41 Mall Rd, Burlington, MA 01805 USA.
EM faruq.pradhan@lahey.org; joseph.d.burns@lahey.org; agameya@lahey.org;
   avignat.s.patel@lahey.org; mohammad.alfaqih@lahey.org;
   juan.e.small@lahey.org; winnie.w.ooi@lahey.org
OI Pradhan, Faruq/0000-0002-5249-188X
CR Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Dominican Republic Ministry of Public Health, 2016, DOM REP MIN PUBL HLT
   Ganguly B, 2016, 054486 BIORXIV
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Handique SK, 2011, NEUROIMAG CLIN N AM, V21, P777, DOI 10.1016/j.nic.2011.07.012
   Mathur M, 2014, HAND CLINIC, V123, P149, DOI 10.1016/B978-0-444-53488-0.00006-7
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization/ World Health Organization, 2016, ZIK EP REP DOM REP D
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281
   Speers DJ, 2013, AM J TROP MED HYG, V88, P481, DOI 10.4269/ajtmh.12-0379
   Vachha Behroze, 2014, Top Magn Reson Imaging, V23, P293, DOI 10.1097/RMR.0000000000000033
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 16
TC 12
Z9 14
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 2
BP 340
EP 343
DI 10.4269/ajtmh.16-0921
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5MI
UT WOS:000423197200008
PM 28829736
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Duggal, NK
   Ritter, JM
   McDonald, EM
   Romo, H
   Guirakhoo, F
   Davis, BS
   Chang, GJJ
   Brault, AC
AF Duggal, Nisha K.
   Ritter, Jana M.
   McDonald, Erin M.
   Romo, Hannah
   Guirakhoo, Farshad
   Davis, Brent S.
   Chang, Gwong-Jen J.
   Brault, Aaron C.
TI Differential Neurovirulence of African and Asian Genotype Zika Virus
   Isolates in Outbred Immunocompetent Mice
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID MODEL; ASSOCIATION; INFECTION; DISEASE
AB Although first isolated almost 70 years ago, Zika virus (ZIKV; Flavivirus, Flaviviridae) has only recently been associated with significant outbreaks of disease in humans. Several severe ZIKV disease manifestations have also been recently documented, including fetal malformations, such as microcephaly, and Guillain-Barre syndrome in adults. Although principally transmitted by mosquitoes, sexual transmission of ZIKV has been documented. Recent publications of several interferon receptor knockout mouse models have demonstrated ZIKV-induced disease. Herein, outbred immunocompetent CD-1/ICR adult mice were assessed for susceptibility to disease by intracranial (i.c.) and intraperitoneal (i.p.) inoculation with the Ugandan prototype strain (MR766; African genotype), a low-passage Senegalese strain (DakAr41524; African genotype) and a recent ZIKV strain isolated from a traveler infected in Puerto Rico (PRVABC59; Asian genotype). Morbidity was not observed in mice inoculated by the i.p. route with either MR766 or PRVABC59 for doses up to 6 log(10) PFU. In contrast, CD-1/ICR mice inoculated i.c. with the MR766 ZIKV strain exhibited an 80-100% mortality rate that was age independent. The DakAr41524 strain delivered by the i.c route caused 30% mortality, and the Puerto Rican ZIKV strain failed to elicit mortality but did induce a serum neutralizing immune response in 60% of mice. These data provide a potential animal model for assessing neurovirulence determinants of different ZIKV strains as well as a potential immunocompetent challenge model for assessing protective efficacy of vaccine candidates.
C1 [Duggal, Nisha K.; McDonald, Erin M.; Romo, Hannah; Davis, Brent S.; Chang, Gwong-Jen J.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Ritter, Jana M.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Infect Dis Pathol Branch, Atlanta, GA USA.
   [Guirakhoo, Farshad] GeoVax Inc, Smyrna, GA USA.
RP Brault, AC (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM nduggal@gmail.com; vtr0@cdc.gov; ngl9@cdc.gov; hannahromo@gmail.com;
   fguirakhoo@geovax.com; bdd5@cdc.gov; gxc7@cdc.gov; abrault@cdc.gov
OI Guirakhoo, Farshad/0000-0003-0124-013X
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Forster JI, 2016, J BIOMOL SCREEN, V21, P496, DOI 10.1177/1087057115625190
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 29
TC 23
Z9 23
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
BP 1410
EP 1417
DI 10.4269/ajtmh.17-0263
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5VW
UT WOS:000423222300021
PM 28820694
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Basso, C
   da Rosa, EG
   Lairihoy, R
   Caffera, RM
   Roche, I
   Gonzalez, C
   da Rosa, R
   Gularte, A
   Alfonso-Sierra, E
   Petzold, M
   Kroeger, A
   Sommerfeld, J
AF Basso, Cesar
   da Rosa, Elsa Garcia
   Lairihoy, Rosario
   Caffera, Ruben M.
   Roche, Ingrid
   Gonzalez, Cristina
   da Rosa, Ricardo
   Gularte, Alexis
   Alfonso-Sierra, Eduardo
   Petzold, Max
   Kroeger, Axel
   Sommerfeld, Johannes
TI Scaling Up of an Innovative Intervention to Reduce Risk of Dengue,
   Chikungunya, and Zika Transmission in Uruguay in the Framework of an
   Intersectoral Approach with and without Community Participation
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; LIFE TABLE MODEL; PUPAL SURVEY; CULICIDAE;
   AMERICA; SURVEILLANCE; PRODUCTIVITY; PREVENTION; DISPERSAL; COUNTRIES
AB To contribute to the prevention of dengue, chikungunya, and Zika, a process of scaling up an innovative intervention to reduce Aedes aegypti habitats, was carried out in the city of Salto (Uruguay) based on a transdisciplinary analysis of the eco-bio-social determinants. The intervention in one-third of the city included the distributions of plastic bags for all households to collect all discarded water containers that were recollected by the Ministry of Health and the Municipality vector control services. The results were evaluated in 20 randomly assigned clusters of 100 households each, in the intervention and control arm. The intervention resulted in a significantly larger decrease in the number of pupae per person index (as a proxy for adult vector abundance) than the corresponding decrease in the control areas (both areas decreased by winter effects). The reduction of intervention costs ("incremental costs") in relation to routine vector control activities was 46%. Community participation increased the collaboration with the intervention program considerably (from 48% of bags handed back out of the total of bags delivered to 59% of bags handed back). Although the costs increased by 26% compared with intervention without community participation, the acceptability of actions by residents increased from 66% to 78%.
C1 [Basso, Cesar] Univ Republica, Fac Agron, Dept Protecc Vegetal, Unidad Entomol, Montevideo, Uruguay.
   [da Rosa, Elsa Garcia; Lairihoy, Rosario] Univ Republ, Fac Vet, Dept Parasitol Vet, Salto, Uruguay.
   [Caffera, Ruben M.] Univ Republica, Fac Agron, Dept Sistemas Ambientales, Montevideo, Uruguay.
   [Roche, Ingrid] Univ Republica, Inst Teoria Arquitectura & Urbanismo, Fac Arquitectura Diseno & Urbanismo, Montevideo, Uruguay.
   [Gonzalez, Cristina; da Rosa, Ricardo; Gularte, Alexis] Minist Salud Publ, Direcc Dept Salud Salto, Salto, Uruguay.
   [Alfonso-Sierra, Eduardo] Freiburg Univ, Ctr Med & Soc Anthropol, Freiburg, Germany.
   [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden.
   [Kroeger, Axel] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Sommerfeld, Johannes] WHO, Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland.
RP Basso, C (corresponding author), Univ Republica, Fac Agron, Unidad Entomol, Av E Garzon 780, Montevideo 12900, Uruguay.
EM cbasso@adinet.com.uy; elsagdr@yahoo.com.ar; barbieri363@gmail.com;
   rmcaffera@gmail.com; ingridroc@gmail.com;
   cristinagonzalezdiaz@hotmail.com; mary-fructos@hotmail.com;
   ale.jgc@gmail.com; edalfon@gmail.com; max.petzold@gu.se;
   kroegera@who.int; sommerfeldj@who.int
RI Sommerfeld, Johannes/AAI-5816-2020
OI Basso, Cesar/0000-0003-0427-3631
FU Special Programme for Research and Training in Tropical Diseases (TDR)
   at the World Health Organization; Ecosystem and Human Health Program of
   the international development research centre (IDRC) of Canada
   [104951-001]
FX This study was supported by a grant from the Special Programme for
   Research and Training in Tropical Diseases (TDR) at the World Health
   Organization, in collaboration with its regional office for the Americas
   (PAHO) and in partnership with the Ecosystem and Human Health Program of
   the international development research centre (IDRC) of Canada to
   develop a research program under the title "Towards Improved Dengue and
   Chagas Disease Control through Innovative Ecosystem Management and
   Community-Directed Interventions: An Eco-Bio-Social Research Programme
   on Dengue and Chagas Disease in Latin America and the Caribbean" Project
   Number 104951-001). There are no relationships or support which might be
   perceived as constituting a conflict of interest.
CR Al-Muhandis N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001278
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Arredondo-Jimenez JI, 2006, ANN TROP MED PARASIT, V100, pS17, DOI 10.1179/136485906X105480
   Barrera R, 2006, AM J TROP MED HYG, V74, P290, DOI 10.4269/ajtmh.2006.74.290
   Basso C, 2010, ABORDAJE ECOSISTEMIC
   Basso C, 2016, J EMERG INFECT DIS, V1, P103
   Basso C, 2015, T ROY SOC TROP MED H, V109, P134, DOI 10.1093/trstmh/tru183
   Basso C, 2012, AM J TROP MED HYG, V87, P1083, DOI 10.4269/ajtmh.2012.12-0328
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brouwer W, 2001, EC EVALUATIONS HLTH
   Caffera RM, 2010, ABORDAJE ECOSISTEMIC, P149
   Chadee DD, 2009, TROP MED INT HEALTH, V14, P220, DOI 10.1111/j.1365-3156.2008.02216.x
   Chadee DD, 2004, B ENTOMOL RES, V94, P201, DOI 10.1079/BER2004297
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Constenla Dagna, 2015, Value Health Reg Issues, V8, P80, DOI 10.1016/j.vhri.2015.06.001
   DARSIE R F JR, 1985, Mosquito Systematics, V17, P153
   Draper AK, 2010, SOC SCI MED, V71, P1102, DOI 10.1016/j.socscimed.2010.05.016
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   FOCKS DA, 2003, REV ENTOMOLOGICAL SA
   Focks DA, 2006, MULTICOUNTY STUDY AE
   Focks DA, 1998, AM ENTOMOLOGIST, V45, P173
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1
   Lebel J, 2003, HLTH ECOSYSTEM APPRO
   Lenhart AE, 2006, ANN TROP MED PARASIT, V100, pS53, DOI 10.1179/136485906X105516
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   Midega JT, 2006, ANN TROP MED PARASIT, V100, pS61, DOI 10.1179/136485906X105525
   Ministerio de Salud Publica, 2011, CAS DENG AUT UR
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   NATHAN MB, 1991, J AM MOSQUITO CONTR, V7, P400
   Pan American Health Organizatio, NUMB REP CCAS SEV DE
   Pan American Health Organization, 2015, ZIK CAS CONG SYNDR A
   Pan American Health Organization, 1994, PAHO SCI PUB, V548
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   RIFKIN S, 2001, PARTNERS PLANNING IN
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   Salvatella R., 1997, REV MED URUG, V13, P118
   Santos S M, 2001, Cad Saude Publica, V17, P1141, DOI 10.1590/S0102-311X2001000500015
   Sommerfeld J, 2012, PATHOG GLOB HEALTH, V106, P428, DOI 10.1179/2047773212Y.0000000055
   Souza-Santos R, 2000, Cad Saude Publica, V16, P31, DOI 10.1590/S0102-311X2000000100004
   TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27
   WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
NR 49
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
BP 1428
EP 1436
DI 10.4269/ajtmh.17-0061
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5VW
UT WOS:000423222300024
PM 28820690
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Contraceptive sales after the Zika epidemic
SO EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Dept Community Med, Navi Mumbai, India.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Bahamondes L, 2017, EUR J CONTRACEP REPR, V22, P381, DOI 10.1080/13625187.2017.1397623
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1362-5187
EI 1473-0782
J9 EUR J CONTRACEP REPR
JI Eur. J. Contracept. Reprod. Health Care
PY 2017
VL 22
IS 6
BP 479
EP 479
DI 10.1080/13625187.2017.1412428
PG 1
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology
GA FT4WN
UT WOS:000423156000014
PM 29260594
DA 2020-07-08
ER

PT J
AU Diniz, SG
   Andrezzo, HF
AF Diniz, Simone G.
   Andrezzo, Halana F.
TI Zika virus - the glamour of a new illness, the practical abandonment of
   the mothers and new evidence on uncertain causality
SO REPRODUCTIVE HEALTH MATTERS
LA English
DT Editorial Material
C1 [Diniz, Simone G.] Univ Sao Paulo, Sch Publ Hlth, Dept Maternal & Child Hlth, Sao Paulo, Brazil.
   [Andrezzo, Halana F.] Sao Paulo Feminist Collect Hlth & Sexual, Sao Paulo, Brazil.
RP Diniz, SG (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Maternal & Child Hlth, Sao Paulo, Brazil.
EM sidiniz@usp.br
CR ABRASCO, NOT TECN MICR DOENC
   Background document for development of WHO Guidelines for Drinking- water Quality, PYR DRINK WAT
   Bar-Yam Y, 2017, CASE PYRIPROXYFEN PO
   Brazil Ministry of Health, 2016, PUBL HLTH EM OP CTR
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   deAndrade I., 2001, BIORXIV, DOI [10.1101/087825, DOI 10.1101/087825]
   Diniz D., 2016, ZIKA SERTAO NORDESTI, P192
   Diniz SG, 2012, REPROD HEALTH MATTER, V20, P94, DOI 10.1016/S0968-8080(12)40657-7
   Lyons-Weiler J, AREAS RES PRELIMINAR
   Marteleto LJ, 2017, POPUL DEV REV, V43, P199, DOI 10.1111/padr.12074
   Scott RP, 2017, CADERNOS GENERO DIVE, V3
   Stern AM, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00081516
   Triunfol M, 2016, LANCET INFECT DIS, V16, P1008, DOI 10.1016/S1473-3099(16)30281-X
   World Health Organization, SIT REP
   Zanatta LF, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00089616
   Zika Diniz D., DOCUMENTARIO
NR 16
TC 3
Z9 3
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0968-8080
EI 1460-9576
J9 REPROD HEALTH MATTER
JI Reprod. Health Matters
PY 2017
VL 25
IS 49
BP 21
EP 25
DI 10.1080/09688080.2017.1397442
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FT6JB
UT WOS:000423259300006
PM 29227208
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Neaterour, P
   Rivera, A
   Galloway, RL
   Negron, MG
   Rivera-Garcia, B
   Sharp, TM
AF Neaterour, Paige
   Rivera, Aidsa
   Galloway, Renee L.
   Garcia Negron, Myriam
   Rivera-Garcia, Brenda
   Sharp, Tyler M.
TI Case Report: Fatal Leptospira spp./Zika Virus Coinfection-Puerto Rico,
   2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID CLINICAL PRESENTATION; OUTBREAK; DISEASE; HAWAII; FLOOD
AB Coinfection with pathogens that cause acute febrile illness (AFI) can complicate patient diagnosis and management. This report describes a fatal case of Leptospira spp./Zika virus (ZIKV) coinfection in Puerto Rico. The patient presented with a 5-day history of AFI; reported behavioral risk factors for leptospirosis; was diagnosed with possible leptospirosis, dengue, chikungunya, or ZIKV disease; and received appropriate treatment for leptospirosis and dengue. Following a 3-day hospitalization, the patient died due to acute gastrointestinal hemorrhage, and kidney and liver failure. Serologic diagnostic testing for leptospirosis and ZIKV disease was negative; however, molecular diagnostic testing performed postmortem was positive for detection of Leptospira spp. and ZIKV nucleic acid. This case demonstrates the need for continued clinical awareness of leptospirosis in areas experiencing outbreaks of pathogens that cause AFI and the need for evaluation of coinfection with AFI-causing pathogens as a risk factor for increased severity of disease.
C1 [Neaterour, Paige; Rivera, Aidsa; Sharp, Tyler M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Dengue Branch, San Juan, PR USA.
   [Galloway, Renee L.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA.
   [Garcia Negron, Myriam; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Med Ctr Area, San Juan, PR USA.
   [Galloway, Renee L.] Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA.
RP Sharp, TM (corresponding author), Puerto Rico Dept Hlth, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
EM paige-neaterour@ouhsc.edu; erj2@cdc.gov; zul0@cdc.gov;
   mgarcia@salud.pr.gov; wtm6@cdc.gov; tsharp@cdc.gov
CR Agampodi SB, 2016, AM J TROP MED HYG, V95, P531, DOI 10.4269/ajtmh.16-0033
   Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   [Anonymous], 2016, TRIOPL REAL TIM RT P
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Biron A, 2016, JMM CASE REP, V3
   Cohen AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128580
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Daher EF, 2010, BRAZ J INFECT DIS, V14, P3, DOI 10.1590/S1413-86702010000100002
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Ellis T, 2008, VECTOR-BORNE ZOONOT, V8, P541, DOI 10.1089/vbz.2007.0241
   Katz AR, 2001, CLIN INFECT DIS, V33, P1834, DOI 10.1086/324084
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Sergio AD, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/519701
   Nabity SA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001878
   Nhan TX, 2016, IDCases, V5, P12, DOI 10.1016/j.idcr.2016.06.003
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rajapakse S, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-014-0060-2
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Sharp TM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004482
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
NR 20
TC 4
Z9 4
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 4
BP 1085
EP 1087
DI 10.4269/ajtmh.17-0250
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5QM
UT WOS:000423208300017
PM 28722594
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Stouffer, RL
   Woodruff, TK
AF Stouffer, Richard L.
   Woodruff, Teresa K.
TI Nonhuman Primates: A Vital Model for Basic and Applied Research on
   Female Reproduction, Prenatal Development, and Women's Health
SO ILAR JOURNAL
LA English
DT Article
DE contraception; endometriosis; germline genome editing; infertility;
   mitochondrial DNA-based diseases; polycystic ovary syndrome; preterm
   labor and delivery; uterine transplantation; Zika virus-induced fetal
   defects
ID POLYCYSTIC-OVARY-SYNDROME; UREAPLASMA INTRAAMNIOTIC INFECTION; UTERUS
   TRANSPLANTATION; CYNOMOLGUS MONKEY; MITOCHONDRIAL REPLACEMENT; INDUCED
   ENDOMETRIOSIS; FOLLICLE GROWTH; COMMON MARMOSET; GENE-EXPRESSION; BABOON
   MODEL
AB The comparative biology of reproduction and development in mammalian species is remarkable. Hence, because of similarities in environmental and neuroendocrine control of the reproductive axis, the cyclic function of the ovary and reproductive tract, establishment and control of the maternal-fetal-placental unit during pregnancy, and reproductive aging from puberty through menopause, nonhuman primates (NHPs) are valuable models for research related to women's reproductive health and its disorders. This chapter provides examples of research over the past 10+ years using Old World monkeys (notably macaque species), baboons, and to a lesser extent New World monkeys (especially marmosets) that contributed to our understanding of the etiology and therapies or prevention of: (1) ovarian disorders, e.g., polycystic ovary syndrome, mitochondrial DNA-based diseases from the oocyte; (2) uterine disorders, for example, endometriosis and uterine transplantation; and (3) pregnancy disorders, for example, preterm labor and delivery, environmental factors. Also, emerging opportunities such as viral (e.g., Zika) induced fetal defects and germline genomic editing to generate valuable primate models of human diseases (e.g., Huntington and muscular dystrophy) are addressed. Although the high costs, specialized resources, and ethical debate challenge the use of primates in biomedical research, their inclusion in fertility and infertility research is vital for continued improvements in women's reproductive health.
C1 [Stouffer, Richard L.] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA.
   [Stouffer, Richard L.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
   [Woodruff, Teresa K.] Northwestern Univ, Obstet & Gynecol, Chicago, IL 60611 USA.
   [Woodruff, Teresa K.] Northwestern Univ, OB GYN, Chicago, IL 60611 USA.
   [Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Div Reprod Sci Med, Chicago, IL 60611 USA.
   [Woodruff, Teresa K.] Northwestern Univ, Weinberg Coll Arts & Sci, Mol Biosci, Chicago, IL 60611 USA.
RP Stouffer, RL (corresponding author), Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA.; Stouffer, RL (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
EM stouffri@ohsu.edu
FU NIH, Eunice Kennedy Shriver National Institute of Child Health and Human
   Development, including the National Centers for Translational Research
   in Reproduction and Infertility [P50 HD076188, P50 HD071836];
   Contraceptive Development and Research Center [U54 HD055744]; NIH
   Primate Centers program, Office of the Director [P51 OD011092]
FX Special thanks to scientists that contributed to the NIH presentation,
   Drs. Charles Roberts (Oregon National Primate Research Center), Jon
   Levine and David Abbott (Wisconsin National Primate Research Center),
   Kyle Orwig (University of Pittsburgh), and Asgi Fazeleabas (Michigan
   State University). The authors' research is funded primarily through the
   NIH, especially the Eunice Kennedy Shriver National Institute of Child
   Health and Human Development, including the National Centers for
   Translational Research in Reproduction and Infertility (P50 HD076188,
   TKW; P50 HD071836, RLS) and Contraceptive Development and Research
   Center (U54 HD055744, RLS). Dr. Stouffer's research is supported by the
   resources and infrastructure of the NIH Primate Centers program, Office
   of the Director (P51 OD011092).
CR Abbott DH, 2016, CURR PHARM DESIGN, V22, P5625, DOI 10.2174/1381612822666160715133437
   Abu Shehab M, 2014, ENDOCRINOLOGY, V155, P1327, DOI 10.1210/en.2013-1759
   Adashi EY, 2016, CELL, V164, P832, DOI 10.1016/j.cell.2016.02.018
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Ataman LM, 2020, JCO GLOB ONCOL, V6, P317, DOI 10.1200/JGO.2015.000307
   Banerjee P, 2011, REV ENDOCR METAB DIS, V12, P323, DOI 10.1007/s11154-011-9193-1
   Bennett AJ, 2016, AM J PRIMATOL, V78, P1282, DOI 10.1002/ajp.22582
   Bethea CL, 2016, NEUROBIOL AGING, V37, P179, DOI 10.1016/j.neurobiolaging.2015.10.004
   Binette A, 2017, J WOMENS HEALTH, V26, P44, DOI 10.1089/jwh.2016.5854
   Bishop CV, 2016, FERTIL STERIL, V105, P1023, DOI 10.1016/j.fertnstert.2015.11.045
   Bishop CV, 2009, AM J PRIMATOL, V71, P384, DOI 10.1002/ajp.20664
   Brannstrom M, 2016, FERTIL STERIL, V106, P261, DOI 10.1016/j.fertnstert.2016.04.001
   Brannstrom M, 2012, FERTIL STERIL, V97, P1269, DOI 10.1016/j.fertnstert.2012.04.001
   Braundmeier A, 2012, HUM REPROD, V27, P1712, DOI 10.1093/humrep/des083
   Braundmeier AG, 2009, MOL HUM REPROD, V15, P577, DOI 10.1093/molehr/gap057
   Cardoso RC, 2016, ENDOCRINOLOGY, V157, P4641, DOI 10.1210/en.2016-1613
   Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054
   Chaffin CL, 2013, EXP BIOL MED, V238, P539, DOI 10.1177/1535370213489437
   Chan AWS, 2001, SCIENCE, V291, P309, DOI 10.1126/science.291.5502.309
   Chen Y, 2016, J INTERN MED, V280, P246, DOI 10.1111/joim.12469
   Chen YC, 2015, CELL STEM CELL, V17, P116, DOI 10.1016/j.stem.2015.06.004
   Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120
   Coksaygan T, 2010, REPROD SCI, V17, p178A
   Cox LA, 2013, ILAR J, V54, P106, DOI 10.1093/ilar/ilt038
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Hooghe TM, 2009, REPROD SCI, V16, P152, DOI 10.1177/1933719108322430
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018
   Duncan FE, 2016, REPRODUCTION, V152, pR201, DOI 10.1530/REP-15-0598
   Falconer H, 2006, HUM REPROD, V21, P1856, DOI 10.1093/humrep/del044
   Fazleabas AT, 2010, SEMIN REPROD MED, V28, P75, DOI 10.1055/s-0029-1242997
   Fereydouni B, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2480298
   Franke K, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00092
   Frias AE, 2015, MAGN RESON MED, V73, P1570, DOI 10.1002/mrm.25264
   Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332
   George JT, 2016, J CLIN ENDOCR METAB, V101, P4313, DOI 10.1210/jc.2016-1202
   Golos TG, 2010, INT J DEV BIOL, V54, P431, DOI 10.1387/ijdb.082797tg
   Goy R W, 1972, UCLA Forum Med Sci, V15, P193
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Grigsby PL, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.871
   Haluska GJ, 2002, J SOC GYNECOL INVEST, V9, P125, DOI 10.1016/S1071-5576(02)00144-2
   Hanson B, 2017, J ASSIST REPROD GEN, V34, P167, DOI 10.1007/s10815-016-0836-8
   Harirchian P, 2012, HUM REPROD, V27, P2341, DOI 10.1093/humrep/des196
   Hayden EC, 2016, NATURE, V532, P16
   Horikoshi M, 2016, NATURE, V538, P248, DOI 10.1038/nature19806
   Hussein M, 2016, FERTIL STERIL, V105, P815, DOI 10.1016/j.fertnstert.2015.11.022
   Jensen JT, 2016, CONTRACEPTION, V94, P527, DOI 10.1016/j.contraception.2016.07.008
   Jiang ZL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17898
   Johannesson L, 2012, HUM REPROD, V27, P1640, DOI 10.1093/humrep/des093
   Joshi NR, 2015, HUM REPROD, V30, P2881, DOI 10.1093/humrep/dev229
   Kang Y, 2015, HUM MOL GENET, V24, P7255, DOI 10.1093/hmg/ddv425
   Kaplan JR, 2004, ILAR J, V45, P83, DOI 10.1093/ilar.45.2.83
   Kapoor A, 2014, PEDIATR RES, V75, P476, DOI 10.1038/pr.2014.1
   Kavitha JV, 2014, FASEB J, V28, P1294, DOI 10.1096/fj.13-242271
   Keator CS, 2011, FERTIL STERIL, V95, P1316, DOI 10.1016/j.fertnstert.2011.01.040
   Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109
   Kisu I, 2013, FERTIL STERIL, V100, P280, DOI 10.1016/j.fertnstert.2013.03.004
   Klein S, 2014, REPROD BIOMED ONLINE, V28, P116, DOI 10.1016/j.rbmo.2013.09.020
   Kohama SG, 2016, J NEUROSCI, V36, P10416, DOI 10.1523/JNEUROSCI.0909-16.2016
   Kuo AH, 2017, J PHYSIOL-LONDON, V595, P1093, DOI 10.1113/JP272908
   Langoi D, 2013, FERTIL STERIL, V99, P656, DOI 10.1016/j.fertnstert.2012.11.021
   Lebovic DI, 2010, ENDOCRINOLOGY, V151, P1846, DOI 10.1210/en.2009-1076
   Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018
   Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014
   Lo JO, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.016
   Lo JO, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.042
   March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399
   McAllister JM, 2014, P NATL ACAD SCI USA, V111, pE1519, DOI 10.1073/pnas.1400574111
   McGee WK, 2014, AM J PHYSIOL-ENDOC M, V306, pE1292, DOI 10.1152/ajpendo.00310.2013
   McGee WK, 2012, HUM REPROD, V27, P531, DOI 10.1093/humrep/der393
   Murphy MJ, 2016, ENDOCRINOLOGY, V157, P4378, DOI 10.1210/en.2016-1283
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027
   Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508
   Peluffo MC, 2014, HUM REPROD, V29, P1400, DOI 10.1093/humrep/deu083
   Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586
   Pereira SP, 2015, AM J PHYSIOL-RENAL, V308, pF1217, DOI 10.1152/ajprenal.00419.2014
   Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281
   Plant TM, 2012, FRONT NEUROENDOCRIN, V33, P160, DOI 10.1016/j.yfrne.2012.02.002
   Porteus MH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0859-y
   Puttabyatappa M, 2016, MOL CELL ENDOCRINOL, V435, P29, DOI 10.1016/j.mce.2015.11.030
   Roberts VHJ, 2012, REPROD SCI, V19, p128A
   Rogers PAW, 2017, REPROD SCI, V24, P202, DOI 10.1177/1933719116654991
   Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090
   Schabel MC, 2016, MAGN RESON MED, V76, P1551, DOI 10.1002/mrm.26052
   Siemionow MZ, 2010, PLAST RECONSTR SURG, V126, P308, DOI 10.1097/PRS.0b013e3181dcb6f4
   Slayden OD, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107722
   Solorzano CMB, 2012, STEROIDS, V77, P332, DOI 10.1016/j.steroids.2011.12.007
   Story L, 2004, ILAR J, V45, P132, DOI 10.1093/ilar.45.2.132
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tang L, 2017, REPRODUCTION, V153, pR27, DOI 10.1530/REP-16-0287
   THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844
   Toner JP, 2016, FERTIL STERIL, V106, P541, DOI 10.1016/j.fertnstert.2016.05.026
   True C, 2016, END SOC 98 ANN M EXP
   True C, 2017, HUM REPROD IN PRESS
   Tryphonopoulos P, 2014, TRANSPLANTATION, V98, pE51, DOI 10.1097/TP.0000000000000322
   Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494
   Waites KB, 2009, SEMIN FETAL NEONAT M, V14, P190, DOI 10.1016/j.siny.2008.11.009
   Wan HF, 2015, CELL RES, V25, P258, DOI 10.1038/cr.2014.158
   Wolf DP, 2017, STEM CELLS, V35, P26, DOI 10.1002/stem.2496
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Wolfe B, 2017, MBIO, V8, DOI 10.1128/mBio.01938-16
   Woodruff T, 2016, NONHUMAN PRIAMTES CR
   Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042
   Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286
   Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975
   Zhang J., 2016, ANN M AM SOC REPR ME
NR 107
TC 6
Z9 6
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1084-2020
EI 1930-6180
J9 ILAR J
JI ILAR J.
PY 2017
VL 58
IS 2
BP 281
EP 294
DI 10.1093/ilar/ilx027
PG 14
WC Veterinary Sciences
SC Veterinary Sciences
GA FT1CW
UT WOS:000422873000012
PM 28985318
OA Green Published, Bronze
DA 2020-07-08
ER

PT S
AU Yeom, JS
   Kostova-Vassilevska, T
   Barnes, PD
   Jefferson, DR
   Oppelstrup, T
AF Yeom, Jae-Seung
   Kostova-Vassilevska, Tanya
   Barnes, Peter D., Jr.
   Jefferson, David R.
   Oppelstrup, Tomas
GP IEEE
TI Exploratory Modeling and Simulation of the Evolutionary Dynamics of
   Single-stranded RNA Virus Populations
SO 2017 IEEE INTERNATIONAL PARALLEL AND DISTRIBUTED PROCESSING SYMPOSIUM
   WORKSHOPS (IPDPSW)
SE IEEE International Symposium on Parallel and Distributed Processing
   Workshops
LA English
DT Proceedings Paper
CT 31st IEEE International Parallel and Distributed Processing Symposium
   Workshops (IPDPS)
CY MAY 29-JUN 02, 2017
CL Orlando, FL
SP IEEE, IEEE Comp Soc, ACM SIGARCH, IEEE Comp Soc Tech Comm Comp Architecture, IEEE Comp Soc Tech Comm Distributed Proc
ID DENGUE VIRUS; FITNESS
AB Infection, replication and mutation govern the population dynamics of viruses and are the key mechanisms driving their evolution. In particular, RNA viruses (such as the causative agents of Ebola, Dengue, Zika, West Nile, and SARS) have the highest mutation rates which enable them to form highly diverse populations within a single host, evade immune responses and develop resistances to drugs. Understanding the complexity of virus evolution is crucial for developing reliable countermeasures.
   We present an exploratory simulation model to study the evolution of heterogeneous virus populations in heterogeneous cell environments. This is a unique model that operates at three scales and captures the core mechanisms of the evolutionary process. To the best of our knowledge, this is the first HPC-based simulation of its kind.
C1 [Yeom, Jae-Seung; Kostova-Vassilevska, Tanya; Barnes, Peter D., Jr.; Jefferson, David R.; Oppelstrup, Tomas] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
RP Yeom, JS (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94551 USA.
EM yeom2@llnl.gov; vassilevska1@llnl.gov; barnes26@llnl.gov;
   drjefferson@llnl.gov; oppelstrup2@llnl.gov
FU U.S. Department of Energy by Lawrence Livermore National Laboratory
   (LDRD project) [14-ERD-062, DE-AC52-07NA27344]; Office of Science of the
   U.S. Department of EnergyUnited States Department of Energy (DOE)
   [DE-AC05-00OR22725]
FX This work was performed under the auspices of the U.S. Department of
   Energy by Lawrence Livermore National Laboratory (LDRD project
   14-ERD-062 under Contract DE-AC52-07NA27344). LLNL-CONF-706818. This
   research used resources of the Oak Ridge Leadership Facility at the Oak
   Ridge National Laboratory, which is supported by the Office of Science
   of the U.S. Department of Energy under Contract No. DE-AC05-00OR22725.
CR Alvarez D., 2008, VIROLOGY, V375
   Asgari E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141287
   BANKES S, 1993, OPER RES, V41, P435, DOI 10.1287/opre.41.3.435
   Barnes  Jr P., 2014, WINT SIM C
   Barua S., 2014, NANOTODAY, V9
   Carothers C., 2002, J PARALLEL DISTRIB C, V62
   Chou T, 2007, BIOPHYS J, V93, P1116, DOI 10.1529/biophysj.107.106708
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   FUJIMOTO R, 1999, PARALLEL DISTRIBUTED
   Hughes A., 2002, IEEE HIGH PERFORMANC
   JEFFERSON DR, 1985, ACM T PROGR LANG SYS, V7, P404, DOI 10.1145/3916.3988
   Jenkins GM, 2001, MOL BIOL EVOL, V18, P987, DOI 10.1093/oxfordjournals.molbev.a003900
   Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272
   Khromykh A., 2001, J VIROL, V75
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Lazaro E, 2002, J VIROL, V76, P8675, DOI 10.1128/JVI.76.17.8675-8681.2002
   Alcaraz-Estrada SL, 2010, FUTURE VIROL, V5, P575, DOI 10.2217/FVL.10.49
   Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889
   Mozhayskiy V., 2011, TERAGRID C EXTR DIG
   Nonacs P., 2012, J EVOLUTIONARY MED, V1
   Ribeiro RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002881
   Simon-Loriere E., 2011, NAT REV MICROBIOL
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Woo HJ, 2014, J VIROL, V88, P1039, DOI 10.1128/JVI.02958-13
   Xia Z, 2011, IBM J RES DEV, V55, DOI 10.1147/JRD.2011.2163276
   Zemla A., 2014, BIOINFORMATICS BIOL, V8
NR 29
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2164-7062
BN 978-0-7695-6149-3
J9 IEEE SYM PARA DISTR
PY 2017
BP 263
EP 272
DI 10.1109/IPDPSW.2017.139
PG 10
WC Computer Science, Hardware & Architecture; Computer Science, Theory &
   Methods
SC Computer Science
GA BJ1DG
UT WOS:000417418900031
DA 2020-07-08
ER

PT S
AU Li, K
   Principe, JC
AF Li, Kan
   Principe, Jose C.
GP IEEE
TI AUTOMATIC INSECT RECOGNITION USING OPTICAL FLIGHT DYNAMICS MODELED BY
   KERNEL ADAPTIVE ARMA NETWORK
SO 2017 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL
   PROCESSING (ICASSP)
SE International Conference on Acoustics Speech and Signal Processing
   ICASSP
LA English
DT Proceedings Paper
CT IEEE International Conference on Acoustics, Speech, and Signal
   Processing (ICASSP)
CY MAR 05-09, 2017
CL New Orleans, LA
SP IEEE, Inst Elect & Elect Engineers, Signal Proc Soc
DE Audio processing; computational entomology; dynamic modeling; kernel
   adaptive filtering
AB Automatic insect recognition (AIR), using noninvasive methods in situ, has far-reaching implications in entomology, agriculture, and disease control and prevention. An emerging technology in computational entomology uses flight information captured by laser sensors. Current methods treat these optical signals as static patterns, rather than time series. We propose a novel approach to AIR by evaluating each insect passage as a nonstationary process involving a sequence of pseudo-acoustic frames and modeling the short-term flight dynamics using the kernel adaptive autoregressive-moving average (KAARMA) algorithm. Since flight behavior is both nonlinear and nonstationary in nature, dynamic modeling provides a general framework that fully exploits the transitional and contextual information. Results show KAARMA classifier outperforms the state-of-the-art AIR methods, using support vector machine (SYM), deep-learning autoencoder, and batch learning, in identifying Zika vector mosquito Aedes aegypti among five species of flying insects, while using significantly more efficient data representation.
C1 [Li, Kan; Principe, Jose C.] Univ Florida, Computat NeuroEngn Lab, Gainesville, FL 32611 USA.
RP Li, K (corresponding author), Univ Florida, Computat NeuroEngn Lab, Gainesville, FL 32611 USA.
FU DARPAUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA) [N66001-10-C-2008, N66001-15-1-4054]
FX This work was supported by DARPA Contracts N66001-10-C-2008 and
   N66001-15-1-4054.
CR ATAL BS, 1971, J ACOUST SOC AM, V50, P637, DOI 10.1121/1.1912679
   Barcellos D. R., 2016, EMERG INFECT DIS, V22
   Batista G., 2011, P 17 ACM SIGKDD INT, P761
   DAVIS SB, 1980, IEEE T ACOUST SPEECH, V28, P357, DOI 10.1109/TASSP.1980.1163420
   de Souza VMA, 2013, 2013 BRAZILIAN CONFERENCE ON INTELLIGENT SYSTEMS (BRACIS), P76, DOI 10.1109/BRACIS.2013.21
   Gill R. J., 2015, J INTELLIGENT ROB S1, V80, pS313
   Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585
   Grube A., 2011, PESTICIDES IND SALES
   Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4
   Li K., 2015, IEEE T NEURAL NETW L
   Liu WF, 2007, IEEE T SIGNAL PROCES, V55, P5286, DOI 10.1109/TSP.2007.896065
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pimentel David, 2009, P89, DOI 10.1007/978-1-4020-8992-3_4
   Potts SG, 2016, ASSESSMENT REPORT PO
   QI YQ, 2015, P IJCNN, V337, P1, DOI DOI 10.1007/978-3-662-46463-2_1
   Reed SC, 1942, GENETICS, V27, P0349
   Sathantriphop S, 2006, TROP BIOMED, V23, P97
   Silva DF, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P99, DOI 10.1109/ICMLA.2013.24
   Vincent P., 2008, P 25 INT C MACH LEAR, P1096, DOI [10.1145/1390156.1390294, DOI 10.1145/1390156.1390294]
   World Health Organization, 2014, WHODCOWHD20141
NR 20
TC 3
Z9 3
U1 0
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1520-6149
BN 978-1-5090-4117-6
J9 INT CONF ACOUST SPEE
PY 2017
BP 2726
EP 2730
PG 5
WC Acoustics; Engineering, Electrical & Electronic
SC Acoustics; Engineering
GA BI7JW
UT WOS:000414286202180
DA 2020-07-08
ER

PT S
AU Liu, Z
AF Liu, Zheng
BE Zhu, L
   Zheng, T
TI How To Weaken Zika Virus?
SO PROCEEDINGS OF THE 2017 2ND INTERNATIONAL CONFERENCE ON MACHINERY,
   ELECTRONICS AND CONTROL SIMULATION (MECS 2017)
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Machinery, Electronics and Control
   Simulation (MECS)
CY JUN 24-25, 2017
CL Taiyuan, PEOPLES R CHINA
SP Xinxiang Univ
DE SEIR; differential equations; delay differential equations; spreading
   trend
AB This paper mainly focuses on providing a plan for using Wolbachia to influence the mosquito population with Zika Virus. In our SEIR Model we first obtain and solve a series of differential equations to predict the tread of Zika spreading, based on this model, we bulid a Wolbachia Spread In Mosquitoes Model to find how Wolbachia invades the population of mosquito. By building a series of delay differential equations, we successfully predict the Zika virus spreading trend after introducing modified mosquitoes. The results shows that at least 450000 modified mosquitoes are needed to meet the constraints.
C1 [Liu, Zheng] Sch North China Elect Power Univ, Baoding 071003, Peoples R China.
RP Liu, Z (corresponding author), Sch North China Elect Power Univ, Baoding 071003, Peoples R China.
EM hbxt3281510@163.com
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S., LANCET
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-6252-352-4
J9 AER ADV ENG RES
PY 2017
VL 138
BP 599
EP 602
PG 4
WC Engineering, Multidisciplinary
SC Engineering
GA BI7ZU
UT WOS:000414864800112
DA 2020-07-08
ER

PT J
AU Webb, D
   Yagnik, P
AF Webb, Douglas
   Yagnik, Pallavi
TI Responding to Zika; the imperative to ensure rights and protection
SO VULNERABLE CHILDREN AND YOUTH STUDIES
LA English
DT Editorial Material
DE Zika; social protection; socio-economic impacts; human rights
ID VIRUS; INEQUALITIES; AMERICA; BRAZIL
AB The Zika virus, transmitted by the Aedes aegypti mosquito, has spread extensively throughout Latin America and the Caribbean. It is the first mosquito-borne disease known to be sexually transmitted and to cause neurological damage to foetuses and neonates, with the developmental sequelae now known as 'congenital Zika syndrome'. 'A Socio-economic Impact Assessment of the Zika Virus in Latin America and the Caribbean' highlights the disproportionate impacts of Zika on the poorest and most vulnerable groups, particularly women and children in peri-urban communities. This distribution of impact has the potential to widen existing inequities and undo impressive health and development gains in the region over the past few decades. The short-term cost for Latin America and the Caribbean is estimated in the range of US$7-18 billion over the period 2015-2017, while the lifetime cost of caring for infants with congenital Zika syndrome (including long-term medical care and lost productivity) is projected between $3 and $29 billion. This article expands on one of the Assessment's recommendations: for governments to ensure the rights of the affected through the enhancement and adaptation of social protection in the context of Zika, while better identifying and including groups susceptible and vulnerable to the impacts of Zika. We analyse the relevant human rights obligations of states and social protection instruments that can be provided to families affected by Zika. We argue that current welfare adaptations, while needed, are insufficient and that further changes should be based on redefined minimumstandards of care and support. Country-specific assessments are needed to identify relevant unit costs to inform fiscal planning. Further analysis of the nature and extent of the unfolding impacts of Zika on vulnerable groups and the efficacy of social protection systems will better inform and strengthen multisectoral responses and support to affected communities.
C1 [Webb, Douglas; Yagnik, Pallavi] UNPD, HIV Hlth & Dev Grp, New York, NY 10017 USA.
RP Webb, D (corresponding author), UNPD, HIV Hlth & Dev Grp, New York, NY 10017 USA.
EM douglas.webb@undp.org
CR Bailey SR, 2014, DEMOGR RES, V31, P735, DOI 10.4054/DemRes.2014.31.24
   Campbell OMR, 2016, TROP MED INT HEALTH, V21, P486, DOI 10.1111/tmi.12681
   Castro J., 2015, CROSS COMP ANAL COUN
   Castro J., 2015, WATERLAT GOBACIT NET
   Center for Reproductive Rights, 2015, AB REPR RIGHTS LAT A
   Devereux S, 2004, TRANSFORMATIVE SOCIA
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Diniz D, 2010, CIENC SAUDE COLETIVA, V15, P959, DOI 10.1590/S1413-81232010000700002
   Economic Commission for Latin America and the Caribbean (ECLAC), 2016, LAT AM WORLDS MOST U
   Fiszbein Arid, 2009, CONDITIONAL CASH TRA
   Fried S., 2016, OPEN DEMOCRACY
   Hall A, 2006, J LAT AM STUD, V38, P689, DOI 10.1017/S0022216X0600157X
   Handa S., 2010, SOCIAL PROTECTION AF, DOI [10.4324/9780203842812, DOI 10.4324/9780203842812]
   Hausmann R., 2012, GLOBAL GENDER GAP RE
   Institute G., 2016, AB LAT AM CAR
   International Fund for Agricultural Development (IFAD) International Development Research Center (IDRC), 2011, POV IN
   International Labour Organization (ILO) Economic Commission for Latin America and the Caribbean (ECLAC) Food and Agriculture Organization of the United Nations (FAO), 2013, DEC WORK GEND EQ POL
   Jamaica Observer, 2016, 1000 WORK BE TRAIN C
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   McDonald B., 2016, NY TIMES
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Pan American Health Organization (PAHO), 2017, SOC PROT HTLH
   Pan American Health Organization (PAHO), 2017, CUM ZIK SUSP CONF CA
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Quinn SC, 2014, BIOSECUR BIOTERROR, V12, P263, DOI 10.1089/bsp.2014.0032
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Simmins J. C. H, 2016, ESTABLISHING B UNPUB, DOI [10.2471/BLT.16.171223, DOI 10.2471/BLT.16.171223]
   Soares V. A., 2008, LAT AM RES REV, V45, P173, DOI [10.1353/lar.2010.0017, DOI 10.1353/LAR.2010.0017]
   Social Research Center (SRC), 2008, INTR EMP COND CASH T
   Stevens P, 2004, DIS POVERTY 10 90 GA
   UNDP, 2016, MULT PROGR WELL BEIN
   [United Nations Development Programme Roll Back Malaria Partnership], 2013, MULT ACT FRAM MAL
   United Nations Development Programme (UNDP) International Federation of Red Cross and Red Crescent Societies (IFRCRCS), 2017, SOC IMP ASS ZIK VIR
   Women Enabled International (WEI), 2016, TALK POINTS ZIK MICR
   World Bank, 2017, LAT AM CAR OV
   World Bank, 2013, IN LAT AM FALLS CHAL
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yale University, 2017, SCIENCEDAILY
NR 40
TC 0
Z9 0
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1745-0128
EI 1745-0136
J9 VULNERABLE CHILD YOU
JI Vulnerable Child. Youth Stud.
PY 2017
VL 12
IS 3
BP 182
EP 194
DI 10.1080/17450128.2017.1330577
PG 13
WC Family Studies
SC Family Studies
GA FQ7FL
UT WOS:000418528200001
DA 2020-07-08
ER

PT J
AU Vroon, P
   Roosblad, J
   Poese, F
   Wilschut, J
   Codrington, J
   Vreden, S
   Zonneveld, R
AF Vroon, Pieter
   Roosblad, Jimmy
   Poese, Fauzia
   Wilschut, Jan
   Codrington, John
   Vreden, Stephen
   Zonneveld, Rens
TI Severity of acute Zika virus infection: A prospective emergency room
   surveillance study during the 2015-2016 outbreak in Suriname
SO IDCASES
LA English
DT Article
DE Zika; ZIKV; Suriname; SIRS
ID EPIDEMIOLOGY; AMERICA
AB Acute Zika virus (ZIKV) infection is usually mild and self-limiting. Earlier, we reported three cases of fatal acute ZIKV infection in patients without typical signs of ZIKV, but rather with criteria of systemic inflammation response syndrome (SIRS). To follow up these observations, we prospectively included patients at the emergency room with temperature instability and suspected to have acute ZIKV infection, SIRS, or both. A total of 102 patients were included of whom N = 21 (21%) were suspected of acute ZIKV infection, N = 56 (55%) of acute ZIKV infection with SIRS criteria, and N = 25 (24%) of SIRS alone. ZIKV-PCR was positive in N = 21 (20%) patients. Eight (38%) ZIKV-positive patients needed admission to the hospital of whom four (50%) presented with SIRS alone. One ZIKV-positive patient had vascular co-morbidity and died following shock and severe coagulopathy. We confirm the hypothesis that acute ZIKV infection can present atypical and severely with systemic inflammation and have lethal course particularly amongst patients with significant prior disease.
C1 [Vroon, Pieter] Erasmus Univ, Rotterdam, Netherlands.
   [Roosblad, Jimmy; Codrington, John] Acad Hosp Paramaribo, Clin Lab, Paramaribo, Suriname.
   [Poese, Fauzia] Acad Hosp Paramaribo, Emergency Dept, Paramaribo, Suriname.
   [Vreden, Stephen] Acad Hosp Paramaribo, Dept Internal Med, Paramaribo, Suriname.
   [Vreden, Stephen] Acad Hosp Paramaribo, Ctr Excellence Neglected Infect Dis, Paramaribo, Suriname.
   [Zonneveld, Rens] Acad Hosp Paramaribo, Sci Res Ctr Suriname, Paramaribo, Suriname.
   [Zonneveld, Rens] Acad Hosp Paramaribo, Dept Pediat, Paramaribo, Suriname.
   [Wilschut, Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Virol, Groningen, Netherlands.
   [Zonneveld, Rens] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.
RP Zonneveld, R (corresponding author), Acad Hosp Paramaribo, Flustr 1, Paramaribo, Suriname.
EM rens.zonneveld@gmail.com
FU Ministry of Health of Suriname
FX Funding was received from the Ministry of Health of Suriname for
   completion of this work. The authors acknowledge all the participating
   employees, students (in particular Mr. Charlton Pika, Ms. Shifana
   Jessurun, Mr. Milton Welzijn, Ms. Rishma Bodhitewarie, Mr. Viresh
   Dwarkasing, Ms. Cindy Reyke, and Ms. Fabiola Inkt) and residents of the
   emergency department of the Academic Hospital Paramaribo. We also thank
   employees of the Clinical Laboratory of the Academic Hospital Paramaribo
   for their efforts, in particular Mr. Henk Brunings for performing ZIKV
   PCR.
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Deseda CC, 2017, CURR OPIN PEDIATR, V29, P97, DOI 10.1097/MOP.0000000000000442
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Lindo J, 2013, PATHOG GLOB HEALTH, V107, P329, DOI 10.1179/2047773213Y.0000000112
   Makhluf H, 2015, CRIT REV IMMUNOL, V35, P253, DOI 10.1615/CritRevImmunol.2015014251
   MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rolle A, 2016, EMERG INFECT DIS, V22, P891, DOI 10.3201/eid2205.151449
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Teixeira MG, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003812
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
   Zonneveld R, 2014, CRIT CARE, V18, DOI 10.1186/cc13733
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-2509
J9 IDCases
JI IDCases
PY 2017
VL 10
BP 117
EP 121
DI 10.1016/j.idcr.2017.10.007
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA FQ5YH
UT WOS:000418436700041
PM 29147641
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Ernawan, B
   Tambunan, UF
   Sugoro, I
   Sasmita, H
AF Ernawan, Beni
   Tambunan, UsmanSumo Friend
   Sugoro, Irawan
   Sasmita, HadianIman
BE Murkovic, M
   Risuleo, C
   Prasetyo, EN
   Shovitri, M
   Nyanhongo, GS
TI Effects of Gamma Irradiation Dose-Rate on Sterile Male Aedesaegypti
SO PROCEEDING OF INTERNATIONAL BIOLOGY CONFERENCE 2016: BIODIVERSITY AND
   BIOTECHNOLOGY FOR HUMAN WELFARE
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 3rd International Biology Conference (IBOC) - Biodiversity and
   Biotechnology for Human Welfare / 10th Korea-ASEAN Biomass Symposium
CY OCT 15, 2016
CL Surabaya, INDONESIA
SP Inst Teknologi, Fac Math Nat Sci, Dept Biol, Kampus ITS Sukolilo
DE gamma-irradiation; dose-rate; Aedesaegypti; emergence; longevity;
   sterility and mating competitiveness
ID MATING COMPETITIVENESS; AEDES-AEGYPTI; ZIKA VIRUS; MOSQUITOS
AB Aedesaegyptiis the most important vector for dengue, yellowfever and Zika viruses. Considering its medical importance, vector population control program utilizing radiation-basedsterile insect technique ( SIT) is one of the potential methods forpreventing and limiting the dispersal ofthese viruses. The present study was undertaken to evaluate the dose-rates effects of gamma-sterilization on quality parameters of sterile males. Males Ae. aegyptiatthe pupal stage were sterilized by applying70 Gy gamma-rays in varies dose-rates, i.e. 0 ( control), 300, 600, 900, 1200 and 1500Gy/h utilizingpanoramic irradiator. Adult malesthat emerged from the pupal stage were assessed for their quality parameters, which are the percentage of emergence, longevity, sterility and mating competitiveness. The results herein indicate that there was no major effect of dose-rate on the percentage of emergence, the data showedthat there were no differences betweenirradiated males compared with control. Generally, thelongevity of irradiated males was lower compared to control. The data also demonstrated that longevity was significantly increased atthe dose-rate from 300 to 900Gy/h, then decreased at the dose-rate 900 to 1500 Gy/h. Sterility of irradiated maleswas significantly different compared to control, whilethere was no significantly different at dose rate 300 to 1500 Gy/h. Mating competitiveness ofirradiated males was increased at the dose rate from 300 to 1200 Gy/h, then the value was decreased significantly at the dose rate 1500 Gy/h. The dose-rate effects of gamma-sterilizationwere discussed in the context genetic vector control, in particular, the SIT. The results give information and contribute to better understanding towards gamma-sterilization optimization and quality parameters of sterile male Ae. aegypti on SIT methods.
C1 [Ernawan, Beni; Sugoro, Irawan; Sasmita, HadianIman] Nat Nucl Energy Agency, Ctr Isotopes & Radiat Applicat, Jl Lebak Bulus Raya 49, Jakarta 12440, Indonesia.
   [Ernawan, Beni] Univ Indonesia, Fac Math & Nat Sci, Dept Chem, Grad Program, Kampus UI Depok, Java 16424, Indonesia.
   [Tambunan, UsmanSumo Friend] Univ Indonesia, Fac Math & Nat Sci, Dept Chem, Bioinformat Res Grp, Kampus UI Depok, Java 16424, Indonesia.
RP Ernawan, B (corresponding author), Nat Nucl Energy Agency, Ctr Isotopes & Radiat Applicat, Jl Lebak Bulus Raya 49, Jakarta 12440, Indonesia.; Ernawan, B (corresponding author), Univ Indonesia, Fac Math & Nat Sci, Dept Chem, Grad Program, Kampus UI Depok, Java 16424, Indonesia.
EM beni_e@batan.go.id; usman@ui.ac.id
RI Tambunan, Usman Sumo Friend/I-9443-2017
OI Tambunan, Usman Sumo Friend/0000-0001-6025-2195; Ernawan,
   Beni/0000-0003-1193-0003
FU Center for Education and Training-National Nuclear Energy Agency
   (Pusdiklat-Batan)
FX The authors grateful to Center for Education and Training-National
   Nuclear Energy Agency (Pusdiklat-Batan) for the research funding.
   Authors also gratefulto the staff of entomology laboratory and the
   operator of panoramic irradiator for the technical assistance.
CR Abdel-Malek A. A., 1966, J EC ENTOMOL, V59
   Abdel-Malek A. A., 1967, J EC ENTOMOL, V60
   Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10
   Chadee DD, 2016, ACTA TROP, V156, P137, DOI 10.1016/j.actatropica.2015.12.022
   Dowell RV, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P297, DOI 10.1007/1-4020-4051-2_11
   FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Helinski MEH, 2008, J MED ENTOMOL, V45, P698, DOI 10.1603/0022-2585(2008)45[698:MCOMAA]2.0.CO;2
   Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41
   Helinski MEH, 2009, ACTA TROP, V109, P64, DOI 10.1016/j.actatropica.2008.10.002
   Hendrichs J., 2007, P3
   Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2
   Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1
   KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459
   Lance DR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P69, DOI 10.1007/1-4020-4051-2_3
   Oliva CF, 2013, ACTA TROP, V125, P287, DOI 10.1016/j.actatropica.2012.11.010
   Sasmita H. I., 2014, SCI J APPL ISOTOPES, V10, P149
   SHARMA VP, 1978, J ECON ENTOMOL, V71, P449, DOI 10.1093/jee/71.3.449
   Shetty Vinaya, 2016, Parasite Epidemiol Control, V1, P26, DOI 10.1016/j.parepi.2016.02.007
   TAMBUNAN USF, 2011, TRENDS BIOINFORM, V4, P1
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wiwanitkit V, 2016, ASIAN PAC J TROP BIO, V6, P551, DOI 10.1016/j.apjtb.2016.03.014
   World Health Organization, 2016, DENG VACC RES
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0631-2
NR 30
TC 3
Z9 3
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1528-7
J9 AIP CONF PROC
PY 2017
VL 1854
AR 020010
DI 10.1063/1.4985401
PG 7
WC Biodiversity Conservation; Biotechnology & Applied Microbiology
SC Biodiversity & Conservation; Biotechnology & Applied Microbiology
GA BJ1BW
UT WOS:000417376200010
OA Bronze
DA 2020-07-08
ER

PT S
AU Souza, VMA
AF Souza, Vinicius M. A.
BE BeltranCastanon, C
   Nystrom, I
   Famili, F
TI Identifying Aedes aegypti Mosquitoes by Sensors and One-Class
   Classifiers
SO PROGRESS IN PATTERN RECOGNITION, IMAGE ANALYSIS, COMPUTER VISION, AND
   APPLICATIONS, CIARP 2016
SE Lecture Notes in Computer Science
LA English
DT Proceedings Paper
CT 21st Iberoamerican Congress on Pattern Recognition (CIARP)
CY NOV 08-11, 2016
CL Lima, PERU
SP Peruvian Assoc Pattern Recognit, Argentine Soc Pattern Recognit, Brazilian Comp Soc, Special Interest Grp, Chilean Assoc Pattern Recognit, Cuban Assoc Pattern Recognit, Mexican Assoc Comp Vis, Neural Comp & Robot, Spanish Assoc Pattern Recognit & Image Anal, Uruguayan Assoc Pattern Recognit, Portuguese Assoc Pattern Recognit, Int Assoc Pattern Recognit
DE Optical sensor; Insect classification; One-class classifiers
ID DENGUE; BURDEN
AB Yellow fever, zika, and dengue are some examples of arboviruses transmitted to the humans by the Aedes aegypti mosquitoes. The efforts to curb the transmission of these viral diseases are focused on the vector control. However, without the knowledge of the exact location of the insects with a reduced time delay, the use of techniques as chemical control becomes costly and inefficient. Recently, an optical sensor was proposed to gather real-time information about the spatio-temporal distributions of insects, supporting different vector control techniques. In field conditions, the assumption of knowledge of all classes of the problem, it is hard to be fulfilled. For this reason, we address the problem of insect classification by one-class classifiers, where the learning is performed only with positive examples (target class). In our experiments, we identify Aedes aegypti mosquitos with an AUC = 0.87.
C1 [Souza, Vinicius M. A.] Univ Sao Paulo, Inst Ciencias Matemat & Comp, Sao Carlos, SP, Brazil.
RP Souza, VMA (corresponding author), Univ Sao Paulo, Inst Ciencias Matemat & Comp, Sao Carlos, SP, Brazil.
EM vsouza@icmc.usp.br
RI Souza, Vinicius MA/B-5997-2013
OI Souza, Vinicius MA/0000-0003-3175-7922
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2011/17698-5, 2015/16004-0]
FX V.M.A. Souza-The author thank the financial support of FAPESP (Grants
   #2011/17698-5, and #2015/16004-0).
CR BEATTY ME, 2009, AM J TROP MED HYG S, V81, P231
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   DESOUZA VMA, 2013, P BRAZ C INT SYST, P76, DOI DOI 10.1109/BRACIS.2013.21
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   QI YQ, 2015, P IJCNN, V337, P1, DOI DOI 10.1007/978-3-662-46463-2_1
   Silva DF, 2015, J INTELL ROBOT SYST, V80, pS313, DOI 10.1007/s10846-014-0168-9
   Silva DF, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P99, DOI 10.1109/ICMLA.2013.24
   Souza V. M., 2015, P 2015 SIAM INT C DA, P873
   Souza V.M.A., 2015, P INT C MACH LEARN A, P214
   Stevens SS, 1937, J ACOUST SOC AM, V8, P185, DOI 10.1121/1.1915893
   Tax D M J, 2015, DDTOOLS DATA DESCRIP
   Tax D. M. J., 2001, THESIS
   Tax DMJ, 1999, PATTERN RECOGN LETT, V20, P1191, DOI 10.1016/S0167-8655(99)00087-2
   Tax DMJ, 2002, J MACH LEARN RES, V2, P155, DOI 10.1162/15324430260185583
   W.H.O, 2015, DENG SEV DENG, V117
   Wiegmann B., 1996, TREE LIFE DIPTERA
   Zhen Bin, 2001, Acta Scientiarum Naturalium Universitatis Pekinensis, V37, P371
NR 19
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0302-9743
EI 1611-3349
BN 978-3-319-52277-7; 978-3-319-52276-0
J9 LECT NOTES COMPUT SC
PY 2017
VL 10125
BP 10
EP 18
DI 10.1007/978-3-319-52277-7_2
PG 9
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods; Imaging Science & Photographic Technology
SC Computer Science; Imaging Science & Photographic Technology
GA BJ1XY
UT WOS:000418399200002
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika vaccine proved safe and immunogenic in early trial
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT News Item
CR Tebas P, 2017, NEW ENGL J MED, DOI [10. 1056/NEJMoa1708120, DOI 10.1056/NEJM0A1708120]
NR 1
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2017
VL 13
IS 12
SI SI
BP 2753
EP 2753
DI 10.1080/21645515.2017.1329070
PG 1
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA FQ0MT
UT WOS:000418052100010
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Maslow, JN
AF Maslow, Joel N.
TI Vaccines for emerging infectious diseases: Lessons from MERS coronavirus
   and Zika virus
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article; Proceedings Paper
CT 10th Annual Congress of the International-Society-for-Vaccines (ISV)
CY OCT 02-04, 2016
CL Boston, MA
SP Int Soc Vaccines
DE coronavirus; DNA vaccine; emerging infectious disease; epidemic;
   epidemiology; flavivirus; MERS-CoV; vaccine; Zika virus
ID EAST RESPIRATORY SYNDROME; ANTIBODY-DEPENDENT ENHANCEMENT; TO-HUMAN
   TRANSMISSION; MIDDLE-EAST; DENGUE VIRUS; NEUTRALIZING ANTIBODIES;
   DROMEDARY CAMELS; SAUDI-ARABIA; MONONUCLEAR PHAGOCYTES; SEXUAL
   TRANSMISSION
AB The past decade and a half has been characterized by numerous emerging infectious diseases. With each new threat, there has been a call for rapid vaccine development. Pathogens such as the Middle East Respiratory Syndrome coronavirus (MERS-CoV) and the Zika virus represent either new viral entities or viruses emergent in new geographic locales and characterized by novel complications. Both serve as paradigms for the global spread that can accompany new pathogens. In this paper, we review the epidemiology and pathogenesis of MERS-CoV and Zika virus with respect to vaccine development. The challenges in vaccine development and the approach to clinical trial design to test vaccine candidates for disease entities with a changing epidemiology are discussed.
C1 [Maslow, Joel N.] GeneOne Life Sci Inc, Seoul, South Korea.
RP Maslow, JN (corresponding author), GeneOne Life Sci Inc, 1040 DeKalb Pike,Suite 200, Blue, PA 19422 USA.
EM jmaslow@geneonels-us.com
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280
   Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Al-amri SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44875
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486
   Assiri A, 2016, EMERG INFECT DIS, V22, P32, DOI 10.3201/eid2201.151370
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barlan A, 2014, J VIROL, V88, P4953, DOI 10.1128/JVI.00161-14
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   BRANDT WE, 1982, INFECT IMMUN, V36, P1036, DOI 10.1128/IAI.36.3.1036-1041.1982
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14
   Chi H, 2017, VACCINE, V35, P2069, DOI 10.1016/j.vaccine.2017.02.063
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coleman CM, 2017, VACCINE, V35, P1586, DOI 10.1016/j.vaccine.2017.02.012
   Coleman CM, 2014, VACCINE, V32, P3169, DOI 10.1016/j.vaccine.2014.04.016
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951
   Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13
   Crameri G, 2016, EMERG INFECT DIS, V22, P1071, DOI 10.3201/eid2206.160007
   Crowe K, 2016, MICROCEPHALY CASES B
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Drosten C, 2014, NEW ENGL J MED, V371, P1359, DOI 10.1056/NEJMc1409847
   Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858
   Du LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13473
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2013, EP UPD ADD CONF CAS
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS
   European Centre for Disease Prevention and Control, 2013, UPD RAP RISK ASS SEV
   Excler JL, 2016, EMERG INFECT DIS, V22, pE1, DOI 10.3201/eid2208.160229
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250
   Farag Elmoubasher A. B. A., 2015, Infection Ecology & Epidemiology, V5, DOI 10.3402/iee.v5.28305
   Feikin DR, 2015, EMERG INFECT DIS, V21, P2029, DOI 10.3201/eid2111.150764
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Gastanaduy PA, 2013, MMWR-MORBID MORTAL W, V62, P480
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HALSTEAD SB, 1977, J EXP MED, V146, P218, DOI 10.1084/jem.146.1.218
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Hemida MG, 2017, TRANSBOUND EMERG DIS, V64, P344, DOI 10.1111/tbed.12401
   Hemida MG, 2015, EMERG INFECT DIS, V21, P699, DOI 10.3201/eid2104.141949
   Hemida MG, 2014, EMERG INFECT DIS, V20, P1231, DOI 10.3201/eid2007.140571
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110, DOI 10.4269/ajtmh.1970.19.110
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Johnson RF, 2015, VIROLOGY, V485, P422, DOI 10.1016/j.virol.2015.07.013
   Kennedy RB, 2016, EBIOMEDICINE, V13, P29, DOI 10.1016/j.ebiom.2016.10.016
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kim E, 2014, VACCINE, V32, P5975, DOI 10.1016/j.vaccine.2014.08.058
   Kim KM, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015041
   Kim SY, 2016, EMERG INFECT DIS, V22, P1813, DOI 10.3201/eid2210.160218
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Lan JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112602
   Laoprasopwattana K, 2005, J INFECT DIS, V192, P510, DOI 10.1086/431520
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee Sang-il, 2015, J Prev Med Public Health, V48, P274, DOI 10.3961/jpmph.15.064
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Majumder MS, 2015, EMERG INFECT DIS, V21, P2088, DOI 10.3201/eid2111.151231
   Malczyk AH, 2015, J VIROL, V89, P11654, DOI 10.1128/JVI.01815-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maslow JN, 2017, VACCINE, V35, P5437, DOI 10.1016/j.vaccine.2017.02.015
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Memish ZA, 2015, INFLUENZA OTHER RESP, V9, P64, DOI 10.1111/irv.12287
   Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172
   Memish ZA, 2013, NEW ENGL J MED, V369, P1761, DOI 10.1056/NEJMc1311004
   Meyer B, 2014, EMERG INFECT DIS, V20, P552, DOI 10.3201/eid2004.131746
   Ministerio da Saude (Brazil), 2015, MIN SAUD INV AUM CAS
   Modjarrad K, 2016, NAT MED, V22, P701, DOI 10.1038/nm.4131
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oh MD, 2015, J KOREAN MED SCI, V30, P1701, DOI 10.3346/jkms.2015.30.11.1701
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Pan Am Health Organization, 2015, EP
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Park WB, 2015, EMERG INFECT DIS, V21, P2186, DOI 10.3201/eid2112.151421
   Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Payne DC, 2016, EMERG INFECT DIS, V22, P1824, DOI 10.3201/eid2210.160706
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Reusken CBEM, 2016, EMERG INFECT DIS, V22, P1129, DOI 10.3201/eid2206.152113
   Reusken CBEM, 2014, EMERG INFECT DIS, V20, P1370, DOI 10.3201/eid2008.140590
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Senaratne T, 2016, J MED VIROL, V88, P1703, DOI 10.1002/jmv.24525
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun L., 2016, WASHINGTON POST
   Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490
   Tao XR, 2016, J VIROL, V90, P57, DOI 10.1128/JVI.02009-15
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12
   van Doremalen N, 2015, ANTIVIR RES, V122, P28, DOI 10.1016/j.antiviral.2015.07.005
   van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14
   Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang LF, 2007, CURR TOP MICROBIOL, V315, P325
   Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712
   Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009
   WHO, 2016, MIDDL E RESP SYNDR C
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Woo PCY, 2014, EMERG INFECT DIS, V20, P560, DOI 10.3201/eid2004.131769
   World Health Organization, 2016, CURR ZIK PROD PIP
   World Health Organization, 2013, GLOB AL RESP GAR NOV
   Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576
   Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111
   Yusof MF, 2015, VIRUS GENES, V50, P509, DOI 10.1007/s11262-015-1174-0
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang NR, 2015, VIRUS RES, V202, P151, DOI 10.1016/j.virusres.2014.11.013
   Zhao GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145561
   Zhao J, 2014, P NATL ACAD SCI USA, V111, P5
   Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10
NR 158
TC 10
Z9 11
U1 1
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2017
VL 13
IS 12
SI SI
BP 2918
EP 2930
DI 10.1080/21645515.2017.1358325
PG 13
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA FQ0MT
UT WOS:000418052100031
PM 28846484
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Bahamondes, L
   Ali, M
   Monteiro, I
   Fernandes, A
AF Bahamondes, Luis
   Ali, Moazzam
   Monteiro, Ilza
   Fernandes, Arlete
TI Stagnant contraceptive sales after the Zika epidemic in Brazil
SO EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE
LA English
DT Article
DE Brazil; contraceptive use; long-acting reversible contraception; Zika
   virus epidemic
AB Objectives: Our aim was to assess national hormonal and non-hormonal contraceptive sales in Brazil after the Zika virus outbreak.
   Methods: Pharmaceutical companies based in Brazil provided data on monthly sales from September 2016 to June 2017. Data from both the public and private sectors were obtained about sales of registered, available modern contraceptive methods: combined oral contraceptive pill; progestin-only pill; vaginal and transdermal contraceptives; injectable contraceptives; long-acting reversible contraceptive (LARC) methods, including the copper-releasing intrauterine device, the levonorgestrel-releasing intrauterine system and the etonogestrel-releasing subdermal implant; and emergency contraceptive pills.
   Results: Seventy-eight percent of sales comprised pills, patches and vaginal rings (11.1-13.8 million cycles/units per month), followed by emergency contraceptive pills (1.8-2.6 million pills), injectables (1.2-1.4 million ampoules) and LARC methods (6500-17,000 devices).
   Conclusions: The data showed much higher sales of short-acting methods compared with more effective LARC methods. The public sector needs to strengthen its focus on ensuring better access to LARC methods through a systematic approach ensuring regular supply, improved professional skills and better demand generation to couples wishing to avoid or delay pregnancy. In Zika virus-affected areas, many women of reproductive age may want to delay or postpone pregnancy by using an effective LARC method. The public sector should review its policies on LARC, as the need for these methods especially in Zika virus endemic areas may increase. A clear emphasis on quality in services, access and use is warranted.
C1 [Bahamondes, Luis; Monteiro, Ilza; Fernandes, Arlete] Univ Estadual Campinas, Family Planning Clin, Dept Obstet & Gynaecol, Med Sch, Caixa Postal 6181, BR-13084971 Campinas, SP, Brazil.
   [Ali, Moazzam] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland.
RP Bahamondes, L (corresponding author), Univ Estadual Campinas, Family Planning Clin, Dept Obstet & Gynaecol, Med Sch, Caixa Postal 6181, BR-13084971 Campinas, SP, Brazil.
EM bahamond@caism.unicamp.br
RI Fernandes, Arlete/I-7561-2018; monteiro, ilza m u/F-4871-2014
OI Fernandes, Arlete/0000-0001-5872-0017; monteiro, ilza m
   u/0000-0002-9536-0564
FU Fundacao de Apoio a Pesquisa do Estado de Sao Paulo, Brazil
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2015/20504-9]
FX The study was supported by Fundacao de Apoio a Pesquisa do Estado de Sao
   Paulo, Brazil (FAPESP) award # 2015/20504-9 and from a large anonymous
   donor. The funding sources did not play a role in the study design, in
   the collection, analysis and interpretation of data, in the writing of
   the report, or in the decision to submit the article for publication.
   This report contains the collective views of an international group of
   experts and does not necessarily represent the decisions or the stated
   policy of the WHO.
CR Ali M, 2017, EUR J CONTRACEP REPR, V22, P102, DOI 10.1080/13625187.2017.1288902
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Brazilian Ministry of Health, 2016, PREV COMB DENG CHIK
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Centers for Disease Control and Prevention, 2016, WOM THEIR PARTN TRYI
   Centers for Disease Control and Prevention, 2017, CDC AN DAT US TERR F
   Garcia-Subirats I, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-10
   Le HH, 2014, IN J WOMENS HEALTH, V6, P663, DOI 10.2147/IJWH.S61543
   World Health Organization, 2016, 5 M EM COMM INT HLTH
   World Health Organization, 2016, ZIK SIT REP 15 SEPT
NR 10
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1362-5187
EI 1473-0782
J9 EUR J CONTRACEP REPR
JI Eur. J. Contracept. Reprod. Health Care
PY 2017
VL 22
IS 5
BP 381
EP 383
DI 10.1080/13625187.2017.1397623
PG 3
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology
GA FP7LF
UT WOS:000417815100010
PM 29166843
OA Other Gold
DA 2020-07-08
ER

PT J
AU Esteves, E
   Rosa, N
   Correia, MJ
   Arrais, JP
   Barros, M
AF Esteves, Eduardo
   Rosa, Nuno
   Correia, Maria Jose
   Arrais, Joel P.
   Barros, Marlene
TI New Targets for Zika Virus Determined by Human-Viral Interactomic: A
   Bioinformatics Approach
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS2A; WEST-NILE-VIRUS; DENGUE VIRUS; JAPANESE
   ENCEPHALITIS; STRUCTURAL BIOLOGY; FLAVIVIRUS; NS1; CELLS; INFECTION;
   RECOGNITION
AB Identifying ZIKV factors interfering with human host pathways represents a major challenge in understanding ZIKV tropism and pathogenesis. The integration of proteomic, gene expression and Protein-Protein Interactions (PPIs) established between ZIKV and human host proteins predicted by the OralInt algorithm identified 1898 interactions with medium or high score (>= 0.7). Targets implicated in vesicular traffic and docking were identified. New receptors involved in endocytosis pathways as ZIKV entry targets, using both clathrin-dependent (17 receptors) and independent (10 receptors) pathways, are described. New targets used by the ZIKV to undermine the host's antiviral immune response are proposed based on predicted interactions established between the virus and host cell receptors and/or proteins with an effector or signaling role in the immune response such as IFN receptors and TLR. Complement and cytokines are proposed as extracellular potential interacting partners of the secreted form of NS1 ZIKV protein. Altogether, in this article, 18 new human targets for structural and nonstructural ZIKV proteins are proposed. These results are of great relevance for the understanding of viral pathogenesis and consequently the development of preventive (vaccines) and therapeutic targets for ZIKV infection management.
C1 [Esteves, Eduardo; Rosa, Nuno; Correia, Maria Jose; Barros, Marlene] Univ Catolica Portuguesa, Ctr Interdisciplinary Res Hlth CIIS, Inst Hlth Sci ICS, Viseu, Portugal.
   [Arrais, Joel P.] Univ Coimbra, CISUC, Dept Informat Engn DEI, Coimbra, Portugal.
RP Barros, M (corresponding author), Univ Catolica Portuguesa, Ctr Interdisciplinary Res Hlth CIIS, Inst Hlth Sci ICS, Viseu, Portugal.
EM mbarros@viseu.ucp.pt
RI Rosa, Nuno/A-5627-2013; Barros, Marlene/A-5604-2013; Correia,
   Maria/H-9952-2012
OI Rosa, Nuno/0000-0003-4604-0780; Esteves, Eduardo/0000-0001-5458-4978;
   Barros, Marlene/0000-0003-0631-4062; Correia, Maria/0000-0002-6141-9089;
   Arrais, Joel/0000-0003-4937-2334
FU Centre for Interdisciplinary Research in Health through FCT (Portuguese
   National Funding Agency for Science, Research, and Technology)
   [UID/MULTI/4279/2016]; SalivaTec through Mais CENTRO: Programa
   Operacional Regional do Centro under the Quadro de Referencia
   Estrategico Nacional (QREN); Fundo Europeu de Desenvolvimento Regional
   (FEDER)European Union (EU) [CENTRO-07-CT62-FEDER-005004]
FX This work was made possible by the support of Centre for
   Interdisciplinary Research in Health through funds from the FCT
   (Portuguese National Funding Agency for Science, Research, and
   Technology) granted to Unit 4279 (UID/MULTI/4279/2016) and by the
   support of SalivaTec through Mais CENTRO: Programa Operacional Regional
   do Centro under the Quadro de Referencia Estrategico Nacional (QREN) and
   through the Fundo Europeu de Desenvolvimento Regional (FEDER)
   (CENTRO-07-CT62-FEDER-005004).
CR Aguilera-Pesantes D., 2016, BIOCH BIOPHYSICAL RE
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Arrais JP, 2013, ARCH ORAL BIOL, V58, P762, DOI 10.1016/j.archoralbio.2012.12.012
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022
   Chang YS, 1999, J VIROL, V73, P6257, DOI 10.1128/JVI.73.8.6257-6264.1999
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Coelho ED, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-24
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   CROOKS AJ, 1990, J CHROMATOGR, V502, P59, DOI 10.1016/S0021-9673(01)89563-7
   Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737
   Dar HA, 2017, INFECT GENET EVOL, V51, P143, DOI 10.1016/j.meegid.2017.03.027
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gack MU, 2014, J VIROL, V88, P5213, DOI 10.1128/JVI.03370-13
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerold G, 2017, MOL CELL PROTEOMICS, V16, pS75, DOI 10.1074/mcp.R116.065649
   Gervasio OL, 2011, J CELL SCI, V124, P3581, DOI 10.1242/jcs.084376
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guirimand T, 2015, NUCLEIC ACIDS RES, V43, pD583, DOI 10.1093/nar/gku1121
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li XD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002891
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10
   McElroy KL, 2006, AM J TROP MED HYG, V75, P1158, DOI 10.4269/ajtmh.2006.75.1158
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rosa N, 2012, ARCH ORAL BIOL, V57, P853, DOI 10.1016/j.archoralbio.2011.12.010
   Rossi SL, 2007, VIROLOGY, V364, P184, DOI 10.1016/j.virol.2007.02.009
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   SCHLESINGER JJ, 1990, J GEN VIROL, V71, P593, DOI 10.1099/0022-1317-71-3-593
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thiemmeca S, 2016, J IMMUNOL, V197, P4053, DOI 10.4049/jimmunol.1600323
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Xu X., 2016, PLOS CURRENTS
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
NR 94
TC 2
Z9 3
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2017
VL 2017
AR 1734151
DI 10.1155/2017/1734151
PG 15
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA FP6OT
UT WOS:000417746100001
PM 29379794
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Aik, LE
   Kiang, LC
   Hong, TW
   Abu, MS
AF Aik, Lim Eng
   Kiang, Lam Chee
   Hong, Tan Wei
   Abu, Mohd Syafarudy
BE Puteh, M
   AbdHamid, NZ
   Adenan, NH
TI The SIR Model of Zika Virus Disease Outbreak in Brazil at Year 2015
SO PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON EDUCATION, MATHEMATICS
   AND SCIENCE 2016 (ICEMS2016) IN CONJUNCTION WITH INTERNATIONAL
   POSTGRADUATE CONFERENCE ON SCIENCE AND MATHEMATICS 2016 (IPCSM2016)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT International Conference on Education, Mathematics and Science (ICEMS)
CY NOV 19, 2016
CL Univ Pendidikan Sultan Idris, Fac Sci & Math, Perak, MALAYSIA
HO Univ Pendidikan Sultan Idris, Fac Sci & Math
AB This research study demonstrates a numerical model intended for comprehension the spread of the year 2015 Zika virus disease utilizing the standard SIR framework. In modeling virulent disease dynamics, it is important to explore whether the illness spread could accomplish a pandemic level or it could be eradicated. Information from the year 2015 Zika virus disease event is utilized and Brazil where the event began is considered in this research study. A three dimensional nonlinear differential equation is formulated and solved numerically utilizing the Euler's method in MS excel. It is appeared from the research study that, with health intercessions of public, the viable regenerative number can be decreased making it feasible for the event to cease to exist. It is additionally indicated numerically that the pandemic can just cease to exist when there are no new infected people in the populace.
C1 [Aik, Lim Eng; Abu, Mohd Syafarudy] Univ Malaysia Perlis, Inst Matemat Kejuruteraan, Ulu Pauh 02600, Perlis, Malaysia.
   [Kiang, Lam Chee; Hong, Tan Wei] Univ Malaysia Perlis, Pusat Pengajian Kejuruteraan Mekatron, Ulu Pauh 02600, Perlis, Malaysia.
RP Aik, LE (corresponding author), Univ Malaysia Perlis, Inst Matemat Kejuruteraan, Ulu Pauh 02600, Perlis, Malaysia.
EM ealim@unimap.edu.my
CR Carter R., 2015, REHABILITATION RES P, P25
   CDC, 2015, ID IS INF EM DEP EV
   Ellen R., 2016, ZIKA VIRUS WHAT HAPP
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Koriko O. K., 2008, American Journal of Applied Sciences, V5, P301
   Murray J. D., 2002, INTERDISCIPLINARY AP, V17, P315
   NHS, 2016, ZIK VIR INF
   Perkins T. A., 2016, 039610 BIORXIV
   Reynolds E., 2016, WHAT IS ZIKA VIRUS C
   Sweeney J., 2016, COLUMBIA NATION CONC
   Weiss Howard, 2013, MAT MATEMATICS, V3, P1
   WHO, 2016, PAR STAT
   WHO, 2016, VEN STAT
   WHO, 2016, BRAZ STAT
   World Health Organization, 2016, ZIK SIT REP
NR 15
TC 0
Z9 0
U1 0
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1519-5
J9 AIP CONF PROC
PY 2017
VL 1847
AR 020004
DI 10.1063/1.4983859
PG 6
WC Education, Scientific Disciplines; Mathematics, Interdisciplinary
   Applications
SC Education & Educational Research; Mathematics
GA BJ1BM
UT WOS:000417369700004
DA 2020-07-08
ER

PT S
AU Nugraha, ES
   Naiborhu, J
   Nuraini, N
   Ahmadin
AF Nugraha, Edwin Setiawan
   Naiborhu, Janson
   Nuraini, Nuning
   Ahmadin
BE Ibrahim, H
   Aziz, N
   Zulkepli, J
   Rohni, AM
   Nawawi, MKM
TI Mathematical Modeling for Control Zika Transmission
SO 13TH IMT-GT INTERNATIONAL CONFERENCE ON MATHEMATICS, STATISTICS AND
   THEIR APPLICATIONS (ICMSA2017)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 13th IMT-GT International Conference on Mathematics, Statistics and
   their Applications (ICMSA)
CY DEC 04-07, 2017
CL Univ Utara Malaysia, MALAYSIA
SP Persatuan Sains & Matematik Malaysia, Nat Sci Publishing
HO Univ Utara Malaysia
ID PREVENTION; BORNE
AB After 70 years since the zika was identified in Uganda, zika is now documented in 62 countries. In general, people infected with this disease do not experience severe conditions, but for pregnant women can cause serious problems because the zika can spread to the fetus. One result, zika can cause abnormalities in the fetal brain called microcephaly. Control and prevention are very important to reduce the spread of this disease. Here, we discussed the problem of optimal control in the model of zika transmission associated with the use of insecticide-treated nets (ITN) and indoor residual spraying (IRS). Using the approach of optimal control theory, we completed the objective function so that the infected population and its control cost are minimum. Numerically using the Forward-Backward Sweep Method, we obtained the control design of ITN and IRS as a function of time. The results show that the use of both simultaneously is more effective in reducing the population of infection than the use of ITN alone or the IRS alone.
C1 [Nugraha, Edwin Setiawan; Naiborhu, Janson; Nuraini, Nuning; Ahmadin] Inst Teknol Bandung, Dept Math, Bandung 40132, Indonesia.
RP Nugraha, ES (corresponding author), Inst Teknol Bandung, Dept Math, Bandung 40132, Indonesia.
EM edwin.setiawan@students.itb.ac.id; janson@math.itb.ac.id;
   nuning@math.itb.ac.id; ahmadin@students.itb.ac.id
FU Ministry of Research, Technology and Higher Education of the Republic of
   Indonesia
FX This research is funded by Ministry of Research, Technology and Higher
   Education of the Republic of Indonesia.
CR Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Blayneh K, 2009, DISCRETE CONT DYN-B, V11, P587, DOI 10.3934/dcdsb.2009.11.587
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brauer F., 2001, MATH MODELS POPULATI, V40
   Brauer F, 2012, MATH MODELS COMMUNIC
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Griffin M. P., 2012, SIAM UNDERGRADUATE R, V6
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Padmanabhan P., 2017, LETT BIOMATHEMATICS, V4, P148, DOI DOI 10.1080/23737867.2017.1319746
   Pontryagin L. S., 1962, MATH THEORY OPTIMAL
NR 17
TC 0
Z9 0
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1595-9
J9 AIP CONF PROC
PY 2017
VL 1905
AR UNSP 030026
DI 10.1063/1.5012172
PG 6
WC Mathematics, Applied; Physics, Applied; Statistics & Probability
SC Mathematics; Physics
GA BJ0MX
UT WOS:000416961400032
DA 2020-07-08
ER

PT J
AU Golos, TG
AF Golos, T. G.
TI Nonhuman Primate Modeling of Zika Virus Vertical Transmission
SO CELL TRANSPLANTATION
LA English
DT Meeting Abstract
CT 24th Annual Meeting of the
   American-Society-for-Neural-Therapy-and-Repair
CY APR 27-29, 2017
CL Clearwater Beach, FL
SP Amer Soc Neural Therapy & Repair
C1 [Golos, T. G.] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA.
   [Golos, T. G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2017
VL 26
IS 4
SI SI
BP 711
EP 711
PG 1
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA ET2SP
UT WOS:000400124700040
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lossia, OV
   Tree, MO
   Goldthorpe, SC
   Srinageshwar, B
   Dunbar, GL
   Conway, MJ
   Rossignol, J
AF Lossia, O. V.
   Tree, M. O.
   Goldthorpe, S. C.
   Srinageshwar, B.
   Dunbar, G. L.
   Conway, M. J.
   Rossignol, J.
TI Zika Virus Dysregulates Gene Expression and Alters Protein Secretion in
   Neural Stem Cells
SO CELL TRANSPLANTATION
LA English
DT Meeting Abstract
CT 24th Annual Meeting of the
   American-Society-for-Neural-Therapy-and-Repair
CY APR 27-29, 2017
CL Clearwater Beach, FL
SP Amer Soc Neural Therapy & Repair
C1 [Lossia, O. V.; Srinageshwar, B.; Dunbar, G. L.; Rossignol, J.] Cent Michigan Univ, Field Neurosci Inst Restorat Neurosci, Mt Pleasant, MI 48859 USA.
   [Lossia, O. V.; Srinageshwar, B.; Dunbar, G. L.; Rossignol, J.] Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA.
   [Lossia, O. V.; Tree, M. O.; Goldthorpe, S. C.; Conway, M. J.; Rossignol, J.] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA.
   [Dunbar, G. L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA.
   [Dunbar, G. L.] Field Neurosci Inst, Saginaw, MI USA.
FU College of Medicine, Field Neurosciences Institute; John G. Kulhavi
   Professorship in Neuroscience at CMU
FX Support for this study was provided by the College of Medicine, Field
   Neurosciences Institute, and the John G. Kulhavi Professorship in
   Neuroscience at CMU. We also thank contributors to our Experiment.com
   crowdfunding campaign, "Does Zika virus replicate in neural cells?"
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2017
VL 26
IS 4
SI SI
BP 716
EP 716
PG 1
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA ET2SP
UT WOS:000400124700056
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Muotri, AR
AF Muotri, A. R.
TI Brain Organoids as a Model for Zika Infection: From Basic Science to
   Treatment
SO CELL TRANSPLANTATION
LA English
DT Meeting Abstract
CT 24th Annual Meeting of the
   American-Society-for-Neural-Therapy-and-Repair
CY APR 27-29, 2017
CL Clearwater Beach, FL
SP Amer Soc Neural Therapy & Repair
C1 [Muotri, A. R.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.
   [Muotri, A. R.] Rady Childrens Hosp San Diego, Dept Cellular & Mol Med, Stem Cell Program, La Jolla, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2017
VL 26
IS 4
SI SI
BP 718
EP 718
PG 1
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA ET2SP
UT WOS:000400124700061
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Raj, Y
   Kumar, S
   Haikerwal, A
   Goel, MM
   Bhatt, MLB
   Saxena, SK
AF Raj, Yash
   Kumar, Swatantra
   Haikerwal, Amrita
   Goel, Madhu M.
   Bhatt, Madan L. B.
   Saxena, Shailendra K.
TI Current Advances in Zika Virus Transmission: Urgency for Effective
   Therapeutics and Prevention
SO AMERICAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika Virus; Antibody Dependent Enhancement; Vaccines; Antiviral Drugs;
   Complementary and Alternative Medicines
ID DENGUE VIRUS; INFECTION; DISEASE; CELLS; EPIDEMIC; AMERICA; TRAVEL;
   INDIA
AB Global emergence of Zika Virus (ZIKV) with prevalent outbreaks has been reported in numerous countries of South America, Central America and the Caribbean region. According to recent World Health Organization (WHO)-ZIKV situation report, 84 countries/territories/subnational areas represented with established mosquito-borne transmission of ZIKV. As of 10 August 2017, cumulative Zika cases and congenital syndrome associated with Zika virus reported by countries and territories in the Americas, 2015 2017 includes 217,471 confirmed cases with the Case Fatality Rate (CFR) of 0.01% and 78.08 incidence rate. ZIKV has undoubtedly become a major threat in countries endemic for other Flavivirus infection. Factors such as urbanization, global trade and travel, tropical/sub-tropical climate, prevalence of Aedes vector and poor waste management altogether are responsible for ZIKV infection in Southeast Asian countries. The occurrence of co-infection by other Flavivirus (Dengue) and ZIKV have been reported in tropical/subtropical region, implying the role of sero-cross reactivity and initiating antibody dependent enhancement of ZIKV infection. The trans-placental transmission of ZIKV in pregnant women makes the fetus more susceptible to ZIKV infection. In order to control ZIKV infection, development of robust vaccine and effective antivirals are required urgently. This review majorly discusses about ZIKV epidemiology, modes of transmission, antibody dependent enhancement and prevention and control strategies.
C1 [Raj, Yash; Kumar, Swatantra; Haikerwal, Amrita; Goel, Madhu M.; Bhatt, Madan L. B.; Saxena, Shailendra K.] KGMU, Stem Cell Cell Culture Unit, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India.
   [Saxena, Shailendra K.] Ctr Cellular & Mol Biol, CSIR, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.
RP Saxena, SK (corresponding author), KGMU, Stem Cell Cell Culture Unit, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India.
EM shailen@kgmcindia.edu
RI amsalu, ribka/G-8780-2019
FU CCRH, Government of India; US NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R37DA025576,
   R01MH085259]
FX The authors are grateful to the Vice Chancellor, King George's Medical
   University (KGMU), Lucknow and Director, Centre for Cellular and
   Molecular Biology, Council of Scientific and Industrial Research
   (CSIR-CCMB), India for the encouragement and support for this work. SK
   Saxena is also supported by CCRH, Government of India and US NIH grants:
   R37DA025576 and R01MH085259. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Besnard M, 2014, EURO SURVEILL
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Chitti Sai V., 2016, VirusDisease, V27, P211, DOI 10.1007/s13337-016-0317-9
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Doss CGP, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0234-6
   ECDPC, 2016, RAP RISK ASS ZIK VIR
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mittal J., 2014, J MED PLANTS STUD, V2, P32
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   PAHO/WHO, 2017, ZIK SUSP CONF CAS RE
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Report S, 2017, ZIK VIR MICR GUILL B
   Rita P., 2011, INT RES J PHARM, V2, P11
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Unwin V., 2017, AGS VACCINE MAGIC BU
   VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004
   World Health Organization [WHO], 2017, ZIK VIR INF IND
NR 42
TC 0
Z9 0
U1 1
U2 2
PU SCIENCE PUBLICATIONS
PI NEW YORK
PA 244, 5TH AVE, STE 207, NEW YORK, NY 10001 USA
SN 1553-6203
EI 1558-6340
J9 AM J INFECT DIS
JI Am. J. Infect. Dis.
PY 2017
VL 13
IS 2
BP 13
EP 20
DI 10.3844/ajidsp.2017.13.20
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA FN9AV
UT WOS:000416320700001
OA Other Gold
DA 2020-07-08
ER

PT J
AU Aagaard, K
   Suter, M
   Seferovic, M
   Hu, M
   Kahr, M
   Eppes, C
   Rac, M
   Belfort, M
AF Aagaard, Kjersti
   Suter, Melissa
   Seferovic, Maxim
   Hu, Min
   Kahr, Maike
   Eppes, Catherine
   Rac, Martha
   Belfort, Michael
TI Potential mechanisms of contemporary strain Zika virus replication in
   human placental trophoblasts
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Aagaard, Kjersti; Suter, Melissa; Seferovic, Maxim; Hu, Min; Kahr, Maike; Eppes, Catherine; Rac, Martha; Belfort, Michael] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 1
Z9 1
U1 0
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 7
BP S5
EP S5
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256400008
DA 2020-07-08
ER

PT J
AU Adhikari, EH
   Jacobs, SO
   Rogers, VL
   Roberts, SW
   Nelson, DB
   Casey, BM
AF Adhikari, Emily H.
   Jacobs, Sara O.
   Rogers, Vanessa L.
   Roberts, Scott W.
   Nelson, David B.
   Casey, Brian M.
TI A county hospital-based prenatal screening program for Zika virus
   infection
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Adhikari, Emily H.; Jacobs, Sara O.; Rogers, Vanessa L.; Roberts, Scott W.; Nelson, David B.; Casey, Brian M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 584
BP S345
EP S345
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256402206
DA 2020-07-08
ER

PT J
AU Adhikari, EH
   Jacobs, SO
   Johnson, K
   Rogers, VL
   Roberts, SW
   Nelson, DB
   Casey, BM
AF Adhikari, Emily H.
   Jacobs, Sara O.
   Johnson, Kathryn
   Rogers, Vanessa L.
   Roberts, Scott W.
   Nelson, David B.
   Casey, Brian M.
TI Frontal occipital circumference percentiles of infants delivered to
   mothers with zika infection during pregnancy
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Adhikari, Emily H.; Jacobs, Sara O.; Johnson, Kathryn; Rogers, Vanessa L.; Roberts, Scott W.; Nelson, David B.; Casey, Brian M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 77
BP S55
EP S56
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256401028
DA 2020-07-08
ER

PT J
AU Antony, KM
   Nguyen, S
   Kohn, S
   Post, J
   Capuano, S
   Schultz-Darken, N
   Dudley, D
   Friedrich, T
   Weiler, A
   Barry, G
   Mohns, M
   Newman, C
   Breitbach, M
   Tarantal, A
   Mohr, E
   Osorio, J
   O'Connor, D
   Golos, TG
AF Antony, Kathleen M.
   Nguyen, Sydney
   Kohn, Sarah
   Post, Jennifer
   Capuano, Saverio, III
   Schultz-Darken, Nancy
   Dudley, Dawn
   Friedrich, Thomas
   Weiler, Andrea
   Barry, Gabrielle
   Mohns, Mariel
   Newman, Christina
   Breitbach, Meghan
   Tarantal, Alice
   Mohr, Emma
   Osorio, Jorge
   O'Connor, David
   Golos, Thaddeus G.
TI Fetal sonographic findings in pregnant rhesus macaques infected with
   zika virus (ZIKV)
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Antony, Kathleen M.; Nguyen, Sydney; Kohn, Sarah; Post, Jennifer; Capuano, Saverio, III; Schultz-Darken, Nancy; Dudley, Dawn; Friedrich, Thomas; Weiler, Andrea; Barry, Gabrielle; Mohns, Mariel; Newman, Christina; Breitbach, Meghan; Mohr, Emma; Osorio, Jorge; O'Connor, David; Golos, Thaddeus G.] Univ Wisconsin, Madison, WI USA.
   [Tarantal, Alice] Univ Calif Davis, Davis, CA 95616 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 75
BP S54
EP S54
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256401026
DA 2020-07-08
ER

PT J
AU Edwards, J
   Villers, MS
   Heine, RP
   Small, MJ
AF Edwards, James
   Villers, Margaret S.
   Heine, R. Phillips
   Small, Maria J.
TI Zika Virus screening and testing: preferences for prenatal diagnosis and
   tolerance of uncertainty
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Edwards, James; Villers, Margaret S.; Heine, R. Phillips; Small, Maria J.] Duke Univ Hlth Syst, Durham, NC USA.
RI Heine, R. Phillips/AAR-1189-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 370
BP S224
EP S224
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256401323
DA 2020-07-08
ER

PT J
AU Grossman, T
   Gelber, S
AF Grossman, Tracy
   Gelber, Shari
TI Microcephaly in the era of the Zika virus: diagnostic criteria needed
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Grossman, Tracy; Gelber, Shari] Weill Cornell Med Coll, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 637
BP S372
EP S373
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256402259
DA 2020-07-08
ER

PT J
AU Merriam, AA
   Nhan-Chang, CL
   Huerta-Bogdan, BI
   Wapner, RJ
   Gyamfi-Bannerman, C
AF Merriam, Audrey Anne
   Nhan-Chang, Chia-Ling
   Huerta-Bogdan, B. Isabel
   Wapner, Ronald J.
   Gyamfi-Bannerman, Cynthia
TI A single-center experience with a pregnant immigrant population and zika
   virus in new york city
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Merriam, Audrey Anne; Nhan-Chang, Chia-Ling; Huerta-Bogdan, B. Isabel; Wapner, Ronald J.; Gyamfi-Bannerman, Cynthia] Columbia Univ, Med Ctr, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 393
BP S236
EP S236
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256402016
DA 2020-07-08
ER

PT J
AU Sanz-Cortes, M
   Yepez, M
   Rivera, AM
   Zarutskie, AJ
   Mastrobatista, J
   Lee, W
   Aagaard, K
   Yunes, ID
   Belfort, M
   Parra, G
   Saavedra, MP
AF Sanz-Cortes, Magdalena
   Yepez, Mayel
   Maria Rivera, Ana
   Zarutskie, Alexander J.
   Mastrobatista, Joan
   Lee, Wesley
   Aagaard, Kjersti
   Diaz Yunes, Isreal
   Belfort, Michael
   Parra, Guido
   Parra Saavedra, Miguel
TI Application of different fetal head circumference normality ranges for
   the identification of abnormal head growth in Zika infected fetuses in a
   Colombian Cohort
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Sanz-Cortes, Magdalena; Yepez, Mayel; Zarutskie, Alexander J.; Mastrobatista, Joan; Lee, Wesley; Aagaard, Kjersti; Belfort, Michael] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   [Maria Rivera, Ana; Parra, Guido; Parra Saavedra, Miguel] CEDIUL, Ctr Diagnost Ultrasonido & Imagenes, CEDIFETAL, Maternal Fetal Unit, Barranquilla, Colombia.
   [Diaz Yunes, Isreal] Unidad Fertilidad & Genet Cartagena, Cartagena De Indias, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 205
BP S131
EP S131
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256401156
DA 2020-07-08
ER

PT J
AU Sanz-Cortes, M
   Zarutskie, AJ
   Yepez, M
   Rivera, AM
   Yunes, ID
   Mahadev, A
   Shetty, A
   Lee, W
   Belfort, M
   Aagaard, K
   Parra, G
   Saavedra, MP
AF Sanz-Cortes, Magdalena
   Zarutskie, Alexander J.
   Yepez, Mayel
   Maria Rivera, Anna
   Diaz Yunes, Isreal
   Mahadev, Arun
   Shetty, Anil
   Lee, Wesley
   Belfort, Michael
   Aagaard, Kjersti
   Parra, Guido
   Parra Saavedra, Miguel
TI Characterization of brain malformations and volume assessment in fetuses
   with zika virus infection using MRI
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Sanz-Cortes, Magdalena; Zarutskie, Alexander J.; Yepez, Mayel; Mahadev, Arun; Shetty, Anil; Lee, Wesley; Belfort, Michael; Aagaard, Kjersti] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   [Maria Rivera, Anna; Parra, Guido; Parra Saavedra, Miguel] CEDIUL, Ctr Diagnost Ultrasonido & Imagenes, CEDIFETAL, Maternal Fetal Unit, Barranquilla, Colombia.
   [Diaz Yunes, Isreal] Unidad Fertilidad & Genet Cartagena, Cartagena De Indias, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 73
BP S52
EP S53
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256401024
DA 2020-07-08
ER

PT J
AU Villers, MS
   Edwards, JM
   Heine, RP
   Small, MJ
AF Villers, Margaret S.
   Edwards, James M.
   Heine, R. Phillips
   Small, Maria J.
TI Knowledge of Zika virus and patient prenatal screening and testing
   preferences
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 23-28, 2017
CL Las Vegas, NV
SP Soc Maternal Fetal Med
C1 [Villers, Margaret S.; Edwards, James M.; Heine, R. Phillips; Small, Maria J.] Duke Univ Hlth Syst, Durham, NC USA.
RI Heine, R. Phillips/AAR-1189-2020
NR 0
TC 1
Z9 1
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2017
VL 216
IS 1
SU S
MA 340
BP S206
EP S206
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FL5FA
UT WOS:000414256401294
DA 2020-07-08
ER

PT J
AU Sowndarya, P
   Ramkumar, G
   Shivakumar, MS
AF Sowndarya, P.
   Ramkumar, G.
   Shivakumar, M. S.
TI Green synthesis of selenium nanoparticles conjugated Clausena dentata
   plant leaf extract and their insecticidal potential against mosquito
   vectors
SO ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
DE Selenium; Clausena dentata; SEM; larvicidal activity; eco-friendly
ID RESISTANCE
AB Mosquitoes are major vectors for the transmission of many diseases like chikungunya, malaria, dengue, zika, etc. worldwide. In the present study, selenium nanoparticles (SeNPs) were synthesized from Clausena dentata and were tested for their larvicidal efficacy against the fourth-instar larvae of Anopheles stephensi, Aedes Aegypti, and Culex quinquefasciatus. The synthesized nanoparticles were characterized using UV-Vis spectroscopy, Fourier Transform Infrared Radiation (FTIR) spectroscopy, EDaX, and SEM. The results recorded from UV-Vis spectroscopy show the peak absorption spectrum at 420nm. In FTIR, the maximum peak value is 2922.25cm(-1) assigned to N-H group (amide group). In EDaX analysis shows peak around 72.64 which confirm the binding intensity of selenium. In SEM analysis, the synthesized SeNPs sizes were ranging from 46.32nm to 78.88nm. The synthesized SeNPs produced high mortality with very low concentration (LC50) were 240.714mg/L; 104.13mg/L, and 99.602mg/L for A. stephensi, A. Aegypti, and C. quinquefasciatus, respectively. These results suggest that the C. dentata leaf extract-mediated biosynthesis of SeNPs has the potential to be used as an ideal ecofriendly approach toward the control of mosquito vectors at early stages.
C1 [Sowndarya, P.; Ramkumar, G.; Shivakumar, M. S.] Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem 11, Tamil Nadu, India.
RP Shivakumar, MS (corresponding author), Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem 11, Tamil Nadu, India.
EM skentomol@gmail.com
RI Ibrahim, Essam H./G-1960-2018; Shivakumar, Muthugounder S/I-3252-2019;
   Govindaraju, Ramkumar/D-5331-2015; Shivakumar, Muthugounder
   S./AAD-6241-2019
OI Ibrahim, Essam H./0000-0003-0130-2257; Shivakumar, Muthugounder
   S/0000-0002-1910-5510; 
FU Department of Biotechnology, Periyar University, Salem, Tamil Nadu,
   India
FX We are grateful thank to the Department of Biotechnology, Periyar
   University, Salem, Tamil Nadu, India for providing funding and the
   infrastructural facility for carrying out this research work.
CR Agarwal SR, 1981, GLIMPSES INDIAN ETHN, P3
   Benelli G., 2016, PARASITOL RES, V115, P925
   BURKILL IH, 1966, DICT EC PRODUCTS MAL, V1
   Clausena NL, 1768, CHINA, V11, P83
   Duran Nelson, 2005, J Nanobiotechnology, V3, P8, DOI 10.1186/1477-3155-3-8
   Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Haverkamp RG, 2010, PARTICUL SCI TECHNOL, V28, P1, DOI 10.1080/02726350903405387
   KILLEEN GF, 2002, MALARIA J, V1, P1
   Krumov N, 2009, CHEM ENG TECHNOL, V32, P1026, DOI 10.1002/ceat.200900046
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104
   Manjari MS, 2014, PARASITOL RES, V113, P2475, DOI 10.1007/s00436-014-3896-7
   Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Ramamurthy C, 2013, BIOPROC BIOSYST ENG, V36, P1131, DOI 10.1007/s00449-012-0867-1
   Ramkumar G, 2015, PARASITOL RES, V114, P2553, DOI 10.1007/s00436-015-4459-2
   Sauvaire Y, 1996, ADV EXP MED BIOL, V405, P37
   Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003
   Shaklee PM, 2013, TRENDS BIOTECHNOL, V31, P1, DOI 10.1016/j.tibtech.2012.11.002
   Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152
   Suganya G, 2014, PARASITOL RES, V113, P1673, DOI 10.1007/s00436-014-3811-2
   World Health Organization, 2006, PEST THIR APPL CONTR
   Yang ZH, 2002, CURR OPIN GENET DEV, V12, P688, DOI 10.1016/S0959-437X(02)00348-9
NR 25
TC 15
Z9 15
U1 1
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2169-1401
EI 2169-141X
J9 ARTIF CELL NANOMED B
JI Artif. Cell. Nanomed. Biotechnol.
PY 2017
VL 45
IS 8
BP 1490
EP 1495
DI 10.1080/21691401.2016.1252383
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA FN3XV
UT WOS:000415936900005
PM 27832715
OA Bronze
DA 2020-07-08
ER

PT J
AU Bharathi, VP
   Ragavendran, C
   Murugan, N
   Natarajan, D
AF Bharathi, V. Pavithra
   Ragavendran, C.
   Murugan, N.
   Natarajan, D.
TI Ipomoea batatas (Convolvulaceae)-mediated synthesis of silver
   nanoparticles for controlling mosquito vectors of Aedes albopictus,
   Anopheles stephensi, and Culex quinquefasciatus (Diptera:Culicidae)
SO ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
DE Ipomoea batatas; larvicide; adulticidal; spectral analysis
ID AEGYPTI DIPTERA-CULICIDAE; FERONIA-ELEPHANTUM RUTACEAE; LARVICIDAL
   ACTIVITY; GREEN SYNTHESIS; LEAF EXTRACT; ZIKA VIRUS; LOW-COST;
   ANTIBACTERIAL PROPERTIES; METHANOL EXTRACT; PLANT-EXTRACTS
AB We proposed an effective and eco-friendly control of dengue, malaria, and filariasis-causing vectors. We tested Ipomoea batatas leaves-mediated silver nanoparticles (AgNPs) against first to fourth instar larvae and adults of Aedes albopictus, Anopheles stephensi, and Culex quinquefasciatus at different concentrations. The synthesized AgNPs showed broad spectrum of larvicidal and adulticidal effects after 48h of exposure. The characterization of synthesized AgNPs was done using various spectral and microscopy analyses. The maximum efficacy was observed in synthesized AgNPs against the adult of Ae. albopictus with the LC50 and LC90 values were 10.069 and 15.657g/mL, respectively, followed by others.
C1 [Bharathi, V. Pavithra; Ragavendran, C.; Murugan, N.; Natarajan, D.] Periyar Univ, Nat Drug Res Lab, Sch Biosci, Dept Biotechnol, Salem 636011, India.
RP Natarajan, D (corresponding author), Periyar Univ, Nat Drug Res Lab, Sch Biosci, Dept Biotechnol, Salem 636011, India.
EM mdnataraj@rediffmail.com
OI C, Ragavendran/0000-0002-7476-8907
FU SAIF, IIT Madras
FX The authors would like to thanks Periyar University, Department of
   Biotechnology, Natural Drug Research Laboratory, Salem, Tamil Nadu,
   India, for providing the excellent facilities to carry out the work. We
   acknowledge the support extended by SAIF, IIT Madras for TEM and EDX
   studies. We wish to acknowledge St Joseph's College, Trichy for helping
   FTIR analysis. The XRD analysis of the AgNPs sample was carried out in
   the Department of Physics, Periyar University, Salem, Tamil Nadu is
   highly acknowledged.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amin ZA, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/241583
   Ankamwar B, 2005, J NANOSCI NANOTECHNO, V5, P1665, DOI 10.1166/jnn.2005.184
   Arjunan NK, 2012, VECTOR-BORNE ZOONOT, V12, P262, DOI 10.1089/vbz.2011.0661
   Bagavan A, 2009, VET PARASITOL, V166, P286, DOI 10.1016/j.vetpar.2009.09.007
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, PARASITOL RES MG, V8, P155, DOI 10.1007/978-3-319-25292-6_8
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Bernhard L, 2003, ALTERN APPROACH PHYS, V89, P743, DOI DOI 10.1016/S0031-9406(05)60500-7
   Chattopadhyay Sourav, 2013, Cancer Nanotechnology, V4, P103, DOI 10.1007/s12645-013-0042-7
   Chattopadhyay S., 2012, Cancer Nanotechnology, V3, P13, DOI 10.1007/s12645-012-0026-z
   Conti B, 2010, PARASITOL RES, V107, P1455, DOI 10.1007/s00436-010-2018-4
   Dash SK, 2014, J APPL TOXICOL, V34, P1130, DOI 10.1002/jat.2976
   Dharumadurai Dhanasekaran, 2013, Asian Pacific Journal of Tropical Disease, V3, P174
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   FAO, 1992, P INT C NUTR 1992 DE
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gad L, 2009, THE SWEET POTATOES, P391, DOI [10.1007/978-1-4020-9475-0, DOI 10.1007/978-1-4020-9475-0]
   Gole A, 2001, LANGMUIR, V17, P1674, DOI 10.1021/la001164w
   Govindarajan M, 2017, ARTIF CELL NANOMED B, V45, P1317, DOI 10.1080/21691401.2016.1228664
   Hamsa TP, 2011, INFLAMMATION, V34, P171, DOI 10.1007/s10753-010-9221-4
   Hermes D, 2013, J ADV RES, V4, P411, DOI 10.1016/j.jare.2012.06.001
   Igwenyi IO, 2011, INT J PHARM BIO SCI, V2, pB593
   Ijaola TO, 2014, J APPL CHEM-USSR, V7, P16, DOI DOI 10.9790/5736-07521625
   Jabeen Q, 2013, IRAN J PHARM RES, V12, P769
   Jayaseelan C, 2011, PARASITOL RES, V109, P185, DOI 10.1007/s00436-010-2242-y
   Kager PA, 2002, TROP MED INT HEALTH, V7, P1042, DOI 10.1046/j.1365-3156.2002.00981.x
   Kamaraj C, 2009, PARASITOL RES, V104, P1163, DOI 10.1007/s00436-008-1306-8
   Kovendan K, 2012, PARASITOL RES, V111, P1481, DOI 10.1007/s00436-012-2984-9
   Kumar A, 2014, ASIAN J PHARM CLIN R, V7, P134
   Kunjiappan S, 2014, FRONT MATER SCI, V8, P123, DOI 10.1007/s11706-014-0246-8
   Kurata R, 2007, J AGR FOOD CHEM, V55, P185, DOI 10.1021/jf0620259
   Lalrotluanga, 2012, PARASITOL RES, V111, P1007, DOI 10.1007/s00436-012-2925-7
   Lin RJ, 2008, NAT PROD RES, V22, P747, DOI 10.1080/14786410701628739
   Logeswari P, 2013, SCI IRAN, V20, P1049, DOI 10.1016/j.scient.2013.05.016
   Ma J, 2003, J MATER CHEM, V21, P3350
   MAILLARD M, 1993, ACS SYM SER, V534, P256
   Majumdar R, 2013, INT NANO LETT, V3, DOI 10.1186/2228-5326-3-53
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   MINJAS JN, 1986, T ROY SOC TROP MED H, V80, P460, DOI 10.1016/0035-9203(86)90345-7
   Mishra A, 2013, COLLOID SURFACE B, V111, P713, DOI 10.1016/j.colsurfb.2013.06.036
   Mukhtar Muhammad, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P72
   Murugan K., 1996, Journal of Entomological Research (New Delhi), V20, P137
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Nagamine R, 2014, FOOD FUNCT, V5, P2309, DOI [10.1039/c4fo00032c, 10.1039/C4FO00032C]
   Ouda S. M., 2014, Research Journal of Microbiology, V9, P34, DOI 10.3923/jm.2014.34.42
   Parashar UK, 2009, DIG J NANOMATER BIOS, V4, P159
   Paska C, 1999, PHYTOCHEMISTRY, V52, P879, DOI 10.1016/S0031-9422(99)00304-0
   Patil SV, 2012, APPL BIOCHEM BIOTECH, V167, P776, DOI 10.1007/s12010-012-9710-z
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Peng ZK, 1999, INSECT BIOCHEM MOLEC, V29, P909, DOI 10.1016/S0965-1748(99)00066-1
   RAHMAN SJ, 1989, MANUAL ENTOMOLOGICAL
   Rahuman AA, 2008, PARASITOL RES, V102, P867, DOI 10.1007/s00436-007-0839-6
   Rajakumar G, 2011, ACTA TROP, V118, P196, DOI 10.1016/j.actatropica.2011.03.003
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Rajesh R, 2009, CURR NANOSCI, V5, P117
   Rao CNR, 2009, ANNU REV ANAL CHEM, V2, P435, DOI 10.1146/annurev-anchem-060908-155236
   Roopan SM, 2013, IND CROP PROD, V43, P631, DOI 10.1016/j.indcrop.2012.08.013
   Santhoshkumar T, 2011, PARASITOL RES, V108, P693, DOI 10.1007/s00436-010-2115-4
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   Soni N, 2014, SCI WORLD J, DOI 10.1155/2014/496362
   Srinivasan B, 2014, PARASIT DIS, V40, P991
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Suman TY, 2013, IND CROP PROD, V47, P239, DOI 10.1016/j.indcrop.2013.03.010
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Tewe OO, 2003, SWEET POTATO PRODUCT, P44
   Vandana Panda, 2012, International Journal of Research in Phytochemistry & Pharmacology, V2, P25
   Vasilakis N, 2007, VIROLOGY, V358, P402, DOI 10.1016/j.virol.2006.08.049
   Veerakumar K, 2014, PARASITOL RES, V113, P4085, DOI 10.1007/s00436-014-4077-4
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Velayutham K, 2013, ASIAN PAC J TROP MED, V6, P95, DOI 10.1016/S1995-7645(13)60002-4
   Velu K, 2015, ENVIRON SCI POLLUT R, V22, P17769, DOI 10.1007/s11356-015-4919-3
   Vivek Marimuthu, 2011, Avicenna Journal of Medical Biotechnology, V3, P143
   *WHO, 2005, GUID LAB FIELD TEST, P1
   WHO, 2012, LYMPHATIC FILARIASIS
   Woolfe J.A., 1992, SWEETPOTATO UNTAPPED, P118
   World Health Organisation, 1981, INSTR DET SUSC RES M, P1
   World Health Organization, 2012, WHO 10 FACTS MAL
   World Health Organization, 2010, ENTOMOL EXP APPL, V35, P11
   Yoshimoto M, 2002, BIOSCI BIOTECH BIOCH, V66, P2336, DOI 10.1271/bbb.66.2336
   Yu BW, 2013, PHYTOCHEMISTRY, V95, P421, DOI 10.1016/j.phytochem.2013.07.006
NR 91
TC 2
Z9 2
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2169-1401
EI 2169-141X
J9 ARTIF CELL NANOMED B
JI Artif. Cell. Nanomed. Biotechnol.
PY 2017
VL 45
IS 8
BP 1568
EP 1580
DI 10.1080/21691401.2016.1261873
PG 13
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA FN3XV
UT WOS:000415936900013
PM 27929364
OA Bronze
DA 2020-07-08
ER

PT J
AU Madhubabu, G
   Yenugu, S
AF Madhubabu, Golla
   Yenugu, Suresh
TI Exposure to allethrin-based mosquito coil smoke during gestation and
   postnatal development affects reproductive function in male offspring of
   rat
SO INHALATION TOXICOLOGY
LA English
DT Article
DE Allethrin; mosquito coils; spermatogenesis; acrosome reaction;
   antioxidants; oxidative stress
ID OXIDATIVE STRESS; ENVIRONMENTAL EXPOSURE; FENVALERATE EXPOSURE; ANDROGEN
   RECEPTOR; CYPERMETHRIN; PERMETHRIN; TOXICITY; TRANSCRIPTION; MICE;
   CHLORPYRIFOS
AB The threat of zika virus looms throughout the world and the use of allethrin-based mosquito coils to prevent mosquito bites during and postpregnancy is on the rise. The aim of this study was to analyze the toxic effects of exposure to allethrin-based mosquito coil smoke in rats under conditions that reflect human settings. Pregnant female rats were exposed to mosquito coil smoke and same was continued to the male pups up to 111days postparturition (21-day weaning plus up to 90days postweaning). Increased oxidative stress, distorted antioxidant enzyme status, downregulation of genes involved in spermatogenesis, sperm maturation and steroidogenesis was observed. Daily sperm production, total sperm count and acrosome reaction was compromised. Results of our study indicate the toxic effects of exposure to allethrin-based mosquito coil smoke in male offspring and calls for preventing mosquito coil use during pregnancy and postnatal development. Community-based programs that will encourage general population to use classical methods such as use of mosquito nets, keeping the surroundings clean and use of natural mosquito repellents should be conducted.
C1 [Madhubabu, Golla; Yenugu, Suresh] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad, Andhra Prades, India.
RP Yenugu, S (corresponding author), Univ Hyderabad, Dept Anim Biol, PO Cent Univ, Hyderabad 500046, Andhra Prades, India.
EM ysnaidu@yahoo.com
RI Yenugu, Suresh/Y-7661-2019
OI Yenugu, Suresh/0000-0002-5431-2267
FU University Grants CommissionUniversity Grants Commission, India; Council
   for Scientific and Industrial Research, Government of IndiaCouncil of
   Scientific & Industrial Research (CSIR) - India
FX GB received a fellowship from University Grants Commission and Council
   for Scientific and Industrial Research, Government of India.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Al-Damegh MA, 2013, INHAL TOXICOL, V25, P292, DOI 10.3109/08958378.2013.781251
   Alaa-Eldin EA, 2017, ENVIRON SCI POLLUT R, V24, P1532, DOI 10.1007/s11356-016-7912-6
   Ben Abdallah F, 2010, ANDROLOGIA, V42, P182, DOI 10.1111/j.1439-0272.2009.00976.x
   Ben Slima A, 2017, HUM EXP TOXICOL, V36, P218, DOI 10.1177/0960327116646617
   Ben Slima A, 2012, ANDROLOGIA, V44, P661, DOI 10.1111/j.1439-0272.2011.01246.x
   BERNHEIM F, 1964, BIOCHIM BIOPHYS ACTA, V90, P426, DOI 10.1016/0304-4165(64)90216-8
   Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196
   Brander SM, 2016, ENVIRON SCI TECHNOL, V50, P8977, DOI 10.1021/acs.est.6b02253
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Chen SC, 2008, J EPIDEMIOL, V18, P19, DOI 10.2188/jea.18.19
   Dahamna S, 2010, Commun Agric Appl Biol Sci, V75, P209
   Ding GD, 2015, J EXPO SCI ENV EPID, V25, P264, DOI 10.1038/jes.2014.86
   Du GZ, 2010, TOXICOL SCI, V116, P58, DOI 10.1093/toxsci/kfq120
   Gao XH, 2012, ARCH TOXICOL, V86, P1443, DOI 10.1007/s00204-012-0825-3
   Garba S. H., 2007, Journal of Medical Sciences (Pakistan), V7, P94
   Gu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070112
   Hu JX, 2013, J APPL TOXICOL, V33, P576, DOI 10.1002/jat.1769
   IANS, 2017, CHIK DENG OUTBR 100
   Idowu ET, 2013, REV BIOL TROP, V61, P1463
   Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383
   Jin YX, 2013, REPROD TOXICOL, V42, P156, DOI 10.1016/j.reprotox.2013.08.006
   Jin YX, 2012, ENVIRON INT, V42, P144, DOI 10.1016/j.envint.2011.05.020
   Jin YX, 2011, CHEMOSPHERE, V84, P124, DOI 10.1016/j.chemosphere.2011.02.034
   John NA, 2015, INT J CLIN EXP PHYSL, V2, P209
   Jurewicz J, 2016, ENVIRON POLLUT, V213, P732, DOI 10.1016/j.envpol.2016.02.008
   Jurewicz J, 2015, SYST BIOL REPROD MED, V61, P37, DOI 10.3109/19396368.2014.981886
   Lee SC, 2006, ATMOS ENVIRON, V40, P2128, DOI 10.1016/j.atmosenv.2005.11.047
   Lemos AJJM, 2013, EXP TOXICOL PATHOL, V65, P489, DOI 10.1016/j.etp.2012.02.004
   LEPOIVRE M, 1990, J BIOL CHEM, V265, P14143
   Liu WL, 2003, ENVIRON HEALTH PERSP, V111, P1454, DOI 10.1289/ehp.6286
   Madhubabu G, 2014, ENVIRON TOXICOL, V29, P1330, DOI 10.1002/tox.21864
   Madhubabu G, 2012, INHAL TOXICOL, V24, P143, DOI 10.3109/08958378.2011.649189
   Mani U, 2002, HUM EXP TOXICOL, V21, P593, DOI 10.1191/0960327102ht298oa
   Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010
   Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901
   Mansour SA, 2010, HUM EXP TOXICOL, V29, P77, DOI 10.1177/0960327109357276
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Mehrpour O, 2014, TOXICOL LETT, V230, P146, DOI 10.1016/j.toxlet.2014.01.029
   Nassr ACC, 2010, J TOXICOL ENV HEAL A, V73, P952, DOI 10.1080/15287391003751745
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pan C, 2013, TOXICOLOGY, V311, P178, DOI 10.1016/j.tox.2013.06.011
   Radwan M, 2014, J OCCUP ENVIRON MED, V56, P1113, DOI 10.1097/JOM.0000000000000297
   Rajesh A, 2015, J REPROD IMMUNOL, V110, P117, DOI 10.1016/j.jri.2015.02.009
   Saillenfait AM, 2015, INT J HYG ENVIR HEAL, V218, P281, DOI 10.1016/j.ijheh.2015.01.002
   Sharma Poonam, 2014, Toxicol Int, V21, P131, DOI 10.4103/0971-6580.139789
   Siddique N, 2015, PAK J MED HEALTH SCI, V9, P672
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Wang H, 2010, ARCH TOXICOL, V84, P53, DOI 10.1007/s00204-009-0479-y
   Wang Q, 2015, ENVIRON TOXICOL PHAR, V40, P172, DOI 10.1016/j.etap.2015.06.008
   Wang XZ, 2009, THERIOGENOLOGY, V72, P599, DOI 10.1016/j.theriogenology.2009.04.016
   Wang X, 2016, ENVIRON RES, V149, P86, DOI 10.1016/j.envres.2016.05.003
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
   Xia D, 2013, REPROD SCI, V20, P1308, DOI 10.1177/1933719113483015
   Xiao H, 2006, REPROD TOXICOL, V21, P48, DOI 10.1016/j.reprotox.2005.05.007
   Yoshinaga J, 2014, ANDROLOGY-US, V2, P416, DOI 10.1111/j.2047-2927.2014.00202.x
   Zhang H, 2010, J APPL TOXICOL, V30, P369, DOI 10.1002/jat.1507
   Zhang H, 2009, TOXICOL LETT, V191, P47, DOI 10.1016/j.toxlet.2009.08.007
   Zhang SY, 2008, TOXICOLOGY, V248, P136, DOI 10.1016/j.tox.2008.03.018
   Zhang SY, 2007, ENDOCRINOLOGY, V148, P3941, DOI 10.1210/en.2006-1497
   Zhao XF, 2011, ARCH TOXICOL, V85, P1101, DOI 10.1007/s00204-011-0654-9
NR 61
TC 2
Z9 2
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0895-8378
EI 1091-7691
J9 INHAL TOXICOL
JI Inhal. Toxicol.
PY 2017
VL 29
IS 8
BP 374
EP 385
DI 10.1080/08958378.2017.1385661
PG 12
WC Toxicology
SC Toxicology
GA FN3WJ
UT WOS:000415931700005
PM 29039229
DA 2020-07-08
ER

PT J
AU Patil, SA
   Patil, V
   Patil, R
   Beaman, K
   Patil, SA
AF Patil, Siddappa A.
   Patil, Vikrant
   Patil, Renukadevi
   Beaman, Kenneth
   Patil, Shivaputra A.
TI Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as
   Antiviral Agents
SO MEDICINAL CHEMISTRY
LA English
DT Article
DE 5,6-Dimethoxyindan-1-one; virus; antiviral; in vitro screening; NIAID;
   ketone; HIV
ID RIFT-VALLEY FEVER; HUMAN-PAPILLOMAVIRUS; MOLECULAR-BIOLOGY; VIRUS;
   DISEASE; MEASLES; VACCINE; ZIKA; EPIDEMIOLOGY; ENCEPHALITIS
AB Background: Discovery of novel antiviral agents is essential because viral infection continues to threaten human life globally. Various heterocyclic small molecules have been developed as antiviral agents. The 5,6-dimethoxyindan-1-on nucleus is of considerable interest as this ring is the key constituent in a range of bioactive compounds, both naturally occurring and synthetic, and often of considerable complexity.
   Objective: The main purpose of this research was to discover and develop small molecule heterocycles as broad-spectrum of antiviral agents.
   Method: A focused small set of 5,6-dimethoxyindan-1-one analogs (6-8) along with a thiopene derivative (9) was screened for selected viruses (Vaccinia virus - VACA, Human papillomavirus HPV, Zika virus - ZIKV, Dengue virus - DENV, Measles virus - MV, Poliovirus 3 - PV, Rift Valley fever virus - RVFV, Tacaribe virus - TCRV, Venezuelan equine encephalitis virus - VEEV, Herpes simplex virus 1 -HSV-1 and Human cytomegalovirus - HCMV) using the National Institute of Allergy and Infectious Diseases (NIAID)'s Division of Microbiology and Infectious Diseases (DMID) antiviral screening program.
   Results: These molecules demonstrated moderate to excellent antiviral activity towards variety of viruses. The 5,6-dimethoxyindan-1-one analog (7) demonstrated high efficacy towards vaccinia virus (EC50: < 0.05 mu M) and was nearly 232 times more potent than the standard drug Cidofovir (EC50: 11.59 mu M) in primary assay whereas it demonstrated moderate activity (EC50: > 30.00 mu M) in secondary plaque reduction assay. The thiophene analog (9) has shown very good viral inhibition towards several viruses such as Human papillomavirus, Measles virus, Rift Valley fever virus, Tacaribe virus and Herpes simplex virus 1.
   Conclusion: Our research identified a novel 5,6-dimethoxyindan-1-one analog (compound 7), as a potent antiviral agent for vaccinia virus, and heterocyclic chalcone analog (compound 9) as a broad spectrum antiviral agent.
C1 [Patil, Siddappa A.; Patil, Vikrant] Jain Univ, Ctr Nano & Mat Sci, Jain Global Campus, Bangalore 562112, Karnataka, India.
   [Patil, Renukadevi; Patil, Shivaputra A.] Rosalind Franklin Univ Med & Sci, Pharmaceut Sci Dept, Coll Pharm, 3333 Green Bay Rd, N Chicago, IL 60064 USA.
   [Beaman, Kenneth] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, N Chicago, IL 60064 USA.
RP Patil, SA (corresponding author), Jain Univ, Ctr Nano & Mat Sci, Jain Global Campus, Bangalore 562112, Karnataka, India.; Patil, SA (corresponding author), Rosalind Franklin Univ Med & Sci, Pharmaceut Sci Dept, Coll Pharm, 3333 Green Bay Rd, N Chicago, IL 60064 USA.
EM p.siddappa@jainuniversity.ac.in; shivaputra.patil@rosalindfranklin.edu
FU DST-SERB, India [SERB/F/7013/2015-16]; DST NanoMission, India
   [SR/NM/NS-20/2014(G)]
FX Siddappa A. Patil thanks DST-SERB (No. SERB/F/7013/2015-16) and DST
   NanoMission (SR/NM/NS-20/2014(G)), India for financial support. Rosalind
   Franklin University of Medicine and Science (Shivaputra A. Patil)
   utilized the non-clinical and pre-clinical services program offered by
   the National Institute of Allergy and Infectious Diseases (NIAID). We
   sincerely thank Dr. M. Prichard (University of Alabama, Birmingham) for
   HSV-1, HCMV, VACA and HPV 11 and Dr. D. Smee (Utah State University) for
   DENV 2, MV, PV 3, RVFV, TCRV, VEEV and ZIKV for the anti-viral
   screening.
CR Albrecht R., 1972, US Patent, Patent No. 3671520
   Bernard HU, 2004, J ANTIMICROB CHEMOTH, V53, P137, DOI 10.1093/jac/dkh023
   Black W. C., 1995, US patent, Patent No. 5409944
   BLUMING AZ, 1971, LANCET, V2, P105
   Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358
   Charrel RN, 2003, ANTIVIR RES, V57, P89, DOI 10.1016/S0166-3542(02)00202-4
   Charris JE, 2007, LETT DRUG DES DISCOV, V4, P49, DOI 10.2174/157018007778992865
   Clemmon NS, 2015, MMWR-MORBID MORTAL W, V64, P373
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   De Clercq E, 2003, CLIN MICROBIOL REV, V16, P569, DOI 10.1128/CMR.16.4.569-596.2003
   De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009
   Debing Y, 2015, CURR OPIN INFECT DIS, V28, P596, DOI 10.1097/QCO.0000000000000212
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369
   Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822
   DOWNS WG, 1963, AM J TROP MED HYG, V12, P640, DOI 10.4269/ajtmh.1963.12.640
   Duarte CD, 2007, MINI-REV MED CHEM, V7, P1108, DOI 10.2174/138955707782331722
   Fenner F, 1988, SMALLPOX ITS ERADICA
   Finkielsztein LM, 2008, EUR J MED CHEM, V43, P1767, DOI 10.1016/j.ejmech.2007.10.023
   Goebel S.J., 1990, VIROLOGY, V179, P517
   Grifin D. E., 2001, FIELDS VIROLOGY
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hammen P. D., 1979, US Patent, Patent No. 4164514
   Howard C. R., 1985, VIRUS J GEN VIROL, V66, P2344
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   John DV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0191-6
   JOHNSON GP, 1993, VIROLOGY, V196, P381, DOI 10.1006/viro.1993.1494
   KINNEY RM, 1993, J VIROL, V67, P1269, DOI 10.1128/JVI.67.3.1269-1277.1993
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Leveque N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004825
   LI CS, 1995, J MED CHEM, V38, P4897, DOI 10.1021/jm00025a007
   Liu HW, 2017, J MED VIROL, V89, P710, DOI 10.1002/jmv.24670
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   Mocarski E., 2007, FIELDS VIROLOGY CYTO
   Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5
   Nagle DG, 2000, J NAT PROD, V63, P1431, DOI 10.1021/np000216e
   Olive MM, 2012, J WILDLIFE DIS, V48, P241, DOI 10.7589/0090-3558-48.2.241
   Omran Z, 2005, EUR J MED CHEM, V40, P1222, DOI 10.1016/j.ejmech.2005.07.009
   PANARA MR, 1995, BRIT J PHARMACOL, V116, P2429, DOI 10.1111/j.1476-5381.1995.tb15091.x
   Parker EPK, 2015, EXPERT REV VACCINES, V14, P1113, DOI 10.1586/14760584.2015.1052800
   Patil V, 2016, CHEMISTRYSELECT, V1, P3647, DOI 10.1002/slct.201600703
   Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033
   Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P1034
   Pittman PR, 1996, VACCINE, V14, P337, DOI 10.1016/0264-410X(95)00168-Z
   Powers A., 2012, 9 INT COMM TAX VIR
   Prichard MN, 2013, ANTIMICROB AGENTS CH, V57, P3518, DOI 10.1128/AAC.00429-13
   RANDALL R, 1964, J IMMUNOL, V93, P293
   RANDALL RAYMOND, 1962, JOUR IMMUNOL, V89, P660
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saravanan VS, 2006, ASIAN J CHEM, V18, P2597
   Saxena HO, 2008, BIOORG MED CHEM LETT, V18, P3914, DOI 10.1016/j.bmcl.2008.06.039
   Seyferth ER, 2016, CURR OPIN PEDIATR, V28, P400, DOI 10.1097/MOP.0000000000000354
   Sheng R., 2008, EUR J MED CHEM, V20, P1
   Shim BS, 2016, J GEN VIROL, V97, P659, DOI 10.1099/jgv.0.000372
   Simmons C. P., 2015, VACCINE, pS0264
   SINDELAR RD, 1982, J MED CHEM, V25, P858, DOI 10.1021/jm00349a019
   Skelly Michael J., 2012, Antiviral Chemistry & Chemotherapy, V23, P13, DOI 10.3851/IMP2129
   Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001
   Smee DF, 2016, ANTIVIR RES, V131, P61, DOI 10.1016/j.antiviral.2016.04.003
   Sugimoto H, 2002, JPN J PHARMACOL, V89, P7, DOI 10.1254/jjp.89.7
   Sugimoto R, 2001, CHEM REC, V1, P63
   VANDERHOEVEN JCM, 1983, CARCINOGENESIS, V4, P1587, DOI 10.1093/carcin/4.12.1587
   Walsh SR, 2011, EXPERT REV VACCINES, V10, P1221, DOI [10.1586/erv.11.79, 10.1586/ERV.11.79]
   Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1
   Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9
   Yang Y, 2011, J ORG CHEM, V76, P1902, DOI 10.1021/jo102298p
   Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153
   ZYGIERT Z, 1971, LANCET, V1, P593
NR 69
TC 4
Z9 4
U1 0
U2 15
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4064
EI 1875-6638
J9 MED CHEM
JI Med. Chem.
PY 2017
VL 13
IS 8
BP 787
EP 795
DI 10.2174/1573406413666170330094822
PG 9
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA FM5JE
UT WOS:000415068900011
PM 28359234
DA 2020-07-08
ER

PT J
AU Holmes, D
AF Holmes, David
TI Zika virus - concerns for male fertility
SO NATURE REVIEWS ENDOCRINOLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-5029
EI 1759-5037
J9 NAT REV ENDOCRINOL
JI Nat. Rev. Endocrinol.
PD JAN
PY 2017
VL 13
IS 1
BP 3
EP 3
DI 10.1038/nrendo.2016.191
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FM9LH
UT WOS:000415590200002
DA 2020-07-08
ER

PT J
AU Masi, M
   Cimmino, A
   Tabanca, N
   Becnel, JJ
   Bloomquist, JR
   Evidente, A
AF Masi, Marco
   Cimmino, Alessio
   Tabanca, Nurhayat
   Becnel, James J.
   Bloomquist, Jeffrey R.
   Evidente, Antonio
TI A survey of bacterial, fungal and plant metabolites against Aedes
   aegypti (Diptera: Culicidae), the vector of yellow and dengue fevers and
   Zika virus
SO OPEN CHEMISTRY
LA English
DT Article
DE secondary metabolites; mosquito control; biopesticides; microbial and
   plant derived natural products
ID GROWTH-INHIBITORY ACTIVITY; POTENTIAL MYCOHERBICIDE; NATURAL-PRODUCTS;
   BITING DETERRENTS; A-C; CYTOCHALASINS; ACID; PHYTOTOXINS; PATHOGEN;
   AMARYLLIDACEAE
AB Aedes aegypti L. is the major vector of the arboviruses responsible for dengue fever, one of the most devastating human diseases. Some bacterial, fungal and plant metabolites belonging to different chemical subgroups, including Amaryllidaceae alkaloids, anthracenes, azoxymethoxytetrahydropyrans, cytochalasans, 2,5-diketopiperazines, isochromanones, naphthoquinones, organic small acids and their methyl esters, sterols and terpenes including sesquiterpenes and diterpenes, were tested for their larvicidal and adulticidal activity against Ae. aegypti. Out of 23 compounds tested, gliotoxin exhibited mosquitocidal activity in both bioassays with an LC50 value of 0.0257 +/- 0.001 mu g/mu L against 1st instar Ae. aegypti and LD50 value of 2.79 +/- 0.1197 mu g/mosquito against adult female Ae. aegypti. 2-Methoxy-1,4-naphthoquinone and cytochalasin A showed LC 50 values of 0.0851 +/- 0.0012 mu g/mu L and 0.0854 +/- 0.0019 mu g/mu L, respectively, against Ae. aegypti larvae. In adult bioassays, fusaric acid (LD 50 = 0.8349 +/- 0.0118 mu g/mosquito), 3-nitropropionic acid (LD 50 = 1.6641 +/- 0.0494 mu g/mosquito) and a-costic acid (LD50 = 2.547 +/- 0.0835 mu g/mosquito) exhibited adulticidal activity. Results from the current study confirm that compounds belonging to cytochalsin, diketopiperazine, naphthoquinone and low molecular weight organic acid groups are active and may stimulate further SAR investigations.
C1 [Masi, Marco; Cimmino, Alessio; Evidente, Antonio] Univ Naples Federico II, Dipartimento Sci Chim, Complesso Univ Monte St Angelo, Via Cintia 4, I-80126 Naples, Italy.
   [Tabanca, Nurhayat; Bloomquist, Jeffrey R.] Univ Florida, Dept Entomol & Nematol, Emerging Pathogens Inst, Gainesville, FL 32610 USA.
   [Tabanca, Nurhayat; Becnel, James J.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
   [Tabanca, Nurhayat] USDA ARS, Subtrop Hort Res Stn, 13601 Old Cutler Rd, Miami, FL 33158 USA.
RP Masi, M (corresponding author), Univ Naples Federico II, Dipartimento Sci Chim, Complesso Univ Monte St Angelo, Via Cintia 4, I-80126 Naples, Italy.
EM marco.masi@unina.it
RI Cimmino, Alessio/I-2121-2012; Masi, Marco/J-7742-2016
OI Cimmino, Alessio/0000-0002-1551-4237; Masi, Marco/0000-0003-0609-8902;
   Evidente, Antonio/0000-0001-9110-1656; Becnel, James/0000-0003-2464-0005
FU Deployed War-Fighter Protection Research Program via U.S. Department of
   Defense through the Armed Forces Pest Management Board [58-0208-5-001]
FX This study was partly funded by the Deployed War-Fighter Protection
   Research Program via grants from the U.S. Department of Defense through
   the Armed Forces Pest Management Board (to JJB and 58-0208-5-001 to
   JRB). We thank Miss Jessica Louton and Dr. Alden S. Estep (USDA-ARS,
   CMAVE, Gainesville, FL) for mosquito bioassays. Prof. A. Evidente is
   associated to Istituto di Chimica Biomolecolare, CNR, Pozzuoli, Italy.
CR Abd Kadir SL, 2013, J NAT MED-TOKYO, V67, P677, DOI 10.1007/s11418-013-0767-y
   Anadon A, 2009, VET J, V182, P7, DOI 10.1016/j.tvjl.2008.04.008
   Andolfi A, 2015, J NAT PROD, V78, P623, DOI 10.1021/np500570h
   Andolfi A, 2014, J NAT PROD, V77, P2352, DOI 10.1021/np500258r
   Andolfi A, 2013, PHYTOCHEMISTRY, V86, P112, DOI 10.1016/j.phytochem.2012.10.003
   Balde ES, 2010, J NAT PROD, V73, P969, DOI 10.1021/np900731p
   Bani M, 2014, J AGR FOOD CHEM, V62, P2574, DOI 10.1021/jf405530g
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Berestetskiy A, 2008, PHYTOCHEMISTRY, V69, P953, DOI 10.1016/j.phytochem.2007.11.003
   BOTTALICO A, 1990, PHYTOCHEMISTRY, V29, P93, DOI 10.1016/0031-9422(90)89018-5
   Cantrell CL, 2012, J NAT PROD, V75, P1231, DOI 10.1021/np300024u
   CAPASSO R, 1991, PHYTOCHEMISTRY, V30, P3945, DOI 10.1016/0031-9422(91)83442-N
   Cimmino A, 2008, J AGR FOOD CHEM, V56, P6304, DOI 10.1021/jf8004178
   Cimmino A, 2016, FITOTERAPIA, V109, P138, DOI 10.1016/j.fitote.2015.12.016
   Cimmino A, 2016, J ANTIBIOT, V69, P9, DOI 10.1038/ja.2015.74
   Cimmino A, 2015, NAT PROD REP, V32, P1629, DOI 10.1039/c5np00081e
   Cimmino A, 2015, MED CHEM RES, V24, P3981, DOI 10.1007/s00044-015-1439-0
   Cimmino A, 2013, PHYTOCHEMISTRY, V96, P208, DOI 10.1016/j.phytochem.2013.10.007
   Cimmino A, 2013, J NAT PROD, V76, P1291, DOI 10.1021/np400218z
   Cimmino A, 2013, CHEM BIODIVERS, V10, P1239, DOI 10.1002/cbdv.201200358
   Clarke T, 2002, NATURE, V416, P672, DOI 10.1038/416672a
   Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046
   Dewick M., 2009, MED NATURAL PRODUCTS
   Duke SO, 2014, RECENT ADV PHYTOCHEM, V43, P71
   Duke SO, 2010, TOXINS, V2, P1943, DOI 10.3390/toxins2081943
   EVIDENTE A, 1990, PHYTOCHEMISTRY, V29, P1491, DOI 10.1016/0031-9422(90)80107-R
   Evidente A., 2010, COMPREHENSIVE BIOACT, P333
   Evidente A, 2014, NAT PROD REP, V31, P617, DOI 10.1039/c3np70078j
   Evidente A, 2011, TETRAHEDRON, V67, P1557, DOI 10.1016/j.tet.2010.12.058
   Evidente A, 2009, J AGR FOOD CHEM, V57, P11168, DOI 10.1021/jf903499y
   Farias DF, 2009, J AM MOSQUITO CONTR, V25, P386, DOI 10.2987/08-5851.1
   Gerwick BC, 2014, PEST MANAG SCI, V70, P1169, DOI 10.1002/ps.3744
   Gross AD, 2017, J MED ENTOMOL, V54, P382, DOI 10.1093/jme/tjw183
   Hoel D, 2010, WINGBEATS, V21, P19
   Kishore N, 2014, PHYTOCHEM REV, V13, P587, DOI 10.1007/s11101-013-9316-2
   Kornienko A, 2008, CHEM REV, V108, P1982, DOI 10.1021/cr078198u
   Kornienko A, 2015, MED RES REV, V35, P937, DOI 10.1002/med.21348
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lallemand B, 2012, PHYTOCHEM LETT, V5, P770, DOI 10.1016/j.phytol.2012.08.011
   Masi M, 2017, J AGR FOOD CHEM, V65, P1124, DOI 10.1021/acs.jafc.6b05193
   Masi M, 2017, FITOTERAPIA, V116, P34, DOI 10.1016/j.fitote.2016.11.007
   Masi M, 2016, MOLECULES, V21, DOI 10.3390/molecules21111432
   Masi M, 2014, J AGR FOOD CHEM, V62, P10304, DOI 10.1021/jf5035515
   Masi M, 2014, J NAT PROD, V77, P925, DOI 10.1021/np4009915
   Masi M, 2014, BIOCONTROL SCI TECHN, V24, P53, DOI 10.1080/09583157.2013.844769
   Masi M, 2013, TETRAHEDRON, V69, P7466, DOI 10.1016/j.tet.2013.06.031
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Schrader KK, 2010, CHEM BIODIVERS, V7, P2261, DOI 10.1002/cbdv.201000041
   SCHRECK CE, 1982, J MED ENTOMOL, V19, P143, DOI 10.1093/jmedent/19.2.143
   Seiber JN, 2014, J AGR FOOD CHEM, V62, P11613, DOI 10.1021/jf504252n
   Swale DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36954
   Tabanca N, 2016, CURR ORG CHEM, V20, P2690, DOI 10.2174/1385272820666160421151503
   Van Goietsenoven G, 2011, PLANTA MED, V77, P711, DOI 10.1055/s-0030-1250523
   Van Goietsenoven G, 2010, J NAT PROD, V73, P1223, DOI 10.1021/np9008255
   Vurro M., 1997, Toxins in plant disease development and evolving biotechnology., P127
   Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019
   WHO, 2009, WHO TECH REP SER, V958, P1
   WHO, 2016, DENG VACC WHO POS PA, V91, P349
NR 62
TC 11
Z9 11
U1 0
U2 11
PU SCIENDO
PI WARSAW
PA DE GRUYTER POLAND SP Z O O, BOGUMILA ZUGA 32A STR, 01-811 WARSAW, POLAND
SN 2391-5420
J9 OPEN CHEM
JI Open Chem.
PD JAN
PY 2017
VL 15
IS 1
BP 156
EP 166
DI 10.1515/chem-2017-0019
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA FM3SV
UT WOS:000414928800003
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Desai, SK
   Hartman, SD
   Jayarajan, S
   Liu, S
   Gallicano, GI
AF Desai, Sruti K.
   Hartman, Steven D.
   Jayarajan, Shilpa
   Liu, Stephanie
   Gallicano, G. Ian
TI Zika Virus (ZIKV): a review of proposed mechanisms of transmission and
   associated congenital abnormalities
SO AMERICAN JOURNAL OF STEM CELLS
LA English
DT Review
DE Zika virus; congenital abnormalities; mechanisms of transmission;
   microcephaly; cellular function; genetic background
ID HUMAN PLACENTAL TROPHOBLASTS; NEURAL PROGENITORS; CELLS; INFECTION;
   AMERICA; BRAZIL
AB Zika virus (ZIKV) has been of major international public health concern following large outbreaks in the Americas occurring in 2015-2016. Most notably, ZIKV has been seen to pose dangers in pregnancy due to its association with congenital abnormalities such as microcephaly. Numerous experimental approaches have been taken to address how the virus can cross the placenta, alter normal fetal development, and disrupt specific cellular functions. Many areas concerning the mechanisms of transmission, especially from mother to fetus, are largely unknown but demand further research. Several promising new studies are presented that provide insight into possible mechanisms of transmission, different cell types affected, and immune responses towards the virus. By aiming to better understand the processes behind altered fetal neuronal development due to ZIKV infection, the hope is to find ways to increase protection of the fetus and prevent congenital abnormalities such as microcephaly. As ZIKV infection is spreading to increasingly more areas and bringing harmful outcomes and birth defects with it, it is imperative to identify the mechanisms of transmitting this infectious agent, consider different genetic backgrounds of hosts and strain types, and navigate methods to protect those affected from the detrimental effects of this newly emerging virus.
C1 [Desai, Sruti K.; Hartman, Steven D.; Jayarajan, Shilpa; Liu, Stephanie] Georgetown Univ, Sch Med, Dept Physiol & Biophys, 3900 Reservoir Rd NW,Room NE203, Washington, DC 20007 USA.
   [Gallicano, G. Ian] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, 3900 Reservoir Rd NW,Room NE203, Washington, DC 20007 USA.
RP Gallicano, GI (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, 3900 Reservoir Rd NW,Room NE203, Washington, DC 20007 USA.
EM gig@georgetown.edu
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Doobin DJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12551
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 27
TC 8
Z9 8
U1 0
U2 3
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 2160-4150
J9 AM J STEM CELLS
JI Am. J. Stem Cells
PY 2017
VL 6
IS 2
BP 13
EP 22
PG 10
WC Cell Biology
SC Cell Biology
GA FM1AB
UT WOS:000414699800001
PM 28804687
DA 2020-07-08
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh RamBihariLal
   Shrivastava, Prateek Saurabh
   Ramasamy, Jegadeesh
TI Zika virus disease: necessity to have a better and sustained
   preparedness
SO CUKUROVA MEDICAL JOURNAL
LA English
DT Letter
C1 [Shrivastava, Saurabh RamBihariLal; Shrivastava, Prateek Saurabh; Ramasamy, Jegadeesh] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, Kancheepuram, India.
RP Shrivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, Kancheepuram, India.
EM drshrishri2008@gmail.com
CR Chan M., 2017, ZIKA WE MUST BE READ
   Shrivastava SR, 2016, ANN TROP MED PUBLIC, V9, P377, DOI 10.4103/1755-6783.193930
   Shrivastava SR, 2015, J RES MED SCI, V2016, P55
NR 3
TC 0
Z9 0
U1 0
U2 0
PU CUKUROVA UNIV, FAC MEDICINE
PI ADANA
PA YAYIN VE DOKUMENTASYON KURULU, BALCALI, ADANA, 01330, TURKEY
SN 0250-5150
J9 CUKUROVA MED J
JI Cukurova Med. J.
PY 2017
VL 42
IS 4
BP 790
EP 791
DI 10.17826/cutf.326904
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FM2WA
UT WOS:000414861000032
OA DOAJ Gold
DA 2020-07-08
ER

PT S
AU Pena-Fernandez, A
   Zinsky, R
   Choi, EML
   Broadbent, AJ
AF Pena-Fernandez, Antonio
   Zinsky, Rica
   Choi, Ed M. L.
   Broadbent, Andrew J.
BE Chova, LG
   Martinez, AL
   Torres, IC
TI DEVELOPING TRAINING TO PREPARE HUMAN HEALTH SCIENCE STUDENTS TO FACE
   BIOLOGICAL INCIDENTS
SO INTED2017: 11TH INTERNATIONAL TECHNOLOGY, EDUCATION AND DEVELOPMENT
   CONFERENCE
SE INTED Proceedings
LA English
DT Proceedings Paper
CT 11th International Conference on Technology, Education and Development
   (INTED)
CY MAR 06-08, 2017
CL Valencia, SPAIN
DE Haemorrhagic virus; biological incidents training; field experience;
   evidence-based public health
AB Biological incidents involve the natural, accidental or deliberate release of biological agents that can lead to outbreaks or contamination of the environment with significant impact on human health. Outbreaks and intentional attacks (bioterrorism) present a significant challenge to the local healthcare infrastructure due to the large numbers of people affected. Biomedical and medical scientists can play a key role in collaborative response efforts to protect public health and reduce the spread of a biological hazard, as demonstrated during the recent international response to the West Africa Ebola outbreak in 2014-2015. Despite the UK playing a major role in the response in Sierra Leone, appropriate training in how best to respond to biological incidents is lacking in biomedical and medical science programmes taught in the UK. Therefore, a series of initiatives have been put in place at De Montfort University (DMU) to address this need. We have developed novel teaching sessions aimed at students studying in the UK following our experience as biomedical scientists at the Public Health England (PHE) mobile laboratories built in Sierra Leone during the Ebola outbreak, described in Pena-Fernandez & Choi (2016) [1]. These sessions aim to facilitate the acquisition of key competences and skills to protect human health in the aftermath of a biological incident. We initially tested them with DMU medical science students in 2015/16 in which students developed intervention programmes during hypothetical scenarios of Ebola and Zika outbreaks in the UK, using evidence based medicine protocols. Following a high level of student satisfaction, we have made the following improvements that will be tested in 2016/ 17: 1) the possible creation of a practical element that includes developing a mock-mobile isolator, so students can learn how to work with this critical equipment to manage highly contagious clinical samples necessary to make a diagnosis; 2) the development of a new workshop in which final year students from both degrees will develop an intervention programme to deal with the emerging disease Crimean-Congo haemorrhagic fever that has recently threatened different EU countries such as Spain this summer 2016. Peer teaching and peer group interaction will be used to enhance students' revision of these topics and overcome current limitations of time in the delivery of these teaching sessions. Learning through peer-to-peer interaction has shown to improve student engagement and improve active learning. Students will also be provided with a workbook to help them with the development of this activity. A validated questionnaire has been developed to analyse whether these teaching sessions are successful in providing undergraduate students with the skills necessary to face future biological incidents. This article describes the novel teaching sessions developed so far that might be adopted in other related human health degrees to teach key competences necessaries in the aftermath of a biological incident to protect human health.
C1 [Pena-Fernandez, Antonio] De Montfort Univ, Fac Hlth & Life Sci, Gateway, Leicester, Leics, England.
   [Zinsky, Rica; Choi, Ed M. L.] Makeni Govt Hosp, Publ Hlth England Lab, Makeni, Sierra Leone.
   [Broadbent, Andrew J.] Pirbright Inst, Pirbright, England.
RP Pena-Fernandez, A (corresponding author), De Montfort Univ, Fac Hlth & Life Sci, Gateway, Leicester, Leics, England.
RI Pena-Fernandez, Antonio/N-7856-2019; Pena-Fernandez, Antonio/Q-3228-2017
OI Pena-Fernandez, Antonio/0000-0002-5690-5445; Pena-Fernandez,
   Antonio/0000-0002-5690-5445
CR Brown N, 2006, J PUBLIC HEALTH, V28, P238, DOI 10.1093/pubmed/fdl015
   Brownson R C, 1999, J Public Health Manag Pract, V5, P86
   Carter H, 2016, PLOS CURR, V8
   Centers for Disease Control and Prevention (CDC), CRIM CONG HAEM FEV
   Djalali A, 2017, EUR J EMERG MED, V24, P371, DOI 10.1097/MEJ.0000000000000383
   Dreshaj S, 2016, TRAVEL MED INFECT DI, V14, P81, DOI 10.1016/j.tmaid.2016.03.012
   Ebadi A, 2015, TRAUMA MON, V20, DOI 10.5812/traumamon.25607
   European Centre for Disease Prevention and Control (ECDC), 2016, CRIM CONG HAEM FEV S
   Iqbal Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156136
   Lansdowne K, 2015, PREHOSP DISASTER MED, V30, P320, DOI 10.1017/S1049023X15004641
   Pena-Fernandez A, 2016, ICERI PROC, P4327
   Pena-Fernandez A., ICERI2016 P, P3559
   Pena-Fernandez A, 2015, CURR PHARM TEACH LEA, V7, P864, DOI 10.1016/j.cptl.2015.08.015
   Valencia C, 2017, J INFECTION, V74, P294, DOI 10.1016/j.jinf.2016.09.012
NR 14
TC 4
Z9 4
U1 0
U2 4
PU IATED-INT ASSOC TECHNOLOGY EDUCATION & DEVELOPMENT
PI VALENICA
PA LAURI VOLPI 6, VALENICA, BURJASSOT 46100, SPAIN
SN 2340-1079
BN 978-84-617-8491-2
J9 INTED PROC
PY 2017
BP 4707
EP 4714
PG 8
WC Education & Educational Research
SC Education & Educational Research
GA BI6TI
UT WOS:000413668604109
DA 2020-07-08
ER

PT J
AU Hugo, N
   Miller, H
AF Hugo, Nichole
   Miller, Hannah
TI Conflict resolution and recovery in Jamaica: the impact of the zika
   virus on destination image
SO WORLDWIDE HOSPITALITY AND TOURISM THEMES
LA English
DT Review
DE Jamaica; Marketing; Destination image; Zika; Risky destinations
ID CLIMATE-CHANGE; TOURISM; CRISIS; PERCEPTIONS; RISK
AB Purpose - The purpose of this paper is to analyze how effectively Jamaica recovers from negative destination image due to the Zika virus to assist other countries with similar destination image issues. Because negative media coverage of a destination is a strong deterrent for visiting a destination, tourism operators should be aware of techniques to effectively promote their area.
   Design/methodology/approach - A review of the literature regarding destination image and an investigation of other destinations with similar issues as a result of the Zika virus.
   Findings - This paper observes that the surge in media coverage regarding the Zika virus threatens the destination image of Jamaica and could lead to a decrease in tourism revenue and foreign travelers.
   Practical implications - This paper provides recommendations for destinations impacted by negative global perception or being seen as a risky area to travel to after a publicized event, such as a natural disaster or disease outbreak.
   Originality/value - This paper examines the potential impact of the Zika virus as a threat to destinations which rely on a tourism economy. In general, little research has been associated with the impact of Zika on tourism despite its recent surge in media.
C1 [Hugo, Nichole; Miller, Hannah] Eastern Illinois Univ, Sch Family & Consumer Sci Hospitality, Charleston, IL 61920 USA.
RP Hugo, N (corresponding author), Eastern Illinois Univ, Sch Family & Consumer Sci Hospitality, Charleston, IL 61920 USA.
EM nhugo@eiu.edu
CR Alvarez MD, 2011, INT J TOUR RES, V13, P310, DOI 10.1002/jtr.838
   Avraham E, 2015, TOURISM MANAGE, V47, P224, DOI 10.1016/j.tourman.2014.10.003
   Biran A, 2014, ANN TOURISM RES, V47, P1, DOI 10.1016/j.annals.2014.03.004
   Boin A., 2007, J CONTING CRISIS MAN, V15, P50, DOI DOI 10.1111/J.1468-5973.2007.00504.X
   Bowater D., 2016, THE TELEGRAPH
   British Broadcasting Company (BBC), 2015, BBC NEWS
   Buultjens JW, 2016, CURR ISSUES TOUR, V19, P355, DOI 10.1080/13683500.2014.1002760
   Caribbean Environment Programme, 2014, EU CLIM CHANG JAM EN
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Chen PY, 2015, GLOBAL ENVIRON CHANG, V30, P12, DOI 10.1016/j.gloenvcha.2014.10.011
   HANNO M. M, 2016, ATHENS J TOURISM, VIII, P89
   Heslop LA, 2008, INT MARKET REV, V25, P354, DOI 10.1108/02651330810887440
   Hubner A, 2012, J DESTIN MARK MANAGE, V1, P47, DOI 10.1016/j.jdmm.2012.09.003
   Lepp A, 2003, ANN TOURISM RES, V30, P606, DOI 10.1016/S0160-7383(03)00024-0
   McNeil Jr Donald G., 2016, NY TIMES
   Parsons W, 1996, CAREER DEV INT, V1, P26, DOI DOI 10.1108/13620439610130614
   Reisinger Y., 2005, Journal of Travel Research, V43, P212, DOI 10.1177/0047287504272017
   Ritchie BW, 2004, TOURISM MANAGE, V25, P669, DOI 10.1016/j.tourman.2003.09.004
   Sayira T, 2016, J DESTIN MARK MANAGE, V5, P351, DOI 10.1016/j.jdmm.2016.09.010
   Scherler P., 1996, MANAGEMENT KRISENKOM
   Scott D, 2012, J SUSTAIN TOUR, V20, P883, DOI 10.1080/09669582.2012.699063
   Senatori P., 2016, MEDIA QUANT
   Staphen C.H., 2016, THE WASHINGTON POST
   Stone PR, 2006, TOURISM, V54, P145
   The Rio Times, 2017, THE RIO TIMES
   Vitic A., 2008, J TRAVEL TOUR MARK, V23, P127, DOI DOI 10.1300/J073V23N02_10
   Webster-Kerr K., 2016, ZIKA VIRUS INFECT OU
   Wolff K, 2016, SCAND J PSYCHOL, V57, P584, DOI 10.1111/sjop.12326
   World Health Organization, 2017, ZIK VIR
   World Tourism Organization, 2017, YB TOUR STAT
NR 30
TC 1
Z9 1
U1 4
U2 8
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1755-4217
EI 1755-4225
J9 WORLDW HOSP TOUR THE
JI Worldw. Hosp. Tour. Themes
PY 2017
VL 9
IS 5
SI SI
BP 516
EP 524
DI 10.1108/WHATT-07-2017-0030
PG 9
WC Hospitality, Leisure, Sport & Tourism
SC Social Sciences - Other Topics
GA FM1PI
UT WOS:000414749700004
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Kadaikunnan, S
   Alharbi, NS
   Benelli, G
AF Govindarajan, Marimuthu
   Kadaikunnan, Shine
   Alharbi, Naiyf S.
   Benelli, Giovanni
TI Single-step biological fabrication of colloidal silver nanoparticles
   using Hugonia mystax: larvicidal potential against Zika virus, dengue,
   and malaria vector mosquitoes
SO ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
DE Dengue; mosquito-borne diseases; nanocomposite; green synthesis; FTIR;
   SEM; TEM; XRD
ID NONTARGET AQUATIC ORGANISMS; AEGYPTI DIPTERA-CULICIDAE; LEAF EXTRACT;
   CULEX-QUINQUEFASCIATUS; GREEN SYNTHESIS; AEDES-AEGYPTI;
   ANOPHELES-STEPHENSI; SYNTHESIZED NANOPARTICLES; VETERINARY IMPORTANCE;
   BORNE DISEASES
AB Mosquito control is facing key challenges, including outbreaks of new arbovirus threats. We proposed an eco-friendly synthesis of silver nanoparticles (AgNPs) employing a low-cost extract of Hugonia mystax. AgNPs were specified by UV, XRD, FTIR and EDX spectroscopy, SEM and TEM. AgNPs were more toxic to Anopheles stephensi, Aedes aegypti, and Culex quinquefasciatus larvae (LC50: 14.45, 15.86, and 17.46g/mL) if compared to aquatic biocontrol organisms Gambusia affinis, Diplonychus indicus, and Anisops bouvieri (LC50: 2567.15, 1075.16, and 829.63g/ml). Overall, we shed light on the mosquito larvicidal efficacy of H. mystax, a possible biological resource for low-cost fabrication of AgNPs.
C1 [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar, Tamil Nadu, India.
   [Kadaikunnan, Shine; Alharbi, Naiyf S.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI Alharbi, Naiyf S/B-9402-2019; /L-2836-2013; GOVINDARAJAN,
   MARIMUTHU/A-8070-2019; Benelli, Giovanni/A-9100-2013
OI /0000-0001-7018-5379; GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931;
   Benelli, Giovanni/0000-0001-8971-6010
FU King Saud UniversityDeanship of Scientific Research at King Saud
   University [PRG-1437-36]
FX King Saud University, 10.13039/501100002383 [PRG-1437-36]
CR Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G, 2015, NANOPARTICLES FIGHT, P115, DOI [10.1007/978-3-319-25292-6, DOI 10.1007/978-3-319-25292-6.P.115-172]
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, PARASITOL RES, V115, P2545, DOI 10.1007/s00436-016-5095-1
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2015, PARASITOL RES, V114, P1011, DOI 10.1007/s00436-014-4267-0
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Chennaiah E, 1997, FLORA ANDHRA PRADESH, V1
   DEO P G, 1988, International Pest Control, V30, P118
   Finney D.T., 1971, PROBIT ANAL
   Govindarajan M, 2011, EUR REV MED PHARMACO, V15, P787
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, PARASITOL RES, V115, P2685, DOI 10.1007/s00436-016-5038-x
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES MG, V8, P99, DOI 10.1007/978-3-319-25292-6_7
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Korbekandi H, 2016, ARTIF CELL NANOMED B, V44, P209, DOI 10.3109/21691401.2014.936064
   Machalova Z, 2015, IND CROP PROD, V67, P310, DOI 10.1016/j.indcrop.2015.01.070
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Mathivanan T, 2010, J VECTOR DIS, V47, P178
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Nammi S., 2003, Asia Pacific Journal of Pharmacology, V16, P1
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Padel SB, 2010, J PHYTOL, V2, P70
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Pavela R, 2017, J PEST SCI, V90, P369, DOI 10.1007/s10340-016-0763-6
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Sanpui P, 2008, INT J FOOD MICROBIOL, V124, P142, DOI 10.1016/j.ijfoodmicro.2008.03.004
   Santapau H, 1983, DICT FLOWERING PLANT, P103
   Santhoshkumar T, 2011, PARASITOL RES, V108, P693, DOI 10.1007/s00436-010-2115-4
   Shahverdi AR, 2007, PROCESS BIOCHEM, V42, P919, DOI 10.1016/j.procbio.2007.02.005
   Shameli K, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-73
   Singh A, 2010, DIG J NANOMATER BIOS, V5, P483
   Singh P, 2016, ARTIF CELL NANOMED B, V44, P1569, DOI 10.3109/21691401.2015.1064937
   Singh P, 2016, ARTIF CELL NANOMED B, V44, P1150, DOI 10.3109/21691401.2015.1011809
   Singh P, 2016, ARTIF CELL NANOMED B, V44, P811, DOI 10.3109/21691401.2015.1008514
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Sutha S, 2010, INDIAN J TRADIT KNOW, V9, P502
   Thirunavoukkarasu M, 2013, SPECTROCHIM ACTA A, V116, P424, DOI 10.1016/j.saa.2013.07.033
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Velayutham K, 2013, ASIAN PAC J TROP MED, V6, P95, DOI 10.1016/S1995-7645(13)60002-4
   Vijayakumar M, 2013, IND CROP PROD, V41, P235, DOI 10.1016/j.indcrop.2012.04.017
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   Wang C, 2016, ARTIF CELL NANOMED B, V44, P1127, DOI 10.3109/21691401.2015.1011805
   Wazed Ali S., 2001, CARBOHYD POLYM, V83, P438
   *WHO, 2005, WHOCDSWHOPESGCDPP200
   Zhang WJ, 2011, COLLOID SURFACE B, V88, P196, DOI 10.1016/j.colsurfb.2011.06.031
NR 65
TC 8
Z9 8
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2169-1401
EI 2169-141X
J9 ARTIF CELL NANOMED B
JI Artif. Cell. Nanomed. Biotechnol.
PY 2017
VL 45
IS 7
BP 1317
EP 1325
DI 10.1080/21691401.2016.1228664
PG 9
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA FL1LC
UT WOS:000413975300007
PM 27611658
OA Bronze
DA 2020-07-08
ER

PT J
AU Sert, H
   Pelin, M
   Seven, A
   Cetinkaya, S
   Yuksel, ZO
   Aygin, D
   Karabay, O
AF Sert, Havva
   Pelin, Meryem
   Seven, Ahmet
   Cetinkaya, Serap
   Yuksel, Zeynep Ozge
   Aygin, Dilek
   Karabay, Oguz
TI Do we know about Zika virus infection?
SO BIOMEDICAL RESEARCH-INDIA
LA English
DT Article
DE Zika virus; Zika virus infection; Zika virus disease; Level of
   knowledge; Student
ID HEALTH-CARE STUDENTS; WORKERS KNOWLEDGE; 2 CITIES; DENGUE; FEVER
AB Background: This study was carried out in order to determine the levels of knowledge of nursing, midwifery and medical faculty students about Zika virus infection.
   Methods: The population of this descriptive study consisted of 733 students who accepted to participate in the study between May-June 2016. The analysis of the data collected with questionnaire form including the socio-demographic features aimed at determining the level of knowledge about Zika virus infection prepared by the researchers in line with the literature, and by taking the permission of the ethics committee was performed using parametric and non-parametric tests in the computer environment.
   Results: The age average of the students is 20.67 +/- 2.04 y, 44.1% are nursing, 34.4% are medical faculty, and 21.6% are midwifery department students. 62.1% of the students had no knowledge about Zika virus infection. It was determined that 67.8% of the participants did not know the symptoms of Zika virus infection, 74.9% did not know the ways of protection, and only 8.2% knew that it was necessary to be protected against mosquitoes. It was observed that the knowledge level total score average of the students was 53.18 +/- 19.96; and the average scores of those who had knowledge about Zika virus infection, who thought that they had sufficient knowledge, and the students of the department of nursing were statistically significantly higher, and the average scores of the first-grade students were low (p<0.05).
   Conclusion: In the study, it was determined that students need more information about Zika virus infection.
C1 [Sert, Havva; Pelin, Meryem; Seven, Ahmet; Cetinkaya, Serap] Sakarya Univ, Dept Internal Med Nursing, Fac Hlth Sci, Sakarya, Turkey.
   [Yuksel, Zeynep Ozge] Sakarya Univ, Fac Med, Sakarya, Turkey.
   [Aygin, Dilek] Sakarya Univ, Fac Hlth Sci, Dept Surg Nursing, Sakarya, Turkey.
   [Karabay, Oguz] Sakarya Univ Training & Res Hosp, Dept Internal Med Infect Dis & Clin Microbiol, Sakarya, Turkey.
RP Sert, H; Pelin, M (corresponding author), Sakarya Univ, Dept Internal Med Nursing, Fac Hlth Sci, Sakarya, Turkey.
RI SEVEN, Ahmet/AAH-9016-2020; SEVEN, AHMET/AAB-2078-2020
OI SEVEN, AHMET/0000-0002-2599-1918; KARABAY, OGUZ/0000-0003-1514-1685
CR Aksoy F., 2016, ZIKA VIRUS INFECT DI, P469
   Canoz K, 2013, TURKIYAT ARAST DERG, P365
   Centers for Disease Control and Prevention (CDC), ZIK VIR RESP PLANN I
   Cherry CC, 2016, TRAVEL MED INFECT DI, V14, P475, DOI 10.1016/j.tmaid.2016.08.011
   Chinnakali P, 2012, N AM J MED SCI, V4, P278, DOI 10.4103/1947-2714.97210
   Colorado State University, ZIK VIR INF STUD FAC
   Degallier N, 2000, J AM MOSQUITO CONTR, V16, P114
   Dhimal M, 2014, PLOS ONE, V9
   East Mediterranean International Tourism and Travel Exhibition (EMITT), TUR IST 2000 2015
   Bedoya-Arias JE, 2015, J INFECT DEV COUNTR, V9, P330, DOI 10.3855/jidc.6445
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ghojazadeh M, 2012, ASIAN PAC J CANCER P, V13, P6115, DOI 10.7314/APJCP.2012.13.12.6115
   Ibrahim Nahla Khamis Ragab, 2009, J Infect Public Health, V2, P30, DOI 10.1016/j.jiph.2009.01.004
   Karaoz S., 2004, CUMHURIYET U J NURS, V8, P30
   Kaya E, 2010, PAMUKKALE U EGIT FAK, P139
   LATMAN NS, 1995, SEX TRANSM DIS, V22, P104, DOI 10.1097/00007435-199503000-00005
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Madeira Newton G., 2002, Rev. Soc. Bras. Med. Trop., V35, P221, DOI 10.1590/S0037-86822002000300004
   Magden D, 2003, ED SCI, P28
   Staples JE, 2016, MMWR-MORBID MORTAL W, P65
   Tavoosi A, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-17
   The University of Tennessee Knoxville Student Health Center, ZIK VIR INF
   TR Ministry of Health Turkey Border and Coastal Health General Directorate, 2016, TRAV HLTH HDB
   TR Ministry of Health Turkey Border and Coastal Health General Directorate, ZIK VIR STAT REP ZIK
   TR Ministry of Health Turkey Border and Coastal Health General Directorate, WHO PUBL HLTH EM ANN
   TR Ministry of Health Turkish Public Health Agency, ZIK VIR DIS INF CAS
   UCONN Student Health Services, INF ADV ZIK VIR
   World Health Organization, ZIK VIR INF MALD
   World Health Organization, ZIK VIR COMPL QUEST
NR 30
TC 0
Z9 0
U1 0
U2 2
PU ALLIED ACAD
PI LONDON
PA 40 BLOOMSBURY WAY, LOWER GROUND FLR, LONDON, WC1A 2SE, ENGLAND
SN 0970-938X
EI 0976-1683
J9 BIOMED RES-INDIA
JI Biomed. Res.-India
PY 2017
VL 28
IS 15
BP 6834
EP 6838
PG 5
WC Engineering, Biomedical; Medicine, Research & Experimental
SC Engineering; Research & Experimental Medicine
GA FJ1ZW
UT WOS:000412521200056
DA 2020-07-08
ER

PT J
AU Marano, G
   Pupella, S
   Pati, I
   Masiello, F
   Franchini, M
   Vaglio, S
   Velati, C
   Liumbruno, GM
AF Marano, Giuseppe
   Pupella, Simonetta
   Pati, Ilaria
   Masiello, Francesca
   Franchini, Massimo
   Vaglio, Stefania
   Velati, Claudio
   Liumbruno, Giancarlo M.
TI Ten years since the last Chikungunya virus outbreak in Italy: history
   repeats itself
SO BLOOD TRANSFUSION
LA English
DT Editorial Material
ID PATIENT BLOOD MANAGEMENT; EMERGING PATHOGENS; ZIKA VIRUS; IMPLEMENTATION
C1 [Marano, Giuseppe; Pupella, Simonetta; Pati, Ilaria; Masiello, Francesca; Franchini, Massimo; Vaglio, Stefania; Velati, Claudio; Liumbruno, Giancarlo M.] Natl Inst Hlth, Italian Natl Blood Ctr, Rome, Italy.
   [Pati, Ilaria] A Moro Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
   [Franchini, Massimo] Carlo Poma Hosp, Dept Haematol & Transfus Med, Mantua, Italy.
   [Vaglio, Stefania] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy.
   [Velati, Claudio] Italian Soc Transfus Med & Immunohaematol, Rome, Italy.
RP Liumbruno, GM (corresponding author), Italian Natl Blood Ctr, Via Giano della Bella 27, I-00162 Rome, Italy.
EM giancarlo.liumbruno@iss.it
RI Marano, Giuseppe/AAC-4903-2019; Pati, Ilaria/R-3414-2018; Liumbruno,
   Giancarlo Maria/AAC-4918-2019; Pati, Ilaria/E-8400-2017
OI Pati, Ilaria/0000-0003-4846-2338; Pati, Ilaria/0000-0003-4846-2338;
   Marano, Giuseppe/0000-0003-0725-4583
CR Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Franchini M, 2017, BLOOD TRANSFUS-ITALY, V15, P292, DOI 10.2450/2017.0078-17
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Guerra R, 2016, BLOOD TRANSFUS-ITALY, V14, P1, DOI 10.2450/2015.0171-15
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Ministero della Salute Italiana, 2015, SURV HUM CAS CHIK DE
   Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Naowarat S., 2013, American Journal of Applied Sciences, V10, P449
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Pisani G, 2016, TRANSFUS MED HEMOTH, V43, P158, DOI 10.1159/000446219
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Vaglio S, 2017, BLOOD TRANSFUS-ITALY, V15, P325, DOI 10.2450/2017.0060-17
   Vaglio S, 2016, BLOOD TRANSFUS-ITALY, V14, P23, DOI 10.2450/2015.0172-15
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 20
TC 14
Z9 14
U1 0
U2 3
PU SIMTI SERVIZI SRL
PI MILAN
PA VIA DESIDERIO 21, MILAN, 20131, ITALY
SN 1723-2007
J9 BLOOD TRANSFUS-ITALY
JI Blood Transf.
PY 2017
VL 15
IS 6
BP 489
EP 490
DI 10.2450/2017.0215-17
PG 2
WC Hematology
SC Hematology
GA FK9AJ
UT WOS:000413802600001
PM 29053100
DA 2020-07-08
ER

PT J
AU Bezerra, MP
   Pedrosa, TFB
   Braz, AF
AF Bezerra, Mariana Pires
   Braz Pedrosa, Tiago Farrant
   Braz, Adriana Farrant
TI ENDOCRINOLOGICAL DISORDERS IN CHILDREN WITH CONGENITAL INFECTION OF ZIKA
   VIRUS
SO HORMONE RESEARCH IN PAEDIATRICS
LA English
DT Meeting Abstract
C1 [Bezerra, Mariana Pires; Braz, Adriana Farrant] Campina Grande Fed Univ, Campina Grande, Brazil.
   [Braz Pedrosa, Tiago Farrant; Braz, Adriana Farrant] Campina Grande Med Coll, Campina Grande, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1663-2818
EI 1663-2826
J9 HORM RES PAEDIAT
JI Horm. Res. Paediatr.
PY 2017
VL 88
SU 1
MA P3-502
BP 464
EP 464
PG 1
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA FJ2XT
UT WOS:000412595405082
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika vaccines successfully protected newborn mice
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT News Item
DE developing countries; development; regulation; Vaccine trials
AB Over the past 10 years there has been an increase in the number of vaccine clinical studies conducted in resource limited countries. These include vaccine trials for diseases such as malaria and dengue fever which are endemic to many low and lower-middle income countries. Concurrent with the increase in the number of trials, has been the increase and improvement in local infrastructure to enable the appropriate conduct and oversight of trials in these settings, including strengthening of local scientific capabilities, ethical and regulatory oversight. While significant advances have been made, there remain gaps to be addressed including strengthening pharmacovigilance in these regions. There are also opportunities to establish novel collaborations to address diseases specific to these populations including strengthening local manufacturers, new ways to engage established large pharmaceutical companies and leveraging established global infrastructure and pathways to develop innovative products beyond vaccines.
CR Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
NR 1
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2017
VL 13
IS 9
BP 1959
EP 1959
DI 10.1080/21645515.2017.1358582
PG 1
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA FK7RU
UT WOS:000413705700011
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Parvez, MK
   Parveen, S
AF Parvez, Mohammad K.
   Parveen, Shama
TI Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future
SO INTERVIROLOGY
LA English
DT Review
DE Emerging infections; Novel viruses; Viral outbreaks; Virus evolution
ID RESPIRATORY SYNCYTIAL VIRUS; AUSTRALIAN BAT LYSSAVIRUS; HEPATITIS-E;
   G-PROTEIN; PANDEMIC INFLUENZA; TRANSMISSION; INFECTION; DYNAMICS; SARS;
   EPIDEMIOLOGY
AB Incidences of emerging/re-emerging deadly viral infections have significantly affected human health despite extraordinary progress in the area of biomedical knowledge. The best examples are the recurring outbreaks of dengue and chikungunya fever in tropical and sub-tropical regions, the recent epidemic of Zika in the Americas and the Caribbean, and the SARS, MERS, and influenza A outbreaks across the globe. The established natural reservoirs of human viruses are mainly farm animals, and, to a lesser extent, wild animals and arthropods. The intricate "host-pathogen-environment" relationship remains the key to understanding the emergence/reemergence of pathogenic viruses. High population density, rampant constructions, poor sanitation, changing climate, and the introduction of anthropophilic vectors create selective pressure on host-pathogen reservoirs. Nevertheless, the knowledge and understanding of such zoonoses and pathogen diversity in their known non-human reservoirs are very limited. Prevention of arboviral infections using vector control methods has not been very successful. Currently, new approaches to protect against food-borne infections, such as consuming only properly cooked meats and animal products, are the most effective control measures. Though significant progress in controlling human immunodeficiency virus and hepatitis viruses has been achieved, the unpredictable nature of evolving viruses and the rare occasions of outbreaks severely hamper control and preventive modalities. (C) 2017 S. Karger AG, Basel
C1 [Parvez, Mohammad K.] King Saud Univ, Dept Pharmacognosy, Coll Pharm, Riyadh, Saudi Arabia.
   [Parveen, Shama] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India.
RP Parvez, MK (corresponding author), King Saud Univ, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia.
EM khalid_parvez@yahoo.com
FU Wellcome TrustWellcome Trust
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Afreen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141628
   Afreen N, 2014, MICROBIOL IMMUNOL, V58, P688, DOI 10.1111/1348-0421.12209
   Ahmed A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166145
   Allworth A., 1996, Communicable Diseases Intelligence, V20, P504
   Anderson LJ, 2010, INT J ANTIMICROB AG, V36, pS21, DOI 10.1016/j.ijantimicag.2010.06.016
   Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490
   Bofill-Mas S, 2001, J VIROL, V75, P10290, DOI 10.1128/JVI.75.21.10290-10299.2001
   CDC, ROD US CARR HANT
   Cleaveland S, 2007, CURR TOP MICROBIOL, V315, P85
   Cleaveland S, 2011, PHIL T R SOC LOND B, V356, P991
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   Deeba F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv119
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268
   Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807
   Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586
   Fooks Anthony, 2004, Expert Rev Vaccines, V3, P333
   French CE, 2016, INFLUENZA OTHER RESP, V10, P268, DOI 10.1111/irv.12379
   GARDNER SD, 1971, LANCET, V1, P1253
   Ge XY, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0483-9
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Hanna JN, 2000, MED J AUSTRALIA, V172, P597, DOI 10.5694/j.1326-5377.2000.tb124126.x
   Holmes E. C, 2009, EVOLUTION EMERGENCE
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Khan G, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-66
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kitchen A, 2011, P NATL ACAD SCI USA, V108, P238, DOI 10.1073/pnas.1011090108
   KRAUSE RM, 1992, SCIENCE, V257, P1073, DOI 10.1126/science.257.5073.1073
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lahariya C, 1996, J VECTOR DIS, V43, P151
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Lu SH, 2013, BIOSCI TRENDS, V7, P109, DOI 10.5582/bst.2013.v7.2.109
   McCall BJ, 2000, EMERG INFECT DIS, V6, P259, DOI 10.3201/eid0603.000305
   McElhinney LM, 2013, ZOONOSES PUBLIC HLTH, V60, P35, DOI 10.1111/zph.12003
   Mertens M, 2013, ANTIVIR RES, V98, P248, DOI 10.1016/j.antiviral.2013.02.007
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   PADGETT BL, 1971, LANCET, V1, P1257
   PAHO, 2016, REG ZIK EP UPD AM 20
   Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06
   Parvez MK, 2013, INTERVIROLOGY, V56, P213, DOI 10.1159/000349888
   Pavio N, 2015, CURR OPIN VIROL, V10, P34, DOI 10.1016/j.coviro.2014.12.006
   Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211
   Pesko KN, 2012, INFECT GENET EVOL, V12, P181, DOI 10.1016/j.meegid.2011.11.014
   Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108
   Simmonds P, 2011, PHIL T R SOC LOND B, V356, P1013
   Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Tazeen A, 2017, EPIDEMIOL INFECT, V145, P67, DOI 10.1017/S0950268816001990
   Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0
   Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Wever PC, 2014, INFLUENZA OTHER RESP, V8, P538, DOI 10.1111/irv.12267
   WHO, 2016, LASS FEV FACT SHEET
   *WHO, SUMM PROB SARS CAS O
   Widen F, 2016, ADV EXP MED BIOL, V948, P61, DOI 10.1007/978-94-024-0942-0_4
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Woolhouse MEJ, 2013, FUTURE VIROL, V8, P159, DOI [10.2217/FVL.12.129, 10.2217/fvl.12.129]
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
NR 63
TC 8
Z9 9
U1 3
U2 24
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PY 2017
VL 60
IS 1-2
BP 1
EP 7
DI 10.1159/000478729
PG 7
WC Virology
SC Virology
GA FJ0XR
UT WOS:000412435000001
PM 28772262
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Khou, C
   Pardigon, N
AF Khou, Cecile
   Pardigon, Nathalie
TI Identifying Attenuating Mutations: Tools for a New Vaccine Design
   against Flaviviruses
SO INTERVIROLOGY
LA English
DT Review
DE Flavivirus vaccines; Molecular infectious clones; Live attenuated virus
   strains; MicroRNA target sequences
ID JAPANESE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS; N-LINKED GLYCOSYLATION;
   ENVELOPE PROTEIN GLYCOSYLATION; AMINO-ACID SUBSTITUTION; NEW-YORK
   STRAIN; DENGUE-VIRUS; MONOCLONAL-ANTIBODIES; VIRULENCE ATTENUATION;
   GENETIC-DETERMINANTS
AB Emerging Flaviviruses pose an increasing threat to global human health. To date, human vaccines against yellow fever virus (YFV), Japanese encephalitis virus (JEV), dengue virus (DV), and tick-borne encephalitis virus (TBEV) exist. However, there is no human vaccine against other Flaviviruses such as Zika virus (ZIKV) and West Nile virus (WNV). In order to restrict their spread and to protect populations against the diseases they induce, vaccines against these emerging viruses must be designed. Obtaining new live attenuated Flavivirus vaccines using molecular biology methods is now possible. Molecular infectious clones of the parental viruses are relatively easy to generate. Key mutations present in live attenuated vaccines or mutations known to have a key role in the Flavivirus life cycle and/or interactions with their hosts can be identified by sequencing, and are then inserted in infectious clones by site-directed mutagenesis. More recently, the use of chimeric viruses and large-scale reencoding and introduction of microRNA target sequences have also been tested. Indeed, a combination of these methods will help in designing new generations of vaccines against emerging and reemerging Flaviviruses. (C) 2017 S. Karger AG, Basel
C1 [Khou, Cecile; Pardigon, Nathalie] Inst Pasteur, Arbovirus Grp, Environm & Infect Risks Unit, 25 Rue Docteur Roux, FR-75015 Paris, France.
RP Pardigon, N (corresponding author), Inst Pasteur, Arbovirus Grp, Environm & Infect Risks Unit, 25 Rue Docteur Roux, FR-75015 Paris, France.
EM pardigon@pasteur.fr
CR Alsaleh K, 2016, VIROLOGY, V492, P53, DOI 10.1016/j.virol.2016.02.009
   Angsubhakorn Subhkij, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P554
   [Anonymous], 2011, Wkly Epidemiol Rec, V86, P241
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372
   Beck A, 2014, J INFECT DIS, V209, P334, DOI 10.1093/infdis/jit546
   BHAMARAPRAVATI N, 1987, B WORLD HEALTH ORGAN, V65, P189
   Brandler S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000096
   Brandler S, 2012, J INFECT DIS, V206, P212, DOI 10.1093/infdis/jis328
   Brandler S, 2010, VACCINE, V28, P6730, DOI 10.1016/j.vaccine.2010.07.073
   Burki T, 2016, LANCET INFECT DIS, V16, P896, DOI 10.1016/S1473-3099(16)30224-9
   Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080
   Catteau A, 2003, J GEN VIROL, V84, P2781, DOI 10.1099/vir.0.19163-0
   Centers for Disease Control and Prevention, 1999, W NIL VIR DIS CAS DE
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   de Fabritus L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004738
   de Wispelaere M, 2016, J VIROL, V90, P2676, DOI 10.1128/JVI.01176-15
   de Wispelaere M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004081
   Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   Domingo E, 2002, J VIROL, V76, P463, DOI 10.1128/JVI.76.1.463-465.2002
   ECKELS KH, 1976, INFECT IMMUN, V14, P1221, DOI 10.1128/IAI.14.5.1221-1227.1976
   EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gamino V, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-39
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   GOULD EA, 1986, J GEN VIROL, V67, P591, DOI 10.1099/0022-1317-67-3-591
   Gromowski GD, 2015, J VIROL, V89, P6328, DOI 10.1128/JVI.00219-15
   Gromowski GD, 2014, VACCINE, V32, P3010, DOI 10.1016/j.vaccine.2014.03.062
   GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Hall RA, 1999, VIROLOGY, V264, P66, DOI 10.1006/viro.1999.9956
   Hall RA, 2003, P NATL ACAD SCI USA, V100, P10460, DOI 10.1073/pnas.1834270100
   HALSTEAD SB, 1984, AM J TROP MED HYG, V33, P679, DOI 10.4269/ajtmh.1984.33.679
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Heiss BL, 2011, J VIROL, V85, P1464, DOI 10.1128/JVI.02091-10
   Huang CYH, 2005, J VIROL, V79, P7300, DOI 10.1128/JVI.79.12.7300-7310.2005
   Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003
   Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000
   Hurrelbrink RJ, 2001, J VIROL, V75, P7692, DOI 10.1128/JVI.75.16.7692-7702.2001
   Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Kanesa-thasan N, 2001, VACCINE, V19, P3179, DOI 10.1016/S0264-410X(01)00020-2
   KAUFMAN BM, 1989, AM J TROP MED HYG, V41, P576, DOI 10.4269/ajtmh.1989.41.576
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   KURANE I, 1986, J GEN VIROL, V67, P1653, DOI 10.1099/0022-1317-67-8-1653
   Le Nouen C, 2014, P NATL ACAD SCI USA, V111, P13169, DOI 10.1073/pnas.1411290111
   Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002
   Lee E, 2000, J VIROL, V74, P8867, DOI 10.1128/JVI.74.19.8867-8875.2000
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Lee E, 2006, J GEN VIROL, V87, P2791, DOI 10.1099/vir.0.82164-0
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Li ZS, 2014, VIRUS RES, V191, P10, DOI 10.1016/j.virusres.2014.07.017
   Liang JJ, 2009, VACCINE, V27, P2746, DOI 10.1016/j.vaccine.2009.03.007
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Lorin C, 2005, THERAPIE, V60, P227, DOI 10.2515/therapie:2005029
   Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000
   MATEU MG, 1989, P NATL ACAD SCI USA, V86, P5883, DOI 10.1073/pnas.86.15.5883
   McElroy KL, 2006, J GEN VIROL, V87, P2993, DOI 10.1099/vir.0.82023-0
   McElroy KL, 2006, AM J TROP MED HYG, V75, P1158, DOI 10.4269/ajtmh.2006.75.1158
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996
   Minke JM, 2004, ARCH VIROL, P221
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   MORENS DM, 1987, J GEN VIROL, V68, P91, DOI 10.1099/0022-1317-68-1-91
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Ni HL, 1998, VIROLOGY, V241, P30, DOI 10.1006/viro.1997.8956
   Pan American Health Organization WHO, 2017, ZIK EP UPD
   PLETNEV AG, 1992, P NATL ACAD SCI USA, V89, P10532, DOI 10.1073/pnas.89.21.10532
   Pletnev AG, 2002, P NATL ACAD SCI USA, V99, P3036, DOI 10.1073/pnas.022652799
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006
   Sampson BA, 2000, HUM PATHOL, V31, P527, DOI 10.1053/hp.2000.8047
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208
   Szentpali-Gavaller K, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020049
   WANG E, 1995, J GEN VIROL, V76, P2749, DOI 10.1099/0022-1317-76-11-2749
   Wang HJ, 2014, VACCINE, V32, P949, DOI 10.1016/j.vaccine.2013.12.050
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   WHITMAN LORING, 1939, AMER JOUR TROP MED, V19, P19
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   WISSEMAN CL, 1963, AM J TROP MED HYG, V12, P620, DOI 10.4269/ajtmh.1963.12.620
   Yang HQ, 2016, ARCH VIROL, V161, P1517, DOI 10.1007/s00705-016-2817-8
   Yasui K, 2002, J NEUROVIROL, V8, P112, DOI 10.1080/13550280290168019
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Yoshii K, 2013, J GEN VIROL, V94, P2249, DOI 10.1099/vir.0.055269-0
   Yu L, 2008, VACCINE, V26, P5981, DOI 10.1016/j.vaccine.2008.08.064
   Yu Y, 2013, INTECH OPEN SCI, DOI [10.5772/52980, DOI 10.5772/52980]
   Yu YX, 2010, VACCINE, V28, P3635, DOI 10.1016/j.vaccine.2010.02.105
   Yun SI, 2016, J GEN VIROL, V97, P2575, DOI 10.1099/jgv.0.000574
   Yun SI, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004290
   Zai J, 2013, ACTA VIROL, V57, P27, DOI 10.4149/av_2013_01_27
   Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4
   ZHAO B, 1987, J VIROL, V61, P4019, DOI 10.1128/JVI.61.12.4019-4022.1987
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 116
TC 6
Z9 6
U1 1
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PY 2017
VL 60
IS 1-2
BP 8
EP 18
DI 10.1159/000479966
PG 11
WC Virology
SC Virology
GA FJ0XR
UT WOS:000412435000002
PM 28869941
OA Bronze
DA 2020-07-08
ER

PT J
AU Afsahi, SJ
   Locascio, LE
   Pan, D
   Gao, YN
   Walker, AE
   Barron, FE
   Goldsmith, BR
   Lerner, MB
AF Afsahi, Savannah J.
   Locascio, Lauren E.
   Pan, Deng
   Gao, Yingning
   Walker, Amy E.
   Barron, Francie E.
   Goldsmith, Brett R.
   Lerner, Mitchell B.
TI Towards Novel Graphene-Enabled Diagnostic Assays with Improved
   Signal-to-Noise Ratio
SO MRS ADVANCES
LA English
DT Article
ID IMMUNOASSAYS; ANTIBODIES; VALIDATION
AB Large numbers of high quality graphene transistors were fabricated by chemical vapor deposition and packaged into a standard electronics assembly, enabling the readout of graphene properties on the benchtop. After chemical functionalization, these sensors demonstrate sensitivity into the pM range to inflammation (IL6) and Zika virus (ZIKV NS1) biomarkers. Signal-to-noise ratio (SNR) of graphene biosensors is over an order of magnitude greater than established diagnostic and biophysical assays, namely ELISA and BLI respectively. High precision measurements of protein kinetics captured using this technology, commercially available as the AGILE R100, are comparable to both clinical diagnostic and state-of-the-art biomolecule characterization tools. These results demonstrate that graphene-based platforms are highly attractive biological sensors for next generation diagnostics.
C1 [Afsahi, Savannah J.; Locascio, Lauren E.; Pan, Deng; Gao, Yingning; Walker, Amy E.; Barron, Francie E.; Goldsmith, Brett R.; Lerner, Mitchell B.] Nanomed Diagnost Inc, 6185 Cornerstone Court East Suite 110, San Diego, CA 92121 USA.
RP Afsahi, SJ (corresponding author), Nanomed Diagnost Inc, 6185 Cornerstone Court East Suite 110, San Diego, CA 92121 USA.
OI Barron, Francie/0000-0001-6568-7358
CR Artiles MS, 2011, ADV DRUG DELIVER REV, V63, P1352, DOI 10.1016/j.addr.2011.07.005
   Borrebaeck CAK, 2000, IMMUNOL TODAY, V21, P379, DOI 10.1016/S0167-5699(00)01683-2
   Choi W, 2010, CRIT REV SOLID STATE, V35, P52, DOI 10.1080/10408430903505036
   Choi YK, 2012, SCIENCE, V335, P319, DOI 10.1126/science.1214824
   Esfandiar A, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4827811
   Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7
   Gao LB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1702
   Goldsmith BR, 2007, SCIENCE, V315, P77, DOI 10.1126/science.1135303
   Gonzalez RM, 2008, J PROTEOME RES, V7, P2406, DOI 10.1021/pr700822t
   Graber M, 2002, ACAD MED, V77, P981, DOI 10.1097/00001888-200210000-00009
   Hughes LJ, 2014, VIROLOGY, V464, P264, DOI 10.1016/j.virol.2014.06.039
   Kybert NJ, 2014, NANO RES, V7, P95, DOI 10.1007/s12274-013-0376-9
   Lerner M. B., 2016, SENSOR ACTUAT B-CHEM, V239, P1261
   Lerner MB, 2014, NANO LETT, V14, P2709, DOI 10.1021/nl5006349
   Lu Y., 2010, APPL PHYS LETT, V97
   Lu Y, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3678024
   McGlennen RC, 2001, CLIN CHEM, V47, P393
   Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002
   Tetin SY, 2004, CURR PHARM BIOTECHNO, V5, P9, DOI 10.2174/1389201043489602
   Zhan BB, 2014, SMALL, V10, P4042, DOI 10.1002/smll.201400463
   Zhu SE, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802799
NR 21
TC 2
Z9 2
U1 1
U2 7
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 2059-8521
J9 MRS ADV
JI MRS Adv.
PY 2017
VL 2
IS 60
BP 3733
EP 3739
DI 10.1557/adv.2017.431
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA FK5MO
UT WOS:000413543500010
DA 2020-07-08
ER

PT J
AU Quintero, J
   Garcia-Betancourt, T
   Caprara, A
   Basso, C
   da Rosa, EG
   Manrique-Saide, P
   Coelho, G
   Sanchez-Tejeda, G
   Dzul-Manzanilla, F
   Garcia, DA
   Carrasquilla, G
   Alfonso-Sierra, E
   Motta, CMV
   Sommerfeld, J
   Kroeger, A
AF Quintero, Juliana
   Garcia-Betancourt, Tatiana
   Caprara, Andrea
   Basso, Cesar
   Garcia da Rosa, Elsa
   Manrique-Saide, Pablo
   Coelho, Giovanini
   Sanchez-Tejeda, Gustavo
   Dzul-Manzanilla, Felipe
   Alejandro Garcia, Diego
   Carrasquilla, Gabriel
   Alfonso-Sierra, Eduardo
   Vasconcelos Motta, Cyntia Monteiro
   Sommerfeld, Johannes
   Kroeger, Axel
TI Taking innovative vector control interventions in urban Latin America to
   scale: lessons learnt from multi-country implementation research
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Aedes aegypti; vector control; prevention; scaling up; process
   evaluation; Latin America
ID CLUSTER RANDOMIZED-TRIAL; UP HIV/AIDS; DENGUE; EXPERIENCE; ENVIRONMENT;
   PROJECT; HEALTH; CARE
AB Prior to the current public health emergency following the emergence of chikungunya and Zika Virus Disease in the Americas during 2014 and 2015, multi-country research investigated between 2011 and 2013 the efficacy of novel Aedes aegypti intervention packages through cluster randomised controlled trials in four Latin-American cities: Fortaleza (Brazil); Girardot (Colombia), Acapulco (Mexico) and Salto (Uruguay). Results from the trials led to a scaling up effort of the interventions at city levels. Scaling up refers to deliberate efforts to increase the impact of successfully tested health interventions to benefit more people and foster policy and program development in a sustainable way. The different scenarios represent examples for a 'vertical approach' and a 'horizontal approach'. This paper presents the analysis of a preliminary process evaluation of the scaling up efforts in the mentioned cites, with a focus on challenges and enabling factors encountered by the research teams, analysing the main social, political, administrative, financial and acceptance factors.
C1 [Quintero, Juliana; Garcia-Betancourt, Tatiana; Carrasquilla, Gabriel] Fdn Santa Fe Bogota, Div Publ Hlth, Bogota, Colombia.
   [Caprara, Andrea; Vasconcelos Motta, Cyntia Monteiro] Univ Estadual Ceara, Ctr Ciencias Saude, Fortaleza, Ceara, Brazil.
   [Basso, Cesar] Univ Republica, Fac Agron, Dept Protecc Vegetal, Montevideo, Uruguay.
   [Garcia da Rosa, Elsa] Univ Republ, Fac Vet, Dept Parasitol Vet, Salto, Uruguay.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Dept Zool, Campus Ciencias Biol & Agr, Merida, Mexico.
   [Coelho, Giovanini] Minist Saude, Natl Dengue Control Programme, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Sanchez-Tejeda, Gustavo; Dzul-Manzanilla, Felipe] Secretaria Salud Mexico, Ctr Nacl Programas Prevent & Control Enfermedades, Mexico City, Mexico.
   [Alejandro Garcia, Diego] Minist Salud & Protecc Social, Subdirecc Enfermedades Transmisibles, Bogota, Colombia.
   [Alfonso-Sierra, Eduardo] Univ Freiburg, Ctr Med & Soc Phys Anthropol, Freiburg, Germany.
   [Sommerfeld, Johannes; Kroeger, Axel] WHO, Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland.
   [Sommerfeld, Johannes] WHO, Ctr Hlth Dev, Kobe, Hyogo, Japan.
RP Quintero, J (corresponding author), Fdn Santa Fe Bogota, Div Publ Hlth, Bogota, Colombia.
EM julianaquinteroe@gmail.com
RI Caprara, Andrea/I-4011-2013; Caprara, Andrea/O-9522-2019; Caprara,
   Andrea/F-8399-2012; Sommerfeld, Johannes/AAI-5816-2020
OI Caprara, Andrea/0000-0003-1972-8205; Caprara,
   Andrea/0000-0003-1972-8205; Caprara, Andrea/0000-0003-1972-8205;
   Quintero, Juliana/0000-0003-3005-4184; Dzul Manzanilla, Felipe
   Antonio/0000-0002-2085-9141; Basso, Cesar/0000-0003-0427-3631;
   Carrasquilla, Gabriel/0000-0002-9449-4931; Garcia-Betancourt,
   Tatiana/0000-0002-1567-5030
FU UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR)World Health Organization; International
   Development Research Center (IDRC) [HQTDR1409927]; Consejo Nacional de
   Ciencia y Tecnologia (CONACYT) through Project 'Control integrado de Ae.
   aegypti con estrategias y herramientas innovadoras en la zona de alto
   riesgo para la transmision del dengue en Guerrero Mexico'; International
   Development Research Center (IDRC); Departamento de Ciencia, Tecnologia
   e Innovacion Colciencias (CTeI); project 'Enfoque Ecobiosocial para el
   diseno e implementacion de una estrategia sostenible para el control del
   vector de dengue en Girardot, Fase 3. Viabilidad y costo efectividad de
   una intervencion innovadora para el control del vector de dengue'
   [622172553374]; Consejo Nacional de Ciencia y Tecnologia (CONACYT)
   through Project 'Casas y escuelas a prueba de Aedes aegypti para
   maximizar el control y la prevencion del dengue en areas de riesgo en
   Yucatan'
FX This work was financially supported by the UNICEF/UNDP/World Bank/WHO
   Special Programme for Research and Training in Tropical Diseases (TDR)
   and International Development Research Center (IDRC) [grant number
   HQTDR1409927]; In Mexico, the studies additionally received financial
   support by el Consejo Nacional de Ciencia y Tecnologia (CONACYT) through
   the Projects 'Control integrado de Ae. aegypti con estrategias y
   herramientas innovadoras en la zona de alto riesgo para la transmision
   del dengue en Guerrero Mexico' y 'Casas y escuelas a prueba de Aedes
   aegypti para maximizar el control y la prevencion del dengue en areas de
   riesgo en Yucatan'. In Colombia, the study received additional support
   of the International Development Research Center (IDRC) through the
   project 'Intersectoral Municipal Leadership for Health' and by the
   Departamento de Ciencia, Tecnologia e Innovacion Colciencias (CTeI) and
   through the project 'Enfoque Ecobiosocial para el diseno e
   implementacion de una estrategia sostenible para el control del vector
   de dengue en Girardot, Fase 3. Viabilidad y costo efectividad de una
   intervencion innovadora para el control del vector de dengue' [project
   number 622172553374].
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alfonso-Sierra E., 2016, PATHOG GLOB HEALTH, V7724, P1
   Anchalia MM, 2011, INT J QUAL HEALTH C, V23, P464, DOI 10.1093/intqhc/mzr007
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Basso C, 2015, T ROY SOC TROP MED H, V109, P134, DOI 10.1093/trstmh/tru183
   Binswanger HP, 2000, SCIENCE, V288, P2173, DOI 10.1126/science.288.5474.2173
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, P3, DOI DOI 10.1371/J0URNAL.PNTD.0004551
   Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187
   Chambers R., 2009, GOING SCALE COMMUNIT
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   Corbin J Hope, 2012, Glob Health Action, V5, P18369, DOI 10.3402/gha.v5i0.18369
   ExpandNet WHO, 2009, PRACT GUID SCAL HLTH
   Fitzgerald J, 2005, REV PANAM SALUD PUBL, V17, P66, DOI 10.1590/S1020-49892005000100012
   Focks DA, 2006, TROP MED, V31, P56
   George A, 2011, HEALTH POLICY PLANN, V26, P327, DOI 10.1093/heapol/czq048
   Ghiron L, 2014, REPROD HEALTH MATTER, V22, P84, DOI 10.1016/S0968-8080(14)43761-3
   Gomez-Dantes H, 2011, SALUD PUBLICA MEXICO, V53, pS349
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Keyonzo N, 2015, REPROD HEALTH MATTER, V23, P103, DOI 10.1016/j.rhm.2015.06.010
   Magesa SM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-34
   Mangham LJ, 2010, HEALTH POLICY PLANN, V25, P85, DOI 10.1093/heapol/czp066
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   Nsutebu EF, 2001, HEALTH POLICY PLANN, V16, P240, DOI 10.1093/heapol/16.3.240
   Pevzner ES, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-550
   Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208
   Simmons R, 2007, SCALING UP HEALTH SERVICE DELIVERY: FROM PILOT INNOVATIONS TO POLICIES AND PROGRAMMES, P1
   Sommerfeld J, 2015, T ROY SOC TROP MED H, V109, P85, DOI 10.1093/trstmh/tru176
   Tambo E, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-7
   Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x
   Walker CLF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000428
   WHO, 2007, SCALING HLTH SERVICE
   WHO, 2013, OUTLOOKS PEST MANAG, V24, P142, DOI 10.1564/v24_jun_14
   WHO ExpandNet, 2011, BEG END MIND PLANN P
   WHO Regional Office for South-East-Asia, 2012, COMPR GUID PREV CONT
   Yamey G, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-11
   Yamey G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001049
NR 36
TC 1
Z9 1
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2017
VL 111
IS 6
BP 306
EP 316
DI 10.1080/20477724.2017.1361563
PG 11
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA FL8RZ
UT WOS:000414519100005
PM 28829235
OA Green Published
DA 2020-07-08
ER

PT J
AU Devnarain, N
   Ramharack, P
   Soliman, ME
AF Devnarain, Nikita
   Ramharack, Pritika
   Soliman, Mahmoud E.
TI Brain grants permission of access to Zika virus but denies entry to
   drugs: a molecular modeling perspective to infiltrate the boundary
SO RSC ADVANCES
LA English
DT Review
ID SOLID LIPID NANOPARTICLES; PHARMACOPHORE MODEL; SEXUAL TRANSMISSION;
   ANTIVIRAL DRUG; DELIVERY; DISCOVERY; DESIGN; INHIBITORS; EFFICIENT;
   DYNAMICS
AB The magnetism of the Zika virus to neuronal cells proves to be one of the major concerns in the development of effective inhibitors. Although the blood-brain barrier limits the entry of most drugs, tailored small molecule inhibitors and drug delivery systems are currently being designed to overcome this obstacle. We have identified the core challenge to be addressed-blood-brain barrier permeability - and provided insight into strategies that can be used to improve drug delivery to the brain. We have compiled drugs that have previously been proposed as potential Zika virus inhibitors and classified chemical features of those drugs, which influence blood-brain barrier permeability. Thereafter, we created a route map to design drugs with improved blood-brain barrier permeability. An alternative approach using drug delivery systems to transport membrane-impermeable Zika virus inhibitors to the brain is also proposed, along with descriptions of known drug carriers. This review provides information for further research toward inhibitors of Zika virus.
C1 [Devnarain, Nikita; Ramharack, Pritika; Soliman, Mahmoud E.] Univ KwaZulu Natal, Sch Hlth Sci, Mol Biocomputat & Drug Design Lab, Westville Campus, ZA-4001 Durban, South Africa.
RP Soliman, ME (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Mol Biocomputat & Drug Design Lab, Westville Campus, ZA-4001 Durban, South Africa.
EM soliman@ukzn.ac.za
OI Ramharack, Pritika/0000-0001-5850-6782; Devnarain,
   Nikita/0000-0002-9538-4611
CR Abouelfadel Zinelabidine, 2008, Ther Clin Risk Manag, V4, P513
   Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067
   Arnott JA, 2012, EXPERT OPIN DRUG DIS, V7, P863, DOI 10.1517/17460441.2012.714363
   Atkins P., 2011, PHYS CHEM LIFE SCI
   Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bazzill JD, 2016, J IMMUNOL, V196
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhowmik D., 2012, PHARMA INNOVATION, V1, P12
   Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330
   Blind M, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2014.74
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Briguglio I, 2011, INT J MED CHEM, DOI 10.1155/2011/213135
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Cele FN, 2016, DRUG DES DEV THER, V10, P1365, DOI 10.2147/DDDT.S95533
   COUNE A, 1988, INFECTION, V16, P141, DOI 10.1007/BF01644088
   da Fonseca NJ, 2017, BIOCHEM BIOPH RES CO, V492, P565, DOI 10.1016/j.bbrc.2017.01.041
   Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717
   Daina A, 2014, J CHEM INF MODEL, V54, P3284, DOI 10.1021/ci500467k
   Daraee H., 2014, ARTIF CELL NANOMED B, V1401, P1
   del Pozo-Rodriguez A, 2016, EUR J PHARM BIOPHARM, V109, P184, DOI 10.1016/j.ejpb.2016.10.016
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Dey AK, 2005, J VIROL, V79, P13806, DOI 10.1128/JVI.79.21.13806-13810.2005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duster AW, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1310
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Ganesan A, 2017, DRUG DISCOV TODAY, V22, P249, DOI 10.1016/j.drudis.2016.11.001
   Ganguly B., 2016, BIORXIV, P54486
   Gavhane YN, 2012, SAUDI PHARM J, V20, P331, DOI 10.1016/j.jsps.2012.03.005
   Gonzalez MA, 2010, EC THEMAT SOC FR NE, P169, DOI 10.1051/sfn/201112009
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gunay MS, 2016, CURR NEUROPHARMACOL, V14, P376, DOI 10.2174/1570159X14666151230124904
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Honarparvar B, 2014, CHEM REV, V114, P493, DOI 10.1021/cr300314q
   Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x
   Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+
   Jayasena SD, 1999, CLIN CHEM, V45, P1628
   Jiang F, 2015, INT J MOL SCI, V16, P23784, DOI 10.3390/ijms161023784
   Kedar U, 2010, NANOMED-NANOTECHNOL, V6, P714, DOI 10.1016/j.nano.2010.05.005
   Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378
   Kore P., 2012, OPEN J MED CHEM, V2, P139, DOI [10.4236/ojmc.2012.24017, DOI 10.4236/OJMC.2012.24017]
   Kovics GJ, 2014, CRIT REV MICROBIOL, V40, P49, DOI 10.3109/1040841X.2012.755948
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lez R. Guixa-Gonza, 2014, BIOINFORMATICS, V30, P1478
   Li G., 2016, P NATL ACAD SCI USA, V114
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Lionta E, 2014, CURR TOP MED CHEM, V14, P1923, DOI 10.2174/1568026614666140929124445
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146
   Mhlongo NN, 2016, LETT DRUG DES DISCOV, V13, P1033, DOI 10.2174/1570180813666160714162534
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mukherjee S, 2009, INDIAN J PHARM SCI, V71, P349, DOI 10.4103/0250-474X.57282
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nelson M., 1996, INT J HIGH PERFORM C, V251-268, P251
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pyzer-Knapp EO, 2015, ANNU REV MATER RES, V45, P195, DOI 10.1146/annurev-matsci-070214-020823
   Qi YF, 2015, BIOPHYS J, V109, P2012, DOI 10.1016/j.bpj.2015.10.008
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Ray P, 2010, PHARMACEUTICALS, V3, P1761, DOI 10.3390/ph3061761
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Roney C, 2005, J CONTROL RELEASE, V108, P193, DOI 10.1016/j.jconrel.2005.07.024
   Saunders NR, 2016, F1000RES, V5, P1
   Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013
   SEELIG A, 1994, P NATL ACAD SCI USA, V91, P68, DOI 10.1073/pnas.91.1.68
   Sharpe LA, 2014, EXPERT OPIN DRUG DEL, V11, P901, DOI 10.1517/17425247.2014.902047
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Skelton AA, 2014, CELL MOL BIOENG, V7, P45, DOI 10.1007/s12195-013-0304-9
   Spuch C, 2011, J DRUG DELIV, DOI 10.1155/2011/469679
   Srivastava A., 2016, J BIOSCI MED, V4, P69, DOI DOI 10.4236/JBM.2016.41009
   Syme MR, 2004, CLIN PHARMACOKINET, V43, P487, DOI 10.2165/00003088-200443080-00001
   Tao WQ, 2017, ANTIVIR RES, V141, P62, DOI 10.1016/j.antiviral.2017.01.021
   Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Torrecilla J, 2016, COLLOID SURFACE B, V146, P808, DOI 10.1016/j.colsurfb.2016.07.026
   Tran MA, 2009, PIGM CELL MELANOMA R, V22, P388, DOI 10.1111/j.1755-148X.2009.00581.x
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Vanommeslaeghe K, 2014, CURR PHARM DESIGN, V20, P3281, DOI 10.2174/13816128113199990600
   Vepuri SB, 2016, J MOL STRUCT, V1105, P194, DOI 10.1016/j.molstruc.2015.10.050
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Xiong XB, 2010, BIOMATERIALS, V31, P5886, DOI 10.1016/j.biomaterials.2010.03.075
   Yu XJ, 2016, J NANOMATER, V2016, DOI 10.1155/2016/1087250
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 98
TC 5
Z9 5
U1 0
U2 5
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
EI 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2017
VL 7
IS 75
BP 47416
EP 47424
DI 10.1039/c7ra05918c
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA FJ7YQ
UT WOS:000412977000027
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Du, LY
   Zhou, YS
   Jiang, SB
AF Du, Lanying
   Zhou, Yusen
   Jiang, Shibo
TI The latest advancements in Zika virus vaccine development
SO EXPERT REVIEW OF VACCINES
LA English
DT Editorial Material
DE Flavivirus; Zika virus; vaccine; advancement; challenge
ID CROSS-REACTIVITY; BIRTH-DEFECTS; INFECTION; IMMUNITY; IMMUNOGENICITY;
   PROTECTION; CHALLENGE; MULTIPLE; OUTBREAK; MODELS
C1 [Du, Lanying; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
   [Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Jiang, Shibo] Fudan Univ, Basic Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai, Peoples R China.
   [Jiang, Shibo] Fudan Univ, Basic Med Coll, Minist Hlth, Key Lab Med Mol Virol, Shanghai, Peoples R China.
   [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai, Peoples R China.
RP Du, LY; Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.; Jiang, SB (corresponding author), Fudan Univ, Basic Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai, Peoples R China.; Du, LY; Jiang, SB (corresponding author), Fudan Univ, Basic Med Coll, Minist Hlth, Key Lab Med Mol Virol, Shanghai, Peoples R China.; Jiang, SB (corresponding author), Fudan Univ, Inst Med Microbiol, Shanghai, Peoples R China.
EM ldu@nybc.org; sjiang@nybc.org
RI Jiang, Shibo/L-4500-2014
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Beigel JH, 2009, J INFECT DIS, V200, P501, DOI 10.1086/599992
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Du LY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13473
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Saxena M, 2013, MICROBIOL-SGM, V159, P1, DOI 10.1099/mic.0.049601-0
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   WHO/UNICEF Zika virus (ZIKV), VACC TARG PROD PROF
   Zhou B, 2016, J VIROL, V90, P8454, DOI 10.1128/JVI.00163-16
NR 20
TC 5
Z9 6
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PY 2017
VL 16
IS 10
BP 951
EP 954
DI 10.1080/14760584.2017.1363648
PG 4
WC Immunology
SC Immunology
GA FH1LH
UT WOS:000410901000001
PM 28783378
OA Bronze
DA 2020-07-08
ER

PT J
AU Panday, A
   Sandy, S
   King, D
   Ramdeen, S
AF Panday, Avidesh
   Sandy, Sherry
   King, David
   Ramdeen, Shivanand
TI A case of suspected symptomatic Zika Neuroretinitis
SO IDCASES
LA English
DT Article
C1 [Panday, Avidesh] Dept Med, Eric Williams Med Sci Complex, Trinidad, WI, Trinidad Tobago.
   [Sandy, Sherry; King, David] Univ West Indies St Augustine, Dept Clin Med Sci, Eric Williams Med Sci Complex, Trinidad, WI, Trinidad Tobago.
   [Ramdeen, Shivanand] Sangre Grande Hosp, Dept Ophthalmol, Trinidad, WI, Trinidad Tobago.
RP Panday, A (corresponding author), Dept Med, Eric Williams Med Sci Complex, Trinidad, WI, Trinidad Tobago.
EM avidesh.panday@gmail.com
CR [Anonymous], STAT AV OFF CHIEF ME
   Fatteh N, 2014, AM ACAD OPHTHALMOL, V2014
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Kaliaperumal S, 2013, J BIOMED SCI ENG, V6, P15
   Maitland CG, 1998, ARCH OPHTHALMOL-CHIC, V102, P1146
   Walsh FB, 1982, NEURORETINITIS CLIN, P234
NR 6
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-2509
J9 IDCases
JI IDCases
PY 2017
VL 9
BP 104
EP 105
DI 10.1016/j.idcr.2017.06.010
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA FH2SW
UT WOS:000410993500037
PM 28736717
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Etienne, C
   dos Santos, T
   Espinal, MA
AF Etienne, Carissa
   dos Santos, Thais
   Espinal, Marcos A.
TI Keynote Address (November 2016): Zika Virus Disease in the Americas: A
   Storm in the Making
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID BRAZIL
AB More than 700,000 cases of Zika virus (ZIKAV) disease have been officially reported to the Pan American Health Organization (PAHO) from 48 countries and territories of the Americas. The response led by thePAHOand partners suggests major lessons of this outbreak. A seemingly innocuous pathogen became the new villain, causing fear, economic losses and, most importantly, debilitating birth defects and neurological problems, reaffirming the well-known war principle of never to underestimate one's opponent. The ZIKAV tested public health capacities under the International Health Regulations, highlighting the need for continued investment in health security. Last but not least, the lack of appropriate tools was another reminder of the pressing need for innovative solutions to persistent problems. Latin America and the Caribbean have approximately 500 million persons living in areas at risk for transmission of ZIKAV. The fight against ZIKAV is not a 100-m race, but rather a marathon in which science and public health need to work hand in hand for the benefit of our peoples.
C1 [Etienne, Carissa] Pan Amer Hlth Org, Washington, DC 20037 USA.
   [dos Santos, Thais; Espinal, Marcos A.] Pan Amer Hlth Org, Communicable Dis & Hlth Anal Dept, 525 23rd St Northwest, Washington, DC 20037 USA.
RP Espinal, MA (corresponding author), Pan Amer Hlth Org, Communicable Dis & Hlth Anal Dept, 525 23rd St Northwest, Washington, DC 20037 USA.
EM director@paho.org; dossantost@paho.org; espinalm@paho.org
CR CEPI (Coalition for Epidemic Preparedness Initiative), 2017, CEPI NEW VACC SAF WO
   Espinal M, 2016, AM J PUBLIC HEALTH, V106, P279, DOI 10.2105/AJPH.2015.302969
   Pan American Health Organization, 2017, EP UPD
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   Pan American Health Orgnization, 2017, ZIK CAS COUNTS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   WHO, 2008, INT HLTH REG 2005
   Woolhouse M, 2016, EMERG INFECT DIS, V22, P12
   World Bank Group, 2016, SHORT TERM EC COSTS
   World Health Organization, 2016, R D BLUEPR ACT PREV
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 7
Z9 7
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 1
BP 16
EP 18
DI 10.4269/ajtmh.17-0207
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FG1AB
UT WOS:000409523900005
PM 28719313
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Quyen, NTH
   Kien, DTH
   Rabaa, M
   Tuan, NM
   Vi, TT
   Tan, LV
   Hung, NT
   Tuan, HM
   Tram, TV
   Ha, NLD
   Quang, HK
   Doanh, NQ
   Chau, NVV
   Wills, B
   Simmons, CP
AF Nguyen Than Ha Quyen
   Duong Thi Hue Kien
   Maia Rabaa
   Nguyen Minh Tuan
   Tran Thuy Vi
   Le Van Tan
   Nguyen Thanh Hung
   Ha Manh Tuan
   Ta Van Tram
   Nguyen Le Da Ha
   Han Khoi Quang
   Nguyen Quoc Doanh
   Nguyen Van Vinh Chau
   Wills, Bridget
   Simmons, Cameron P.
TI Chikungunya and Zika Virus Cases Detected against a Backdrop of Endemic
   Dengue Transmission in Vietnam
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID REEMERGENCE
AB Between 2010 and 2014, four chikungunya and two Zika virus infections were identified among 8,105 febrile children in southern Vietnam. Zika viruses were linked to French Polynesian strains, chikungunya to Cambodian strains. Against a backdrop of endemic dengue transmission, chikungunya and Zika present an additional arboviral disease burden in Vietnam.
C1 [Wills, Bridget] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.
   [Nguyen Than Ha Quyen; Duong Thi Hue Kien; Nguyen Minh Tuan; Tran Thuy Vi; Simmons, Cameron P.] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Wellcome Trust Major Overseas Programme,Dengue, Ho Chi Minh City, Vietnam.
   [Maia Rabaa; Le Van Tan] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Wellcome Trust Major Overseas Programme,Enter Inf, Ho Chi Minh City, Vietnam.
   [Maia Rabaa; Wills, Bridget; Simmons, Cameron P.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England.
   [Nguyen Minh Tuan; Nguyen Thanh Hung] Childrens Hosp 1, Dept Dengue Hemorrhag Fever, Ho Chi Minh, Vietnam.
   [Ha Manh Tuan] Childrens Hosp 2, Ho Chi Minh, Vietnam.
   [Ta Van Tram] Tien Giang Hosp, Paediat Dept, My Tho, Vietnam.
   [Nguyen Le Da Ha] Dong Nai Children Hosp, Pediat, Bien Hoa, Vietnam.
   [Han Khoi Quang] Binh Duong Hosp, Pediat, Thu Dau Mot, Vietnam.
   [Nguyen Quoc Doanh] Long An Hosp, Pediat, Tan An, Vietnam.
   [Nguyen Van Vinh Chau] Hosp Trop Dis, Ho Chi Minh, Vietnam.
   [Simmons, Cameron P.] Univ Melbourne, Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.
   [Simmons, Cameron P.] Univ Melbourne, Microbiol & Immunol, Parkville, Vic, Australia.
RP Simmons, CP (corresponding author), Univ Melbourne, Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.
EM quyennth@oucru.org; kiendth@oucru.org; mrabaa@oucru.org;
   tuannm@oucru.org; vitt@oucru.org; tanlv@oucru.org;
   drthanhhung@gmail.com; manhtuanzu@yahoo.com; tavantram@gmail.com;
   daha_nl@yahoo.com; hkquang@gmail.com; nguyenquocdoanh1964@gmail.com;
   chaunvv@oucru.org; bwills@oucru.org; csimmons@unimelb.edu.au
RI Rabaa, Maia/W-2223-2019
OI Rabaa, Maia/0000-0003-0529-2228; Le Van, Tan/0000-0002-1791-3901; Ha
   Manh, Tuan/0000-0002-4998-2581; Nguyen, Tuan/0000-0001-8058-7750;
   Simmons, Cameron P./0000-0002-9039-7392
FU Wellcome Trust (United Kingdom)Wellcome Trust
FX This work was funded by the Wellcome Trust (United Kingdom).
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duong V, 2012, EMERG INFECT DIS, V18, P2066, DOI 10.3201/eid1812.120471
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Grossi-Soyster EN, 2017, CURR OPIN PEDIATR, V29, P102, DOI 10.1097/MOP.0000000000000449
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hapuarachchi HC, 2010, J GEN VIROL, V91, P1067, DOI 10.1099/vir.0.015743-0
   Kien DTH, 2011, J VIROL METHODS, V177, P168, DOI 10.1016/j.jviromet.2011.08.002
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Tuan NM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003638
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Sam IC, 2009, J CLIN VIROL, V46, P180, DOI 10.1016/j.jcv.2009.07.016
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tun MMN, 2014, EMERG INFECT DIS, V20, P1378, DOI 10.3201/eid2008.131431
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 15
TC 13
Z9 14
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 1
BP 146
EP 150
DI 10.4269/ajtmh.16-0979
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FG1AB
UT WOS:000409523900025
PM 28719300
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Santos, VS
   Oliveira, SJG
   Gurgel, RQ
   Lima, DRR
   dos Santos, CA
   Martins, PRS
AF Santos, Victor S.
   Oliveira, Sheila J. G.
   Gurgel, Ricardo Q.
   Lima, Dorothy R. R.
   dos Santos, Cliomar A.
   Martins-Filho, Paulo R. S.
TI Case Report: Microcephaly in Twins due to the Zika Virus
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID BRAIN-STEM; INFECTION; INFANTS; PLACENTA; BRAZIL
AB Recent studies have demonstrated an association between congenital Zika virus (ZIKV) infection and microcephaly; however, to date, there have been no reports on the consequences of ZIKV infection on fetuses in twin pregnancies. Herein, we reported on the first case of a monochorionic diamniotic (MCDA) twin pregnancy having ZIKV-related microcephaly. Our findings suggested that, in an MCDA twin pregnancy, the ZIKV may cause infection in both fetuses, resulting in severe abnormalities in the central nervous system due to neural cell destruction and the disruption of the normal development processes of the brain. This case report and other similar twin casesmay help to understand the pathogenesis and to confirm the etiology of ZIKV as a teratogenicmicroorganism.
C1 [Santos, Victor S.; Oliveira, Sheila J. G.; Gurgel, Ricardo Q.; Lima, Dorothy R. R.; Martins-Filho, Paulo R. S.] Univ Fed Sergipe, Aracaju, Brazil.
   [dos Santos, Cliomar A.] Cent Publ Hlth Lab, Aracaju, Brazil.
RP Martins, PRS (corresponding author), Univ Fed Sergipe, Univ Hosp, Invest Pathol Lab, Rua Claudio Batista S-N, BR-49060100 Aracaju, Sergipe, Brazil.
EM santosvictor19@gmail.com; sheilajgsoliveira@gmail.com;
   ricardoqgurgel@gmail.com; dorothyribeiro@hotmail.com;
   cliomar.santos@fsph.se.gov.br; martins-filho@ufs.br
RI Martins-Filho, Paulo/AAC-4773-2019; Gurgel, RQ/N-5105-2018; Santos,
   Victor S/B-8738-2014; Santos, Victor/M-5710-2019
OI Gurgel, RQ/0000-0001-9651-3713; Santos, Victor S/0000-0003-0194-7397;
   Santos, Victor/0000-0003-0194-7397; Martins-Filho, Paulo
   Ricardo/0000-0001-8779-0727
CR Bae YJ, 2013, RADIOGRAPHICS, V33, P47, DOI 10.1148/rg.331125033
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brazil Ministerio da Saude, 2016, 31 MIN SAUD
   Buttmer U, 2006, PROG BRAIN RES, V151, P1, DOI 10.1016/S0079-6123(05)51001-X
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dahle A J, 2000, J Am Acad Audiol, V11, P283
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Egana-Ugrinovic G, 2016, J MATERN-FETAL NEO M, V29, P3439, DOI 10.3109/14767058.2015.1130818
   Fenton TR, 2013, BMC PEDIATR, V13, P1, DOI DOI 10.1186/1471-2431-13-1
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Lazzarotto T, 2003, PEDIATRICS, V112, pE153, DOI 10.1542/peds.112.2.e153
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   NAHMIAS AJ, 1994, TROPHOBLAST RES, V8, P193, DOI DOI 10.1016/S0143-4004(05)80344-3
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues L. C., 2016, LANCET INFECT DIS, V3099, P1
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Satosar A, 2004, HUM PATHOL, V35, P536, DOI 10.1016/j.humpath.2004.01.015
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Strupp M, 2011, DTSCH ARZTEBL INT, V108, P197, DOI 10.3238/arztebl.2011.0197
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Yinon Y, 2006, BJOG-INT J OBSTET GY, V113, P295, DOI 10.1111/j.1471-0528.2006.00854.x
NR 28
TC 3
Z9 4
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 1
BP 151
EP 154
DI 10.4269/ajtmh.16-1021
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FG1AB
UT WOS:000409523900026
PM 28719330
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Contreras-Gutierrez, MA
   Guzman, H
   Thangamani, S
   Vasilakis, N
   Tesh, RB
AF Angelica Contreras-Gutierrez, Maria
   Guzman, Hilda
   Thangamani, Saravanan
   Vasilakis, Nikos
   Tesh, Robert B.
TI Experimental Infection with and Maintenance of Cell Fusing Agent Virus
   (Flavivirus) in Aedes aegypti
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID INSECT-SPECIFIC FLAVIVIRUS; TRANSMISSION; MOSQUITOS; COINFECTION
AB During the past two decades, there has been a dramatic increase in the recognition and characterization of novel insect-specific flaviviruses (ISFVs). Some of these agents are closely related to important mosquito-borne flavivirus pathogens. Results of experimental studies suggest that mosquitoes and mosquito cell cultures infected with someISFVs are refractory to superinfection with related flavivirus pathogens; and it has been proposed that ISFVs potentially could be used to alter the vector competence of mosquitoes and reduce transmission of specific flavivirus pathogens, such as dengue, West Nile, or Zika viruses. In order for an ISFV to be used in such a control strategy, the virus would have to be vertically transmitted at a high rate in the target vector population to insure its continued maintenance. This study compared the vertical transmission rates of an ISFV, cell fusing agent virus (CFAV), in two Aedes aegypti colonies: one naturally infected with CFAV and the other experimentally infected but previously free of the virus. CFAV filial infection rates in progeny of female mosquitoes from both colonies were > 90% after two generations of selection, indicating the feasibility of introducing an ISFV into a mosquito population. This and other considerations for evaluating the feasibility of using ISFVs as an arbovirus control strategy are discussed.
C1 [Angelica Contreras-Gutierrez, Maria] Univ Antioquia, Sede Invest Univ, Programa Estudio Control Enfermedades Trop, Medellin, Colombia.
   [Angelica Contreras-Gutierrez, Maria] Univ Nacl Colombia, Fac Ciencias, Grp Invest Sistemat Mol GSM, Medellin, Colombia.
   [Guzman, Hilda; Thangamani, Saravanan; Vasilakis, Nikos; Tesh, Robert B.] Univ Texas Med Branch, Inst Human Infect & Immun, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Angelica Contreras-Gutierrez, Maria] Univ Antioquia, Sede Invest Univ, Medellin, Colombia.
   [Guzman, Hilda; Thangamani, Saravanan; Vasilakis, Nikos; Tesh, Robert B.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Dept Pathol, Houston, TX USA.
RP Tesh, RB (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
EM maria.contreras@pecet-colombia.org; hguzman@utmb.edu; sathanga@utmb.edu;
   nivasila@utmb.edu; rtesh@utmb.edu
RI Thangamani, Saravanan/E-7371-2010
OI Thangamani, Saravanan/0000-0002-4269-5993
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R24AI120942];
   Programa de Doctorados Nacionales-Colciencias Ph.D. fellowship from the
   Colombian government [Convocatoria 567]
FX This work was funded in part by grant R24AI120942 from the National
   Institutes of Health. MAC was supported by a Programa de Doctorados
   Nacionales-Colciencias (Convocatoria 567) Ph.D. fellowship from the
   Colombian government.
CR Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Calzolari M, 2016, INFECT GENET EVOL, V40, P381, DOI 10.1016/j.meegid.2015.07.032
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Cholleti H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162751
   Collao X, 2015, REV CHIL INFECTOL, V32, P113, DOI 10.4067/S0716-10182015000200021
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Datta S, 2015, INTERVIROLOGY, V58, P149, DOI 10.1159/000381901
   Espinoza-Gomez F, 2011, ARCH VIROL, V156, P1263, DOI 10.1007/s00705-011-0967-2
   Fan H, 2016, ARCH VIROL, V161, P1723, DOI 10.1007/s00705-016-2827-6
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Higgs Stephen, 2005, P733
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025
   IGARASHI A, 1976, VIROLOGY, V74, P174, DOI 10.1016/0042-6822(76)90139-2
   Jupatanakul N, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P107
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Kuwata R, 2015, ARCH VIROL, V160, P2151, DOI 10.1007/s00705-015-2488-x
   Misencik MJ, 2016, VECTOR-BORNE ZOONOT, V16, P181, DOI 10.1089/vbz.2015.1889
   PELEG J, 1969, J GEN VIROL, V5, P463, DOI 10.1099/0022-1317-5-4-463
   Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   SINGH KRP, 1967, CURR SCI INDIA, V36, P506
   Stollar V, 1975, VIROLOGY, V47, P122
   Tesh RB, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P191
   Vanlandingham DL, 2007, AM J TROP MED HYG, V77, P925, DOI 10.4269/ajtmh.2007.77.925
   World Health Organization, 1985, WHO TECH REP SER, V719
   Yamanaka A, 2013, INFECT GENET EVOL, V19, P188, DOI 10.1016/j.meegid.2013.07.012
NR 32
TC 6
Z9 6
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 1
BP 299
EP 304
DI 10.4269/ajtmh.16-0987
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FG1AB
UT WOS:000409523900046
PM 28719335
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Liu, J
   Wan, PF
   Li, QQ
   Li, XX
   Li, A
   Chen, HY
   Li, JJ
   Liang, WH
   Zheng, HF
   Gu, WW
   Li, HW
AF Liu, Jun
   Wan, Pengfei
   Li, Qingqing
   Li, Xiaoxin
   Li, Andrew
   Chen, Huangyao
   Li, Jingjing
   Liang, Wenhan
   Zheng, Haifa
   Gu, Weiwang
   Li, Hongwei
TI Construction and Identification of Recombinant HEK293T Cell Lines
   Expressing Non-structural Protein 1 of Zika Virus
SO INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE ZIKV; Non-structural protein 1; HEK293T cell; Secretory expression;
   Purification
ID NS1 PROTEIN; INFECTION; DIAGNOSIS; DENGUE; SPECIFICITY; EPIDEMIC;
   COLOMBIA; BRAZIL
AB Background: Zika virus (ZIKV) infection has become a major public health problem all around the world. Early diagnosis of Zika infection is important for better management of the disease. Non-structural protein 1 (NS1) is a potential biomarker for ZIKV infections. The purpose of this study was to produce the ZIKV NS1 protein for establishing serological diagnostic methods for ZIKV.
   Methods: The cDNA fragment encoding a chimeric protein composed of murine Ig. signal peptide, NS1 and histidine tag was synthesized and cloned into the lentiviral expression vector pLV-eGFP. The resulting expression vector pLV-eGFP-ZIKV-NS1 was packaged and transduced into human embryonic kidney (HEK) 293T cells and clonal cell lines with NS1 gene were generated from the tranduced cells by limiting dilution. Over expressed recombination NS1 (rNS1) fusion protein was purified by nickel affinity chromatography. Mice immunization and enzyme-linked immunosorbent assay (ELISA) were carried out to evaluate the immunogenicity of rNS1.
   Results: Western blot analysis revealed that the reconstituted cells stably expressed and secreted high levels of approximately 45-kDa NS1, and no significant changes were observed in green fluorescent protein (GFP) fluorescence ratio and fluorescence intensity. The scanned gels showed that the purity of the purified rNS1 was 99.42%. BALB/c mice were then immunized with purified rNS1 and a high level of antibodies against NS1 was elicited in the mice.
   Conclusion: Overall, recombinant NS1 proteins were successfully purified and their antigenicity was assessed. Immunization of mice with recombinant proteins demonstrated the immunogenicity of the NS1 protein. Thus, the generated recombinant NS1 can be potentially used in the development of serological diagnostic methods for ZIKV.
C1 [Liu, Jun; Wan, Pengfei; Li, Qingqing; Li, Xiaoxin; Chen, Huangyao; Li, Jingjing; Liang, Wenhan; Li, Hongwei] Southern Med Univ, Sch Lab Med & Biotechnol, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
   [Liu, Jun; Gu, Weiwang] Southern Med Univ, Inst Comparat Med, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
   [Liu, Jun; Gu, Weiwang] Southern Med Univ, Ctr Lab Animals, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
   [Li, Andrew] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.
   [Zheng, Haifa] Beijing Minhai Biotechnol CO LTD, Beijing, Peoples R China.
RP Li, HW (corresponding author), Southern Med Univ, Sch Lab Med & Biotechnol, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.; Gu, WW (corresponding author), Southern Med Univ, Inst Comparat Med, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.; Gu, WW (corresponding author), Southern Med Univ, Ctr Lab Animals, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.; Zheng, HF (corresponding author), Beijing Minhai Biotechnol CO LTD, Biotechnol & Pharmaceut Ind Base, 1 Simiao Rd, Beijing 102600, Peoples R China.
EM zhenghaifa@sina.com; guww100@163.com; lihw@smu.edu.cn
OI Liu, Jun/0000-0002-5275-2656
FU National Key RD Projects [2017YFD0500600]; Industrial High-tech Fields
   of Science and Technology Plan Projects of Guangdong Province
   [2013B010404026]; Science and Technology Planning Project of Guangdong
   Province [2010A011200003, 2012B011000004, 2016A030303008,
   2012B060300003]; International S&T Cooperation Program of China
   [2011DFA33290]; Medical Scientific Research Foundation of Guangdong
   Province [A2017124]
FX This study was financially supported by the National Key R&D Projects
   grant 2017YFD0500600, the Industrial High-tech Fields of Science and
   Technology Plan Projects of Guangdong Province grant 2013B010404026, the
   Science and Technology Planning Project of Guangdong Province, Grant
   2010A011200003, 2012B011000004, 2016A030303008, 2012B060300003, the
   International S&T Cooperation Program of China grant 2011DFA33290, the
   Medical Scientific Research Foundation of Guangdong Province, Grant
   A2017124.
CR Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Burke A, 2016, SEMIN REPROD MED, V34, P305, DOI 10.1055/s-0036-1592068
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Conde JN, 2016, J VIROL, V90, P9570, DOI 10.1128/JVI.00912-16
   Machado-Alba JE, 2016, INT J INFECT DIS, V51, P133, DOI 10.1016/j.ijid.2016.09.010
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Galula JU, 2016, J CLIN MICROBIOL, V54, P412, DOI 10.1128/JCM.02469-15
   He Y, 2016, PLOS ONE, V11, pe162
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Mao YY, 2015, INT J MED SCI, V12, P407, DOI 10.7150/ijms.11270
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   Oliveira ER, 2016, PLOS ONE, V11
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
NR 21
TC 1
Z9 1
U1 0
U2 3
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-1907
J9 INT J MED SCI
JI Int. J. Med. Sci.
PY 2017
VL 14
IS 11
BP 1072
EP 1079
DI 10.7150/ijms.20417
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA FG7PW
UT WOS:000410612200005
PM 29104460
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ahmed, QA
   Memish, ZA
AF Ahmed, Qanta A.
   Memish, Ziad A.
TI Zika in Singapore: implications for Saudi Arabia
SO EASTERN MEDITERRANEAN HEALTH JOURNAL
LA English
DT Editorial Material
ID DENGUE-FEVER; VIRUS
C1 [Ahmed, Qanta A.] Winthrop Univ Hosp, Dept Med, Div Pulm Dis & Crit Care Med, Mineola, NY 11501 USA.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Minist Hlth, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
RP Memish, ZA (corresponding author), Alfaisal Univ, Coll Med, Minist Hlth, Riyadh, Saudi Arabia.; Memish, ZA (corresponding author), Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
EM Zmemish@yahoo.com
CR Alwafi OM, 2013, AM J RES COMMUN, V1, P123
   [Anonymous], 2016, LANCET, V388, P1026
   [Anonymous], 2014, STAT YB MIN HLTH
   Aziz Al Thabiany, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P849, DOI 10.1016/S2221-1691(12)60242-1
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   El-Kafrawy SA, 2016, VECTOR-BORNE ZOONOT, V16, P391, DOI 10.1089/vbz.2015.1911
   Elachola H, 2016, J HLTH SPECIALTIES, V4, P87
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Fakeeh M, 2001, AM J TROP MED HYG, V65, P764, DOI 10.4269/ajtmh.2001.65.764
   Gostin LO, 2016, LANCET INFECT DIS, V16, P1099, DOI 10.1016/S1473-3099(16)30332-2
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   Joint MOH-NEA media statement on zika, 2016, JOINT MOH NE MED STA
   Lipkin WI., 2016, WALL STREET J
   Pew Research Center, 2015, FUT WORLD REL POP GR
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
NR 16
TC 0
Z9 0
U1 0
U2 0
PU WHO EASTERN MEDITERRANEAN REGIONAL OFFICE
PI NASR CITY, CAIRO
PA P. O. BOX 7608, NASR CITY, CAIRO, EGYPT
SN 1020-3397
EI 1687-1634
J9 E MEDITERR HEALTH J
JI East Mediterr. Health J.
PY 2017
VL 23
IS 4
BP 311
EP 313
DI 10.26719/2017.23.4.311
PG 3
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA FG2JB
UT WOS:000409922300008
PM 28634982
OA Bronze
DA 2020-07-08
ER

PT B
AU Pal, R
   Misra, G
   Mathur, P
AF Pal, Rajesh
   Misra, Gauri
   Mathur, Puniti
GP IEEE
TI In silico screening of small molecule modulators of Zika vir us proteins
SO PROCEEDINGS OF THE 7TH INTERNATIONAL CONFERENCE ON CLOUD COMPUTING, DATA
   SCIENCE AND ENGINEERING (CONFLUENCE 2017)
LA English
DT Proceedings Paper
CT 7th International Conference on Cloud Computing, Data Science and
   Engineering (Confluence)
CY JAN 12-13, 2017
CL Amity Univ, Noida, INDIA
SP IEEE UP Sect, Amity Sch Engn & Technol, Dept Comp Sci & Engn, IEEE
HO Amity Univ
DE Zika virus; NS2B/NS3 protease; NS3 helicase; molecular docking; virtual
   screening; structure based drug design
ID NS2B-NS3 PROTEASE; ACCURATE DOCKING; GLIDE; HELICASE
AB Zika virus (ZIKV) has recently infected around 2 million people around the world and presently there is no USFDA approved drug in the market. In the present study, molecular docking analysis of two essential non-structural proteins NS2B/NS3 protease and NS3 helicase, which are involved in viral replication, has been reported. Identification of potential inhibitors could be considered as a strategy for treatment of the ZIKV infection. Using structure based drug design, docking of 1, 15,203 compounds were performed for both the proteins and 10 ligands were identified for each protein, which may serve as potential inhibitors. These molecules can further be validated in experimental studies.
C1 [Pal, Rajesh; Misra, Gauri; Mathur, Puniti] Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Sect 125, Noida, India.
RP Pal, R (corresponding author), Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Sect 125, Noida, India.
EM rajpal22288@gmail.com; gmisra@amity.edu; pmathur@amity.edu
CR [Anonymous], PYMOL MOL GRAPHICS S
   [Anonymous], 2016, SCHROD REL 2016 3
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Entrican G, 2002, J COMP PATHOL, V126, P79, DOI 10.1053/jcpa.2001.0539
   Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   KOCHHAR DM, 1980, TOXICOL APPL PHARM, V52, P99, DOI 10.1016/0041-008X(80)90252-5
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK SIT REP
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
NR 25
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-3519-9
PY 2017
BP 381
EP 386
PG 6
WC Computer Science, Information Systems; Computer Science, Theory &
   Methods
SC Computer Science
GA BI2FG
UT WOS:000408970200066
DA 2020-07-08
ER

PT J
AU Alvarado-Castro, V
   Paredes-Solis, S
   Nava-Aguilera, E
   Morales-Perez, A
   Alarcon-Morales, L
   Balderas-Vargas, NA
   Andersson, N
AF Alvarado-Castro, Victor
   Paredes-Solis, Sergio
   Nava-Aguilera, Elizabeth
   Morales-Perez, Arcadio
   Alarcon-Morales, Lidia
   Alejandra Balderas-Vargas, Norma
   Andersson, Neil
TI Assessing the effects of interventions for Aedes aegypti control:
   systematic review and meta-analysis of cluster randomised controlled
   trials
SO BMC PUBLIC HEALTH
LA English
DT Review
DE Dengue; chemical control; biological control; community mobilisation;
   meta-analysis
ID DENGUE VECTOR CONTROL; INSECTICIDE-TREATED CURTAINS; WATER CONTAINER
   COVERS; COMMUNITY EFFECTIVENESS; FEVER; PREVENTION; MOBILIZATION;
   STRATEGIES; MEXICO; CITY
AB Background: The Aedes aegypti mosquito is the vector for dengue fever, yellow fever, chikungunya, and zika viruses. Inadequate vector control has contributed to persistence and increase of these diseases. This review assesses the evidence of effectiveness of different control measures in reducing Aedes aegypti proliferation, using standard entomological indices.
   Methods: A systematic search of Medline, Ovid, BVS, LILACS, ARTEMISA, IMBIOMED and MEDIGRAPHIC databases identified cluster randomised controlled trials (CRCTs) of interventions to control Aedes aegypti published between January 2003 and October 2016. Eligible studies were CRCTs of chemical or biological control measures, or community mobilization, with entomological indices as an endpoint. A meta-analysis of eligible studies, using a random effects model, assessed the impact on household index (HI), container index (CI), and Breteau index (BI).
   Results: From 848 papers identified by the search, eighteen met the inclusion criteria: eight for chemical control, one for biological control and nine for community mobilisation. Seven of the nine CRCTs of community mobilisation reported significantly lower entomological indices in intervention than control clusters; findings from the eight CRCTs of chemical control were more mixed. The CRCT of biological control reported a significant impact on the pupae per person index only. Ten papers provided enough detail for meta-analysis. Community mobilisation (four studies) was consistently effective, with an overall intervention effectiveness estimate of -0.10 (95% CI -0.20 -0.00) for HI, -0.03 (95% CI -0.05 - -0.01) for CI, and -0.13 (95% CI -0.22 - -0.05) for BI. The single CRCT of biological control had effectiveness of -0.02 (95% CI -0.07-0.03) for HI, -0.02 (95% CI -0.04- -0.01) for CI and -0.08 (95% CI -0.15- -0.01) for BI. The five studies of chemical control did not show a significant impact on indices: the overall effectiveness was -0.01 (95% CI -0.05- 0.03) for HI, 0.01 (95% CI -0.01- 0.02) for CI, and 0.01 (95% CI -0.03 -0.05) for BI.
   Conclusion: Governments that rely on chemical control of Aedes aegypti should consider adding community mobilization to their prevention efforts. More well-conducted CRCTs of complex interventions, including those with biological control, are needed to provide evidence of real life impact. Trials of all interventions should measure impact on dengue risk.
C1 [Alvarado-Castro, Victor; Paredes-Solis, Sergio; Nava-Aguilera, Elizabeth; Morales-Perez, Arcadio; Alejandra Balderas-Vargas, Norma; Andersson, Neil] Univ Autonoma Guerrero, CIET, Acapulco, Guerrero, Mexico.
   [Alarcon-Morales, Lidia] Univ Autonoma Guerrero, Unidad Acad Matemat, Chilpancingo, Guerrero, Mexico.
   [Andersson, Neil] McGill Univ, Dept Family Med, Montreal, PQ, Canada.
RP Alvarado-Castro, V (corresponding author), Univ Autonoma Guerrero, CIET, Acapulco, Guerrero, Mexico.
EM alvarado@cimat.mx
RI Andersson, Neil/G-2248-2011
FU UBS Optimus Foundation
FX The UBS Optimus Foundation Funding provided funding for publication of
   this manuscript.
CR Abeyewickreme W, 2012, PATHOG GLOB HEALTH, V106, P479, DOI 10.1179/2047773212Y.0000000060
   Al-Muhandis N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001278
   Andersson Neil, 2006, Int J Health Geogr, V5, P1, DOI 10.1186/1476-072X-5-1
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   [Anonymous], 2015, STATEMENT DENGUE VAC
   Arunachalam N, 2012, PATHOG GLOB HEALTH, V106, P488, DOI 10.1179/2047773212Y.0000000056
   Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Basso C, 2015, T ROY SOC TROP MED H, V109, P134, DOI 10.1093/trstmh/tru183
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187
   Castro M, 2012, T ROY SOC TROP MED H, V106, P315, DOI 10.1016/j.trstmh.2012.01.013
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Donalisio M. R. C., 2002, Dengue Bulletin, V26, P173
   Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533
   Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x
   Espinoza-Gomez F, 2002, J EPIDEMIOL COMMUN H, V56, P148, DOI 10.1136/jech.56.2.148
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   George L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004006
   Han WW, 2015, TROP MED INT HEALTH, V20, P1239, DOI 10.1111/tmi.12538
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Kittayapong P, 2012, PATHOG GLOB HEALTH, V106, P446, DOI 10.1179/2047773212Y.0000000059
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224
   Lazaro A, 2015, TROP MED INT HEALTH, V20, P685, DOI 10.1111/tmi.12485
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Lima EP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2199-y
   McLeroy KR, 2003, AM J PUBLIC HEALTH, V93, P529, DOI 10.2105/AJPH.93.4.529
   Mitchell-Fostera K, 2015, T ROY SOC TROP MED H, V109, P126, DOI 10.1093/trstmh/tru209
   Morales-Perez A, 2017, BMC PUBLIC HLTH S1, V17, pS14
   Ocampo CB, 2009, BIOMEDICA, V29, P282, DOI 10.7705/biomedica.v29i2.30
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pilger D, DENGUE OUTBREAK RESP
   Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208
   R Core Team, 2013, R LANG ENV STAT COMP
   Rizzo N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-931
   Sanofi Pasteur, 2015, DENGV 1 DENG VACC AP
   Sanofi Pasteur, 2015, DENGV WORLDS 1 DENG
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Steichen TJ, 1998, STATA TECHNICAL B, V7, P125
   Vanlerberghe V, 2010, MEDICC REV, V12, P41
   Vanlerberghe V, 2013, AM J TROP MED HYG, V89, P93, DOI 10.4269/ajtmh.13-0015
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, INT VECT MAN
   World Health Organisation, 2016, WHOZIKVSRF162
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, WHOZIKVSRF161
   World Health Organization, DENG CONTR STRAT
NR 55
TC 15
Z9 16
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PY 2017
VL 17
SU 1
AR 384
DI 10.1186/s12889-017-4290-z
PG 18
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FG8DO
UT WOS:000410658400001
PM 28699552
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sanin-Blair, JE
   Gutierrez-Marquez, C
   Herrera, DA
   Vossough, A
AF Sanin-Blair, Jose Enrique
   Gutierrez-Marquez, Carolina
   Herrera, Diego A.
   Vossough, Arastoo
TI Fetal Magnetic Resonance Imaging Findings in Prenatal Zika Virus
   Infection
SO FETAL DIAGNOSIS AND THERAPY
LA English
DT Article
DE Congenital Zika virus syndrome; Fetal magnetic resonance; Fetal
   ultrasound; Intrauterine infection
ID CYTOMEGALOVIRUS-INFECTION
AB Brain lesions and malformations have been described on ultrasonography of prenatal Zika infection; however, there are scarce reports about fetal magnetic resonance (MR) findings. We report 3 cases of fetuses with confirmed intrauterine Zika virus infection evaluated by ultrasound and fetal MR. Various morphometric measurements were assessed and brain maturation was calculated with the fetal total maturation score. Fetuses with prenatal Zika virus infection showed retardation in brain maturation indexes evaluated by fetal MR. Brain calcifications were demonstrated by neurosonography in all cases, while fetal MR characterized the specific type of cortical development malformation. (C) 2017 S. Karger AG, Basel
C1 [Sanin-Blair, Jose Enrique] Med Fetal SA, Clin Univ Bolivariana, Dept Maternal Fetal Med, Medellin, Antioquia, Colombia.
   [Gutierrez-Marquez, Carolina] Univ Pontificia Bolivariana, Cedimed, Dept Radiol, Calle 42 Numero 63-107, Medellin 050030, Colombia.
   [Herrera, Diego A.] Univ Antioquia, Cedimed, Dept Radiol, Medellin 050030, Colombia.
   [Vossough, Arastoo] Univ Penn, Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA.
RP Gutierrez-Marquez, C (corresponding author), Univ Pontificia Bolivariana, Cedimed, Dept Radiol, Calle 42 Numero 63-107, Medellin 050030, Colombia.
EM carogutmar@gmail.com
OI Herrera, Diego/0000-0001-6043-6998
FU Clinica Bolivariana
FX Special gratitude to Clinica Bolivariana for their support.
CR de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization World Health Organization, 2015, EP AL
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Vossough A, 2013, RADIOLOGY, V268, P200, DOI 10.1148/radiol.13111715
   Wright R, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.1.e9
NR 10
TC 1
Z9 1
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-3837
EI 1421-9964
J9 FETAL DIAGN THER
JI Fetal Diagn. Ther.
PY 2017
VL 42
IS 2
BP 153
EP 157
DI 10.1159/000454860
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FF6HP
UT WOS:000409108100011
PM 28288452
DA 2020-07-08
ER

PT J
AU Monteiro, M
   Shelley-Egan, C
   Dratwa, J
AF Monteiro, Marko
   Shelley-Egan, Clare
   Dratwa, Jim
TI On irresponsibility in times of crisis: learning from the response to
   the Zika virus outbreak
SO JOURNAL OF RESPONSIBLE INNOVATION
LA English
DT Article
DE Zika virus; responsible research and innovation; public health ethics;
   research policy
AB This perspective paper offers some first thoughts regarding the current Zika virus outbreak and the immediate response it generated in health and research policy. We suggest that in times of emergent health crises, irresponsibilities may arise in the way responses which involve science and technology are framed and implemented. These pertain both to how such situations emerge under a crisis frame, and to pre-existing irresponsibilities which condition how such crises unfold. Reflecting on these irresponsibilities helps to clarify both how crucial it is to promote responsibility in research and innovation in everyday situations, and how important it is to maintain vigilance in times of crisis. We argue that care for the future needs to incorporate attention to persisting inequalities, which become especially salient in moments of emergency and which condition how crises are dealt with and the role innovation is perceived to play in their solution.
C1 [Monteiro, Marko] State Univ Campinas UNICAMP, Inst Geosci IG, Dept Sci & Technol Policy, Campinas, SP, Brazil.
   [Shelley-Egan, Clare] Oslo & Akershus Univ, Coll Appl Sci, Oslo, Norway.
   [Dratwa, Jim] Woodrow Wilson Int Ctr Scholars, Washington, DC USA.
RP Monteiro, M (corresponding author), State Univ Campinas UNICAMP, Inst Geosci IG, Dept Sci & Technol Policy, Campinas, SP, Brazil.
EM markosy@uol.com.br
RI Monteiro, Marko/F-4012-2012
OI Monteiro, Marko/0000-0003-4008-4985
FU National Science FoundationNational Science Foundation (NSF) [1257246]
FX This work was supported by National Science Foundation [grant number
   1257246].
CR [Anonymous], 2016, CBS NEWS
   [Anonymous], 2016, BBC NEWS
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   Boadle Anthony, 2016, REUTERS         0222
   Bowater D, 2016, TELEGRAPH
   Brooks Brad, 2016, REYTERS         0315
   Brum E., 2016, GUARDIAN
   Caplan A., 2016, FORBES
   de Campos TC, 2017, MED HEALTH CARE PHIL, V20, P443, DOI 10.1007/s11019-016-9739-9
   Epstein S., 1996, IMPURE SCI AIDS ACTI
   Firger J., 2016, NEWSWEEK
   Formenti L., 2015, EXAME           0712
   Hartl G., 2016, LATEST EBOLA OUTBREA
   Macnaghten P, 2014, J RESPONSIBLE INNOV, V1, P191, DOI 10.1080/23299460.2014.922249
   Macnaghten P, 2011, NATURE, V479, P293, DOI 10.1038/479293a
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nco B., 2012, EMERGING BIOTECHNOLO
   Pollack A, 2016, NY TIMES
   Shilts Randy, 2007, BAND PLAYED POLITICS
   Stilgoe J, 2013, RES POLICY, V42, P1568, DOI 10.1016/j.respol.2013.05.008
   vandenHoven J., 2013, OPTIONS STRENGTHENIN
   Wallace Matthew, 2016, ZIKA NEEDS RES PORTF
   Watts J., 2016, GUARDIAN
   WHO, 2016, WHO FACT SHEET ZIK V
   Yamin Alicia E., HLTH HUMAN RIGHTS ZI
NR 25
TC 3
Z9 3
U1 1
U2 1
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2329-9460
EI 2329-9037
J9 J RESPONSIBLE INNOV
JI J. Responsible Innov.
PY 2017
VL 4
IS 1
BP 71
EP 77
DI 10.1080/23299460.2017.1312959
PG 7
WC Ethics; History & Philosophy Of Science; Management; Social Issues
SC Social Sciences - Other Topics; History & Philosophy of Science;
   Business & Economics; Social Issues
GA FE8NV
UT WOS:000408463000007
DA 2020-07-08
ER

PT J
AU Padmanabhan, P
   Seshaiyer, P
AF Padmanabhan, P.
   Seshaiyer, P.
TI Computational and Mathematical Methods to Estimate the Basic
   Reproduction Number and Final Size for Single-Stage and Multistage
   Progression Disease Models for Zika with Preventive Measures
SO COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE
LA English
DT Article
ID TREATED BED NETS; VIRUS
AB We present new mathematical models that include the impact of using selected preventative measures such as insecticide treated nets (ITN) in controlling or ameliorating the spread of the Zika virus. For these models, we derive the basic reproduction number and sharp estimates for the final size relation. We first present a single-stage model which is later extended to a new multistage model for Zika that incorporates more realistic incubation stages for both the humans and vectors. For each of these models, we derive a basic reproduction number and a final size relation estimate. We observe that the basic reproduction number for the multistage model converges to expected values for a standard Zika epidemic model with fixed incubation periods in both hosts and vectors. Finally, we also perform several computational experiments to validate the theoretical results obtained in this work and study the influence of various parameters on the models.
C1 [Padmanabhan, P.] Foxcroft Sch, Middleburg, VA USA.
   [Seshaiyer, P.] George Mason Univ, Dept Math Sci, Fairfax, VA 22030 USA.
RP Seshaiyer, P (corresponding author), George Mason Univ, Dept Math Sci, Fairfax, VA 22030 USA.
EM pseshaiy@gmu.edu
CR Agusto FB, 2016, COMPUT MATH METHOD M, DOI 10.1155/2016/4320514
   ANDERSON R M, 1991
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113
   Birget PLG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144173
   Brauer F, 2005, MATH BIOSCI, V198, P119, DOI 10.1016/j.mbs.2005.07.006
   Brauer F., 2016, INFECT DIS MODELLING, V2, P12
   Brauer F., 2001, TEXTS APPL MATH, V40
   Brauer F., 2012, CBMS NSF REGIONAL C, V84
   Castillo-Chavez C., 1989, LECTURE NOTES BIOMAT, V8, P177
   Castillo-Chavez Carlos, 1994, Lecture Notes in Biomathematics, V100, P454
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Diekmann O, 1995, EPIDEMIC MODELS THEI, P95
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16
   Griffin M., 2013, SIAM UNDERGRADUATE R, V6
   Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121
   Hyman JM, 1999, MATH BIOSCI, V155, P77, DOI 10.1016/S0025-5564(98)10057-3
   JACQUEZ JA, 1985, COMPARTMENTAL ANAL B
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022
   Padmanabhan P., 2017, LETT BIOMATHEMATICS, V4, P148, DOI DOI 10.1080/23737867.2017.1319746
   Premaratne MK, 2017, COMPUT MATH METHOD M, DOI 10.1155/2017/2187390
   Ross R., 1911, PREVENTION MALARIA A
   Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174
NR 29
TC 1
Z9 1
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1748-670X
EI 1748-6718
J9 COMPUT MATH METHOD M
JI Comput. Math. Method Med.
PY 2017
AR 4290825
DI 10.1155/2017/4290825
PG 17
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA FE8QQ
UT WOS:000408470600001
PM 28894473
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, LM
AF Lee, Lisa M.
TI A Bridge Back to the Future: Public Health Ethics, Bioethics, and
   Environmental Ethics
SO AMERICAN JOURNAL OF BIOETHICS
LA English
DT Article
DE environmental ethics; bioethics; medicine; public health
ID CLIMATE-CHANGE; ZIKA VIRUS; EMERGENCE; NEED
AB Contemporary biomedical ethics and environmental ethics share a common ancestry in Aldo Leopold's and Van Rensselaer Potter's initial broad visions of a connected biosphere. Over the past five decades, the two fields have become strangers. Public health ethics, a new subfield of bioethics, emerged from the belly of contemporary biomedical ethics and has evolved over the past 25 years. It has moved from its traditional concern with the tension between individual autonomy and community health to a wider focus on social justice and solidarity. Public health has a broad focus that includes individual, community, and environmental health. Public health ethics attends to these broad commitments reflected in the increasing concern with the connectedness of health of individuals to the health of populations, to the health of animals, to the health of the environment; it is well situated to reconnect all three "fields" of ethics to promote a healthier planet.
C1 [Lee, Lisa M.] Presidential Commiss Study Bioeth Issues, 330 C St SW,Ste L001, Washington, DC 20201 USA.
RP Lee, LM (corresponding author), Presidential Commiss Study Bioeth Issues, 330 C St SW,Ste L001, Washington, DC 20201 USA.
EM Lisa.Lee@bioethics.gov
CR Accreditation Council for Graduate Medical Education, 2017, ACGME COMM PROGR REQ
   Beauchamp TL, 2013, PRINCIPLES BIOMEDICA
   Carmody Tim, 2016, THE VERGE       0226
   Cronon William, 1997, J MUIR NATURE WRITIN
   Dawson A., 2012, PUBLIC HLTH REV, V34, P65, DOI DOI 10.1007/BF03391656
   Dawson A, 2010, BIOETHICS, V24, P218, DOI 10.1111/j.1467-8519.2010.01814.x
   DeSalvo KB, 2016, AM J PUBLIC HEALTH, V106, P621, DOI 10.2105/AJPH.2016.303063
   Dwyer J, 2009, BIOETHICS, V23, P497, DOI 10.1111/j.1467-8519.2009.01759.x
   EHRLICH P, 1968, POPULATION BOMB
   Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362
   Galea S, 2016, JAMA-J AM MED ASSOC, V315, P655, DOI 10.1001/jama.2016.0198
   Goldberg TL, 2015, LANCET, V386, pE37, DOI 10.1016/S0140-6736(15)60757-7
   Gutmann A, 1997, HASTINGS CENT REP, V27, P38, DOI 10.2307/3528667
   JAHR F, 1927, HANDWEISER NATURFREU, V24, P2
   Jennings B, 2016, BIOETHICAL INSIGHTS
   Jennings B, 2015, PUBLIC HEALTH ETH-UK, V8, P7, DOI 10.1093/phe/phu045
   JONES JH, 1993, BAD BLOOD TUSKEGEE S
   Jonsen AR, 2015, CLIN ETHICS PRACTICA
   Kaebnick G, 2015, BIOETHICS FORUM 0220
   Koh HK, 2010, NEW ENGL J MED, V363, P1296, DOI 10.1056/NEJMp1008560
   Lane SD, 2000, ANN NY ACAD SCI, V925, P25
   Lee LM, 2014, PUBLIC HEALTH, V128, P579, DOI 10.1016/j.puhe.2014.04.001
   Lee LM, 2016, HASTINGS CENT REP, V46, P19, DOI 10.1002/hast.543
   Lee LM, 2012, J LAW MED ETHICS, V40, P85, DOI 10.1111/j.1748-720X.2012.00648.x
   Leonardi J. M, 2001, 27 MICH DEP NAT RES
   Leopold A, 1949, SAND COUNTY ALMANAC
   Liaison Committee on Medical Education, 2017, FUNCT STRUCT MED SCH
   Lolas F, 2008, BIOL RES, V41, P119, DOI [10.4067/S0716-97602008000100013, /S0716-97602008000100013]
   Macpherson CC, 2013, BIOETHICS, V27, P305, DOI 10.1111/bioe.12029
   Marmot M., 2004, STATUS SYNDROME
   Naess A., 2005, SELECTED WORKS ARNE, V1-10
   *NAT COMM PROT HUM, 1979, BELM REP ETH PRINC G
   O'Neill Onora, 2002, Ethics Int Aff, V16, P35, DOI 10.1111/j.1747-7093.2002.tb00395.x
   Potter V. R., 1971, BIOETHICS BRIDGE FUT
   Powers M., 2006, SOCIAL JUSTICE MORAL
   Presidential Commission for the Study of Bioethical Issues, 2016, BIOETH EV GEN DEL ED
   Reich Warren Thomas, 1995, Kennedy Institute of Ethics Journal, V5, P19
   RELMAN AS, 1980, NEW ENGL J MED, V303, P963, DOI 10.1056/NEJM198010233031703
   Resnik DB, 2009, HEALTH CARE ANAL, V17, P261, DOI 10.1007/s10728-008-0104-x
   Resnik DB, 2012, ENV HLTH ETHICS
   Rubin CS, 2015, ONE HEALTH: THE THEORY AND PRACTICE OF INTEGRATED HEALTH APPROACHES, P318, DOI 10.1079/9781780643410.0318
   Rudolph L, 2013, HLTH ALL POLICIES GU
   Sabate J, 2016, AM J PUBLIC HEALTH, V106, P815, DOI 10.2105/AJPH.2016.303046
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sulmasy D. P, 2001, PHILOS FDN MED ESSAY, pxvii
   Tuskegee Syphilis Study Ad Hoc Advisory Panel, 1973, FINAL REPORT TUSKEGE
   WHITE L, 1967, SCIENCE, V155, P1203, DOI 10.1126/science.155.3767.1203
   WHO (World Health Organization), 1948, OFF REC WHO, V2, P100
   Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955
   World Health Organization, 2015, HLTH ALL POLICIES
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 51
TC 19
Z9 20
U1 3
U2 33
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1526-5161
EI 1536-0075
J9 AM J BIOETHICS
JI Am. J. Bioeth.
PY 2017
VL 17
IS 9
BP 5
EP 12
DI 10.1080/15265161.2017.1353164
PG 8
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA FE3EM
UT WOS:000408099200003
PM 28829266
DA 2020-07-08
ER

PT J
AU Alkahtani, BST
   Atangana, A
   Koca, I
AF Alkahtani, Badr Saad T.
   Atangana, Abdon
   Koca, Ilknur
TI Novel analysis of the fractional Zika model using the Adams type
   predictor-corrector rule for non-singular and non-local fractional
   operators
SO JOURNAL OF NONLINEAR SCIENCES AND APPLICATIONS
LA English
DT Article
DE Zika virus; reproduction number; numerical approximation
AB A mathematical system of equations using the concept of fractional differentiation with non-local and non-singular kernel has been analysed in this work. The developed mathematical model is designed to portray the spread of Zika virus within a given population. We presented the equilibrium point and also the reproductive number. The model was solving analytically using the Adams type predictor-corrector rule for Atangana-Baleanu fractional integral. The existence and uniqueness exact solution was presented under some conditions. The numerical replications were also presented. (C) 2017 All rights reserved.
C1 [Atangana, Abdon] King Saud Univ, Colle Sci, Dept Math, POB 1142, Riyadh 11989, Saudi Arabia.
   Univ Free State, Fac Nat & Agr Sci, Inst Groundwater Studies, ZA-9300 Bloemfontein, South Africa.
   Mehmet Akif Ersoy Univ, Fac Sci, Dept Math, TR-15100 Burdur, Turkey.
RP Atangana, A (corresponding author), King Saud Univ, Colle Sci, Dept Math, POB 1142, Riyadh 11989, Saudi Arabia.
EM balqahtani1@ksu.edu.sa; abdonatangana@yahoo.fr; ikoca@mehmetakif.edu.tr
FU Deanship of Science Research at King Saud University [PRG-1437-35]
FX The authors extend their sincere appreciations to the Deanship of
   Science Research at King Saud University for funding this prolific
   research group PRG-1437-35.
CR Algahtani OJJ, 2016, CHAOS SOLITON FRACT, V89, P552, DOI 10.1016/j.chaos.2016.03.026
   Alkahtani BST, 2016, CHAOS SOLITON FRACT, V89, P547, DOI 10.1016/j.chaos.2016.03.020
   Atangana A, 2017, J ENG MECH, V143, DOI 10.1061/(ASCE)EM.1943-7889.0001091
   Atangana A, 2016, CHAOS SOLITON FRACT, V89, P447, DOI 10.1016/j.chaos.2016.02.012
   Atangana A, 2016, THERM SCI, V20, P763, DOI 10.2298/TSCI160111018A
   Bonyah E., 2016, Asian Pacific Journal of Tropical Disease, V6, P673, DOI 10.1016/S2222-1808(16)61108-8
   Chen LP, 2013, ENTROPY-SWITZ, V15, P3265, DOI 10.3390/e15083355
   Hadamard J., 1892, J MATH PURE APPL, V8, P101
   Katugampola UN, 2011, APPL MATH COMPUT, V218, P860, DOI 10.1016/j.amc.2011.03.062
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Mainardi F, 2001, FRACT CALC APPL ANAL, V4, P153
   Makinde OD, 2011, BIOSYSTEMS, V104, P32, DOI 10.1016/j.biosystems.2010.12.010
   Okosun K.O., 2011, INT J PHYS SCI, V6, P6479, DOI DOI 10.5897/IJPS10.542
NR 13
TC 11
Z9 11
U1 0
U2 2
PU INT SCIENTIFIC RESEARCH PUBLICATIONS
PI AMOL
PA 14, 4TH FAJR, NOOR ST, AMOL, 4617654553, IRAN
SN 2008-1898
EI 2008-1901
J9 J NONLINEAR SCI APPL
JI J. Nonlinear Sci. Appl.
PY 2017
VL 10
IS 6
BP 3191
EP 3200
DI 10.22436/jnsa.010.06.32
PG 10
WC Mathematics, Applied; Mathematics
SC Mathematics
GA FD5NO
UT WOS:000407577300032
OA Bronze
DA 2020-07-08
ER

PT J
AU Joaquim, DC
   Borges, ED
   Viana, IGR
   Navarro, PA
   Vireque, AA
AF Joaquim, Daniel C.
   Borges, Eduardo D.
   Viana, Iara G. R.
   Navarro, Paula A.
   Vireque, Alessandra A.
TI Risk of Contamination of Gametes and Embryos during Cryopreservation and
   Measures to Prevent Cross-Contamination
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID MOUSE EMBRYOS; HUMAN OOCYTES; MICROBIAL-CONTAMINATION; CLOSED
   VITRIFICATION; SEXUAL TRANSMISSION; HEPATITIS-B; ZIKA VIRUS; SEMEN;
   SURVIVAL; STORAGE
AB The introduction and widespread application of vitrification are one of the most important achievements in human assisted reproduction techniques (ART) of the past decade despite controversy and unclarified issues, mostly related to concerns about disease transmission. Guidance documents published by US Food and Drug Administration, which focused on the safety of tissue/organ donations during Zika virus spread in 2016, as well as some reports of virus, bacteria, and fungi survival to cryogenic temperatures, highlighted the need for a review of the way how potentially infectious material is handled and stored in ART-related procedures. It was experimentally demonstrated that cross-contamination between liquid nitrogen (LN2) and embryos may occur when infectious agents are present in LN2 and oocytes/embryos are not protected by a hermetically sealed device. Thus, this review summarizes pertinent data and opinions regarding the potential hazard of infectious transmission through cryopreserved and banked reproductive cells and tissues in LN2. Special attention is given to the survival of pathogens in LN2, the risk of cross-contamination, vitrification methods, sterility of LN2, and the risks associated with the use of straws, cryovials, and storage dewars.
C1 [Joaquim, Daniel C.; Borges, Eduardo D.; Vireque, Alessandra A.] Assisted Reprod Technol Ltd, Invitra, Supera Innovat & Technol Pk, BR-14056680 Ribeirao Preto, SP, Brazil.
   [Borges, Eduardo D.; Viana, Iara G. R.; Navarro, Paula A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Obstet & Gynecol, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Navarro, Paula A.] CNPq, Natl Inst Hormones & Womans Hlth, Porto Alegre, RS, Brazil.
RP Vireque, AA (corresponding author), Assisted Reprod Technol Ltd, Invitra, Supera Innovat & Technol Pk, BR-14056680 Ribeirao Preto, SP, Brazil.
EM alessandra@invitra.com.br
RI Borges, Eduardo/Y-5712-2019; Vireque, Alessandra/G-2208-2012
OI Borges, Eduardo/0000-0002-0131-1121; Navarro, Paula
   Andrea/0000-0003-2368-4188; Vireque, Alessandra/0000-0002-2597-531X
CR Arav A, 2016, REPROD BIOMED ONLINE, V33, P71, DOI 10.1016/j.rbmo.2016.03.010
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bielanski A, 2005, THERIOGENOLOGY, V63, P1946, DOI 10.1016/j.theriogenology.2004.09.003
   Bielanski A, 2000, CRYOBIOLOGY, V40, P110, DOI 10.1006/cryo.1999.2227
   Bielanski A, 2014, ADV EXP MED BIOL, V753, P429, DOI 10.1007/978-1-4939-0820-2_17
   Bielanski A, 2012, THERIOGENOLOGY, V77, P467, DOI 10.1016/j.theriogenology.2011.07.043
   Bielanski A, 2003, CRYOBIOLOGY, V46, P146, DOI 10.1016/S0011-2240(03)00020-8
   British Fertility Society, 2016, ZIK VIR FERT TREATM
   Bujan L., 2016, ZIKA VIRUS ASSISTED
   Chen Y, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-107
   Chian RC, 2014, J ASSIST REPROD GEN, V31, P411, DOI 10.1007/s10815-014-0180-9
   Cobo A, 2012, FERTIL STERIL, V97, P74, DOI 10.1016/j.fertnstert.2011.10.006
   De Munck N, 2013, J ASSIST REPROD GEN, V30, P361, DOI 10.1007/s10815-013-9930-3
   De Munck N., 2015, HUMAN REPROD, V31, P377
   Edgar DH, 2012, HUM REPROD UPDATE, V18, P536, DOI 10.1093/humupd/dms016
   Fuller B, 2004, REPROD BIOMED ONLINE, V9, P680, DOI 10.1016/S1472-6483(10)61780-4
   Fuller Barry J, 2007, Methods Mol Biol, V368, P325
   Gook DA, 2016, J ASSIST REPROD GEN, V33, P1247, DOI 10.1007/s10815-016-0748-7
   Grout BWW, 2009, THERIOGENOLOGY, V71, P1079, DOI 10.1016/j.theriogenology.2008.12.011
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hesters L, 2013, GYNECOL OBSTET FERTI, V41, P554, DOI 10.1016/j.gyobfe.2013.07.003
   Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4
   JONES SK, 1989, BRIT J DERMATOL, V121, P481, DOI 10.1111/j.1365-2133.1989.tb15515.x
   Kuleshova L, 1999, HUM REPROD, V14, P3077, DOI 10.1093/humrep/14.12.3077
   Kuleshova LL, 2000, HUM REPROD, V15, P2604, DOI 10.1093/humrep/15.12.2604
   Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019
   LEIBO SP, 1984, THERIOGENOLOGY, V21, P767, DOI 10.1016/0093-691X(84)90022-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mazzilli F., 2006, Cell and Tissue Banking, V7, P75, DOI 10.1007/s10561-005-1966-x
   McBurnie LD, 2002, PHARM TECHNOLOGY N A, V26, P74
   Morris GJ, 2005, CRYOBIOLOGY, V50, P231, DOI 10.1016/j.cryobiol.2005.01.005
   Mukaida T, 1998, HUM REPROD, V13, P2874, DOI 10.1093/humrep/13.10.2874
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Parmegiani L, 2008, HUM REPROD, V23, P1771, DOI 10.1093/humrep/den119
   Parmegiani L, 2011, REPROD BIOMED ONLINE, V23, P505, DOI 10.1016/j.rbmo.2011.07.003
   Parmegiani L, 2012, FERTIL STERIL, V98, P870, DOI 10.1016/j.fertnstert.2012.06.028
   Parmegiani L, 2009, HUM REPROD, V24, P2969, DOI 10.1093/humrep/dep329
   Piasecka-Serafin M., 1972, B ACAD POL SCI, P20
   RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0
   Ruppert-Lingham CJ, 2006, CRYOBIOLOGY, V52, P219, DOI 10.1016/j.cryobiol.2005.11.004
   Schaffer TW., 1976, CAME PE BIOHAZARD PO, P13
   Stoop D, 2012, REPROD BIOMED ONLINE, V24, P180, DOI 10.1016/j.rbmo.2011.10.015
   Tan FCK, 2007, CRYOLETTERS, V28, P445
   TEDDER RS, 1995, LANCET, V346, P137, DOI 10.1016/S0140-6736(95)91207-X
   Tedeschi R, 2011, METHODS MOL BIOL, V675, P313, DOI 10.1007/978-1-59745-423-0_18
   Tomlinson Mathew, 2008, Hum Fertil (Camb), V11, P33, DOI 10.1080/14647270701553280
   U. S. Food, 2016, FDA ISS REC RED RISK
   Vajta G, 2015, REPROD BIOMED ONLINE, V30, P325, DOI 10.1016/j.rbmo.2014.12.012
   WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411
   WILMUT I, 1972, LIFE SCI 2-BIOCH GEN, V11, P1071, DOI 10.1016/0024-3205(72)90215-9
NR 51
TC 8
Z9 8
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2017
VL 2017
AR 1840417
DI 10.1155/2017/1840417
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA FD4JV
UT WOS:000407498300001
PM 28890894
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Erwin, PC
   Brownson, RC
AF Erwin, Paul Campbell
   Brownson, Ross C.
BE Fielding, JE
TI Macro Trends and the Future of Public Health Practice
SO ANNUAL REVIEW OF PUBLIC HEALTH, VOL 38
SE Annual Review of Public Health
LA English
DT Review; Book Chapter
DE forces of change; Affordable Care Act; accreditation; climate change;
   health in all policies; social media; demographic transitions;
   globalized travel; evidence-based public health; practice-based
   research; policy surveillance
ID CLIMATE-CHANGE; UNITED-STATES; SOCIAL MEDIA; ZIKA VIRUS; SEXUAL
   TRANSMISSION; QUALITY IMPROVEMENT; FOODBORNE ILLNESS; IMPACT ASSESSMENT;
   IMPLEMENTATION; DISEASE
AB Public health practice in the twenty-first century is in a state of significant flux. Several macro trends are impacting the current practice of governmental public health and will likely have effects for many years to come. These macro trends are described as forces of change, which are changes that affect the context in which the community and its public health system operate. This article focuses on seven such forces of change: the Patient Protection and Affordable Care Act, public health agency accreditation, climate change, health in all policies, social media and informatics, demographic transitions, and globalized travel. Following the description of each of these, this article then turns to possible approaches to measuring, tracking, and understanding the impact of these forces of change on public health practice, including the use of evidence-based public health, practice-based research, and policy surveillance.
C1 [Erwin, Paul Campbell] Univ Tennessee, Dept Publ Hlth, Knoxville, TN 37996 USA.
   [Brownson, Ross C.] Washington Univ, Prevent Res Ctr St Louis, Brown Sch, St Louis, MO 63130 USA.
   [Brownson, Ross C.] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO 63130 USA.
   [Brownson, Ross C.] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63130 USA.
RP Erwin, PC (corresponding author), Univ Tennessee, Dept Publ Hlth, Knoxville, TN 37996 USA.
EM perwin@utk.edu; rbrownson@wustl.edu
CR Alcindor Y., 2014, US TODAY        1027
   Balaban V, 2015, PUBLIC HEALTH REP, V130, P349, DOI 10.1177/003335491513000413
   Beitsch LM, 2015, ANNU REV PUBL HEALTH, V36, P273, DOI 10.1146/annurev-publhealth-031914-122810
   Beitsch LM, 2014, J PUBLIC HEALTH MAN, V20, P57, DOI 10.1097/PHH.0b013e31829a2cdd
   Bellarby J, 2008, GREENPEACE      0107
   Bender K, 2014, J PUBLIC HEALTH MAN, V20, P4, DOI 10.1097/PHH.0b013e3182a778a0
   Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759
   Biener L, 2000, BRIT MED J, V321, P351, DOI 10.1136/bmj.321.7257.351
   Birkhead GS, 2015, ANNU REV PUBL HEALTH, V36, P345, DOI 10.1146/annurev-publhealth-031914-122747
   Bliss D, 2016, J PUBLIC HEALTH MAN, V22, pS87, DOI 10.1097/PHH.0000000000000330
   Brownson RC, 2004, PUBLIC HEALTH REP, V119, P230, DOI 10.1016/j.phr.2004.04.001
   Brownson RC, 2015, ANN EPIDEMIOL, V25, P458, DOI 10.1016/j.annepidem.2015.03.002
   Brownson RC, 2012, AM J PREV MED, V43, P309, DOI 10.1016/j.amepre.2012.06.006
   Brownson RC, 2009, AM J PUBLIC HEALTH, V99, P1576, DOI 10.2105/AJPH.2008.156224
   Capurro D, 2014, J MED INTERNET RES, V16, P213, DOI 10.2196/jmir.2679
   Carter M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6946
   CDC(Cent. Dis. Control. Prev.), 1979, MOD STAND COMM PREV
   Chastonay P, 2015, INT J PUBLIC HEALTH, V60, P763, DOI 10.1007/s00038-015-0709-4
   Cohn D, 2010, BABY BOOMERS APPROAC
   Cole BL, 2007, ANNU REV PUBL HEALTH, V28, P393, DOI 10.1146/annurev.publhealth.28.083006.131942
   Collins J, 2009, JAMA-J AM MED ASSOC, V302, P315, DOI 10.1001/jama.2009.1050
   Community Preventive Services Task Force, 2016, GUID COMM PREV SERV
   COVIN JG, 1989, STRATEGIC MANAGE J, V10, P75, DOI 10.1002/smj.4250100107
   Cullen KA, 2011, MMWR SURVEILL SUMM, V62
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Rodriguez JD, 2013, MEDICC REV, V15, P54
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowshen N, 2015, AIDS BEHAV, V19, pS106, DOI 10.1007/s10461-014-0991-9
   Drainoni ML, 2014, SEX TRANSM DIS, V41, P455, DOI 10.1097/OLQ.0000000000000135
   Eggertson L, 2015, CAN MED ASSOC J, V187, pE333, DOI 10.1503/cmaj.109-5104
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Erwin PC, 2014, J PUBLIC HEALTH MAN, V20, P270, DOI 10.1097/PHH.0000000000000016
   Erwin PC, 2016, SCUTCHFIELD KECKS PR
   Fawcett SB, 2016, COMMUNITY DEV POPULA
   Flynn MB, 2015, AM J PUBLIC HEALTH, V105, pS686, DOI 10.2105/AJPH.2015.302734
   Gastanaduy PA, 2014, MMWR-MORBID MORTAL W, V63, P496
   Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214
   Green LW, 2009, AM J PREV MED, V37, pS187, DOI 10.1016/j.amepre.2009.08.017
   Halverson P K, 2000, J Public Health Manag Pract, V6, pvi
   Harris JK, 2014, MMWR-MORBID MORTAL W, V63, P681
   Harris JK, 2013, FRONTIERS PHSSR, V2, P5, DOI [10.2105/AJPH.2012.301166, DOI 10.2105/AJPH.2012.301166]
   Harrison C, 2014, MMWR-MORBID MORTAL W, V63, P441
   Higgs ES, 2014, J HEALTH COMMUN, V19, P164, DOI 10.1080/10810730.2014.929763
   Inst. Med. Comm, 2011, PUBL HLTH REV LAW PO
   Intern. Revenue Serv, 2014, FED REGISTER, V79, P78954
   Jackson R, 2008, ANNU REV PUBL HEALTH, V29, P57, DOI 10.1146/annurev.publhealth.29.020907.090755
   Jane M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1849-4
   Kjellstrom T, 2016, ANNU REV PUBL HEALTH, V37, P97, DOI 10.1146/annurev-publhealth-032315-021740
   Kleber de Oliveira W, 2016, MMWR-MORBID MORTAL W, V65, P242
   KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6
   Knight MA, 2014, FRONT PUBLIC HLTH SE, V3
   Knight MA, 2014, FRONT PUBLIC HLTH SE, V3
   Kofinas JD, 2014, OBSTET GYNECOL, V123, P763, DOI 10.1097/AOG.0000000000000172
   Kohatsu ND, 2004, AM J PREV MED, V27, P417, DOI 10.1016/j.amepre.2004.07.019
   Kreuter M.W., 1992, J HLTH ED, V23, P135
   Landers GM, 2016, AM J PUBLIC HEALTH, V106, P271, DOI 10.2105/AJPH.2015.302949
   LAST JM, 1993, ANNU REV PUBL HEALTH, V14, P115
   Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8
   Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222
   Mattig T, 2015, HLTH PROMOT INT
   Mays GP, 2013, AM J PREV MED, V45, P752, DOI 10.1016/j.amepre.2013.08.011
   McFarland JM, 1997, CLIN INFECT DIS, V25, P1143, DOI 10.1086/516111
   McMichael C, 2012, ENVIRON HEALTH PERSP, V120, P646, DOI 10.1289/ehp.1104375
   Mettenbrink C, 2015, SEX TRANSM DIS, V42, P725, DOI 10.1097/OLQ.0000000000000375
   MILLER D, 1983, MANAGE SCI, V29, P770, DOI 10.1287/mnsc.29.7.770
   Molnar A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147003
   NACCHO, 2012, MOB ACT PLANN PARTN
   NACCHO (Natl. Assoc. County City Health Off.), 2016, IMPL HLTH ALL POL LO
   NACCHO (Natl. Assoc. County City Health Off.), 2016, NAT PROF LOC HLTH DE
   NACCHO(Natl. Assoc. County CityHealthOff.), 1991, ASS PROT EXC PUBL HL
   Natl. Travel Tour. Off. US Dep. Commer, 2016, LAT STAT OUTR
   North East Public Health Obs, 2001, 1 U DURH WOLFS RES I
   Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023
   Oeltmann JE, 2008, EMERG INFECT DIS, V14, P1715, DOI 10.3201/eid1411.071629
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   Pecanha S, 2016, NEW YORK TIMES  0206, P6
   Pennel CL, 2015, J PUBLIC HLTH MANAG
   Petkova EP, 2015, INT J ENV RES PUB HE, V12, P9342, DOI 10.3390/ijerph120809342
   PHAB (Public Health Accredit. Board), 2013, PUBL HLTH ACCR BOARD
   PHAB(Public Health Accredit. Board), 2016, NAT VOL ACCR PROGR
   Piette JD, 2015, CIRCULATION, V132, P2012, DOI 10.1161/CIRCULATIONAHA.114.008723
   Polsky C, 2015, J LAW MED ETHICS, V43, P52, DOI 10.1111/jlme.12216
   Puska P, 2010, ANNU REV PUBL HEALTH, V31, P315, DOI 10.1146/annurev.publhealth.012809.103658
   Ramo DE, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.5209
   Rubin DB, 2015, ANNU REV PUBL HEALTH, V36, P545, DOI 10.1146/annurev-publhealth-031914-122357
   Rudolph L, 2013, HLTH ALL POLICIES IM
   Satariano WA, 2012, AM J PUBLIC HEALTH, V102, P1508, DOI 10.2105/AJPH.2011.300631
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seiler N, 2016, AFFORDABLE CARE ACT, V32, P525
   Shah GH, 2016, PUBLIC HEALTH REP, V131, P272, DOI 10.1177/003335491613100211
   Shannon KL, 2015, ANNU REV PUBL HEALTH, V36, P151, DOI 10.1146/annurev-publhealth-031914-122621
   Swamy N, 2012, AM J PREV MED, V42, pS72, DOI 10.1016/j.amepre.2012.01.026
   Teutsch SM, 2013, ANNU REV PUBL HEALTH, V34, P287, DOI 10.1146/annurev-publhealth-031912-114433
   THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021
   Thacker SB, 2007, J ATHL TRAINING, V42, P171
   Tob. Educ. Res. Overs. Comm. Calif. Calif. Dep. Health, 2006, CONFR REL ADV PLAN S
   *US PREV SERV TASK, 1989, GUID CLIN PREV SERV
   WHO (World Health Organ.), 2013, C STAT 8 GLOB C HLTH
   Wong R, 2015, J PUBLIC HLTH MANAG
   Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6
   Woolf SH, 2015, ANNU REV PUBL HEALTH, V36, P463, DOI 10.1146/annurev-publhealth-082214-110901
   Wu XX, 2016, ENVIRON INT, V86, P14, DOI 10.1016/j.envint.2015.09.007
   Zaza S., 2005, GUIDE COMMUNITY PREV
   Zumla A, 2016, INT J INFECT DIS, V47, P1, DOI 10.1016/j.ijid.2016.06.010
NR 104
TC 21
Z9 21
U1 0
U2 12
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0163-7525
BN 978-0-8243-2738-5
J9 ANNU REV PUBL HEALTH
JI Annu. Rev. Public Health
PY 2017
VL 38
BP 393
EP 412
DI 10.1146/annurev-publhealth-031816-044224
PG 20
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA BH9MX
UT WOS:000404166400020
PM 27992728
OA Other Gold
DA 2020-07-08
ER

PT J
AU Rao, VD
   Dattatreya, A
   Dan, MM
   Sarangi, T
   Sasidhar, K
   Rahul, J
AF Rao, Dhilleswara, V
   Dattatreya, A.
   Dan, Meria M.
   Sarangi, T.
   Sasidhar, K.
   Rahul, J.
TI Translational approach in emerging infectious disease treatment: an
   update
SO BIOMEDICAL RESEARCH-INDIA
LA English
DT Review
DE Infectious diseases; Disease control; Virus infection; Translational
   medicine; Therapeutic challenges
ID EBOLA HEMORRHAGIC-FEVER; STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT;
   VIRUS
AB While the rational understanding on the therapeutic and preventive care of epidemic diseases have enriched our knowledge, recent outbreak of complicated infectious diseases have presented newest challenges towards humankind. It started from the beginning of 19th century when disease infection from unknown origin preferred its host as human and mass mortality altered the socio-economic strata of various corners of the globe. For instance, human being witnessed some newly emerged global burdens such as HIV, Ebola hemorrhage fever, Zika Virus, Sever Acute Respiratory Syndrome (SARS) in the last century. Nevertheless, drastic changes in the environment, mutations in genetic composition and increased population extend the chances for new disease emergence. The inception of biomedical research has brought new diagnosis and treatment options; however, the outbreaks are being surprised and caused by new strains or modified strains. Translational biomedicine is a new context in this regard and raised the hope in integrated approaches to develop new diagnostic and treatment methods. In this review, we have summarized timely information about recently reported disease pathologies, which have challenged the world with mass mortality, and discussed about the causative agents, possible treatment strategies and future perspective for respective diseases.
C1 [Rao, Dhilleswara, V] MKU, Ctr Excellence Genom, Madurai, Tamil Nadu, India.
   [Dattatreya, A.] GITAM Univ, Dept Microbiol, Visakhapatnam, Andhra Pradesh, India.
   [Dan, Meria M.] AMITY Univ, Dept Biotechnol, Noida, Uttar Pradesh, India.
   [Sarangi, T.] VIT Univ, Dept Biotechnol, Vellore, Tami Nadu, India.
   [Sasidhar, K.] Andhra Univ, Dept Pharmaceut Technol, Visakhapatnam, Andhra Pradesh, India.
   [Rahul, J.] JNTU, Dept Arora Technol & Res Inst, Hyderabad, Telangana State, India.
RP Rao, VD (corresponding author), MKU, Ctr Excellence Genom, Madurai, Tamil Nadu, India.; Dattatreya, A (corresponding author), GITAM Univ, Dept Microbiol, Visakhapatnam, Andhra Pradesh, India.
RI Adapa, Dattatreya/I-9361-2019
CR Abu AH, 2017, ADV TECH BIOL MED, V5, pe203
   Aceti A., 2016, J MED MICROB DIAGN, V5, pe223
   Aderem A, 2011, MBIO, V2, DOI 10.1128/mBio.00325-10
   Amblard J, 1997, LANCET, V349, P181, DOI 10.1016/S0140-6736(05)60984-1
   [Anonymous], 2009, CBS NEWS
   Arora N, 2016, FUTURE VIROL, V11, P395, DOI 10.2217/fvl-2016-0048
   Arpan A, 2016, BIOL SYST OPN ACC, V5, pe154
   Awasthi S., 2016, J ANTIVIR ANTIRETROV, V8, pe130
   Aziz N, 2014, J AIDS CLIN RES, V5, pe360
   BARRETT FF, 1968, NEW ENGL J MED, V279, P441, DOI 10.1056/NEJM196808292790901
   Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545
   Betina HSM, 2016, J NURS CARE, V5, pe369
   Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114
   Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858
   Cardenas GJ, 2015, J PULM RESP MED, V5, pe260
   CDC, 2011, HIV SURV REP
   CDC, 2015, TOD HIV AIDS EP 2015
   Ceron-Carrasco J. P., 2016, DRUG DES, V5, pe131, DOI [10.1016/j.jaut.2016.02.006, DOI 10.1016/J.JAUT.2016.02.006]
   Chapp AU, 2016, J CHILD ADOLESC BEHA, V4, pe269
   Chaudhary M, 2014, J MICROB BIOCH TECHN, V10, pe001
   Coloma J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000142
   Dahlke C, 2017, E BIO MED, V19, P128
   Dash Raju, 2017, Adv Appl Bioinform Chem, V10, P11, DOI 10.2147/AABC.S115859
   Delany I, 2014, EMBO MOL MED, V6, P708, DOI 10.1002/emmm.201403876
   Diop Doudou, 2016, Pan Afr Med J, V24, P33, DOI 10.11604/pamj.2016.24.33.9749
   Dudas G, 2017, EPIDEMICS, V544, P1755
   ECDC, 2016, SURV REP INFL VIR CH
   Efird JT, 2013, TROP MED SURG, V1, pe105
   Ethiopian Public Health Institute, 2014, ADDIS ABABA ETHIOPIA, P1
   FDA, 2016, COMPL LIST VACC LIC
   Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8
   Fontana JM, 2012, TRANSL RES, V159, P430, DOI 10.1016/j.trsl.2011.12.009
   Gaglani M, 2016, J INFECT DIS, V213, P1546, DOI 10.1093/infdis/jiv577
   Gebretadik F. A., 2015, Epidemiology: Open Access, V5, P204
   Gulich GA, 2016, J INFECT DIS THER, V4, pe278
   Harris G, 2009, NY TIMES
   HEYMANN DL, 1980, J INFECT DIS, V142, P372, DOI 10.1093/infdis/142.3.372
   Honigsberg HRN, 2016, J HLTH ED RES DEV, V4, pe159
   Ikeuchi T, 2015, GEN MED, V3, pe215
   Ines P, 2016, J AIDS CLIN RES, V7, pe603
   Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P32
   James J, 2015, EBOLA OUTBREAK 2013
   Jayant R, 2016, J BIOSENS BIOELECTRO, V7, pe141
   Jayant RD, 2015, INT J NANOMED, V10, P1077, DOI 10.2147/IJN.S76517
   Jose CVS, 2016, J VACCINES VACCIN, V7, pe335
   Joshi RM, 2014, CLIN MICROBIAL, V3, pe119
   Kandi V., 2016, J PAT CARE, V2, pe110
   Khan R, 2016, BIOL SYST, V5, pe157
   Kitano Y, 2015, EMERGEN MED, V5, pe286
   Konda S, 2016, J NEUROINFECT DIS, V7, pe215
   Kuehnert MJ, 2005, EMERG INFECT DIS, V11, P868
   Kumar A, 2015, J AIDS CLIN RES, V6, pe406
   Lamunu M, 2004, INT J INFECT DIS, V8, P27, DOI 10.1016/j.ijid.2003.04.001
   Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167
   Lorenzo MMG, 2013, CHEST, V143, P502, DOI 10.1378/chest.12-1711
   Lu DY, 2017, INFECT DISORD DRUG T, V17, P140
   Meirelles BHS, 2016, J NURS CARE, V5, pe369
   Menicucci AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01032-8
   Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005
   Muthuirulan P., 2016, J CLIN CASE REP, V6, pe859
   Muyembe TJJ, 2012, ONDERSTEPOORT J VET, V79, pe451
   Nair M, 2016, ADV DRUG DELIVER REV, V103, P202, DOI 10.1016/j.addr.2016.02.008
   Nemaura T., 2013, Journal of AIDS and Clinical Research, V4, P203
   Nguyen KK, 2016, J NEUROL NEUROPHYSIO, V7, pe390
   Novel influenza A (H1N1) virus infections among health-care personnel-United States, 2009, MMWR-MORBID MORTAL W, V58, P641
   Nsimba S. E. D., 2010, Journal of AIDS and Clinical Research, V1, P111
   Onyango CO, 2007, J INFECT DIS, V196, pS193, DOI 10.1086/520609
   Panlilio Culver DH, 1991, AM J INFECT CONTROL, V13, P582
   Prakash N, 2011, J ANTIVIR ANTIRETROV, V3, pe011
   Prifti E., 2016, J GASTROINTEST DIG S, V6, pe438
   Pushpanathan Muthuirulan, 2013, Int J Pept, V2013, P675391, DOI 10.1155/2013/675391
   Rao VD, 2016, ANAT PHYSL, V6, pe234
   Rao VD, 2016, TRANSL BIOMED, V7, pe2
   Rapose A., 2013, TROP MED SURG, V1, pe128
   Rosales MS, 2017, FRONT IMMUNOL, V8, pe252
   Rothschild B., 2015, J PRIMATOL, V4, pe130
   Sagar V, 2014, REV MED VIROL, V24, P103, DOI 10.1002/rmv.1778
   Santosh K., 2012, J DRUG METAB TOXICOL, V3, pe102
   Sardi JDCO, 2016, CLIN MICROBIOL, V5, pe133
   Saxena SK, 2012, MINI-REV MED CHEM, V12, P236
   Schweneker M, 2017, J VIROL, V91, DOI [10.1128/JVI.00343-17, 10.1128/jvi.00343-17]
   Shaik IK, 2015, J PHARM PHARM SCI, V4, P1
   Shinde SP, 2015, J VECTOR DIS, V52, P11
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220
   Solomon S, 2003, AM J INFECT CONTROL, V31, P481
   Sundar SS, 2011, CLIN INFECT DIS, V82, pe012
   Tacconelli E, 2014, J ANTIMICROB CHEMOTH, V69, P2889, DOI 10.1093/jac/dku244
   Taniguchi J, 2014, J INFECT DIS THER, V2, pe172
   The White House, 2015, NAT HIV AIDS STRAT U
   Therese N, 2015, J BACTERIOL PARASITO, V6, pe208
   Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212
   Weingartl HM, 2013, DEV BIOLOGICALS, V135, P211, DOI 10.1159/000178495
   Weltman JK, 2016, J MED MICROB DIAGN, V5, pe235
   WHO, 2016, INFL UPD NO 254
   *WHO, 2009, CUM NUMB CONF HUM CA
   Wickramasinghe NC, 2016, ASTROBIOL OUTREACH, V4, pe147
   Williams LL, 2012, MED AROMATIC PLANTS, V1, pe117
   Witkamp RF, 2005, J VET PHARMACOL THER, V28, P235, DOI 10.1111/j.1365-2885.2005.00662.x
   World Health Organization, 2010, WHO GUID PHARM MAN P
   Yndart A, 2015, ACS CHEM NEUROSCI, V6, P1600, DOI 10.1021/acschemneuro.5b00156
   Zaghloul MZ, 2016, J MED MICROB DIAGN, V5, pe131
NR 101
TC 1
Z9 1
U1 0
U2 0
PU ALLIED ACAD
PI LONDON
PA 40 BLOOMSBURY WAY, LOWER GROUND FLR, LONDON, WC1A 2SE, ENGLAND
SN 0970-938X
EI 0976-1683
J9 BIOMED RES-INDIA
JI Biomed. Res.-India
PY 2017
VL 28
IS 13
BP 5678
EP 5686
PG 9
WC Engineering, Biomedical; Medicine, Research & Experimental
SC Engineering; Research & Experimental Medicine
GA FD1VK
UT WOS:000407324600011
DA 2020-07-08
ER

PT J
AU Barrett, PN
   Terpening, SJ
   Snow, D
   Cobb, RR
   Kistner, O
AF Barrett, P. Noel
   Terpening, Sara J.
   Snow, Doris
   Cobb, Ronald R.
   Kistner, Otfried
TI Vero cell technology for rapid development of inactivated whole virus
   vaccines for emerging viral diseases
SO EXPERT REVIEW OF VACCINES
LA English
DT Review
DE Vero cell; emerging viruses; inactivated whole virus vaccine; rapid
   development
ID H5N1 INFLUENZA VACCINE; IMMUNE-RESPONSES; RNA VACCINES; A VIRUS;
   CULTURE; IMMUNOGENICITY; SAFETY; CORRELATE; LINE; IMMUNIZATION
AB Introduction: Rapid development and production of vaccines against emerging diseases requires well established, validated, robust technologies to allow industrial scale production and accelerated licensure of products.
   Areas covered: A versatile Vero cell platform has been developed and utilized to deliver a wide range of candidate and licensed vaccines against emerging viral diseases. This platform builds on the 35years' experience and safety record with inactivated whole virus vaccines such as polio vaccine. The current platform has been optimized to include a novel double inactivation procedure in order to ensure a highly robust inactivation procedure for novel emerging viruses. The utility of this platform in rapidly developing inactivated whole virus vaccines against pandemic (-like) influenza viruses and other emerging viruses such as West Nile, Chikungunya, Ross River and SARS is reviewed. The potential of the platform for development of vaccines against other emerging viruses such as Zika virus is described.
   Expert commentary: Use of this platform can substantially accelerate process development and facilitate licensure because of the substantial existing data set available for the cell matrix. However, programs to provide vaccines against emerging diseases must allow alternative clinical development paths to licensure, without the requirement to carry out large scale field efficacy studies.
C1 [Barrett, P. Noel; Terpening, Sara J.; Snow, Doris; Cobb, Ronald R.; Kistner, Otfried] Nanotherapeutics Inc, 13200 NW Nano Court, Alachua, FL 32615 USA.
RP Barrett, PN (corresponding author), Nanotherapeutics Inc, 13200 NW Nano Court, Alachua, FL 32615 USA.
EM nbarrett@nanotherapeutics.com
FU Federal (United States Government) funds from the Department of Health
   and Human Services, Office of the Assistant Secretary for Preparedness
   and Response, Biomedical Advanced Research and Development Authority
   [HHS0100200600013C]
FX This work was partially supported by Federal (United States Government)
   funds from the Department of Health and Human Services, Office of the
   Assistant Secretary for Preparedness and Response, Biomedical Advanced
   Research and Development Authority (contract number HHS0100200600013C).
CR Aaskov J, 1997, VACCINE, V15, P1396, DOI 10.1016/S0264-410X(97)00051-0
   Aghebati-Maleki L, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0285-9
   Aichinger G, 2015, CLIN VACCINE IMMUNOL, V22, P46, DOI 10.1128/CVI.00275-14
   Aichinger G, 2011, VACCINE, V29, P9376, DOI 10.1016/j.vaccine.2011.09.125
   [Anonymous], 2010, EMA5279852010
   [Anonymous], 1998, WHO TECHN REP SER, V878, P19
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Barrett P., 2013, VACCINES, P773, DOI 10.1016/B978-1-4557-0090-5.00011-2
   Barrett PN, 2013, EXPERT REV VACCINES, V12, P395, DOI [10.1586/erv.13.21, 10.1586/ERV.13.21]
   Black S, 2011, PEDIATR INFECT DIS J, V30, P1081, DOI 10.1097/INF.0b013e3182367662
   Cameron MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045842
   Crowe BA, 2010, VACCINE, V29, P166, DOI 10.1016/j.vaccine.2010.10.065
   DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968
   Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31
   Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121
   Ehrlich HJ, 2012, VACCINE, V30, P4543, DOI 10.1016/j.vaccine.2012.03.061
   Ellis W. R., 2013, VACCINES, P1182
   ENDERS JF, 1949, SCIENCE, V109, P85, DOI 10.1126/science.109.2822.85
   Fiore AE, 2013, VACCINES, P257
   Fleeton MN, 2001, J INFECT DIS, V183, P1395, DOI 10.1086/319857
   Frietze KM, 2016, CURR OPIN VIROL, V18, P44, DOI 10.1016/j.coviro.2016.03.001
   Fritz R, 2012, J INFECT DIS, V205, P28, DOI 10.1093/infdis/jir711
   Furesz J, 1989, Dev Biol Stand, V70, P233
   Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Halstead S.B., 2013, VACCINES, P312
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Harrison SC, 2013, FIELDS VIROLOGY, P59
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Holzer GW, 2011, VACCINE, V29, P4132, DOI 10.1016/j.vaccine.2011.03.089
   HORAUD F, 1992, DEV BIOLOGICALS, V76, P43
   Khan Kishwar Hayat, 2013, Germs, V3, P26, DOI 10.11599/germs.2013.1034
   Kofler RM, 2004, P NATL ACAD SCI USA, V101, P1951, DOI 10.1073/pnas.0307145101
   LAMB JR, 1987, HUM IMMUNOL, V19, P79, DOI 10.1016/0198-8859(87)90096-6
   LEVENBOOK IS, 1984, J BIOL STAND, V12, P391, DOI 10.1016/S0092-1157(84)80063-3
   Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x
   Loew-Baselli A, 2012, VACCINE, V30, P5956, DOI 10.1016/j.vaccine.2012.07.039
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montagnon B J, 1999, Dev Biol Stand, V98, P137
   MONTAGNON BJ, 1981, DEV BIOL STAND, V47, P55
   Murphy TV, 2013, VACCINES, P183
   Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661
   Orlinger KK, 2010, VACCINE, V28, P3318, DOI 10.1016/j.vaccine.2010.02.092
   Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9
   Pereira VB, 2014, WORLD J VACCIN, V4, P50, DOI [10.4236/wjv.2014.42008, DOI 10.4236/WJV.2014.42008]
   Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436
   PLOTKIN SA, 1980, REV INFECT DIS, V2, P433
   Plotkin SL, 2013, VACCINES, P1
   Reiter M, 2014, IND SCALE SUSPENSION, P391
   RHIM JS, 1969, P SOC EXP BIOL MED, V132, P670, DOI 10.3181/00379727-132-34285
   Roozendaal R, 2008, INT IMMUNOL, V20, P1483, DOI 10.1093/intimm/dxn110
   Rupprecht C.E., 2013, VACCINES, P646
   Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278
   SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114
   Schiller JT, 2013, VACCINES, V235-56
   Siegrist C-A, 2013, VACCINES, V2, P14, DOI DOI 10.1016/B978-1-4557-0090-5.00004-5
   Spruth M, 2006, VACCINE, V24, P652, DOI 10.1016/j.vaccine.2005.08.055
   Sutter RW, 2013, VACCINES, P598
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trombetta C, 2015, VACCINES-BASEL, V3, P172, DOI 10.3390/vaccines3010172
   US Department of Health and Human Services, 2015, PROD DEV AN RUL GUID
   US Department of Health Education and Welfare Public Health Service, 1971, DHEW PUB 73, P71
   Van Damme P, 2013, VACCINES, P205
   van der Velden MVW, 2014, CLIN VACCINE IMMUNOL, V21, P867, DOI 10.1128/CVI.00065-14
   van der Velden MVW, 2014, J INFECT DIS, V209, P12, DOI 10.1093/infdis/jit498
   van der Velden MVW, 2012, VACCINE, V30, P6127, DOI 10.1016/j.vaccine.2012.07.077
   Vidor E, 2013, VACCINES, P573
   Vincent-Falquet J C, 1989, Dev Biol Stand, V70, P153
   Wodal W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113963
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Wressnigg N, 2015, CLIN VACCINE IMMUNOL, V22, P267, DOI 10.1128/CVI.00546-14
   Yasumura Y, 1963, NIPPON RINSHO, V21, P1201
NR 73
TC 13
Z9 16
U1 3
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PY 2017
VL 16
IS 9
BP 883
EP 894
DI 10.1080/14760584.2017.1357471
PG 12
WC Immunology
SC Immunology
GA FD2TV
UT WOS:000407388600003
PM 28724343
DA 2020-07-08
ER

PT J
AU Sareen, S
   Gupta, SK
   Sood, SK
AF Sareen, Sanjay
   Gupta, Sunil Kumar
   Sood, Sandeep K.
TI An intelligent and secure system for predicting and preventing Zika
   virus outbreak using Fog computing
SO ENTERPRISE INFORMATION SYSTEMS
LA English
DT Article
DE Zika virus; mosquito sensor; Fog computing; fuzzy k-nearest neighbour;
   Google map
ID HEALTH; TRANSMISSION; INFECTION
AB Zika virus is a mosquito-borne disease that spreads very quickly in different parts of the world. In this article, we proposed a system to prevent and control the spread of Zika virus disease using integration of Fog computing, cloud computing, mobile phones and the Internet of things (IoT)-based sensor devices. Fog computing is used as an intermediary layer between the cloud and end users to reduce the latency time and extra communication cost that is usually found high in cloud-based systems. A fuzzy k-nearest neighbour is used to diagnose the possibly infected users, and Google map web service is used to provide the geographic positioning system (GPS)-based risk assessment to prevent the outbreak. It is used to represent each Zika virus (ZikaV)-infected user, mosquito-dense sites and breeding sites on the Google map that help the government healthcare authorities to control such risk-prone areas effectively and efficiently. The proposed system is deployed on Amazon EC2 cloud to evaluate its performance and accuracy using data set for 2 million users. Our system provides high accuracy of 94.5% for initial diagnosis of different users according to their symptoms and appropriate GPS-based risk assessment.
C1 [Sareen, Sanjay] Guru Nanak Dev Univ, Comp Sect, Amritsar, Punjab, India.
   [Sareen, Sanjay] IK Gujral Punjab Tech Univ, Kapurthala, Punjab, India.
   [Gupta, Sunil Kumar] Beant Coll Engn & Technol, Dept Comp Sci & Engn, Gurdaspur, Punjab, India.
   [Sood, Sandeep K.] Guru Nanak Dev Univ Reg Campus, Dept Comp Sci & Engn, Gurdaspur, Punjab, India.
RP Sareen, S (corresponding author), Guru Nanak Dev Univ, Comp Sect, Amritsar, Punjab, India.
EM sareen.gndu@gmail.com
OI Singh, Kiran Deep/0000-0002-8154-0986
CR Ahmad M, 2016, J SUPERCOMPUT, V72, P3677, DOI 10.1007/s11227-016-1634-x
   Amazon A. W. S., 2014, AMAZON EC2 INSTANCE
   [Anonymous], 2016, ZIK OUTB WHOS GLOB E
   Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Chen RY, 2017, FOOD CONTROL, V71, P124, DOI 10.1016/j.foodcont.2016.06.042
   Dastjerdi AV, 2016, COMPUTER, V49, P112, DOI 10.1109/MC.2016.245
   De Maio C, 2017, FUTURE GENER COMP SY, V66, P146, DOI 10.1016/j.future.2016.05.039
   De Maio C, 2016, INT J INF TECH DECIS, V15, P923, DOI 10.1142/S0219622016500231
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hagan MT, 1996, NEURAL NETWORK DESIG
   Hall M., 2009, SIGKDD EXPLORATIONS, V11, P1, DOI DOI 10.1145/1656274.1656278
   He CG, 2013, IEEE T BIO-MED ENG, V60, P230, DOI 10.1109/TBME.2012.2222404
   Jalali F, 2016, IEEE J SEL AREA COMM, V34, P1728, DOI 10.1109/JSAC.2016.2545559
   John G.H., 1995, ESTIMATING CONTINUOU
   KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426
   Koc M, 2014, NEUROCOMPUTING, V131, P331, DOI 10.1016/j.neucom.2013.10.009
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lounis A, 2016, FUTURE GENER COMP SY, V55, P266, DOI 10.1016/j.future.2015.01.009
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Sareen S, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0579-1
   Sareen S, 2016, COMPUT SCI ENG, V18, P56, DOI 10.1109/MCSE.2016.82
   Sareen S, 2016, INF SECUR J, V25, P39, DOI 10.1080/19393555.2015.1134732
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Thilakanathan D, 2014, FUTURE GENER COMP SY, V35, P102, DOI 10.1016/j.future.2013.09.011
   Wang SL, 2016, IEEE T INF FOREN SEC, V11, P1661, DOI 10.1109/TIFS.2016.2549004
   Wang SL, 2016, IEEE T INF FOREN SEC, V11, P1265, DOI 10.1109/TIFS.2016.2523941
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   World Health Organization, 2016, ZIK SIT REP
   Wu LB, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0491-8
   Xhafa F, 2015, INT C NETWB INFO, P476, DOI 10.1109/NBiS.2015.122
   Xhafa F, 2015, INT CON ADV INFO NET, P263, DOI 10.1109/AINA.2015.194
   Yan HM, 2006, EXPERT SYST APPL, V30, P272, DOI 10.1016/j.eswa.2005.07.022
   Yao YY, 2007, LECT NOTES ARTIF INT, V4585, P101, DOI 10.1007/978-3-540-73451-2_12
   Zheng YL, 2014, IEEE T BIO-MED ENG, V61, P1538, DOI 10.1109/TBME.2014.2309951
NR 45
TC 19
Z9 19
U1 3
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1751-7575
EI 1751-7583
J9 ENTERP INF SYST-UK
JI Enterp. Inf. Syst.
PY 2017
VL 11
IS 9
BP 1436
EP 1456
DI 10.1080/17517575.2016.1277558
PG 21
WC Computer Science, Information Systems
SC Computer Science
GA FD4OW
UT WOS:000407511400009
DA 2020-07-08
ER

PT J
AU Page, TF
   Williams, ML
   Cassella, G
   Amick, BC
   Adler, JL
AF Page, Timothy F.
   Williams, Mark L.
   Cassella, Graziana
   Amick, Benjamin C., III
   Adler, Jessica L.
TI The impact of Zika on local businesses
SO DISASTER PREVENTION AND MANAGEMENT
LA English
DT Article
DE Economics; Disaster prevention; Economic impact; Zika
ID DISEASE; VIRUS; MEDIA; OUTBREAK; CRISES; COSTS
AB Purpose - In June 2016, the first cases of Zika were reported in the USA in the Wynwood neighborhood of Miami, Florida. The purpose of this paper is to present the results of a survey of Wynwood businesses about their perceptions of their financial well-being and the government and media's responses to the Zika outbreak.
   Design/methodology/approach - A survey instrument was developed, and 44 owners/managers of Wynwood businesses were interviewed by telephone or in-person during the period when the outbreak was being managed.
   Findings - Businesses reported downturns in revenues, profits, and customer traffic following the Zika outbreak. Believing that the downturn would be temporary, few businesses laid off workers or reduced prices. All businesses reported dissatisfaction with the government's response to the outbreak.
   Originality/value - This is the first study to document the impact of Zika on businesses located in outbreak areas. The findings highlight the business impact of Zika outbreaks and suggest a need for improved communication and response from state and local governments to business concerns when future outbreaks occur.
C1 [Page, Timothy F.; Williams, Mark L.; Cassella, Graziana; Amick, Benjamin C., III; Adler, Jessica L.] Florida Int Univ, Hlth Policy & Management, Miami, FL 33199 USA.
RP Page, TF (corresponding author), Florida Int Univ, Hlth Policy & Management, Miami, FL 33199 USA.
EM tpage@fiu.edu
CR Dalrymple KE, 2016, SCI COMMUN, V38, P442, DOI 10.1177/1075547016655546
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hais W, 2004, ASIAN ECON PAP, V3, P57, DOI DOI 10.1162/1535351041747905
   Jung H, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8050454
   Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003
   Kuo HI, 2008, TOURISM MANAGE, V29, P917, DOI 10.1016/j.tourman.2007.10.006
   Macciocchi D, 2016, NEW MICROBIOL, V39, P287
   Owens S., 2016, NEUROLOGY TODAY
   Sands P, 2016, LANCET, V388, P2443, DOI 10.1016/S0140-6736(16)30594-3
   Sell TK, 2016, PREV MED, V93, P115, DOI 10.1016/j.ypmed.2016.09.016
   Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670
   Siu A, 2004, ASIAN ECON PAP, V3, P62, DOI DOI 10.1162/1535351041747996
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Staples JE, 2014, AM J TROP MED HYG, V90, P402, DOI 10.4269/ajtmh.13-0206
   Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353
   Ungar S, 1998, BRIT J SOCIOL, V49, P36, DOI 10.2307/591262
   Verikios G, 2016, WORLD ECON, V39, P1225, DOI 10.1111/twec.12296
   World Bank Group, 2016, SHORY TERM EC COSTS
   World Health Organization [WHO], 2016, MOSQ CONTR CAN IT ST
NR 20
TC 1
Z9 1
U1 2
U2 5
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0965-3562
EI 1758-6100
J9 DISASTER PREV MANAG
JI Disaster Prev. Manag.
PY 2017
VL 26
IS 4
BP 452
EP 457
DI 10.1108/DPM-04-2017-0090
PG 6
WC Environmental Studies; Public, Environmental & Occupational Health;
   Management
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Business & Economics
GA FC4FQ
UT WOS:000406794700006
DA 2020-07-08
ER

PT J
AU Munjal, A
   Khandia, R
   Tiwari, R
   Chakraborty, S
   Karthik, K
   Dhama, K
AF Munjal, Ashok
   Khandia, Rekha
   Tiwari, Ruchi
   Chakraborty, Sandip
   Karthik, Kumaragurubaran
   Dhama, Kuldeep
TI Advances in Designing and Developing Vaccines Against Zika Virus
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Review
DE Zika virus; zika fever; vaccines
ID ORIGINAL ANTIGENIC SIN; IN-DEPTH ANALYSIS; DENGUE VIRUS; SECONDARY
   INFECTION; IMMUNE-RESPONSE; FLAVIVIRUSES; VACCINOMICS; VACCINOLOGY;
   ANTIBODIES; OUTBREAK
AB The recent outbreaks of Zika virus (ZIKV) infections has changed the ZIKV status from a very mild self-limiting febrile virus to a highly pathogenic virus causing visual impairment, autoimmune response against myelin layer and microcephaly in affected fetus. The serious social impact on society has drawn the attention of the researchers globally. The search for an effective vaccine against ZIKV is on the way. Several researches as well as commercial organizations are indulged in developing vaccine for prophylactic and treatment purposes. In the present review, various vaccine strategies have been described including inactivated, attenuated, DNA, subunit, recombinant viral vectored and nucleic acid based vaccines. The vaccines developed should be clinically tested in animal models, which are susceptible for ZIKV infection like Stat2(-/-) mice, A129 (IFNAR(-/-)) Mice, Swiss Jim Lambert (SJL) mice or Rhesus macaques. Efficacy of each vaccination strategy is required to be meticulously evaluated. The use of vaccinomics could also help to discover appropriate vaccine candidate to induce the effective immune response. DNA and subunit vaccines may not be that much beneficial in endemic areas due to poor immunogenic potential; however, by adjuvanting or using specific devise to deliver DNA vaccine construct, efficacy may be improved. Investigations exploring the cross reaction between the already existing immunity and immunity against newly developed vaccines would be of interest and useful for researchers. Further, researches should target whether vaccines and/or antibodies against ZIKV can induce Antibody Dependent Enhancement (ADE) resulting in subsequent enhancement of flavivirus infection. There are utmost requirements of sufficient resources in terms of infrastructure, funding, manpower, along with producing effective and safe ZIKV vaccine in commercial basis.
C1 [Munjal, Ashok; Khandia, Rekha] Barkatullah Univ, Dept Biochem & Genet, Bhopal, Madhya Pradesh, India.
   [Tiwari, Ruchi] UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vig, Dept Vet Microbiol & Immunol, Coll Vet Sci, Mathura, Uttar Pradesh, India.
   [Chakraborty, Sandip] Coll Vet Sci & Anim Husb, Dept Vet Microbiol, Rk Nagar 799008, West Tripura, India.
   [Karthik, Kumaragurubaran] Tamil Nadu Vet & Anim Sci Univ, Cent Univ Lab, Chennai, Tamil Nadu, India.
   [Dhama, Kuldeep] Indian Vet Res Inst, Div Pathol, ICAR, Bareilly, Uttar Pradesh, India.
RP Dhama, K (corresponding author), Indian Vet Res Inst, Div Pathol, ICAR, Bareilly, Uttar Pradesh, India.
RI Dhama, Kuldeep/B-7852-2015
OI Dhama, Kuldeep/0000-0001-7469-4752
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Ashfaq UA, 2016, VIRAL IMMUNOL, V29, P436, DOI 10.1089/vim.2016.0033
   Awasthi S., 2016, J ANTIVIR ANTIRETROV, V8, P61, DOI DOI 10.4172/JAA.1000E130
   Bonin CRB, 2017, HUM VACC IMMUNOTHER, V13, P484, DOI 10.1080/21645515.2017.1264774
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chokephaibulkit K, 2010, PEDIATR INFECT DIS J, V29, P1111, DOI 10.1097/INF.0b013e3181f68e9c
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203
   Guy B, 2010, HUM VACCINES, V6, P696, DOI 10.4161/hv.6.9.12739
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/erv.11.7, 10.1586/ERV.11.7]
   Hampton T, 2016, JAMA-J AM MED ASSOC, V316, P1755, DOI 10.1001/jama.2016.15862
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Izurieta RO, 2009, J GLOB INFECT DIS, V1, P111, DOI 10.4103/0974-777X.56257
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Kennedy RB, 2016, EBIOMEDICINE, V13, P29, DOI 10.1016/j.ebiom.2016.10.016
   Kennedy RB, 2011, OMICS, V15, P533, DOI 10.1089/omi.2011.0012
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Mirza Muhammad Usman, 2017, Sci Rep, V7, P44633, DOI 10.1038/srep44633
   Mizumoto K, 2014, J VECTOR DIS, V51, P153
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pawitwar SS, 2017, J NEUROIMMUNE PHARM, V12, P371, DOI 10.1007/s11481-017-9743-8
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Poland GA, 2013, SEMIN IMMUNOL, V25, P89, DOI 10.1016/j.smim.2013.04.007
   Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schlothauer T, 2016, PROTEIN ENG DES SEL, V29, P457, DOI 10.1093/protein/gzw040
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Singh R.K., 2015, CURRENT TRENDS FUTUR, P1, DOI DOI 10.2118/175057-MS
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   Veljkovic Veljko, 2016, F1000Res, V5, P190, DOI 10.12688/f1000research.8102.2
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 72
TC 4
Z9 4
U1 0
U2 6
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PY 2017
VL 13
IS 7
BP 667
EP 676
DI 10.3923/ijp.2017.667.676
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FB9YO
UT WOS:000406495500001
OA Bronze
DA 2020-07-08
ER

PT B
AU Oprescu, DN
   Fetecau, A
   Moldoveanu-Said, A
   Ionescu, CA
   Dragan, I
AF Oprescu, Daniela-Nuti
   Fetecau, Andreea
   Moldoveanu-Said, Amira
   Ionescu, Cringu-Antoniu
   Dragan, Ioana
BE Vladareanu, S
   Marginean, C
   Vladareanu, R
TI Primary Microcephaly: Difficulties of Prenatal Diagnosis and Parental
   Counselling
SO 5TH ROMANIAN CONGRESS OF THE ROMANIAN SOCIETY OF ULTRASOUND IN
   OBSTETRICS AND GYNECOLOGY
LA English
DT Proceedings Paper
CT 5th Romanian Congress of the
   Romanian-Society-of-Ultrasound-in-Obstetrics-and-Gynecology
CY APR 20-22, 2017
CL Targu Mures, ROMANIA
SP Romanian Soc Ultrasound Obstetr & Gynecol
DE microcephaly; prenatal diagnosis; outcome; management
ID POWER DOPPLER; ULTRASOUND
AB Microcephaly is defined as a head circumference which is below - 2 standard deviations for the mean of gestational age. Although the above definition is simple and straightforward the prenatal diagnosis of the condition is not always simple and more so, the counselling of parents faced with such a diagnosis poses a challenge for perinatologists. In the last two years, perinatal microcephaly has received a lot of attention due to the discovery that in endemic areas infection with Zika virus in the pregnancy can determine microcephaly of the fetus. However, we need to remember that fetal microcephaly can be cause by an array of causes which include not only acquired conditions such as intrauterine infections but also vascular insults, genetic syndromes and chromosomal abnormalities.
   In the clear majority of cases diagnosed prenatally, microcephaly is part of a wider spectrum of abnormalities, thus making the diagnosis of syndromic microcephaly the most common cause of prenatal microcephaly. Surprisingly, only 14% of total cases of microcephaly that develops in the first year of life has been diagnosed prenatally, the reminder being usually the isolated form of the condition where the lack of associated ultrasound abnormalities raises the threshold of diagnosis, thus eluding clinical recognition of the condition antenatal.
   We will present a rare case of isolated microcephaly diagnosed early in the second trimester, emphasizing the most relevant ultrasound markers. We will also review the current literature on practical aspects of counselling those parents that are faced with such a diagnosis in terms of neurodevelopmental outcome.
C1 [Oprescu, Daniela-Nuti; Ionescu, Cringu-Antoniu] Univ Med & Pharm Carol Davila, Bucharest, Romania.
   [Oprescu, Daniela-Nuti; Fetecau, Andreea; Moldoveanu-Said, Amira; Dragan, Ioana] Polizu Hosp, Alfred Rusescu Inst, Bucharest, Romania.
   [Moldoveanu-Said, Amira; Dragan, Ioana] Univ Medcine & Pharm Craiova, Craiova, Romania.
   [Ionescu, Cringu-Antoniu] Sf Pantelimon Emergency Hosp, Bucharest, Romania.
RP Oprescu, DN (corresponding author), Univ Med & Pharm Carol Davila, Bucharest, Romania.; Oprescu, DN (corresponding author), Polizu Hosp, Alfred Rusescu Inst, Bucharest, Romania.
CR Berger I, 2009, J CHILD NEUROL, V24, P97, DOI 10.1177/0883073808321045
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   den Hollander N. S., 2000, OFFICIAL J INT SOC G, V15, P282
   Desir J, 2006, PRENATAL DIAG, V26, P989, DOI 10.1002/pd.1536
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Douglas L, 2001, FETAL DIAGN THER, V16, P323, DOI 10.1159/000053935
   GOLDSTEIN I, 1988, AM J OBSTET GYNECOL, V158, P1057
   Malinger G, 2002, ULTRASOUND OBST GYN, V20, P51, DOI 10.1046/j.1469-0705.2002.00743.x
   Malinger Gustavo, 2003, Reprod Biol Endocrinol, V1, P110, DOI 10.1186/1477-7827-1-110
   Persutte W. H., 1998, SF
   Persutte WH, 1998, ULTRASOUND OBST GYN, V11, P317, DOI 10.1046/j.1469-0705.1998.11050317.x
   PESCIA G, 1983, PRENATAL DIAG, V3, P363, DOI 10.1002/pd.1970030416
   Pilu G, 1998, ULTRASOUND OBST GYN, V11, P357, DOI 10.1046/j.1469-0705.1998.11050357.x
   Ross Frias, J ULTRASOUND MED OFF, V14, P303
   Schwarzler P., 2003, ULTRASOUND OBSTET G, V22
   STEINLIN M, 1991, NEUROPEDIATRICS, V22, P184, DOI 10.1055/s-2008-1071438
   Stoler- Poria S., 2010, ULTRASOUND OBSTET GY, V36
   TOLMIE JL, 1987, AM J MED GENET, V27, P583, DOI 10.1002/ajmg.1320270311
   Viora E, 2000, ULTRASOUND OBST GYN, V15, P263, DOI 10.1046/j.1469-0705.2000.00013.x
   Vladareanu S, 2015, PROCEEDINGS OF THE 49TH ANNUAL SCIENTIFIC MEETING OF THE EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION, P343
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 21
TC 1
Z9 1
U1 0
U2 2
PU FILODIRITTO PUBLISHER
PI BOLOGNA
PA INFOROMATICA SRL, VIA CASTIGLIONE, 81, BOLOGNA, 40124, ITALY
BN 978-88-95922-88-1
PY 2017
BP 464
EP 470
PG 7
WC Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging
SC Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging
GA BI1MS
UT WOS:000406419700086
DA 2020-07-08
ER

PT J
AU Choo, MS
   Blackwood, RA
AF Choo, Monica Seungah
   Blackwood, R. Alexander
TI School-based health education in Yucatan, Mexico about the Chikungunya
   virus and mosquito illness prevention
SO INFECTIOUS DISEASE REPORTS
LA English
DT Article
DE School-based; community education; mosquito; Chikungunya; prevention
ID AEDES-AEGYPTI; CONTROL PROGRAM; INFECTION; AMERICA; REGION; MERIDA
AB The Chikungunya virus (CHIKV) has been rapidly spreading throughout Latin America, utilizing pre-existing vectors to infiltrate the immunologically naive populations. With the current rise of the Zika Virus, there is an urgent need for more rigorous vector control efforts to prevent further Zika breakout. We designed a school-based education module on CHIKV and mosquito prevention and presented it to the local students of ages of 6-18 in a rural town called Sudzal in Yucatan, Mexico. We distributed questionnaires before and after education to test the students' knowledge of CHIKV and mosquito prevention. Chi-squared test was performed to determine the efficacy of the presentation in increasing their knowledge. The education presentation has proven to effectively educate the local residents in several critical methods of mosquito prevention, increasing the average test scores by 67% post-education. These include applying repellent, staying hydrated during recuperation, and cleaning indoor water containers to eliminate breeding sites (P<0.001). Furthermore, the questionnaire captured the residents' behavioral patterns regarding CHIKV and mosquito prevention and identified cultural, ecological, and socioeconomic factors hindering effective implementation of vector control.
C1 [Choo, Monica Seungah; Blackwood, R. Alexander] Univ Michigan, Dept Pediat, Div Infect Dis, Off Hlth Equ & Inclus, M7330 Med Sci Bldg 1,1150 W Med Ctr Dr,SPC 5603, Ann Arbor, MI 48109 USA.
RP Choo, MS (corresponding author), Univ Michigan, Dept Pediat, Div Infect Dis, Off Hlth Equ & Inclus, M7330 Med Sci Bldg 1,1150 W Med Ctr Dr,SPC 5603, Ann Arbor, MI 48109 USA.
EM seungahc@med.umich.edu
FU Phi Kappa Phi University of Michigan Chapter; dward Ginsberg Center of
   the University of Michigan, Ann Arbor
FX we have received personal donations from members of New Hope Baptist
   Church to fund the project expenses. We thank Phi Kappa Phi University
   of Michigan Chapter and the Edward Ginsberg Center of the University of
   Michigan, Ann Arbor for their generous donations toward the mosquito
   installation in Sudzal, Mexico.
CR Cardenas-Marrufo M, 2015, CIENCIA HUMANISMO SA, V2, P27
   Cassadou S, 2013, EUR COMMUN DIS B, P19
   Castro M, 2012, T ROY SOC TROP MED H, V106, P315, DOI 10.1016/j.trstmh.2012.01.013
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Garcia-Rejon JE, 2011, AM J TROP MED HYG, V84, P489, DOI 10.4269/ajtmh.2011.10-0654
   Gobbi F., 2015, CURR TROP MED REP, V2, P4
   GORDON A J, 1988, Health Education Research, V3, P399, DOI 10.1093/her/3.4.399
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Kroeger A., 1987, ATENCION PRIMARIA SA
   Kuehn BM, 2014, JAMA-J AM MED ASSOC, V312, P776, DOI 10.1001/jama.2014.9916
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   LLOYD LS, 1994, AM J TROP MED HYG, V50, P401, DOI 10.4269/ajtmh.1994.50.401
   LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Mosquera Mario, 2010, Investig. desarro., V18, P186
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Ricalde RS, 2004, J AGR RURAL DEV TROP, V105, P165
   Saxena SK, 2012, P NATL A SCI INDIA B, V82, P153, DOI 10.1007/s40011-011-0012-y
   SCHARLOO M, 1997, PERCEPTIONS HLTH ILL, P103
   (SEDESOL) SdDS, 2014, INF AN SIT PROBR REZ
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
NR 24
TC 1
Z9 1
U1 0
U2 4
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 2036-7430
EI 2036-7449
J9 INFECT DIS REP
JI Infect. Dis. Rep.
PY 2017
VL 9
IS 2
BP 53
EP 57
DI 10.4081/idr.2017.6894
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA FB7JQ
UT WOS:000406317300002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tosepu, R
AF Tosepu, Ramadhan
TI Humidity is an ambient parameter to development of Zika virus: an
   Indonesian case
SO AFRICAN HEALTH SCIENCES
LA English
DT Letter
ID INFECTION; CLIMATE; DENGUE
C1 [Tosepu, Ramadhan] Univ Halu Oleo Kendari, Dept Environm Hlth, Fac Publ Hlth, Kendari, Southest Sulawe, Indonesia.
RP Tosepu, R (corresponding author), Univ Halu Oleo Kendari, Dept Environm Hlth, Fac Publ Hlth, Kendari, Southest Sulawe, Indonesia.
EM adhan_lpmi@yahoo.co.id
RI Tosepu, Ramadhan/P-8564-2015
OI Tosepu, Ramadhan/0000-0002-6092-9992
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Ehelepola NDB, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29359
   Jambi DKP, 2014, PROFILE OF HLTH
   Joob B, 2016, ASIAN PAC J TROP MED, V9, P700, DOI 10.1016/j.apjtm.2016.05.016
   Mehra MR, 2016, J HEART LUNG TRANSPL, V35, P1, DOI 10.1016/j.healun.2015.10.023
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Yudhastuti R, 2005, JURNAL KESEHATAN LIN, V1, P170
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 1
Z9 1
U1 0
U2 0
PU MAKERERE UNIV, FAC MED
PI KAMPALA
PA PO BOX 7072, KAMPALA, 00000, UGANDA
SN 1680-6905
EI 1729-0503
J9 AFR HEALTH SCI
JI Afr. Health Sci.
PY 2017
VL 17
IS 2
BP 597
EP 598
DI 10.4314/ahs.v17i2.39
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA FB4QK
UT WOS:000406126400039
PM 29062360
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Durbin, A
   Wilder-Smith, A
AF Durbin, Anna
   Wilder-Smith, Annelies
TI An update on Zika vaccine developments
SO EXPERT REVIEW OF VACCINES
LA English
DT Article
DE Zika; Zika vaccine; vaccine development; purified inactivated virus;
   live attenuated virus; sub-unit protein; mRNA vaccines; DNA vaccines;
   chimeric vaccines; dengue
ID VIRUS-LIKE PARTICLES; DENGUE VIRUS; DNA VACCINE; PROTECTIVE EFFICACY;
   IMMUNOGENICITY; CHALLENGE; INFECTION; ANTIBODY; ADULTS; SAFE
AB Introduction: The devastating consequences of congenital Zika virus (ZIKV) infection led to a global response directed toward a better understanding of the epidemiology and pathogenesis of ZIKV and to efforts at vaccine development. As a result, there are currently 45 ZIKV vaccine candidates in development.
   Areas covered: Both traditional (purified inactivated, live attenuated, viral-vectored, recombinant sub-unit) and novel (DNA, self-replicating RNA, mRNA) vaccine platforms are being utilized. For emergency use, vaccines that are appropriate for women of child-bearing age (including pregnant women) are being developed. Live vaccines that may be contraindicated in pregnancy are also in development for potential inclusion in national immunization programmes in childhood or pre-teenage age groups. WHO developed a target product profile for Zika vaccines for use in an emergency.
   Expert commentary: Although ZIKV vaccine development had a quick head start, further development may be hampered because of the inability to conduct large efficacy trials with the decline in cases globally and unpredictability of new outbreaks. Furthermore, there are complex ethical issues involved in conducting efficacy trials in pregnant women.
C1 [Durbin, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, London, England.
   [Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.
RP Durbin, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.
EM adurbin1@jhu.edu
RI amsalu, ribka/G-8780-2019; Wilder-Smith, Annelies/F-8751-2015
CR ABBASI J, 2016, JAMA J AM MED ASSOC, V316, P1249
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086
   Brandler S, 2010, VACCINE, V28, P6730, DOI 10.1016/j.vaccine.2010.07.073
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coller BA, 2010, AM J TROP MED HYG, V83, P248
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494
   Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Jimenez RO, 2000, VACCINE, V19, P648, DOI 10.1016/S0264-410X(00)00247-4
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Lim JK, 2016, EXPERT REV VACCINES, V15, P529, DOI 10.1586/14760584.2016.1129279
   Liu Yan, 2014, BMC Microbiol, V14, P233, DOI 10.1186/s12866-014-0233-3
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8
   Raviprakash K, 2000, J GEN VIROL, V81, P1659, DOI 10.1099/0022-1317-81-7-1659
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Suphatrakul A, 2015, VACCINE, V33, P5613, DOI 10.1016/j.vaccine.2015.08.090
   Vannice KS, 2016, VACCINE
   WHO, 2017, WHO VACC PIP TRACK
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   World Health Organization, 2017, WHO SIT REP ZIK VIR
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
NR 36
TC 28
Z9 28
U1 2
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PY 2017
VL 16
IS 8
BP 781
EP 787
DI 10.1080/14760584.2017.1345309
PG 7
WC Immunology
SC Immunology
GA FB8MV
UT WOS:000406394000003
PM 28633549
DA 2020-07-08
ER

PT J
AU Cao, RY
   Xu, YF
   Zhang, TH
   Yang, JJ
   Yuan, Y
   Hao, P
   Shi, Y
   Zhong, J
   Zhong, W
AF Cao, Rui-Yuan
   Xu, Yong-fen
   Zhang, Tian-Hong
   Yang, Jing-Jing
   Yuan, Ye
   Hao, Pei
   Shi, Yi
   Zhong, Jin
   Zhong, Wu
TI Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE antiviral; drug repurposing; nitazoxanide; Zika virus
ID C VIRUS ENTRY; INFECTION; INHIBITORS; SCREEN
AB Zika virus (ZIKV) infection can be the cause of congenital malformations, including microcephaly in infants and can cause other disorders such as Guillain-Barre syndrome, meningoencephalitis, and myelitis, which can also occur in some infected adults. However, at this time, there is no drug approved to treat ZIKV infection. Drug repurposing is the promptest way to obtain an effective drug during a global public health emergency such as the spread of Zika virus. In this study, we report a US Food and Drug Admistration-approved drug that is safe for pediatric use. Nitazoxanide and its bioactive metabolite, tizoxanide, have anti-ZIKV potential in vitro, and we identified that they exerts antiviral effect possibly by targeting the viral postattachment step.
C1 [Cao, Rui-Yuan; Zhang, Tian-Hong; Yang, Jing-Jing; Yuan, Ye; Zhong, Wu] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China.
   [Xu, Yong-fen; Hao, Pei; Zhong, Jin] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China.
   [Shi, Yi] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.
RP Zhong, W (corresponding author), Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China.
EM jzhong@sibs.ac.cn; zhongwu@bmi.ac.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81590766, 81302702]; National Major Program Project
   Grant on Biosafety [2016YFC1201000]; Beijing Nova programBeijing
   Municipal Science & Technology Commission [xxjh2015A052]; National Key
   Research and Development Program of China [2016YFC1200400]
FX This work was funded by the Major Program of National Natural Science
   Foundation of China (Grant number 81590766; to W.Z.); J.Z. was supported
   by the National Major Program Project Grant on Biosafety (Grant number
   2016YFC1201000); R.-Y.C. was supported by the National Natural Science
   Foundation of China (Grant number 81302702) and Beijing Nova program
   (Grant number xxjh2015A052); Y.-X. was supported by National Key
   Research and Development Program of China (Grant number 2016YFC1200400).
CR Ashiru O, 2014, VIROLOGY, V462, P135, DOI 10.1016/j.virol.2014.05.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rossignol JF, 2009, J BIOL CHEM, V284, P29798, DOI 10.1074/jbc.M109.029470
   Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014
   Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin P, 2016, J VIRAL HEPATITIS, V23, P62, DOI 10.1111/jvh.12446
NR 14
TC 16
Z9 16
U1 1
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD JAN 1
PY 2017
VL 4
IS 1
DI 10.1093/ofid/ofx009
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FA8EE
UT WOS:000405678200063
PM 28480282
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Michael, GC
   Aliyu, I
   Grema, BA
   Ashimi, AO
AF Michael, G. C.
   Aliyu, I.
   Grema, B. A.
   Ashimi, A. O.
TI Knowledge of Zika virus disease among reproductive-age women attending a
   general outpatient clinic in Northern Nigeria
SO SOUTH AFRICAN FAMILY PRACTICE
LA English
DT Article
DE knowledge; Nigeria; outpatients; reproductive-age women; Zika virus
AB Background: Nigeria is not insulated from the global threat of Zika virus disease (ZVD) because of international travel and the presence of Zika-virus-carrying mosquitoes in the country. A paucity of studies exists concerning knowledge of ZVD among at-risk populations. Thus, the necessity for assessment of knowledge of ZVD among reproductive-age women in general outpatient setting.Materials and methods: A cross-sectional study was conducted on 377 reproductive-age women attending a Nigerian tertiary hospital's general outpatient clinic. Their knowledge of ZVD was assessed using a structured questionnaire. A chi-square test was used to assess the relationship between participants' sociodemographics and ZVD knowledge.Results: The participants' median age was 27.07.19years. Though 68.97% of participants were aware of ZVD, only 23.85% of those had good knowledge of ZVD. Their median knowledge score was 57.14%. Participants' age (< 27years) (p = 0.00399), tribe (Hausa) (p = 0.0174) and monogamous family type (p = 0.0108) were associated with good knowledge of ZVD. Only 5% knew that ZVD is transmitted through both mosquito bites and a sexual route. Some 80% were unaware that everybody was at risk of ZVD but 80.77% knew it could cause microcephaly. Insecticide-treated nets (80.77%), environmental sanitation (78.08%) and indoor insecticide spraying (58.85%) were preventive measures reported by most participants; a minority reported mosquito repellents (28.46%), wearing of protective clothing (36.15%), and traditional medicines (20.00%) as preventive measures. They lacked knowledge of prevention of sexual transmission.Conclusion: Participants' knowledge of ZVD was inadequate despite the high awareness rate. Stakeholders may need to address existing knowledge gaps through effective public enlightenment.
C1 [Michael, G. C.; Grema, B. A.] Aminu Kano Teaching Hosp, Dept Family Med, Kano, Nigeria.
   [Aliyu, I.] Aminu Kano Teaching Hosp, Dept Paediat, Kano, Nigeria.
   [Ashimi, A. O.] Fed Med Ctr, Dept Obstet & Gynaecol, Birnin Kudu, Nigeria.
RP Michael, GC (corresponding author), Aminu Kano Teaching Hosp, Dept Family Med, Kano, Nigeria.
EM drgcmichael@gmail.com
RI Ashimi, Adewale Olufemi/AAI-2341-2019; Godpower Michael,
   MBBS/F-2035-2016
OI Godpower Michael, MBBS/0000-0003-4008-4483; Ashimi,
   Adewale/0000-0002-5414-0821
CR Adebayo Bukola, 2016, PUNCH NEWSPAPER 0210
   Adebote A. David, 2006, Journal of Entomology, V3, P180
   Afolabi O. J., 2013, J PARASITOLOGY VECTO, V5, P132
   Ana P, 2013, ONLINE J PHYS ENV SC, V2, P38
   Anatsui TC, 2014, JORIND, V12
   Anyaoku EN, 2014, J HLTH INF, V2, P22
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Dallas County Health and Human Services, 2016, DCHHS REP 1 ZIK VIR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Hunt DP., 2003, J INTELLECT CAP, V4, P100, DOI DOI 10.1108/14691930310455414
   Macnamara FN, 1958, T ROY SOC TROP MED H, V49, P139
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Odo GE, 2015, J PARASIT VECTOR BIO, V7, P94
   Okogun Godwin R. A., 2005, Journal of Vector Borne Diseases, V42, P1
   Olusanya BO, 2012, INT HEALTH, V4, P128, DOI 10.1016/j.inhe.2011.12.006
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2005, 1 M INT HLTH REG 200
   World Health Organization, 2016, ZIK SIT REP
NR 22
TC 5
Z9 5
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2078-6190
EI 2078-6204
J9 S AFR FAM PRACT
PY 2017
VL 59
IS 4
BP 148
EP 153
DI 10.1080/20786190.2017.1313484
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA FB4ZA
UT WOS:000406149700006
OA Bronze
DA 2020-07-08
ER

PT S
AU Tandon, J
   Akhavian, R
   Gumina, M
   Pakpour, N
AF Tandon, James
   Akhavian, Reza
   Gumina, Mario
   Pakpour, Nazzy
GP IEEE
TI CSU East Bay Hack Day: A University Hackathon to Combat Malaria and Zika
   with Drones
SO PROCEEDINGS OF 2017 IEEE GLOBAL ENGINEERING EDUCATION CONFERENCE
   (EDUCON2017)
SE IEEE Global Engineering Education Conference
LA English
DT Proceedings Paper
CT 8th IEEE Global Engineering Education Conference (EDUCON)
CY APR 25-28, 2017
CL Athens, GREECE
SP IEEE, Greek Minist Educ Res & Religious Affairs, Univ Piraeus, TEI, Univ Piraeus, Res Ctr, MathWorks, Hellenic Open Univ, Hellenic Air Force Acad, Piraeus Univ Appl Sci, IEEE Educ Soc, Reg 8
DE hackathon; hack-a-thon; active learning; drone; quadcopter; mosquito;
   malaria; zika; biotechnolgy
AB This paper introduces the CSU East Bay Hack Day event-a hackathon with a theme of drones and disease. This was a 1-day event that introduced California State University (CSU) East Bay students of all skill levels to the problem of combatting mosquito borne illness with land-based and flying drones. Questionnaires were conducted prior to the event, and after it ended, in order to gauge its effectiveness as a teaching tool. This study found that students had an overall increase in interest in science and engineering after participating in the event. It also found that students felt their knowledge increased significantly by participating in East Bay Hack Day. Finally, of all the students surveyed, all but one student stated that they would participate again in a hackathon if given the chance.
C1 [Tandon, James; Akhavian, Reza] Calif State Univ Hayward, Dept Engn, Hayward, CA 94542 USA.
   [Gumina, Mario; Pakpour, Nazzy] Calif State Univ Hayward, Dept Biol, Hayward, CA 94542 USA.
RP Tandon, J (corresponding author), Calif State Univ Hayward, Dept Engn, Hayward, CA 94542 USA.
RI Akhavian, Reza/AAO-2905-2020
OI Akhavian, Reza/0000-0001-9691-8016
FU California State University, East Bay Collaborative Faculty Support
   Grant "Science & Technology Hack Day"
FX This research was funded by the California State University, East Bay
   Collaborative Faculty Support Grant "Science & Technology Hack Day"
   2015-2016.
CR Albano Michele, 2016, 2016 IEEE WORLD C FA, P1
   Gates B., 2014, GATESNOTES      0425
   Hecht B.A., 2014, 2014 IEEE INT STEM E, P1
   Komssi M, 2015, IEEE SOFTWARE, V32, P60, DOI 10.1109/MS.2014.78
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Perez-Artieda G, 2015, IEEE GLOB ENG EDUC C, P716
   Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x
   World Health Organization, 2015, WORLD MAL REP 2015
NR 8
TC 1
Z9 1
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2165-9567
BN 978-1-5090-5467-1
J9 IEEE GLOB ENG EDUC C
PY 2017
BP 985
EP 989
PG 5
WC Education & Educational Research; Education, Scientific Disciplines
SC Education & Educational Research
GA BI0WA
UT WOS:000405192300151
DA 2020-07-08
ER

PT J
AU Al-Quorain, AA
AF Al-Quorain, Abdulaziz A.
TI Zika Virus: An Emerging Pathogen
SO SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES
LA English
DT Editorial Material
ID 2015-FEBRUARY 2016; UNITED-STATES; TRANSMISSION; INFECTION
C1 [Al-Quorain, Abdulaziz A.] Univ Dammam, Dept Internal Med, Coll Med, Dammam, Saudi Arabia.
RP Al-Quorain, AA (corresponding author), POB 40001, Al Khobar 31952, Saudi Arabia.
EM sjmms@uod.edu.sa
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Dallas Country Health and Human Services, DCHHS REP 1 ZIK VIR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 13
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 2321-4856
J9 SAUDI J MED MED SCI
JI Saudi J. Med. Med. Sci.
PD JAN-APR
PY 2017
VL 5
IS 1
BP 1
EP 1
DI 10.4103/1658-631X.194246
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA FA3SU
UT WOS:000405365500001
PM 30787744
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Al-Afaleq, AI
AF Al-Afaleq, Adel I.
TI Zika Virus Disease
SO SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES
LA English
DT Review
DE Arbovirus; microcephaly; review; Zika virus; zoonotic
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; INFECTION; OUTBREAK; NIGERIA;
   STATES; ISLAND; BRAZIL; TRAVEL; FEVER
AB The Zika virus is an arbovirus belonging to the virus family Flaviviridae. The virus was isolated in 1947 from a rhesus monkey in the Zika Forest of Uganda. The virus causes sporadic mild human infections in Africa and later in Asia. However, by 2007 a major shift in its infection pattern was noticed and thousands of human infections were reported in the State of Yap and Federated States of Micronesia. In the last 3 years, major outbreaks have continued to occur and the virus has spread to several Pacific and American countries. These outbreaks were mostly asymptomatic; however, there were more severe clinical signs associated with the infections. Those signs included microcephaly and Guillain-Barre syndrome. It is believed that various species of mosquitoes can biologically transmit the virus. However, Aedes aegypti is most widely associated with the Zika virus. Recently, new modes of virus transmission have been reported, including mother-to-fetus, sexual, blood transfusion, animal bites, laboratory exposure and breast milk. Differential diagnosis is very important as some other arboviruses such as yellow fever virus, West Nile virus, dengue virus, and chikungunya virus have similar clinical manifestations to the Zika virus infection as well as relating serologically to some of these viruses. Established laboratory diagnostic tests to detect the Zika virus are limited, with reverse transcription polymerase chain reaction being the most widely used test. Taking into consideration the quickness of the spread of infection, size of the infected population and change of the infection severity pattern, the Zika virus infection merits collective efforts on all levels to prevent and control the disease. Limited research work and data, concurrent infection with other arboviruses, involvement of biological vectors, mass crowd events, human and trade movements and lack of vaccines are some of the challenges that we face in our efforts to prevent and control the Zika virus infection.
C1 [Al-Afaleq, Adel I.] Univ Dammam, Dept Environm Hlth, Coll Publ Hlth, Dammam, Saudi Arabia.
RP Al-Afaleq, AI (corresponding author), Univ Dammam, Dept Environm Hlth, POB 1982, Dammam 31441, Saudi Arabia.
EM aalafaleq@uod.edu.sa
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], RAP RISK ASS ZIK VIR
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, MMWR-MORBID MORTAL W, V65, P30
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnston D, 2016, MMWR-MORBID MORTAL W, V65, P34, DOI 10.15585/mmwr.mm6502a4
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines Roosecelis Brasil, 2016, MMWR Morb Mortal Wkly Rep, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, EP AL NEUR SYNDR CON
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organization, ZIK VIR MICR GUILL B
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zika situation report neurological syndrome and congenital anomalies, ZIK SIT REP NEUR SYN
NR 79
TC 1
Z9 1
U1 0
U2 3
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2321-4856
J9 SAUDI J MED MED SCI
JI Saudi J. Med. Med. Sci.
PD JAN-APR
PY 2017
VL 5
IS 1
BP 2
EP 8
DI 10.4103/1658-631X.194260
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA FA3SU
UT WOS:000405365500002
PM 30787745
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Srinivasan, K
   Tapia, B
   Rodriguez, A
   Wood, R
   Salinas, AJ
AF Srinivasan, Krithika
   Tapia, Beatriz
   Rodriguez, Arturo
   Wood, Robert
   Salinas, Jennifer J.
TI Species abundance and temporal variation of arbovirus vectors in
   Brownsville, Texas
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Arboviruses; vector control; Aedes; border health; health surveillance;
   Texas; Mexico; United States; Americas
ID DENGUE HEMORRHAGIC-FEVER; UNITED-STATES; EPIDEMIC DENGUE; MEXICO BORDER;
   URBAN
AB The recent outbreaks of the dengue fever and West Nile viruses and the looming threats of the Zika and chikungunya viruses highlight the importance of establishing effective, proactive arboviral surveillance in communities at high risk of transmission, such as those on the Texas-Mexico border. Currently, there are no approved human vaccines available for these mosquito-borne diseases, so entomological control and case management are the only known methods for decreasing disease incidence. The principal vectors, which include Culex quinquefasciatus, Aedes aegypti, and Ae. Albopictus, all have an established presence in South Texas. The public health response to most arbovirus outbreaks in the region has been reactionary rather than proactive. However, after the 2005 dengue outbreak and subsequent fatality, the City of Brownsville Public Health Department began collecting data on mosquito vector abundance and incidence. The objective of this study was to describe the various species of mosquitoes found in vector surveillance in Brownsville, Texas, during 2009-2013; quantify their prevalence; and identify any associations with temporal or weather-related variations. The results confirm a significant mosquito population in Brownsville in late winter months, indicating a high risk of arbovirus transmission in South Texas year-round, and not just until November, previously considered the end date of arbovirus season by state health services. The data from Brownsville's surveillance program can help characterize local vector ecology and facilitate more proactive mitigation of future arboviral threats in South Texas.
C1 [Srinivasan, Krithika; Tapia, Beatriz; Wood, Robert] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
   [Rodriguez, Arturo] City Brownsville Dept Publ Hlth, Brownsville, TX USA.
   [Salinas, Jennifer J.] Texas Tech Univ, Hlth Sci Ctr El Paso, El Paso, TX USA.
RP Srinivasan, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
EM srinivasan.krithi@gmail.com
CR Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Bolling B, 2015, MOSQUITO TESTING PRO
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Champion SR, 2014, ENVIRON HEALTH INSIG, V8, P35, DOI 10.4137/EHI.S16004
   Clark GG, 2008, AM J TROP MED HYG, V78, P361, DOI 10.4269/ajtmh.2008.78.361
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858
   Knowlton K., 2009, FEVER PITCH MOSQUITO
   Lee JH, 2009, J ENVIRON HEALTH, V71, P24
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   National Weather Service Forecast Office, 2006, NOAA ONL WEATH DAT
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Smith BR, 2014, DENGUE REGION 11 201
   Thomas DL, 2016, EMERG INFECT DIS, V22, P1002, DOI 10.3201/eid2206.152000
   U.S. Centers for Disease Control and Prevention, 2016, CDC HLTH AL NETW HAN
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WHO, 1997, DENG HAEM FEV DIAGN, P48
   World Health Organization (WHO), 2012, DENG FACT SHEET
NR 19
TC 2
Z9 3
U1 1
U2 3
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2017
VL 41
AR UNSP e28
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EZ3XM
UT WOS:000404644600015
PM 28444003
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kollars, TM
AF Kollars, Thomas M.
TI Assessing likely invasion sites of Zika virus-infected mosquitoes in
   civilian and naval maritime ports in Florida
SO RESEARCH AND REPORTS IN TROPICAL MEDICINE
LA English
DT Article
DE Aedes; Zika virus; invasive species; maritime ports; biological agents
   arbovirus; Geographic Information System
ID AEDES-AEGYPTI; DISPERSAL; ALBOPICTUS; AREA
AB Several mosquito species are capable of invading new geographic regions and exploiting niches that are similar to their natural home ranges where they may introduce, or reintroduce, pathogens. In addition to initial invasion, introduction of new genotypes into established populations may also occur. Zika virus is spreading throughout the world, posing significant health risks to human populations, particularly pregnant women and their infants. The first locally acquired case of Zika virus in the US occurred in July 2016 in Miami, Florida on the Atlantic coast; the first locally acquired case in another US county occurred in the Tampa, Florida area. Three port cities in Florida were chosen to assess the risk of import and spread of Zika virus: Mayport Naval Station, Miami, and Tampa. The bioagent transport and enviromental modeling system TIGER model and ArcGIS were used to analyze abiotic and biotic factors influencing potentially Zika-infected Aedes species, should they enter through these ports. The model was tested by overlaying documented and suspected concurrent Zika cases and comparing published high-risk areas for Zika virus. In addition to Zika hot zones being identified, output indicates surveillance and integrated mosquito management should expect larger zones. Surveillance sites at ports should be identified and prioritized for pathogen and vector control to reduce the import of mosquitoes infected with Zika virus. Low resolution maps often provide valuable suitability of the geographic expansion of organisms. Providing a higher resolution predictive map, identifying probable routes of invasion, and providing areas at high risk for initial invasion and control zones, will aid in controlling and perhaps eliminating the spread of arboviruses through mosquito vectors.
C1 [Kollars, Thomas M.] Liberty Univ, Coll Hlth Sci, 1971 Univ Blvd, Lynchburg, VA 24515 USA.
RP Kollars, TM (corresponding author), Liberty Univ, Coll Hlth Sci, 1971 Univ Blvd, Lynchburg, VA 24515 USA.
EM tkollars@liberty.edu
CR BUGHER JC, 1949, SCIENCE, V110, P146, DOI 10.1126/science.110.2849.146
   CDC, ADV PEOPL LIV TRAV S
   Centers for Disease Control and Prevention, ZIK CAS COUNTS
   Centers for Disease Control and Prevention, INF AER SPRAYING
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Florida Department of Health, DAIL ZIK UPD
   Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028
   Gardner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072129
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Heusel JL, CHIKUNGUNYA ZIKA DO
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Howard JJ, 1997, J AM MOSQUITO CONTR, V13, P315
   Kollars Jr TM, 2016, INT J MED, V4, P70, DOI DOI 10.14419/IJM.V4I2.5922
   Liew C, 2004, MED VET ENTOMOL, V18, P351, DOI 10.1111/j.0269-283X.2004.00517.x
   Lodge D., 2006, P EC SOC AM INT C
   Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2
   Miami Dade Government, PORT MIAM YOUR GLOB
   Monaghan AJ, 2016, PLOS CURR OUTBREAKS
   O'Donnel C., 2016, CONTAINING ZIKA TAMP
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   SUTHERLAND DJ, 1978, MOSQ NEWS, V38, P488
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   World Health Organization, ZIK FACT SHEET
   World Health Organization International Health Regulations, 2012, IHR AUTH PORTS LIST
   Yalwala S, 2016, J MED ENTOMOL, V53, P1242, DOI 10.1093/jme/tjw075
NR 27
TC 2
Z9 2
U1 0
U2 5
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-7282
J9 RES REP TROP MED
JI Res. Rep. Trop. Med.
PY 2017
VL 8
BP 1
EP 6
DI 10.2147/RRTM.S123456
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EZ3SJ
UT WOS:000404630400001
PM 30050340
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Richards, SL
   White, AV
   Balanay, JAG
AF Richards, Stephanie L.
   White, Avian V.
   Balanay, Jo Anne G.
TI Potential for sublethal insecticide exposure to impact vector competence
   of Aedes albopictus (Diptera: Culicidae) for dengue and Zika viruses
SO RESEARCH AND REPORTS IN TROPICAL MEDICINE
LA English
DT Article
DE mosquito; insecticide exposure; arbovirus
ID PLASMODIUM-FALCIPARUM; NORTH-CAROLINA; MOSQUITOS; SUSCEPTIBILITY;
   INFECTION; AEGYPTI
AB Chikungunya, dengue, and Zika viruses (CHIKV, family Togaviridae, genus Alphavirus; DENV and ZIKV, family Flaviviridae, genus Flavivirus) are arboviruses that cause human epidemics. Due to the lack of vaccines for many mosquito-borne diseases, there is a need for mosquito control. In the US and other regions, residual barrier insecticide sprays are applied to foliage where female mosquitoes rest and/or sugar feed between blood meals. Residual sprays are an important control method for anthropogenic day-active sylvan mosquitoes such as Aedes albopictus (vector of CHIKV, DENV, and ZIKV) that are difficult to control using ultralow-volume sprays applied only at dusk or dawn when these mosquitoes are not active. In this exploratory study, we analyzed the extent to which ingestion of a sublethal dose of the active ingredient bifenthrin affected vector competence (i.e., infection, dissemination, and transmission) of Ae. albopictus for DENV and ZIKV. Two incubation periods (IPs; 7 and 14 d) were tested at 28 degrees C for insecticide-fed and sugar-fed mosquitoes. We show that mosquitoes that were fed bifenthrin (0.128 mu g/mL) mixed with sucrose solution exhibited significantly lower DENV infection rates and body titers after a 14-d IP. During the 7-d IP, one mosquito (sugar group) transmitted ZIKV. During the 14-d IP, 100% of mosquitoes showed body and leg ZIKV infections, and one mosquito (sugar+bifenthrin group) transmitted ZIKV. This is a preliminary communication, and more studies will be required to further investigate these findings. We expect the findings of this small-scale study to spur larger-scale investigations of the impacts of insecticides on mechanisms regulating vector competence, and exposure to other active ingredients, and aid in development of new insecticides.
C1 [Richards, Stephanie L.; White, Avian V.; Balanay, Jo Anne G.] East Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, 3403 Carol Belk Bldg,300 Curry Court, Greenville, NC 27858 USA.
RP Richards, SL (corresponding author), East Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, 3403 Carol Belk Bldg,300 Curry Court, Greenville, NC 27858 USA.
EM richardss@ecu.edu
RI /AAD-1974-2020
OI /0000-0003-3173-3293
CR Alout H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063849
   Alto BW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004370
   Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Centers for Disease Control and Prevention, 2015, CDC BOTTL BIOASS
   Chan HH, 2013, J MED ENTOMOL, V50, P362, DOI 10.1603/ME12182
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Fernandez Z, 2004, J MED ENTOMOL, V41, P961, DOI 10.1603/0022-2585-41.5.961
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Halasa YA, 2012, AM J TROP MED HYG, V86, P745, DOI 10.4269/ajtmh.2012.11-0784
   Kristan M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1384-x
   Lee H. L., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P664
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   Richards SL, 2017, J MED ENTOMOL, V54, P682, DOI 10.1093/jme/tjw231
   Richards SL, 2012, J MED ENTOMOL, V49, P942, DOI 10.1603/ME11293
   Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000
   Saez-Llorens X, LANCET INFECT DIS
   van Dodewaard CAM, 2016, J MED ENTOMOL, V53, P39, DOI 10.1093/jme/tjv148
   VanDusen AE, 2016, PEST MANAG SCI, V72, P1004, DOI 10.1002/ps.4081
   Vantaux A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1514-5
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
NR 29
TC 2
Z9 2
U1 3
U2 8
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-7282
J9 RES REP TROP MED
JI Res. Rep. Trop. Med.
PY 2017
VL 8
BP 53
EP 57
DI 10.2147/RRTM.S133411
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EZ3SJ
UT WOS:000404630400008
PM 30050345
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pinto, IC
   Cerqueira-Coutinho, C
   de Freitas, ZMF
   dos Santos, EP
   do Carmo, FA
   Ricci, E
AF Pinto, Isadora Cabral
   Cerqueira-Coutinho, Cristal
   Faria de Freitas, Zaida Maria
   dos Santos, Elisabete Pereira
   do Carmo, Flavia Almada
   Ricci Junior, Eduardo
TI Development and validation of an analytical method using High
   Performance Liquid Chromatography (HPLC) to determine ethyl
   butylacetylaminopropionate in topical repellent formulations
SO BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Ethyl butylacetylaminopropionate (EB)/quantification; Ethyl
   butylacetylaminopropionate (EB)/topical formulations; Analytical method;
   Validation; Repellents; Prophylaxis; High Performance Liquid
   Chromatography
ID ZIKA VIRUS; INSECT REPELLENTS
AB Diseases caused by insects are frequent in poor countries, leading to epidemic scenarios in urban areas; e.g., Dengue, Zika and Chikungunya. For this reason, the development of a safe and efficient topical formulation is essential. Ethyl butylacetylaminopropionate (EB) is a mosquito repellent developed by Merck, which is used in products for adults, children and especially babies, due to its low allergenic potential. The aim of this work was to validate an analytical methodology to quantify EB in a new poloxamer-based formulation by high-performance liquid chromatography (HPLC). The quantification methodology was performed at 40 degrees C using a Kromasil reverse-phase column (C18), with the dimensions of 250 x 4.6 mm. The mobile phase was acetonitrile: water (1: 1) at a 1.0 mL/min flow-rate. The detector wavelength was set at 218 nm to detect EB. The methodology was considered validated since the results indicated linearity (R-2>0.99), specificity, selectivity, precision and accuracy (active recovery between 98% and 102%). It also presented limits of detection and quantification of 0.255 mu g/mL and 0.849 mu g/mL, respectively. The present study demonstrated the EB vehiculated in poloxamer gel is promising as a new insect repellent formulation, since it could be quantified and quality control evaluated.
C1 [Pinto, Isadora Cabral; Faria de Freitas, Zaida Maria; dos Santos, Elisabete Pereira; do Carmo, Flavia Almada; Ricci Junior, Eduardo] Univ Fed Rio de Janeiro, Dept Med, LADEG, Fac Pharm,Galen Dev Lab, Rio De Janeiro, Brazil.
   [Cerqueira-Coutinho, Cristal] Univ Fed Rio de Janeiro, Inst Macromol, Technol Ctr, Rio De Janeiro, Brazil.
RP Ricci, E (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, Av Carlos Chagas Filho, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM ricci@pharma.ufrj.br
RI Carmo, Flavia Almada do/AAP-3384-2020; Santos, Elisabete P/D-3710-2015
OI Carmo, Flavia Almada do/0000-0003-0474-9070; Santos,
   Elisabete/0000-0002-6712-0643
FU National Scientific and Technological Research Council (CNPQ)National
   Council for Scientific and Technological Development (CNPq); Rio de
   Janeiro State Research Foundation (FAPERJ)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX We would like to thank the National Scientific and Technological
   Research Council (CNPQ) and the Rio de Janeiro State Research Foundation
   (FAPERJ) for funding. The authors have declared no conflict of interest.
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Almeida H, 2012, J PHARM PHARM SCI, V15, P592, DOI 10.18433/J3HW2B
   Campos D, 2016, CHEMOSPHERE, V149, P177, DOI 10.1016/j.chemosphere.2016.01.098
   Chattopadhyay P, 2015, ACTA TROP, V147, P45, DOI 10.1016/j.actatropica.2015.03.027
   Devi D. R., 2013, J PHARM SCI RES, V5, P159
   Diaz JH, 2016, WILD ENVIRON MED, V27, P153, DOI 10.1016/j.wem.2015.11.007
   Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4
   Frederiksen K, 2015, EUR J PHARM BIOPHARM, V91, P9, DOI 10.1016/j.ejpb.2015.01.002
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   *ICH, 1996, GUID IND Q2B VAL AN
   Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005
   Marcus J, 2014, COLLOID SURFACE A, V458, P3, DOI 10.1016/j.colsurfa.2013.11.030
   Minesterio da Saude ANVISA, 2003, GUIA VAL MET AN BIOA
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pinto IC, 2017, DRUG DEV IND PHARM, V43, P67, DOI 10.1080/03639045.2016.1220564
   Reegan AD, 2014, J ASIA-PAC ENTOMOL, V17, P327, DOI 10.1016/j.aspen.2014.02.008
   Tisgratog R, 2016, ACTA TROP, V157, P136, DOI 10.1016/j.actatropica.2016.01.024
   Wang T, 2014, ACTA PHARM SIN B, V4, P43, DOI 10.1016/j.apsb.2013.11.002
   Wille T, 2011, CHEM-BIOL INTERACT, V190, P79, DOI 10.1016/j.cbi.2011.02.022
   WORLD HEALTH ORGANIZATION, 2006, WHO SP EV PUBL HLTH
NR 21
TC 0
Z9 0
U1 0
U2 2
PU UNIV SAO PAULO, CONJUNTO QUIMICAS
PI SAO PAULO
PA SERVICO PUBLICACOES E CIRCULACAO, CAIXA POSTAL 66083, SAO PAULO, 00000,
   BRAZIL
SN 1984-8250
EI 2175-9790
J9 BRAZ J PHARM SCI
JI Braz. J. Pharm. Sci.
PY 2017
VL 53
IS 2
AR UNSP e16033
DI 10.1590/s2175-97902017000216033
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EZ1NZ
UT WOS:000404479000008
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Gautam, R
   Mishra, S
   Milhotra, A
   Nagpal, R
   Mohan, M
   Singhal, A
   Kumari, P
AF Gautam, Renu
   Mishra, Sweta
   Milhotra, Archana
   Nagpal, Ritika
   Mohan, Mradul
   Singhal, Anchal
   Kumari, Pratibha
TI Challenges with Mosquito-borne Viral Diseases: Outbreak of the Monsters
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Mosquito-borne diseases; Viral diseases; Zika; Dengue; Chikungunya;
   Vaccine
ID ZIKA VIRUS-INFECTION; RESEARCH-AND-DEVELOPMENT; CHIKUNGUNYA-VIRUS;
   DENGUE VIRUS; SEXUAL TRANSMISSION; FRENCH-POLYNESIA; RISK-FACTORS;
   FEVER; EPIDEMIC; VACCINES
AB Background: The viruses responsible for mosquito-borne diseases are on an exploring mode, expanding their horizon, adapting to the situation and comfortably making their presence felt globally, from South Africa to Asia, Europe and United States. The current global scenario and recent documentations indicate towards the real monsters, outbreak of Zika, dengue and chikungunya viruses. Zika, dengue and chikungunya viruses are positive sense single-stranded RNA arbovirus and so their initial symptoms are almost 80% similar and all three are spread by mosquitos which bite during the day. Zika virus may damage brain by targeting the neuron cells in babies, and thereby it is very perilous to pregnant women.
   Dangerous Type: A less common but highly dangerous type of dengue is one which causes haemorrhagic fever and shock syndrome which are lethal. Chikungunya is not as lethal as Zika and dengue are, but it triggers joints pain which could last for months and even for years.
   Conclusion: The vaccines against Zika, dengue and chikungunya viruses are at different stages of development. The challenges associated with the epidemic wave of Zika, dengue and chikungunya viruses have been explained and the current status of drug/vaccine development against these viruses has been reviewed.
C1 [Gautam, Renu; Nagpal, Ritika; Singhal, Anchal] Univ Delhi, Dept Chem, Delhi 110007, India.
   [Mishra, Sweta] GGSIP Univ, HMR Inst Technol & Management, Dept Chem, New Delhi, India.
   [Milhotra, Archana; Kumari, Pratibha] Univ Delhi, Deshbandhu Coll, Dept Chem, Delhi 110019, India.
   [Mohan, Mradul] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, Delhi, India.
RP Kumari, P (corresponding author), Univ Delhi, Deshbandhu Coll, Dept Chem, Delhi 110019, India.
EM pkumari@db.du.ac.in
RI amsalu, ribka/G-8780-2019
FU Science and Engineering Research Board (SERB), New Delhi
   [ECR/2015/000541]; University Grant Commission, IndiaUniversity Grants
   Commission, India
FX Authors are thankful to Prof. S. M. S. Chauhan, Department of Chemistry,
   University of Delhi, New Delhi, India for his kind support and guidance.
   Author P.K. is thankful to Science and Engineering Research Board
   (SERB), New Delhi (Project File no. ECR/2015/000541) for financial
   support and Author Mradul Mohan is grateful to the University Grant
   Commission, India for Dr. D.S. Kothari post doctoral fellowship for
   financial assistance.
CR Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Alford J, 2014, HUFFINGTON POST
   [Anonymous], 1997, DENG GUID DIAGN TREA
   [Anonymous], 2009, DENG GUID DIAGN TREA, P111
   Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0
   Ashley EA, 2011, TRENDS ANAESTH CRIT, V1, P39, DOI 10.1016/j.tacc.2010.10.002
   Baker A., INFECT MOSQUITOES BA
   Barrett A. D. T., 2002, MED MICROBIOLOGY, P520
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, CLIN GUID DENG VIR
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   Chandren JR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003954
   Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Cruz DJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002073
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   FOCKS DA, 2006, MULTICOUNTRY STUDY A
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   GLASGOW LA, 1970, SCIENCE, V170, P854, DOI 10.1126/science.170.3960.854
   Grassi M.F.R., 2016, BRAZILIAN J MED HUM, V4, P57
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   L'Azou M, 2016, NEW ENGL J MED, V374, P1155, DOI 10.1056/NEJMoa1503877
   Lee-Jah C., 2014, LANCET, V384, P2046
   LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maek-A-Nantawat W, 2009, CASE REP MED, DOI 10.1155/2009/840183
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   McClain DJ, 1998, J INFECT DIS, V177, P634, DOI 10.1086/514240
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Niedrig M, 2009, CLIN MICROBIOL INFEC, V15, P880, DOI 10.1111/j.1469-0691.2009.02851.x
   Nosten F, 2006, CURR DRUG SAF, V1, P1, DOI 10.2174/157488606775252584
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042
   *PAHO, 1994, DENG DENG HEM FEV AM
   Pardigon N, 2009, PATHOL BIOL, V57, P127, DOI 10.1016/j.patbio.2008.02.016
   Patrick G. L., 2010, INTRO MED CHEM
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rodriguez-Roche R, 2005, VIROLOGY, V334, P154, DOI 10.1016/j.virol.2005.01.037
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sautto G, 2013, BIOMED RES INT, DOI 10.1155/2013/838491
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sciascia S, 2016, THROMB HAEMOSTASIS, V115, P285, DOI 10.1160/TH15-06-0491
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Speir JA, 2012, CURR OPIN STRUC BIOL, V22, P65, DOI 10.1016/j.sbi.2011.11.002
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Talarmin F, 2007, Med Trop (Mars), V67, P167
   Teixeira MG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4338
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054
   Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038
   Weaver SC, 2015, NEW ENGL J MED, V373, P94, DOI 10.1056/NEJMc1505501
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   WHO, 2011, COMPR GUID PREV CONT
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World health organization, EM HIST ZIK VIR
   World health organization, EM PREP RESP
NR 106
TC 3
Z9 2
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PY 2017
VL 17
IS 19
BP 2199
EP 2214
DI 10.2174/1568026617666170130122921
PG 16
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA EY2UC
UT WOS:000403826400007
PM 28137229
DA 2020-07-08
ER

PT J
AU Pant, A
   Pasupureddy, R
   Pande, V
   Seshadri, S
   Dixit, R
   Pandey, KC
AF Pant, A.
   Pasupureddy, R.
   Pande, V.
   Seshadri, S.
   Dixit, R.
   Pandey, K. C.
TI Proteases in Mosquito Borne Diseases: New Avenues in Drug Development
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Malaria; Dengue; Zika; Protease; Plasmepsin V; NS2B-NS3; Protein
   Interaction; Protease Inhibition
ID PLASMODIUM-FALCIPARUM MEROZOITES; FLAVIVIRUS NS2B-NS3 PROTEASE; DENGUE
   VIRUS; MALARIA PARASITES; PLASMEPSIN-V; CYSTEINE PROTEASES; VIRAL
   REPLICATION; HOST ERYTHROCYTE; HEMOGLOBIN DEGRADATION;
   ENDOPLASMIC-RETICULUM
AB Introduction: Mosquito borne diseases continue to propagate and cause millions of deaths annually. They are caused either by protozoan parasites such as Plasmodium, Toxoplasma or by flaviviruses including Dengue and Zika. Among the proteome of such parasitic organisms, proteases play essential roles in events such as host invasion, hemoglobin hydrolysis, replication and immune evasion. Plasmepsin V (PMV), an endoplasmic reticulum resident aspartic protease of Plasmodium spp., is involved in the export of similar to 400 proteins containing the conserved Plasmodium Export Element motif (PEXEL). Interactions and cleavage of PEXEL proteins by PM V is necessary for export to and across the parasitophorous vacuole membrane.
   Protease System: Similarly in flaviviruses, a two-component protease system consisting of nonstructural proteins, NS2B and NS3, interacts with other non-structural proteins and plays a major role in viral replication, polyprotein cleavage and virion particle assembly. Thus, proteases involved in indispensable roles in pathogen machinery can be considered as attractive drug targets. Inhibitors against proteases are being used in clinical trials for other communicable and non-communicable diseases. Currently, hydroxyethylamine based inhibitors targeting the catalytic site of PM V with picomolar inhibitory concentrations have been tested in vitro.
   Conclusion: For recently characterized disease such as Zika, no known treatments exist while compound such as Policresulen has high affinity for Dengue NS2B/NS3 complex. Understanding proteases structure-function relationship and protease-inhibitor interactions can provide new insights for novel chemotherapeutic strategies.
C1 [Pant, A.; Pasupureddy, R.; Dixit, R.] Natl Inst Malaria Res, Dwarka Sect 8, New Delhi 110077, India.
   [Pant, A.; Pande, V.] Kumaun Univ, Dept Biotechnol, Naini Tal 263001, Uttarakhand, India.
   [Pasupureddy, R.; Seshadri, S.] Nirma Univ, Inst Sci, SG Highway, Ahmadabad 382481, Gujarat, India.
RP Pandey, KC (corresponding author), Natl Inst Res Environm Hlth, Dept Biochem, Bhopal 462001, MP, India.
EM kailash.pandey.nireh@gov.in
RI Seshadri, Sriram/A-2526-2010
OI Seshadri, Sriram/0000-0003-1547-2193; Pasupureddy,
   Rahul/0000-0003-4502-2716
FU Indian Council of Medical Research (ICMR)Indian Council of Medical
   Research (ICMR) [BIC/11(16)/2015]; Council of Scientific and Industrial
   Research (CSIR), Govt. of IndiaCouncil of Scientific & Industrial
   Research (CSIR) - India [09-905(0013)2013-EMR-I]
FX We thank Indian Council of Medical Research (ICMR) for fellowship
   assistance to Ms. Akansha Pant Pasupureddy (Award no. BIC/11(16)/2015).
   We also thank Council of Scientific and Industrial Research (CSIR),
   Govt. of India for fellowship assistance to Mr. Rahul Pasupureddy (Award
   no. 09-905(0013)2013-EMR-I). Special thanks to National Institute of
   Malaria Research (NIMR), New Delhi for providing basic infrastructural
   facilities.
CR Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Alam Asrar, 2014, Interdiscip Perspect Infect Dis, V2014, P453186, DOI 10.1155/2014/453186
   [Anonymous], 2015, WHO REPORT 2015
   Arastu-Kapur S., NAT CHEM BIOL
   Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001
   Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161
   Bachmann A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0784-2
   Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113
   Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200
   Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051
   Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16
   Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728
   Brunsveld L, 2012, AMINO ACIDS PEP PROT, V37, P1, DOI 10.1039/9781849734677
   Bultrini E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-445
   Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033
   Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011
   Charrier N, 2008, J MED CHEM, V51, P3313, DOI 10.1021/jm800138h
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Child MA, 2013, TRAFFIC, V14, P1053, DOI 10.1111/tra.12092
   Choi KY, 2012, THERANOSTICS, V2, P156, DOI 10.7150/thno.4068
   Cubillos M, 2003, BIOCHIMIE, V85, P651, DOI 10.1016/S0300-9084(03)00136-6
   da Silva FL, 2016, EXP PARASITOL, V169, P13, DOI 10.1016/j.exppara.2016.06.013
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053
   Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239
   Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Gambini L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142509
   Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126
   Gazdik M, 2016, BIOORGAN MED CHEM, V24, P1993, DOI 10.1016/j.bmc.2016.03.027
   Gazdik M, 2015, MEDCHEMCOMM, V6, P437, DOI 10.1039/c4md00409d
   Giganti D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5833
   Gilson P.R., 2014, HEAT SHOCK PROTEINS, P99
   Giovani S, 2014, BIOORG MED CHEM LETT, V24, P3582, DOI 10.1016/j.bmcl.2014.05.044
   Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812
   Goldberg DE, 2015, NAT STRUCT MOL BIOL, V22, P647, DOI 10.1038/nsmb.3077
   Hackett F, 1999, MOL BIOCHEM PARASIT, V103, P183, DOI 10.1016/S0166-6851(99)00122-X
   Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d
   Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737
   Hodder AN, 2015, NAT STRUCT MOL BIOL, V22, P590, DOI 10.1038/nsmb.3061
   Horrocks P, 2005, TRENDS PARASITOL, V21, P396, DOI 10.1016/j.pt.2005.07.004
   Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015
   Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200
   Le Chat L, 2007, MOL BIOCHEM PARASIT, V153, P41, DOI 10.1016/j.molbiopara.2007.01.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li X.-D., 2016, J VIROL
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   Liang Q., 2016, CELL STEM CELL, P1
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110
   Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452
   McGillewie L, 2015, PROTEINS, V83, P1693, DOI 10.1002/prot.24855
   McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106
   McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151
   Meslin B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023867
   Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Murata CE, 2003, J BIOL CHEM, V278, P38022, DOI 10.1074/jbc.M306842200
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004
   O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257
   Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011
   Pandey KC, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/345195
   Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694
   Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102
   Pandey KC, 2004, J BIOL CHEM, V279, P3484, DOI 10.1074/jbc.M310536200
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Proellocks NI, 2014, FASEB J, V28, P3103, DOI 10.1096/fj.14-250399
   Raut R, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0248-x
   Rawlings ND, 2013, HDB PROTEOLYTIC ENZY, V1
   Recacha R, 2016, ACTA CRYSTALLOGR F, V72, P659, DOI 10.1107/S2053230X16011663
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rodrigues L.C., 2016, LANCET, V6736, P15
   Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3
   Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003
   ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766
   Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726
   Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12
   Setoh YX, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0303-7
   Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200
   Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013
   Singh AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139347
   Singh S, 2007, P NATL ACAD SCI USA, V104, P20043, DOI 10.1073/pnas.0709999104
   Sleebs BE, 2014, J MED CHEM, V57, P7644, DOI 10.1021/jm500797g
   Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897
   Soni R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00194
   Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862
   Trenholme Katharine R., 2010, Infectious Disorders - Drug Targets, V10, P217
   Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008
   Warncke JD, 2016, MICROBIOL MOL BIOL R, V80, P905, DOI 10.1128/MMBR.00014-16
   Weng HB, 2014, BBA-BIOMEMBRANES, V1838, P185, DOI 10.1016/j.bbamem.2013.09.014
   White NJ, 2010, LANCET, V376, P2051, DOI 10.1016/S0140-6736(10)61963-0
   Wu DW, 2015, ACTA PHARMACOL SIN, V36, P1126, DOI 10.1038/aps.2015.56
   Wu R, 2015, PROC NAECON IEEE NAT, P89, DOI 10.1109/NAECON.2015.7443044
   Xiao HG, 2011, ARCH BIOCHEM BIOPHYS, V513, P102, DOI 10.1016/j.abb.2011.06.017
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   Zhao Y., 2015, INT J DISTRIB SENS N, V2015, P1
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 117
TC 2
Z9 2
U1 2
U2 13
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-5294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PY 2017
VL 17
IS 19
BP 2221
EP 2232
DI 10.2174/1568026617666170130122231
PG 12
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA EY2UC
UT WOS:000403826400009
PM 28137230
DA 2020-07-08
ER

PT J
AU Sareen, S
   Sood, SK
   Gupta, SK
AF Sareen, Sanjay
   Sood, Sandeep K.
   Gupta, Sunil Kumar
TI SECURE INTERNET OF THINGS-BASED CLOUD FRAMEWORK TO CONTROL ZIKA VIRUS
   OUTBREAK
SO INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
LA English
DT Article
DE Zika virus; Mosquito; IoT; Cloud computing; Naive Bayesian Network;
   Google map
AB Objectives: Zika virus (ZikaV) is currently one of the most important emerging viruses in the world which has caused outbreaks and epidemics and has also been associated with severe clinical manifestations and congenital malformations. Traditional approaches to combat the ZikaV outbreak are not effective for detection and control. The aim of this study is to propose a cloud-based system to prevent and control the spread of Zika virus disease using integration of mobile phones and Internet of Things (IoT).
   Methods: A Naive Bayesian Network (NBN) is used to diagnose the possibly infected users, and Google Maps Web service is used to provide the geographic positioning system (GPS)-based risk assessment to prevent the outbreak. It is used to represent each ZikaV infected user, mosquito-dense sites, and breeding sites on the Google map that helps the government healthcare authorities to control such risk-prone areas effectively and efficiently.
   Results: The performance and accuracy of the proposed system are evaluated using dataset for 2 million users. Our system provides high accuracy for initial diagnosis of different users according to their symptoms and appropriate GPS-based risk assessment.
   Conclusions: The cloud-based proposed system contributed to the accurate NBN-based classification of infected users and accurate identification of risk-prone areas using Google Maps.
C1 [Sareen, Sanjay] IK Gujral Punjab Tech Univ, Comp Sect, Guru Nanak Dev Univ, Amritsar, Punjab, India.
   [Sood, Sandeep K.] Guru Nanak Dev Univ, Dept Comp Sci & Engn, Amritsar, Punjab, India.
   [Gupta, Sunil Kumar] Beant Coll Engn & Technol, Dept Comp Sci & Engn, Gurdaspur, India.
RP Sareen, S (corresponding author), IK Gujral Punjab Tech Univ, Comp Sect, Guru Nanak Dev Univ, Amritsar, Punjab, India.
EM sareen.gndu@gmail.com
OI Sood, Sandeep/0000-0002-8196-5503; Singh, Kiran Deep/0000-0002-8154-0986
CR Al Mamun KA, 2017, FUTURE GENER COMP SY, V66, P36, DOI 10.1016/j.future.2015.11.010
   [Anonymous], 2016, GOOGLE MAPS
   [Anonymous], 2016, ADULTDATASET
   [Anonymous], 2016, ZIK OUTBR WHOS GLOB
   [Anonymous], 2016, AMAZON EC2 INSTANCE
   Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hall M., 2009, SIGKDD EXPLORATIONS, V11, P1, DOI DOI 10.1145/1656274.1656278
   He CG, 2013, IEEE T BIO-MED ENG, V60, P230, DOI 10.1109/TBME.2012.2222404
   John G.H., 1995, ESTIMATING CONTINUOU
   Lopez-Barbosa N, 2016, ANAL BIOANAL CHEM, V408, P2827, DOI 10.1007/s00216-015-9249-2
   Lounis A, 2016, FUTURE GENER COMP SY, V55, P266, DOI 10.1016/j.future.2015.01.009
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Quwaider M, 2016, PERVASIVE MOB COMPUT, V28, P35, DOI 10.1016/j.pmcj.2015.07.012
   Sareen S, 2016, COMPUT SCI ENG, V18, P56, DOI 10.1109/MCSE.2016.82
   Sareen S, 2016, INF SECUR J, V25, P39, DOI 10.1080/19393555.2015.1134732
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Silva DF, 2015, J INTELL ROBOT SYST, V80, pS313, DOI 10.1007/s10846-014-0168-9
   World Health Organization, 2016, ZIK SIT REP
   Zhang ZY, 2015, IEEE T PARALL DISTR, V26, P681, DOI 10.1109/TPDS.2014.2313331
NR 25
TC 9
Z9 9
U1 3
U2 11
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0266-4623
EI 1471-6348
J9 INT J TECHNOL ASSESS
JI Int. J. Technol. Assess. Health Care
PY 2017
VL 33
IS 1
BP 11
EP 18
DI 10.1017/S0266462317000113
PG 8
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health; Medical Informatics
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health; Medical Informatics
GA EY2FB
UT WOS:000403782800003
PM 28434408
DA 2020-07-08
ER

PT J
AU Matysiak, A
   Roess, A
AF Matysiak, Angela
   Roess, Amira
TI Interrelationship between Climatic, Ecologic, Social, and Cultural
   Determinants Affecting Dengue Emergence and Transmission in Puerto Rico
   and Their Implications for Zika Response
SO JOURNAL OF TROPICAL MEDICINE
LA English
DT Review
ID AEDES-AEGYPTI DIPTERA; CULEX-QUINQUEFASCIATUS; CULICIDAE PRODUCTIVITY;
   SEPTIC TANKS; VIRUS; VARIABILITY; SURVEILLANCE; KNOWLEDGE; DYNAMICS;
   HABITAT
AB Objective. The global resurgence of dengue has been attributed to rapid population growth, urban expansion, increased air travel, globalization, and climate change. Dengue is now endemic in Puerto Rico. Puerto Rico is at risk for Zika, another emerging arbovirus. The interrelationship between climatic, ecological, social, and cultural factors that affect dengue and other arboviruses' transmission is understudied. Design. The objective of this systematic review is to examine the interrelationship between climatic, ecological, social, and cultural factors on dengue transmission in Puerto Rico and to draw lessons for Zika response. Results. A comprehensive search of peer-reviewed journal articles was performed, producing 562 articles; 26 were selected for this review. Findings indicate that human activities and behaviors (urbanization, migration, and consumption) as well as climate have a significant impact on the abundance and the transmission potential of Ae. aegypti, the vector for dengue, Zika, and other viruses. Conclusion. Despite the public health burden of dengue limited investments have been made in research and surveillance. Future research is needed to develop models that integrate the multivariate effects of climatic, ecological, social, and cultural factors, which for Puerto Rico have mostly been examined independently. Such models have the potential to inform response to dengue, Zika, and other arboviruses.
C1 [Matysiak, Angela; Roess, Amira] George Washington Univ, Dept Global Hlth, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
RP Roess, A (corresponding author), George Washington Univ, Dept Global Hlth, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
EM aroess@gwu.edu
OI Roess, Amira/0000-0003-2321-1575
CR Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   Barrera R, 2006, AM J TROP MED HYG, V74, P290, DOI 10.4269/ajtmh.2006.74.290
   Barrera R, 2006, ANN TROP MED PARASIT, V100, pS33, DOI 10.1179/136485906X105499
   Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2
   Barrera R, 2009, AM J TROP MED HYG, V81, P100, DOI 10.4269/ajtmh.2009.81.100
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burke R, 2010, MED VET ENTOMOL, V24, P117, DOI 10.1111/j.1365-2915.2010.00864.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012
   CDC, 2016, DENG EP
   CDC, 2011, DENG CLIM
   Clark G. G., 2004, Dengue Bulletin, V28, P48
   Cox J, 2007, AM J TROP MED HYG, V76, P820, DOI 10.4269/ajtmh.2007.76.820
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durand J., 2015, IMMIGRANT VULNERABIL, P183
   Ebi KL, 2006, ENVIRON HEALTH PERSP, V114, P1957, DOI 10.1289/ehp.8429
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Focks D. A., 2007, DENGUE TRANSMISSION
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2008, DENGUE
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   IPCC, 2007, CLIMATE CHANGE 2007
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Jury MR, 2008, INT J ENVIRON HEAL R, V18, P323, DOI 10.1080/09603120701849836
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Keating J, 2001, SOC SCI MED, V53, P1587, DOI 10.1016/S0277-9536(00)00443-3
   Kolivras KN, 2006, PROF GEOGR, V58, P139, DOI 10.1111/j.1467-9272.2006.00521.x
   Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8
   Luz PM, 2009, TROP MED INT HEALTH, V14, P237, DOI 10.1111/j.1365-3156.2008.02203.x
   Mackay AJ, 2009, J AM MOSQUITO CONTR, V25, P409, DOI 10.2987/09-5888.1
   McConnell K. John, 2003, Rev Panam Salud Publica, V14, P9, DOI 10.1590/S1020-49892003000600003
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Mendez-Lazaro P, 2014, INT J ENV RES PUB HE, V11, P9409, DOI 10.3390/ijerph110909409
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   OLEARY DR, 1998, AM J TROP MED HYG, V66, P35
   PAHO, REG EP ZIK UPD AM
   Pan American Health Organization (PAHO), 2016, DENG PAHO WHO DAT MA
   Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005
   Perez-Guerra CL, 2005, REV PANAM SALUD PUBL, V17, P243, DOI 10.1590/S1020-49892005000400005
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phillips ML, 2008, ENVIRON HEALTH PERSP, V116, pA382, DOI 10.1289/ehp.116-a382
   Ramos MM, 2008, AM J TROP MED HYG, V79, P123, DOI 10.4269/ajtmh.2008.79.123
   Ramos MM, 2009, T ROY SOC TROP MED H, V103, P878, DOI 10.1016/j.trstmh.2008.11.009
   Ramos-Zayas AnaY, 2003, NATL PERFORMANCES PO
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rigau-Perez JG, 2002, AM J TROP MED HYG, V67, P355, DOI 10.4269/ajtmh.2002.67.355
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P75
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931
   Thai KTD, 2011, EXP BIOL MED, V236, P944, DOI 10.1258/ebm.2011.010402
   US Census Briefs, 2011, HISP POP 2010
   US Census Bureau, 2016, QUICK FACTS PUERT RI
   Van Middeldyk R. A., 1910, HIST PUERTO RICO SPA
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   WHO, 2011, COMPR GUID PREV CONT
   WHO, 2012, DENG DIS DISTR MAP
   Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 66
TC 6
Z9 6
U1 0
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9686
EI 1687-9694
J9 J TROP MED-US
JI J. Trop. Med.
PY 2017
VL 2017
AR 8947067
DI 10.1155/2017/8947067
PG 14
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EY3OB
UT WOS:000403880400001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Waterhouse, RM
   Chen, XG
   Bonizzoni, M
   Gasperi, G
AF Waterhouse, Robert M.
   Chen, Xiaoguang
   Bonizzoni, Mariangela
   Gasperi, Giuliano
CA IWAA Participants
TI The third International Workshop on Aedes albopictus: building
   scientific alliances in the fight against the globally invasive Asian
   tiger mosquito
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Aedes albopictus; Asian tiger mosquito; dengue; zika; chikungunya
C1 [Waterhouse, Robert M.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.
   [Chen, Xiaoguang] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Pathogen Biol, Guangzhou, Guangdong, Peoples R China.
   [Bonizzoni, Mariangela; Gasperi, Giuliano] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
RP Waterhouse, RM (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.
EM robert.waterhouse@gmail.com
RI Rosa, Roberto/B-8562-2011; Waterhouse, Robert M/A-1858-2010
OI Rosa, Roberto/0000-0002-8655-2230; Waterhouse, Robert
   M/0000-0003-4199-9052; Bonizzoni, Mariangela/0000-0003-0568-8564
NR 0
TC 1
Z9 1
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2017
VL 111
IS 4
BP 161
EP 165
DI 10.1080/20477724.2017.1333560
PG 5
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA EY2SL
UT WOS:000403820900001
OA Green Published
DA 2020-07-08
ER

PT S
AU Oliveira, EC
   Ishikawa, E
   Hironouchi, LH
   Granja, TH
   Nunes, MVD
   Rodriguez, D
   Menegassi, RB
   Gois, L
   Ghinea, G
AF Oliveira, Edgard Costa
   Ishikawa, Edison
   Hironouchi, Lucas Hiroshi
   Granja, Thabata Hellen
   Nunes, Marcos V. de A.
   Rodriguez, Daniel
   Menegassi, Rafael Batista
   Gois, Luciano
   Ghinea, George
GP IEEE
TI Ontology-based CMS news authoring environment
SO 2017 11TH IEEE INTERNATIONAL CONFERENCE ON SEMANTIC COMPUTING (ICSC)
SE IEEE International Conference on Semantic Computing
LA English
DT Proceedings Paper
CT 11th IEEE International Conference on Semantic Computing (ICSC)
CY JAN 30-FEB 01, 2017
CL San Diego, CA
SP IEEE, IEEE Comp Soc
DE Semantic Web; Ontology; Authoring tool; Content Management System - CMS;
   Semantic authoring
AB This paper describes the specification, modelling and design of an ontology-based news authoring environment for the Semantic Web, that takes into account the construction and use of an ontology of the Zika disease. CMSs are being adapted in order to receive semantic features, such as automatic generations of keywords, semantic annotation and tagging, content reviewing etc. We present here the infrastructure designed to foster research on semantic CMSs as well as semantic web technologies that can be integrated into an ontology-based news authoring environment.
C1 [Oliveira, Edgard Costa; Hironouchi, Lucas Hiroshi; Granja, Thabata Hellen] Univ Brasilia, Software Engn Fac UnB Gama, Brasilia, DF, Brazil.
   [Ishikawa, Edison; Nunes, Marcos V. de A.; Menegassi, Rafael Batista] Univ Brasilia, Dept Comp Sci, Brasilia, DF, Brazil.
   [Rodriguez, Daniel] Univ Alcala De Henares, Dept Comp Sci, Madrid, Spain.
   [Gois, Luciano] Brasilia Heath Dept, SES DF, Brasilia, DF, Brazil.
   [Ghinea, George] Brunel Univ London, Dept Comp Sci UK, London, England.
   [Ghinea, George] Westerdals Oslo Sch Arts Commun & Technol, Fac Technol, Oslo, Norway.
RP Oliveira, EC (corresponding author), Univ Brasilia, Software Engn Fac UnB Gama, Brasilia, DF, Brazil.
EM ecosta@unb.br; ishikawa@unb.br; lucashh@hotmail.com;
   thabata.helen@gmail.com; marcosnunesmbs@gmail.com;
   daniel.rodriguezg@uah.es; batista7r@gmail.com;
   luciano.gois@saude.df.gov.br; george.ghinea@brunel.ac.uk
RI Rodriguez, Daniel/N-8939-2018
CR Behrendt Wemher, 2013, DEV SEM CMS APPL IKS
   Daconta M. C, 2003, SEMANTIC WEB GUIDE F
   Gandon F., 2014, RDF 1 1 XML SYNTAX
   ISOTANI Seiji, 2015, DADOS ABERTOS CONECT
   Noy N. F., 2001, ONTOLOGY DEV
   Schiessl M., 2015, THESIS, P261
   Talas J., 2011, KNOWLEDGE MANAGEMENT, V111
NR 7
TC 0
Z9 0
U1 0
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2325-6516
BN 978-1-5090-4284-5
J9 IEEE INT C SEMANT CO
PY 2017
BP 264
EP 265
DI 10.1109/ICSC.2017.91
PG 2
WC Computer Science, Artificial Intelligence
SC Computer Science
GA BH8IU
UT WOS:000403391300044
DA 2020-07-08
ER

PT S
AU Yang, E
   Gu, B
   Yoon, T
AF Yang, Eujin
   Gu, Bokyung
   Yoon, Taeseon
GP IEEE
TI Intensified Analysis and Comparison of 5 Flacicirus with the use of
   Decision Tree and Support Vector Machine (SVM)
SO 2017 19TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATIONS TECHNOLOGY
   (ICACT) - OPENING NEW ERA OF SMART SOCIETY
SE International Conference on Advanced Communication Technology
LA English
DT Proceedings Paper
CT 19th International Conference on Advanced Communication Technology
   (ICACT)
CY FEB 19-22, 2017
CL Pyeongchang, SOUTH KOREA
SP Global IT Res Inst, IEEE Commun Soc, Natl Informat Soc Agcy, Elect & Telecommunicat Res Inst, Gangwon Convent & Visitors Bur, Korean Inst Commun Sci, IEEK Commun Soc, Korean Inst Informat Scientists & Engineers, Open Stand & Internet Assoc, Korea Inst Informat Secur & Crytol
DE Zika virus; Yellow fever; West Nile virus; Dengue virus; Tick borne
   encephalitis; Flavivirus; Decision tree algorithm; Support Vector
   Machine(SVM)
AB Flavivirus is spreaded with the help of intermediary, especially mosquitoes. In preceding research, we found out that Leucine has high frequency. Wanting to know specific relationship between 5 flaviviruses; Yellow fever, West Nile virus, Dengue virus, Tick borne encephalitis, decision tree and support vector machine algorithm were used. Analyzing results of the algorithms, difference or similarity about the viruses and a group as flavivirus were found.
C1 [Yang, Eujin; Gu, Bokyung] Hankuk Acad Foreign Studies, Nat Sci, Young In, South Korea.
   [Yoon, Taeseon] Hankuk Acad Foreign Studies, Fac, Young In, South Korea.
RP Yang, E (corresponding author), Hankuk Acad Foreign Studies, Nat Sci, Young In, South Korea.
EM eujin0001@hafs.hs.kr; jpj27@naver.com; tsyoon@hafs.hs.kr
CR Amicizia Daniela, 2013, EPIDEMIOLOGY TICK BO
   Bogovic Petra, 2015, TICK BORNE ENCEPHALI
   Cho Younghoon, 2016, MATEC WEB C
   Jung Chaeyun, 2015, INT C INT ICIC
   Kim Hyunseong, 2016, INT C FUT COMP COMM
   Kim Taehwan, 2015, INT J MACHINE LEARNI
   Lee Donghyun, 2016, INT C EL ENG INF ICE
   Park Hyorin, 2016, MATEC WEB C MATEC C
   Reisen William K., 2013, ECOLOGY W NILE VIRUS
   Roh Yihyun, 2016, INT C INT ICIC
   Song Jiwon, LECT NOTES COMPUTER
   Song Seung Hye, 2016, INT C ADV COMM TECHN
   Song Sutao, 2011, COMP STUDY SVM METHO
   Tonya M, 2012, W NILE BIOL TRANSMIS
   Yang Youjin, 2016, MATEC WEB C MATEC WE
   Zhang Yi, 2015, COMBINING MLC SVM CL
NR 16
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1738-9445
BN 978-8-9968-6509-4
J9 INT CONF ADV COMMUN
PY 2017
BP 526
EP 529
PG 4
WC Computer Science, Theory & Methods; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA BH8BP
UT WOS:000403150000102
DA 2020-07-08
ER

PT J
AU Gao, B
   Fang, YL
   Zhang, JQ
   Wu, RQ
   Xu, BH
   Xie, LH
AF Gao, Bo
   Fang, Yiliang
   Zhang, Jianqing
   Wu, Rongquan
   Xu, Baohai
   Xie, Lianhui
TI A DNA Barcoding Based Study to Identify Main Mosquito Species in Taiwan
   and its Difference from Those in Mainland China
SO COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
LA English
DT Article
DE Mosquito species; DNA barcoding; phylogenetic tree; DNA sequencing
ID RECONSTRUCT PHYLOGENETIC NETWORKS; CULICIDAE; OCHLEROTATUS; SEQUENCES;
   SUBGENUS; DIPTERA; AEDES; GENUS
AB Aim and Objective: Mosquitoes can transmit many types of viruses such as West Nile virus and Zika virus and are responsible for a number of virus-causing diseases including malaria, dengue fever, yellow fever, lymphatic filariasis, and Japanese B encephalitis. On January 19, 2016, the first case of Zika virus infection was identified in Taiwan, which presents the need for studying the mosquito species in the Taiwan Strait and evaluating the risk of the outbreak of this infection.
   Materials and Method: In this study, we have collected 144 mosquito specimens from 42 species belonging to nine genera from both sides of the Taiwan Strait during 2013 and 2014. We then applied the COI DNA Barcoding technique to classify the specimens and performed a phylogenetic analysis to infer the evolutionary history of these mosquitoes. Based on the analyses, we found that though the mosquitoes from different sides of the Taiwan Strait share a lot of commonality, they have a few regional specificities.
   Results: Our results also suggested a very small divergences (1%similar to 9%) between specimens from the same mosquito species and relatively large divergences (8%similar to 25%) between specimens from different mosquito species. Within the same species, the divergence of specimens from the same region is significantly smaller than that between two regions. A few highly divergent species between Fujian and Taiwan (e.g., An. maculatus and Ae. elsiae) might be formed due to the so-called "cryptic evolutionary events", in which the species has differentiation into cryptic species due to geographical differences without changing morphological characteristics.
   Conclusion: In conclusion, the phylogenetic analyses showed a very similar taxonomy to the historical one based on morphological characteristics, validating again the application of COI DNA Barcoding technique in classifying mosquito species. However, there are also some inconsistencies between COI DNA Barcoding and historical taxonomy, which points out the differences between mosquito DNA and morphological characteristics and suggests the possibility to improve mosquito taxonomy based on DNA techniques.
C1 [Gao, Bo; Xie, Lianhui] Fujian Agr & Forestry Univ, Key Lab Plant Virol Fujian Prov, Fuzhou 350002, Fujian Province, Peoples R China.
   [Gao, Bo; Fang, Yiliang; Zhang, Jianqing; Xu, Baohai] Int Travel Healthcare Ctr, Fuzhou 350001, Fujian Province, Peoples R China.
   [Wu, Rongquan] Quanzhou Entry Exit Inspect & Quarantine Bur, Quanzhou, Fujian Province, Peoples R China.
RP Xie, LH (corresponding author), Fujian Agr & Forestry Univ, Key Lab Plant Virol Fujian Prov, Fuzhou 350002, Fujian Province, Peoples R China.
EM xielh@fafu.edu.cn
FU National Science and Technology support program [2012BAK11B05];
   Administration of Quality Supervision, Inspection and Quarantine (AQSIQ)
   [2015IK037]; National key research and development [2016YFF0203202]
FX This work was financially supported by the National Science and
   Technology support program "2012BAK11B05 (http://program.most.gov.
   cn/)", Administration of Quality Supervision, Inspection and Quarantine
   (AQSIQ) support program " 2015IK037 (http://zjkygl.aqsiq.gov.cn)", and
   National key research and development project (2016YFF0203202).
CR [Anonymous], 2016, 1 IMP CAS ZIK VIR IN
   Arnaiz-Villena A, 2001, CELL MOL LIFE SCI, V58, P1159, DOI 10.1007/PL00000930
   Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x
   Beebe NW, 1996, AM J TROP MED HYG, V54, P395, DOI 10.4269/ajtmh.1996.54.395
   Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x
   Damgaard J, 2000, ZOOL J LINN SOC-LOND, V130, P511, DOI 10.1006/zjls.1999.0236
   Diaz-Nieto LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075516
   Feng Lan Chou., 1938, Peking Natural History Bulletin, V12, P169
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025
   Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2
   LIEN J. C., 1965, J MED ENTOMOL, V2, P1, DOI 10.1093/jmedent/2.1.1
   Lu B., 1997, DIPTERA CULICIDAE 1, V9
   Otranto D., 2009, PARASITES VECTORS S1, V2, P2, DOI DOI 10.1186/1756-3305-2-S1-S2
   Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003
   Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208
   Sharma AK, 2010, ACTA TROP, V116, P89, DOI 10.1016/j.actatropica.2010.06.003
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Wang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047051
   Yang JL, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-21
   Yang JL, 2013, MOL BIOL EVOL, V30, P1206, DOI 10.1093/molbev/mst040
   Yang JL, 2008, J COMPUT BIOL, V15, P1295, DOI 10.1089/cmb.2007.0209
NR 25
TC 2
Z9 2
U1 1
U2 10
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1386-2073
EI 1875-5402
J9 COMB CHEM HIGH T SCR
JI Comb. Chem. High Throughput Screen
PY 2017
VL 20
IS 2
BP 147
EP 152
DI 10.2174/1386207320666170217153548
PG 6
WC Biochemical Research Methods; Chemistry, Applied; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA EW9FZ
UT WOS:000402823500008
PM 28215143
DA 2020-07-08
ER

PT J
AU Rosales, A
   Yepes-Mayorga, A
   Arias, A
   Franz, F
   Thomas, J
   Huddle, J
   Soto, RJ
   Haynes, M
   Prado, M
   Cherian, D
AF Rosales, Alfonso
   Yepes-Mayorga, Adriana
   Arias, Alejandro
   Franz, Fabiano
   Thomas, Joanne
   Huddle, Jamo
   Soto, Ramon Jeremias
   Haynes, Maya
   Prado, Monica
   Cherian, Dennis
TI A cross-sectional survey on ZIKV in Honduras Implications for governance
   and risk communication approaches
SO INTERNATIONAL JOURNAL OF HEALTH GOVERNANCE
LA English
DT Article
DE Honduras; Risk communication; Infectious disease outbreaks; Knowledge;
   attitudes and practices (KAP); Public health emergency preparedness;
   Zika virus
AB Purpose - Zika virus (ZIKV) statistics in Honduras are the highest among countries in Central America. National risk communication strategies have primarily focused on vector control and are integrated into existing approaches for Dengue and Chikungunya. Given the new evidence on ZIKV, there is a need to revamp risk communication strategies so that they are informed by dynamic listening methods such as knowledge, attitudes, and practices. The paper aims to discuss this issue.
   Design/methodology/approach - A cross-sectional survey was administered to 604 respondents in 21 designated Honduran communities using a two-stage, 30-cluster sampling method.
   Findings - Almost eight out of ten Hondurans knew that Zika can be transmitted by the bite of a mosquito; however, only 2 and 0.1 percent, respectively, were aware that Zika can be spread by sexual intercourse and from a pregnant woman to her fetus. In total, four out of ten Hondurans knew that there is a causal relationship between Zika and microcephaly in newborns, and three out of ten knew that there is an association between Zika and Guillian-Barre syndrome. Overall, 50 percent of respondents said that they did not have enough information about the disease.
   Social implications - The findings of this study clearly identify information priority gaps that need to be urgently addressed by national stakeholders involved in public health activities to protect the most vulnerable population against Zika disease and its complications.
   Originality/value - This study is the first of its kind in Central America to inform any national risk communication strategy since the inception of the ZIKV response, particularly among at risk populations.
C1 [Rosales, Alfonso; Thomas, Joanne; Haynes, Maya; Cherian, Dennis] World Vis, Dept Hlth, Washington, DC 20002 USA.
   [Arias, Alejandro] World Vis Honduras, Tegucigalpa, Honduras.
   [Franz, Fabiano] World Vis LACRO Reg, Panama City, Panama.
   [Huddle, Jamo] World Vis Int, Hamilton, ON, Canada.
   [Soto, Ramon Jeremias] World Vis Latin Amer & Caribbean Reg Off, Tegucigalpa, Honduras.
   [Prado, Monica] Pan Amer Hlth Org, CHA Risk Commun, San Diego, CA USA.
RP Rosales, A (corresponding author), World Vis, Dept Hlth, Washington, DC 20002 USA.
EM arosales@worldvision.org
RI amsalu, ribka/G-8780-2019; Prado, Monica Igreja do/U-9221-2017
OI Prado, Monica Igreja do/0000-0003-2657-3619
FU Pan American Health Organization Regional Office for the Americas, World
   Health Organization
FX This publication is based upon work supported by the Pan American Health
   Organization Regional Office for the Americas, World Health
   Organization.
CR Bostoen K, 2006, INT J EPIDEMIOL, V35, P751, DOI 10.1093/ije/dyl019
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Glik D. C., 2007, ANN REV PUBLIC HLTH, V28, P33
   Honduras Secretary of Health, 2016, B EP NOT HAST SEM EP
   Pan American Health Organization and World Health Organization, 2016, FIN REP FOC GROUP ST
   Pan American Health Organization/World Health Organization, 2016, TIM EM ZIK VIR AM
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   San Diego Union- Tribune, 2016, SAN DIEGO UNION TRIB
   SANDMAN P, 2002, SMALLPOX VACCINATION
   USAID, 2005, USAIDS VIS HLTH SYST
   WHO, 2016, HIST ZIK VIR
   WHO, 2016, RISK COMM CONT ZIK V
   WHO, 2016, PREV SEX TRANSM ZIK
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK VIR INF HOND
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization, 2016, RISK COMM COMM ENG Z
   World Health Organization and Pan American Health Organization, 2016, ZIKA COMM MAT
   World Health Organization and Pan American Health Organization, 2016, PWR HOND
   World Vision, 2016, EM ZIK GUAT RES CONS
   World Vision, 2016, EM ZIKV RES CONS PRO
NR 26
TC 3
Z9 4
U1 1
U2 1
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 2059-4631
J9 INT J HEALTH GOV
JI Int. J. Health Gov.
PY 2017
VL 22
IS 2
BP 83
EP 92
DI 10.1108/IJHG-11-2016-0053
PG 10
WC Health Policy & Services
SC Health Care Sciences & Services
GA EX0HZ
UT WOS:000402902200003
DA 2020-07-08
ER

PT J
AU Khandia, R
   Munjal, A
   Dhama, K
AF Khandia, Rekha
   Munjal, Ashok
   Dhama, Kuldeep
TI Consequences of Zika Virus Infection During Fetal Stage and Pregnancy
   Safe Drugs: An Update
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Review
DE Zika virus; microcephaly; ZIKV detection; fetal infection; therapies
   during pregnancy; drugs
ID CHLOROQUINE; MEBENDAZOLE; SOFOSBUVIR; INHIBITORS; EMERGENCE; MECHANISM
AB Zika virus (ZIKV), is a member of the Flaviviridae family and cause congenital microcephaly and Guillain-Barre' Syndrome (GBS). The fetus of the mothers infected with ZIKV during first trimester are suffered from severe neurological damage like change of head shape and circumference celled microcephaly, convoluted scalp, deformed joints and vision and hearing loss. Its capability to infect fetus caused Public Health Emergency of International Concern. The information related to ZIKV infecting pregnant women and safe drugs were retrieved from the authentic published resources available on Medline, Pubmed, Pubmed Central, Science Direct and other scientific databases. The retrieved information has been compiled and analyzed. Microcephaly is a rare paediatric condition, implicated with severe consequences on fetus. The consequences of ZIKV infection to the fetus, statistical analysis summarizing association of microcephaly with ZIKV infection with other teratogenic congenital disease manifestations like ZIKV infection and about the therapies which can work for fetus and pregnant women include the use of chloroquine, amodiaquine, sofosbuvir, macrolide antibiotic azithromycin, niclosamide, albendazole/mebendazole, palonosetron and use of convalescent serum. Present review explains techniques of virus detection in fetus. Detailed case study analysis of affected fetus and the mechanism by which virus cause damage to the tissues and the target of fetus might be helpful in future to prevent the detrimental effects of the virus.
C1 [Khandia, Rekha; Munjal, Ashok] Barkatullah Univ, Dept Biochem & Genet, Bhopal 462026, Madhya Pradesh, India.
   [Dhama, Kuldeep] ICAR Indian Vet Res Inst, Div Pathol, Bareilly 243122, Uttar Pradesh, India.
RP Munjal, A (corresponding author), Barkatullah Univ, Dept Biochem & Genet, Bhopal 462026, Madhya Pradesh, India.
RI Dhama, Kuldeep/B-7852-2015
OI Dhama, Kuldeep/0000-0001-7469-4752; Munjal, Ashok/0000-0001-6294-1584
FU DBT-IPLS
FX Financial assistance from DBT-IPLS is gratefully acknowledged. Authors
   of the manuscript thank and acknowledge their respective
   Universities/Institutes.
CR Acs Nandor, 2005, Congenital Anomalies, V45, P85, DOI 10.1111/j.1741-4520.2005.00072.x
   Adjei G O, 2009, Ghana Med J, V43, P135
   Akpovwa H, 2016, CELL BIOCHEM FUNCT, V34, P191, DOI 10.1002/cbf.3182
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Blecher K, 2011, VIRULENCE, V2, P395, DOI 10.4161/viru.2.5.17035
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Silva NR, 1999, LANCET, V353, P1145, DOI 10.1016/S0140-6736(98)06308-9
   Dhama K, 2016, RECENT PATENTS INFLA, V10, P105, DOI 10.2174/1872213X10666161226162229
   Dhama K, 2015, INT J PHARMACOL, V11, P253, DOI 10.3923/ijp.2015.253.290
   Diav-Citrin O, 2003, AM J OBSTET GYNECOL, V188, P282, DOI 10.1067/mob.2003.79
   Dohgu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039565
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Iqbal H.M., 2016, ALLERGY DRUG DISCOV, V10, DOI [10.2174/1872213X10666161213162823, DOI 10.2174/1872213X10666161213162823]
   Junquera Elena C, 2014, Recent Pat Antiinfect Drug Discov, V9, P14
   Kawadkar J, 2011, J PHARM CLIN RES, V4, P23
   Kemp MW, 2014, ANTIMICROB AGENTS CH, V58, P6581, DOI 10.1128/AAC.03721-14
   Khandia R., 2016, ALLERGY DRUG DISCOV, V10, DOI [10.2174/1872213X10666161213163301, DOI 10.2174/1872213X10666161213163301]
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lin KJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.023
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Malik Y. S., 2013, South Asian Journal of Experimental Biology, V3, P207
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McDonagh P, 2015, VET MICROBIOL, V176, P370, DOI 10.1016/j.vetmic.2015.02.007
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ndibazza J, 2010, CLIN INFECT DIS, V50, P531, DOI 10.1086/649924
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Pascoalino B.S., 2016, F1000RESEARCH, V5
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rather IA, 2015, BANGL J PHARMACOL, V10, P475, DOI 10.3329/bjp.v10i2.23068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Savarino A, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0178-0
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Sutton AL, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.015
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TITUS EO, 1989, THER DRUG MONIT, V11, P369, DOI 10.1097/00007691-198911040-00001
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WOLFE MS, 1985, BRIT MED J, V290, P1466, DOI 10.1136/bmj.290.6480.1466
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 65
TC 4
Z9 4
U1 0
U2 12
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PY 2017
VL 13
IS 4
BP 370
EP 377
DI 10.3923/ijp.2017.370.377
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EW9IG
UT WOS:000402831300004
OA Bronze
DA 2020-07-08
ER

PT J
AU Pacher-Zavisin, MC
AF Pacher-Zavisin, Margit C.
TI Successful mRNA-based Zika-Vaccine
SO BIOENGINEERED
LA English
DT News Item
EM margit.c.pacher-zavisin@taylorandfrancis.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2165-5979
EI 2165-5987
J9 BIOENGINEERED
JI Bioengineered
PY 2017
VL 8
IS 3
BP 192
EP 192
PG 1
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EW9ZV
UT WOS:000402878800004
DA 2020-07-08
ER

PT J
AU Beattie, J
   Parajuli, S
   Sanger, M
   Lee, G
   Pleninger, P
   Crowley, G
   Kwon, S
   Murthy, V
   Manko, J
   Caplan, A
   Dufort, E
   Staples, JE
   Pastula, D
   Nolan, A
AF Beattie, J.
   Parajuli, S.
   Sanger, M.
   Lee, G.
   Pleninger, P.
   Crowley, G.
   Kwon, S.
   Murthy, V.
   Manko, J.
   Caplan, A.
   Dufort, E.
   Staples, J. E.
   Pastula, D.
   Nolan, A.
TI Zika Virus-Associated Guillain-Barre Syndrome In A Returning United
   States Traveler
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Beattie, J.; Parajuli, S.; Sanger, M.; Lee, G.; Pleninger, P.; Crowley, G.; Kwon, S.; Murthy, V.; Manko, J.; Caplan, A.; Nolan, A.] NYU, Sch Med, New York, NY USA.
   [Dufort, E.] New York State Dept Hlth, Albany, NY USA.
   [Staples, J. E.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Pastula, D.] Univ Colorado, Ctr Dis Control & Prevention, Aurora, CO USA.
RI Nolan, Anna/C-2796-2012; Pastula, Daniel M./M-1325-2019
OI Nolan, Anna/0000-0002-0631-1171; Pastula, Daniel M./0000-0001-9342-4459
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A2008
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372501178
DA 2020-07-08
ER

PT J
AU Ramos-Rossy, J
   Rodriguez-Cintron, W
   Flores-Gonzalez, J
   Torres-Palacios, J
AF Ramos-Rossy, J.
   Rodriguez-Cintron, W.
   Flores-Gonzalez, J.
   Torres-Palacios, J.
TI Hypoxemic Respiratory Failure Secondary To Zika Virus Infection
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Ramos-Rossy, J.; Rodriguez-Cintron, W.; Flores-Gonzalez, J.; Torres-Palacios, J.] VA Caribbean Healthcare Syst, San Juan, PR USA.
EM william@prmail.net
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A5864
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372505664
DA 2020-07-08
ER

PT J
AU Pacheco-Romero, JC
AF Pacheco-Romero, Jose C.
TI EDITORIAL
SO REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA
LA English
DT Editorial Material
ID ZIKA VIRUS-INFECTION; OBSTETRICIANS; CHALENGE
EM jpachecoperu@yahoo.com
CR Barcellos C, 2016, EMERGING INFECT DIS, V22
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pacheco-Romero J, 2016, REV PERU GINECOL OBS, V62, P247
   Pacheco-Romero J, 2016, REV PERU GINECOL OBS, V62, P219
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Velasquez A, 2017, DIARIO COMERCIO 0210, P34
NR 11
TC 0
Z9 0
U1 0
U2 0
PU SOC PERUANA OBSTETRICIA & GINECOLOGIA
PI LIMA
PA AV ARUMBURU 321, OFICINA 4, SAN ISIDRO, LIMA, 27, PERU
SN 2304-5124
J9 REV PERU GINECOL OBS
JI Rev. Peru. Ginecol. Obstet.
PD JAN-MAR
PY 2017
VL 63
IS 1
BP 5
EP 10
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EV5ZX
UT WOS:000401850100001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kenney, JL
   Romo, H
   Duggal, NK
   Tzeng, WP
   Burkhalter, KL
   Brault, AC
   Savage, HM
AF Kenney, Joan L.
   Romo, Hannah
   Duggal, Nisha K.
   Tzeng, Wen-Pin
   Burkhalter, Kristen L.
   Brault, Aaron C.
   Savage, Harry M.
TI Transmission Incompetence of Culex quinquefasciatus and Culex pipiens
   pipiens from North America for Zika Virus
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID HOST-FEEDING PATTERNS; WEST-NILE-VIRUS; NEW-YORK-CITY;
   DIPTERA-CULICIDAE; POTENTIAL VECTOR; MOSQUITOS DIPTERA; AEDES;
   SUSCEPTIBILITY; INFECTIONS; FLAVIVIRUS
AB In late 2014, Zika virus (ZIKV; Flaviviridae, Flavivirus) emerged as a significant arboviral disease threat in the Western hemisphere. Aedes aegypti and Aedes albopictus have been considered the principal vectors of ZIKV in the New World due to viral isolation frequency and vector competence assessments. Limited reports of Culex transmission potential have highlighted the need for additional vector competence assessments of North American Culex species. Accordingly, North American Culex pipiens and Culex quinquefasciatus were orally exposed and intrathoracically inoculated with the African prototype ZIKV strain and currently circulating Asian lineage ZIKV strains to assess infection, dissemination, and transmission potential. Results indicated that these two North American Culex mosquito species were highly refractory to oral infection with no dissemination or transmission observed with any ZIKV strains assessed. Furthermore, both Culex mosquito species intrathoracically inoculated with either Asian or African lineage ZIKVs failed to expectorate virus in saliva. These in vivo results were further supported by the observation that multiple mosquito cell lines of Culex species origin demonstrated significant growth restriction of ZIKV strains compared with Aedes-derived cell lines. In summation, no evidence for the potential of Cx. pipiens or Cx. quinquefasciatus to serve as a competent vector for ZIKV transmission in North America was observed.
C1 [Kenney, Joan L.; Romo, Hannah; Duggal, Nisha K.; Tzeng, Wen-Pin; Burkhalter, Kristen L.; Brault, Aaron C.; Savage, Harry M.] Ctr Dis Control & Prevent, Ft Collins, CO 80521 USA.
RP Kenney, JL (corresponding author), Ctr Dis Control & Prevent, Ft Collins, CO 80521 USA.
EM vwx1@cdc.gov; vym8@cdc.gov; wwd3@cdc.gov; wdt6@cdc.gov; ktb3@cdc.gov;
   zlu5@cdc.gov; hms1@cdc.gov
RI Kenney, Joan L./AAE-7416-2019
OI Kenney, Joanie/0000-0002-6761-4272
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EURO SURVEILL, V21
   Apperson CS, 2002, J MED ENTOMOL, V39, P777, DOI 10.1603/0022-2585-39.5.777
   BEATY BJ, 1989, DIAGNOSTIC PROCEDURE
   Boccolini D, 2016, EURO SURVEILL, V21
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kothera L, 2010, J MED ENTOMOL, V47, P805, DOI 10.1603/ME10031
   KRAMER LD, 1990, J MED ENTOMOL, V27, P1008, DOI 10.1093/jmedent/27.6.1008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Mackay AJ, 2010, J MED ENTOMOL, V47, P238, DOI 10.1603/ME09168
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004
   Molaei G, 2008, J MED ENTOMOL, V45, P1143, DOI 10.1603/0022-2585(2008)45[1143:HPOPMV]2.0.CO;2
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Patrican LA, 2007, EMERG INFECT DIS, V13, P1921, DOI 10.3201/eid1312.070275
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   ROSEN L, 1985, AM J TROP MED HYG, V34, P603, DOI 10.4269/ajtmh.1985.34.603
   Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   Thiemann TC, 2012, J MED ENTOMOL, V49, P903, DOI 10.1603/ME11272
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 50
TC 25
Z9 25
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 96
IS 5
BP 1235
EP 1240
DI 10.4269/ajtmh.16-0865
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EV4WO
UT WOS:000401764600038
PM 28500817
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Kahanm, DM
   Jamieson, KH
   Landrum, A
   Asheley
   Winneg, K
AF Kahanm, D. M.
   Jamieson, K. H.
   Landrum, A.
   Asheley
   Winneg, K.
TI Culturally antagonistic memes and the Zika virus: an experimental test
   (vol 20, pg 1, 2016)
SO JOURNAL OF RISK RESEARCH
LA English
DT Correction
CR Kahan DM, 2017, J RISK RES, V20, P1, DOI 10.1080/13669877.2016.1260631
NR 1
TC 0
Z9 0
U1 0
U2 2
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1366-9877
EI 1466-4461
J9 J RISK RES
JI J. Risk Res.
PY 2017
VL 20
IS 4
BP 568
EP 568
DI 10.1080/13669877.2017.1288415
PG 1
WC Social Sciences, Interdisciplinary
SC Social Sciences - Other Topics
GA EV3JW
UT WOS:000401656100009
OA Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Ultrastructural and immunofluorescence studies of Zika infection
SO ULTRASTRUCTURAL PATHOLOGY
LA English
DT Letter
DE Finding; infection; Zika
AB This letter to the editor is for discussion on publication of Ultrastructural and immunofluorescence studies of Zika infection.
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Publ Hlth Curriculum, Wiwanitkit House, Bangkok 10160, Surin Province, Thailand.
RP Wiwanitkit, V (corresponding author), Surindra Rajabhat Univ, Publ Hlth Curriculum, Wiwanitkit House, Bangkok 10160, Surin Province, Thailand.
EM virojwiwan@hotmail.com
CR Alves de Matos A P, 2017, Ultrastruct Pathol, V41, P105, DOI 10.1080/01913123.2016.1270737
   MONATH TP, 1984, AM J TROP MED HYG, V33, P695, DOI 10.4269/ajtmh.1984.33.695
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
NR 3
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0191-3123
EI 1521-0758
J9 ULTRASTRUCT PATHOL
JI Ultrastruct. Pathol.
PY 2017
VL 41
IS 3
BP 264
EP 264
DI 10.1080/01913123.2017.1315205
PG 1
WC Microscopy; Pathology
SC Microscopy; Pathology
GA EV4LS
UT WOS:000401732100007
PM 28463081
DA 2020-07-08
ER

PT J
AU Srivastava, SR
   Shrivastava, PS
   Jegadeesh, R
AF Srivastava, Saurabh R.
   Shrivastava, Prateek S.
   Jegadeesh, Ramasamy
TI Zika virus disease: The current status and necessity to implement
   Strategic Response Framework
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Srivastava, Saurabh R.; Shrivastava, Prateek S.; Jegadeesh, Ramasamy] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, Madras, Tamil Nadu, India.
RP Srivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvanchery Main Rd, Kanchipuram, Tamil Nadu, India.
EM drshrishri2008@gmail.com
OI Shrivastava, Saurabh/0000-0001-6102-7475
CR Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   WHO, 2016, 5 WHO
   World Health Organization, 2016, WHO ONE YEAR ZIK OUT
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JAN-FEB
PY 2017
VL 10
IS 1
BP 277
EP U345
DI 10.4103/1755-6783.205569
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EU4II
UT WOS:000400992600056
DA 2020-07-08
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh R.
   Shrivastava, Prateek S.
   Ramasamy, Jegadeesh
TI Strengthening reproductive and sexual health services to minimize the
   risk of Zika virus associated complications in newborn
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Shrivastava, Saurabh R.; Shrivastava, Prateek S.; Ramasamy, Jegadeesh] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, Madras, Tamil Nadu, India.
RP Shrivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Guduvancherry Main Rd, Kanchipuram, Tamil Nadu, India.
EM drshrishri2008@gmail.com
OI Shrivastava, Saurabh/0000-0001-6102-7475
CR Galli B, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00031116
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   UNFPA, 2016, IMPR ACC FAM PLANN H
   WHO, 2016, ZIK VIR FACT SHEET
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JAN-FEB
PY 2017
VL 10
IS 1
BP 287
EP 288
DI 10.4103/1755-6783.205579
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EU4II
UT WOS:000400992600065
DA 2020-07-08
ER

PT J
AU Smith, DR
AF Smith, Duncan R.
TI Waiting in the wings: The potential of mosquito transmitted flaviviruses
   to emerge
SO CRITICAL REVIEWS IN MICROBIOLOGY
LA English
DT Review
DE Emerging infectious diseases; zoonosis; global footprint; human disease
ID ST-LOUIS ENCEPHALITIS; BORNE VIRUS-INFECTIONS; WEST-NILE-VIRUS; MURRAY
   VALLEY ENCEPHALITIS; CAPE-YORK PENINSULA; SAO-PAULO STATE; USUTU-VIRUS;
   ZIKA VIRUS; WESSELSBRON-DISEASE; ILHEUS VIRUS
AB The sudden dramatic emergence of the mosquito transmitted flavivirus Zika virus has bought to the world's attention a relatively obscure virus that was previously only known to specialist researchers. The genus Flavivirus of the family Flaviviridae contains a number of well-known mosquito transmitted human pathogenic viruses including the dengue, yellow fever, Japanese encephalitis and West Nile viruses. However, the genus also contains a number of lesser known human pathogenic viruses transmitted by mosquitoes including Wesselsbron virus, Ilheus virus, St. Louis encephalitis virus and Usutu virus. This review summarizes our knowledge of these lesser known mosquito transmitted flaviviruses and highlights their potential to emerge.
C1 [Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamontol Sai 4, Salaya, Nakorn Pathom, Thailand.
   [Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamontol Sai 4, Salaya, Nakorn Pathom, Thailand.
EM duncan.smi@mahidol.ac.th
RI Smith, Duncan R/C-6891-2011
OI Smith, Duncan R/0000-0002-6592-9852
FU Mahidol University; National Science and Technology Development Agency
   [FDA-CO-2559-1569-TH, P-16-50685]; Office of the Higher Education
   Commission and Mahidol University under the National Research
   Universities Initiative, Thailand Research Fund [IRG570009, RTA5780009]
FX Mahidol University, 10.13039/501100004156, National Science and
   Technology Development Agency, 10.13039/501100004192
   [FDA-CO-2559-1569-TH, P-16-50685], Office of the Higher Education
   Commission and Mahidol University under the National Research
   Universities Initiative, Thailand Research Fund, 10.13039/501100004396
   [IRG570009, RTA5780009].
CR AASKOV JG, 1993, T ROY SOC TROP MED H, V87, P452, DOI 10.1016/0035-9203(93)90032-L
   Diaz LA, 2006, EMERG INFECT DIS, V12, P1752, DOI 10.3201/eid1211.060486
   Aguero M, 2011, EMERG INFECT DIS, V17, P1498, DOI 10.3201/eid1708.110077
   AITKEN THG, 1964, AM J TROP MED HYG, V13, P450, DOI 10.4269/ajtmh.1964.13.450
   ALLEN R, 1970, AM J TROP MED HYG, V19, P851, DOI 10.4269/ajtmh.1970.19.851
   Allering L, 2012, EUROSURVEILLANCE, V17, P2
   ALLWRIGHT DM, 1995, VET REC, V136, P99, DOI 10.1136/vr.136.4.99
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P688, DOI 10.4269/ajtmh.1957.6.688
   ANDERSON CR, 1956, AM J TROP MED HYG, V5, P621, DOI 10.4269/ajtmh.1956.5.621
   [Anonymous], 1969, RAPPORT ANNUEL I PAS, P45
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737
   Baba S S, 1988, Rev Elev Med Vet Pays Trop, V41, P329
   Bakonyi T, 2014, VECTOR-BORNE ZOONOT, V14, P324, DOI 10.1089/vbz.2013.1510
   BARNARD BJH, 1980, ONDERSTEPOORT J VET, V47, P89
   Batista PM, 2013, REV SOC BRAS MED TRO, V46, P684, DOI 10.1590/0037-8682-0181-2013
   Batista WC, 2011, REV SOC BRAS MED TRO, V44, P528, DOI 10.1590/S0037-86822011000400028
   BELLE EA, 1964, AM J TROP MED HYG, V13, P452, DOI 10.4269/ajtmh.1964.13.452
   BELONJE C. W. A., 1958, Journal of the South African Veterinary Medical Association, V29, P1
   Ben Hassine T, 2014, TRANSBOUND EMERG DIS, V61, P385, DOI 10.1111/tbed.12259
   BENNETT NMK, 1976, MED J AUSTRALIA, V2, P446, DOI 10.5694/j.1326-5377.1976.tb130324.x
   Berger S., 2015, LESS COMMON FLAVIVIR
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BLACKBURN NK, 1980, J HYG-CAMBRIDGE, V85, P1, DOI 10.1017/S0022172400027066
   Bondre VP, 2009, J GEN VIROL, V90, P2644, DOI 10.1099/vir.0.012336-0
   BOORMAN J. P. T., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P383, DOI 10.1016/0035-9203(58)90053-1
   BOUGHTON CR, 1986, MED J AUSTRALIA, V145, P90, DOI 10.5694/j.1326-5377.1986.tb101087.x
   BRINKER KR, 1979, ARCH INTERN MED, V139, P561, DOI 10.1001/archinte.139.5.561
   Broom AK, 2002, AM J TROP MED HYG, V67, P319, DOI 10.4269/ajtmh.2002.67.319
   BROOM AK, 1989, J MED ENTOMOL, V26, P101
   BROTTES H, 1966, B WORLD HEALTH ORGAN, V35, P811
   Buchebner N, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-153
   BUCKLEY SM, 1972, B WORLD HEALTH ORGAN, V46, P451
   Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CALISHER CH, 1983, AM J TROP MED HYG, V32, P877, DOI 10.4269/ajtmh.1983.32.877
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Calzolari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063978
   Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Casseb AR, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-9
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   CDC, 1984, JUGR
   CDC, 1985, YOUAND
   CDC, 1985, BUSS
   CDC, 1984, SAB
   CDC, 1984, US
   CDC, 1984, BOUB
   CDC, 1984, AR
   CDC, 1984, BAG
   CDC, 1984, KOUT
   CDC, 1985, NTAYA
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   COETZER JAW, 1977, ONDERSTEPOORT J VET, V44, P205
   COETZER JAW, 1979, ONDERSTEPOORT J VET, V46, P165
   COETZER JAW, 1978, ONDERSTEPOORT J VET, V45, P93
   COIMBRA TLM, 1993, INTERVIROLOGY, V36, P144, DOI 10.1159/000150333
   Cordova S P, 2000, Commun Dis Intell, V24, P368
   Cornet M., 1979, ORSTOM ENTOMOL MED P, V17, P149
   COZ J, 1976, CR ACAD SCI D NAT, V283, P109
   COZ J, 1975, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V13, P57
   CUPP EW, 1986, AM J TROP MED HYG, V35, P851, DOI 10.4269/ajtmh.1986.35.851
   DERODANICHE E, 1961, AM J TROP MED HYG, V10, P390, DOI 10.4269/ajtmh.1961.10.390
   DERODANICHE E, 1961, AM J TROP MED HYG, V10, P387, DOI 10.4269/ajtmh.1961.10.387
   DERODANICHE E, 1957, AM J TROP MED HYG, V6, P686, DOI 10.4269/ajtmh.1957.6.686
   DERONDA.E, 1961, AM J TROP MED HYG, V10, P393, DOI 10.4269/ajtmh.1961.10.393
   DESOUZALOPES O, 1978, AM J EPIDEMIOL, V108, P394, DOI 10.1093/oxfordjournals.aje.a112637
   Diallo M, 2005, MED VET ENTOMOL, V19, P119, DOI 10.1111/j.0269-283X.2005.00564.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   DIGOUTTE JP, 1971, ANN I PASTEUR PARIS, V120, P98
   Digoutte JP., 1966, RAPPORT ANNUEL I PAS, P40
   Doggett S, 2015, 2014 2015 ANN REPORT, P35
   DOHERTY RL, 1979, AUST J EXP BIOL MED, V57, P509, DOI 10.1038/icb.1979.52
   DOHERTY RL, 1968, T ROY SOC TROP MED H, V62, P430, DOI 10.1016/0035-9203(68)90095-3
   DOHERTY RL, 1964, AUST J EXP BIOL MED, V42, P149, DOI 10.1038/icb.1964.16
   DOHERTY RL, 1963, AUST J EXP BIOL MED, V41, P17, DOI 10.1038/icb.1963.2
   DOHERTY RL, 1977, AUST J EXP BIOL MED, V55, P103, DOI 10.1038/icb.1977.9
   DOWNS WG, 1957, AM J TROP MED HYG, V6, P693, DOI 10.4269/ajtmh.1957.6.693
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ESSED WCA, 1965, TROP GEOGR MED, V17, P52
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Felices V, 2014, EMERG INFECT DIS, V20, P730, DOI 10.3201/eid2004.131735
   Fernandez-Pinero J, 2014, J GEN VIROL, V95, P883, DOI 10.1099/vir.0.061465-0
   Ferreira Ivani B., 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P265, DOI 10.1590/S0036-46651994000300011
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   FRENCH E. L., 1952, MED JOUR AUSTRALIA, V1, P100
   FRENCH EL, 1957, AM J TROP MED HYG, V6, P827, DOI 10.4269/ajtmh.1957.6.827
   Gaibani P, 2012, VECTOR-BORNE ZOONOT, V12, P431, DOI 10.1089/vbz.2011.0813
   GALINDO P, 1966, AM J TROP MED HYG, V15, P385, DOI 10.4269/ajtmh.1966.15.385
   GALINDO P, 1959, AM J TROP MED HYG, V8, P557, DOI 10.4269/ajtmh.1959.8.557
   GALINDO P, 1961, AM J TROP MED HYG, V10, P395, DOI 10.4269/ajtmh.1961.10.395
   Gamino V, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-65
   Garcia-Bocanegra I, 2013, TRANSBOUND EMERG DIS, V60, P120, DOI 10.1111/j.1865-1682.2012.01324.x
   Glowacki G., 1998, Revista Argentina de Microbiologia, V30, P170
   GOLDSMITH RS, 1979, ARCH INVEST MED, V10, P239
   GOMES G, 1959, P SOC EXP BIOL MED, V101, P275, DOI 10.3181/00379727-101-24909
   GORDON SW, 1992, AM J TROP MED HYG, V47, P742, DOI 10.4269/ajtmh.1992.47.742
   Griffiths MJ, 2014, HAND CLINIC, V123, P561, DOI 10.1016/B978-0-444-53488-0.00026-2
   GROOT H, 1961, AM J TROP MED HYG, V10, P397, DOI 10.4269/ajtmh.1961.10.397
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   HALE J H, 1956, Ann Trop Med Parasitol, V50, P268
   HAMMON WM, 1946, J EXP MED, V83, P175, DOI 10.1084/jem.83.3.175
   Hammon WM, 1941, SCIENCE, V94, P328, DOI 10.1126/science.94.2440.328
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   HARDY JL, 1984, AM J TROP MED HYG, V33, P166, DOI 10.4269/ajtmh.1984.33.166
   HAWKES RA, 1985, MED J AUSTRALIA, V143, P555, DOI 10.5694/j.1326-5377.1985.tb119949.x
   HAWKES RA, 1993, MED J AUSTRALIA, V159, P159, DOI 10.5694/j.1326-5377.1993.tb137778.x
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HEINZ FX, 2000, VIRUS TAXONOMY, P859
   Hermann LL, 2015, J CLIN VIROL, V64, P153, DOI 10.1016/j.jcv.2014.08.031
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   IVERSSON LB, 1988, ARBOVIRUSES EPIDEMIO, V4, P77
   Iversson Lygia Busch, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P355, DOI 10.1590/S0036-46651993000400009
   Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248
   Johansen CA, 2004, MED VET ENTOMOL, V18, P281, DOI 10.1111/j.0269-283X.2004.00510.x
   Johansen CA, 2003, J AM MOSQUITO CONTR, V19, P392
   Jupp PG, 1998, J AM MOSQUITO CONTR, V14, P40
   King AMQ, 2012, VIRUS TAXONOMY, V9
   KOKERNOT R. H., 1960, S AFRICAN MED JOUR, V34, P871
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P103
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6
   Komarov A., 1960, Veterinary Record, V72, P257
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   LAEMMERT HW, 1947, J IMMUNOL, V55, P61
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   LIEHNE CG, 1976, AUST J EXP BIOL MED, V54, P499, DOI 10.1038/icb.1976.50
   LIEHNE PFS, 1981, AUST J EXP BIOL MED, V59, P347, DOI 10.1038/icb.1981.29
   Llorente F, 2013, EMERG INFECT DIS, V19, P1023, DOI 10.3201/eid1906.130122
   Lobo JMD, 2014, ENVIRON HEALTH INSIG, V8, P9, DOI 10.4137/EHI.S16005
   LOPES OD, 1981, AM J EPIDEMIOL, V113, P122
   LOPES ODS, 1978, AM J EPIDEMIOL, V107, P444
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   MACNAMARA FN, 1953, BRIT J EXP PATHOL, V34, P392
   Manock SR, 2009, AM J TROP MED HYG, V81, P146, DOI 10.4269/ajtmh.2009.81.146
   MARSHALL ID, 1982, AUST J EXP BIOL MED, V60, P471, DOI 10.1038/icb.1982.52
   MARSHALL ID, 1980, AUST J EXP BIOL MED, V58, P91, DOI 10.1038/icb.1980.9
   May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0
   McINTOSH B. M., 1961, S AFRICAN MED JOUR, V35, P647
   McIntosh B. M., 1971, J Ent Soc S Africa, V34, P319
   MCINTOSH BM, 1972, J MED ENTOMOL, V9, P155
   MCINTOSH BM, 1962, AM J TROP MED HYG, V11, P685, DOI 10.4269/ajtmh.1962.11.685
   McIntosh BM, 1962, S AFR J MED SCI, V27, P87
   MCLEAN RG, 1985, J WILDLIFE DIS, V21, P85, DOI 10.7589/0090-3558-21.2.85
   McVey DS, 2015, REV SCI TECH OIE, V34, P431, DOI 10.20506/rst.34.2.2369
   Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0
   Meehan PJ, 2000, EPIDEMIOL INFECT, V125, P181, DOI 10.1017/S0950268899004227
   Mein J, 1998, Commun Dis Intell, V22, P105
   METSELAAR D, 1974, T ROY SOC TROP MED H, V68, P114, DOI 10.1016/0035-9203(74)90184-9
   METTLER N E, 1985, Revista Argentina de Microbiologia, V17, P47
   METTLER NE, 1971, ACTA VIROL, V15, P148
   MITCHELL CJ, 1984, J MED ENTOMOL, V21, P34, DOI 10.1093/jmedent/21.1.34
   MITCHELL CJ, 1986, REV SAUDE PUBL, V20, P171, DOI 10.1590/S0034-89101986000300001
   MITCHELL CJ, 1980, J MED ENTOMOL, V17, P282, DOI 10.1093/jmedent/17.3.282
   MITCHELL CJ, 1983, J MED ENTOMOL, V20, P526, DOI 10.1093/jmedent/20.5.526
   MITCHELL CJ, 1981, AM J TROP MED HYG, V30, P465, DOI 10.4269/ajtmh.1981.30.465
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Coimbra TLM, 2008, REV INST MED TROP SP, V50, P89, DOI 10.1590/S0036-46652008000200005
   MORVAN J, 1990, Archives de l'Institut Pasteur de Madagascar, V57, P183
   Muckenfuss R S, 1941, Bull N Y Acad Med, V17, P487
   Muckenfuss RS, 1933, PUBLIC HEALTH REP, V48, P1341, DOI 10.2307/4580968
   Mushi EZ, 1998, J VET DIAGN INVEST, V10, P191, DOI 10.1177/104063879801000216
   MUSPRATT J., 1957, S AFRICAN JOUR MED SCI, V22, P121
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PANON G, 1979, B SOC PATHOL EXOT, V72, P315
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Pauvolid-Correa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002318
   Pauvolid-Correa A, 2011, MEM I OSWALDO CRUZ, V106, P467, DOI 10.1590/S0074-02762011000400014
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Pereira LE, 2001, REV SAUDE PUBL, V35, P119, DOI 10.1590/S0034-89102001000200003
   Pesko K, 2009, VECTOR-BORNE ZOONOT, V9, P281, DOI 10.1089/vbz.2007.0281
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P145, DOI 10.4269/ajtmh.1981.30.145
   Poidinger M, 1996, VIROLOGY, V218, P417, DOI 10.1006/viro.1996.0213
   Poidinger M, 2000, VIRUS RES, V68, P7, DOI 10.1016/S0168-1702(00)00143-X
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Powers AM, 2011, EXP BIOL MED, V236, P909, DOI 10.1258/ebm.2011.011078
   PRIASLANDINEZ E, 1968, AM J TROP MED HYG, V17, P112, DOI 10.4269/ajtmh.1968.17.112
   PRICE JL, 1978, AM J TROP MED HYG, V27, P162, DOI 10.4269/ajtmh.1978.27.162
   Prow NA, 2014, J VIROL, V88, P9947, DOI 10.1128/JVI.01304-14
   Prow NA, 2013, INT J ENV RES PUB HE, V10, P4432, DOI 10.3390/ijerph10094432
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Reisen WK, 2003, J MED ENTOMOL, V40, P300, DOI 10.1603/0022-2585-40.3.300
   Richards SL, 2009, AM J TROP MED HYG, V81, P264, DOI 10.4269/ajtmh.2009.81.264
   Rizzo F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-395
   ROBIN Y, 1978, ANN INST PASTEUR MIC, VA129, P239
   Romano-Lieber NS, 2000, REV SAUDE PUBL, V34, P236, DOI 10.1590/S0034-89102000000300005
   Rosenberg R, 2013, P NATL ACAD SCI USA, V110, P13961, DOI 10.1073/pnas.1307243110
   ROSS R. W., 1956, JOUR HYG, V54, P177
   SAVAGE HM, 1994, J AM MOSQUITO CONTR, V10, P501
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Selvey LA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002656
   SEYMOUR C, 1983, AM J TROP MED HYG, V32, P854, DOI 10.4269/ajtmh.1983.32.854
   Shope Robert E, 2003, Adv Virus Res, V61, P373, DOI 10.1016/S0065-3527(03)61009-2
   SHOPE ROBERT E., 1963, AN MICROBIOL, V11, P167
   SHROYER DA, 1991, J AM MOSQUITO CONTR, V7, P63
   Silva JR, 2014, REV SOC BRAS MED TRO, V47, P414, DOI 10.1590/0037-8682-0117-2014
   SIMASATHIEN P, 1973, J MED ENTOMOL, V10, P587, DOI 10.1093/jmedent/10.6.587
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SIMPSON VR, 1979, VET REC, V105, P329, DOI 10.1136/vr.105.14.329
   SMITHBURN K. C., 1959, S AFRICAN MED JOUR, V33, P959
   SMITHBURN K. C, 1959, S AFRICAN MED JOUR, V33, P555
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130, DOI 10.3181/00379727-77-18700
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   SPENCE L., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P504, DOI 10.1016/0035-9203(62)90074-3
   SPENCE L. P., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P248, DOI 10.1016/0035-9203(59)90004-5
   SRIHONGS.S, 1971, T ROY SOC TROP MED H, V65, P541, DOI 10.1016/0035-9203(71)90179-9
   SRIHONGSE S, 1967, AM J TROP MED HYG, V16, P516, DOI 10.4269/ajtmh.1967.16.516
   STANDFAST HA, 1984, AUST J BIOL SCI, V37, P351, DOI 10.1071/BI9840351
   Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106
   Sudeep AB, 2013, INDIAN J MED RES, V138, P257
   SUDIA WD, 1975, AM J EPIDEMIOL, V101, P51, DOI 10.1093/oxfordjournals.aje.a112070
   SULKIN SE, 1966, SCIENCE, V152, P223, DOI 10.1126/science.152.3719.223
   Svoboda WK, 2014, REV SOC BRAS MED TRO, V47, P280, DOI 10.1590/0037-8682-0083-2014
   Swanepoel R., 2004, Infectious diseases of livestock. Volume Two, P987
   TAVARES-NETO J, 1986, Memorias do Instituto Oswaldo Cruz, V81, P351, DOI 10.1590/S0074-02761986000400001
   Tavares-Neto José, 2004, Rev. Soc. Bras. Med. Trop., V37, P1, DOI 10.1590/S0037-86822004000100001
   THEODORIDIS A, 1980, ONDERSTEPOORT J VET, V47, P221
   TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P934, DOI 10.1093/jmedent/31.6.934
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Turell MJ, 2005, J MED ENTOMOL, V42, P891, DOI 10.1603/0022-2585(2005)042[0891:IOVFMD]2.0.CO;2
   Ulloa A, 2003, VECTOR-BORNE ZOONOT, V3, P3, DOI 10.1089/153036603765627406
   Van den Hurk AF, 2001, AM J TROP MED HYG, V64, P125, DOI 10.4269/ajtmh.2001.64.125
   Vazquez A, 2011, AM J TROP MED HYG, V85, P178, DOI 10.4269/ajtmh.2011.11-0042
   Venegas EA, 2012, EMERG INFECT DIS, V18, P516, DOI 10.3201/eid1803.111486
   Venkat H, 2015, MMWR-MORBID MORTAL W, V64, P1349, DOI 10.15585/mmwr.mm6448a5
   Webster LT, 1933, SCIENCE, V78, P463, DOI 10.1126/science.78.2029.463
   WEISS K. E., 1956, ONDERSTEPOORT JOUR VET RES, V27, P183
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Weyer J, 2013, VECTOR-BORNE ZOONOT, V13, P330, DOI 10.1089/vbz.2012.1181
   WHITEHEAD RH, 1968, T ROY SOC TROP MED H, V62, P439, DOI 10.1016/0035-9203(68)90096-5
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Williams DT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004240
   WILLIAMS MC, 1964, ANN TROP MED PARASIT, V58, P367, DOI 10.1080/00034983.1964.11686258
   Williams RAJ, 2012, AFR J MICROBIOL RES, V6, P1966, DOI 10.5897/AJMR11.479
   WOLFE MS, 1982, LANCET, V2, P1306
   Woodroofe GM, 1971, ARBOVIRUSES SEPIK DI, P90
   WOODRUFF AW, 1978, BRIT MED J, V1, P956, DOI 10.1136/bmj.1.6118.956
   WORTH CB, 1961, AM J TROP MED HYG, V10, P583, DOI 10.4269/ajtmh.1961.10.583
   Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 256
TC 7
Z9 7
U1 0
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1040-841X
EI 1549-7828
J9 CRIT REV MICROBIOL
JI Crit. Rev. Microbiol.
PY 2017
VL 43
IS 4
BP 405
EP 422
DI 10.1080/1040841X.2016.1230974
PG 18
WC Microbiology
SC Microbiology
GA EU6HA
UT WOS:000401133900002
PM 27800692
DA 2020-07-08
ER

PT J
AU Bozzo, J
   Jorquera, JI
AF Bozzo, Jordi
   Jorquera, Juan I.
TI Use of human immunoglobulins as an anti-infective treatment: the
   experience so far and their possible re-emerging role
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE Emerging disease; immunoglobulin; infection; outbreak; plasma; serum
ID RESPIRATORY SYNCYTIAL VIRUS; INTRAVENOUS IMMUNE GLOBULIN;
   CLOSTRIDIUM-DIFFICILE DIARRHEA; RENAL-TRANSPLANT RECIPIENTS; CONGO
   HEMORRHAGIC-FEVER; DISSEMINATED ADENOVIRUS INFECTION; ANTIBODY-DEPENDENT
   ENHANCEMENT; TICK-BORNE ENCEPHALITIS; BIRTH-WEIGHT INFANTS; HEPATITIS-A
   VACCINE
AB Introduction: Pooled human immunoglobulins (IGs) are prepared from plasma obtained from healthy donors as a concentrated antibody-containing solution. In addition, high-titer IGs (hyperimmune) against a specific pathogen can be obtained from vaccinated or convalescing donors. Currently, IGs can be used for the treatment of a variety of infections for which no specific therapy exists or that remain difficult to treat. Moreover, the recent pathogen outbreaks for which there is no approved treatment have renewed attention to the role of convalescent plasma and IGs.Areas covered: In this review, a historical perspective of the use of sera and IGs in humans as anti-infective agents (any viral, bacterial, parasitic infection), excluding immunodeficient patients, is presented from early development to the latest clinical studies. A Medline search was conducted to examine the peer-reviewed literature, with no date limits.Expert commentary: Human pooled plasma-derived IG products benefit from the polyclonal response of every individual donor and from the interindividual variability in such response. The trend to increased availability of vaccines for infectious diseases also opens new potential applications of hyperimmune IGs for emerging or re-emerging infectious diseases (e.g.: Ebola, Zika, Dengue), for the prevention and treatment in the general population, healthcare personnel and caregivers.
C1 [Bozzo, Jordi] Grifols, Global Sci & Med Affairs, Avi Generalitat 152-158, Barcelona 08174, Spain.
   [Jorquera, Juan I.] Grifols, Res & Dev, Biosci Ind Grp, Barcelona, Spain.
RP Bozzo, J (corresponding author), Grifols, Global Sci & Med Affairs, Avi Generalitat 152-158, Barcelona 08174, Spain.
EM jordi.bozzo@grifols.com
CR Abougergi Marwan S, 2010, J Hosp Med, V5, pE1, DOI 10.1002/jhm.542
   Agarwal M, 1998, NATL MED J INDIA, V11, P209
   Agostini G, 1992, Clin Ter, V141, P11
   Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Ait-Khaled M, 1998, J INFECT DIS, V177, P1097, DOI 10.1086/517403
   Alexander BT, 2010, PHARMACOTHERAPY, V30, P554, DOI 10.1592/phco.30.6.554
   AlHemsi B, 1996, CLIN TRANSPLANT, V10, P668
   Calvano RA, 2013, ARCH ARGENT PEDIATR, V111, pE24, DOI 10.5546/aap.2013.e24
   AMER J, 1963, PEDIATRICS, V32, P4
   Anderson RD, 2007, CLIN TRANSPLANT, V21, P510, DOI 10.1111/j.1399-0012.2007.00678.x
   [Anonymous], 2015, WHO MODEL LIST ESSEN
   Arabi YM, 2016, EMERG INFECT DIS, V22, P1554, DOI 10.3201/eid2209.151164
   Arkilo D, 2014, J CHILD NEUROL, V29, P564, DOI 10.1177/0883073813480242
   Armstrong S, 1895, POPULAR SCI, VXLVI, P512
   Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926
   Attilakos A, 2008, PEDIATR NEUROL, V38, P357, DOI 10.1016/j.pediatrneurol.2008.01.003
   Babes V, 1891, ANN I PASTEUS, V10, P630
   BABES V, 1889, ANN I PASTEUR, V3, P385
   Balakrishna K, 2014, J APPL MICROBIOL, V116, P1465, DOI 10.1111/jam.12465
   BARANDUN S, 1962, VOX SANG, V7, P157, DOI 10.1111/j.1423-0410.1962.tb03240.x
   Beales ILP, 2002, GUT, V51, P456, DOI 10.1136/gut.51.3.456
   Bebbington C, 2008, CURR OPIN BIOTECH, V19, P613, DOI 10.1016/j.copbio.2008.10.002
   BEHRING E, 1892, Z HYG, V12, P10
   Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870
   Ben-Nathan D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-18
   BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6
   Bloom B, 2005, PEDIATR INFECT DIS J, V24, P858, DOI 10.1097/01.inf.0000180504.66437.1f
   Bressan S, 2011, ACTA PAEDIATR, V100, pE238, DOI 10.1111/j.1651-2227.2011.02342.x
   Briassoulis G, 2000, PEDIATR CARDIOL, V21, P391, DOI 10.1007/s002460010090
   Bruss JB, 1999, CLIN DIAGN LAB IMMUN, V6, P464, DOI 10.1128/CDLI.6.4.464-470.1999
   Bruss JB, 1999, PEDIATR INFECT DIS J, V18, P505, DOI 10.1097/00006454-199906000-00006
   Buda S, 2005, J CARDIOTHOR VASC AN, V19, P440, DOI 10.1053/j.jvca.2005.05.003
   Burnouf T, 2016, VOX SANG, V111, P456, DOI 10.1111/vox.12445
   CABASSO VJ, 1971, B WORLD HEALTH ORGAN, V45, P303
   Cao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064024
   Cao RY, 2011, J CLIN VIROL, V51, P242, DOI 10.1016/j.jcv.2011.05.002
   Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516
   CENCI F, 1907, RIV CLIN PEDIATR, V5, P1017
   Chaichana P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092173
   Chandrasekar T, 2008, CLIN KIDNEY J, V1, P20, DOI 10.1093/ndtplus/sfm008
   Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9
   Chong JL, 2011, J MICROBIOL IMMUNOL, V44, P319, DOI 10.1016/j.jmii.2010.07.001
   COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034
   COHN EJ, 1945, SCIENCE, V101, P51, DOI 10.1126/science.101.2612.51
   Cohn EJ, 1944, J CLIN INVEST, V23, P417, DOI 10.1172/JCI101508
   Cohn EJ, 1940, J AM CHEM SOC, V62, P3396, DOI 10.1021/ja01869a032
   Condie R M, 1984, Birth Defects Orig Artic Ser, V20, P327
   Connor E, 1997, PEDIATRICS, V99, P93
   Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381
   CRAWFORD RJ, 1980, J CLIN PATHOL, V33, P180, DOI 10.1136/jcp.33.2.180
   Cross AS, 1995, ADV EXP MED BIOL, V383, P123
   CUMMINS LM, 1991, BLOOD, V77, P1111
   Czer LSC, 2011, TRANSPL P, V43, P1887, DOI 10.1016/j.transproceed.2011.01.189
   Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejonge M, 2007, J PEDIATR-US, V151, P260, DOI 10.1016/j.jpeds.2007.04.060
   Douzinas EE, 2000, CRIT CARE MED, V28, P8, DOI 10.1097/00003246-200001000-00002
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   DUHEM C, 1994, CLIN EXP IMMUNOL, V97, P79
   Ehrlich P, 1891, DEUT MED WOCHENSCHR, V17, P976, DOI DOI 10.1055/S-0029-1206682
   Ehrlich P, 1894, DEUT MED WOCHENSCHR, V20, P353
   EHRLICH P, 1891, DEUT MED WOCHENSCHR, V17, P1218, DOI DOI 10.1055/S-0029-1206825
   Elsterova J, 2017, TICKS TICK-BORNE DIS, V8, P253, DOI 10.1016/j.ttbdis.2016.11.007
   EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541
   Emovon OE, 2003, NEPHROL DIAL TRANSPL, V18, P2436, DOI 10.1093/ndt/gfg365
   Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010
   Enserink M, 2002, SCIENCE, V295, P777
   FANAROFF AA, 1994, NEW ENGL J MED, V330, P1107, DOI 10.1056/NEJM199404213301602
   Forrat R, 1998, ANTIMICROB AGENTS CH, V42, P298
   FRAME JD, 1984, T ROY SOC TROP MED H, V78, P319, DOI 10.1016/0035-9203(84)90107-X
   Fried AJ, 2009, CLIN MICROBIOL REV, V22, P396, DOI 10.1128/CMR.00001-09
   Gacouin A, 1999, EUR J CLIN MICROBIOL, V18, P233, DOI 10.1007/s100960050269
   GARCES H, 1954, Rev Chil Pediatr, V25, P109
   Garcia A, 2015, RECENT PATENTS INFLA, V9, P31, DOI 10.2174/1872213X09666150223114226
   GELLIS SS, 1945, JAMA-J AM MED ASSOC, V128, P1062, DOI 10.1001/jama.1945.02860320004002
   Gibson RB, 1906, J BIOL CHEM, V1, P161
   GOKALP AS, 1994, CLIN PEDIATR, V33, P349, DOI 10.1177/000992289403300607
   Gorantala J, 2014, J BIOTECHNOL, V176, P1, DOI 10.1016/j.jbiotec.2014.01.033
   Gordon CL, 2011, CLIN INFECT DIS, V52, P421, DOI 10.1093/cid/ciq082
   Gouveia FL, 2013, BRAZ J PHARM SCI, V49, P821, DOI 10.1590/S1984-82502013000400022
   GRANSTROM M, 1991, LANCET, V338, P1230, DOI 10.1016/0140-6736(91)92101-7
   GRIFOLSLUCAS JA, 1952, BRIT MED J, V1, P854, DOI 10.1136/bmj.1.4763.854
   GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102
   Grover Shilpa, 2007, MedGenMed, V9, P46
   Gulland A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5539
   Gupta N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069390
   Gysin J, 1996, RES IMMUNOL, V147, P397, DOI 10.1016/0923-2494(96)82048-7
   Halperin SA, 2007, PEDIATR INFECT DIS J, V26, P79, DOI 10.1097/01.inf.0000247103.01075.cc
   HAMMON WM, 1952, JAMA-J AM MED ASSOC, V150, P739, DOI 10.1001/jama.1952.03680080001001
   HAMMON WM, 1952, JAMA-J AM MED ASSOC, V150, P750, DOI 10.1001/jama.1952.03680080012002
   HAMMON WM, 1952, JAMA-J AM MED ASSOC, V150, P757, DOI 10.1001/jama.1952.03680080019003
   Han XH, 2012, J MED MICROBIOL, V61, P426, DOI 10.1099/jmm.0.030098-0
   HAVENS WP, 1945, JAMA-J AM MED ASSOC, V129, P270, DOI 10.1001/jama.1945.02860380028008
   Heidelberger M, 1937, J EXP MED, V65, P393, DOI 10.1084/jem.65.3.393
   HEMMING VG, 1987, ANTIMICROB AGENTS CH, V31, P1882, DOI 10.1128/AAC.31.12.1882
   HEMMING VG, 1985, J INFECT DIS, V152, P1083, DOI 10.1093/infdis/152.5.1083
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Hendricks Katherine A, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2002.130687
   Huang YC, 2001, EUR J PEDIATR, V160, P91, DOI 10.1007/s004310000640
   Hung IEN, 2013, CHEST, V144, P464, DOI 10.1378/chest.12-2907
   Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106
   ICHIMARU T, 1993, ACTA PAEDIATR, V82, P1076, DOI 10.1111/j.1651-2227.1993.tb12817.x
   IGARASHI A, 1971, BIKEN J, V14, P353
   Jenson HB, 1997, PEDIATRICS, V99, pE21, DOI 10.1542/peds.99.2.e2
   Jorda FD, 1939, LANCET, V1, P773
   Juang P, 2007, AM J INFECT CONTROL, V35, P131, DOI 10.1016/j.ajic.2006.06.007
   Kalimuddin S, 2013, J CLIN VIROL, V56, P37, DOI 10.1016/j.jcv.2012.10.005
   Karelitz S, 1938, AM J DIS CHILD, V55, P768
   KARK JD, 1982, J EPIDEMIOL COMMUN H, V36, P176, DOI 10.1136/jech.36.3.176
   KARK JD, 1983, SCAND J INFECT DIS, V15, P3, DOI 10.3109/inf.1983.15.issue-1.01
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000
   KEMPE CH, 1961, B WORLD HEALTH ORGAN, V25, P41
   Kerensky T, 2013, TRANSPL P, V45, P293, DOI 10.1016/j.transproceed.2012.06.059
   King SM, 1997, CLIN INFECT DIS, V25, P1173, DOI 10.1086/516095
   Kong L K, 2006, Hong Kong Med J, V12, P489
   Koulaouzidis A, 2008, J GASTROINTEST LIVER, V17, P353
   Kreyrnann KG, 2007, CRIT CARE MED, V35, P2677, DOI 10.1097/01.CCM.0000295263.12774.97
   Kubar A, 2011, JPN J INFECT DIS, V64, P439
   Kudoyarova-Zubavichene NM, 1999, J INFECT DIS, V179, pS218, DOI 10.1086/514294
   Lachmann RA, 2004, EXP LUNG RES, V30, P251, DOI 10.1080/01902140490439013
   Lambert JS, 1997, J INFECT DIS, V175, P283, DOI 10.1093/infdis/175.2.283
   LERMAN Y, 1993, CLIN INFECT DIS, V17, P411, DOI 10.1093/clinids/17.3.411
   Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139
   MAIZTEGUI JI, 1979, LANCET, V2, P1216
   Makam SS, 2014, MOL IMMUNOL, V59, P91, DOI 10.1016/j.molimm.2014.01.012
   Marzano A, 2010, MINERVA MED, V101, P373
   MASCI S, 1995, IMMUNOPHARM IMMUNOT, V17, P33, DOI 10.3109/08923979509052718
   McPherson S, 2006, DIS COLON RECTUM, V49, P640, DOI 10.1007/s10350-006-0511-8
   MEYERS JD, 1983, ANN INTERN MED, V98, P442, DOI 10.7326/0003-4819-98-4-442
   MOFENSON LM, 1994, PEDIATR INFECT DIS J, V13, P477, DOI 10.1097/00006454-199406000-00003
   MOZEN MM, 1980, ARZNEIMITTEL-FORSCH, V30-2, P1484
   Murphy C, 2006, AGE AGEING, V35, P85, DOI 10.1093/ageing/afi212
   Mytle N, 2013, ANTIMICROB AGENTS CH, V57, P5684, DOI 10.1128/AAC.00458-13
   NAGINGTON J, 1983, LANCET, V2, P443
   NEEFE JR, 1945, JAMA-J AM MED ASSOC, V128, P1063, DOI 10.1001/jama.1945.02860320005003
   Neilson AR, 2005, J CRIT CARE, V20, P239, DOI 10.1016/j.jcrc.2005.03.003
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   Ohlsson A, 2000, COCHRANE DB SYST REV, V2
   Olivieri BP, 2010, PARASITE IMMUNOL, V32, P464, DOI 10.1111/j.1365-3024.2010.01212.x
   Onyango-Makumbi C, 2011, JAIDS-J ACQ IMM DEF, V58, P399, DOI 10.1097/QAI.0b013e31822f8914
   Park IH, 2012, KOREAN CIRC J, V42, P709, DOI 10.4070/kcj.2012.42.10.709
   Park UJ, 2015, TRANSPL P, V47, P791, DOI 10.1016/j.transproceed.2014.11.054
   Passi D, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.199641
   PILZ G, 1994, CHEST, V105, P76, DOI 10.1378/chest.105.1.76
   Planitzer CB, 2007, J INFECT DIS, V196, P435, DOI 10.1086/519392
   Price H, 2012, PRODUCTION PLASMA PR, P207
   PRINCE GA, 1985, VIRUS RES, V3, P193, DOI 10.1016/0168-1702(85)90045-0
   Randhawa P, 2015, AM J TRANSPLANT, V15, P1014, DOI 10.1111/ajt.13083
   REED EC, 1988, ANN INTERN MED, V109, P783, DOI 10.7326/0003-4819-109-10-783
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Rodriguez A, 2005, SHOCK, V23, P298, DOI 10.1097/01.shk.0000157302.69125.f8
   Rodriguez WJ, 1997, PEDIATRICS, V100, P937, DOI 10.1542/peds.100.6.937
   Rodriguez WJ, 1997, PEDIATRICS, V99, P454, DOI 10.1542/peds.99.3.454
   Roux E., 1888, ANN I PASTEUR, V2, P629
   Roux ME, 1894, J COMP PATHOLOGY THE, V7, P332
   Ruzek D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-306
   SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297
   Saenz-Farret M, 2017, CLIN NEUROPHARMACOL, V40, P43, DOI 10.1097/WNF.0000000000000195
   Salehi H, 2013, J RES MED SCI, V18, P497
   Salliot C, 2006, SCAND J INFECT DIS, V38, P192, DOI 10.1080/00365540500388776
   Sandberg K, 2000, J PEDIATR-US, V137, P623, DOI 10.1067/mpd.2000.109791
   Sanna PP, 2000, J VIROL, V74, P9813, DOI 10.1128/JVI.74.21.9813-9817.2000
   Saquib R, 2010, TRANSPL INFECT DIS, V12, P77, DOI 10.1111/j.1399-3062.2009.00452.x
   SCHEDEL I, 1991, CRIT CARE MED, V19, P1104, DOI 10.1097/00003246-199109000-00003
   Sechet A, 2002, TRANSPLANT P, V34, P812, DOI 10.1016/S0041-1345(01)02920-7
   SENNEVILLE E, 1990, PATHOL BIOL, V38, P568
   SHIRKEY HC, 1965, J PEDIATR-US, V67, P643, DOI 10.1016/S0022-3476(65)80436-X
   SHOUVAL D, 1993, J HEPATOL, V18, pS32, DOI 10.1016/S0168-8278(05)80375-7
   Singham J, 2010, ANN HEPATOL, V9, P166, DOI 10.1016/S1665-2681(19)31656-4
   SNYDMAN DR, 1987, NEW ENGL J MED, V317, P1049, DOI 10.1056/NEJM198710223171703
   SPECTOR SA, 1994, NEW ENGL J MED, V331, P1181, DOI 10.1056/NEJM199411033311802
   Steen JA, 1960, ARCH PEDIATR, V77, P291
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiehm ER, 2000, J INFECT DIS, V181, P548, DOI 10.1086/315224
   Stiehm ER, 1999, J INFECT DIS, V179, P567, DOI 10.1086/314637
   Takada A, 2003, J VIROL, V77, P7539, DOI 10.1128/JVI.77.13.7539-7544.2003
   TAYLOR TE, 1992, CLIN EXP IMMUNOL, V90, P357, DOI 10.1111/j.1365-2249.1992.tb05851.x
   Tezer H, 2008, TURKISH J PEDIATR, V50, P585
   Tiselius A, 1938, SCIENCE, V87, P416, DOI 10.1126/science.87.2262.416-a
   van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812
   Vani J, 2008, AUTOIMMUN REV, V7, P440, DOI 10.1016/j.autrev.2008.04.011
   VASSILENKO SM, 1990, LANCET, V335, P791, DOI 10.1016/0140-6736(90)90906-L
   Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546
   VONBEHRING E, 1890, DEUT MED WOCHENSCHR, V16, P1113, DOI DOI 10.1055/S-0029-1207589
   Walsh JJ, 2007, CLIN INFECT DIS, V44, P968, DOI 10.1086/512372
   WEISMAN LE, 1992, J PEDIATR-US, V121, P434, DOI 10.1016/S0022-3476(05)81802-5
   Werdan K, 2007, CRIT CARE MED, V35, P2693, DOI 10.1097/01.CCM.0000295426.37471.79
   Wever PC, 2012, MED HUMANIT, V38, P78, DOI 10.1136/medhum-2011-010157
   Wilcox MH, 2004, J ANTIMICROB CHEMOTH, V53, P882, DOI 10.1093/jac/dkh176
   Winkler AM, 2015, CURR OPIN HEMATOL, V22, P521, DOI 10.1097/MOH.0000000000000191
   Wolff-Eisner A, 1910, HDB SERUMTHERAPIE EX, V1
   Wong HK, 2010, TRANSFUSION, V50, P1967, DOI 10.1111/j.1537-2995.2010.02651.x
   WOODSON RD, 1969, J AMER MED ASSOC, V209, P1053, DOI 10.1001/jama.209.7.1053
   Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346
   ZAAIJER HL, 1993, J MED VIROL, V40, P22, DOI 10.1002/jmv.1890400106
NR 196
TC 5
Z9 5
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PY 2017
VL 15
IS 6
BP 585
EP 604
DI 10.1080/14787210.2017.1328278
PG 20
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA EV1RS
UT WOS:000401524600007
PM 28480779
DA 2020-07-08
ER

PT J
AU Gruber, MF
   Krause, PR
AF Gruber, Marion F.
   Krause, Philip R.
TI Regulating vaccines at the FDA: development and licensure of Zika
   vaccines
SO EXPERT REVIEW OF VACCINES
LA English
DT Editorial Material
DE Accelerated approval; animal rule; immune response; infectious disease;
   licensure pathways; surrogate marker; US FDA; vaccine development; Zika;
   vaccine approval process
C1 [Gruber, Marion F.; Krause, Philip R.] US FDA, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Bldg 71,Rm 3230,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.
RP Gruber, MF (corresponding author), US FDA, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Bldg 71,Rm 3230,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.
EM marion.gruber@fda.hhs.gov
CR [Anonymous], 2017, GUIDANCE IND EMERGEN
   [Anonymous], 2011, GUIDANCE IND GEN PRI
   [Anonymous], 2015, GUIDANCE IND PRODUCT
   [Anonymous], 2016, GUIDANCE IND EXPANDE
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
NR 5
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PY 2017
VL 16
IS 6
BP 525
EP 527
DI 10.1080/14760584.2017.1324304
PG 3
WC Immunology
SC Immunology
GA EV0NN
UT WOS:000401437800001
PM 28447498
OA Bronze
DA 2020-07-08
ER

PT J
AU Bahado-Singh, RO
   Citil-Dogan, A
   Wayne, S
   Bauer, S
   Ogunyemi, D
   Kulkarni, SK
   Maulik, D
   Carpenter, CF
AF Bahado-Singh, R. O.
   Citil-Dogan, A.
   Wayne, S.
   Bauer, S.
   Ogunyemi, D.
   Kulkarni, S. K.
   Maulik, D.
   Carpenter, C. F.
TI Zika virus and pregnancy REPLY
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Editorial Material
C1 [Bahado-Singh, R. O.; Citil-Dogan, A.; Wayne, S.; Bauer, S.; Ogunyemi, D.; Carpenter, C. F.] Oakland Univ, William Beaumont Sch Med, Rochester, MN 48309 USA.
   [Kulkarni, S. K.] Univ West Indies, Jamaica, NY USA.
   [Maulik, D.] Childrens Mercy Hosp & Cllin, Kansas City, MO USA.
RP Citil-Dogan, A (corresponding author), Oakland Univ, William Beaumont Sch Med, Rochester, MN 48309 USA.
EM ayse.citil-dogan@beaumont.org
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PY 2017
VL 30
IS 13
BP 1539
EP 1539
DI 10.1080/14767058.2016.1199295
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EV1DN
UT WOS:000401486600006
PM 27285308
DA 2020-07-08
ER

PT J
AU Musso, D
   Aubry, M
   Broult, J
   Stassinopoulos, A
   Green, J
AF Musso, Didier
   Aubry, Maite
   Broult, Julien
   Stassinopoulos, Adonis
   Green, Jennifer
TI Zika virus: new emergencies, potential for severe complications, and
   prevention of transfusion-transmitted Zika fever in the context of
   co-circulation of arboviruses
SO BLOOD TRANSFUSION
LA English
DT Letter
C1 [Musso, Didier; Aubry, Maite] Inst Louis Malarde, Unit Emerging Infect Dis, POB 98713, Tahiti, Fr Polynesia, France.
   [Broult, Julien] Taone Hosp, Blood Ctr, Pirae, Fr Polynesia, France.
   [Stassinopoulos, Adonis; Green, Jennifer] Cerus Corp, Global Sci Affairs, San Francisco, CA USA.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, POB 98713, Tahiti, Fr Polynesia, France.
EM dmusso@ilm.pf
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Aubry, Maite/0000-0002-9913-5794
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Gallian P, 2015, TRANSFUSION, V55, p17A
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
NR 6
TC 12
Z9 12
U1 0
U2 1
PU SIMTI SERVIZI SRL
PI MILAN
PA VIA DESIDERIO 21, MILAN, 20131, ITALY
SN 1723-2007
J9 BLOOD TRANSFUS-ITALY
JI Blood Transf.
PY 2017
VL 15
IS 3
BP 272
EP 273
DI 10.2450/2016.0003-16
PG 2
WC Hematology
SC Hematology
GA EU0EO
UT WOS:000400682100013
PM 27177409
DA 2020-07-08
ER

PT J
AU Hou, WJ
   Li, CX
   Dong, YD
   Xing, D
   Zhang, YM
   Zhang, HD
   Shi, QM
   Guo, XX
   Zhao, TY
AF Hou, Wenjun
   Li, Chunxiao
   Dong, Yande
   Xing, Dan
   Zhang, Yingmei
   Zhang, Hengduan
   Shi, Qingming
   Guo, Xiaoxia
   Zhao, Tongyan
TI An alternating passage model between mosquitoes and rodents for a
   genetic study of Japanese encephalitis virus (JEV)
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
LA English
DT Article
DE Japanese encephalitis virus (JEV); SA14; alternating passage;
   experimental model; genetic mutation
ID IN-VITRO; EPIDEMIOLOGY; ADAPTATION; INFECTION; CELLS; SWINE
AB To set up an alternating model between Culex tritaeniorhynchus and Kunming neonatal rats for determining the genomic evolution of Japanese encephalitis virus (JEV). A sequencing analysis of the JEV-SA14 strain was conducted in the rat brain. After 14 cycles of alternate passages, JEV-RNA showed a relatively high mutation rate in the nucleotides over the entire coding genome, and most of the mutations were single synonymous nucleotide substitutions without amino acid changes. Neither insertions nor deletions were observed. In particular, the viral regions involved in viral infectivity and immunogenicity were well conserved. JEV-SA14 has a relatively stable genetic mutation pattern, and the alternating model is useful for laboratory studies on the evolution of JEV, as well as for other arboviruses, such as the Zika virus.
C1 [Hou, Wenjun; Li, Chunxiao; Dong, Yande; Xing, Dan; Zhang, Yingmei; Zhang, Hengduan; Shi, Qingming; Guo, Xiaoxia; Zhao, Tongyan] Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Dept Vector Biol & Control, 20 Dongda Rd, Beijing 100071, Peoples R China.
   [Hou, Wenjun] Ctr Dis Prevent & Control Chinese Peoples Armed P, Beijing 102613, Peoples R China.
RP Guo, XX; Zhao, TY (corresponding author), Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Dept Vector Biol & Control, 20 Dongda Rd, Beijing 100071, Peoples R China.
EM guoxx99@163.com; tongyanzhao@126.com
FU Infective Diseases Prevention and Cure Project of China [2012ZX10004219]
FX This study was supported by the Infective Diseases Prevention and Cure
   Project of China (No. 2012ZX10004219).
CR Cai YH, 2015, INT J MOL SCI, V16, P2204, DOI 10.3390/ijms16012204
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Chen Ning, 2013, Bing Du Xue Bao, V29, P457
   de Wispelaere M, 2016, J VIROL, V90, P2676, DOI 10.1128/JVI.01176-15
   Fan JM, 2010, VIRUS GENES, V40, P357, DOI 10.1007/s11262-010-0464-9
   Gao XY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0270-z
   Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005
   Hemmerter S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-100
   Le Flohic G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002208
   Li C, 2014, ARCH VIROL, V159, P1045, DOI 10.1007/s00705-013-1925-y
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   McCurdy K, 2011, VIROLOGY, V415, P20, DOI 10.1016/j.virol.2011.03.030
   NI HL, 1995, J GEN VIROL, V76, P409, DOI 10.1099/0022-1317-76-2-409
   Schuh AJ, 2014, J VIROL, V88, P4522, DOI 10.1128/JVI.02686-13
   Su CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003122
   Tang WF, 2010, INFECT GENET EVOL, V10, P329, DOI 10.1016/j.meegid.2009.12.005
   TAYLOR WP, 1975, J GEN VIROL, V28, P59, DOI 10.1099/0022-1317-28-1-59
   Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Yang D, 2014, VACCINE, V32, P2675, DOI 10.1016/j.vaccine.2014.03.074
NR 22
TC 0
Z9 0
U1 0
U2 1
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1936-2625
J9 INT J CLIN EXP PATHO
JI Int. J. Clin. Exp. Pathol.
PY 2017
VL 10
IS 4
BP 4719
EP 4728
PG 10
WC Oncology; Pathology
SC Oncology; Pathology
GA ET8LF
UT WOS:000400550200081
DA 2020-07-08
ER

PT S
AU de Camargo, JTF
   de Camargo, EAF
   Veraszto, EV
   Barreto, G
   Aceti, PAZ
   Salvi, A
AF Franco de Camargo, Jose Tarcisio
   Franco de Camargo, Eliana Anunciato
   Veraszto, Estefano Vizconde
   Barreto, Gilmar
   Zibordi Aceti, Patricia Aparecida
   Salvi Junior, Ademir
BE Ginters, E
   Kohlhammer, J
TI Information Technology and Public Health: Possibilities for Innovation
   through Interdisciplinary Actions
SO ICTE 2016
SE Procedia Computer Science
LA English
DT Proceedings Paper
CT ICTE Conference
CY 2016
CL Riga Tech Univ, Riga, LATVIA
HO Riga Tech Univ
DE System design; Environmental monitoring; Interdisciplinary research
AB The new technologies of information and communication permeate our daily lives in various contexts. This reality allows us to reflect on the use of technology as a mechanism for the development of innovative solutions to various problems affecting society. In this sense, this work presents some tools that contribute to the solution of a serious public health problem, common in tropical countries: the monitoring of breeding sites of the Aedes aegypti mosquito larvae, vector of diseases such as dengue, Zika virus, yellow fever and Chikungunya fever. In its larval stage, this mosquito uses containers with stagnant water as breeding sites. The localization and elimination of breeding sites, together with the guidance to the population, is an effective way to combat mosquitoes and reduce the number of cases of infected individuals. To do so, it was developed and made available to the population in general, a set of technological tools, based on "apps" for smartphones, through which anyone can indicate breeding sites of mosquito larvae. In addition to an app for the geographic markup of breeding sites, there is also another app and a website that allows everyone to view the marked sites, making it possible to build a geographic representation for the distribution of Aedes larvae breeding sites. In a pilot test, it was possible to verify that the use of new technologies in controlling and monitoring of insects that are considered vectors of diseases is significantly efficient. It was generated a considerable volume of information that enables the development of control strategies and actions to combat the vector in question by the competent authorities. Also, this pilot test involved a large number of persons: undergraduate students and teachers from information technology and health areas, public professionals that are responsible for epidemiological monitoring and the population in general. Indirectly, the implementation of these technological tools promoted the interdisciplinary integration among teachers and students in the areas of information technology and public health in a Brazilian university. Similarly, the project also integrated university, population and the government around the purpose of controlling the advancement of diseases that have caused severe negative impacts on society. It was concluded that the rational use of new technologies, pointing towards solving problems that affect society, is able to provide innovative solutions, promoting the construction of interdisciplinary actions in education, integrating different areas of knowledge and these with competent agencies and society in general. (C) 2017 The Authors. Published by Elsevier B.V.
C1 [Franco de Camargo, Jose Tarcisio; Franco de Camargo, Eliana Anunciato; Zibordi Aceti, Patricia Aparecida; Salvi Junior, Ademir] Ctr Reg Univ ES do Pinhal UNIPINHAL, Ave Helio V Leite S-N, BR-13890000 Es Do Pinhal, SP, Brazil.
   [Veraszto, Estefano Vizconde] Univ Fed Sao Carlos UFSCar, Rodovia Anhanguera,Km 174, BR-13604900 Araras, SP, Brazil.
   [Barreto, Gilmar] Univ Estadual Campinas UNICAMP, Ave Albert Einstein 400, BR-13083852 Campinas, SP, Brazil.
RP de Camargo, JTF (corresponding author), Ctr Reg Univ ES do Pinhal UNIPINHAL, Ave Helio V Leite S-N, BR-13890000 Es Do Pinhal, SP, Brazil.
EM jtfc@bol.com.br; eafcamargo@yahoo.com.br; estefanovv@gmail.com;
   gbarreto@dsif.fee.unicamp.br; patriciazibordi@uol.com.br;
   salvi_fcfar@yahoo.com.br
RI Veraszto, Estefano Vizconde/AAI-5466-2020; Veraszto, Estefano
   V/B-9749-2014; Camargo, Jose/P-5464-2016
OI Veraszto, Estefano Vizconde/0000-0002-4029-4803; Veraszto, Estefano
   V/0000-0002-4029-4803; Camargo, Jose/0000-0001-5451-4494
FU Regional Universitary Center of Espirito Santo do Pinhal, UNIPINHAL
FX This project was fully supported by the Regional Universitary Center of
   Espirito Santo do Pinhal, UNIPINHAL.
CR Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Brassolatti Rejane Cristina, 2002, Ciênc. saúde coletiva, V7, P243, DOI 10.1590/S1413-81232002000200005
   Follari RA, 1995, INTERDISCIPLINARITY, P204
   Forattini OP, 2003, REV SAUDE PUBL, V37, P676, DOI 10.1590/S0034-89102003000500021
   Free C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001363
   Kahn JG, 2010, HEALTH AFFAIR, V29, P254, DOI 10.1377/hlthaff.2009.0965
   Madeira Newton G., 2002, Rev. Soc. Bras. Med. Trop., V35, P221, DOI 10.1590/S0037-86822002000300004
   Piaget J., 1988, OU VA L ED, P116
   Santos-Gouw AM, DENGUE SCH CONTRIBUT
   Sommerman A, 2005, P 10 INT SEM ED CACH
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
NR 12
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-0509
J9 PROCEDIA COMPUT SCI
PY 2017
VL 104
BP 294
EP 301
DI 10.1016/j.procs.2017.01.138
PG 8
WC Computer Science, Theory & Methods
SC Computer Science
GA BH2XY
UT WOS:000399478800040
OA Other Gold
DA 2020-07-08
ER

PT J
AU Meireles, JFF
   Neves, CM
   Morgado, FFD
   Ferreira, MEC
AF Filgueiras Meireles, Juliana Fernandes
   Neves, Clara Mockdece
   da Rocha Morgado, Fabiane Frota
   Caputo Ferreira, Maria Elisa
TI Zika virus and pregnant women: A psychological approach
SO PSYCHOLOGY & HEALTH
LA English
DT Article
DE Zika virus; pregnancy; fetus; transmission; microcephaly; wellbeing
ID INTERIM GUIDELINES; UNITED-STATES
AB Zika virus presents risk of physical harm to pregnant women, but the fear of infection is also affecting women around the world. There is a gap in the research on Zika virus in the areas involving the impact on the psychosocial well-being of pregnant women. Therefore, this study is aimed at the investigation of the psychosocial adjustment of pregnant women to the risks of Zika virus infection during pregnancy. We investigated 14 pregnant women who were classified in three different groups: six in the first trimester, five in the second trimester and three in the third trimester, aged from 28 to 40years (33.43 +/- 3.76years). Content analysis was used to interpret data. Our results show that the psychosocial adjustment of participants was significantly negative and included five aspects: (1) negative feelings, (2) changes in family planning, (3) adopting new customs (avoiding places of risk, use of specific clothes and use of repellent), (4) changed attitudes regarding body image and (5) feeling of external demand regarding prevention. The fear of Zika virus infection and all its associated risks have a negative biopsychosocial impact on the pregnant women in this study.
C1 [Filgueiras Meireles, Juliana Fernandes; Neves, Clara Mockdece; Caputo Ferreira, Maria Elisa] Univ Fed Juiz de Fora, Psychol Postgrad Program, Juiz De Fora, Brazil.
   [da Rocha Morgado, Fabiane Frota] Rural Fed Univ Rio de Janeiro, Fac Phys Educ, Rio De Janeiro, Brazil.
RP Meireles, JFF (corresponding author), Univ Fed Juiz de Fora, Psychol Postgrad Program, Juiz De Fora, Brazil.
EM eujuly90@hotmail.com
RI Neves, Clara Mockdece/P-2412-2018; Ferreira, Maria Elisa
   Caputo/D-3496-2019
OI Neves, Clara Mockdece/0000-0002-5240-6710; Ferreira, Maria Elisa
   Caputo/0000-0002-3294-7560
CR American Psychiatric Association, 2014, DIAGN STAT MAN MENT
   Araújo Daniele Marano Rocha, 2008, Rev. Bras. Saude Mater. Infant., V8, P333, DOI 10.1590/S1519-38292008000300013
   Bardin L., 2011, ANALISE CONTEUDO
   Brasil. Ministerio da Saude, 2012, GEST ALT RISC MAN TE
   Brasil. Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Acoes Programaticas Estrategicas, 2005, MAN TECN PREN PUERP
   Brazil, 2016, 55 CTR OP EM SAUD PU
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Cairolli PB, 2009, THESIS
   Cash T. F., 2011, BODY IMAGE HDB SCI P
   Centers for Disease Control and Prevention, 2016, PREV INF PREGN
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Ferreira M. E. C., 2014, IMAGEM CORPORAL REFL
   Meireles JFF, 2015, CIENC SAUDE COLETIVA, V20, P2091, DOI 10.1590/1413-81232015207.05502014
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Meireles Juliana Fernandes Filgueiras, 2016, J. bras. psiquiatr., V65, P223, DOI 10.1590/0047-2085000000128
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Safadi MAP, 2017, PEDIATR INFECT DIS J, V36, P333, DOI 10.1097/INF.0000000000001449
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Santiago Leonéa Vitória, 2012, Rev. bras. educ. fís. esporte, V26, P627, DOI 10.1590/S1807-55092012000400008
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sweeney AC, 2013, JOGNN-J OBST GYN NEO, V42, P551, DOI 10.1111/1552-6909.12236
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Venturi G, 2016, EUROSURVEILLANCE, V21, P1
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Watson B, 2015, BODY IMAGE, V14, P102, DOI 10.1016/j.bodyim.2015.04.005
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 32
TC 1
Z9 1
U1 1
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0887-0446
EI 1476-8321
J9 PSYCHOL HEALTH
JI Psychol. Health
PY 2017
VL 32
IS 7
BP 798
EP 809
DI 10.1080/08870446.2017.1307369
PG 12
WC Public, Environmental & Occupational Health; Psychology,
   Multidisciplinary
SC Public, Environmental & Occupational Health; Psychology
GA ET6MN
UT WOS:000400405900003
PM 28343414
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika Virus Infection In Cancerous Patient
SO INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Dr DY Patil Univ, Dept Community Med, Bombay, Maharashtra, India.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Dept Med Sci, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayo Babalola Univ, Dept Biol Sci, Ikeji Arakeji, Osun State, Nigeria.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Dept Trop Med, Haikou, Peoples R China.
EM virojwiwan@hotmail.com
CR Bahl A, 2011, PEDIATR BLOOD CANCER, V57, P1249, DOI 10.1002/pbc.23229
   Hepner Adriana, 2016, J Glob Oncol, V2, P250, DOI 10.1200/JGO.2016.003533
NR 2
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0971-5851
EI 0975-2129
J9 INDIAN J MED PAEDIAT
JI Indian J. Med. Paediatr. Oncol.
PD JAN-MAR
PY 2017
VL 38
IS 1
BP 94
EP 95
DI 10.4103/ijmpo.ijmpo_191_16
PG 2
WC Oncology
SC Oncology
GA ES6NA
UT WOS:000399663900025
PM 28469351
OA Green Published
DA 2020-07-08
ER

PT J
AU Larson, RB
AF Larson, Rhett B.
TI LAW IN THE TIME OF CHOLERA
SO NOTRE DAME LAW REVIEW
LA English
DT Article
ID WEST-NILE-VIRUS; DISINFECTION BY-PRODUCTS; PUBLIC TRUST DOCTRINE;
   SENEGAL RIVER-BASIN; DRINKING-WATER; INFECTIOUS-DISEASE;
   MICROBIAL-CONTAMINATION; PRECAUTIONARY PRINCIPLE; ENVIRONMENTAL-LAW;
   CLIMATE-CHANGE
AB Thousands die each day from infections related to water, as evidenced in the ongoing crises of cholera in Haiti, Zika in the Western Hemisphere, and Legionnaires' Disease in Flint, Michigan. Yet water law focuses primarily on two agendas. First, the "Blue Agenda" aims to provide an equitable allocation of water to individuals and communities while encouraging sustainable water management. Second, the "Green Agenda" aims to efficiently protect water in the natural environment from pollution. These two agendas often ignore, and can be inconsistent with, the "Red Agenda." The Red Agenda addresses prevention of waterborne infections, like cholera, and the habitat of water-related disease vectors, like mosquitoes transmitting malaria. Additionally, the Red Agenda focuses on access to water for sanitation and hygiene, with implications for epidemics like Ebola. In simplified terms, the Blue Agenda is about water quantity, the Green Agenda about water quality, and the Red Agenda about water diseases. Laws made in pursuit of the Blue Agenda, like building a dam or irrigation system, can interfere with the Red Agenda by bringing mosquito habitat closer to human communities. And laws made in the pursuit of the Green Agenda, like prohibiting discharges of pesticides into a river, can interfere with the Red Agenda by preventing a response to a malaria outbreak. This Article is the first to introduce the Blue, Green, and Red framework for water law, and explains why these agendas often conflict with each other and how to more effectively integrate these agendas into water law.
C1 [Larson, Rhett B.] Arizona State Univ, Law, Sandra Day OConnor Coll Law, Tempe, AZ 85287 USA.
RP Larson, RB (corresponding author), Arizona State Univ, Law, Sandra Day OConnor Coll Law, Tempe, AZ 85287 USA.
CR Abayev Inessa, 2013, FORDHAM ENV L REV, V24, P275
   ACKERMAN BRUCE A., 1974, UNCERTAIN SEARCH ENV, P270
   ACKERMAN F, 2004, PRICELESS KNOWING PR, P35
   Adler RW, 2013, WASH LAW REV, V88, P759
   Adreen W. L., 2000, COLUM J ENV L, V25, P17
   AFRICAN DEV. BANK GRP, 1988, SEN MAL MAUR DIAM DA, P1
   Ahmad A., 2000, J ISLAMIC LAW CULTUR, V5, P159
   Allan JA, 2003, WATER INT, V28, P106, DOI 10.1080/02508060.2003.9724812
   AM. WATER WORKS ASSN, 2003, PROT OUR WAT DRINK W, p[9, 11]
   Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2
   Anderson Charles B., 1997, TUL L REV, V72, P417
   Anderson Charles B., 1997, TUL L REV, V72, P449
   Anderson Robert T., 2006, TULSA L REV, V42, P30
   Anderson Robert T., 2006, TULSA L REV, V42, P23
   [Anonymous], 2004, GUID DRINK WAT QUAL, P1, DOI DOI 10.1037/E333612004-001
   [Anonymous], 2003, FED REGISTER, V68, P47665
   [Anonymous], 1997, ILM, V36, P703
   [Anonymous], 1996, GUID DRINK WAT QUAL
   ARLIAN LG, 1995, AM J TROP MED HYG, V52, P539, DOI 10.4269/ajtmh.1995.52.539
   Ashbolt Nicholas John, 2004, TOXICOLOGY, V198, P233
   Ashbolt NJ, 2004, TOXICOLOGY, V198, P255, DOI 10.1016/j.tox.2004.01.034
   Ashbolt NJ, 2004, TOXICOLOGY, V198, P229, DOI 10.1016/j.tox.2004.01.030
   ATAPATTU S, 2002, TULANE ENV LAW J, V16, P65
   Atapattu Sumudu, 2002, TUL ENV LJ, V16, P90
   Attaran A, 2000, BRIT MED J, V321, P1403, DOI 10.1136/bmj.321.7273.1403
   AUSNESS R, 1986, U ILLINOIS LAW REV, P407
   Ausness Richard, 1986, U ILL L REV, P416
   Avery C., 2007, ARIZ L REV, P339
   Avery Chris, 2007, ARIZ L REV, V49, P347
   Babcock HM, 2006, CORNELL LAW REV, V91, P1203
   Babich Adam, 2003, COLUM J ENV L, V28, P167
   Babich Adam, 2003, COLUM J ENV L, V28, P119
   Baker M, 2011, UTAH ENV LAW REV, V31, P241
   Baker Mason, 2011, UTAH ENV L REV, V31, P246
   Bartram J, 2004, WATERBORNE ZOONOSES, P17
   Batterman S, 2009, ENVIRON HEALTH PERSP, V117, P1023, DOI 10.1289/ehp.0800423
   BEAIL-FARKAS L., 2013, WISCONSIN INT LAW J, V30, P761
   Beaton Kevin J., 2009, ADVOCATE, V52, P16
   Beaton Kevin J., 2009, ADVOCATE, V52, P15
   Becker M, 2011, LAT AM PERSPECT, V38, P47, DOI 10.1177/0094582X10384209
   Belenyesi Pal, 2014, EUR NETWORKS L REC Q, P17
   Benson R. D., 2012, U COLO L REV, V675, P675
   Benson Reed, 2006, UTAH L REV, V2006, P241
   Benson Reed D., 2006, UTAH L REV, P251
   Benson Reed D., 2012, U COLO L REV, V83, P676
   Berlin Isaiah, 1969, 4 ESSAYS LIBERTY, P118
   Bertuzzo E, 2016, STOCH ENV RES RISK A, V30, P2043, DOI 10.1007/s00477-014-0906-3
   Biber E, 2014, DUKE LAW J, V64, P133
   Biber Eric, 2014, DUKE LAW J, V64, P215
   BIGNAMI F, 2005, MICHIGAN J INT LAW, V26, P807
   Bignami Francesca, 2007, BOSTON COLL LAW REV, V48, P609
   Bignami Francesca, 2007, BC L REV, V48, P622
   Bluemel EB, 2004, ECOL LAW QUART, V31, P957
   Bluemel EB, 2007, U PENN LAW REV, V155, P1981, DOI 10.2307/40041389
   Bluemel Erik B., 2007, U PENN LAW REV, V155, P1990
   Bluemel Erik B., 2004, ECOLOGY L Q, V31, P983
   BLUMM MC, 1994, HARVARD ENVIRON LAW, V18, P405
   BLUMM MC, 1994, HARVARD ENVIRON LAW, V18, P410
   Bodansky Daniel, 2010, GEORGIA J INT COMP L, V38, P511
   Bodansky Daniel, 2010, GA J INT COMP L, V38, P514
   Bokum C, 1996, NAT RESOUR J, V36, P681
   Boorman GA, 1999, ENVIRON HEALTH PERSP, V107, P207, DOI 10.2307/3434484
   BRADLEY D, 1994, AGRICULTURE, ENVIRONMENT, AND HEALTH: SUSTAINABLE DEVELOPMENT IN THE 21ST CENTURY, P308
   Bradley D., 2013, PHILOS T R SOC, V371, P1
   Bradley D. J., 1988, Vector-borne disease control in humans through rice agroecosystem management. Proceedings of the Workshop on Research and Training Needs in the Field of Integrated Vector-borne Disease Control in Riceland Agroecosystems of Developing Countries, 9-14 March 1987., P29
   Bradley David J., 1974, HUMAN RIGHTS HLTH, P81
   Bradley David J., 2013, PHIL T ROYAL SOC, V371, P6
   BRENNAN TA, 1993, VANDERBILT LAW REV, V46, P1
   Brennan Troyen A., 1993, VANDERBILT LAW REV, V46, P6
   BRIEGER WR, 1994, HEALTH EDUC RES, V9, P257, DOI 10.1093/her/9.2.257
   Briffault R, 2010, U CHICAGO LAW REV, V77, P65
   Briffault Richard, 2010, U CHICAGO LAW REV, V77, P68
   Brisman Avi, 2004, WILLIAM MARY ENV LAW, V28, P423
   Brisman Avi, 2004, WM MARY ENV L POLY R, V28, P450
   Bronsteen J, 2013, DUKE LAW J, V62, P1603
   Bronsteen John, 2013, DUKE LAW J, V62, P1633
   Buchanan KS, 2015, MINN LAW REV, V99, P1231
   BURGER M, 2003, COLUM J ENV L, V28, P371
   Burger Michael, 2003, COLUM J ENV L, V28, P381
   Burleson Elizabeth, 2012, Cornell J Law Public Policy, V22, P289
   CARNEY M, 1991, J AM WATER WORKS ASS, V83, P48
   Cassuto D N, 2011, W MARY ENV LAW POLIC, V35, P371
   Cavallo G. A., 2012, PACE INT L REV ONLIN, V3, P136
   CDC, 2016, CHIK VIR 2016 PROV D
   CDC Web Site, 2016, CHIK VIR GEOGR DISTR
   Centers for Disease Control and Prevention, 2016, GLOB WAT SAN HYG WAS
   CHEEVER AW, 1993, AM J PATHOL, V142, P699
   Clasen T, 2008, AM J TROP MED HYG, V79, P407, DOI 10.4269/ajtmh.2008.79.407
   Cohen Glenn, 2013, J LEGAL ANAL, V5, P287
   Cohen IG, 2013, J LEGAL ANAL, V5, P221, DOI 10.1093/jla/lat001
   Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025
   Cooper E, 2001, IOWA LAW REV, V86, P869
   Cooter R., 2000, STRATEGIC CONSTITUTI, P107
   Cox William E., 1997, WM MARY ENV L POLY R, V21, P69
   Cox William E., 1997, WM MARY ENV L POLY R, V21, P111
   CRAIG RK, 2007, CARDOZO L REV, V29, P149
   CRAIG ROBIN KUNDIS, 2009, CLEAN WATER ACT CONS, P9
   Craig Robin Kundis, 2007, CARDOZO L REV, V29, P164
   Craig Robin Kundis, 2008, U COLO LAW REV, V79, P825
   Craig Robin Kundis, 2008, U COLO L REV, V79, P836
   Long Sharon C., 2006, Journal of Water and Health, V4, P277, DOI 10.2166/wh.2006.016
   CRAVIOTO ALEJANDRO, 2011, FINAL REP INDEP PANE
   Crow B, 2002, SOC NATUR RESOUR, V15, P709, DOI 10.1080/08941920290069308
   Czarnezki Jason J., 2007, BC ENV AFF L REV, V34, P1
   Dan Tarlock A, 2009, TUL ENV LJ, V23, P397
   Dan Tarlock A, 2009, TULANE ENV LAW J, V23, P369
   Dannenberg AL, 2006, AM J PUBLIC HEALTH, V96, P262, DOI 10.2105/AJPH.2005.069880
   Darlington Shasta, 2015, CNN             1224
   Date KA, 2011, EMERG INFECT DIS, V17, P2105, DOI 10.3201/eid1711.110822
   Daugirdas Kristina, 2014, AM J INT LAW, V108, P819
   Davis Jeffrey P., 2010, OUTBREAK INVESTIGATI, p[197, 219, 223]
   Davison Steven G., 2009, PACE ENV L REV, V26, P35
   DEGEORGES ANDRE, 2006, DAMS LARGE SCALE IRR, P4
   DeLaPaz A, 2013, U ILLINOIS LAW REV, P1211
   DeLaPaz Anthony, 2013, U ILL L REV, P1212
   Dellapenna J. W., 2011, MARQ L REV, V95, P53
   Dellapenna Joseph W., 2011, MARQ L REV, V95, P61
   Dernbach JC, 1997, HARVARD ENVIRON LAW, V21, P1
   Derouin James G., 2007, ARIZ L REV, V49, P469
   Derouin James G., 2007, ARIZ L REV, V49, P471
   DWORSKY LB, 1991, NAT RESOUR J, V31, P475
   EASTERBROOK FH, 1996, U CHI LEGAL F, P207
   ECKSTEIN G, 2002, HYDROPOLITICS DEV WO, P81
   Eckstein Gabriel, 2015, NYU ENV LJ, V23, P37
   Elston DM, 2005, CLIN DERMATOL, V23, P164, DOI 10.1016/j.clindermatol.2004.06.010
   ENVTL. PROT. AGENCY, 1993, 230R93007 EPA, P11
   European Centre for Health Policy, 1999, HLTH IMP ASS MAIN CO
   Ezroj Aaron, 2010, VA ENV LJ, V28, P71
   Ezroji A., 2010, VA ENV LJ, V28, P45
   Fairfield JAT, 2014, CORNELL LAW REV, V99, P981
   Fairfield Joshua A.T., 2014, CORNELL LAW REV, V99, P1016
   Farnese PL, 2014, QUEENS LAW J, V39, P471
   Faruqui Naser I., 2001, WATER NEPAL, V9, P201
   Faruqui Naser I., 2001, WATER NEPAL, V9, P197
   Feze Ida Ngueng, 2014, J ENV L PRAC, V26, P206
   Fidler David P., 1997, MINN LAW REV, V81, P802
   Fidler DP, 1997, MINN LAW REV, V81, P771
   Fitzmaurice M., 2007, FORDHAM ENV L REV, P538
   Fitzmaurice Malgosia, 2007, FORDHAM ENV LAW REV, V18, P537
   Flan Victor B., 2004, ALA L REV, V55, P595
   Flatt Victor B., 2004, ALA L REV, V55, P599
   Ford Matt, 2016, ATLANTIC
   Freedman R, 2014, EUR J INT LAW, V25, P239, DOI 10.1093/ejil/cht082
   Freedman Rosa, 2014, EUR J INT LAW, V25, P240
   Freeman J, 2012, HARVARD LAW REV, V125, P1131
   Freeman Jody, 2012, HARVARD LAW REV, V125, P1164
   Frerichs RR, 2012, CLIN MICROBIOL INFEC, V18, pE158, DOI 10.1111/j.1469-0691.2012.03841.x
   Freyfogle Eric T., 1986, U ILL L REV, P499
   FREYFOGLE ET, 1986, U ILLINOIS LAW REV, P481
   Friendly HJ, 1935, HARVARD LAW REV, V49, P163, DOI 10.2307/1333250
   Friendly Henry J., 1935, HARVARD LAW REV, V49, P165
   Gadgil A, 1998, ANNU REV ENERG ENV, V23, P253, DOI 10.1146/annurev.energy.23.1.253
   Galbraith Kate, 2014, NY TIMES
   Gathii James, 2012, VA ENV LJ, V30, P16
   Gathii James, 2012, VA ENV LJ, V30, P1
   Getches D. H., 1997, U COLO L REV, V68, P573
   GETCHES DH, 1997, U COLO L REV, V68, P576
   Giordano MA, 2003, NAT RESOUR J, V43, P111
   Gleick Peter H., 2007, HUMAN RIGHT WATER, P1
   Gleick PH, 1996, WATER INT, V21, P83, DOI 10.1080/02508069608686494
   GLENNON ROBERT, 2002, WATER FOLLIES GROUND, P29
   GLICKSMAN ROBERT L., 2015, ENV PROTECTION LAW P, P554
   Gonzales Suzannah, 2016, REUTERS
   Gostin Lawrence O., 1999, COLUMBIA LAW REV, V99, P70
   Gostin LO, 1999, COLUMBIA LAW REV, V99, P59, DOI 10.2307/1123597
   Greenaway C, 2004, CAN MED ASSOC J, V170, P495
   Grey D, 2007, WATER POLICY, V9, P545, DOI 10.2166/wp.2007.021
   Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gyapong JO, 2010, LANCET, V375, P160, DOI 10.1016/S0140-6736(09)61249-6
   Haddadin MJ, 2006, ISSUES WATER RESOURC, P28
   Haddaway Arthur S., 1929, TEX LAW REV, V7, P453
   Haddaway Arthur S., 1929, TEX LAW REV, V7, P468
   Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227
   HARDBERGER A, 2005, NW U J INT HUM RTS, V4, P331
   Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hecht SB, 2008, UCLA LAW REV, V55, P1559
   HEINZERLING L, 1999, LAND WATER L REV, V34, P39
   HEINZERLING L, 1995, STAN ENV LJ, V14, P302
   HEINZERLING L, 1995, STAN ENV LJ, V14, P300
   Heinzerling L, 2008, GEORGETOWN LAW J, V96, P445
   Heinzerling Lisa, 1999, LAND WATER L REV, V34, P57
   HEMPEL SANDRA, 2007, STRANGE CASE BROAD S, P163
   Herman J. S., 2001, STANFORD ENV LAW J, V20, P479
   HERMAN JS, 2001, STAN ENV L J, V20, P482
   Hickox Kaci, 2015, J HLTH BIOMEDICAL L, V11, P9
   Hickox Kaci, 2015, J HLTH BIOMEDICAL L, V11, P17
   Hirokawa Keith H., 2010, ALB L REV, V74, P175
   Hirokawa Keith H., 2010, ALB L REV, V74, P230
   Hobbs Jr Gregory J., 2002, ENV L, V32, P54
   Hobbs Jr Gregory J., 2002, ENV L, V32, P37
   Hodge JG, 2014, J LAW MED ETHICS, V42, P595, DOI 10.1111/jlme.12179
   Howarth William, 2006, PACE ENV LAW REV, V23, P351
   HRUDEY ELIZABETH J., 2014, ENSURING SAFE DRINKI, P11
   Hua GH, 2007, WATER RES, V41, P1667, DOI 10.1016/j.watres.2007.01.032
   Huang Ziyi, 2015, GEO INT ENV L REV, V27, P229
   Hurtado Patricia, 2014, BLOOMBERG
   Imseis A, 2003, HARVARD INT LAW J, V44, P65
   Imseis Ardi, 2003, HARV INT L J, V44, P105
   INT'L HUMAN RIGHTS LAW CLINIC U.C. BERKELEY, 2013, HUM RIGHT WAT BILL C
   JOBIN WILLIAM, 1999, DAMS DIS ECOLOGICAL, P21
   JOHNSON NK, 1989, NAT RESOUR J, V29, P347
   Johnson Reed, 2015, WALL ST J
   JOHNSON STEVEN, 2006, GHOST MAP STORY LOND, P30
   Jones JA, 1999, INDIANA LAW J, V74, P1035
   Jungreis Jeremy N., 2005, HARVARD ENVIRON LAW, V29, P378
   Kahn BA, 1999, STANFORD J INT LAW, V35, P49
   Kahn Benjamin A., 1999, STAN J INT L, V35, P56
   Kamminga Menno T., 1996, PRECAUTIONARY PRINCI, P171
   Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002
   Karkkainen BC, 2002, COLUMBIA LAW REV, V102, P903, DOI 10.2307/1123648
   Karkkainen Bradley C., 2004, NYU ENV LJ, V12, P339
   Karkkainen Bradley C., 2004, NYU ENV LJ, V12, P333
   KE Jian, 2013, PACE ENV L REV, V30, P950
   Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392
   Kerr Thomas M., 1995, GEO INT ENV L REV, V8, P91
   Kerr Thomas M., 1995, GEO INT ENV L REV, V8, P92
   Khalaileh Yaser, 2012, BERKELEY J MIDDLE E, V5, P73
   Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041
   Killeen GF, 2006, AM J TROP MED HYG, V74, P517, DOI 10.4269/ajtmh.2006.74.517
   KIMERLING J, 2001, COLUM J ENV L, V26, P289
   Kimerling Judith, 2001, COLUM J ENV, V26, P371
   Kirkwood MR, 1948, STANFORD LAW REV, V1, P1, DOI 10.2307/1226155
   Klass AB, 2007, IOWA LAW REV, V92, P545
   Klein CA, 2012, MINN LAW REV, V97, P560
   Klein Christine A., 1995, VA ENV LJ, V14, P343
   Klein Christine A., 2012, MINN LAW REV, V97, p[560, 568]
   Knudsen Guy R., 2014, NAT RES ENV, V29, P14
   Knudsen Guy R., 2014, NAT RES ENV, V29, P15
   Kohn Diane M., 2002, ENVIRON LAW, V9, P281
   Kohn Diane M., 2002, ENVIRON LAW, V9, P286
   Kornfeld Itzach, 2010, J TRANSNATL L, V43, P701
   Kornfeld Itzchak E., 2012, FLA A M U L REV, V7, P206
   Kornfeld Itzchak E., 2012, FLA A M U L REV, V7, P181
   Kotze LJ, 2012, U DENV WATER L REV, V15, P221
   Kotzh Louis J., 2012, U DENV WATER L REV, V15, P257
   LACHMAN BETH E., 1997, LINKING SUSTAINABLE, P6
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Larson Charles D., 1990, SAFE DRINKING WATER, p[3, 4]
   Larson R.B., 2012, UTAH L REV, P759
   LARSON RHETT, 2015, CASE CANADIAN BULK W
   Larson RB, 2015, UCLA LAW REV, V62, P908
   Larson Rhett B., 2013, ARIZ ST LJ, V45, P991
   Larson Rhett B., 2014, U RICH L REV, V48, P929
   Larson Rhett B., 2014, HUFFINGTON POST
   Larson Rhett B., 2012, UTAH L REV, P779
   Larson Rhett B., 2013, WASH LEE L REV, V70, P2181, DOI DOI 10.2139/ssrn.2279557
   Latham Mark A., 2010, VA ENV LJ, V28, P411
   LATIN H, 1985, STANFORD LAW REV, V37, P1267, DOI 10.2307/1228632
   Lazarus RJ, 2000, UCLA LAW REV, V47, P703
   LeMarquand D. G., 1990, Water International, V15, P222, DOI 10.1080/02508069008691654
   LeMarquand David G., 1990, WATER INT, V15, P225
   LeVine Michael, 2014, ALASKA L REV, V31, P245
   LeVine Michael, 2014, ALASKA L REV, V31, P231
   Levy RE, 2011, TEX LAW REV, V89, P499
   Levy Richard E., 2011, TEX LAW REV, V89, P511
   Lietman TM, 2000, MED J AUSTRALIA, V172, P93, DOI 10.5694/j.1326-5377.2000.tb139214.x
   Lindstrom B, 2011, EMORY INT LAW REV, V25, P1145
   Lyster Rosemary, 2004, GEORGETOWN INT ENV L, V16, P561
   M H-Black E C, 2010, GEORGETOWN INT ENV L, V22, P359
   MacDonald Erin K., 2001, ENV L, V31, P1018
   MacDonald Erin K., 2001, ENV L, V31, P1011
   Makdisi John, 1989, NC L REV, V67, P1063
   Mallat Chibli, 1995, WATER MIDDLE E LEGAL, P127
   Malone Linda A., 2003, WM MARY ENV L POLY R, V27, P365
   Mara DD, 1999, J ENVIRON ENG-ASCE, V125, P334, DOI 10.1061/(ASCE)0733-9372(1999)125:4(334)
   Markell David L., 1993, SYRACUSE L REV, V44, P891
   Markell David L., 1993, SYRACUSE L REV, V44, P885
   Marshall Skylar, 2013, U DENV WATER L REV
   MARTINES J, 1993, DIS CONTROL PRIORITI, P91
   Masur JS, 2010, U CHICAGO LAW REV, V77, P657
   MATHAN MM, 1986, AM J PATHOL, V123, P25
   McBeth Adam, 2009, G WASHINGTON INT LAW, V40, P1101
   McBeth Adam, 2009, G WASH INT L REV, V40, P1130
   MCCAFFREY S, 2009, GEORGETOWN INT ENV L, V21, P679
   McCaffrey S., 1992, GEORGETOWN INT ENV L, V5, P7
   McCaffrey Stephen C., 1992, GEO INT ENV L REV, V5, P1
   McCaffrey Stephen C., 2001, LAW INT WATERCOURSES, P76
   McCubbin Patricia Ross, 2005, DUKE ENV L POLY F, V16, P4
   McCubbin PR., 2005, DUKE ENV L POLY F, V16, P1
   McLeod KS, 2000, SOC SCI MED, V50, P923, DOI 10.1016/S0277-9536(99)00345-7
   Mergen A. C., 1997, U COLO L REV, V68, P683
   Mergen Andrew C., 1997, U COLO L REV, V68, P711
   Merrill Thomas W., 1997, DUKE LAW J, V46, P955
   Merrill TW, 1997, DUKE LAW J, V46, P931, DOI 10.2307/1372915
   Minan J.H., 2010, SAN DIEGO LAW REV, V47, P109
   Minan John H., 2010, SAN DIEGO L REV, V47, P135
   Moe CL, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P222
   Moeller James W., 2007, WM MARY ENV L POLY R, V31, P661
   Morenberg Paul W., 1995, BC ENV AFF L REV, V22, P666
   Morenberg Paul W., 1995, BC ENV AFF L REV, V22, P623
   Morris Jon, 2014, U KAN L REV, V62, P1003
   Morris Jon, 2014, U KAN L REV, V62, P1033
   Morriss Andrew P., 2002, FORD HAM ENV LJ, V14, P28
   Morriss Andrew P., 2002, FORDHAM ENVTL LJ, V14, P1
   Murthy Shannila L., 2013, BERKELEY J INT L, V31, P99
   NAT'L RES. COUNCIL, 2000, WAT MAN POT WAT SUPP, P23
   Neuman Janet C., 2003, U DENV WATER L REV, V7, P92
   Neuman Janet C., 1999, STANFORD ENV LAW J, V18, P3
   Ngueng Feze I, 2014, J ENV LAW PRACTICE, V26, P201
   Noble-Allgire Alice M., 1990, AM SOC INT L P, V84, P12
   Noble-Allgire Alice M., 1990, AM SOC INT L P, V84, P25
   Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/s10393-004-0008-7
   NORTH DOUGLASS C., 1990, N I I CHANGE EC PERF, P112
   NORTH DOUGLASS C., 2004, N I I CHANGE EC PERF, P112
   Okster Lee R., 1999, WM MARY ENV L POLY R, V23, P381
   Osofsky Hari M., 2005, STAN ENV LJ, V24, P71
   Osofsky Hari M., 2005, STAN ENV LJ, V24, P129
   Osofsky Hari M., 2011, ALA L REV, V62, P237
   Paneth N, 2004, EPIDEMIOLOGY, V15, P514, DOI 10.1097/01.ede.0000135915.94799.00
   Pannu C, 2012, CALIF LAW REV, V100, P223
   Pannu Camille, 2012, CALIF LAW REV, V100, P244
   Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877
   Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843
   Pejan R., 2004, G WASHINGTON INT LAW, V36, P1181
   Pejan Ramin, 2004, G WASH INT L REV, V36, P1188
   PETERS STEPHANIE TRUE, 2005, CHOLERA CURSE 19 CEN, P46
   Picquet M, 1996, T ROY SOC TROP MED H, V90, P340, DOI 10.1016/S0035-9203(96)90501-5
   Pilkington Ed, 2014, GUARDIAN
   PINFOLD JV, 1990, EPIDEMIOL INFECT, V105, P377, DOI 10.1017/S0950268800047968
   Popovic N., 1996, COLUM HUM RTS L REV, V27, P487
   Porter Keith S., 2006, PACE ENV LAW REV, V23, P389
   Porter Keith S., 2006, PACE ENV L REV, V23, P403
   Pound R, 1923, HARVARD LAW REV, V36, P641, DOI 10.2307/1328278
   Pound Roscoe, 1923, HARVARD LAW REV, V36, P642
   Priddle Alisa, 2014, US TODAY
   Prunty Allen R., 1989, W VA L REV, V91, P683
   Prunty Allen R., 1989, W VA L REV, V91, P665
   Rappleye Hannah, 2016, NBC NEWS
   Reiblich Jesse, 2014, PEPP L REV, V41, P458
   Reisen W, 2004, EMERG INFECT DIS, V10, P1369, DOI 10.3201/eid1008.040077
   Rieblich J., 2014, PEPP L REV, V41, P439
   Roberson J. Alan, 2006, AM WATER WORKS ASS, V98, P204
   Roberson JA, 2006, J AM WATER WORKS ASS, V98, P198
   Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2
   Roberts DR, 2000, J VECTOR ECOL, V25, P48
   Rodrick Stephen, 2016, ROLLING STONE
   Rogers Emily, 2015, TEX ENV L J, V45, P419
   Roithmayr D., 2010, CONSTITUTIONAL COURT, V3, P317
   Rowell A, 2012, U CHICAGO LAW REV, V79, P985
   Rowell Arden, 2012, U CHICAGO LAW REV, V79, P999
   Rubl J. B., 1997, UC DAVIS L REV, V30, P471
   Ruhl J.B., 2001, ECOLOGY L Q, V27, P263
   RUHL JB, 1997, UC DAVIS L REV, V30, P405
   Russell AFS, 2010, J HUM RIGHTS, V9, P1, DOI 10.1080/14754830903530292
   Sachs Noah, 1999, COLUM J ENV L, V24, P309
   Sachs Noah, 1999, COLUM J ENV L, V24, P289
   Sachs NM, 2011, U ILLINOIS LAW REV, P1285
   Sachs Noah M., 2011, U ILL L REV, P1288
   Salzman J, 2005, NEW YORK U LAW REV, V80, P870
   Salzman J., 2008, DUKE ENV L POLY F, P1
   SALZMAN J, 2006, YALE J LAW HUMANITIE, V18, P94
   SALZMAN JAMES, 2003, ENV LAW POLICY, P123
   Salzman James, 2006, YALE JL HUMAN, V18, P100
   Salzman James, 2005, NEW YORK U LAW REV, V80, P877
   SAX JOSEPH L., 2000, LEGAL CONTROL WATER, P154
   Scanlan MK, 2012, ECOL LAW QUART, V39, P123
   Scanlan Melissa K., 2012, ECOLOGY L Q, V39, P136
   Schulz Anna, 2007, GEORGETOWN INT ENV L, V19, P117
   Schwabach Aaron, 1996, BERKELEY J INT L, V14, P322
   Schwabach Aaron, 1996, BERKELEY J INT L, V14, P290
   Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599
   SHARFMAN I.L., 1935, INTERSTATE COMMERCE
   Sharmila L, 2013, INT LAW, V31, P89, DOI DOI 10.15779/Z38665F
   Shermer Steven D., 2006, UCLA J ENVM L POLY, V24, P355
   Shimoni Z, 2001, EMERG INFECT DIS, V7, P759
   Sivas Debbie, 1988, STAN ENV LJ, V7, P117
   Smith Henry, 2008, ARIZ L REV, V50, P445
   Smith Henry E., 2008, ARIZ L REV, V50, P467
   Smith Paula K., 1986, ENV L, V16, P797
   Smith Paula K., 1986, ENV L, V16, P862
   SNOW JOHN, 1855, MODE COMMUNICATION C, P3
   Snow SJ, 2008, LANCET, V372, P22, DOI 10.1016/S0140-6736(08)60978-2
   Southgate VR, 1997, J HELMINTHOL, V71, P125, DOI 10.1017/S0022149X00015790
   Sow S, 2002, ANN TROP MED PARASIT, V96, P575, DOI 10.1179/000349802125001636
   Steinzor RI, 1996, MINN LAW REV, V81, P97
   Stoa Ryan B., 2014, VAND J TRANSNATL L, V47, P1321
   STOUT LA, 1992, GEORGETOWN LAW J, V80, P1787
   Stout Lynn A., 1992, GEORGETOWN LAW J, V80, P1797
   Straub TM, 2003, J MICROBIOL METH, V53, P185, DOI 10.1016/S0167-7012(03)00023-X
   Sunstein Cass, 2005, LAWS FEAR PRECAUTION, P18
   Sunstein Cass R., 2002, GEORGETOWN LAW J, V90, P2259
   Sunstein CR, 2002, GEORGETOWN LAW J, V90, P2255
   Susser M, 1996, AM J PUBLIC HEALTH, V86, P668, DOI 10.2105/AJPH.86.5.668
   Tarlock AD, 2010, NAT RESOUR J, V50, P471
   Tarlock AD, 2001, NAT RESOUR J, V41, P769
   THOMPSON BH, 1993, CALIF LAW REV, V81, P671, DOI 10.2307/3480942
   Thompson J., 2002, DRAWERS OF WATER
   Thompson Jr B. H., 2011, MARQ L REV, V95, P17
   Thompson  Jr Barton H., 2000, WM MARY ENV L POLY R, V25, P296
   Thompson Jr Barton H, 2000, WILLIAM MARY ENV LAW, V25, P261
   Thompson Jr Barton H., 2011, MARQ L REV, V95, P32
   Thompson Jr Barton H., 2011, MARQ L REV, V95, P33
   Thorson John E., 2005, U DENV WATER L REV, V8, P355
   TISDELL JG, 2003, SOCIAL JUSTICE RES, V16, P401, DOI DOI 10.1023/A:1026365700255
   Tomoszkova Veronika, 2015, WASH LEE J ENERGY CL, V6, P451
   Totaro Martin V., 2008, VA J INT L, V48, P758
   Totaro Martin V., 2008, VIRGINIA J INT LAW, V48, P719
   Trelease FJ, 1954, TEX LAW REV, V33, P24
   Tremblay H, 2011, NAT RESOUR J, V51, P307
   Truelsen Julie B., 2005, COLO J INT ENV L POL, V16, P217
   Truelsen Julie B., 2005, COLO J INT ENV L POL, V16, P218
   U.S. Environmental Protection Agency, 2011, FED REGISTER, V76, P68750
   UNITED NATIONS CHILDREN'S FUND & WORLD HEALTH ORG, 2012, PROGR DRINK WAT SAN, P18
   Vera Luis Inaraja, 2015, GEO INT ENV L REV, V27, P199
   Vick MJ, 2006, NAT RESOUR J, V46, P211
   VOLLMAR LC, 1994, J LEGAL MED, V15, P385, DOI 10.1080/01947649409510952
   Wagner WE, 2004, DUKE LAW J, V53, P1619
   Wagner WE, 1999, U ILLINOIS LAW REV, P181
   Wagner Wendy E., 1999, U ILL L REV, P209
   Wagner Wendy E., 2004, DUKE LAW J, V53, P1742
   Walton DA, 2011, NEW ENGL J MED, V364, P3, DOI 10.1056/NEJMp1012997
   Wang M. Y., 2008, VILL ENV LAW J, V19, P95
   Weiner Kenneth S., 2009, ENV L REP, V39, P10676
   Weiner Kenneth S., 2009, ENV L REP, V39, P10675
   Westerhoff P, 2005, ENVIRON SCI TECHNOL, V39, P6649, DOI 10.1021/es0484799
   Wiener JB, 1999, YALE LAW J, V108, P677, DOI 10.2307/797394
   Wiseman H., 2009, FORDHAM ENV L REV, V20, P115
   Wiseman Hannah, 2012, DUKE ENV L POLY F, V22, P361
   WOOD MC, 1988, HARVARD ENVIRON LAW, V12, P569
   Wood SG, 2006, AM J COMP LAW, V54, P581, DOI 10.1093/ajcl/54.suppl1.581
   WORLD HEALTH ORG, 2014, WORLD MALARIA REPORT, P32
   Zellmer Sandra B., 2008, ALA L REV, V59, P679
   Zerbe RO, 1998, WASH LAW REV, V73, P349
   2003, FED REG, V68, P47640
NR 426
TC 2
Z9 2
U1 1
U2 15
PU NOTRE DAME LAW SCHOOL
PI NOTRE DAME
PA NOTRE DAME LAW SCHOOL, ROOM B1, NOTRE DAME, IN 46556 USA
SN 0745-3515
J9 NOTRE DAME LAW REV
JI Notre Dame Law Rev.
PD JAN
PY 2017
VL 92
IS 3
BP 1271
EP 1321
PG 51
WC Law
SC Government & Law
GA ES4NT
UT WOS:000399512700006
DA 2020-07-08
ER

PT J
AU McLean, E
   Bhattarai, R
   Hughes, BW
   Mahalingam, K
   Bagasra, O
AF McLean, Ewen
   Bhattarai, Roshan
   Hughes, Brandon W.
   Mahalingam, Kuhanandha
   Bagasra, Omar
TI Computational identification of mutually homologous Zika virus miRNAs
   that target microcephaly genes
SO LIBYAN JOURNAL OF MEDICINE
LA English
DT Article
DE Zika virus; microcephaly; miRNAs
ID OUTBREAK
AB Background Zika virus (ZIKV) has been associated with a variety of neuropathologies, including microcephaly. We hypothesize that ZIKV genes activate host microRNAs (miRNAs) causing dysfunctional development of human fetal brains.
   Objectives/methods A bioinformatics search for miRNA genome-wide binding sites in the prototypic ZIKV (strain MR766) was undertaken to hunt for miRNAs with significant similarities with MCPH genetic sequences responsible for inducing MCHP in human fetal brains.
   Results Six ZIKV miRNAs were found to share mutual homology with 12 MCPH genetic sequences responsible for inducing MCPH. Noteworthy was miR-1304, which expressed 100% identity to six different MCPH genes.
   Conclusions We suggest that following infection of fetal neurons ZIKV may modulate the action of various miRNAs, and miR-1304 in particular, resulting in microcephaly.
C1 [McLean, Ewen; Bhattarai, Roshan; Hughes, Brandon W.; Bagasra, Omar] Claflin Univ, South Carolina Ctr Biotechnol, Dept Biol, Orangeburg, SC 29115 USA.
   [Mahalingam, Kuhanandha] Claflin Univ, Informat Technol, Orangeburg, SC USA.
   [Mahalingam, Kuhanandha] Claflin Univ, Dept Comp Sci & Math, Orangeburg, SC USA.
RP Bagasra, O (corresponding author), Claflin Univ, South Carolina Ctr Biotechnol, Dept Biol, Orangeburg, SC 29115 USA.
EM obagasra@claflin.edu
RI McLean, Ewen/AAO-6863-2020
CR Bagasra O, 2004, J MOL HISTOL, V35, P545
   Bagasra O, 2012, EXPERT REV VACCINES, V11, P335, DOI [10.1586/erv.11.191, 10.1586/ERV.11.191]
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Budday S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00257
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Kaddumukasa A. M., 2015, AFR J BIOTECHNOL, V14, P1418, DOI DOI 10.5897/AJB2015.14474
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Lopez-Valenzuela M, 2012, MOL BIOL EVOL, V29, P1797, DOI 10.1093/molbev/mss023
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Nunes ML, 2016, PEDIATRICS, P30001
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wakabayashi T, 2014, ADV GENET, V86, P27, DOI 10.1016/B978-0-12-800222-3.00002-4
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 37
TC 5
Z9 5
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1993-2820
EI 1819-6357
J9 LIBYAN J MED
JI Libyan J. Med.
PY 2017
VL 12
AR 1304505
DI 10.1080/19932820.2017.1304505
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA ER3ZB
UT WOS:000398737700001
PM 28385119
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Donalisio, MR
   Freitas, ARR
   Von Zuben, APB
AF Donalisio, Maria Rita
   Ribas Freitas, Andre Ricardo
   Bruno Von Zuben, Andrea Paula
TI Arboviruses emerging in Brazil: challenges for clinic and implications
   for public health
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Dengue; Zika Virus Infection; Chikungunya Fever; Arbovirus Infections;
   epidemiology; Communicable Diseases, Emerging
ID WEST-NILE-VIRUS; ZIKA VIRUS; EPIDEMIOLOGY; ENCEPHALITIS; EMERGENCE;
   OUTBREAK; MANAUS; FEVER
AB Arboviruses have been emerging in different parts of the world due to genetic changes in the virus, alteration of the host and vector population dynamics, or because of anthropogenic environmental factors. These viruses' capacity for adaptation is notable, as well as the likelihood of their emergence and establishment in new geographic areas. In Brazilian epidemiologic scenario, the most common arboviruses are DENV, CHIKV, and ZIKV, although others may spread in the country. Little is yet known of the impact of viral co-circulation, which would theoretically result in more intense viremia or other immunological alterations that could trigger autoimmune diseases, such as Guillain-Barre syndrome. The impact on morbidity and mortality intensifies as extensive epidemics lead to a high number of affected individuals, severe cases, and implications for health services, mainly due to the absence of treatment, vaccines, and effective prevention and control measures.
C1 [Donalisio, Maria Rita] Univ Estadual Campinas, Fac Ciencias Med, Dept Saude Coletiva, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo; Bruno Von Zuben, Andrea Paula] Secretaria Municipal Saude Campinas, Dept Vigilancia Saude, Programa Municipal Controle Arboviroses, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo] Fac Med Sao Leopoldo Mandic, Campinas, SP, Brazil.
RP Donalisio, MR (corresponding author), Rua Tessalia Vieira Camargo, BR-13083887 Campinas, SP, Brazil.
EM donalisi@fcm.unicamp.br
RI Donalisio, Maria Rita/Z-3934-2019; Donalisio, Maria Rita/C-5263-2012;
   Freitas, Andre Ricardo Ribas/L-1969-2016
OI Donalisio, Maria Rita/0000-0003-4457-9897; Donalisio, Maria
   Rita/0000-0003-4457-9897; Freitas, Andre Ricardo
   Ribas/0000-0003-0291-7771
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos CLS, 2006, MEM I OSWALDO CRUZ, V101, P57, DOI 10.1590/S0074-02762006000100011
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Freire CCM, 2015, BIORXIV
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Gray TJ, 2014, INT J GEN MED, V7, P193, DOI 10.2147/IJGM.S59902
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Roth A, 2014, EURO SURVEILL, V19
   Silva JR, 2013, MEM I OSWALDO CRUZ, V108, P921, DOI 10.1590/0074-0276130052
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 26
TC 32
Z9 33
U1 1
U2 6
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2017
VL 51
AR 30
DI 10.1590/S1518-8787.2017051006889
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ER9BX
UT WOS:000399119500007
PM 28423140
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moreno-Banda, GL
   Riojas-Rodriguez, H
   Hurtado-Diaz, M
   Danis-Lozano, R
   Rothenberg, SJ
AF Litai Moreno-Banda, Grea
   Riojas-Rodriguez, Horacio
   Hurtado-Diaz, Magali
   Danis-Lozano, Rogelio
   Joel Rothenberg, Stephen
TI Effects of climatic and social factors on dengue incidence in Mexican
   municipalities in the state of Veracruz
SO SALUD PUBLICA DE MEXICO
LA English
DT Article
DE dengue; disease vectors; El Nino-southern oscillation; climate; time
   series studies
ID AEDES-AEGYPTI DIPTERA; EL-NINO; RISK-FACTORS; FEVER; TEMPERATURE;
   VARIABILITY; TRANSMISSION; CULICIDAE; SURVIVAL; WEATHER
AB Objective. To assess links between the social variables and longer-term El Nino-Southern Oscillation (ENSO) related weather conditions as they relate to the week-to-week changes in dengue incidence at a regional level. Materials and methods. We collected data from 10 municipalities of the Olmeca region in Mexico, over a 10 year period (January 1995 to December 2005). Negative binomial models with distributed lags were adjusted to look for associations between changes in the weekly incidence rate of dengue fever and climate variability. Results. Our results show that it takes approximately six weeks for sea surface temperatures (SST -34) to affect dengue incidence adjusted by weather and social variables. Conclusion. Such models could be used as early as two months in advance to provide information to decision makers about potential epidemics. Elucidating the effect of climatic variability and social variables, could assist in the development of accurate early warning systems for epidemics like dengue, Chikungunya and Zika.
C1 [Litai Moreno-Banda, Grea; Riojas-Rodriguez, Horacio; Hurtado-Diaz, Magali; Joel Rothenberg, Stephen] Inst Nacl Salud Publ, Av Univ 655, Cuernavaca 62100, Morelos, Mexico.
   [Danis-Lozano, Rogelio] Inst Nacl Salud Publ, Tapachula, Mexico.
RP Riojas-Rodriguez, H (corresponding author), Inst Nacl Salud Publ, Av Univ 655, Cuernavaca 62100, Morelos, Mexico.
EM hriojas@insp.mx
RI Rothenberg, Stephen J/A-1313-2008
CR Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465
   Bai L, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-10
   Banu S, 2014, NATURE, V5, P1
   Barrera R, 2006, AM J TROP MED HYG, V74, P290, DOI 10.4269/ajtmh.2006.74.290
   Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133
   Bhatnagar Sunil, 2012, Indian J Public Health, V56, P281, DOI 10.4103/0019-557X.106415
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brunkard JM, 2008, SALUD PUBLICA MEXICO, V50, P227, DOI 10.1590/s0036-36342008000300006
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106
   Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Consejo Nacional de Evaluacion de la Politica de Desarrollo Social (CONEVAL), 2006, DAT BAS IND REZ SOC
   Consejo Nacional de Poblacion (Conapo), 2015, DAT BAS IND MARG ENT
   Consejo Nacional de Poblacion (Conapo), 2015, DAT BAS IND MARG MUN
   Dear K, 2010, ARCH ENV OCCUPATIONA, V60, P205
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868
   Direccion General de Epidemiologia (DGE), 2014, AN MORB 1995 2005 SI
   Durban M., 2009, B ESTADISTICA INVEST, V25, P195
   Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X
   Ferreira MC, 2014, GEOSPATIAL HEALTH, V9, P141, DOI 10.4081/gh.2014.12
   Frenk J, 2007, SALUD PUBLICA MEXICO, V49, P156, DOI 10.1590/s0036-36342007000200011
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364
   Hopp MJ, 2003, CLIM RES, V25, P85, DOI 10.3354/cr025085
   Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x
   Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x
   Instituto Nacional de Estadistica y Geografia (INEGI), 2001, DAT BAS 12 CENS GEN
   Instituto Nacional de Estadistica y Geografia (INEGI), 1996, DAT BAS 1 CONT POBL
   Instituto Nacional de Estadistica y Geografia (INEGI), 1992, DAT BAS 11 CENS GEN
   Instituto Nacional de Estadistica y Geografia (INEGI), 2006, DAT BAS 2 CONT POBL
   Instituto Nacional de Estadistica y Geografia (INEGI), 2011, DAT BAS CENS POBL VI
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Mondini Adriano, 2007, Rev. Saúde Pública, V41, P923, DOI 10.1590/S0034-89102007000600006
   Montgomery BL, 2002, AM J TROP MED HYG, V67, P244, DOI 10.4269/ajtmh.2002.67.244
   MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Nagao Y, 2003, TROP MED INT HEALTH, V8, P650, DOI 10.1046/j.1365-3156.2003.01075.x
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   National Oceanic and Atmospheric Administration (NOAA), 2009, DAT BAS GLOB TEMP WE
   NEWTON HJ, 1996, TIME SERIES ANAL LAB
   Bulto PLO, 2006, ENVIRON HEALTH PERSP, V114, P1942, DOI 10.1289/ehp.8434
   Ortiz PL, 2015, MEDICC REV, V17, P20
   Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217
   Patz JA, 2000, ENVIRON HEALTH PERSP, V108, P367, DOI 10.2307/3454357
   Poveda G, 2001, ENVIRON HEALTH PERSP, V109, P489, DOI 10.2307/3454707
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Romer David, 2012, ADV MACROECONOMICS
   Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   SAID SE, 1984, BIOMETRIKA, V71, P599
   Servicio Meteorologico Nacional (SMN), 2006, DAT BAS EST MET EST
   SHOPE R, 1991, ENVIRON HEALTH PERSP, V96, P171, DOI 10.2307/3431227
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Thai KTD, 2011, EXP BIOL MED, V236, P944, DOI 10.1258/ebm.2011.010402
   Tong SL, 2001, ENVIRON HEALTH PERSP, V109, P1271, DOI 10.2307/3454750
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Uriel E, 1992, ANALISIS SERIES TEMP
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   World Health Organization, 2015, DENG FACTSH
   Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
   Zell R, 2008, CURR OPIN BIOTECH, V19, P652, DOI 10.1016/j.copbio.2008.10.009
NR 69
TC 4
Z9 4
U1 1
U2 5
PU INST NACIONAL SALUD PUBLICA
PI CUERNAVACA
PA AV UNIVERSIDAD 655, COL SANTA MARIA AHUACATITLAN, CUERNAVACA 62508,
   MORELOS, MEXICO
SN 0036-3634
EI 1606-7916
J9 SALUD PUBLICA MEXICO
JI Salud Publica Mexico
PD JAN-FEB
PY 2017
VL 59
IS 1
BP 41
EP 52
DI 10.21149/8414
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ES1HI
UT WOS:000399278300013
PM 28423109
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ali, M
   Miller, K
   de Leon, RFGP
AF Ali, Moazzam
   Miller, Kelsey
   Ponce de Leon, Rodolfo Federico Gomez
TI Family planning and Zika virus: need for renewed and cohesive efforts to
   ensure availability of intrauterine contraception in Latin America and
   the Caribbean
SO EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE
LA English
DT Article
DE Caribbean region; intrauterine contraception; Latin America; long-acting
   reversible contraception; Zika virus
AB Objectives: The advantages of intrauterine contraception (IUC) are well established (highly effective, low discontinuation rate, easy to use, low cost, and suitable for immediate postpartum use), but low levels of use in many countries and declining use in others are causes for concern. Due to the ongoing Zika virus outbreak, public health officials are calling for the continued practice of safe sex and the delay of pregnancy. Our study was conducted to assess the current situation of IUC availability and provision in Latin America and to determine the role of national policies in meeting the contraceptive needs of the populations in these countries.
   Methods: A survey was conducted in Latin America and the Caribbean between December 2015 and January 2016 to assess national policies with regard to IUC provision, availability and accessibility. 18 countries participated.
   Results: All responding countries had national policies on IUC. Many in the public sector provided the intrauterine device (IUD) free of charge, but the levonorgestrel-releasing intrauterine system (LNG-IUS) was generally available in the private sector. Some countries had very restrictive policies on who was permitted to carry out IUC insertions, but most permitted a range of health professionals to do so. Immediate postpartum IUC insertion was uncommon. Some countries placed restrictions on IUC use in women who were nulliparous, young, at high risk of catching a sexually transmitted infection or who had multiple sexual partners.
   Conclusions: IUC is underused in Latin America. The study reveals policy level barriers that may impede access to IUC, one of the most effective, long-acting, non-hormonal, reversible contraceptive methods. Governments should consider reviewing and rethinking their policies on contraception to ensure IUC service provision among populations at high risk of unplanned pregnancy, especially those vulnerable to Zika virus.
C1 [Ali, Moazzam; Miller, Kelsey] WHO, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
   [Ponce de Leon, Rodolfo Federico Gomez] Pan Americana Hlth Org, Latin Amer Ctr Perinatal Women & Reprod Hlth, Montevideo, Uruguay.
RP Ali, M (corresponding author), WHO, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
EM alimoa@who.int
FU UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research,
   Development; Research Training in Human Reproduction (HRP)
FX The research was funded by the UNDP-UNFPA-UNICEF-WHO-World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP), a cosponsored program executed by the World Health
   Organization; and a Large Anonymous Donor under the Grant for Women,
   Communities, and Health Systems in the Context of Zika.
CR Blumenthal PD, 2011, HUM REPROD UPDATE, V17, P121, DOI 10.1093/humupd/dmq026
   British Broadcasting Corporation, 2016, ZIK VIR TRIGG PREGN
   McNeil Jr Donald G., 2016, NY TIMES
   *NAT COLL CTR WOM, 2005, LONG ACT REV CONTR E
   Pan American Health Organization, 2016, PROV CONS CAR PREGN
   Pan American Health Organization, 2016, ZIK ETH CONS ETH GUI
   Pan American Health Organization, 2016, PAHO WHO REG RES AG
   Pan American Health Organization, 2016, CLAP WR PAHO WHO CAL
   Pan American Health Organization/ World Health Organization, 2016, GUID SURV ZIK VIR DI
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   The LGH, 2016, LANCET GLOB HLTH, V4, pe427
   United Nations Department of Economic and Social Affairs, 2015, TRENDS CONTR US WORL
   WHO, 2016, ON YEAR ZIK OUTBR OB
   WHO, 2016, PREV SEX TRANSM ZIK
   WHO, 2016, PREGN MAN CONT ZIK V
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, INF FEED AR ZIK VIR
   World Health Organization, 2015, MED EL CRIT CONTR US
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 19
TC 4
Z9 4
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1362-5187
EI 1473-0782
J9 EUR J CONTRACEP REPR
JI Eur. J. Contracept. Reprod. Health Care
PY 2017
VL 22
IS 2
BP 102
EP 106
DI 10.1080/13625187.2017.1288902
PG 5
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology
GA EQ5PB
UT WOS:000398134000004
PM 28256913
OA Other Gold
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Espinoza-Flores, LA
AF Rodriguez-Morales, Alfonso J.
   Espinoza-Flores, Luisa Alejandra
TI Should we be worried about sexual transmission of Zika and other
   arboviruses?
SO INTERNATIONAL MARITIME HEALTH
LA English
DT Letter
ID VIRUS
C1 [Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Espinoza-Flores, Luisa Alejandra] Hosp Roatan, Thicket Mouth Rd, Coxen Hole, Roatan Isl, Honduras.
   [Espinoza-Flores, Luisa Alejandra] Univ Nacl Autonoma Honduras, Fac Med Sci, Tegucigalpa, Honduras.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Joob B, 2016, INT MARIT HEALTH, V67, P260, DOI 10.5603/IMH.2016.0046
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Kuna A, 2016, INT MARIT HEALTH, V67, P179, DOI 10.5603/IMH.2016.0033
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
NR 6
TC 0
Z9 0
U1 0
U2 0
PU VIA MEDICA
PI GDANSK
PA UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND
SN 1641-9251
EI 2081-3252
J9 INT MARIT HEALTH
JI Int. Marit. Health
PY 2017
VL 68
IS 1
BP 68
EP 69
DI 10.5603/IMH.2017.0011
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ER6PJ
UT WOS:000398927500011
PM 28357839
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Zammarchi, L
   Spinicci, M
   Bartoloni, A
AF Zammarchi, Lorenzo
   Spinicci, Michele
   Bartoloni, Alessandro
TI The Importance of Updating and Continuous Education on Imported Emerging
   Diseases
SO MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
LA English
DT Letter
DE Zika virus; Emerging Diseases
C1 [Zammarchi, Lorenzo; Spinicci, Michele; Bartoloni, Alessandro] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy.
   [Zammarchi, Lorenzo; Bartoloni, Alessandro] Azienda Osped Univ Careggi, SOD Malattie Infett & Trop, Florence, Italy.
RP Bartoloni, A (corresponding author), Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy.; Bartoloni, A (corresponding author), Azienda Osped Univ Careggi, SOD Malattie Infett & Trop, Florence, Italy.
EM alessandro.bartoloni@unifi.it
RI BARTOLONI, ALESSANDRO/K-3403-2018
OI BARTOLONI, ALESSANDRO/0000-0001-9758-1523; ZAMMARCHI,
   Lorenzo/0000-0003-0892-8404
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Hayes EB, 2009, EMERG INFECT DIS
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Wiwanitkit S, 2016, J FORMOS MED ASSOC, V115, P822, DOI 10.1016/j.jfma.2016.06.003
   Wiwanitkit V, 2017, MEDITERR J HEMATOL I, V9, DOI 10.4084/MJHID.2017.016
   Zammarchi L, 2016, EMERG INFECT DIS
   Zammarchi L, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.056
NR 8
TC 0
Z9 0
U1 0
U2 2
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 2035-3006
J9 MEDITERR J HEMATOL I
JI Med. J. Hematol. Infect. Dis.
PY 2017
VL 9
AR e2017022
DI 10.4084/MJHID.2017.022
PG 2
WC Hematology; Infectious Diseases
SC Hematology; Infectious Diseases
GA EP9QT
UT WOS:000397708800004
PM 28293410
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Luksic, B
   Pandak, N
   Drazic-Maras, E
   Karabuva, S
   Radic, M
   Babic-Erceg, A
   Barbic, L
   Stevanovic, V
   Vilibic-Cavlek, T
AF Luksic, Boris
   Pandak, Nenad
   Drazic-Maras, Edita
   Karabuva, Svjetlana
   Radic, Mislav
   Babic-Erceg, Andrea
   Barbic, Ljubo
   Stevanovic, Vladimir
   Vilibic-Cavlek, Tatjana
TI First case of imported chikungunya infection in Croatia, 2016
SO INTERNATIONAL MEDICAL CASE REPORTS JOURNAL
LA English
DT Article
DE chikungunya; imported; Croatia
ID VIRUS CHIKV INFECTION; SEROPREVALENCE
AB In recent years, several European countries reported cases of imported chikungunya infection. We present the first imported clinically manifested chikungunya fever in Croatia. A 27-year-old woman returned to Croatia on 21 March 2016, after she stayed in Costa Rica for two months where she had noticed a mosquito bite on her left forearm. Five days after the mosquito bite she developed severe arthralgias, fever and erythematous papular rash. In next few days symptoms gradually subsided. After ten days she felt better, but arthralgias re-appeared accompanied with morning stiffness. Two weeks after the onset of the disease she visited the infectious diseases outpatient department. The physical examination revealed rash on the trunk, extremities, palms and soles. Laboratory findings showed slightly elevated liver transaminases. Serological tests performed on day 20 after disease onset showed a high titer of chikungunya virus (CHIKV) IgM and IgG antibodies which indicated CHIKV infection. CHIKV-RNA was not detected. Serology to dengue and Zika virus was negative. The patient was treated with nonsteroid anti-inflammatory drugs and paracetamol. Her symptoms ameliorated, however, three months later she still complaint of arthralgias. The presented case highlights the need for inclusion of CHIKV in the differential diagnosis of arthralgia in all travelers returning from countries with documented CHIKV transmission.
C1 [Luksic, Boris; Drazic-Maras, Edita; Karabuva, Svjetlana] Univ Hosp Ctr Split, Clin Dept Infect Dis, Split, Croatia.
   [Luksic, Boris; Pandak, Nenad; Radic, Mislav] Univ Split, Sch Med, Split, Croatia.
   [Pandak, Nenad] Gen Hosp Dr Josip Bencev, Dept Infect Dis, Andrije Stampara 42, Slavonski Brod 350002, Croatia.
   [Radic, Mislav] Univ Hosp Ctr Split, Dept Rheumatol & Clin Immunol, Split, Croatia.
   [Barbic, Ljubo; Vilibic-Cavlek, Tatjana] Croatian Natl Inst Publ Hlth, Zagreb, Croatia.
   [Barbic, Ljubo; Stevanovic, Vladimir] Univ Zagreb, Fac Vet Med, Dept Microbiol & Infect Dis Clin, Zagreb 41000, Croatia.
   [Vilibic-Cavlek, Tatjana] Minist Hlth Republ Crotia, Reference Ctr Diag & Surveillance Viral Zoonoses, Zagreb, Croatia.
   [Vilibic-Cavlek, Tatjana] Univ Zagreb, Sch Med, Zagreb 41000, Croatia.
RP Pandak, N (corresponding author), Gen Hosp Dr Josip Bencev, Dept Infect Dis, Andrije Stampara 42, Slavonski Brod 350002, Croatia.
EM npandak@gmail.com
RI Luksic, Boris/E-4071-2017; Vilibic-Cavlek, Tatjana/AAI-2010-2019; Radic,
   Mislav/H-3306-2017
OI Luksic, Boris/0000-0002-3823-457X; Radic, Mislav/0000-0003-0350-6800
CR Angelini R, 2007, Euro Surveill, V12
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P410
   Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161
   Bottieau E, 2009, EUROSURVEILLANCE, V14, P2
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Pfeffer Martin, 2008, Wien Klin Wochenschr, V120, P95, DOI 10.1007/s00508-008-1035-0
   Receveur M, 2010, EUROSURVEILLANCE, V15, P7
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Riswari SF, 2016, J CLIN VIROL, V74, P61, DOI 10.1016/j.jcv.2015.11.017
   Rossini G, 2016, EPIDEMIOL INFECT, V144, P1912, DOI 10.1017/S0950268815002940
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Smith DR, 2009, AM J TROP MED HYG, V81, P679, DOI 10.4269/ajtmh.2009.09-0138
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623
   Tsiodras S, 2016, PATHOG GLOB HEALTH, V110, P68, DOI 10.1080/20477724.2016.1176311
   Vilibic-Cavlek T, 2015, ACTA MICROBIOL IMM H, V62, P199, DOI 10.1556/030.62.2015.2.9
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
NR 21
TC 5
Z9 5
U1 0
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1179-142X
J9 INT MED CASE REP J
JI INT. MED. CASE REP. J.
PY 2017
VL 10
BP 117
EP 121
DI 10.2147/IMCRJ.S130210
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA EQ4FA
UT WOS:000398029000001
PM 28435330
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Update: Interim Guidance for Preconception Counseling and Prevention of
   Sexual Transmission of Zika Virus for Persons with Possible Zika Virus
   Exposure
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
CR 2016, MMWR, V65, P75101
NR 1
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 1
PY 2017
VL 64
IS 1
BP I
EP II
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP1CN
UT WOS:000397123100004
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI US CDC Issues Zika Travel Advisory For 11 Southeast Asian Countries
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 1
PY 2017
VL 64
IS 1
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP1CN
UT WOS:000397123100003
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Adult, Larval Insecticides Pack Deadly Punch to Mosquitoes, Zika: United
   States
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 1
PY 2017
VL 64
IS 1
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP1CN
UT WOS:000397123100002
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Vela Diagnostics Receives FDA Emergency Use Authorization for Zika Virus
   Molecular Assay
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 1
PY 2017
VL 64
IS 1
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP1CN
UT WOS:000397123100006
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Zika No Threat to Plasma-Derived Drugs, Says EU Regulator
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN 1
PY 2017
VL 64
IS 1
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP1CN
UT WOS:000397123100005
DA 2020-07-08
ER

PT J
AU Packard, RM
AF Packard, Randall M.
TI ZIKA, THE EMERGING EPIDEMIC
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Book Review
C1 [Packard, Randall M.] Johns Hopkins Univ, Baltimore, MD USA.
RP Packard, RM (corresponding author), Johns Hopkins Univ, Inst Hist Med, 1900 East Monument St, Baltimore, MD 21205 USA.
EM rpackar2@jhmi.edu
CR McNeil D., 2016, ZIKA EMERGING EPIDEM
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD JAN
PY 2017
VL 107
IS 1
BP 9
EP 10
DI 10.2105/AJPH.2016.303556
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EO2KD
UT WOS:000396524500013
PM 27925821
OA Green Published
DA 2020-07-08
ER

PT S
AU Everts, M
   Cihlar, T
   Bostwick, JR
   Whitley, RJ
AF Everts, Maaike
   Cihlar, Tomas
   Bostwick, J. Robert
   Whitley, Richard J.
BE Insel, PA
TI Accelerating Drug Development: Antiviral Therapies for Emerging Viruses
   as a Model
SO ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57
SE Annual Review of Pharmacology and Toxicology
LA English
DT Review; Book Chapter
DE drug discovery; antivirals; emerging infections
ID WEST-NILE-VIRUS; EBOLA-VIRUS; DENGUE VIRUS; ZIKA VIRUS; PROTEASE
   INHIBITORS; HUMAN CORONAVIRUS; VIRAL-INFECTIONS; ANIMAL-MODELS;
   UNITED-STATES; DISEASE
AB Drug discovery and development is a lengthy and expensive process. Although no one, simple, single solution can significantly accelerate this process, steps can be taken to avoid unnecessary delays. Using the development of antiviral therapies as a model, we describe options for acceleration that cover target selection, assay development and high-throughput screening, hit confirmation, lead identification and development, animal model evaluations, toxicity studies, regulatory issues, and the general drug discovery and development infrastructure. Together, these steps could result in accelerated timelines for bringing antiviral therapies to market so they can treat emerging infections and reduce human suffering.
C1 [Everts, Maaike; Whitley, Richard J.] Univ Alabama Birmingham, Dept Pediat, Div Infect Dis, Birmingham, AL 35233 USA.
   [Cihlar, Tomas] Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA.
   [Bostwick, J. Robert] Southern Res, Drug Discovery Div, Birmingham, AL 35205 USA.
RP Everts, M (corresponding author), Univ Alabama Birmingham, Dept Pediat, Div Infect Dis, Birmingham, AL 35233 USA.
EM maaike@uab.edu; tomas.cihlar@gilead.com; bbostwick@southernresearch.org;
   rwhitley@peds.uab.edu
OI Everts, Maaike/0000-0001-7421-4691
CR Arden KE, 2005, J MED VIROL, V75, P455, DOI 10.1002/jmv.20288
   Asselah T, 2016, LIVER INT, V36, P47, DOI 10.1111/liv.13027
   Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249
   Baker M, 2016, NATURE, V530, P141, DOI 10.1038/nature.2016.19269
   Bastien N, 2005, J INFECT DIS, V191, P503, DOI 10.1086/426869
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530
   Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7
   Cho A, 2012, BIOORG MED CHEM LETT, V22, P2705, DOI 10.1016/j.bmcl.2012.02.105
   Chow SC, 2014, ANNU REV MED, V65, P405, DOI 10.1146/annurev-med-092012-112310
   Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014
   Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309
   Cooper B, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001815
   Cox E, 2014, NEW ENGL J MED, V371, P2350, DOI 10.1056/NEJMp1414145
   Cox JT, 2004, J WOMENS HEALTH, V13, P265, DOI 10.1089/154099904323016428
   De Clercq E, 2007, ANTIVIR RES, V75, P1, DOI 10.1016/j.antiviral.2006.10.006
   De Luca A, 2014, CURR OPIN PHARMACOL, V18, P9, DOI 10.1016/j.coph.2014.07.016
   Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Everts M, 2016, FUTURE VIROL, V11, P187, DOI 10.2217/fvl-2015-0011
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FDA (US Food Drug Admin.), 2015, CDER BREAKTHR THER D
   FDA (US Food Drug Admin.), 2015, FDA ACC DEV NEW PHAR
   Feng JY, 2016, ANTIMICROB AGENTS CH, V60, P806, DOI 10.1128/AAC.01922-15
   Frye S, 2011, NAT REV DRUG DISCOV, V10, P409, DOI 10.1038/nrd3462
   Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214
   Glass JD, 2002, NEW ENGL J MED, V347, P1280, DOI 10.1056/NEJM200210173471616
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Jacobs M, 2015, LANCET INFECT DIS, V15, P1300, DOI 10.1016/S1473-3099(15)00228-5
   Jafri SMR, 2010, CLIN LIVER DIS, V14, P425, DOI 10.1016/j.cld.2010.05.005
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   Kowalski S. P., 2007, Intellectual property management in health and agricultural innovation: a handbook of best practices, Volumes 1 and 2, P1329
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lee SMY, 2012, ANTIVIR RES, V96, P391, DOI 10.1016/j.antiviral.2012.09.013
   Leis AA, 2002, NEW ENGL J MED, V347, P1279, DOI 10.1056/NEJM2002c021587
   Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850
   Lisziewicz J, 2003, DRUG SAFETY, V26, P605, DOI 10.2165/00002018-200326090-00002
   Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838
   Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099
   Messacar K, 2016, J MED VIROL, V88, P739, DOI 10.1002/jmv.24410
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Naeger LK, 2010, ANTIVIR RES, V85, P232, DOI 10.1016/j.antiviral.2009.07.016
   Nakamura M, 2016, WORLD J HEPATOL, V8, P183, DOI 10.4254/wjh.v8.i3.183
   Nhan TX, 2014, EMERG INFECT DIS, V20, P1773, DOI 10.3201/eid2010.141060
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Norman T, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002399
   Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Scannell JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147215
   Slusher BS, 2013, NAT REV DRUG DISCOV, V12, P811, DOI 10.1038/nrd4155
   Song YN, 2014, COMB CHEM HIGH T SCR, V17, P536, DOI 10.2174/1386207317666140122101631
   US Department of Health and Human Services, 2015, PROD DEV AN RUL GUID
   Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874
   van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 60
TC 7
Z9 7
U1 3
U2 19
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0362-1642
BN 978-0-8243-0457-7
J9 ANNU REV PHARMACOL
JI Annu. Rev. Pharmacol. Toxicol.
PY 2017
VL 57
BP 155
EP 169
DI 10.1146/annurev-pharmtox-010716-104533
PG 15
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA BH0QN
UT WOS:000396044800009
PM 27483339
DA 2020-07-08
ER

PT J
AU Duca, LM
   Beckham, JD
   Tyler, KL
   Pastula, DM
AF Duca, Lindsey M.
   Beckham, J. David
   Tyler, Kenneth L.
   Pastula, Daniel M.
TI Zika Virus Disease and Associated Neurologic Complications
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Zika; Zika virus; Arbovirus; Flavivirus; Neurologic; Guillain-Barre
   syndrome
ID UPDATE INTERIM GUIDANCE; GUILLAIN-BARRE-SYNDROME; SEXUAL TRANSMISSION;
   UNITED-STATES; PUERTO-RICO; INFECTION; BRAZIL; TRAVELERS; OUTBREAK;
   INFANTS
AB Purpose of Review The purpose of this article is to review what is currently known about Zika virus (ZIKV) disease and associated neurologic complications.
   Recent Findings ZIKV is a mosquito-borne or sexually transmitted flavivirus rapidly spreading throughout the Americas. While ZIKV infection is usually asymptomatic, it may cause a non-specific illness with fever, rash, myalgia, headache, and/or non-purulent conjunctivitis. Additionally, ZIKV has been associated with a number of neurologic complications including microcephaly and other birth defects, Guillain-Barre syndrome, meningoencephalitis, myelitis, and various ophthalmologic abnormalities.
   Summary Treatment for ZIKV disease is supportive. Those in ZIKVendemic areas should protect themselves from mosquito bites by wearing insect repellent, wearing long-sleeved shirts and pants when outdoors, and/or using air conditioning or window screens when indoors. Furthermore, unprotected sexual intercourse should be temporarily avoided by those who recently traveled to endemic areas. Suspected ZIKV disease cases should be reported to local, state, or territorial health departments.
C1 [Duca, Lindsey M.; Pastula, Daniel M.] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO 80045 USA.
   [Beckham, J. David; Tyler, Kenneth L.; Pastula, Daniel M.] Univ Colorado Denver, Dept Neurol, Neuroinfect Dis Grp, Aurora, CO 80045 USA.
   [Beckham, J. David; Tyler, Kenneth L.; Pastula, Daniel M.] Univ Colorado Denver, Div Infect Dis, Aurora, CO 80045 USA.
   [Pastula, Daniel M.] Univ Colorado, Sch Med, 12401 East 17th Ave,Room 486,Mailstop L950, Aurora, CO 80045 USA.
RP Pastula, DM (corresponding author), Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO 80045 USA.; Pastula, DM (corresponding author), Univ Colorado, Sch Med, 12401 East 17th Ave,Room 486,Mailstop L950, Aurora, CO 80045 USA.
EM Daniel.Pastula@ucdenver.edu
RI Tyler, Kenneth L./J-2420-2019; Beckham, John/AAE-6694-2020; Pastula,
   Daniel M./M-1325-2019
OI Tyler, Kenneth L./0000-0003-3294-5888; Beckham,
   John/0000-0001-9305-2683; Pastula, Daniel M./0000-0001-9342-4459; Duca,
   Lindsey/0000-0003-2998-646X
FU BLRD VA [I01 BX003863]
CR [Anonymous], 2014, TEST ZIK VIR
   [Anonymous], 2014, ZIK VIR PREV MOSQ BI
   [Anonymous], 2014, ZIK VIR CAS COUNT US
   [Anonymous], 2014, TRANSM ZIK VIR
   [Anonymous], 2014, TREATM ZIK VIR
   [Anonymous], 2014, ZIK VIR HLTH EFF RIS
   [Anonymous], 2014, PROT ZIK VIR SEX
   [Anonymous], 2016, COUNTR TERR ACT LOC
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Besnard M, 2014, EURO SURVEILL B EUR, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Clinical Guidance for Healthcare Providers Caring for Infants and Children, 2014, CLIN GUID HEALTHC PR
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   De Freitas B Paula, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaopthalmol.2016.0267, DOI 10.1001/JAMAOPTHALMOL.2016.0267]
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET LOND ENGL, V387, P1051
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Ferreira ML, 2016, AM AC NEUR 68 ANN M
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freour T, 2016, EURO SURVEILL B EUR, V21
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Kleber de Oliveira W, 2016, MMWR-MORBID MORTAL W, V65, P242
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mitchell C., 2016, PAHO WHO ZIKA CUMULA
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Parke DW, 2016, OPHTHALMOLOGY, DOI [10.1016/j.optha.2016.06.039., DOI 10.1016/J.OPTHA.2016.06.039, 10.1016/j.optha.2016.06.039]
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Styczynski AR, 2016, EP INT SERV C ATL
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zika Virus Symptoms, 2014, ZIK VIR SYMPT
NR 89
TC 12
Z9 12
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD JAN
PY 2017
VL 19
IS 1
AR 4
DI 10.1007/s11908-017-0557-x
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA EM0GX
UT WOS:000394997900004
PM 28220392
DA 2020-07-08
ER

PT J
AU Diniz, D
   Gumieri, S
   Bevilacqua, BG
   Cook, RJ
   Dickens, BM
AF Diniz, Debora
   Gumieri, Sinara
   Bevilacqua, Beatriz Galli
   Cook, Rebecca J.
   Dickens, Bernard M.
TI Zika virus infection in Brazil and human rights obligations
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Children's rights; Congenital Zika virus syndrome; Disability rights;
   Human rights; Public health; Women's rights; Zika infection
ID HEALTH EQUITY; AMERICA
AB The February 2016 WHO declaration that congenital Zika virus syndrome constitutes a Public Health Emergency of International Concern reacted to the outbreak of the syndrome in Brazil. Public health emergencies can justify a spectrum of human rights responses, but in Brazil, the emergency exposed prevailing inequities in the national healthcare system. The government's urging to contain the syndrome, which is associated with microcephaly among newborns, is confounded by lack of reproductive health services. Women with low incomes in particular have little access to such health services. The emergency also illuminates the harm of restrictive abortion legislation, and the potential violation of human rights regarding women's health and under the UN Conventions on the Rights of the Child and on the Rights of Persons with Disabilities. Suggestions have been proposed by which the government can remedy the widespread healthcare inequities among the national population that are instructive for other countries where congenital Zika virus syndrome is prevalent.
C1 [Diniz, Debora] Univ Brasilia, Fac Law, Brasilia, DF, Brazil.
   [Gumieri, Sinara] Anis Inst Bioeth, Brasilia, DF, Brazil.
   [Bevilacqua, Beatriz Galli] Ipas, Rio De Janeiro, Brazil.
   [Cook, Rebecca J.; Dickens, Bernard M.] Univ Toronto, Fac Med, Fac Law, Toronto, ON, Canada.
   [Cook, Rebecca J.; Dickens, Bernard M.] Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada.
RP Dickens, BM (corresponding author), Univ Toronto, Fac Law, Toronto, ON, Canada.
EM bernard.dickens@utoronto.ca
RI Diniz, Debora/K-9000-2012
OI Diniz, Debora/0000-0001-6987-2569
CR Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Barroso LR, 2014, PA STUD HUM RIGHTS, P258
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   Bayer R, 2004, BIOETHICS, V18, P473, DOI 10.1111/j.1467-8519.2004.00412.x
   Boseley S, 2016, GUARDIAN
   Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   COOK Rebecca, 2012, UN CONVENTION ELIMIN, P311
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Diniz D., 2016, NY TIMES
   Diniz D, 2016, DEV WORLD BIOETH, V16, P62, DOI 10.1111/dewb.12119
   Diniz D, 2010, CIENC SAUDE COLETIVA, V15, P959, DOI 10.1590/S1413-81232010000700002
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Erdman JN, 2009, AM J LAW MED, V35, P365, DOI 10.1177/009885880903500207
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Galli B., 2011, U MIAMI L REV, V65, p[969, 970]
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Jenkins A., 1961, LAW RICH PLEA REFORM
   Langer A, 2016, STUD FAMILY PLANN, V47, P179, DOI 10.1111/j.1728-4465.2016.00058.x
   Lopes da Costa A., 2013, SUR, V19, P175
   Maisonnave F., 2016, FOLHA SAO PAULO 0912
   Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7
   Maurice J, 2016, LANCET, V387, P733, DOI 10.1016/S0140-6736(16)00390-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Selgelid MJ, 2011, GLOBAL HEALTH AND GLOBAL HEALTH ETHICS, P89
   Sun L., 2016, WASHINGTON POST
   Tierney L., 2016, BIONEWS, V857
   UN Committee on Economic Social and Cultural Rights, 2016, EC12GC22 UN COMM EC
   United Nations, 1994, INT C POP DEV CAIR 5
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Webb JLA, 2016, LANCET, V388, P556, DOI 10.1016/S0140-6736(16)31225-9
   WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Yamin AE, 2016, SUFFERING STRUGGLE D
   Zika Diniz D., 2016, ZIKA SERTAO NORDESTI
NR 37
TC 14
Z9 14
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2017
VL 136
IS 1
BP 105
EP 110
DI 10.1002/ijgo.12018
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EP0SW
UT WOS:000397098000021
PM 28099714
DA 2020-07-08
ER

PT J
AU Veletzky, L
   Knafl, D
   Schuster, C
   Aberle, SW
   Stiasny, K
   Ramharter, M
   Lagler, H
AF Veletzky, Luzia
   Knafl, Daniela
   Schuster, Christopher
   Aberle, Stephan W.
   Stiasny, Karin
   Ramharter, Michael
   Lagler, Heimo
TI Zika virus-induced itching rash in a returning traveller from Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Veletzky, Luzia; Knafl, Daniela; Ramharter, Michael; Lagler, Heimo] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
   [Schuster, Christopher] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria.
   [Aberle, Stephan W.; Stiasny, Karin] Med Univ Vienna, Dept Virol, Vienna, Austria.
RP Lagler, H (corresponding author), Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM heimo.lagler@meduniwien.ac.at
RI ; Ramharter, Michael/C-5273-2013
OI Gerges, Daniela/0000-0001-6810-615X; Ramharter,
   Michael/0000-0002-9259-1885; Lagler, Heimo/0000-0003-3240-7385; Stiasny,
   Karin/0000-0002-1902-8674; Veletzky, Luzia/0000-0002-6136-8170
CR Brasil P, 2016, N ENGL J MED
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   European Centre for Disease Prevention and Control, 2016, FACTSH HLTH PROF ZIK
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
NR 5
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JAN
PY 2017
VL 54
BP 13
EP 14
DI 10.1016/j.ijid.2016.11.004
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA EO0YY
UT WOS:000396425800004
PM 27832979
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Li, XF
   Li, XD
   Deng, CL
   Dong, HL
   Zhang, QY
   Ye, Q
   Ye, HQ
   Huang, XY
   Deng, YQ
   Zhang, B
   Qin, CF
AF Li, Xiao-Feng
   Li, Xiao-Dan
   Deng, Cheng-Lin
   Dong, Hao-Long
   Zhang, Qiu-Yan
   Ye, Qing
   Ye, Han-Qing
   Huang, Xing-Yao
   Deng, Yong-Qiang
   Zhang, Bo
   Qin, Cheng-Feng
TI Visualization of a neurotropic flavivirus infection in mouse reveals
   unique viscerotropism controlled by host type I interferon signaling
SO THERANOSTICS
LA English
DT Article
DE Flavivirus; Japanese encephalitis virus; Bioluminescence imaging; Mouse;
   Interferon signaling
ID JAPANESE ENCEPHALITIS-VIRUS; GLYCOSAMINOGLYCAN-BINDING VARIANTS;
   WEST-NILE; DENGUE VIRUS; CODING REGION; MICE; PATHOGENESIS; REPLICATION;
   GENOME; FEVER
AB Flavivirus includes a large group of human pathogens with medical importance. Especially, neurotropic flaviviruses capable of invading central and peripheral nervous system, e.g. Japanese encephalitis virus (JEV) and Zika virus (ZIKV), are highly pathogenic to human and constitute major global health problems. However, the dynamic dissemination and pathogenesis of neurotropic flavivirus infections remain largely unknown. Here, using JEV as a model, we rationally designed and constructed a recombinant reporter virus that stably expressed Renilla luciferase (Rluc). The resulting JEV reporter virus (named Rluc-JEV) and parental JEV exhibited similar replication and infection characteristics, and the magnitude of Rluc activity correlated well with progeny viral production in vitro and in vivo. By using in vivo bioluminescence imaging (BLI) technology, we dissected the replication and dissemination dynamics of JEV infection in mice upon different inoculation routes. Interestingly, besides replicating in mouse brain, Rluc-JEV predominantly invaded the abdominal organs in mice with typical viscerotropism. Further tests in mice deficient in type I interferon (IFN) receptors demonstrated robust and prolonged viral replication in the intestine, spleen, liver, kidney and other abdominal organs. Combined with histopathological and immunohistochemical results, the host type I IFN signaling was evidenced as the major barrier to the viscerotropism and pathogenicity of this neurotropic flavivirus. Additionally, the Rluc-JEV platform was readily adapted for efficacy assay of known antiviral compounds and a live JE vaccine. Collectively, our study revealed abdominal organs as important targets of JEV infection in mice and profiled the unique viscerotropism trait controlled by the host type I IFN signaling. This in vivo visualization technology described here provides a powerful tool for testing antiviral agents and vaccine candidates for flaviviral infection.
C1 [Li, Xiao-Feng; Dong, Hao-Long; Ye, Qing; Huang, Xing-Yao; Deng, Yong-Qiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Li, Xiao-Dan; Deng, Cheng-Lin; Zhang, Qiu-Yan; Ye, Han-Qing; Zhang, Bo] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430072, Peoples R China.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Zhang, B (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430072, Peoples R China.
EM zhangbo@wh.iov.cn; qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Zhang, Bo/0000-0002-8895-3679
FU National Key Research and Development Program of China [2016YFD0500400,
   2016YFD0500304]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81572003, 31300151, 81621005,
   31470265]; Excellent Young Scientist Foundation from NSFC [81522025];
   Newton Advanced Fellowship from the UK Academy of Medical Sciences;
   NSFCNational Natural Science Foundation of China [81661130162]
FX This work was supported by the National Key Research and Development
   Program of China (No. 2016YFD0500400 and No. 2016YFD0500304), and the
   National Natural Science Foundation of China (No. 81572003, No.
   31300151, No. 81621005 and No. 31470265). Cheng-Feng Qin was supported
   by the Excellent Young Scientist Foundation from NSFC (No. 81522025) and
   the Newton Advanced Fellowship from the UK Academy of Medical Sciences
   and NSFC (No. 81661130162). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x
   Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   CDC, 1999, W NIL VIR DIS CAS DE
   Centers for Disease C Prevention. Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001, MMWR-MORBID MORTAL W, V51, P989
   Chan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7
   Chang MH, 2011, JOVE-J VIS EXP, DOI 10.3791/2547
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Harmache A, 2006, J VIROL, V80, P3655, DOI 10.1128/JVI.80.7.3655-3659.2006
   HUANG CH, 1963, ACTA VIROL, V7, P322
   Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x
   IGARASHI A, 1994, MICROBIOL IMMUNOL, V38, P827, DOI 10.1111/j.1348-0421.1994.tb01866.x
   Le Flohic G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002208
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002
   Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005
   Li XT, 2014, 2015 7th International Conference on Modelling, Identification and Control (ICMIC), P95
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li XF, 2013, APPL MICROBIOL BIOT, V97, P4589, DOI 10.1007/s00253-013-4799-8
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lobigs M, 2003, J GEN VIROL, V84, P567, DOI 10.1099/vir.0.18654-0
   Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002
   Luker KE, 2005, VIROLOGY, V341, P284, DOI 10.1016/j.virol.2005.06.049
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P49
   Mandl S, 2002, J CELL BIOCHEM, P239, DOI 10.1002/jcb.10454
   Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107
   Martin M, 2001, LANCET, V358, P98, DOI 10.1016/S0140-6736(01)05327-2
   MATHUR A, 1981, INFECT IMMUN, V34, P26, DOI 10.1128/IAI.34.1.26-29.1981
   MATHUR A, 1989, J GEN VIROL, V70, P461, DOI 10.1099/0022-1317-70-2-461
   Pan WQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3369
   PAUL WS, 1993, J INFECT DIS, V167, P1053, DOI 10.1093/infdis/167.5.1053
   Peltier DC, 2013, J VIROL, V87, P1821, DOI 10.1128/JVI.02858-12
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rameix-Welti MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6104
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Solomon T, 2002, CURR TOP MICROBIOL, V267, P171
   Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263
   Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004
   Tokusumi T, 2002, VIRUS RES, V86, P33, DOI 10.1016/S0168-1702(02)00047-3
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   Wang LC, 2010, ANTIVIR RES, V87, P50, DOI 10.1016/j.antiviral.2010.04.010
   Welte T, 2009, J GEN VIROL, V90, P2660, DOI 10.1099/vir.0.011783-0
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zaitseva M, 2009, J VIROL, V83, P10437, DOI 10.1128/JVI.01296-09
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhang PT, 2016, VIRUS RES, V211, P17, DOI 10.1016/j.virusres.2015.09.015
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 61
TC 12
Z9 12
U1 0
U2 10
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2017
VL 7
IS 4
BP 912
EP 925
DI 10.7150/thno.16615
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EO2XP
UT WOS:000396559600009
PM 28382163
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Theall, KP
   Wallace, M
   Wesson, DM
AF Theall, Katherine P.
   Wallace, Maeve
   Wesson, Dawn M.
TI Zika: A Missed Opportunity to Protect Women's Health and Prevent
   Unwanted Pregnancies
SO WOMENS HEALTH ISSUES
LA English
DT Editorial Material
ID UNITED-STATES; REPRODUCTIVE HEALTH; UNINTENDED PREGNANCY; VIRUS;
   DISPARITIES; PREPAREDNESS; AMERICA; CDC
C1 [Theall, Katherine P.; Wallace, Maeve] Tulane Sch Publ Hlth Trop Med, Dept Global Community Hlth & Behav Sci, 1440 Canal St, New Orleans, LA 70112 USA.
   [Theall, Katherine P.] Mary Amelia Douglas Whited Community Womens Hlth, New Orleans, LA USA.
   [Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA.
RP Theall, KP (corresponding author), Tulane Sch Publ Hlth Trop Med, Dept Global Community Hlth & Behav Sci, 1440 Canal St, New Orleans, LA 70112 USA.
EM ktheall@tulane.edu
FU Frost Foundation; Tulane Cecile Usdin Professorship in Women's Health
FX As principal investigator on this manuscript, I, Katherine Theall, had
   full access to all the data in the study and take responsibility for the
   integrity of the data and the accuracy of the data analysis. This
   research was supported by the Frost Foundation and the Tulane Cecile
   Usdin Professorship in Women's Health.
CR American College of Obstetricians Gynecologists, 2015, OBSTET GYNECOLOGY, V118, P184
   [Anonymous], 2016, HLTH COV TRENDS US W
   Auerbach J, 2016, J PUBLIC HEALTH MAN, V22, P215, DOI 10.1097/PHH.0000000000000381
   Bearak JM, 2016, CONTRACEPTION, V93, P139, DOI 10.1016/j.contraception.2015.08.018
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   Brasil P., 2016, NEW ENGLAND J MED
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Centers for Disease Control and Prevention, 2016, ZIK TRANSM RISK
   Centers for Disease Control and Prevention, 2016, EST RANG AED ALB AED
   Centers for Disease Control and Prevention, 2011, EFF FAM PLANN METH
   Centers for Disease Control and Prevention, 2016, OUTC PREGN LAB EV PO
   Creanga AA, 2015, OBSTET GYNECOL, V125, P5, DOI 10.1097/AOG.0000000000000564
   Daniels Kimberly, 2015, Natl Health Stat Report, P1
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Dreweke J, 2016, GUTTMACHER POLICY RE, V19
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Frost JJ, 2013, CONTRACEPTIVE NEEDS
   Frost JJ, 2014, CONTRACEPTIVE NEEDS
   Gavin L, 2014, MMWR RECOMM REP, V63, P1
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Guttmacher Institute, 2015, CONTR US US
   Hall KS, 2012, AM J PUBLIC HEALTH, V102, P359, DOI 10.2105/AJPH.2011.300380
   Hathaway M, 2014, CLIN OBSTET GYNECOL, V57, P718, DOI 10.1097/GRF.0000000000000071
   Hess Cynthia, 2015, STATUS WOMEN STATES
   Johnson PJ, 2010, AM J PUBLIC HEALTH, V100, P122, DOI 10.2105/AJPH.2008.148908
   Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   NARAL - Pro Choice America Foundation, 2015, WHO DEC STAT WOM REP
   Ngui E. M., 2016, J RACIAL ETHNIC HLTH
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Sonfield A., 2013, GUTTMACHER POLICY RE, V16
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
   Walker LO, 2010, JOGNN-J OBST GYN NEO, V39, P328, DOI 10.1111/j.1552-6909.2010.01144.x
   Wright RL, 2015, SOC WORK, V60, P295, DOI 10.1093/sw/swv028
   Zotti ME, 2016, J WOMENS HEALTH, V25, P861, DOI 10.1089/jwh.2016.5993
NR 40
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1049-3867
EI 1878-4321
J9 WOMEN HEALTH ISS
JI Womens Health Iss.
PD JAN-FEB
PY 2017
VL 27
IS 1
BP 2
EP 4
DI 10.1016/j.whi.2016.10.005
PG 3
WC Public, Environmental & Occupational Health; Women's Studies
SC Public, Environmental & Occupational Health; Women's Studies
GA EO1EX
UT WOS:000396442300001
PM 27876484
OA Bronze
DA 2020-07-08
ER

PT J
AU Attaway, DF
   Waters, NM
   Geraghty, EM
   Jacobsen, KH
AF Attaway, David F.
   Waters, Nigel M.
   Geraghty, Estella M.
   Jacobsen, Kathryn H.
TI Zika virus: Endemic and epidemic ranges of Aedes mosquito transmission
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Geographic; information systems; Geographic; information science; Risk
   mapping; Zika; Aedes modeling
AB As evidence linking Zika virus with serious health complications strengthens, public health officials and clinicians worldwide need to know which locations are likely to be at risk for autochthonous Zika infections. We created risk maps for epidemic and endemic Aedes-borne Zika virus infections globally using a predictive analysis method that draws on temperature, precipitation, elevation, land cover, and population density variables to identify locations suitable for mosquito activity seasonally or year-round. Aedes mosquitoes capable of transmitting Zika and other viruses are likely to live year-round across many tropical areas in the Americas, Africa, and Asia. Our map provides an enhanced global projection of where vector control initiatives may be most valuable for reducing the risk of Zika virus and other Aedes-borne infections. (C)2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
C1 [Attaway, David F.] Esri, 8615 Westwood Ctr Dr, Vienna, VA 22182 USA.
   [Waters, Nigel M.] Univ Calgary, Calgary, AB, Canada.
   [Geraghty, Estella M.] Esri, Redlands, CA USA.
   [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA.
RP Attaway, DF (corresponding author), Esri, 8615 Westwood Ctr Dr, Vienna, VA 22182 USA.
EM DAttaway@esri.com; nwaters@gmu.edu; EGeraghty@esri.com; kjacobse@gmu.edu
RI Jacobsen, Kathryn H./B-5857-2008
OI Jacobsen, Kathryn H./0000-0002-4198-6246; Attaway,
   David/0000-0003-1204-7626
CR Attaway DF, 2016, ACTA TROP, V158, P248, DOI 10.1016/j.actatropica.2016.02.018
   Bontemps S., 2010, GLOBCOVER 2009 PRODU
   Bright EA, 2016, LANDSCAN 2011
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Esri, 2014, ARCGIS PRED AN TOOLS
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P633
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   World Health Organization W, 2016, TECHNICAL REPORT
NR 11
TC 14
Z9 15
U1 0
U2 9
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN-FEB
PY 2017
VL 10
IS 1
BP 120
EP 123
DI 10.1016/j.jiph.2016.09.008
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EO0SQ
UT WOS:000396408600015
PM 27707632
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Villamil-Gomez, WE
   Rodriguez-Morales, AJ
AF Villamil-Gomez, Wilmer E.
   Rodriguez-Morales, Alfonso J.
TI Reply: Dengue RT-PCR-positive, Chikungunya IgM-positive and Zika
   RT-PCR-positive co-infection in a patient from Colombia
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Letter
ID LATIN-AMERICA; THREAT
C1 [Villamil-Gomez, Wilmer E.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Cartagena, Programa Doctorado Med Trop, Cartagena, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Barranquilla, Colombia.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Asociac Colombiana Infectol, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res & Incubator Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Santander, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res & Incubator Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Arzusa-Ortega L, 2016, EMERG INFECT DIS
   Faccini-Martinez AA, 2016, J INFECT PU IN PRESS
   Hoz JM, 2015, J CLIN VIROL, V69, P27, DOI DOI 10.1016/J.JCV.2015.05.021
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   National Institute of Health of Colombia, 2015, CIR CONJ EXT 061 201
   Rodriguez-Morales A.J., 2015, ARCH MED, V11, P3, DOI [10.3823/1245., DOI 10.3823/1245]
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
NR 10
TC 5
Z9 5
U1 1
U2 5
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN-FEB
PY 2017
VL 10
IS 1
BP 133
EP 134
DI 10.1016/j.jiph.2016.02.003
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EO0SQ
UT WOS:000396408600018
PM 26970698
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hussain, HF
   Hafiz, MY
   Hussain, SA
AF Hussain, Hareem F.
   Hafiz, Muhammad Y.
   Hussain, Syed A.
TI Rumor has it; the truth behind Zika virus
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Letter
C1 [Hussain, Hareem F.; Hafiz, Muhammad Y.; Hussain, Syed A.] Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan.
RP Hussain, SA (corresponding author), Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan.
EM drsahussain121@gmail.com
CR European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
NR 2
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JAN-FEB
PY 2017
VL 10
IS 1
BP 135
EP 136
DI 10.1016/j.jiph.2016.04.004
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EO0SQ
UT WOS:000396408600019
PM 27102926
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ahmed, QA
   Memish, ZA
AF Ahmed, Qanta A.
   Memish, Ziad A.
TI The public health planners' perfect storm: Hurricane Matthew and Zika
   virus
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
DE Hurricane; Natural disaster; Zika virus; Communicable diseases
ID CLIMATE-CHANGE; TRANSMISSION; DISEASE; KATRINA
AB Hurricane Matthew threatened to be one of the most powerful Hurricanes to hit the United States in a century. Fortunately, it avoided making landfall on Florida, the eye of the Hurricane remaining centered 40 miles off the Florida coast. Even so it has resulted in over $7 Billion USD in damage according to initial estimates with much of the damage ongoing in severe flooding. Response to and recovery from Hurricane Matthew challenged Florida's public health services and resources just as emergency Zika-specific congressional funding to combat Zika outbreaks in Florida had become available. Hurricanes can disrupt the urban environment in a way that increases the likelihood of vector-borne illnesses and their aftermath can severely strain the very infectious disease and infection control academe needed to combat vector-borne outbreaks. This commentary attempts to examine the challenges posed by Hurricane Matthew in Florida's efforts to contain Zika. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Ahmed, Qanta A.] Winthrop Univ Hosp, Dept Med, Div Pulm Dis & Crit Care Med, Mineola, NY 11501 USA.
   [Ahmed, Qanta A.] SUNY Stony Brook, Stony Brook, NY USA.
   [Memish, Ziad A.] Alfaisal Univ, Minist Hlth, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
RP Memish, ZA (corresponding author), Alfaisal Univ, Minist Hlth, Riyadh, Saudi Arabia.; Memish, ZA (corresponding author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
EM qahmed@winthrop.org; Zmemish@yahoo.com
CR Caillouet KA, 2008, EMERG INFECT DIS, V14, P804, DOI 10.3201/eid1405.071066
   Casey-Lockyer M, 2013, MMWR-MORBID MORTAL W, V62, P393
   Costa M, 2015, TRAVEL MED INFECT DI, V13, P449, DOI 10.1016/j.tmaid.2015.11.006
   Harris JW, 2014, ENVIRON HEALTH INSIG, V8, P29, DOI [10.4137/EHI.S16001, 10.4137/EHi.s16001]
   Howland RE, 2014, DISASTER MED PUBLIC, V8, P489, DOI 10.1017/dmp.2014.133
   Infectious Diseases Section Louisiana State University Health Science Center, 2006, CLIN INFECT DIS, V43, P485
   Iversa LC, CURR OPIN INFECT DIS, V19, P408
   Knowlton K, 2011, HEALTH AFFAIR, V30, P2167, DOI 10.1377/hlthaff.2011.0229
   Lehman JA, 2007, EMERG INFECT DIS, V13, P1273, DOI 10.3201/eid1308.061570
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   O'Leary DR, 2002, AM J TROP MED HYG, V66, P35, DOI 10.4269/ajtmh.2002.66.35
   Petkova EP, 2015, INT J ENV RES PUB HE, V12, P9342, DOI 10.3390/ijerph120809342
   Powell MD, TROPICAL CYCLONE DES, V207, P507
   Torres JR, 2015, J PEDIAT INF DIS SOC, V4, P288, DOI 10.1093/jpids/piv057
   Waring Stephen C, 2005, Disaster Manag Response, V3, P41, DOI 10.1016/j.dmr.2005.02.003
   Wilson SG, COASTLINE POPULATION
NR 16
TC 2
Z9 2
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2017
VL 15
BP 63
EP 66
DI 10.1016/j.tmaid.2016.12.004
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EO2TY
UT WOS:000396550100012
PM 28017726
DA 2020-07-08
ER

PT J
AU Rodrguez-Morales, AJ
   Paniz-Mondolfi, AE
   Villamil-Gomez, WE
   Navarro, JC
AF Rodrguez-Morales, Alfonso J.
   Paniz-Mondolfi, Alberto E.
   Villamil-Gomez, Wilmer E.
   Navarro, Juan Carlos
TI Mayaro, Oropouche and Venezuelan Equine Encephalitis viruses: Following
   in the footsteps of Zika?
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
C1 [Rodrguez-Morales, Alfonso J.] Univ Tecnol Pereira, Publ Hlth & Infect Res Incubator & Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
   [Rodrguez-Morales, Alfonso J.; Paniz-Mondolfi, Alberto E.; Villamil-Gomez, Wilmer E.; Navarro, Juan Carlos] Colombian Collaborat Network Zika & Other Arbovir, Pereira, Risaralda, Colombia.
   [Rodrguez-Morales, Alfonso J.; Paniz-Mondolfi, Alberto E.; Villamil-Gomez, Wilmer E.] Pan Amer Assoc Infect Dis, Comm Travel Med, Quito, Ecuador.
   [Rodrguez-Morales, Alfonso J.] Asociac Colombiana Infectol, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
   [Paniz-Mondolfi, Alberto E.] Hosp Int, Dept Pathol & Lab Med, Barquisimeto, Venezuela.
   [Paniz-Mondolfi, Alberto E.] IVSS, Biochem Lab, Inst Biomed, Caracas, Venezuela.
   [Villamil-Gomez, Wilmer E.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Programa Doctorado Med Trop, SUE Caribe, Barranquilla, Colombia.
   [Navarro, Juan Carlos] Univ Int SEK, Biodivers & Environm Hlth Res Grp, Nat Sci & Environm Fac, Quito, Ecuador.
   [Navarro, Juan Carlos] Cent Univ Venezuela, Vector Biol Lab IZET, Caracas, Venezuela.
RP Rodrguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Patino-Barbosa AM, 2016, J INFECT PUBLIC HEAL, V9, P532, DOI 10.1016/j.jiph.2015.10.001
NR 6
TC 20
Z9 21
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2017
VL 15
BP 72
EP 73
DI 10.1016/j.tmaid.2016.11.001
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EO2TY
UT WOS:000396550100015
PM 27826073
DA 2020-07-08
ER

PT J
AU Chiodini, J
AF Chiodini, Jane
TI 'Preventing the Zika virus: Understanding and controlling the Aedes
   Mosquito' - A free online course
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
C1 [Chiodini, Jane] Clapham Rd Surg, Bedford, England.
RP Chiodini, J (corresponding author), Clapham Rd Surg, Bedford, England.
EM janechiodini@btinternet.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2017
VL 15
BP 86
EP 87
DI 10.1016/j.tmaid.2017.01.002
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EO2TY
UT WOS:000396550100022
PM 28159620
DA 2020-07-08
ER

PT J
AU Lennemann, NJ
   Coyne, CB
AF Lennemann, Nicholas J.
   Coyne, Carolyn B.
TI Dengue and Zika viruses subvert reticulophagy by NS2B3-mediated cleavage
   of FAM134B
SO AUTOPHAGY
LA English
DT Article
DE autophagy; dengue virus; ER-phagy; FAM134B; flavivirus; reticulon;
   reticulophagy; Zika virus
ID ENDOPLASMIC-RETICULUM TURNOVER; SELECTIVE AUTOPHAGY; 3-DIMENSIONAL
   ARCHITECTURE; VIRAL REPLICATION; CELLS; INFECTION; SITES; RECEPTOR;
   INHIBITION; DEGRADES
AB The endoplasmic reticulum (ER) is exploited by several diverse viruses during their infectious life cycles. Flaviviruses, including dengue virus (DENV) and Zika virus (ZIKV), utilize the ER as a source of membranes to establish their replication organelles and to facilitate their assembly and eventual maturation along the secretory pathway. To maintain normal homeostasis, host cells have evolved highly efficient processes to dynamically regulate the ER, such as through reticulophagy, a selective form of autophagy that leads to ER degradation. Here, we identify the ER-localized reticulophagy receptor FAM134B as a host cell restriction factor for both DENV and ZIKV. We show that RNAi-mediated depletion of FAM134B significantly enhances both DENV and ZIKV replication at an early stage of the viral life cycle. Consistent with its role as an antiviral host factor, we found that several flaviviruses including DENV, ZIKV, and West Nile virus (WNV), utilize their NS3 virally-encoded proteases to directly cleave FAM134B at a single site within its reticulon homology domain (RHD). Mechanistically, we show that NS3-mediated cleavage of FAM134B blocks the formation of ER and viral protein-enriched autophagosomes, suggesting that the cleavage of FAM134B serves to specifically suppress the reticulophagy pathway. These findings thus point to an important role for FAM134B and reticulophagy in the regulation of flavivirus infection and suggest that these viruses specifically target these pathways to promote viral replication.
C1 [Lennemann, Nicholas J.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.
RP Coyne, CB (corresponding author), 427 Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15219 USA.
EM coynec2@pitt.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T32-AI049820, F32-AI122456,
   R01-AI081759]; Burroughs Wellcome Investigators in the Pathogenesis of
   Infectious Disease AwardBurroughs Wellcome Fund
FX This project was supported by NIH T32-AI049820 (N.J.L), NIH F32-AI122456
   (N.J.L), NIH R01-AI081759 (C.B.C) and a Burroughs Wellcome Investigators
   in the Pathogenesis of Infectious Disease Award (C.B.C).
CR Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bhattacharyya S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-11
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chiramel AI, 2016, J INFECT DIS, V214, pS319, DOI 10.1093/infdis/jiw270
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Farre JC, 2016, NAT REV MOL CELL BIO, V17, P537, DOI 10.1038/nrm.2016.74
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Houck SA, 2014, MOL CELL, V54, P166, DOI 10.1016/j.molcel.2014.02.025
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lipatova Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005390
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350
NR 42
TC 51
Z9 51
U1 2
U2 15
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PY 2017
VL 13
IS 2
BP 322
EP 332
DI 10.1080/15548627.2016.1265192
PG 11
WC Cell Biology
SC Cell Biology
GA EM2CY
UT WOS:000395125200008
PM 28102736
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Tosepu, R
AF Tosepu, Ramadhan
TI The Appropriate Rainfall to Development of Zika Virus: An Indonesian
   Case
SO ETHIOPIAN JOURNAL OF HEALTH SCIENCES
LA English
DT Letter
ID CLIMATE; DENGUE
C1 [Tosepu, Ramadhan] Univ Halu Oleo Kendari, Fac Publ Hlth, Dept Environm Hlth, Kendari, Southest Sulawe, Indonesia.
RP Tosepu, R (corresponding author), Univ Halu Oleo Kendari, Fac Publ Hlth, Dept Environm Hlth, Kendari, Southest Sulawe, Indonesia.
EM adhan_lpmi@yahoo.co.id
RI Tosepu, Ramadhan/P-8564-2015
OI Tosepu, Ramadhan/0000-0002-6092-9992
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Ariati J, 2012, J EKOLOGI KESEHATAN, V11, P279
   Brisbois BW, 2010, ECOHEALTH, V7, P425, DOI 10.1007/s10393-010-0354-6
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P614, DOI 10.1016/j.apjtm.2016.04.017
NR 9
TC 1
Z9 1
U1 0
U2 0
PU JIMMA UNIV, ETHIOPIA
PI JIMMA
PA PO BOX 378, JIMMA, OROMIA 00000, ETHIOPIA
SN 1029-1857
EI 2413-7170
J9 ETHIOP J HEALTH SCI
JI Ethiop. J. Health Sci.
PD JAN
PY 2017
VL 27
IS 1
BP 104
EP 105
DI 10.4314/ejhs.v27i1.15
PG 2
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA EN1AO
UT WOS:000395742800015
PM 28458498
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ravi, SJ
AF Ravi, Sanjana J.
TI STRENGTHENING HEALTH SYSTEMS THROUGH INTERNATIONAL BLOOD PRODUCT SHARING
   AGREEMENTS
SO HEALTH SECURITY
LA English
DT Article
DE Countermeasures; Epidemic management/response; International
   coordination; Medical management/response; Policy
ID CASUALTY EVENTS; DISASTER; LESSONS; EXPERIENCE; MULTIPLE; DISEASE
AB Blood products are critical to the success of both routine healthcare delivery and emergency response efforts. Ensuring the safety and availability of blood products presents nations with considerable collection, screening, and distribution challenges that are often exacerbated by public health crises, particularly mass-casualty events involving traumatic injuries. However, recent outbreaks of Ebola and Zika virus disease have also illustrated the importance of securing blood product supplies during ongoing infectious disease emergencies. The United States and other nations should consider enhancing existing mechanisms for sharing medical countermeasures by creating formal agreements for sharing blood products during public health emergencies.
C1 [Ravi, Sanjana J.] Johns Hopkins Ctr Hlth Secur, Baltimore, MD USA.
RP Ravi, SJ (corresponding author), JHSPH Ctr Hlth Secur, 621 East Pratt St,Ste 210, Baltimore, MD 21202 USA.
EM sravi@upmc.edu
CR AABB, 2013, AABB BLOOD SURV RE 1
   AABB, 2009, TRANSFUSION S2, V49, p67S
   AABB Interorganizational Task Force on Pandemic Influenza and the Blood Supply, 2006, PAND INFL PLANN EFF
   Abolghasemi H, 2008, PREHOSP DISASTER MED, V23, P391, DOI 10.1017/S1049023X00006117
   [Anonymous], BLOOD BLOOD PROD
   [Anonymous], 2016, EM PREP RESP
   [Anonymous], 2015, IMPR BLOOD SYST EB A
   [Anonymous], WHAT AR MED COUNT
   [Anonymous], 2016, INT HLTH REG
   Beekley AC, 2009, J TRAUMA, V66, pS129, DOI 10.1097/TA.0b013e31819d85e7
   Campion EM, 2016, JAMA SURG, V151, P512, DOI 10.1001/jamasurg.2015.5107
   CDC, 2014 EB OUTBR W AFR
   Centers for Disease Control and Prevention, DENG PUERT RIC
   Centers for Disease Control and Prevention, MAN SURG NEEDS INJ B
   Centers for Disease Control and Prevention, ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P790
   Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x
   Federal Emergency Management Agency, 2015, INT ASS SYST CONC OP
   Food & Drug Administration, 2015, REC ASS BLOOD DON SU
   Giahyue J., 2014, DOCTOR CALLS BLOOD D
   Gilcher RO, 2005, CURR OPIN HEMATOL, V12, P503, DOI 10.1097/01.moh.0000180436.98990.ce
   Glynn SA, 2003, JAMA-J AM MED ASSOC, V289, P2246, DOI 10.1001/jama.289.17.2246
   Heinrich J, 2002, PUBLIC HLTH MAINTAIN
   Hess JR, 2003, TRANSFUSION, V43, P1622, DOI 10.1046/j.1537-2995.2003.00576.x
   Holley A, 2013, ANAESTH INTENS CARE, V41, P10, DOI 10.1177/0310057X1304100104
   International Federation of Red Cross and Red Crescent Societies, 2010, PROM SAF SUST NAT BL
   Liberia Sendolo J., 2015, LIBERIA PEOPLE AFRAI
   Lurie N., 2016, EXAMINING US PUBLIC
   Manning F, 1996, BLOOD DON SUPPL BLOO
   Marinissen MJ, 2014, BIOSECUR BIOTERROR, V12, P284, DOI 10.1089/bsp.2014.0049
   Marinissen MJ., 2011, BRIEFING DIVISION IN
   Marks PW, 2016, J INFECT DIS, V213, P1676, DOI 10.1093/infdis/jiw089
   McNeil Jr Donald G., 2016, NY TIMES
   Organisation for the Prohibition of Biological Weapons, 1972, CONV PROH DEV PROD S
   Schmidt PJ, 2002, NEW ENGL J MED, V346, P617, DOI 10.1056/NEJM200202213460813
   Sternberg S., 2016, US NEWS WORLD REPORT
   U.S. Department of Health and Human Services, 2015, 2015 PUBL HLTH EM ME
   United Nations, ID ADDR BARR EM SHAR
   US Department of Health and Human Services, 2011, 2011 NATL BLOOD COLL
   US Department of Health & Human Services, 2016, HHS SHIPS BLOODS PRO
   van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812
   White House, 2020, FED RESP HURR KATR L
   WHO, 2015, WHO MOD LIST ESS MED
   WHO, 2009, SCREEN DON BLOOD TRA
   WHO, 2015, GLOB STAT REP ROAD S
   Wolrd Health Organization, 2016, SIT REP EB VIR DIS
   World Health Organization, 2012, ASS CRIT NAT BLOOD R
   World Health Organization, 2015, M DEV PLANS STRENGTH
   World Health Organization, 2014, US CONV WHOL BLOOD P
   World Health Organization, 2006, RES REL BLOOD SAF AD
   World Health Organization, 2010, 63 WORLD HLTH ASS MA
   World Health Organization, 2011, BLOOD COLD CHAIN AID
NR 52
TC 1
Z9 1
U1 2
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD JAN-FEB
PY 2017
VL 15
IS 1
BP 110
EP 117
DI 10.1089/hs.2016.0039
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EL0ZA
UT WOS:000394349100021
PM 28192051
DA 2020-07-08
ER

PT J
AU Bahamondes, L
   Ali, M
   Monteiro, I
   Fernandes, A
AF Bahamondes, Luis
   Ali, Moazzam
   Monteiro, Ilza
   Fernandes, Arlete
TI Contraceptive sales in the setting of the Zika virus epidemic
SO HUMAN REPRODUCTION
LA English
DT Article
DE Zika virus; contraception; long-acting contraceptive methods; Brazil;
   unintended pregnancies
ID SEXUAL TRANSMISSION; UNITED-STATES; NO-COST; PROVISION
AB STUDY QUESTION: Has there been any influence of the Zika virus (ZIKV) outbreak on the sales of contraceptive methods in Brazil?
   SUMMARY ANSWER: Contraceptive sales in the 24 months of evaluation showed little variation and no significant change has been observed since the ZIKV outbreak.
   WHAT IS KNOWN ALREADY: Transmission of ZIKV is primarily by Aedes aegypti mosquitoes; however, sexual transmission has also been described. The association of several birth defects and the ZIKV infection during pregnancy has been established, and it was estimated in Bahia, Brazil that the infection rate could range from 10% to 80%. The World Health Organisation (WHO) declared the cluster of microcephaly cases and other neurological disorders a health emergency on 1 February 2016. The Brazilian government also made recommendations for women who were planning to become pregnant and who reside in ZIKV-affected areas to reconsider or postpone pregnancy.
   STUDY DESIGN, SIZE, DURATION: The objective of this study was to assess the sales of contraceptive methods in Brazil, tracking it from before and through the ZIKV outbreak. We obtained information from all pharmaceutical companies based in Brazil and from the manufacturers of long-acting reversible contraceptives (LARCs), including the copper-intrauterine device (IUD), the levonorgestrel-releasing intrauterine system (LNG-IUS) and implants, about contraceptives sales in the public and private sectors between September 2014 and August 2016.
   PARTICIPANTS/MATERIALS, SETTING, METHODS: We analyzed the data for: (i) oral contraceptives, i.e. combined oral contraceptives (COC) and progestin-only pills (POP), and vaginal and transdermal contraceptives, (ii) injectable contraceptives, i.e. once-a-month and depot-medroxyprogesterone acetate, (iii) LARCs and (iv) emergency contraceptive (EC) pills.
   MAIN RESULTS AND THE ROLE OF CHANCE: Monthly sales of COC, POP, patches and vaginal rings represent the major sales segment of the market, i.e. 12.7-13.8 million cycles/units per month (90%). The second largest group of sales was injectables, representing 0.81.5 million ampoules per month (9.5%). Following this, are LARC methods with sales of 37 000-41 000 devices per month (0.5%). It is important to note that although the peak months of sales were different for each group of contraceptives, there were no significant differences overall between the months of observation. The EC pill sales were between 1.0 million and 1.3 million of pills per month.
   LIMITATIONS, REASONS FOR CAUTION: Although the use of contraceptive methods was already high and no change was noted, the ZIKV outbreak may have changed the pregnancy intentions of Brazilian women. Consequently, the number of women planning pregnancy may be lower than that recorded. The contraceptive sales figures did not include condoms. Since condoms might not only prevent pregnancies, but also sexual transmission of ZIKV, this lack of information is a limitation.
   WIDER IMPLICATIONS OF THE FINDINGS: The results from this assessment showed that the sales of contraceptives presented little variation during the ZIKV outbreak in Brazil. Furthermore, it is possible that access to LARC methods was limited. Although we did not investigate the reason for low LARC uptake, we suspect that it is due to lack of availability of LARC in the public sector, the high cost of the methods and the incomplete insurance coverage on contraception for women. Projections estimate millions of additional cases of ZIKV transmission. Thus, a coordinated response is needed to ensure access to a wide range of contraceptive methods for women during the ZIKV outbreak. In conclusion, this assessment of contraceptive sales in Brazil identifies challenges in contraceptive access, especially for LARC methods, and represents an alternative source of data to help us understand the trends in demand for contraception in ZIKV-affected areas.
C1 [Bahamondes, Luis; Monteiro, Ilza; Fernandes, Arlete] Univ Estadual Campinas, UNICAMP, Sch Med, Family Planning Clin,Dept Obstet & Gynaecol, Caixa Postal 6181, BR-13084971 Campinas, SP, Brazil.
   [Ali, Moazzam] WHO, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
RP Bahamondes, L (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med, Family Planning Clin,Dept Obstet & Gynaecol, Caixa Postal 6181, BR-13084971 Campinas, SP, Brazil.
EM bahamond@caism.unicamp.br
RI Fernandes, Arlete/I-7561-2018; monteiro, ilza m u/F-4871-2014
OI Fernandes, Arlete/0000-0001-5872-0017; monteiro, ilza m
   u/0000-0002-9536-0564
FU Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/20504-9]
FX The Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) award #
   2015/20504-9 and from an anonymous donor. The funding sources did not
   play a role in the study design, in the collection, analysis and
   interpretation of data, in the writing of the report, or in the decision
   to submit the article for publication. This report contains the
   collective views of an international group of experts, and does not
   necessarily represent the decisions or the stated policy of the World
   Health Organisation.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Bahamondes L, 2014, HUM REPROD, V29, P2163, DOI 10.1093/humrep/deu191
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P., 2016, N ENGL J ME IN PRESS
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daniels K, 2015, NATL HLTH STAT REPOR
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Le HH, 2014, IN J WOMENS HEALTH, V6, P663, DOI 10.2147/IJWH.S61543
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rocha RCL, 2010, J PEDIATR ADOL GYNEC, V23, P142, DOI 10.1016/j.jpag.2009.08.011
   Secura GM, 2014, NEW ENGL J MED, V371, P1316, DOI 10.1056/NEJMoa1400506
   Trussell J, 2011, CONTRACEPTIVE TECHNO
NR 20
TC 15
Z9 17
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JAN
PY 2017
VL 32
IS 1
BP 88
EP 93
DI 10.1093/humrep/dew310
PG 6
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA EL7QH
UT WOS:000394815100011
PM 27932442
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Bonin, CRB
   Fernandes, GC
   dos Santos, RW
   Lobosco, M
AF Barbosa Bonin, Carla Rezende
   Fernandes, Guilherme Cortes
   dos Santos, Rodrigo Weber
   Lobosco, Marcelo
TI Mathematical modeling based on ordinary differential equations: A
   promising approach to vaccinology
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE computational science; computational modeling; computational immunology;
   computational vaccinology; immune system; ordinary differential
   equations; yellow fever
ID YELLOW-FEVER VACCINE; REVERSE VACCINOLOGY; DISCOVERY; PREDICTS;
   DYNAMICS; ORIGIN; SYSTEM; FLOW
AB New contributions that aim to accelerate the development or to improve the efficacy and safety of vaccines arise from many different areas of research and technology. One of these areas is computational science, which traditionally participates in the initial steps, such as the pre-screening of active substances that have the potential to become a vaccine antigen. In this work, we present another promising way to use computational science in vaccinology: mathematical and computational models of important cell and protein dynamics of the immune system. A system of Ordinary Differential Equations represents different immune system populations, such as B cells and T cells, antigen presenting cells and antibodies. In this way, it is possible to simulate, in silico, the immune response to vaccines under development or under study. Distinct scenarios can be simulated by varying parameters of the mathematical model.
   As a proof of concept, we developed a model of the immune response to vaccination against the yellow fever. Our simulations have shown consistent results when compared with experimental data available in the literature. The model is generic enough to represent the action of other diseases or vaccines in the human immune system, such as dengue and Zika virus.
C1 [Barbosa Bonin, Carla Rezende; dos Santos, Rodrigo Weber; Lobosco, Marcelo] Univ Fed Juiz de Fora, Postgrad Program Computat Modeling, Juiz De Fora, Brazil.
   [Fernandes, Guilherme Cortes] Presidente Antonio Carlos Univ, Sch Med, Juiz De Fora, Brazil.
RP Fernandes, GC (corresponding author), Presidente Antonio Carlos Univ, Sch Med, Juiz De Fora, Brazil.
EM cortesfernandes@gmail.com
RI Lobosco, Marcelo/J-9108-2012; Santos, Rodrigo Weber dos/E-6494-2015
OI Lobosco, Marcelo/0000-0002-7205-9509; Santos, Rodrigo Weber
   dos/0000-0002-0633-1391
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); UFJF
FX The authors would like to express their thanks to CAPES, CNPq, FAPEMIG
   and UFJF for funding this work.
CR Andreoni F, 2016, METHODS MOL BIOL, V1404, P181, DOI 10.1007/978-1-4939-3389-1_12
   Beard DA, 2001, STRUCTURE, V9, P105, DOI 10.1016/S0969-2126(01)00572-X
   Bernholdt D, 2005, P IEEE, V93, P485, DOI 10.1109/JPROC.2004.842745
   Bicerano J, 1992, PLASTICS ENG, V25
   Bonin CRB, 2016, J COMPUT APPL MATH, V295, P127, DOI 10.1016/j.cam.2015.01.020
   Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021
   CLARKE S, 1987, PHYS REV LETT, V58, P2235, DOI 10.1103/PhysRevLett.58.2235
   CUITINO AM, 1993, MODEL SIMUL MATER SC, V1, P225, DOI 10.1088/0965-0393/1/3/001
   DAS S, 1977, J GEOPHYS RES, V82, P5658, DOI 10.1029/JB082i036p05658
   De Groot Anne S., 2009, V2, P39, DOI 10.1007/978-0-387-79208-8_3
   De Groot AS, 2001, VACCINE, V19, P4385, DOI 10.1016/S0264-410X(01)00145-1
   DELISI C, 1985, P NATL ACAD SCI USA, V82, P7048, DOI 10.1073/pnas.82.20.7048
   Doddi SK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046318
   Feldgus S, 2000, J AM CHEM SOC, V122, P12714, DOI 10.1021/ja0019373
   Geanes AR, 2016, BIOORG MED CHEM LETT, V26, P4487, DOI 10.1016/j.bmcl.2016.07.071
   Gomez-Bombarelli R, 2016, NAT MATER, V15, P1120, DOI [10.1038/nmat4717, 10.1038/NMAT4717]
   Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044
   Kay A, 2011, AM J TROP MED HYG, V85, P748, DOI 10.4269/ajtmh.2011.11-0363
   Khalili S, 2016, TURK J MED SCI, V46, P1135, DOI 10.3906/sag-1503-2
   Knepell PL, 1993, SIMULATION VALIDATIO
   Kuhl E, 2007, BIOMECH MODEL MECHAN, V6, P321, DOI 10.1007/s10237-006-0062-x
   Kumar N, 2006, DRUG DISCOV TODAY, V11, P806, DOI 10.1016/j.drudis.2006.07.010
   Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162
   Loomis H. G., 1979, MAR GEOD, V2, P27, DOI DOI 10.1080/15210607909379333
   MCHUGH PE, 1993, ACTA METALL MATER, V41, P1461, DOI 10.1016/0956-7151(93)90255-Q
   Meunier M, 2016, J IMMUNOL RES, DOI 10.1155/2016/5715790
   Michalik M, 2016, METHODS MOL BIOL, V1403, P87, DOI 10.1007/978-1-4939-3387-7_4
   Monath TP, 2012, VACCINES, P870
   Nefedova V, 2006, E SCI, P32, DOI DOI 10.1109/ESCIENCE.2006.261116
   Oliveira FM, 2016, APPL BIOCHEM BIOTECH, V179, P1023, DOI 10.1007/s12010-016-2048-1
   Pappalardo F, 2015, PHARMACOL RES, V92, P40, DOI 10.1016/j.phrs.2014.08.006
   Porter B, 2005, J BIOMECH, V38, P543, DOI 10.1016/j.jbiomech.2004.04.011
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Randall DA, 2002, COMPUT SCI ENG, V4, P32, DOI 10.1109/MCISE.2002.1032427
   Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960
   Rots JG, 1988, THESIS
   Roussel N, 2007, CEMENT CONCRETE RES, V37, P1298, DOI 10.1016/j.cemconres.2007.06.007
   SAKURAI T, 1989, SPACE SCI REV, V51, P11
   Schafer BW, 1998, J CONSTR STEEL RES, V47, P193, DOI 10.1016/S0143-974X(98)00007-8
   Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370
   US PITA, 2005, COMP SCI ENS AM COMP
   Wiley HS, 2003, TRENDS CELL BIOL, V13, P43
   World Health Organization (WHO), 2013, WKLY EPIDEMIOL REC, V88, P269, DOI DOI 10.1016/J.IJPORL.2014.03.035
   Xu Y, 2016, J CHEM INF MODEL, V56, P1847, DOI 10.1021/acs.jcim.6b00185
   Yanez J, 2016, PHYS LETT A, V380, P2549, DOI 10.1016/j.physleta.2016.05.048
   Yang YT, 2016, ANTIVIR RES, V132, P225, DOI 10.1016/j.antiviral.2016.06.014
NR 46
TC 8
Z9 8
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2017
VL 13
IS 2
BP 484
EP 489
DI 10.1080/21645515.2017.1264774
PG 6
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA EL9RB
UT WOS:000394956600046
PM 28027002
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Arnaoutakis, D
   Padhya, T
AF Arnaoutakis, Demetri
   Padhya, Tapan
TI Zika Virus-What the Otolaryngologist Should Know A Review
SO JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY
LA English
DT Review
ID DENGUE VIRUS; DYNAMICS
AB IMPORTANCE Initially discovered in 1947, Zika virus infection received little notoriety as a tropical disease until 2015 when an outbreak of microcephaly cases was reported in Brazil. Zika is a single-stranded RNA arbovirus of the Flaviviridae family. The primary source of infection in humans stems from Aedes aegypti mosquito bites but can also occur through sexual, blood, and perinatal transmission. With expectations that 3 to 4 million people across the Americas will be infected over the next year, theWorld Health Organization has declared this event a Public Health Emergency of International Concern.
   OBSERVATIONS Although acute Zika virus infection is typically mild and self-limited, researchers have demonstrated serious neurologic complications associated with it such as microcephaly and Guillain-Barre syndrome. Otolaryngologists should be aware of head and neck manifestations which include conjunctivitis, retro-orbital pain, cephalgia, and odynophagia. The Centers for Disease Control and Prevention have developed specific molecular and serologic testing protocols and algorithms for follow-up care of suspected cases. Currently, the mainstay of management is conservative care while researchers attempt to develop a vaccine. Strategies to contain the Zika virus include vector control, travel restriction for women who are pregnant or trying to become pregnant, and avoidance of mosquito bites in endemic regions of the world.
   CONCLUSIONS AND REVELANCE The future outlook regarding the current Zika virus outbreak in the Americas remains uncertain. What is certain is our need to promptly and efficiently address research gaps in our understanding of clinical outcomes from infection and environmental factors that influence emergence meanwhile improving diagnostic, therapeutic, and preventive measures against the disease.
C1 [Arnaoutakis, Demetri] Univ Texas Southwestern Med Ctr Dallas, Dept Otolaryngol Head & Neck Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
   [Padhya, Tapan] Univ S Florida, Coll Med, Dept Otolaryngol Head & Neck Surg, Tampa, FL USA.
RP Arnaoutakis, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Otolaryngol Head & Neck Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
EM takis.demetri@gmail.com
RI amsalu, ribka/G-8780-2019
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   HALSTEAD SB, 1984, REV INFECT DIS, V6, P251
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Lauren M., 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   Leal MC, 2016, BRAZ J OTORHINOLARYN
   Lessler J, 2016, BIORXIV, DOI [10.1101/041913, DOI 10.1101/041913]
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pan American Health Organization, EP UPD NEUR SYNDR CO
   PanAmerican Health Organization, 1994, SCI PUBLICATION, V548
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2014, FIELDS VIROLOGY, P746
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040
   US Centers for Disease Control and Prevention, ZIK VIR
   World Health Organization, 1982, OFFS PUBL, V66
   World Health Organization, CURR ZIK PROD PIP
   World Health Organization (WHO), EM PREP RESP ZIK VIR
NR 30
TC 2
Z9 2
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6181
EI 2168-619X
J9 JAMA OTOLARYNGOL
JI JAMA Otolaryngol-Head Neck Surg.
PD JAN
PY 2017
VL 143
IS 1
BP 81
EP 84
DI 10.1001/jamaoto.2016.3427
PG 4
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA EL2HP
UT WOS:000394441000014
PM 27892990
DA 2020-07-08
ER

PT J
AU Brook, I
AF Brook, Itzhak
TI Otolaryngologist-Beware of Zika
SO JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY
LA English
DT Editorial Material
ID VIRUS
C1 [Brook, Itzhak] Georgetown Univ, Sch Med, Dept Pediat, 4431 Albemarle St NW, Washington, DC 20016 USA.
RP Brook, I (corresponding author), Georgetown Univ, Sch Med, Dept Pediat, 4431 Albemarle St NW, Washington, DC 20016 USA.
EM ib6@georgetown.edu
CR Arnaoutakis D, JAMA OTOLARYNGOL, DOI [10.1001/jamaoto.2016.3427, DOI 10.1001/JAMA0T0.2016.3427]
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Centers for Disease Control and Prevention, ZIK VIR
   FitzSimmons J, 2016, NEW ENGL J MED, V375, P293, DOI 10.1056/NEJMc1606769
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
NR 5
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6181
EI 2168-619X
J9 JAMA OTOLARYNGOL
JI JAMA Otolaryngol-Head Neck Surg.
PD JAN
PY 2017
VL 143
IS 1
BP 84
EP 86
DI 10.1001/jamaoto.2016.3432
PG 3
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA EL2HP
UT WOS:000394441000015
PM 27892997
DA 2020-07-08
ER

PT J
AU Diniz, D
   Medeiros, M
   Madeiro, A
AF Diniz, Debora
   Medeiros, Marcelo
   Madeiro, Alberto
TI Brazilian women avoiding pregnancy during Zika epidemic
SO JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE
LA English
DT Letter
C1 [Diniz, Debora] Univ Brasilia, Anis, Inst Bioet Direitos Humanos & Genero, Brasilia, DF, Brazil.
   [Medeiros, Marcelo] Univ Brasilia, IPEA, Brasilia, DF, Brazil.
   [Madeiro, Alberto] Univ Estadual Piaui, Res Ctr, Teresina, PI, Brazil.
   [Madeiro, Alberto] Univ Estadual Piaui, Extens Ctr Womens Hlth, Teresina, PI, Brazil.
RP Madeiro, A (corresponding author), Univ Estadual Piaui, Res Ctr, Teresina, PI, Brazil.; Madeiro, A (corresponding author), Univ Estadual Piaui, Extens Ctr Womens Hlth, Teresina, PI, Brazil.
EM d.diniz@anis.org.br; marcelo.medeiros.cs@gmail.com; madeiro@uol.com.br
RI Diniz, Debora/K-9000-2012
OI Diniz, Debora/0000-0001-6987-2569; Madeiro, Alberto/0000-0002-5258-5982
CR Ministerio da Saude Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias Brasil, 2016, 40 MIN SAUD CTR OP E
   Ministerio da Saude Secretaria de Vigilancia em Saude Brasil, 2016, B EPIDEMIOLOGICO, V31
NR 2
TC 11
Z9 13
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1471-1893
EI 2045-2098
J9 J FAM PLAN REPROD H
JI J. Fam. Plan. Reprod. Health Care
PD JAN
PY 2017
VL 43
IS 1
BP 80
EP 80
DI 10.1136/jfprhc-2016-101678
PG 1
WC Family Studies; Obstetrics & Gynecology; Social Sciences, Biomedical
SC Family Studies; Obstetrics & Gynecology; Biomedical Social Sciences
GA EL4WX
UT WOS:000394622700023
PM 28007828
OA Bronze
DA 2020-07-08
ER

PT J
AU Ratanacharoensiri, A
   Huggins, L
   Johnson, M
   Patel, I
AF Ratanacharoensiri, Anna
   Huggins, Luke
   Johnson, Mark
   Patel, Isha
TI Zika Virus: An Emerging Epidemic
SO JOURNAL OF RESEARCH IN PHARMACY PRACTICE
LA English
DT Editorial Material
C1 [Ratanacharoensiri, Anna; Huggins, Luke] Shenandoah Univ, Bernard J Dunn Sch Pharm, Winchester, VA USA.
   [Johnson, Mark] Shenandoah Univ, Dept Pharm Practice, Winchester, VA USA.
   [Patel, Isha] Marshall Univ, Dept Pharm Practice Adm & Res, Huntington, WV 25755 USA.
RP Patel, I (corresponding author), Marshall Univ, Dept Pharm Practice Adm & Res, Huntington, WV 25755 USA.
EM pateli@marshall.edu
CR Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, SYMPT TEST TREATM
   Centers for Disease Control and Prevention, 2016, PREVENTION
   Clarke T, 2016, C SENDS OB BILL ZIK
   [Clinical Evaluation & Disease Centers for Disease Control and Prevention], 2016, ZIK VIR HOM HEALTHC
   Fleming-Dutra K, 2016, UPDATE INTERIM ZIKA
   WHO, 2016, ZIK SIT REP NEUR SYN
   World Health Organization, 2016, VIK VIR MICR GUILL B
NR 8
TC 2
Z9 2
U1 0
U2 2
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 2319-9644
EI 2279-042X
J9 J RES PHARM PRACT
JI J. Res. Pharm. Pract.
PD JAN-MAR
PY 2017
VL 6
IS 1
BP 1
EP 2
DI 10.4103/2279-042X.200984
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EN6RW
UT WOS:000396132100001
PM 28331858
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hashem, MA
   Shuvo, MA
   Arifuzzaman
AF Hashem, M. A.
   Shuvo, Moinul Abedin
   Arifuzzaman
TI A Computational Approach to Design Potential Antiviral RNA for 3 ' UTR
   Post Transcriptional Gene Silencing of Different Strains of Zika Virus
SO JOURNAL OF YOUNG PHARMACISTS
LA English
DT Article
DE Antiviral RNA; RNAi technology; siRNA; Zika virus; 3 ' UTR region
ID FUNCTIONAL SIRNA; GENOME; INTERFERENCE; SEQUENCES; REPLICATION;
   EXPRESSION; EFFICIENCY; INFECTION; SELECTION
AB Background: Zika virus is a flare-up mosquito-borne virus that manifests itself in sporadic human infections with Zika fever. It has a serious affect in pregnant women. Mother transmits Zika virus infection to her infant during the time of delivery which results in the birth of newborn with microcephaly and some neurological malformations. Molecular studies revealed that the 3' UTR of Zika virus genome plays a vital role in viral replication and pathogenicity. So, the 3' UTR can be a suitable target for the prevention of viral multiplications and degree of pathogenicity. The activity of the 3' UTR of Zika virus genome can be controlled by blocking or down regulating its expression through RNAi technology. RNAi works by silencing or turning off target gene expression using siRNA. Hence there arises an urgent need to design potential siRNA against the target sequence of Zika virus genome to control its replication and pathogenicity. This study is aimed to predict potential siRNA based therapeutics that might be used for the treatment of Zika virus infection. Methods: Designing siRNA against the target region of different strains of Zika virus is difficult due to its genetic diversity. Therefore, the work is done on the basis of rational siRNA designing method by targeting the 3' UTR of Zika virus strains. The prediction of potential siRNA was done by using various computational tools as searching target sequences, multiple sequences alignment, secondary structure prediction, siRNA-Target sequence interaction prediction and finally the evaluation of effectiveness of predicted and depicted siRNA. Results: Out of sixty siRNA only four potential siRNA were predicted and depicted rationally for silencing 3' UTR of 37 different Zika virus genome used in the study through RNAi technology. Conclusion: The outcomes of this study are four potential siRNA molecules which might be used as a potential antiviral RNA based therapeutics to suppress the Zika virus mediated infection.
C1 [Hashem, M. A.; Shuvo, Moinul Abedin; Arifuzzaman] USTC, Dept Biochem & Biotechnol, Foys Lake 4202, Chittagong, Bangladesh.
RP Hashem, MA (corresponding author), USTC, Dept Biochem & Biotechnol, Foys Lake 4202, Chittagong, Bangladesh.
EM hashem_bmb@yahoo.com
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157
   [Anonymous], TIMES INDIA
   Bangladesh still free from Zika virus, DAILY OBSERVER  0131
   Boudreau RL, 2010, BRAIN RES, V1338, P112, DOI 10.1016/j.brainres.2010.03.038
   Burger K, 2015, NAT REV MOL CELL BIO, V16, P417, DOI 10.1038/nrm3994
   CDC-Centers for Disease Control and Prevention, CDC CONCL ZIK CAUS M
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan CY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S33
   Chen Y, 2008, PHARM RES-DORDR, V25, P72, DOI 10.1007/s11095-007-9504-0
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   Czech MP, 2011, NAT REV ENDOCRINOL, V7, P473, DOI 10.1038/nrendo.2011.57
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ENDMEMO, DNA RNA GC CONT CALC
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Motavaf M, 2012, J VIRAL HEPATITIS, V19, P757, DOI 10.1111/jvh.12006
   Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392
   Nobelprize.org, NOB PRIZ PHYS MED 20
   Nur SM, 2013, J YOUNG PHARM, V5, P46, DOI 10.1016/j.jyp.2013.05.001
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936
   RNA Institute, MFOLD WEB SERV
   Saengkrit N, 2012, CARBOHYD POLYM, V90, P1323, DOI 10.1016/j.carbpol.2012.06.079
   Singh S, 2012, BIOINFORMATION, V8, P749, DOI 10.6026/97320630008749
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247
   Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P7100, DOI 10.1093/nar/gkn902
   World Health Organization, ZIK VIR MICR GUILL B
   Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998
NR 43
TC 3
Z9 3
U1 0
U2 3
PU INPHARM ASSOC, PHCOG NET
PI BANGELORE
PA 17, II FLOOR, BUDDHA VIHAR RD, COX TOWN, BANGELORE, 560 005, INDIA
SN 0975-1483
EI 0975-1505
J9 J YOUNG PHARM
JI J. Young Pharm.
PD JAN-MAR
PY 2017
VL 9
IS 1
BP 23
EP 30
DI 10.5530/jyp.2017.9.5
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EO0WQ
UT WOS:000396419700005
OA Other Gold
DA 2020-07-08
ER

PT J
AU Levine, D
   de Oliveira-Szejnfeld, PS
   Melo, ASD
   Tovarmoll, F
AF Levine, Deborah
   de Oliveira-Szejnfeld, Patricia Soares
   de Oliveira Melo, Adriana Suely
   Tovarmoll, Fernanda
TI Congenital Brain Abnormalities and Zika Virus Response
SO RADIOLOGY
LA English
DT Letter
C1 [Levine, Deborah] Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Dept Diagnost Imaging, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira Melo, Adriana Suely] Inst Pesquisa Prof Amorim Neto, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Inst Saude Elpidio Almeida, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Fac Ciencias Med Campina Grande, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Hosp Municipal Pedro I, Serv Municipal Atendimento Transdisciplinar Gesta, Campina Grande, PB, Brazil.
   [Tovarmoll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovarmoll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Tovarmoll, Fernanda] DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
RP Tovarmoll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Tovarmoll, F (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.; Tovarmoll, F (corresponding author), DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
EM Fernanda.tovarmoll@idor.org
RI Melo, Adriana S O/H-5650-2016
CR de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
NR 1
TC 0
Z9 0
U1 0
U2 0
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JAN
PY 2017
VL 282
IS 1
BP 302
EP 303
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EM7VG
UT WOS:000395519800037
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Congenital Brain Abnormalities and Zika Virus
SO RADIOLOGY
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Xueyuan Rd, Longhua Dist 571199, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Wiwanitkit House, Bangkok, Thailand.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Xueyuan Rd, Longhua Dist 571199, Haikou, Peoples R China.; Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Sriwijitalai W, 2016, REV BRAS GINECOL OBS, V38, P314, DOI 10.1055/s-0036-1584947
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 0
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JAN
PY 2017
VL 282
IS 1
BP 302
EP 302
DI 10.1148/radiol.2017161999
PG 1
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EM7VG
UT WOS:000395519800036
PM 28005499
OA Bronze
DA 2020-07-08
ER

PT J
AU de Sousa, AA
   Fraga, E
   Sampaio, I
   Schneider, H
   Barrosa, MC
AF de Sousa, Andrelina Alves
   Fraga, Elmary
   Sampaio, Iracilda
   Schneider, Horacio
   Barrosa, Maria Claudene
TI Genetic differentiation in populations of Aedes aegypti (Diptera,
   Culicidae) dengue vector from the Brazilian state of Maranhao
SO REVISTA BRASILEIRA DE ENTOMOLOGIA
LA English
DT Article
DE Gene flow; Mitochondrial DNA; ND4
ID POLYMERASE-CHAIN-REACTION; MITOCHONDRIAL-DNA; MOSQUITO; PHYLOGEOGRAPHY;
   POLYMORPHISM; VARIABILITY
AB Aedes (Stegomyia) aegypti is the vector responsible for the transmission of the viruses that cause zika, yellow and chikungunya fevers, the four dengue fever serotypes (DENV - 1, 2, 3, 4), and hemorrhagic dengue fever in tropical and subtropical regions around the world. The present study investigated the genetic differentiation of the 15 populations of this vector in the Brazilian state of Maranhao, based on the mitochondrial ND4 marker. A total of 177 sequences were obtained for Aedes aegypti, with a fragment of 337 bps, 15 haplotypes, 15 polymorphics sites, haplotype diversity of h=0.6938, and nucleotide diversity of pi = 0.01486. The neutrality tests (D and Fs) were not significant. The AMOVA revealed that most of the variation (58.47%) was found within populations, with F-sT = 0.41533 (p<0.05). Possible isolation by distance was tested and a significant correlation coefficient (r = 0.3486; p = 0.0040) was found using the Mantel test. The phylogenetic relationships among the 15 haplotypes indicated the existence of two distinct clades. This finding, together with the population parameters, was consistent with a pattern of genetic structuring that underpinned the genetic differentiation of the study populations in Maranhao, and was characterized by the presence of distinct lineages of Aedes aegypti. (C) 2016 Sociedade Brasileira de Entomologia. Published by Elsevier Editora Ltda.
C1 [de Sousa, Andrelina Alves; Fraga, Elmary; Barrosa, Maria Claudene] Univ Estadual Maranhao, CESC, Caxias, MA, Brazil.
   [de Sousa, Andrelina Alves] Univ Estadual Maranhao, Ctr Ciencias Agr, Sao Luis, MA, Brazil.
   [Sampaio, Iracilda; Schneider, Horacio] Univ Fed Para UFPA, Inst Estudos Costeiros IECOS, Braganca, PA, Brazil.
RP Barrosa, MC (corresponding author), Univ Estadual Maranhao, CESC, Caxias, MA, Brazil.
EM mbdene@yahoo.com.br
FU Brazilian National Research Council, CNPqNational Council for Scientific
   and Technological Development (CNPq)
FX This study was supported financially by the Brazilian National Research
   Council, CNPq.
CR Ayres CFJ, 2004, J AM MOSQUITO CONTR, V20, P350
   Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006
   Black WC, 2009, INSECT MOL BIOL, V18, P705, DOI 10.1111/j.1365-2583.2009.00925.x
   Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Corander J., 2013, BAPS BAYESIAN ANAL P
   Costa M.C.V., 2006, TEMPORAL ANAL MITOCH
   Costa-da-Silva AL, 2005, MEM I OSWALDO CRUZ, V100, P639, DOI 10.1590/S0074-02762005000600007
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Fraga E. C., 2013, Open Tropical Medicine Journal, V6, P11, DOI 10.2174/1874315301306010011
   Fu YX, 1997, GENETICS, V147, P915
   Gorrochotegui-Escalante N, 2002, AM J TROP MED HYG, V66, P213, DOI 10.4269/ajtmh.2002.66.213
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008
   Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Lima RS, 2009, GENET MOL BIOL, V32, P414, DOI 10.1590/S1415-47572009005000036
   MANTEL N, 1967, CANCER RES, V27, P209
   Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paduan KD, 2008, J MED ENTOMOL, V45, P59, DOI 10.1603/0022-2585(2008)45[59:MDPAHI]2.0.CO;2
   Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Leite LAR, 2012, BIOTA NEOTROP, V12, P301, DOI 10.1590/S1676-06032012000300029
   Rieger T. T., 2006, Floresta e Ambiente, V13, P11
   Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SANTOS J M M D, 1981, Acta Amazonica, V11, P789
   Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895
   Silva A.G., 2012, EVOL APPL, P1752
   TAJIMA F, 1989, GENETICS, V123, P597
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Thompson J.D., 1994, GENETICS, V147, P915
   Twerdochlib AL, 2012, REV BRAS ENTOMOL, V56, P249, DOI 10.1590/S0085-56262012005000030
   Urdaneta-Marquez L, 2008, AM J TROP MED HYG, V78, P479, DOI 10.4269/ajtmh.2008.78.479
   WILKERSON RC, 1995, J MED ENTOMOL, V32, P697, DOI 10.1093/jmedent/32.5.697
   Wilkerson RC, 2005, ANN ENTOMOL SOC AM, V98, P918, DOI 10.1603/0013-8746(2005)098[0918:MPONAN]2.0.CO;2
   Yáñez Pamela, 2013, Rev. perú. med. exp. salud publica, V30, P246
NR 44
TC 2
Z9 2
U1 0
U2 8
PU SOC BRASILEIRA ENTOMOLOGIA
PI CURITIBA
PA CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL
SN 0085-5626
EI 1806-9665
J9 REV BRAS ENTOMOL
JI Rev. Bras. Entomol.
PD JAN-MAR
PY 2017
VL 61
IS 1
BP 51
EP 59
DI 10.1016/j.rbe.2016.10.003
PG 9
WC Entomology
SC Entomology
GA EO9NQ
UT WOS:000397015800006
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika virus infection: What should we know as nephrologists
SO SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Dept Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2010, J INFECT DEV COUNTR, V4, P51, DOI 10.3855/jidc.145
NR 11
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1319-2442
EI 2320-3838
J9 SAUDI J KIDNEY DIS T
JI Saudi J. Kidney Dis. Transplant.
PD JAN-FEB
PY 2017
VL 28
IS 1
BP 186
EP 187
DI 10.4103/1319-2442.198274
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA EK5PA
UT WOS:000393977100031
PM 28098126
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Schwartz, DA
AF Schwartz, David A.
TI The Origins and Emergence of Zika Virus, the Newest TORCH Infection
   What's Old Is New Again
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Editorial Material
ID FRENCH-POLYNESIA; RUBELLA; CONSEQUENCES; TRANSMISSION; PLACENTA;
   OUTBREAK; HISTORY; COMPLEX; AGENTS; BRAZIL
C1 [Schwartz, David A.] Augusta Univ, Med Coll Georgia, Augusta, GA USA.
RP Schwartz, DA (corresponding author), 1950 Grace Arbor Ct, Atlanta, GA 30329 USA.
EM davidalanschwartz@gmail.com
CR ALFORD CA, 1967, NEW ENGL J MED, V277, P437, DOI 10.1056/NEJM196708312770901
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   BALE JF, 1992, PEDIATR CLIN N AM, V39, P669
   Berger S, 2015, CHIKUNGUNYA ZIKA GLO, P75
   BRUMBACK RA, 1976, PEDIATRICS, V58, P916
   Bugler T, 2016, MIRROR          0525
   Cohen Jon, 2016, SCI MAGAZINE
   COOPER LZ, 1985, REV INFECT DIS, V7, pS2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dontigny L, 2008, J OBSTET GYNAECOL CA, V30, P152, DOI 10.1016/S1701-2163(16)32740-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fuerst HT, 1975, PEDIATRICS, V56, P107
   Gabbe SG, 2002, OBSTET NORMAL PROBLE, P1328
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   KINNEY JS, 1988, CLIN PERINATOL, V15, P727
   Kron Josh., 2016, NY TIMES
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McKay IM., 2016, VIROLOGY BLOGSP 0106
   MILLER E, 1982, LANCET, V2, P781
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   NAHMIAS AJ, 1971, PEDIATR RES, V5, P405, DOI 10.1203/00006450-197108000-00144
   NAHMIAS AJ, 1994, TROPH RES, V8, P107, DOI DOI 10.1016/S0143-4004(05)80339-X
   NAHMIAS AJ, 1994, TROPHOBLAST RES, V8, P193, DOI DOI 10.1016/S0143-4004(05)80344-3
   National Institute for Communicable Disease Center, 1969, RUB SURV
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schwartz DA, 2014, RUBINS PATHOLOGY CLI, P535
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   The college of Physicians of Philadelphia, RUB HIST VACC
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
NR 39
TC 19
Z9 20
U1 0
U2 6
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 18
EP 25
DI 10.5858/arpa.2016-0429-ED
PG 8
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800004
PM 27763793
OA Bronze
DA 2020-07-08
ER

PT J
AU Medin, CL
   Rothman, AL
AF Medin, Carey L.
   Rothman, Alan L.
TI Zika Virus The Agent and Its Biology, With Relevance to Pathology
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article
ID WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; NONSTRUCTURAL
   GLYCOPROTEIN NS1; JAPANESE ENCEPHALITIS-VIRUS; VIRAL-RNA REPLICATION;
   SINGLE-STRANDED RNA; DENGUE-VIRUS; IN-VITRO; ATYPICAL MANIFESTATIONS;
   SERINE-PROTEASE
AB Once obscure, Zika virus (ZIKV) has attracted significant medical and scientific attention in the past year because of large outbreaks associated with the recent introduction of this virus into the Western hemisphere. In particular, the occurrence of severe congenital infections and cases of Guillain-Barre syndrome has placed this virus squarely in the eyes of clinical and anatomic pathologists. This review article provides a basic introduction to ZIKV, its genetics, its structural characteristics, and its biology. A multidisciplinary effort will be essential to establish clinicopathologic correlations of the basic virology of ZIKV in order to advance development of diagnostics, therapeutics, and vaccines.
C1 [Medin, Carey L.; Rothman, Alan L.] Univ Rhode Isl, Dept Cell & Mol Biol, Inst Immunol & Informat, 825 Chalkstone Ave, Providence, RI 02908 USA.
RP Rothman, AL (corresponding author), Inst Immunol & Informat, FCCE Rm 302F,80 Washington St, Providence, RI 02903 USA.
EM alan_rothman@uri.edu
OI Medin, Carey/0000-0002-9346-6760; Rothman, Alan/0000-0002-4064-6848
CR Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Andoh T, 2004, FASEB J, V18, P182, DOI 10.1096/fj.02-1169fje
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16
   Bordignon J, 2007, J MED VIROL, V79, P1506, DOI 10.1002/jmv.20958
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carbone F, 2013, THROMB HAEMOSTASIS, V109, P854, DOI 10.1160/TH12-10-0768
   Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Chu JJH, 2006, VIROLOGY, V349, P463, DOI 10.1016/j.virol.2006.01.022
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   CHU PWG, 1985, VIROLOGY, V140, P68, DOI 10.1016/0042-6822(85)90446-5
   CLEAVES GR, 1981, VIROLOGY, V111, P73, DOI 10.1016/0042-6822(81)90654-1
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Congdon EE, 2013, J BIOL CHEM, V288, P35452, DOI 10.1074/jbc.M113.491001
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durand Mark A, 2005, Pac Health Dialog, V12, P99
   Engel AR, 2011, VECTOR-BORNE ZOONOT, V11, P665, DOI 10.1089/vbz.2010.0179
   Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EURO SURVEILL, V21
   Fuller JP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00235
   GARCIA JG, 1994, J VIROL METHODS, V48, P31, DOI 10.1016/0166-0934(94)90086-8
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P276
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029
   Hunsperger EA, 2016, J INFECT DIS, V214, P836, DOI 10.1093/infdis/jiw103
   Huppertz B, 2008, J CLIN PATHOL, V61, P1296, DOI 10.1136/jcp.2008.055277
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   JAN LR, 1995, J GEN VIROL, V76, P573, DOI 10.1099/0022-1317-76-3-573
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   KAWANO H, 1993, J VIROL, V67, P6567, DOI 10.1128/JVI.67.11.6567-6575.1993
   Khunchai S, 2012, BIOCHEM BIOPH RES CO, V423, P398, DOI 10.1016/j.bbrc.2012.05.137
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kristoffersen E K, 1996, APMIS Suppl, V64, P5
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohamed HA, 2002, J NEUROSCI RES, V69, P110, DOI 10.1002/jnr.10271
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Murthy JMK, 2010, NEUROL INDIA, V58, P581, DOI 10.4103/0028-3886.68654
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Pawaria A, 2014, INDIAN PEDIATR, V51, P495, DOI 10.1007/s13312-014-0434-8
   Pereira L, 2003, J VIROL, V77, P13301, DOI 10.1128/JVI.77.24.13301-13314.2003
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Pothapregada S, 2016, INDIAN J PEDIATR, V83, P493, DOI 10.1007/s12098-015-1942-9
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raviprakash K, 1998, AM J TROP MED HYG, V58, P90, DOI 10.4269/ajtmh.1998.58.90
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/revreprod/4.2.81
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teoh PG, 2014, J VIROL, V88, P7998, DOI 10.1128/JVI.00940-14
   TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x
   Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0
   Varatharaj A, 2010, NEUROL INDIA, V58, P585, DOI 10.4103/0028-3886.68655
   Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   Westaway EG, 1999, VIROLOGY, V258, P108, DOI 10.1006/viro.1999.9683
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Wu R, 2015, PROC NAECON IEEE NAT, P89, DOI 10.1109/NAECON.2015.7443044
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   Zhang SL, 2006, VIROLOGY, V353, P35, DOI 10.1016/j.virol.2006.05.025
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 150
TC 5
Z9 5
U1 0
U2 4
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 33
EP 42
DI 10.5858/arpa.2016-0409-RA
PG 10
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800006
PM 27763795
OA Bronze
DA 2020-07-08
ER

PT J
AU Ritter, JM
   Martines, RB
   Zaki, SR
AF Ritter, Jana M.
   Martines, Roosecelis B.
   Zaki, Sherif R.
TI Zika Virus Pathology From the Pandemic
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; INTERIM GUIDANCE; INFECTION;
   OUTBREAK; BRAZIL; BRAIN; AUTOIMMUNITY; PREGNANCY; DISEASE
AB Context.-As the number of Zika virus (ZIKV) infections continues to grow, so, too, does the spectrum of recognized clinical disease, in both adult and congenital infections. Defining the tissue pathology associated with the various disease manifestations provides insight into pathogenesis and diagnosis, and potentially future prevention and treatment, of ZIKV infections.
   Objective.-To summarize the syndromes and pathology associated with ZIKV infection, the implications of pathologic findings in the pathogenesis of ZIKV disease, and the use of pathology specimens for diagnosis of ZIKV infection.
   Data Sources.-The major sources of information for this review were published articles obtained from PubMed and pathologic findings from cases submitted to the Infectious Diseases Pathology Branch at the Centers for Disease Control and Prevention.
   Conclusions.-Pathologic findings associated with ZIKV infection are characteristic but not specific. In congenital Zika syndrome, tissue pathology is due to direct viral infection of neural structures, whereas in Guillain-Barre syndrome, pathology is likely due to a postviral, aberrant host-directed immune response. Both fetal and placental pathology specimens are useful for ZIKV diagnosis by molecular and immunohistochemical assays; however, the implications of ZIKV detection in placentas from secondand third-trimester normal live births are unclear, as the potential postnatal effects of late gestational exposure remain to be seen.
C1 [Ritter, Jana M.; Martines, Roosecelis B.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, 1600 Clifton Rd NE,Mailstop G-32, Atlanta, GA 30329 USA.
RP Ritter, JM (corresponding author), Ctr Dis Control & Prevent, Infect Dis Pathol Branch, 1600 Clifton Rd NE,Mailstop G-32, Atlanta, GA 30329 USA.
EM jritter@cdc.gov
CR Abdel-Salam GMH, 2015, AM J MED GENET A, V167, P1089, DOI 10.1002/ajmg.a.37010
   Akyar I, 2011, IRAN J PUBLIC HEALTH, V40, P63
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Benirschke K, 2000, PATHOLOGY HUMAN PLAC, P196
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2016, 32 CLIN VIR S MAY 19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, GUID US CIT RES LIV
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Cohen J, 2016, SCIENCE, V352, P752, DOI 10.1126/science.352.6287.752
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dahle A J, 2000, J Am Acad Audiol, V11, P283
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, ZIK VIR EP AM POT AS
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Okazaki H., 1989, FUNDAMENTALS NEUROPA, P151
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 1996, CLIN INFECT DIS, V23, P248, DOI 10.1093/clinids/23.2.248
   Schwartz DA, SPRINGER NATURE EXPE
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Turrini F, 2016, NEW MICROBIOL, V39, P86
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weitzel T, 2016, AM J TROP MED HYG, V95, P255, DOI 10.4269/ajtmh.16-0096
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
   World Health Organization, ZIK VIR MICR GUILL B
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zambrano H, 2016, AM J TROP MED HYG
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 109
TC 35
Z9 36
U1 1
U2 5
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 49
EP 59
DI 10.5858/arpa.2016-0397-SA
PG 11
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800008
PM 27704909
OA Bronze
DA 2020-07-08
ER

PT J
AU Landry, ML
   St George, K
AF Landry, Marie Louise
   St George, Kirsten
TI Laboratory Diagnosis of Zika Virus Infection
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; SEXUAL TRANSMISSION; UNITED-STATES; OUTBREAK
AB Context.-The rapid and accurate diagnosis of Zika virus infection is an international priority.
   Objective.-To review current recommendations, methods, limitations, and priorities for Zika virus testing.
   Data Sources.-Sources include published literature, public health recommendations, laboratory procedures, and testing experience.
   Conclusions.-Until recently, the laboratory diagnosis of Zika infection was confined to public health or research laboratories that prepared their own reagents, and test capacity has been limited. Furthermore, Zika cross-reacts serologically with other flaviviruses, such as dengue, West Nile, and yellow fever. Current or past infection, or even vaccination with another flavivirus, will often cause falsepositive or uninterpretable Zika serology results. Detection of viral RNA during acute infection using nucleic acid amplification tests provides more specific results, and a number of commercial nucleic acid amplification tests have received emergency use authorization. In addition to serum, testing of whole blood and urine is recommended because of the higher vial loads and longer duration of shedding. However, nucleic acid amplification testing has limited utility because many patients are asymptomatic or present for testing after the brief period of Zika shedding has passed. Thus, the greatest need and most difficult challenge is development of accurate antibody tests for the diagnosis of recent Zika infection. Research is urgently needed to identify Zika virus epitopes that do not crossreact with other flavivirus antigens. New information is emerging at a rapid pace and, with ongoing public-private and international collaborations and government support, it is hoped that rapid progress will be made in developing robust and widely applicable diagnostic tools.
C1 [Landry, Marie Louise] Yale Univ, Sch Med, Dept Lab Med, POB 208035, New Haven, CT 06520 USA.
   [Landry, Marie Louise] Yale Univ, Sch Med, Dept Med, POB 208035, New Haven, CT 06520 USA.
   [St George, Kirsten] New York State Dept Hlth, Viral Dis Lab, Wadsworth Ctr, Albany, NY 12237 USA.
RP Landry, ML (corresponding author), Yale Univ, Sch Med, Dept Lab Med, POB 208035, New Haven, CT 06520 USA.; Landry, ML (corresponding author), Yale Univ, Sch Med, Dept Med, POB 208035, New Haven, CT 06520 USA.
EM marie.landry@yale.edu
FU ThermoFisher (Holtsville, New York); Akonni Biosystems (Frederick,
   (Maryland))
FX Dr St. George receives research support from ThermoFisher (Holtsville,
   New York) for the evaluation of new Zika virus diagnostic assays and for
   research on Zika and other viruses. She also has a royalty-generating
   collaborative agreement with Zeptometrix (Buffalo, New York) as well as
   research support and a collaborative research agreement with Akonni
   Biosystems (Frederick, (Maryland). Dr Landry has no relevant financial
   interest in the products or companies described in this article.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cunha M. S., 2016, GENOME ANNOUNC, V4
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2016, CLIN VACCINE IMMUNOL, V23, P540, DOI 10.1128/CVI.00211-16
   Lustig Y, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917., DOI 10.2807/1560-7917]
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
NR 36
TC 57
Z9 61
U1 4
U2 16
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 60
EP 67
DI 10.5858/arpa.2016-0406-SA
PG 8
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800009
PM 27763787
OA Bronze
DA 2020-07-08
ER

PT J
AU Strafela, P
   Vizjak, A
   Mraz, J
   Mlakar, J
   Pizem, J
   Tul, N
   Zupanc, TA
   Popovic, M
AF Strafela, Peter
   Vizjak, Alenka
   Mraz, Jerica
   Mlakar, Jernej
   Pizem, Joze
   Tul, Natasa
   Zupanc, Tatjana Avsic
   Popovic, Mara
TI Zika Virus-Associated Micrencephaly A Thorough Description of
   Neuropathologic Findings in the Fetal Central Nervous System
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article
ID INTRACRANIAL CALCIFICATION; INFECTION; BRAZIL; BRAIN; POLYMICROGYRIA
AB Context.-The 2015 outbreak of Zika virus in Brazil resulted in a 20-times increased prevalence of congenital microcephaly in stillborns and neonates and was instrumental in raising the suspicion of a causal association between Zika virus and microcephaly.
   Objective.-To provide a comprehensive description of the neuropathologic features of congenital Zika virus infection.
   Design.-Autopsy evaluation of the brain from a fetus of 32 weeks and 6 days of gestation, with a prenatal diagnosis of microcephaly associated with polymerase chain reaction-confirmed, fetal, Zika virus infection.
   Results.-Multiple severe pathology findings were present. These included lissencephaly, except for the occipital lobes, where some pachygyria was observed. Also present was reduction and thinning of white matter, ventriculomegaly of the lateral ventricles, and coalescent calcifications in the cortical-subcortical white matter border associated with glioneuronal outbursting into the subarachnoid space above and heterotopias below. There were small, scattered calcifications in the basal ganglia, with fewer in the white matter and germinal matrix, and none in the cerebellum and brainstem. The cerebellum and pontine base were atrophic because of Wallerian degeneration or maldevelopment of descending tracts and pontocerebellar connections.
   Conclusion.-Our findings are in agreement with neuroimaging of Zika virus-associated fetal and infant micrencephalic brains and, to some extent, with neuroimaging of other intrauterine infections causing microcephaly.
C1 [Strafela, Peter] Univ Clin Ctr, Dept Pathol, Maribor, Slovenia.
   [Vizjak, Alenka; Mraz, Jerica; Mlakar, Jernej; Pizem, Joze; Popovic, Mara] Univ Ljubljana, Fac Med, Inst Pathol, Korytkova 2, Ljubljana 1000, Slovenia.
   [Zupanc, Tatjana Avsic] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.
   [Tul, Natasa] Univ Med Ctr, Div Obstet & Gynecol, Dept Perinatol, Ljubljana, Slovenia.
RP Popovic, M (corresponding author), Univ Ljubljana, Fac Med, Inst Pathol, Korytkova 2, Ljubljana 1000, Slovenia.
EM mara.popovic@mf.uni-lj.si
OI AVSIC ZUPANC, TATJANA/0000-0001-6243-0688
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   Barkovich AJ, 2010, NEURORADIOLOGY, V52, P479, DOI 10.1007/s00234-009-0644-2
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Brasil P, 2006, NEW ENGL J MED, V374, P951
   Briggs TA, 2008, AM J MED GENET A, V146A, P3173, DOI 10.1002/ajmg.a.32614
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chitra TV, 2011, J VECTOR DIS, V48, P210
   Courtier J, 2012, ULTRASOUND OBST GYN, V40, P604, DOI 10.1002/uog.11121
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca Cristiane Miranda, 2004, Spec Care Dentist, V24, P250, DOI 10.1111/j.1754-4505.2004.tb01701.x
   Kulkarni AM, 2010, AM J MED GENET A, V152A, P930, DOI 10.1002/ajmg.a.33358
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2009, SEMIN PEDIATR NEUROL, V16, P120, DOI 10.1016/j.spen.2009.07.001
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Popa RT, 2012, EUR SOC RAD M MARCH, DOI [10.1594/ecr2012/C-2491, DOI 10.1594/ECR2012/C-2491]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
NR 31
TC 20
Z9 21
U1 0
U2 1
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 73
EP 81
DI 10.5858/arpa.2016-0341-SA
PG 9
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800011
PM 27726416
OA Bronze
DA 2020-07-08
ER

PT J
AU Singh, VD
   Lathrop, SL
AF Singh, Veena D.
   Lathrop, Sarah L.
TI Role of the Medical Examiner in Zika Virus and Other Emerging Infections
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article
ID DIAGNOSTIC ERRORS; PATHOLOGY; BIOTERRORISM; AUTOPSY
AB Context.-Medical examiners and coroners have long been an integral component of public health, often being the first to recognize and describe emerging infectious diseases. Given their experience and access, medical examiners and coroners will provide valuable contributions to better understanding Zika virus infection and its sequelae.
   Objective.-To review past examples of medical examiner/coroner involvement in recognition of emerging infectious diseases and describe how medical examiners and coroners will be critical in understanding the pathophysiology of Zika infections.
   Design.-Review of the existing literature on the role of medical examiners and coroners in the identification of emergent infections and the available literature on Zika virus.
   Results.-Medical examiners and coroners have played a crucial role in identifying numerous emerging infectious diseases such as hantavirus pulmonary syndrome and West Nile virus, and have the expertise and experience to aid in elucidating the pathophysiologic effects of Zika virus and tracking its distribution and risk factors.
   Conclusions.-Medical examiners and coroners will be a significant factor in the unified public health approach needed to mitigate the effects of Zika virus and other, heretofore unrecognized, infectious diseases.
C1 [Singh, Veena D.; Lathrop, Sarah L.] Off Med Investigator, Albuquerque, NM USA.
   [Singh, Veena D.; Lathrop, Sarah L.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA.
RP Singh, VD (corresponding author), Univ New Mexico, Sch Med, Dept Pathol, Off Med Investigator, MSC07 4040,1 Univ New Mexico, Albuquerque, NM 87131 USA.
EM VSingh@salud.unm.edu
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Beadsworth MBJ, 2009, INT J STD AIDS, V20, P84, DOI 10.1258/ijsa.2008.008271
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Custer JW, 2015, PEDIATR CRIT CARE ME, V16, P29, DOI 10.1097/PCC.0000000000000274
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Garrett L, 1994, COMING PLAGUE NEWLY, P528
   Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8
   LaBeaud AD., ZIKA VIRUS INFECT OV
   Lynfield R, 2013, INFECTIOUS DISEASE SURVEILLANCE, 2ND EDITION, P223
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Nolte K. B., 1999, Emerging infections 3., P201
   Nolte KB, 1996, ARCH PATHOL LAB MED, V120, P125
   Nolte KB, 2007, HUM PATHOL, V38, P718, DOI 10.1016/j.humpath.2007.02.003
   Nunez JJ, 2014, EMERG INFECT DIS, V20, P386, DOI 10.3201/eid2003.131581
   Ramaswamy C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv146
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rigau-Perez Jose G, 2006, P R Health Sci J, V25, P67
   Schwartz DA, 1996, CLIN INFECT DIS, V23, P248, DOI 10.1093/clinids/23.2.248
   SCHWARTZ DA, 1995, AM J PATHOL, V147, P1525
   Schwartz DA, 2016, PATHOLOGY HELPS UNDE
   Schwartz DA, 2016, NATURE
   Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407
   Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849
   Winters B, 2012, BMJ QUAL SAF, V21, P894, DOI 10.1136/bmjqs-2012-000803
   World Health Organization, 2016, ZIK SIT REP
NR 26
TC 1
Z9 1
U1 0
U2 0
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 82
EP 84
DI 10.5858/arpa.2016-0327-SA
PG 3
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800012
PM 27608262
OA Bronze
DA 2020-07-08
ER

PT J
AU Katz, LM
   Rossmann, SN
AF Katz, Louis M.
   Rossmann, Susan N.
TI Zika and the Blood Supply A Work in Progress
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article
ID WEST-NILE-VIRUS; NEW-YORK-CITY; TRANSMISSION; TRANSFUSION; BRAZIL;
   EPIDEMIC; OUTBREAK; DISEASE; SALIVA; SEMEN
AB Zika virus can be transmitted by transfusion, but the harm caused to recipients is not clear in most cases. It is very likely that the virus could also be transmitted by transplanted organs. Sensitivity to the risk from transfusion is elevated by consideration of possible severe neurologic damage in fetuses. Strategies for dealing with transfusion risk vary with the presence of Zika in the region. In nonendemic areas, risks can be reduced by excluding donors who have exposure through travel or sexual contact with someone at risk. In both endemic and nonendemic areas, the risk can be further reduced by nucleic acid testing of donors, or pathogen reduction of platelet and plasma products. The real risk to the population depends on the frequency of infection as well as the efficacy of these interventions. The interventions chosen will depend on the risk assessment for any situation; in the United States at this time, a combination of travel deferrals, testing, and, to a lesser extent, pathogen reduction is being used, but universal testing of US blood donors under investigational use has been mandated by the US Food and Drug Administration, beginning with states most at risk of local transmission. Canada is largely using travel deferrals. A precautionary approach may be taken; however, a formal decision-making framework has been suggested. The situation globally is clearly very fluid, as the epidemic continues to spread and we continue to learn how to best protect recipients of blood and transplants.
C1 [Katz, Louis M.] Amer Blood Ctr, Washington, DC USA.
   [Katz, Louis M.] Roy J & Lucille A Carver Coll Med, Div Infect Dis, Dept Med, Iowa City, IA USA.
   [Rossmann, Susan N.] Gulf Coast Reg Blood Ctr, 1400 La Concha Ln, Houston, TX 77054 USA.
RP Rossmann, SN (corresponding author), Gulf Coast Reg Blood Ctr, 1400 La Concha Ln, Houston, TX 77054 USA.
EM srossman@giveblood.org
CR Alleghany County Health Department, HLTH DEP REP 4 CONF
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, AM J TROP MED HYG, V93, P231
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Benjamin R., 2016, ZIK VIR S BLOOD HCT
   Biggerstaff BJ, 2002, TRANSFUSION, V42, P1019, DOI 10.1046/j.1537-2995.2002.00167.x
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P790
   Chung KW, 2016, TRANSFUSION, V56, P2184, DOI 10.1111/trf.13644
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dengue, DENGUE
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Eder A, 2014, TECHNICAL MANUAL, P117
   European Centre for Disease Prevention and Control, 2016, ZIK VIR SAF SUBST HU
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Galel S, 2016, ZIK VIR S BLOOD HCT
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Germain M, 2016, AABB ZIK VIR S BLOOD
   Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x
   Goodrich R., 2016, ZIK VIR S BLOOD HCT
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Linnen J, 2016, ZIK VIR S BLOOD HCT
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   McClure M, 2016, ZIK VIR S BLOOD HCT
   Menitove JE, 2014, TRANSFUSION, V54, P753, DOI 10.1111/trf.12569
   Ministerio da Saude (Brazil), MICR MIN SAUD DIV B
   Motta IJ, 2016, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regan DM, ASS B
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Spencer BR, 2015, TRANSFUSION, V55, p3A
   State of Hawaii Department of Health., DENG OUTBR 2015 2016
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tavernise S, 2016, NY TIMES
   U.S. Department of Health and Human Services, GUID ZIK VIR
   U.S. Food and Drug Administration, 2016, REV REC RED RISK ZIK
   US Centers for Disease Control and Prevention, ZIK VIR POT RANG
   US Centers for Disease Control and Prevention, CHIK
   US Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   US Food and Drug Administration, 2016, QUEST ANSW REG REC D
   US Food and Drug Administration, ZIK VIR EUA INF
   US Food and Drug Administration, ZIK VIR RESP UPD FDA
   US Food and Drug Administration, DON SCREEN REC RED R
   WHO, ZIK VIR SIT REP
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 66
TC 16
Z9 16
U1 0
U2 0
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD JAN
PY 2017
VL 141
IS 1
BP 85
EP 92
DI 10.5858/arpa.2016-0430-RA
PG 8
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA EO0GH
UT WOS:000396375800013
PM 27788336
OA Bronze
DA 2020-07-08
ER

PT J
AU Dean, R
   Melnyk, H
   Anglin, C
AF Dean, Ranekka
   Melnyk, Halia
   Anglin, Carlita
TI Zika Virus and Zika Virus Disease
SO JOURNAL OF CONSUMER HEALTH ON THE INTERNET
LA English
DT Article
DE Aedes agepti; emerging communicable diseases; Flavivirus; Guillain-Barre
   syndrome; microcephaly; mosquito-borne disease; Zika virus; Zika virus
   disease
AB During recent months, there has been growing international public concern about the Zika virus. As scientific understanding of the Zika virus unfolds, there are still many unanswered questions. Public health officials, clinicians, and consumers alike have questions about the Zika virus and the Zika virus disease. There is a need to know where to turn for the most up-to-date and reliable online information sources. Although aspects of Zika virus disease and associated medical conditions can be frightening, information seekers may find reassurance in the following online sources to guide their understanding of risk, prevention, transmission, affected geographical areas, symptoms, and disease management.
C1 [Dean, Ranekka; Melnyk, Halia; Anglin, Carlita] NYU, Langone Med Ctr, 545 First Ave,Greenberg Hall SC1-165, New York, NY 10016 USA.
RP Dean, R (corresponding author), NYU, Langone Med Ctr, 545 First Ave,Greenberg Hall SC1-165, New York, NY 10016 USA.
EM Ranekka.Dean@nyumc.org; Halia.Melnyk@nyumc.org; Lita.Anglin@nyumc.org
OI Dean, Ranekka/0000-0002-9467-844X; Anglin, Carlita/0000-0002-5937-4782
CR American Mosquito Control Association (AMCA), 2016, WELC AM MOSQ CONTR A
   CDC (Centers for Disease Control and Prevention), 2016, ZIK VIR ALL COUNTR T
   Centers for Disease Control and Prevention, 2016, ZIK VIR WHAT CDC IS
   Centers for Disease Control and Prevention, 2016, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR PLAN TRAV
   Centers for Disease Control and Prevention (CDC), 2017, ZIK VIR CONTR MOSQ H
   Centers for Disease Control and Prevention (CDC), 2016, ZINK VIR PROT YOURS
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR OV
   Davidson A., 2016, MORBIDITY MORTALITY
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kenneley I., 2016, PREVENTION STRATEGIS, V9, P38
   MedlinePlus, 2016, ZIK VIR
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   World Health Organization, 2016, ZIK VIR
NR 14
TC 0
Z9 0
U1 1
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1539-8285
EI 1539-8293
J9 J CONS HLTH INTERNET
JI J. Consum. Health Internet
PY 2017
VL 21
IS 1
BP 62
EP 70
DI 10.1080/15398285.2017.1280340
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EO4UA
UT WOS:000396688600005
DA 2020-07-08
ER

PT J
AU Panas, D
   Waz, P
   Bielinska-Waz, D
   Nandy, A
   Basak, SC
AF Panas, Damian
   Waz, Piotr
   Bielinska-Waz, Dorota
   Nandy, Ashesh
   Basak, Subhash C.
TI 2D-Dynamic Representation of DNA/RNA Sequences as a Characterization
   Tool of the Zika Virus Genome
SO MATCH-COMMUNICATIONS IN MATHEMATICAL AND IN COMPUTER CHEMISTRY
LA English
DT Article
ID 2D GRAPHICAL REPRESENTATION; DNA-SEQUENCES; DESCRIPTORS; SIMILARITY;
   OUTBREAK; HEALTH; CURVE
AB 2D-dynamic representation of DNA/RNA sequences has been applied for the characterization of the complete genome sequence of Zika virus. Graphically, the 2D-dynamic graphs evolve with time. Numerically, applying descriptors related to the 2D-dynamic graphs, correct classification of the sequences has been obtained. These descriptors have been shown to give an adequate characteristics of the Zika virus genome. The classification diagrams form a new mathematical description of the evolution of the genome sequence of the Zika virus.
C1 [Panas, Damian; Bielinska-Waz, Dorota] Med Univ Gdansk, Dept Radiol Informat & Stat, Tuwima15, PL-80210 Gdansk, Poland.
   [Waz, Piotr] Med Univ Gdansk, Dept Nucl Med, Tuwima15, PL-80210 Gdansk, Poland.
   [Nandy, Ashesh] Ctr Interdisciplinary Res & Educ, 404B Jodhpur Pk, Kolkata 700068, India.
   [Basak, Subhash C.] Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55811 USA.
   [Basak, Subhash C.] Univ Minnesota, Dept Chem & Biochem, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
RP Panas, D (corresponding author), Med Univ Gdansk, Dept Radiol Informat & Stat, Tuwima15, PL-80210 Gdansk, Poland.
RI Waz, Piotr/AAG-6860-2019; Bielinska-Waz, Dorota/AAG-6741-2019
OI Waz, Piotr/0000-0002-0696-9950; Bielinska-Waz,
   Dorota/0000-0003-4674-0576
CR Aram V, 2014, J COMPUT THEOR NANOS, V11, P418, DOI 10.1166/jctn.2014.3371
   Bielinska D., 2016, AIP C P
   Bielinska-Waz D, 2007, AIP CONF PROC, V2, P28, DOI 10.1063/1.2836064
   Bielinska-Waz D, 2007, CHEM PHYS LETT, V445, P68, DOI 10.1016/j.cplett.2007.07.044
   Bielinska-Waz D, 2007, CHEM PHYS LETT, V443, P408, DOI 10.1016/j.cplett.2007.06.088
   Bielinska-Waz D, 2007, CHEM PHYS LETT, V442, P140, DOI 10.1016/j.cplett.2007.05.050
   Bielinska-Waz D, 2011, J MATH CHEM, V49, P2345, DOI 10.1007/s10910-011-9890-8
   Cross J. W., 2016, 2016 CUMULATIVE SELE
   Dai Q, 2006, J MOL GRAPH MODEL, V25, P340, DOI 10.1016/j.jmgm.2005.12.004
   Dyer O, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4740
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Gonzalez-Diaz H, 2009, J THEOR BIOL, V261, P136, DOI 10.1016/j.jtbi.2009.07.029
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HE PA, 2002, INT ELECT J MOL DES, V1, P668
   Jafarzadeh N, 2013, MATH BIOSCI, V241, P217, DOI 10.1016/j.mbs.2012.11.009
   Li YS, 2016, PHYSICA A, V456, P256, DOI 10.1016/j.physa.2016.03.061
   Liao B., 2005, J MOL STRUCT, V717, P99
   NANDY A, 1994, CURR SCI INDIA, V66, P309
   Nandy A, 2007, J CHEM INF MODEL, V47, P945, DOI 10.1021/ci600558w
   Nandy A, 2006, ARKIVOC, P211, DOI 10.3998/ark.5550190.0007.907
   Nandy A, 2016, CURR COMPUT-AID DRUG, V12, P87, DOI 10.2174/1573409912666160401115812
   Randic M, 2000, J CHEM INF COMP SCI, V40, P599, DOI 10.1021/ci9901082
   Randic M, 2001, J CHEM INF COMP SCI, V41, P619, DOI 10.1021/ci000120q
   Randic M, 2003, CHEM PHYS LETT, V371, P202, DOI 10.1016/S0009-2614(03)00244-6
   Randic M, 2013, INT J QUANTUM CHEM, V113, P2413, DOI 10.1002/qua.24479
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Waz P, 2014, J MATH CHEM, V52, P132, DOI 10.1007/s10910-013-0249-1
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Yao YH, 2004, CHEM PHYS LETT, V398, P318, DOI 10.1016/j.cplett.2004.09.087
   Zhang ZJ, 2012, MATCH-COMMUN MATH CO, V68, P621
NR 31
TC 6
Z9 6
U1 2
U2 28
PU UNIV KRAGUJEVAC, FAC SCIENCE
PI KRAGUJEVAC
PA PO BOX 60, RADOJA DOMANOVICA 12, KRAGUJEVAC 34000, SERBIA
SN 0340-6253
J9 MATCH-COMMUN MATH CO
JI Match-Commun. Math. Comput. Chem.
PY 2017
VL 77
IS 2
BP 321
EP 332
PG 12
WC Chemistry, Multidisciplinary; Computer Science, Interdisciplinary
   Applications; Mathematics, Interdisciplinary Applications
SC Chemistry; Computer Science; Mathematics
GA EN7KM
UT WOS:000396181700006
DA 2020-07-08
ER

PT J
AU Roth, H
   Magg, V
   Uch, F
   Mutz, P
   Klein, P
   Haneke, K
   Lohmann, V
   Bartenschlager, R
   Fackler, OT
   Locker, N
   Stoecklin, G
   Ruggieri, A
AF Roth, Hanna
   Magg, Vera
   Uch, Fabian
   Mutz, Pascal
   Klein, Philipp
   Haneke, Katharina
   Lohmann, Volker
   Bartenschlager, Ralf
   Fackler, Oliver T.
   Locker, Nicolas
   Stoecklin, Georg
   Ruggieri, Alessia
TI Flavivirus Infection Uncouples Translation Suppression from Cellular
   Stress Responses
SO MBIO
LA English
DT Article
ID INITIATION-FACTOR 4E; DENGUE VIRUS; PROTEIN-SYNTHESIS; GRANULE
   FORMATION; ZIKA VIRUS; P-BODIES; EIF4E PHOSPHORYLATION;
   BINDING-PROTEINS; GENE-EXPRESSION; I INTERFERON
AB As obligate parasites, viruses strictly depend on host cell translation for the production of new progeny, yet infected cells also synthesize antiviral proteins to limit virus infection. Modulation of host cell translation therefore represents a frequent strategy by which viruses optimize their replication and spread. Here we sought to define how host cell translation is regulated during infection of human cells with dengue virus (DENV) and Zika virus (ZIKV), two positive-strand RNA flaviviruses. Polysome profiling and analysis of de novo protein synthesis revealed that flavivirus infection causes potent repression of host cell translation, while synthesis of viral proteins remains efficient. Selective repression of host cell translation was mediated by the DENV polyprotein at the level of translation initiation. In addition, DENV and ZIKV infection suppressed host cell stress responses such as the formation of stress granules and phosphorylation of the translation initiation factor eIF2 alpha (alpha subunit of eukaryotic initiation factor 2). Mechanistic analyses revealed that translation repression was uncoupled from the disruption of stress granule formation and eIF2 alpha signaling. Rather, DENV infection induced p38-Mnk1 signaling that resulted in the phosphorylation of the eukaryotic translation initiation factor eIF4E and was essential for the efficient production of virus particles. Together, these results identify the uncoupling of translation suppression from the cellular stress responses as a conserved strategy by which flaviviruses ensure efficient replication in human cells.
   IMPORTANCE For efficient production of new progeny, viruses need to balance their dependency on the host cell translation machinery with potentially adverse effects of antiviral proteins produced by the infected cell. To achieve this, many viruses evolved mechanisms to manipulate host cell translation. Here we find that infection of human cells with two major human pathogens, dengue virus (DENV) and Zika virus (ZIKV), leads to the potent repression of host cell translation initiation, while the synthesis of viral protein remains unaffected. Unlike other RNA viruses, these flaviviruses concomitantly suppress host cell stress responses, thereby uncoupling translation suppression from stress granule formation. We identified that the p38-Mnk1 cascade regulating phosphorylation of eIF4E is a target of DENV infection and plays an important role in virus production. Our results define several molecular interfaces by which flaviviruses hijack host cell translation and interfere with stress responses to optimize the production of new virus particles.
C1 [Roth, Hanna; Magg, Vera; Uch, Fabian; Mutz, Pascal; Klein, Philipp; Lohmann, Volker; Bartenschlager, Ralf; Ruggieri, Alessia] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.
   [Haneke, Katharina; Stoecklin, Georg] Heidelberg Univ, Div Biochem 1, Ctr Biomed & Med Technol Mannheim, Med Fac Mannheim, Mannheim, Germany.
   [Haneke, Katharina; Stoecklin, Georg] Heidelberg Univ ZMBH, Ctr Mol Biol, Heidelberg, Germany.
   [Bartenschlager, Ralf] German Canc Res Ctr, Div Virus Associated Carcinogenesis, Heidelberg, Germany.
   [Fackler, Oliver T.] Heidelberg Univ, Dept Infect Dis, Integrat Virol, Heidelberg, Germany.
   [Locker, Nicolas] Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Guildford, Surrey, England.
RP Ruggieri, A (corresponding author), Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.
EM alessia.ruggieri@med.uni-heidelberg.de
RI Lohmann, Volker/H-4211-2019; Bartenschlager, Ralf/L-2582-2015
OI Lohmann, Volker/0000-0001-8719-7608; Bartenschlager,
   Ralf/0000-0001-5601-9307; Haneke, Katharina/0000-0002-6676-3583;
   Ruggieri, Alessia/0000-0001-9981-3308; Locker,
   Nicolas/0000-0002-0053-2897; Fackler, Oliver/0000-0003-2982-4209
FU Chica and Heinz Schaller Foundation; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 1129, TRR
   179, TRR 186, SFB 1036]; Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/N000943/1]
FX This work was supported by funds from the Chica and Heinz Schaller
   Foundation (to A.R. and F.U.) and grants from the Deutsche
   Forschungsgemeinschaft (SFB 1129 to A.R., O.T.F., and R.B., TRR 179 to
   A.R., V.L., and R.B., TRR 186 to A.R. and G.S., and SFB 1036 to G.S.).
   Work in N.L.'s laboratory is supported by Biotechnology and Biological
   Sciences Research Council research grants BB/N000943/1.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Ali IK, 2001, J VIROL, V75, P7854, DOI 10.1128/JVI.75.17.7854-7863.2001
   Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003
   Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776
   Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009
   CELIS JE, 1990, P NATL ACAD SCI USA, V87, P4231, DOI 10.1073/pnas.87.11.4231
   Cervantes-Salazar M, 2015, VIROLOGY, V484, P113, DOI 10.1016/j.virol.2015.05.017
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8
   Clemens MJ, 2001, J CELL MOL MED, V5, P221, DOI 10.1111/j.1582-4934.2001.tb00157.x
   Courtney SC, 2012, J VIROL, V86, P3647, DOI 10.1128/JVI.06549-11
   CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080
   FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x
   Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107
   Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000
   Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001
   Gingras AC, 2001, GENE DEV, V15, P2852
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06
   Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291
   Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296
   Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618
   Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002
   Ishida M, 2003, CIRC RES, V93, P1218, DOI 10.1161/01.RES.0000105570.34585.F2
   Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983
   Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200
   Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje
   Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Lara-Ramirez EE, 2014, BIOMED RES INT, DOI 10.1155/2014/851425
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200
   MADER S, 1995, MOL CELL BIOL, V15, P4990
   Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318
   McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Merrick WC, 2015, J BIOL CHEM, V290, P24091, DOI 10.1074/jbc.R115.675280
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N
   Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015
   Muller D, 2013, TRANSLATION, V1, DOI 10.4161/trla.25819
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NATHANS D, 1964, FED PROC, V23, P984
   Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112
   OBRIG TG, 1971, J BIOL CHEM, V246, P174
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Panas MD, 2015, METHODS, V90, P57, DOI 10.1016/j.ymeth.2015.04.009
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891
   Poblete-Duran N, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070180
   Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270
   Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603
   Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017
   Royall E, 2015, J BIOL CHEM, V290, P4748, DOI 10.1074/jbc.M114.602649
   Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013
   Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]
   Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200
   Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10
   St John AL, 2013, NAT REV MICROBIOL, V11, P420, DOI 10.1038/nrmicro3030
   Taniuchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32886
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Topisirovic I, 2009, MOL CELL BIOL, V29, P1152, DOI 10.1128/MCB.01532-08
   Tschopp C., 2000, Molecular Cell Biology Research Communications, V3, P205, DOI 10.1006/mcbr.2000.0217
   Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351
   Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655
   Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871
   Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077239
NR 89
TC 31
Z9 31
U1 1
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JAN-FEB
PY 2017
VL 8
IS 1
AR e02150-16
DI 10.1128/mBio.02150-16
PG 18
WC Microbiology
SC Microbiology
GA EN2JE
UT WOS:000395835000058
PM 28074025
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Wolfe, B
   Wiepz, GJ
   Schotzko, M
   Bondarenko, GI
   Durning, M
   Simmons, HA
   Mejia, A
   Faith, NG
   Sampene, E
   Suresh, M
   Kathariou, S
   Czuprynski, CJ
   Golos, TG
AF Wolfe, Bryce
   Wiepz, Gregory J.
   Schotzko, Michele
   Bondarenko, Gennadiy I.
   Durning, Maureen
   Simmons, Heather A.
   Mejia, Andres
   Faith, Nancy G.
   Sampene, Emmanuel
   Suresh, Marulasiddappa
   Kathariou, Sophia
   Czuprynski, Charles J.
   Golos, Thaddeus G.
TI Acute Fetal Demise with First Trimester Maternal Infection Resulting
   from Listeria monocytogenes in a Nonhuman Primate Model
SO MBIO
LA English
DT Article
ID INCUBATION PERIOD; PREGNANCY; IMMUNE; OUTBREAK; DECIDUA; MACAQUE;
   SYSTEM; COLONY
AB Infection with Listeria monocytogenes during pregnancy is associated with miscarriage, preterm birth, and neonatal complications, including sepsis and meningitis. While the risk of these conditions is thought to be greatest during the third trimester of pregnancy, the determinants of fetoplacental susceptibility to infection, the contribution of gestational age, and the in vivo progression of disease at the maternal-fetal interface are poorly understood. We developed a nonhuman primate model of listeriosis to better understand antecedents of adverse pregnancy outcomes in early pregnancy. Four pregnant cynomolgus macaques (Macaca fascicularis) received a single intragastric inoculation between days 36 and 46 of gestation with 107 CFU of an L. monocytogenes strain isolated from a previous cluster of human listeriosis cases that resulted in adverse pregnancy outcomes. Fecal shedding, maternal bacteremia, and fetal demise were consistently noted within 7 to 13 days. Biopsy specimens of maternal liver, spleen, and lymph node displayed variable inflammation and relatively low bacterial burden. In comparison, we observed greater bacterial burden in the decidua and placenta and the highest burden in fetal tissues. Histopathology indicated vasculitis, fibrinoid necrosis, and thrombosis of the decidual spiral arteries, acute chorioamnionitis and villitis in the placenta, and hematogenous infection of the fetus. Vascular pathology suggests early impact of L. monocytogenes infection on spiral arteries in the decidua, which we hypothesize precipitates subsequent placentitis and fetal demise. These results demonstrate that L. monocytogenes tropism for the maternal reproductive tract results in infection of the decidua, placenta, and the fetus itself during the first trimester of pregnancy.
   IMPORTANCE Although listeriosis is known to cause significant fetal morbidity and mortality, it is typically recognized in the third trimester of human pregnancy. Its impact on early pregnancy is poorly defined. Here we provide evidence that exposure to L. monocytogenes in the first trimester poses a greater risk of fetal loss than currently appreciated. Similarities in human and nonhuman primate placentation, physiology, and reproductive immunology make this work highly relevant to human pregnancy. We highlight the concept that the maternal immune response that protects the mother from serious disease is unable to protect the fetus, a concept relevant to classic TORCH (toxoplasmosis, other, rubella, cytomegalovirus, and herpes) infections and newly illuminated by current Zika virus outbreaks. Studies with this model, using the well-understood organism L. monocytogenes, will permit preciseanalysis of host-pathogen interactions at the maternal-fetal interface and have broad significance to both recognized and emerging infections in the setting of pregnancy.
C1 [Wolfe, Bryce; Wiepz, Gregory J.; Schotzko, Michele; Bondarenko, Gennadiy I.; Durning, Maureen; Simmons, Heather A.; Mejia, Andres; Golos, Thaddeus G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53705 USA.
   [Wolfe, Bryce] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.
   [Wolfe, Bryce; Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA.
   [Faith, Nancy G.; Suresh, Marulasiddappa; Czuprynski, Charles J.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA.
   [Sampene, Emmanuel] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53705 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53705 USA.
   [Kathariou, Sophia] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.
RP Golos, TG (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53705 USA.; Golos, TG (corresponding author), Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA.; Golos, TG (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53705 USA.
EM golos@primate.wisc.edu
OI Wolfe, Bryce/0000-0003-0418-8816; Suresh,
   Marulasiddappa/0000-0003-1794-3358
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 HD37120, R21 AI100156, R01
   AI107157, P51 OD011106]; Renk Endowed Laboratory; Food Research
   Institute; Vilas Life Cycle Professorship; Research Facilities
   Improvement ProgramUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [RR15459-01, RR020141-01]; Clinical and
   Translational Science Award (CTSA) program through the NIH National
   Center for Advancing Translational Sciences (NCATS)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR000427]
FX This work was supported by NIH grants R01 HD37120, R21 AI100156, and R01
   AI107157 to T. G. Golos, P51 OD011106 to the WNPRC, the Renk Endowed
   Laboratory for Food Safety and the Food Research Institute to C. J.
   Czuprynski, and bridge support to T. G. Golos from the UW-Madison
   Department of Obstetrics and Gynecology and School of Veterinary
   Medicine. T. G. Golos was supported in part by a Vilas Life Cycle
   Professorship. This research was conducted in part at a facility
   constructed with support from Research Facilities Improvement Program
   grant no. RR15459-01 and RR020141-01. Statistical consultation was
   supported by the Clinical and Translational Science Award (CTSA) program
   through the NIH National Center for Advancing Translational Sciences
   (NCATS), grant UL1TR000427. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of
   ORIP or the NIH.
CR Baergen RN, 2011, MANUAL OF PATHOLOGY OF THE HUMAN PLACENTA, SECOND EDITION, P1, DOI 10.1007/978-1-4419-7494-5
   Bakardjiev AI, 2006, PLOS PATHOG, V2, P623, DOI 10.1371/journal.ppat.0020066
   Bondarenko GI, 2012, AM J REPROD IMMUNOL, V68, P309, DOI 10.1111/j.1600-0897.2012.01174.x
   BOUCHER M, 1986, OBSTET GYNECOL, V68, P593
   Cao B, 2014, PLACENTA, V35, P139, DOI 10.1016/j.placenta.2013.12.007
   Dambaeva SV, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094383
   DOYLE ME, 2001, VIRULENCE CHARACTERI
   Egal ES, 2015, J AM ASSOC LAB ANIM, V54, P399
   ENDERS AC, 1991, AM J ANAT, V192, P329, DOI 10.1002/aja.1001920403
   Goddijn M, 1997, Infect Dis Obstet Gynecol, V5, P219
   Golos TG, 2006, METH MOLEC MED, V122, P93
   Goulet V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-11
   Janakiraman Vanitha, 2008, Rev Obstet Gynecol, V1, P179
   Kang DH, 1999, J FOOD PROTECT, V62, P1346, DOI 10.4315/0362-028X-62.11.1346
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]
   Lancaster DP, 2015, J CLIN MICROBIOL, V53, P3609, DOI 10.1128/JCM.01706-15
   Lash GE, 2016, J LEUKOCYTE BIOL, V100, P315, DOI 10.1189/jlb.1A0815-351R
   Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101
   MacDonald PDM, 2005, CLIN INFECT DIS, V40, P677, DOI 10.1086/427803
   Mylonakis E, 2002, MEDICINE, V81, P260, DOI 10.1097/00005792-200207000-00002
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   Poulsen KP, 2013, MICROB PATHOGENESIS, V56, P47, DOI 10.1016/j.micpath.2012.11.003
   Poulsen KP, 2011, MICROB PATHOGENESIS, V50, P360, DOI 10.1016/j.micpath.2011.02.003
   Qiu X, 2009, INFECT IMMUN, V77, P85, DOI 10.1128/IAI.01022-08
   RIEDO FX, 1994, J INFECT DIS, V170, P693, DOI 10.1093/infdis/170.3.693
   Riley JK, 2008, AM J REPROD IMMUNOL, V59, P371, DOI 10.1111/j.1600-0897.2008.00593.x
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   Smith JL, 1999, J FOOD PROTECT, V62, P818, DOI 10.4315/0362-028X-62.7.818
   Smith MA, 2003, INFECT IMMUN, V71, P1574, DOI 10.1128/IAI.71.3.1574-1579.2003
   Smith MA, 2008, INFECT IMMUN, V76, P726, DOI 10.1128/IAI.01366-06
   Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995
   TARANTAL AF, 1988, ANAT REC, V222, P177, DOI 10.1002/ar.1092220210
   TOPALOVSKI M, 1993, AM J OBSTET GYNECOL, V169, P616, DOI 10.1016/0002-9378(93)90632-S
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
NR 36
TC 12
Z9 12
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JAN-FEB
PY 2017
VL 8
IS 1
AR e01938-16
DI 10.1128/mBio.01938-16
PG 10
WC Microbiology
SC Microbiology
GA EN2JE
UT WOS:000395835000083
PM 28223455
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Moraes, FM
   Esposito, DLA
   Da Fonseca, BAL
AF de Moraes, Flavia Masson
   Alves Esposito, Danillo Lucas
   Lopes Da Fonseca, Benedito Antonio
TI Zika - The road from an obscure disease to an epidemic of information
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
C1 [de Moraes, Flavia Masson; Alves Esposito, Danillo Lucas; Lopes Da Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RP Da Fonseca, BAL (corresponding author), Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Esposito, Danillo L.A./N-9261-2017; Fonseca, Benedito/F-3252-2012
OI Esposito, Danillo L.A./0000-0002-2755-4471; Fonseca,
   Benedito/0000-0003-3159-5687
CR Brasil. Ministerio da Saude, 2016, B EPIDEMIOLOGICO
   CDC National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Vogel G, 2016, SCIENCE, V351, P1377, DOI 10.1126/science.351.6280.1377
NR 8
TC 0
Z9 0
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2017
VL 50
IS 1
BP 1
EP 2
DI 10.1590/0037-8682-0541-2016
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EO1ZY
UT WOS:000396497600001
PM 28327795
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Guerra-Gomes, IC
   Gois, BM
   Peixoto, RF
   Oliveira, CA
   Maciel, BLL
   Sarmento, MIF
   Pacha, ASC
   Araujo, JMG
   Amaral, IPG
   Keesen, TSL
AF Guerra-Gomes, Isabel Cristina
   Gois, Bruna Macedo
   Peixoto, Rephany Fonseca
   Oliveira, Camila Alves
   Lima Maciel, Bruna Leal
   Ferreira Sarmento, Maria Izabel
   Cysneiros Pacha, Anna Stella
   Galvao Araujo, Joselio Maria
   Gurgel Amaral, Ian Porto
   Lima Keesen, Tatjana Souza
TI Molecular and clinical epidemiological surveillance of dengue virus in
   Paraiba, Northeast Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE DENV serotypes; Molecular epidemiology; Arboviruses
ID HEMORRHAGIC-FEVER; SEVERE DISEASE; INFECTION; PREGNANCY; SINGAPORE;
   ADULTS
AB Introduction: Despite being the most prevalent arboviral disease worldwide, dengue has been neglected lately. However, recent epidemics of arboviruses such as Zika and chikungunya in locations throughout the world have alerted health authorities to these diseases. This study evaluated the incidence pattern of dengue, its clinical characteristics, and co-circulation of serotypes from 2007 to 2015 in Paraiba State, Northeast Brazil. Methods: Data on dengue cases from 2007 to 2015 were extracted from clinical reports of the National System for Notifiable Diseases [Sistema Nacional de Agravos de Notificacao (SINAN)] of Brazil provided by the Paraiba Health Department. Reverse transcription polymerase chain reaction (RT-PCR) assays for dengue serotypes were carried out on plasma samples obtained from patients with suspected dengue. The data were analysed using descriptive statistics. Results: According to clinical features, dengue fever [n = 39,083 (70.2%)] and dengue without warning signs [n = 15,365 (27.7%)] were the most common classifications of dengue. On RT-PCR, DENV 1 was the most commonly identified serotype (80.5%) in all years studied. Co-circulation of all four DENV serotypes was observed in 2013 and 2014. Furthermore, we observed an increase in dengue notifications in 2015, possibly due to the rise of Zika and chikungunya. Conclusions: Our findings support the hypothesis that co-circulation of the four DENV serotypes may be a reason for the increased prevalence of severe forms of dengue in the years studied. This study may contribute to directing research, health policy, and financial resources toward reducing poorly controlled epidemic diseases.
C1 [Guerra-Gomes, Isabel Cristina; Gois, Bruna Macedo; Peixoto, Rephany Fonseca; Lima Keesen, Tatjana Souza] Univ Fed Paraiba, Lab Imunol Doencas Infecciosas, Dept Biol Celular & Mol, Joao Pessoa, Paraiba, Brazil.
   [Guerra-Gomes, Isabel Cristina; Gurgel Amaral, Ian Porto; Lima Keesen, Tatjana Souza] Univ Fed Paraiba, Programa Posgrad Biotecnol, Ctr Biotecnol, Joao Pessoa, Paraiba, Brazil.
   [Oliveira, Camila Alves; Galvao Araujo, Joselio Maria; Lima Keesen, Tatjana Souza] Univ Fed Rio Grande do Norte, Programa Posgrad Biol Parasitaria, Natal, RN, Brazil.
   [Lima Maciel, Bruna Leal] Univ Fed Rio Grande do Norte, Dept Nutr, Natal, RN, Brazil.
   [Ferreira Sarmento, Maria Izabel; Cysneiros Pacha, Anna Stella] Secretaria Estado Saude Paraiba, Joao Pessoa, Paraiba, Brazil.
RP Keesen, TSL (corresponding author), Univ Fed Paraiba, Lab Imunol Doencas Infecciosas, Dept Biol Celular & Mol, Joao Pessoa, Paraiba, Brazil.; Keesen, TSL (corresponding author), Univ Fed Paraiba, Programa Posgrad Biotecnol, Ctr Biotecnol, Joao Pessoa, Paraiba, Brazil.; Keesen, TSL (corresponding author), Univ Fed Rio Grande do Norte, Programa Posgrad Biol Parasitaria, Natal, RN, Brazil.
EM tat.keesen@cbiotec.ufpb.br
RI Araujo, Joselio M G/B-5502-2013; Amaral, Ian Porto Gurgel
   do/AAC-6999-2019
OI Araujo, Joselio M G/0000-0003-3548-2786; Amaral, Ian Porto Gurgel
   do/0000-0003-1923-6219; Guerra-Gomes, Isabel
   Cristina/0000-0001-9238-5793
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   BrazilNational Council for Scientific and Technological Development
   (CNPq) [446315/2014-1]
FX This work was supported by grant from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - Brazil (#446315/2014-1).
CR Alvarenga CF, 2009, AM J INFECT DIS, V5, P288, DOI 10.3844/ajidsp.2009.288.293
   Brasil MS, 2014, GHG EM ALL PLAN KOR, P1
   Cavalcanti LP, 2011, EMERG INFECT DIS, V17, P132, DOI 10.3201/eid1701.100321
   Chen RF, 2007, T ROY SOC TROP MED H, V101, P1106, DOI 10.1016/j.trstmh.2007.06.019
   Cavalcanti LPD, 2015, REV SOC BRAS MED TRO, V48, P658, DOI 10.1590/0037-8682-0287-2015
   Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003
   Braga JCD, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/276912
   Endy TP, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00183
   Evangelista LSM, 2012, BEPA, V9, P32
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Gibson Gerusa, 2014, Infection Ecology & Epidemiology, V4, P22110, DOI 10.3402/iee.v4.22110
   Goncalves NV, 2004, CAD SAUDE PUBLICA, V20, P1424
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2008, TROPICAL MED SCI PRA, V370, P1644
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Hii YL, 2009, GLOBAL HEALTH ACTION, V2, P124, DOI 10.3402/gha.v2i0.2036
   Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47
   Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x
   Instituto Brasileiro de Geografia e Estatastica [Homepage], 2012, ORC GEST
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leo YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-498
   Lye DC, 2010, INT J INFECT DIS, V14, pE410, DOI 10.1016/j.ijid.2009.06.026
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Ministerio Secretaria General de la Presidencia, 2015, PROT AT SAUD RESP OC, P1
   Montenegro D, 2006, REV SOC BRAS MED TRO, V39, P9, DOI 10.1590/S0037-86822006000100002
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Negev M, 2015, INT J ENV RES PUB HE, V12, P6745, DOI 10.3390/ijerph120606745
   Rodrigues NCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165945
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Secretaria de Saude da Paraiba, 2014, B EP DENG
   Souza AI, 2016, REV SOC BRAS MED TRO, V49, P380, DOI 10.1590/0037-8682-0306-2015
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, pe2520, DOI [10.1371/journal.pntd.0002520, DOI 10.1371/J0URNAL.PNTD.0002520]
   Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060
   Travassos Cláudia, 2002, Rev Panam Salud Publica, V11, P365, DOI 10.1590/S1020-49892002000500011
   *WHO, 1997, DENG HEM FEV DIAGN T
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, ZIK VIR
   Yacoub S, 2015, CLIN MED, V15, P82, DOI 10.7861/clinmedicine.15-1-82
   Yung CF, 2015, AM J TROP MED HYG, V92, P999, DOI 10.4269/ajtmh.14-0628
NR 44
TC 0
Z9 0
U1 0
U2 9
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2017
VL 50
IS 1
BP 19
EP 26
DI 10.1590/0037-8682-0419-2016
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EO1ZY
UT WOS:000396497600004
PM 28327798
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU da Silva, MD
   Branco, MDFC
   Aquino, J
   Queiroz, RCD
   Bani, E
   Moreira, EPB
   Medeiros, MNL
   Rodrigues, ZMR
AF da Silva, Maria do Socorro
   Freitas Carvalho Branco, Maria dos Remedios
   Aquino Junior, Jose
   de Sousa Queiroz, Rejane Christine
   Bani, Emanuele
   Borges Moreira, Emnielle Pinto
   Lima Medeiros, Maria Nilza
   Ribeiro Rodrigues, Zulimar Marita
TI Spatial-temporal analysis of dengue deaths: identifying social
   vulnerabilities
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Dengue fever; Death; Spatial analysis
AB Introduction: Currently, dengue fever, chikungunya fever, and zika virus represent serious public health issues in Brazil, despite efforts to control the vector, the Aedes aegypti mosquito. Methods: This was a descriptive and ecological study of dengue deaths occurring from 2002 to 2013 in Sao Luis, Maranhao, Brazil. Geoprocessing software was used to draw maps, linking the geo-referenced deaths with urban/social data at census tract level. Results: There were 74 deaths, concentrated in areas of social vulnerability. Conclusions: The use of geo-technology tools pointed to a concentration of dengue deaths in specific intra-urban areas.
C1 [da Silva, Maria do Socorro] Programa Municipal Controle Dengue, Sao Luis, Maranhao, Brazil.
   [Freitas Carvalho Branco, Maria dos Remedios] Univ Fed Maranhao, Dept Patol, Sao Luis, Maranhao, Brazil.
   [Freitas Carvalho Branco, Maria dos Remedios; Aquino Junior, Jose; Bani, Emanuele; Borges Moreira, Emnielle Pinto; Ribeiro Rodrigues, Zulimar Marita] Univ Fed Maranhao, Programa Posgrad Saude & Ambiente, Sao Luis, Maranhao, Brazil.
   [Freitas Carvalho Branco, Maria dos Remedios] Univ Fed Maranhao, Programa Posgrad Saude Colet, Sao Luis, Maranhao, Brazil.
   [Aquino Junior, Jose; de Sousa Queiroz, Rejane Christine; Ribeiro Rodrigues, Zulimar Marita] Univ Fed Maranhao, Dept Geociencias, Sao Luis, Maranhao, Brazil.
   [de Sousa Queiroz, Rejane Christine] Univ Fed Maranhao, Dept Saude Publ, Sao Luis, Maranhao, Brazil.
   [Lima Medeiros, Maria Nilza] Univ Fed Maranhao, Programa Posgrad Gestao Programas & Serv Saude, Sao Luis, Maranhao, Brazil.
RP da Silva, MD (corresponding author), Programa Municipal Controle Dengue, Sao Luis, Maranhao, Brazil.
EM socorroepidemiologia@gmail.com
OI Queiroz, Rejane/0000-0003-4019-2011; Freitas Carvalho Branco, Maria dos
   Remedios/0000-0002-3537-0840
FU Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao
   (FAPEMA) [003/2016]
FX We thank the Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico
   do Maranhao (FAPEMA) for the program of support for the publication of
   articles, public notice no. 003/2016.
CR Aquino Jr J., 2014, THESIS
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia epidemiologica, 2009, DIR NAC PREV CONTR E
   Brito CAA, 2007, REV SOC BRAS MED TRO, V40, P220, DOI 10.1590/S0037-86822007000200015
   Escosteguy CC, 2013, EPIDEMIOL SERV SAUDE, V22, P67, DOI 10.5123/S1679-49742013000100007
   Farias Martin, 2011, THESIS
   Figueiro AC, 2011, CAD SAUDE PUBLICA, V27, P2373, DOI 10.1590/S0102-311X2011001200009
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, CTR DOC DISS INF BAS
   Instituto Brasileiro de Geografia e Estatistica (IBGE). Maranhao Sao Luis, 2010, CENS DEM 2010 RES AM
   Pereira MG, 2012, EPIDEMIOLOGIA TEORIA
   PIGNATTI M. G, 1996, THESIS
   Secretaria Municipal de Saude de Sao Luis. Vigilancia Epidemiologica, 1997, 03 SEMUS
   Torres EM, 2005, DENGUE
   Vigano S. S., 2015, MODELAGEM SISTEMAS C, P11
   Vinhal LC, 2008, THESIS
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 15
TC 1
Z9 1
U1 1
U2 7
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2017
VL 50
IS 1
BP 104
EP 109
DI 10.1590/0037-8682-0272-2016
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EO1ZY
UT WOS:000396497600016
PM 28327810
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Badshah, SL
   Naeem, A
   Mabkhot, Y
AF Badshah, Syed Lal
   Naeem, Abdul
   Mabkhot, Yahia
TI The New High Resolution Crystal Structure of NS2B-NS3 Protease of Zika
   Virus
SO VIRUSES-BASEL
LA English
DT Editorial Material
DE Zika virus; microcephaly; non-structural protein; protease; inhibitors
AB Zika virus (ZIKV) is the cause of a significant viral disease affecting humans, which has spread throughout many South American countries and has also become a threat to Southeastern Asia. This commentary discusses the article "Crystal structure of unlinked NS2B-NS3 protease from Zika virus" published recently in the journal Science by Zhang et al. of Nanyang Technological University, Singapore. They resolved a 1.58 angstrom resolution structure of the NS2B-NS3 protease of ZIKV and demonstrated how peptide and non-peptide inhibitors interact with this structure, along with the different conformational states that were observed. This protease crystal structure offers new opportunities for the design and development of novel antiviral drugs used for the treatment and control of ZIKV.
C1 [Badshah, Syed Lal] Islamia Coll Univ, Dept Chem, Peshawar 25120, Khyber Pukhtoon, Pakistan.
   [Naeem, Abdul] Univ Peshawar, Natl Ctr Excellence Phys Chem, Peshawar 25120, Khyber Pukhtoon, Pakistan.
   [Mabkhot, Yahia] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia.
RP Badshah, SL (corresponding author), Islamia Coll Univ, Dept Chem, Peshawar 25120, Khyber Pukhtoon, Pakistan.; Mabkhot, Y (corresponding author), King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia.
EM shahbiochemist@gmail.com; naeeem64@yahoo.com; yahia@ksu.edu.sa
RI Mabkhot, Yahia/E-9301-2017; badshah, syed lal/H-3197-2017
OI Mabkhot, Yahia/0000-0002-9762-0323; badshah, syed
   lal/0000-0002-0229-1425
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [PRG-1437-29]
FX The authors appreciate the Deanship of Scientific Research at King Saud
   University for the funding of this Prolific Research group
   (PRG-1437-29).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67, DOI 10.1128/CMR.13.1.67-82.2000
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Simmonds P., 2012, VIRUS TAXONOMY, P1003
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   White M. K., 2016, ANN NEUROL
   World Health Organization, 2016, ZIK VIR SIT REP
   Zhang Y, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6236
NR 21
TC 5
Z9 6
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2017
VL 9
IS 1
AR 7
DI 10.3390/v9010007
PG 3
WC Virology
SC Virology
GA EO1RS
UT WOS:000396476200007
PM 28075376
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Azarudeen, RMST
   Govindarajan, M
   Amsath, A
   Muthukumaran, U
   Benelli, G
AF Azarudeen, Raja Mohamed Sait Thameem
   Govindarajan, Marimuthu
   Amsath, Abubucker
   Muthukumaran, Udaiyan
   Benelli, Giovanni
TI Single-Step Biofabrication of Silver Nanocrystals Using Naregamia alata:
   A Cost Effective and Eco-Friendly Control Tool in the Fight Against
   Malaria, Zika Virus and St. Louis Encephalitis Mosquito Vectors
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Green-synthesis; AFM; SEM; TEM; Neglected tropical diseases;
   Nanotechnology
ID CULEX-QUINQUEFASCIATUS DIPTERA; NONTARGET AQUATIC ORGANISMS;
   FERONIA-ELEPHANTUM RUTACEAE; LEAF EXTRACT; ANOPHELES-STEPHENSI; GREEN
   SYNTHESIS; AEDES-AEGYPTI; ANTIBACTERIAL ACTIVITY; VETERINARY IMPORTANCE;
   OVICIDAL ACTIVITY
AB Botanical-based nanosynthesis has been recently reported as a cheap alternative for mosquito management. Screening different botanicals as reducing and capping agents led to the production of metal nanoparticles with different biophysical and mosquitocidal features. Here, Naregamia alata-mediated biosynthesis of silver nanoparticles (AgNPs) was conducted. AgNPs were tested on egg, larval and adult populations of three important mosquito vectors, Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus. AgNPs were characterized using UV-Vis spectrophotometry, FTIR, AFM, SEM, TEM, EDX, and XRD analyses. Maximum larvicidal toxicity was detected against A. stephensi (LC50 = 12.40 A mu g/ml), followed by A. aegypti (LC50 = 13.57 A mu g/ml) and C. quinquefasciatus (LC50 = 14.84 A mu g/ml). A single treatment with AgNPs tested at 60, 75 and 90 mu g/ml led to no egg hatchability. In adulticidal experiments, the maximum efficacy was observed on A. stephensi (LD50 = 31.60 mu g/ml), followed by A. aegypti (LD50 = 34.31 mu g/ml) and C. quinquefasciatus (LD50 = 37.52 mu g/ml), respectively. AgNPs were safer for three non-target mosquito natural enemies, Anisops bouvieri, Diplonychus indicus and Gambusia affinis, with LC50 ranging from 629 to 2111 A mu g/ml. Overall, N. alata-fabricated AgNPs are a promising and eco-friendly tool against Anopheles, Aedes and Culex mosquito vectors, with negligible toxicity against non-target aquatic organisms.
C1 [Azarudeen, Raja Mohamed Sait Thameem; Amsath, Abubucker] Khadir Mohideen Coll, Dept Zool, Adirampattinam 614701, Tamil Nadu, India.
   [Govindarajan, Marimuthu; Muthukumaran, Udaiyan] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; Benelli, Giovanni/A-9100-2013
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; Benelli,
   Giovanni/0000-0001-8971-6010
CR Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Ankamwar B, 2005, SYNTH REACT INORG M, V35, P19, DOI 10.1081/SIM-200047527
   Benelli G., 2016, PARASITOL RES MONOGR, P155
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   DEO P G, 1988, International Pest Control, V30, P118
   Devendra T. M., 2016, INDIAN J MED RES, V143, P553
   Falade C, 2007, TROP MED INT HEALTH, V12, P1279, DOI 10.1111/j.1365-3156.2007.01931.x
   Foster WA, 2002, MED ENTOMOL, P245
   Geethalakshmi R, 2010, INT J ENG SCI TECHNO, V2, P976
   Govindarajan M, 2008, PARASITOL RES, V102, P289, DOI 10.1007/s00436-007-0761-y
   Govindarajan M., 2016, GREEN SYNTHESIZED SI, P99
   Govindarajan M, 2017, J CLUST SCI, V28, P15, DOI 10.1007/s10876-016-1035-6
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, PARASITOL RES, V115, P2685, DOI 10.1007/s00436-016-5038-x
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Raut RW, 2010, NANO-MICRO LETT, V2, P106, DOI 10.1007/BF03353627
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Saxena A, 2010, DIG J NANOMATER BIOS, V5, P427
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shanmugam N, 2014, APPL NANOSCI, V4, P881, DOI 10.1007/s13204-013-0271-4
   Singh BP, 2010, J ENVIRON QUAL, V39, P1
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Su TY, 1998, J AM MOSQUITO CONTR, V14, P204
   Thirunavoukkarasu M, 2013, SPECTROCHIM ACTA A, V116, P424, DOI 10.1016/j.saa.2013.07.033
   Veerakumar K, 2014, PARASITOL RES, V113, P4085, DOI 10.1007/s00436-014-4077-4
   Veerakumar K, 2014, PARASITOL RES, V113, P2363, DOI 10.1007/s00436-014-3895-8
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   Warrier PK, 1994, INDIAN MED PLANTS CO, P1
   WHO, 2010, WORLD MALARIA REPORT 2010, P1
   WHO (World Health Organization), 1981, WHOVBC81806
   World Health Organization, 2013, REP WAS LAUNCH NAT P
   World Health Organization, 2005, HOCDSWHOPESGCDPP13
   Zaheer Z, 2013, COLLOID SURFACE B, V108, P90, DOI 10.1016/j.colsurfb.2013.02.023
   Zargar M, 2011, MOLECULES, V16, P6667, DOI 10.3390/molecules16086667
NR 51
TC 12
Z9 12
U1 0
U2 10
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD JAN
PY 2017
VL 28
IS 1
SI SI
BP 179
EP 203
DI 10.1007/s10876-016-1067-y
PG 25
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA EL0QB
UT WOS:000394325800014
OA Bronze
DA 2020-07-08
ER

PT J
AU Azarudeen, RMST
   Govindarajan, M
   AlShebly, MM
   AlQahtani, FS
   Amsath, A
   Benelli, G
AF Azarudeen, Raja Mohamed Sait Thameem
   Govindarajan, Marimuthu
   AlShebly, Mashael Marzouq
   AlQahtani, Fatma Saeed
   Amsath, Abubucker
   Benelli, Giovanni
TI One Pot Green Synthesis of Colloidal Silver Nanocrystals Using the
   Ventilago maderaspatana Leaf Extract: Acute Toxicity on Malaria, Zika
   Virus and Filariasis Mosquito Vectors
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Biofabrication; Silver nanoparticles; SEM; TEM; AFM; Culicidae;
   Mosquito-borne diseases
ID CULEX-QUINQUEFASCIATUS DIPTERA; RUBIA-CORDIFOLIA LINN.;
   ANOPHELES-STEPHENSI; AEDES-AEGYPTI; VETERINARY IMPORTANCE; MADRASPATANA
   GAERTN.; BIOLOGICAL SYNTHESIS; LARVICIDAL ACTIVITY; OVICIDAL ACTIVITY;
   PLANT LATEX
AB Mosquitoes act as a vector for most of the life-threatening diseases. The green synthesis of eco-friendly metal nanoparticles is a fast-growing branch of current nanoscience with a number of biomedical and entomological implications. Here, we have synthesized silver nanoparticles (AgNPs) by using a poorly studied Indian plant, Ventilago maderaspatana. The results recorded from UV-Visible spectrophotometry, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD), atomic force microscopy (AFM), scanning electron microscopy (SEM) and transmission electron microscopy (TEM) confirmed the quick synthesis of AgNPs. The toxic activity of V. maderaspatana leaf extract and biosynthesized AgNPs was evaluated against the malaria vector Anopheles stephensi, the Zika virus vector Aedes aegypti and the filariasis vector Culex quinquefasciatus. Compared to the leaf aqueous extract, AgNPs showed higher toxicity against A. stephensi, A. aegypti, and C. quinquefasciatus with LC50 values of 24.89, 26.92 and 29.24 mu g/mL, respectively. A single treatment with AgNPs tested at 120, 150 and 180 mu g/mL led to no egg hatchability. In adulticidal experiments, the maximum efficacy was observed on A. stephensi (LD50 = 41.19 mu g/mL), followed by A. aegypti (LD50 = 44.85 mu g/mL) and C. quinquefasciatus (LD50 = 48.94 mu g/mL), respectively. V. maderaspatana extract and green fabricated AgNPs were found safer to non-target aquatic biocontrol organisms Anisops bouvieri, Diplonychus indicus and Gambusia affinis, with LC50 ranging from 1673 to 41,854 A mu g/ml.
C1 [Azarudeen, Raja Mohamed Sait Thameem; Amsath, Abubucker] Khadir Mohideen Coll, Dept Zool, Adirampattinam 614701, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [AlShebly, Mashael Marzouq] King Saud Univ, Coll Med, Dept Obstet & Gynecol, Riyadh, Saudi Arabia.
   [AlShebly, Mashael Marzouq; AlQahtani, Fatma Saeed] King Saud Univ Med City, Riyadh, Saudi Arabia.
   [AlQahtani, Fatma Saeed] King Saud Univ, Coll Med, Dept Pathol, Hematol Unit, Riyadh, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; Benelli, Giovanni/A-9100-2013
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; Benelli,
   Giovanni/0000-0001-8971-6010
CR Angajala G, 2014, ACTA TROP, V135, P19, DOI 10.1016/j.actatropica.2014.03.012
   Basu S, 2005, PHYTOTHER RES, V19, P888, DOI 10.1002/ptr.1752
   Benelli G., 2016, PARASITOL RES MONOGR, P155
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Chopra RN, 1956, GLOSSARY INDIAN MED
   DEO P G, 1988, International Pest Control, V30, P118
   Duganath N, 2010, INT J PHARM BIOL SCI, V1, P1
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Ghosh S, 2010, J PHARM PHARMACOL, V62, P1158, DOI 10.1111/j.2042-7158.2010.01151.x
   Gopinath V, 2013, SPECTROCHIM ACTA A, V106, P170, DOI 10.1016/j.saa.2012.12.087
   Gopinath V, 2012, COLLOID SURFACE B, V96, P69, DOI 10.1016/j.colsurfb.2012.03.023
   Govindarajan M, 2008, PARASITOL RES, V102, P289, DOI 10.1007/s00436-007-0761-y
   Govindarajan M, 2017, J CLUST SCI, V28, P15, DOI 10.1007/s10876-016-1035-6
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Krishnakumari GN, 2001, FITOTERAPIA, V72, P671, DOI 10.1016/S0367-326X(01)00280-5
   Machalova Z, 2015, IND CROP PROD, V67, P310, DOI 10.1016/j.indcrop.2015.01.070
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Muniyappan N, 2014, PROCESS BIOCHEM, V49, P1054, DOI 10.1016/j.procbio.2014.03.015
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Pavela R, 2017, J PEST SCI, V90, P683, DOI [10.1007/s10340-016-0828-6, 10.1007/s10340-016-0763-6]
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   RAO BK, 1983, PHYTOCHEMISTRY, V22, P2583, DOI 10.1016/0031-9422(83)80170-8
   SALAM HA, 2012, INT RES J BIOL SCI, V1, P85
   Sanghi R, 2009, BIORESOURCE TECHNOL, V100, P501, DOI 10.1016/j.biortech.2008.05.048
   Sap-lam N, 2010, Journal of Applied Sciences, V10, P3132
   Shankar SS, 2003, BIOTECHNOL PROGR, V19, P1627, DOI 10.1021/bp034070w
   Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6
   Su TY, 1998, J AM MOSQUITO CONTR, V14, P204
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vignesh V, 2013, COLLOID SURFACE A, V439, P184, DOI 10.1016/j.colsurfa.2013.04.011
   WHO (World Health Organization), 1981, WHOVBC81806
   World Health Organization, 2005, HOCDSWHOPESGCDPP13
   Yokoyama K, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105101
NR 50
TC 6
Z9 6
U1 0
U2 6
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD JAN
PY 2017
VL 28
IS 1
SI SI
BP 369
EP 392
DI 10.1007/s10876-016-1103-y
PG 24
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA EL0QB
UT WOS:000394325800024
OA Bronze
DA 2020-07-08
ER

PT J
AU Mahyoub, JA
   Aziz, A
   Panneerselvam, C
   Murugan, K
   Roni, M
   Trivedi, S
   Nicoletti, M
   Hawas, UW
   Shaher, FM
   Bamakhrama, MA
   Canale, A
   Benelli, G
AF Mahyoub, Jazem A.
   Aziz, Al Thabiani
   Panneerselvam, Chellasamy
   Murugan, Kadarkarai
   Roni, Mathath
   Trivedi, Subrata
   Nicoletti, Marcello
   Hawas, Usama W.
   Shaher, Fekri M.
   Bamakhrama, Muneer A.
   Canale, Angelo
   Benelli, Giovanni
TI Seagrasses as Sources of Mosquito Nano-Larvicides? Toxicity and Uptake
   of Halodule uninervis-Biofabricated Silver Nanoparticles in Dengue and
   Zika Virus Vector Aedes aegypti
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Arbovirus; Yellow fever; West Nile; Nanotechnology; Multi-drug resistant
   bacteria
ID ANTIBACTERIAL ACTIVITY; ANOPHELES-STEPHENSI; PLASMODIUM-FALCIPARUM;
   GREEN SYNTHESIS; IN-VITRO; SYNTHESIZED NANOPARTICLES; VETERINARY
   IMPORTANCE; PREDATION EFFICIENCY; BACTERIAL PATHOGENS; BORNE DISEASES
AB Mosquitoes (Diptera: Culicidae) act as vectors for devastating pathogens and parasites. Zika virus, an Aedes mosquito-borne flavivirus, is becoming a worldwide public health concern following its suspected association with over 4000 recent cases of microcephaly in the infants of some women who were pregnant when they contracted the disease. There are no specific treatments for Zika virus, thus the eco-friendly and effective control of mosquito vectors is crucial. This research proposed a novel method of seagrass-mediated synthesis of silver nanoparticles (AgNP) using Halodule uninervis as a reducing and capping agent. UV-Vis spectroscopy, FTIR spectroscopy, SEM, EDX spectroscopy, XRD and Raman analysis confirmed the rapid and cheap synthesis of AgNP. LC50 of H. uninervis extract against Aedes aegypti was 295.629 ppm and LC50 of H. uninervis-synthesized AgNP was 12.554 ppm. Microscopy analysis pointed out the uptake of H. uninervis-fabricated AgNP in the midgut of mosquito larvae. In MIC assays, low doses of the AgNP inhibited the growth of Bacillus subtilis, Klebsiella pneumoniae and Salmonella typhi. Overall, this research shed light on the mosquitocidal potential of H. uninervis, as a bio-resource for the cheap and effective nanosynthesis of mosquitocidal biopesticides.
C1 [Mahyoub, Jazem A.] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia.
   [Mahyoub, Jazem A.] IBB Univ, Ibb, Yemen.
   [Aziz, Al Thabiani; Panneerselvam, Chellasamy; Trivedi, Subrata] Univ Tabuk, Dept Biol, Fac Sci, Tabuk, Saudi Arabia.
   [Murugan, Kadarkarai; Roni, Mathath] Bharathiar Univ, Sch Life Sci, Div Entomol, Dept Zool, Coimbatore 641046, Tamil Nadu, India.
   [Murugan, Kadarkarai] Thiruvalluvar Univ, Vellore 632115, Tamil Nadu, India.
   [Nicoletti, Marcello] Sapienza Univ Rome, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Hawas, Usama W.; Shaher, Fekri M.; Bamakhrama, Muneer A.] King Abdulaziz Univ, Fac Marine Sci, Dept Marine Chem, Jeddah, Saudi Arabia.
   [Canale, Angelo; Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM cpselva@ymail.com; benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013; Murugan, Kadarkarai/AAP-3937-2020;
   Mahyoub, jazem/F-6648-2014; amsalu, ribka/G-8780-2019
OI Benelli, Giovanni/0000-0001-8971-6010; Hawas, usama/0000-0003-3276-9001;
   Panneerselvam, Chellasamy/0000-0003-3994-8141
FU Deanship of Scientific Research (DSR) at King Abdulaziz University,
   Jeddah [G-256-130-37]; Deanship of Scientific Research
FX Dr. Jazem A. Mahyoub is grateful to the Deanship of Scientific Research
   (DSR) at King Abdulaziz University, Jeddah, Grant No. G-256-130-37. The
   authors would like to extend their sincere appreciation to the Deanship
   of Scientific Research for its technical and financial support.
CR Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Anbu P., 2015, NAT PROD RES, DOI [10.1080/14786419.2015.1114935, DOI 10.1080/14786419.2015.1114935.]
   Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3
   Basavegowda N, 2014, J NANOSCI NANOTECHNO, V14, P4377, DOI 10.1166/jnn.2014.8646
   Benelli G., 2016, J CLUST SCI, DOI [10.1007/s10876-016-1088-6, DOI 10.1007/S10876-016-1088-6.]
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Biswas N, 2007, CHEM PHYS LETT, V444, P338, DOI 10.1016/j.cplett.2007.07.049
   Chowdhury J, 2004, J COLLOID INTERF SCI, V277, P121, DOI 10.1016/j.jcis.2004.04.030
   COSGROVE JB, 1994, J AM MOSQUITO CONTR, V10, P434
   de Aragao A. P., 2016, ARAB J CHEM, DOI [10.1016/j.arabjc.2016.04.014, DOI 10.1016/J.ARABJC.2016.04.014.]
   Dhand V, 2016, MAT SCI ENG C-MATER, V58, P36, DOI 10.1016/j.msec.2015.08.018
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Dubey P, 2005, PRAMANA-J PHYS, V65, P681, DOI 10.1007/BF03010456
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF FACTSH H
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Fortes M. D., 1990, ICLARM ED SER, P46
   George DR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-28
   Ghaffari-Moghaddam M, 2014, J IND ENG CHEM, V20, P739, DOI 10.1016/j.jiec.2013.09.005
   Global Alert and Response, 2015, GLOB AL RESP IMP DEN
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Green E. P., 2003, WORLD ATLAS SEAGRASS
   Huang P, 2011, NANOSCALE, V3, P3623, DOI 10.1039/c1nr10586h
   Kalimuthu K., 2016, HYDROBIOLOGIA, DOI [10.1007/s10750-016-2943-z, DOI 10.1007/S10750-016-2943-Z.]
   Kaviya S, 2011, SPECTROCHIM ACTA A, V79, P594, DOI 10.1016/j.saa.2011.03.040
   Kulikova OG, 2015, APPL BIOCHEM MICRO+, V51, P362, DOI 10.1134/S0003683815030114
   Kumar SR, 2014, RSC ADV, V4, P13409, DOI 10.1039/c3ra47542e
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Mahyoub J. A., 2016, Asian Pacific Journal of Tropical Disease, V6, P361
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711
   Murugan K, 1999, CURR SCI INDIA, V76, P631
   Murugan K., 1996, Journal of Entomological Research (New Delhi), V20, P137
   Murugan K, 2016, ENVIRON SCI POLLUT R, V23, P16671, DOI 10.1007/s11356-016-6832-9
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, PARASITOL RES, V114, P4087, DOI 10.1007/s00436-015-4638-1
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Patra JK, 2008, TURK J BIOL, V32, P119
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rajaganesh R, 2016, RES VET SCI, V109, P40, DOI 10.1016/j.rvsc.2016.09.012
   Ravikumar S, 2010, J ENVIRON BIOL, V31, P387
   Ravikumar S, 2011, PARASITOL RES, V108, P107, DOI 10.1007/s00436-010-2041-5
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Sathishkumar G, 2012, COLLOID SURFACE B, V95, P235, DOI 10.1016/j.colsurfb.2012.03.001
   Sathyavathi R, 2010, ADV SCI LETT, V3, P138, DOI 10.1166/asl.2010.1099
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shanthi S, 2016, MICROB PATHOGENESIS, V93, P70, DOI 10.1016/j.micpath.2016.01.014
   Singh M, 2008, DIG J NANOMATER BIOS, V3, P115
   Song HY, 2006, EUR CELLS MATER, V11, P58
   Stuart B., 2002, POLYM ANAL
   Suresh G, 2014, SPECTROCHIM ACTA A, V127, P61, DOI 10.1016/j.saa.2014.02.030
   Venkataraman K, 2015, COASTAL MARINE BIODI, P303
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 66
TC 18
Z9 18
U1 1
U2 14
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD JAN
PY 2017
VL 28
IS 1
SI SI
BP 565
EP 580
DI 10.1007/s10876-016-1127-3
PG 16
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA EL0QB
UT WOS:000394325800035
DA 2020-07-08
ER

PT J
AU Benelli, G
   Govindarajan, M
   Kadaikunnan, S
   Alharbi, NS
AF Benelli, Giovanni
   Govindarajan, Marimuthu
   Kadaikunnan, Shine
   Alharbi, Naiyf S.
TI What Kind of Reducing Botanical? High Mosquitocidal Efficacy of a Silver
   Nanocomposite Synthesized Using a Leaf Aqueous Extract of Fumaria indica
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Green synthesis; Nanoparticles; Malaria; Zika virus; Japanese
   encephalitis
ID GREEN SYNTHESIS; NANOPARTICLES; BIOSYNTHESIS; MALARIA; TOOL; DENGUE
AB Mosquito vector control is a crucial challenge nowadays. Recently, the relevance of screening poorly studied plant products for green synthesis of nanopesticides was highlighted. Different plant products for nanosynthesis led to nano-composites with distinct biophysical features and toxicity. Here we fabricated silver nanoparticles capped with metabolites from Fumaria indica aqueous extract. Several biophysical methods were used to validate nanosynthesis F. indica-synthesized nanomaterial showed high efficacy as pesticide on Anopheles subpictus (LC50 = 10.34 A mu g/ml), Aedes albopictus (LC50 = 11.42 A mu g/ml) and Culex tritaeniorhynchus (LC50 = 12.50 A mu g/ml) larvae, allowing us to propose this easy to obtain nano-material as an effective source of novel mosquito pesticides.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Kadaikunnan, Shine; Alharbi, Naiyf S.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
EM benelli.giovanni@gmail.com; drgovind1979@gmail.com
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; Alharbi, Naiyf S/B-9402-2019;
   /L-2836-2013; Benelli, Giovanni/A-9100-2013
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; /0000-0001-7018-5379;
   Benelli, Giovanni/0000-0001-8971-6010
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [PRG-1437-36]
FX The authors extend their sincere appreciations to the Deanship of
   Scientific Research at King Saud University for funding this Prolific
   Research Group (PRG-1437-36).
CR Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Gopinath V, 2012, COLLOID SURFACE B, V96, P69, DOI 10.1016/j.colsurfb.2012.03.023
   Govindarajan M, 2016, ENZYME MICROB TECH, V95, P155, DOI 10.1016/j.enzmictec.2016.05.005
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Shankar SS, 2004, APPL NANOSCI, V1, P69, DOI DOI 10.1088/0957-4484/18/10/105104
   Tavakoli F, 2015, MATER RES BULL, V63, P51, DOI 10.1016/j.materresbull.2014.11.045
   Thirunavoukkarasu M, 2013, SPECTROCHIM ACTA A, V116, P424, DOI 10.1016/j.saa.2013.07.033
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   World Health Organization, 2005, GUID LAB FIELD TEST, P13
NR 17
TC 4
Z9 4
U1 0
U2 10
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD JAN
PY 2017
VL 28
IS 1
SI SI
BP 637
EP 643
DI 10.1007/s10876-017-1159-3
PG 7
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA EL0QB
UT WOS:000394325800040
DA 2020-07-08
ER

PT J
AU Abad-Franch, F
   Zamora-Perea, E
   Luz, SLB
AF Abad-Franch, Fernando
   Zamora-Perea, Elvira
   Luz, Sergio L. B.
TI Mosquito-Disseminated Insecticide for Citywide Vector Control and Its
   Potential to Block Arbovirus Epidemics: Entomological Observations and
   Modeling Results from Amazonian Brazil
SO PLOS MEDICINE
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; ZIKA VIRUS; DENGUE; EFFICACY; VACCINE;
   PYRIPROXYFEN; CULICIDAE; SURVIVAL; AMERICA
AB Background
   Mosquito-borne viruses threaten public health worldwide. When the ratio of competent vectors to susceptible humans is low enough, the virus's basic reproductive number (R-0) falls below 1.0 (each case generating, on average, <1.0 additional case) and the infection fades out from the population. Conventional mosquito control tactics, however, seldom yield R-0 < 1.0. A promising alternative uses mosquitoes to disseminate a potent growth-regulator larvicide, pyriproxyfen (PPF), to aquatic larval habitats; this kills most mosquito juveniles and substantially reduces adult mosquito emergence. We tested mosquito-disseminated PPF in Manacapuru, a 60,000-inhabitant city (similar to 650 ha) in Amazonian Brazil.
   Methods and Findings
   We sampled juvenile mosquitoes monthly in 100 dwellings over four periods in February 2014-January 2016: 12 baseline months, 5 mo of citywide PPF dissemination, 3 mo of focal PPF dissemination around Aedes-infested dwellings, and 3 mo after dissemination ended. We caught 19,434 juvenile mosquitoes (66% Aedes albopictus, 28% Ae. aegypti) in 8,271 trap-months. Using generalized linear mixed models, we estimated intervention effects on juvenile catch and adult emergence while adjusting for dwelling-level clustering, unequal sampling effort, and weather-related confounders. Following PPF dissemination, Aedes juvenile catch decreased by 79%-92% and juvenile mortality increased from 2%-7% to 80%-90%. Mean adult Aedes emergence fell from 1,077 per month (range 653-1,635) at baseline to 50.4 per month during PPF dissemination (range 2-117). Female Aedes emergence dropped by 96%-98%, such that the number of females emerging per person decreased to 0.06 females per person-month (range 0.002-0.129). Deterministic models predict, under plausible biological-epidemiological scenarios, that the R-0 of typical Aedes-borne viruses would fall from 3-45 at baseline to 0.004-0.06 during PPF dissemination. The main limitations of our study were that it was a before-after trial lacking truly independent replicates and that we did not measure mosquito-borne virus transmission empirically.
   Conclusions
   Mosquito-disseminated PPF has potential to block mosquito-borne virus transmission city-wide, even under adverse scenarios. Our results signal new avenues for mosquito-borne disease prevention, likely including the effective control of Aedes-borne dengue, Zika, and chikungunya epidemics. Cluster-randomized controlled trials will help determine whether mosquito-disseminated PPF can, as our findings suggest, develop into a major tool for improving global public health.
C1 [Abad-Franch, Fernando] Fundacao Oswaldo Cruz, Lab Triatomineos & Epidemiol Doenca Chagas, Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil.
   [Abad-Franch, Fernando; Zamora-Perea, Elvira; Luz, Sergio L. B.] Fundacao Oswaldo Cruz, Lab Ecol Doenc Transmissiveis Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP Abad-Franch, F (corresponding author), Fundacao Oswaldo Cruz, Lab Triatomineos & Epidemiol Doenca Chagas, Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil.; Abad-Franch, F (corresponding author), Fundacao Oswaldo Cruz, Lab Ecol Doenc Transmissiveis Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
EM fernando.abad@cpqrr.fiocruz.br
RI Abad-Franch, Fernando/AAG-2432-2020
OI Abad-Franch, Fernando/0000-0002-7715-0328; Luz, Sergio Luiz
   Bessa/0000-0001-5887-7372
FU Institute Leonidas e Maria Deane (ILMD/Fiocruz, Brazil); Fiocruz-FAPEAM
   agreement; Centro de Pesquisa Rene Rachou; Vice-Presidencia de Pesquisa
   e Laboratorios de Referenda (CPqRR, Brazil); Vice-Presidencia de
   Pesquisa e Laboratorios de Referenda (VPPLR/Fiocruz, Brazil)
FX This study was primarily supported by intramural funds of the Institute
   Leonidas e Maria Deane (ILMD/Fiocruz, Brazil). Additional support came
   from the Fiocruz-FAPEAM agreement, the Centro de Pesquisa Rene Rachou
   and the Vice-Presidencia de Pesquisa e Laboratorios de Referenda (CPqRR
   and VPPLR/Fiocruz, Brazil). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   ANDERSON R M, 1991
   Bates D, 2016, LME4 MIXED EFFECTS M
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Burnham K. P., 2002, MODEL SELECTION MULT
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   FOCKS DA, 2003, REV ENTOMOLOGICAL SA
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Herve JP, 1986, I EVANDRO CHAGAS 50, VI, P409
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Institute of Medicine, 2008, VECT BORN DIS UND EN
   Itoh T, 1994, TROP MED, V36, P243
   Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lipsitch M, 2016, SCIENCE, V353, P1094, DOI 10.1126/science.aai8126
   [Ministerio da Saude do Brasil Secretaria devigilanciaem Saude], 2016, B EPIDEMIOLOGICO, V47, P1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   R Development Core Team, 2014, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Thomas SJ, 2015, NEW ENGL J MED, V372, P172, DOI 10.1056/NEJMe1413146
   Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vontas J, 2014, TRENDS PARASITOL, V30, P191, DOI 10.1016/j.pt.2014.02.005
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wilder-Smith A, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17273
   World Health Organization, 2008, PYR DRINK WAT US VEC
   World Health Organization (WHO), 2009, SPEC PROGR RES TRAIN
NR 51
TC 9
Z9 10
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD JAN
PY 2017
VL 14
IS 1
AR e1002213
DI 10.1371/journal.pmed.1002213
PG 22
WC Medicine, General & Internal
SC General & Internal Medicine
GA EN0SM
UT WOS:000395719900009
PM 28095414
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Von Seidlein, L
   Kekule, AS
   Strickman, D
AF Von Seidlein, Lorenz
   Kekule, Alexander S.
   Strickman, Daniel
TI Novel Vector Control Approaches: The Future for Prevention of Zika Virus
   Transmission?
SO PLOS MEDICINE
LA English
DT Editorial Material
ID AEDES-AEGYPTI; CHIKUNGUNYA; WOLBACHIA; MOSQUITOS; BRAZIL
C1 [Von Seidlein, Lorenz] Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand.
   [Kekule, Alexander S.] Martin Luther Univ Halle Wittenberg, Halle, Saale, Germany.
   [Strickman, Daniel] Bill & Melinda Gates Fdn, Seattle, WA USA.
RP Von Seidlein, L (corresponding author), Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand.
EM Lorenz@tropmedres.ac
OI von Seidlein, Lorenz/0000-0002-0282-6469
CR Abad-Franch F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002213
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   CHAMBERLAIN WF, 1975, J MED ENTOMOL, V12, P395, DOI 10.1093/jmedent/12.4.395
   de Andrade PP, 2016, B WORLD HEALTH ORGAN, V94, P766, DOI 10.2471/BLT.16.173377
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hirano M, 1998, REV TOXICOL, V2, P357
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Main Douglas, 2016, NEWSWEEK
   Specter M, 2012, NEW YORKER
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vreysen MJB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002857
   World Health Organization, 2008, PYR DRINK WAT US VEC
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
NR 17
TC 16
Z9 16
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1676
J9 PLOS MED
JI PLos Med.
PD JAN
PY 2017
VL 14
IS 1
AR e1002219
DI 10.1371/journal.pmed.1002219
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EN0SM
UT WOS:000395719900015
PM 28095418
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Albuquerque, PC
   Castro, MJC
   Santos-Gandelman, J
   Oliveira, AC
   Peralta, JM
   Rodrigues, ML
AF Albuquerque, Priscila C.
   Castro, Mauro Jorge C.
   Santos-Gandelman, Juliana
   Oliveira, Ana Claudia
   Peralta, Jose M.
   Rodrigues, Marcio L.
TI Bibliometric Indicators of the Zika Outbreak
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS
C1 [Albuquerque, Priscila C.; Santos-Gandelman, Juliana; Oliveira, Ana Claudia; Rodrigues, Marcio L.] Fiocruz MS, Fundacao Oswaldo Cruz, CDTS, Rio De Janeiro, Brazil.
   [Albuquerque, Priscila C.; Castro, Mauro Jorge C.; Peralta, Jose M.; Rodrigues, Marcio L.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
   [Oliveira, Ana Claudia] Associacao Brasileira Ind Qum Fina Biotecnol & Su, Rio De Janeiro, Brazil.
RP Rodrigues, ML (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, CDTS, Rio De Janeiro, Brazil.; Rodrigues, ML (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
EM marciolr@cdts.fiocruz.br
RI Albuquerque, Priscila C/L-4884-2015; Cabral-Castro, Mauro
   Jorge/L-8868-2016; Rodrigues, Marcio/J-3727-2013
OI Albuquerque, Priscila C/0000-0001-8185-024X; Cabral-Castro, Mauro
   Jorge/0000-0002-1755-999X; Rodrigues, Marcio/0000-0002-6081-3439
FU CAPESCAPES; Instituto Nacional de Ciencia e Tecnologia de Inovacao em
   Doencas Negligenciadas (INCT-IDN, CNPq)National Council for Scientific
   and Technological Development (CNPq) [573642/2008-7]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [443586/2014-4, 300699/2013-1]; FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/102.835/2012, 210.918/2015]
FX The Brazilian agency CAPES supported the institutional use of Scopus,
   Orbit, and Web of Science databases. MLR acknowledges support from the
   Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas
   Negligenciadas (INCT-IDN, CNPq, grant number 573642/2008-7), CNPq (grant
   numbers 443586/2014-4 and 300699/2013-1), and FAPERJ (grant numbers
   E-26/102.835/2012 and 210.918/2015). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Albuquerque PC, 2012, FUTURE MICROBIOL, V7, P319, DOI [10.2217/FMB.11.162, 10.2217/fmb.11.162]
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, CDC RESP ZIK VIR OUT
   CellPress, 2016, ZIK VIR
   Cruz-Calderon S, 2015, TRAVEL MED INFECT DI, V13, P202, DOI 10.1016/j.tmaid.2015.02.007
   Delvecchio R., 2016, BIORXIV
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Martins MFM, 2016, REV ELETRON COMUN IN, V10, P1
   MRC, 2016, MRC LAUNCH RAP RESP
   NEJM, 2016, ZIK VIR
   NIH- Fogarty, 2016, ZIK VIR INF RES
   PLOS- Blogs, 2016, WILL ZIK BEC 2016 NT
   PLOS- Collections, 2016, ZIK
   Sacramento CQ, 2016, BIORXIV
   Scopus, 2016, ELS SCOP LARG ABSTR
   Thomson Reuters, 2016, WEB SCI RES PLATF
   Vera-Polania F, 2015, J INFECT PUBLIC HEAL, V8, P386, DOI 10.1016/j.jiph.2015.03.006
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, ZIK SIT REP
   Zyoud SH, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0534-2
NR 23
TC 9
Z9 10
U1 2
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005132
DI 10.1371/journal.pntd.0005132
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000004
PM 28103326
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kittayapong, P
   Olanratmanee, P
   Maskhao, P
   Byass, P
   Logan, J
   Tozan, Y
   Louis, V
   Gubler, DJ
   Wilder-Smith, A
AF Kittayapong, Pattamaporn
   Olanratmanee, Phanthip
   Maskhao, Pongsri
   Byass, Peter
   Logan, James
   Tozan, Yesim
   Louis, Valerie
   Gubler, Duane J.
   Wilder-Smith, Annelies
TI Mitigating Diseases Transmitted by Aedes Mosquitoes: A
   Cluster-Randomised Trial of Permethrin-Impregnated School Uniforms
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID BORNE DISEASES; DENGUE; CHILDREN; BURDEN; VIRUS
AB Background
   Viral diseases transmitted via Aedes mosquitoes are on the rise, such as Zika, dengue, and chikungunya. Novel tools to mitigate Aedes mosquitoes-transmitted diseases are urgently needed. We tested whether commercially insecticide-impregnated school uniforms can reduce dengue incidence in school children.
   Methods
   We designed a cluster-randomised controlled trial in Thailand. The primary endpoint was laboratory-confirmed dengue infections. Secondary endpoints were school absenteeism; and impregnated uniforms' 1-hour knock-down and 24 hour mosquito mortality as measured by standardised WHOPES bioassay cone tests at baseline and after repeated washing. Furthermore, entomological assessments inside classrooms and in outside areas of schools were conducted.
   Results
   We enrolled 1,811 pupils aged 6-17 from 5 intervention and 5 control schools. Paired serum samples were obtained from 1,655 pupils. In the control schools, 24/641 (3.7%) and in the intervention schools 33/1,014 (3.3%) students had evidence of new dengue infections during one school term (5 months). There was no significant difference in proportions of students having incident dengue infections between the intervention and control schools, with adjustment for clustering by school. WHOPES cone tests showed a 100% knock down and mortality of Aedes aegypti mosquitoes exposed to impregnated clothing at baseline and up to 4 washes, but this efficacy rapidly declined to below 20% after 20 washes, corresponding to a weekly reduction in knock-down and mosquito mortality by 4.7% and 4.4% respectively. Results of the entomological assessments showed that the mean number of Aedes aegypti mosquitoes caught inside the classrooms of the intervention schools was significantly reduced in the month following the introduction of the impregnated uniforms, compared to those collected in classrooms of the control schools (p = 0.04)
   Conclusions
   Entomological assessments showed that the intervention had some impact on the number of Aedes mosquitoes inside treatment schools immediately after impregnation and before insecticidal activity declined. However, there was no serological evidence of protection against dengue infections over the five months school term, best explained by the rapid washing-out of permethrin after 4 washes. If rapid washing-out of permethrin could be overcome by novel technological approaches, insecticide-treated clothes might become a potentially cost-effective and scalable intervention to protect against diseases transmitted by Aedes mosquitoes such as dengue, Zika, and chikungunya.
C1 [Kittayapong, Pattamaporn] Mahidol Univ Salaya, Ctr Excellence Vectors & Vector Borne Dis, Fac Sci, Nakhon Phatom, Thailand.
   [Kittayapong, Pattamaporn] Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand.
   [Olanratmanee, Phanthip] Rajabhat Rajanagarindra Univ, Fac Sci & Technol, Chachoengsao, Thailand.
   [Maskhao, Pongsri] Rajabhat Rajanagarindra Univ, Fac Humanities & Social Sci, Chachoengsao, Thailand.
   [Byass, Peter; Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res Epidemiol & Global Hlth, Umea, Sweden.
   [Logan, James; Wilder-Smith, Annelies] London Sch Hyg & Trop Med, London, England.
   [Tozan, Yesim; Louis, Valerie] Heidelberg Univ, Sch Med, Inst Publ Hlth, D-69115 Heidelberg, Germany.
   [Tozan, Yesim] NYU, Coll Global Publ Hlth, New York, NY USA.
   [Gubler, Duane J.] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
RP Kittayapong, P (corresponding author), Mahidol Univ Salaya, Ctr Excellence Vectors & Vector Borne Dis, Fac Sci, Nakhon Phatom, Thailand.; Kittayapong, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand.; Wilder-Smith, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res Epidemiol & Global Hlth, Umea, Sweden.; Wilder-Smith, A (corresponding author), London Sch Hyg & Trop Med, London, England.; Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.; Wilder-Smith, A (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
EM PKittayapong@msn.com; anneliesws@gmail.com
RI Wilder-Smith, Annelies/F-8751-2015
FU EU/FP7 through Dengue Tools Consortium [282589]
FX This research was funded by EU/FP7 through the Dengue Tools Consortium
   (grant agreement number 282589). (http://ec.europa.eu/
   research/fp7/index_en.cfm). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384
   Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0
   Banks S, 2015, PLOS NTD IN PRESS
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138
   Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008
   Faulde MK, 2006, MIL MED, V171, P472, DOI 10.7205/MILMED.171.6.472
   Faulde M, 2016, PARASITOL RES, V115, P1573, DOI 10.1007/s00436-015-4892-2
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Londono-Renteria B, 2015, AM J TROP MED HYG, V93, P869, DOI 10.4269/ajtmh.15-0130
   Massad E, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20473
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Murray N, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24887
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   SCHRECK CE, 1984, AM J TROP MED HYG, V33, P725, DOI 10.4269/ajtmh.1984.33.725
   Strickman D, 2000, AM J TROP MED HYG, V63, P27, DOI 10.4269/ajtmh.2000.63.27
   Vaughn MF, 2014, AM J PREV MED, V46, P473, DOI 10.1016/j.amepre.2014.01.008
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Wilder-Smith A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-212
NR 24
TC 18
Z9 18
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005197
DI 10.1371/journal.pntd.0005197
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000017
PM 28103255
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Manni, M
   Guglielmino, CR
   Scolari, F
   Vega-Rua, A
   Failloux, AB
   Somboon, P
   Lisa, A
   Savini, G
   Bonizzoni, M
   Gomulski, LM
   Malacrida, AR
   Gasperi, G
AF Manni, Mose
   Guglielmino, Carmela R.
   Scolari, Francesca
   Vega-Rua, Anubis
   Failloux, Anna-Bella
   Somboon, Pradya
   Lisa, Antonella
   Savini, Grazia
   Bonizzoni, Mariangela
   Gomulski, Ludvik M.
   Malacrida, Anna R.
   Gasperi, Giuliano
TI Genetic evidence for a worldwide chaotic dispersion pattern of the
   arbovirus vector, Aedes albopictus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MULTILOCUS GENOTYPE DATA; DIPTERA-CULICIDAE; POPULATION-STRUCTURE;
   INDIAN-OCEAN; MICROSATELLITE DATA; CHIKUNGUNYA VIRUS; INVASION BIOLOGY;
   SKUSE DIPTERA; DNA-SEQUENCE; MOSQUITO
AB Background
   Invasive species represent a global concern for their rapid spread and the possibility of infectious disease transmission. This is the case of the global invader Aedes albopictus, the Asian tiger mosquito. This species is a vector of medically important arboviruses, notably chikungunya (CHIKV), dengue (DENV) and Zika (ZIKV). The reconstruction of the complex colonization pattern of this mosquito has great potential for mitigating its spread and, consequently, disease risks.
   Methodology/Principal findings
   Classical population genetics analyses and Approximate Bayesian Computation (ABC) approaches were combined to disentangle the demographic history of Aedes albopictus populations from representative countries in the Southeast Asian native range and in the recent and more recently colonized areas. In Southeast Asia, the low differentiation and the high co-ancestry values identified among China, Thailand and Japan indicate that, in the native range, these populations maintain high genetic connectivity, revealing their ancestral common origin. China appears to be the oldest population. Outside Southeast Asia, the invasion process in La Re A union, America and the Mediterranean Basin is primarily supported by a chaotic propagule distribution, which cooperates in maintaining a relatively high genetic diversity within the adventive populations.
   Conclusions/Significance
   From our data, it appears that independent and also trans-continental introductions of Ae. albopictus may have facilitated the rapid establishment of adventive populations through admixture of unrelated genomes. As a consequence, a great amount of intra-population variability has been detected, and it is likely that this variability may extend to the genetic mechanisms controlling vector competence. Thus, in the context of the invasion process of this mosquito, it is possible that both population ancestry and admixture contribute to create the conditions for the efficient transmission of arboviruses and for outbreak establishment.
C1 [Manni, Mose; Guglielmino, Carmela R.; Scolari, Francesca; Savini, Grazia; Bonizzoni, Mariangela; Gomulski, Ludvik M.; Malacrida, Anna R.; Gasperi, Giuliano] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
   [Vega-Rua, Anubis] Morne Joliviere Inst Pasteur Guadeloupe, Lab Med Entomol, Environm & Hlth Unit, Les Abymes, Guadeloupe, France.
   [Vega-Rua, Anubis] Inst Pasteur, Dept Virol, Arboviruses & Insect Vectors Unit, Paris, France.
   [Somboon, Pradya] Chiang Mai Univ, Dept Parasitol, Chiang Mai, Thailand.
   [Lisa, Antonella] CNR, Computat Biol Unit, Inst Mol Genet, Pavia, Italy.
RP Gasperi, G (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
EM gasperi@unipv.it
RI Somboon, Pradya/AAL-3458-2020; scolari, francesca/L-9233-2015; Gasperi,
   Giuliano/Y-1894-2019; Lisa, Antonella/B-3117-2015
OI scolari, francesca/0000-0003-3085-9038; Gasperi,
   Giuliano/0000-0001-6972-8591; Somboon, Pradya/0000-0002-0760-4363;
   Savini, Grazia/0000-0002-0080-678X; Lisa, Antonella/0000-0003-2458-5499;
   malacrida, anna/0000-0003-4566-8795
FU EU-FP7 Research Infrastructures project (INFRAVEC)European Union (EU)
   [228421]; Italian Ministry of HealthMinistry of Health, Italy
   [RF-2010-2318965]; Fondazione Banca del Monte di Lombardia, Pavia,
   Italy; Cariplo-Regione Lombardia IMPROVERegione Lombardia
FX This study received support from the EU-FP7 Research Infrastructures
   project (INFRAVEC) (http://infravec.eu), Grant No 228421 (GG) and also
   from the Italian Ministry of Health (http://www.salute.gov.it), Grant No
   RF-2010-2318965 (ARM), the Fondazione Banca del Monte di Lombardia,
   Pavia, Italy (http://www.fbml.it)(GG), and Cariplo-Regione Lombardia
   IMPROVE (http://www.fondazionecariplo.it)(FS). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   Angelini P., 2008, Parassitologia (Rome), V50, P97
   Angelini R., 2007, EUROSURVEILLANCE, V12, P3313
   Baer B, 2001, EVOLUTION, V55, P1639, DOI 10.1111/j.0014-3820.2001.tb00683.x
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   BLACK WC, 1989, GENETICS, V121, P539
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Cargo Router, ROUT ALT SHIPP CARG
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Centers for Disease Control and Prevention, SURV CONTR AED AEG A
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107
   Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763
   Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401
   Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514
   Costanzo KS, 2015, J VECTOR ECOL, V40, P164, DOI 10.1111/jvec.12146
   Dalet D., 2016, D MAPS
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7
   Egizi A, 2016, MOL ECOL, V25, P3033, DOI 10.1111/mec.13653
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Falush D, 2003, GENETICS, V164, P1567
   Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x
   Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x
   Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836
   Gavaudan S, 2014, VET ITAL, V50, P109
   Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Goudet J., 2001, FSTAT PROGRAM ESTIMA
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Hoban S, 2013, METHODS ECOL EVOL, V4, P299, DOI 10.1111/2041-210x.12025
   Hotta Susumu, 1998, Medical Entomology and Zoology, V49, P267
   Jackson H, 2015, MOL ECOL, V24, P4269, DOI 10.1111/mec.13307
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012
   Khamis FM, 2009, MOL ECOL, V18, P4798, DOI 10.1111/j.1365-294X.2009.04391.x
   Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kuno G, 2012, J MED ENTOMOL, V49, P1163, DOI 10.1603/ME12022
   Lacour G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145311
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lefevre T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003365
   Leong Mark K. H., 2009, Proceedings of the Hawaiian Entomological Society, V41, P57
   Levine JM, 2008, FUNCT ECOL, V22, P934, DOI 10.1111/j.1365-2435.2008.01462.x
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004
   Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743
   Lucy FE, 2016, MANAG BIOL INVASION, V7, P131, DOI 10.3391/mbi.2016.7.2.01
   Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303
   Mccoy KD, 2008, PARASITE, V15, P444, DOI 10.1051/parasite/2008153444
   Medley KA, 2015, MOL ECOL, V24, P284, DOI 10.1111/mec.12925
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Mogi M, 2015, J MED ENTOMOL, V52, P647, DOI 10.1093/jme/tjv038
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Oki M, 2013, EPIDEMIOL INFECT, V141, P2612, DOI 10.1017/S0950268813000447
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x
   Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Poelchau Monica F., 2013, Proceedings of the Royal Society Biological Sciences Series B, V280, P1
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Pritchard JK, 2000, GENETICS, V155, P945
   RAI KS, 1991, ANNU REV ENTOMOL, V36, P459, DOI 10.1146/annurev.en.36.010191.002331
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Reiter P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004769
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x
   Romi R., 1995, Parassitologia (Rome), V37, P99
   Roques L, 2012, P NATL ACAD SCI USA, V109, P8828, DOI 10.1073/pnas.1201695109
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Rueda LM, 2004, ZOOTAXA, V589, P60
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Samanidou-Voyadjoglou A., 2005, European Mosquito Bulletin, V19, P10
   Schottenhammer A., 2012, J MARINE ISLAND CULT, V1, P63, DOI DOI 10.1016/J.IMIC.2012.11.002
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013
   Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   Suter TT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004315
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vazeille M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29564
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zalasiewicz J, 2010, ENVIRON SCI TECHNOL, V44, P2228, DOI 10.1021/es903118j
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
NR 119
TC 37
Z9 38
U1 0
U2 31
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005332
DI 10.1371/journal.pntd.0005332
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000081
PM 28135274
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Manore, CA
   Ostfeld, RS
   Agusto, FB
   Gaff, H
   LaDeau, SL
AF Manore, Carrie A.
   Ostfeld, Richard S.
   Agusto, Folashade B.
   Gaff, Holly
   LaDeau, Shannon L.
TI Defining the Risk of Zika and Chikungunya Virus Transmission in Human
   Population Centers of the Eastern United States
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-ALBOPICTUS DIPTERA; HOST-FEEDING PATTERNS; DENGUE-FEVER;
   REPRODUCTION NUMBER; VECTOR COMPETENCE; RESIDENTIAL AREAS; SEEKING
   BEHAVIOR; CULEX-PIPIENS; BORNE DISEASE; CULICIDAE
AB The recent spread of mosquito-transmitted viruses and associated disease to the Americas motivates a new, data-driven evaluation of risk in temperate population centers. Temperate regions are generally expected to pose low risk for significant mosquito-borne disease; however, the spread of the Asian tiger mosquito (Aedes albopictus) across densely populated urban areas has established a new landscape of risk. We use a model informed by field data to assess the conditions likely to facilitate local transmission of chikungunya and Zika viruses from an infected traveler to Ae. albopictus and then to other humans in USA cities with variable human densities and seasonality. Mosquito-borne disease occurs when specific combinations of conditions maximize virus-to-mosquito and mosquito-to-human contact rates. We develop a mathematical model that captures the epidemiology and is informed by current data on vector ecology from urban sites. The model demonstrates that under specific but realistic conditions, fifty-percent of introductions by infectious travelers to a high human, high mosquito density city could initiate local transmission and 10% of the introductions could result in 100 or more people infected. Despite the propensity for Ae. albopictus to bite non-human vertebrates, we also demonstrate that local virus transmission and human outbreaks may occur when vectors feed from humans even just 40% of the time. Inclusion of human behavioral changes and mitigations were not incorporated into the models and would likely reduce predicted infections. This work demonstrates how a conditional series of non-average events can result in local arbovirus transmission and outbreaks of human disease, even in temperate cities.
C1 [Manore, Carrie A.] Tulane Univ, Ctr Computat Sci, New Orleans, LA 70118 USA.
   [Manore, Carrie A.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87544 USA.
   [Manore, Carrie A.] New Mexico Consortium, Suite Los Alamos, Los Alamos, NM 87544 USA.
   [Ostfeld, Richard S.; LaDeau, Shannon L.] Cary Inst Ecosyst Studies, Box AB, Millbrook, NY USA.
   [Agusto, Folashade B.] Univ Kansas, Dept Ecol & Evolutionary Biol, Haworth Hall, Lawrence, KS 66045 USA.
   [Gaff, Holly] Old Dominion Univ, Dept Biol Sci, MGB, Norfolk, VA 23529 USA.
   [Gaff, Holly] Univ KwaZulu Natal, Math Stat & Comp Sci, Durban, South Africa.
RP Manore, CA (corresponding author), Tulane Univ, Ctr Computat Sci, New Orleans, LA 70118 USA.; Manore, CA (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87544 USA.; Manore, CA (corresponding author), New Mexico Consortium, Suite Los Alamos, Los Alamos, NM 87544 USA.
EM cmanore@tulane.edu
OI LaDeau, Shannon/0000-0003-4825-5435; Ostfeld,
   Richard/0000-0002-3707-9301; Agusto, Folashade/0000-0001-6137-6480;
   Gaff, Holly/0000-0002-4034-2684
FU National Science Foundation through NSFNational Science Foundation (NSF)
   [DBI-1300426]; University of Tennessee, Knoxville; NSF SEES
   grantNational Science Foundation (NSF)NSF - Office of the Director (OD)
   [CHE-1314029]; NSF RAPID [DEB 1641130]; Los Alamos National Laboratory
   Directors Postdoctoral FellowshipUnited States Department of Energy
   (DOE)Los Alamos National Laboratory; NIH-MIDAS grant [U01-GM097661]; NSF
   CHNS grant [DEB 1211797]; KU grant [NFGRF 2302100]
FX This work was conducted as a part of the Climate Change and Vector-borne
   Diseases Working Group at the National Institute for Mathematical and
   Biological Synthesis, by National Science Foundation through NSF Award
   #DBI-1300426, with additional support from The University of Tennessee,
   Knoxville. CM was supported by NSF SEES grant CHE-1314029, NSF RAPID
   (DEB 1641130), a Los Alamos National Laboratory Directors Postdoctoral
   Fellowship, and NIH-MIDAS grant U01-GM097661. SL was supported by NSF
   CHNS grant DEB 1211797. FA was supported by KU grant NFGRF 2302100. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103
   Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031
   Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Champion SR, 2014, ENVIRON HEALTH INSIG, V8, P35, DOI 10.4137/EHI.S16004
   Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043
   Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876
   Chen CD, 2014, ASIAN BIOMED, V8, P315, DOI 10.5372/1905-7415.0803.295
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Chowell G., 2016, PLOS CURRENTS OUTBRE, V1
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008
   Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313
   Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2
   Esteva L, 1999, J MATH BIOL, V38, P220, DOI 10.1007/s002850050147
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Furuya H, 2015, ENVIRON HEALTH PREV, V20, P466, DOI 10.1007/s12199-015-0488-9
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Jansen CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134975
   Kamgang B, 2012, PARASITES VECTORS, V5
   Kek R, 2014, J MED ENTOMOL, V51, P880, DOI 10.1603/ME13213
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski A. J., 2016, PLOS NEGLECTED TROPI, V10
   LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487
   LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lee C, 2016, MMWR MORB MORTAL WKL, V65
   Leisnham PT, 2009, OECOLOGIA, V160, P343, DOI 10.1007/s00442-009-1305-1
   Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Manore CA, 2015, J BIOL DYNAM, V9, P52, DOI 10.1080/17513758.2015.1005698
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Moro ML, 2012, J INFECTION, V65, P165, DOI 10.1016/j.jinf.2012.04.005
   Moulay D, 2013, J THEOR BIOL, V318, P129, DOI 10.1016/j.jtbi.2012.11.008
   Moulay D, 2012, MATH BIOSCI ENG, V9, P369, DOI 10.3934/mbe.2012.9.369
   Munoz J, 2011, J MED ENTOMOL, V48, P956, DOI 10.1603/ME11016
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P447
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Pepin KM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0659-y
   Poletti P, 2011, PLOS ONE, V6
   Quam MB, 2015, AM J TROPICAL MED HY
   Reiskind MH, 2010, J VECTOR ECOL, V35, P61, DOI 10.1111/j.1948-7134.2010.00029.x
   Rey JR, 2015, BIOMEDICA, V35, P177, DOI [10.1590/S0120-41572015000200005, 10.7705/biomedica.v35i2.2514]
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Richards SL, 2010, J VECTOR ECOL, V35, P439, DOI 10.1111/j.1948-7134.2010.00105.x
   Robert MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161365
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   SAVAGE HM, 1993, J MED ENTOMOL, V30, P27, DOI 10.1093/jmedent/30.1.27
   Sawabe K, 2010, J MED ENTOMOL, V47, P442, DOI 10.1603/ME09256
   Scott TW, 2010, CURR TOP MICROBIOL, V338, P115, DOI 10.1007/978-3-642-02215-9_9
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Tsuda Y, 2016, JPN J INFECT DIS, V69, P1, DOI 10.7883/yoken.JJID.2014.576
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174
   Westbrook CJ, 2010, VECTOR-BORNE ZOONOT, V10, P241, DOI 10.1089/vbz.2009.0035
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 90
TC 26
Z9 26
U1 3
U2 41
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005255
DI 10.1371/journal.pntd.0005255
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000036
PM 28095405
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Smith, DR
   Hollidge, B
   Daye, S
   Zeng, XK
   Blancett, C
   Kuszpit, K
   Bocan, T
   Koehler, JW
   Coyne, S
   Minogue, T
   Kenny, T
   Chi, XL
   Yim, S
   Miller, L
   Schmaljohn, C
   Bavari, S
   Golden, JW
AF Smith, Darci R.
   Hollidge, Bradley
   Daye, Sharon
   Zeng, Xiankun
   Blancett, Candace
   Kuszpit, Kyle
   Bocan, Thomas
   Koehler, Jeff W.
   Coyne, Susan
   Minogue, Tim
   Kenny, Tara
   Chi, Xiaoli
   Yim, Soojin
   Miller, Lynn
   Schmaljohn, Connie
   Bavari, Sina
   Golden, Joseph W.
TI Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent
   Mouse Model after Antibody Blockade of Type I Interferon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TRANSMISSION; INFECTION; PREGNANCY; OUTBREAK; SPREADS; DENGUE; STATES;
   AREAS
AB Animal models are needed to better understand the pathogenic mechanisms of Zika virus (ZIKV) and to evaluate candidate medical countermeasures. Adult mice infected with ZIKV develop a transient viremia, but do not demonstrate signs of morbidity or mortality. Mice deficient in type I or a combination of type I and type II interferon (IFN) responses are highly susceptible to ZIKV infection; however, the absence of a competent immune system limits their usefulness for studying medical countermeasures. Here we employ a murine model for ZIKV using wild-type C57BL/6 mice treated with an antibody to disrupt type I IFN signaling to study ZIKV pathogenesis. We observed 40% mortality in antibody treated mice exposed to ZIKV subcutaneously whereas mice exposed by intraperitoneal inoculation were highly susceptible incurring 100% mortality. Mice infected by both exposure routes experienced weight loss, high viremia, and severe neuropathologic changes. The most significant histopathological findings occurred in the central nervous system where lesions represent an acute to subacute encephalitis/encephalomyelitis that is characterized by neuronal death, astrogliosis, microgliosis, scattered necrotic cellular debris, and inflammatory cell infiltrates. This model of ZIKV pathogenesis will be valuable for evaluating medical countermeasures and the pathogenic mechanisms of ZIKV because it allows immune responses to be elicited in immunologically competent mice with IFN I blockade only induced at the time of infection.
C1 [Smith, Darci R.; Hollidge, Bradley; Golden, Joseph W.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.
   [Daye, Sharon; Zeng, Xiankun; Blancett, Candace; Yim, Soojin] US Army, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA.
   [Kuszpit, Kyle; Bocan, Thomas; Kenny, Tara; Chi, Xiaoli] US Army, Med Res Inst Infect Dis, Mol & Translat Sci Div, Ft Detrick, MD 21702 USA.
   [Koehler, Jeff W.; Coyne, Susan; Minogue, Tim] US Army, Med Res Inst Infect Dis, Diagnost Syst Div, Ft Detrick, MD 21702 USA.
   [Miller, Lynn] US Army, Med Res Inst Infect Dis, Vet Med Div, Ft Detrick, MD 21702 USA.
   [Schmaljohn, Connie; Bavari, Sina] US Army, Med Res Inst Infect Dis, Headquarters Div, Ft Detrick, MD 21702 USA.
RP Smith, DR (corresponding author), US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.
EM darci.r.smith.ctr@mail.mil; joseph.w.golden.ctr@mail.mil
RI Bavari, Sina/L-3642-2019
OI Bavari, Sina/0000-0001-8424-5635; Koehler, Jeffrey/0000-0003-3225-6599;
   Zeng, Xiankun (Kevin)/0000-0003-3526-8755; Golden,
   Joseph/0000-0002-9709-313X
FU DARPAUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA)
FX This work was supported by DARPA. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ansar V, 2015, PRIMARY CARE, V42, P189, DOI 10.1016/j.pop.2015.01.001
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0
   Ladner J. T., 2016, GENOME ANNOUNC, V4, P4, DOI DOI 10.1128/GEN0MEA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear H. M., 2016, J VIROL
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maria AT, 2016, EURO SURVEILL, V21
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner J.J., 2016, CELL REP
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407
   PROPHET EB, 1992, LAB METHODS HISTOTEC
   REAGAN R L, 1955, Tex Rep Biol Med, V13, P934
   Rossi SL, 2016, AM J TROP MED HYG
   Roth A, 2014, EURO SURVEILL, V19
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Solomon I. H., 2016, J NEUROINFECT DIS, V7
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 60
TC 50
Z9 52
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005296
DI 10.1371/journal.pntd.0005296
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000063
PM 28068342
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ross, PA
   Wiwatanaratanabutr, I
   Axford, JK
   White, VL
   Endersby-Harshman, NM
   Hoffmann, AA
AF Ross, Perran A.
   Wiwatanaratanabutr, Itsanun
   Axford, Jason K.
   White, Vanessa L.
   Endersby-Harshman, Nancy M.
   Hoffmann, Ary A.
TI Wolbachia Infections in Aedes aegypti Differ Markedly in Their Response
   to Cyclical Heat Stress
SO PLOS PATHOGENS
LA English
DT Article
ID CYTOPLASMIC INCOMPATIBILITY; DROSOPHILA-SIMULANS; BACTERIOPHAGE WO; ZIKA
   VIRUS; ACARI PHYTOSEIIDAE; DENGUE VIRUS; DENSITY; TEMPERATURE;
   POPULATIONS; MOSQUITOS
AB Aedes aegypti mosquitoes infected with Wolbachia bacteria are currently being released for arbovirus suppression around the world. Their potential to invade populations and persist will depend on interactions with environmental conditions, particularly as larvae are often exposed to fluctuating and extreme temperatures in the field. We reared Ae. aegypti larvae infected with different types of Wolbachia (wMel, wAlbB and wMelPop-CLA) under diurnal cyclical temperatures. Rearing wMel and wMelPop-CLA-infected larvae at 26-37 degrees C reduced the expression of cytoplasmic incompatibility, a reproductive manipulation induced by Wolbachia. We also observed a sharp reduction in the density of Wolbachia in adults. Furthermore, the wMel and wMelPop-CLA infections were not transmitted to the next generation when mosquitoes were exposed to 26-37 degrees C across all life stages. In contrast, the wAlbB infection was maintained at a high density, exhibited complete cytoplasmic incompatibility, and was transmitted from mother to offspring with a high fidelity under this temperature cycle. These findings have implications for the potential success of Wolbachia interventions across different environments and highlight the importance of temperature control in rearing.
C1 [Ross, Perran A.; Wiwatanaratanabutr, Itsanun; Axford, Jason K.; White, Vanessa L.; Endersby-Harshman, Nancy M.; Hoffmann, Ary A.] Univ Melbourne, Inst Bio21, Pest & Environm Adaptat Res Grp, Parkville, Vic, Australia.
   [Ross, Perran A.; Wiwatanaratanabutr, Itsanun; Axford, Jason K.; White, Vanessa L.; Endersby-Harshman, Nancy M.; Hoffmann, Ary A.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.
   [Wiwatanaratanabutr, Itsanun] King Mongkuts Inst Technol Ladkrabang, Fac Agr Technol, Dept Plant Prod Technol, Bangkok, Thailand.
RP Ross, PA (corresponding author), Univ Melbourne, Inst Bio21, Pest & Environm Adaptat Res Grp, Parkville, Vic, Australia.; Ross, PA (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.
EM paross@student.unimelb.edu.au
RI Ross, Perran/L-5778-2019; Wiwatanaratanabutr, Itsanun/H-6174-2018;
   Hoffmann, Ary/R-2972-2019
OI Ross, Perran/0000-0001-7645-7523; Hoffmann, Ary/0000-0001-9497-7645
FU National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia [1037003]; Australian Research
   CouncilAustralian Research Council [FL100100066]
FX The research was supported by the National Health and Medical Research
   Council (1037003, www.nhmrc.gov.au) and the Australian Research Council
   (FL100100066, www.arc.gov.au). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Bordenstein SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029106
   Bordenstein SR, 2006, PLOS PATHOG, V2, P384, DOI 10.1371/journal.ppat.0020043
   Bourtzis K, 1996, GENETICS, V144, P1063
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Chauvatcharin N, 2006, MOL ECOL, V15, P2451, DOI 10.1111/j.1365-294X.2006.02947.x
   CHEONG WH, 1967, B WORLD HEALTH ORGAN, V36, P586
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761
   Correa CC, 2014, J INVERTEBR PATHOL, V118, P20, DOI 10.1016/j.jip.2014.02.009
   Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844
   Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x
   Dyer KA, 2005, EVOLUTION, V59, P838, DOI 10.1111/j.0014-3820.2005.tb01757.x
   Feder ME, 1999, AM ZOOL, V39, P363
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fujii Y, 2004, BIOCHEM BIOPH RES CO, V317, P1183, DOI 10.1016/j.bbrc.2004.03.164
   Garcia Gde A., 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0160196
   Gavotte L, 2004, INSECT MOL BIOL, V13, P147, DOI 10.1111/j.0962-1075.2004.00471.x
   Gavotte L, 2007, MOL BIOL EVOL, V24, P427, DOI 10.1093/molbev/msl171
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1990, GENETICS, V126, P933
   HOFFMANN AA, 1988, ENTOMOL EXP APPL, V48, P61, DOI 10.1007/BF00343386
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hurst GDD, 2000, GENETICS, V156, P699
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Ikeda T, 2003, J INVERTEBR PATHOL, V84, P1, DOI 10.1016/S0022-2011(03)00106-X
   Jeyaprakash A, 2010, FLA ENTOMOL, V93, P464, DOI 10.1653/024.093.0326
   Johanowicz DL, 1996, ANN ENTOMOL SOC AM, V89, P435, DOI 10.1093/aesa/89.3.435
   Johanowicz DL, 1998, ENTOMOL EXP APPL, V87, P51, DOI 10.1023/A:1003207830606
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Kent BN, 2010, TRENDS MICROBIOL, V18, P173, DOI 10.1016/j.tim.2009.12.011
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P158
   Lee SF, 2012, APPL ENVIRON MICROB, V78, P4740, DOI 10.1128/AEM.00069-12
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x
   Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932
   Nguyen TH, 2015, PARASITES V IN PRESS
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Paaijmans KP, 2008, HYDROL PROCESS, V22, P4789, DOI 10.1002/hyp.7099
   Pintureau B, 1999, J APPL ENTOMOL, V123, P473, DOI 10.1046/j.1439-0418.1999.00412.x
   Rasic G, 2014, ECOL APPL, V24, P1226, DOI 10.1890/13-1305.1
   Richardson K, 2011, J MED ENTOMOL, V48, P914, DOI 10.1603/ME10204
   Richardson KM, 2013, AUSTRAL ECOL, V38, P219, DOI 10.1111/j.1442-9993.2012.02394.x
   Rigaud T, 2001, J INVERTEBR PATHOL, V77, P251, DOI 10.1006/jipa.2001.5026
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   Shan JY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00599
   STEVENS L, 1989, J INVERTEBR PATHOL, V53, P78, DOI 10.1016/0022-2011(89)90076-1
   STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424
   Sugimoto TN, 2015, J INSECT PHYSIOL, V81, P48, DOI 10.1016/j.jinsphys.2015.06.016
   Sun LV, 2003, J BACTERIOL, V185, P7077, DOI 10.1128/JB.185.24.7077-7084.2003
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Tortosa P, 2008, INSECT MOL BIOL, V17, P677, DOI 10.1111/j.1365-2583.2008.00842.x
   Tram U, 2003, MICROBES INFECT, V5, P999, DOI 10.1016/S1286-4579(03)00192-8
   TRPIS M, 1981, J HERED, V72, P313, DOI 10.1093/oxfordjournals.jhered.a109513
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   Unckless RL, 2009, P ROY SOC B-BIOL SCI, V276, P2805, DOI 10.1098/rspb.2009.0287
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916
   Veneti Z, 2003, GENETICS, V164, P545
   Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wiwatanaratanabutr I, 2016, ACTA TROP, V159, P153, DOI 10.1016/j.actatropica.2016.03.026
   Wiwatanaratanabutr I, 2009, J INVERTEBR PATHOL, V102, P220, DOI 10.1016/j.jip.2009.08.009
   Wiwatanaratanabutr S, 2006, MED VET ENTOMOL, V20, P300, DOI 10.1111/j.1365-2915.2006.00640.x
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Ye YH, 2016, AM J TROP MED HYG, V94, P812, DOI 10.4269/ajtmh.15-0801
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zchori-Fein E, 2000, J INVERTEBR PATHOL, V75, P267, DOI 10.1006/jipa.2000.4927
NR 93
TC 51
Z9 52
U1 4
U2 39
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JAN
PY 2017
VL 13
IS 1
AR e1006006
DI 10.1371/journal.ppat.1006006
PG 17
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EN1AV
UT WOS:000395743500002
PM 28056065
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ornelas, AMM
   Pezzuto, P
   Silveira, PP
   Melo, FO
   Ferreira, TA
   Oliveira-Szejnfeld, PS
   Leal, JI
   Amorim, MMR
   Hamilton, S
   Rawlinson, WD
   Cardoso, CC
   Nixon, DF
   Tanuri, A
   Melo, AS
   Aguiar, RS
AF Ornelas, Alice M. M.
   Pezzuto, Paula
   Silveira, Paola P.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Oliveira-Szejnfeld, Patricia S.
   Leal, Jeime I.
   Amorim, Melania M. R.
   Hamilton, Stuart
   Rawlinson, William D.
   Cardoso, Cynthia C.
   Nixon, Douglas F.
   Tanuri, Amilcar
   Melo, Adriana S.
   Aguiar, Renato S.
TI Immune activation in amniotic fluid from Zika virus-associated
   microcephaly
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID INFECTION; CYTOKINES; GROWTH; BRAIN; WOMEN
AB Recent advances in the understanding of neuropathogenesis associated with Zika virus (ZIKV) infection has led to descriptions of neonatal microcephaly cases. However, none of these reports have evaluated the humoral response during ZIKV infection. We report here polyfunctional immune activation associated with increased interferon-gamma-inducible protein 10, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), monocyte chemoattractive protein 1 (MCP-1), and granulocyte colony-stimulating factor (G-CSF) levels in the amniotic fluid of ZIKV-positive pregnant women with neonatal microcephaly. These cytokines have been associated not only with neuronal damage, but also with differentiation and proliferation of neural progenitor cells. Our results suggested that the immune activation caused by ZIKV infection in the uterine environment could also interfere with fetal development. ANN NEUROL 2017;81:152-156
C1 [Ornelas, Alice M. M.; Pezzuto, Paula; Silveira, Paola P.; Cardoso, Cynthia C.; Tanuri, Amilcar; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
   [Melo, Fabiana O.; Ferreira, Thales A.; Leal, Jeime I.; Amorim, Melania M. R.; Melo, Adriana S.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Univ Fed Sao Paulo, Fundacao Inst Ensino & Pesquisa Diagnost Imagem F, Dept Diagnost Imagem, Sao Paulo, Brazil.
   [Hamilton, Stuart; Rawlinson, William D.] Prince Wales Hosp, POWH & UNSW Res Labs, Virol Res, Randwick, NSW, Australia.
   [Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
RP Aguiar, RS (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
EM santanarnt@gmail.com
RI Cardoso, Cynthia/K-5824-2012; Melo, Adriana S O/H-5650-2016; Ferreira,
   Thales Araujo/AAA-6252-2019; Amorim, Melania M/C-5807-2013; Aguiar,
   Renato S/G-3542-2015
OI Cardoso, Cynthia/0000-0003-0565-7047; Amorim, Melania
   M/0000-0003-1047-2514; Aguiar, Renato S/0000-0001-5180-3717; FERREIRA,
   THALES/0000-0002-6699-5886
FU Consellho Nacional de Desenvolvimento e Pesquisa (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); CAPESCAPES; Brazilian Ministry of Education (CAPES)CAPES
FX This work was funded by Consellho Nacional de Desenvolvimento e Pesquisa
   (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ).; We thank CAPES for student's fellowship. A.M.M.O. has been
   sponsored by a Ph.D. scholarship from the Brazilian Ministry of
   Education (CAPES) and this work is part of her requirements for
   obtaining a Ph.D. degree by the Graduate Program in Genetics at the
   Federal University of rio de janeiro, Brazil.
CR Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748
   Breton J, 2011, J NEUROL NEUROPHYSIO, pS4, DOI DOI 10.4172/2155-9562.S4-001
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chow SSW, 2008, CYTOKINE, V44, P78, DOI 10.1016/j.cyto.2008.06.009
   Fortunato SJ, 1998, AM J REPROD IMMUNOL, V39, P16
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GREIG PC, 1995, AM J OBSTET GYNECOL, V173, P1223, DOI 10.1016/0002-9378(95)91358-0
   Hui L, 2012, OBSTET GYNECOL, V119, P111, DOI 10.1097/AOG.0b013e31823d4150
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006
   Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022
   Miceli M, 2016, PROTEOMICS, V16, P674, DOI 10.1002/pmic.201500223
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Onis M., 2007, WHO CHILD GROWTH STA
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Suzuki Y, 2006, FETAL DIAGN THER, V21, P45, DOI 10.1159/000089047
   Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3
   Wallner Stephanie, 2015, Front Cell Dev Biol, V3, P48, DOI 10.3389/fcell.2015.00048
   Watanabe Y, 2010, PSYCHIAT CLIN NEUROS, V64, P217, DOI 10.1111/j.1440-1819.2010.02094.x
NR 20
TC 20
Z9 20
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JAN
PY 2017
VL 81
IS 1
BP 152
EP 156
DI 10.1002/ana.24839
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EJ9QV
UT WOS:000393562300015
PM 27977881
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Neuroimaging findings of Zika virus infection
SO JAPANESE JOURNAL OF RADIOLOGY
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Wiwanitkit House, Bangkok, Thailand.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Haikou, Peoples R China.; Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 3
TC 2
Z9 2
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1867-1071
EI 1867-108X
J9 JPN J RADIOL
JI Jpn. J. Radiol.
PD JAN
PY 2017
VL 35
IS 1
BP 40
EP 40
DI 10.1007/s11604-016-0595-6
PG 1
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EK0BN
UT WOS:000393591500007
PM 27804004
OA Bronze
DA 2020-07-08
ER

PT J
AU Mehrjardi, MZ
   Poretti, A
   Keshavarz, E
AF Mehrjardi, Mohammad Zare
   Poretti, Andrea
   Keshavarz, Elham
TI Neuroimaging findings of Zika virus infection: emphasis of congenital
   versus acquired aspects
SO JAPANESE JOURNAL OF RADIOLOGY
LA English
DT Letter
C1 [Mehrjardi, Mohammad Zare] Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
   [Poretti, Andrea] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Sect Pediat Neuroradiol, Div Pediat Radiol,Sch Med, Baltimore, MD USA.
   [Keshavarz, Elham] Shahid Beheshti Univ Med Sci, Mahdieh Womens Hosp, Dept Radiol, Tehran, Iran.
RP Mehrjardi, MZ (corresponding author), Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
EM zare@sbmu.ac.ir; aporett1@jhmi.edu; elhamkeshavarz@yahoo.com
RI Mehrjardi, Mohammad Zare/G-8980-2017
OI Mehrjardi, Mohammad Zare/0000-0001-5793-5323
CR Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Poretti A, 2016, AM J NEURORADIOL, V37, P1764, DOI 10.3174/ajnr.A4924
   Wiwanitkit V, 2017, JPN J RADIOL, V35, P40, DOI 10.1007/s11604-016-0595-6
NR 5
TC 8
Z9 8
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1867-1071
EI 1867-108X
J9 JPN J RADIOL
JI Jpn. J. Radiol.
PD JAN
PY 2017
VL 35
IS 1
BP 41
EP 42
DI 10.1007/s11604-016-0599-2
PG 2
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EK0BN
UT WOS:000393591500008
PM 27830429
DA 2020-07-08
ER

PT J
AU Lopes, AB
   Neri, V
   Alvarenga, RMP
   Mendes, MFX
AF Lopes, Alexandre Bussinger
   Neri, Vanderson
   Papais Alvarenga, Regina Maria
   Xavier Mendes, Maria Filomena
TI Acute transverse myelitis after Zika virus infection
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Meeting Abstract
CT 9th Latin American Congress of Multiple Sclerosis (LACTRIMS)
CY NOV 17-19, 2016
CL Buenos Aires, ARGENTINA
C1 [Lopes, Alexandre Bussinger; Neri, Vanderson; Papais Alvarenga, Regina Maria; Xavier Mendes, Maria Filomena] Hosp Lagoa, Rio De Janeiro, Brazil.
NR 0
TC 1
Z9 1
U1 0
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD JAN
PY 2017
VL 23
IS 1
MA 89
BP 148
EP 148
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EK4OH
UT WOS:000393906000070
DA 2020-07-08
ER

PT J
AU Hodge, RAV
AF Hodge, R. Anthony Vere
TI Meeting report: 29th International Conference on Antiviral Research in
   La Jolla, CA, USA
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Antiviral research; Antiviral therapy; HIV; Respiratory syncytial virus
   (RSV); Ebola virus; Zika virus
ID HERPES
AB The 29th International Conference on Antiviral Research (ICAR) was held in La Jolla, CA, USA from April 17 to 21, 2016. This report opens with a tribute to the late Chris McGuigan, a Past-President of ISAR, then continues with summaries of the principal invited lectures. Doug Richman (Elion Award) investigated HIV resistance, Bob Vince (Holy Award) showed how carbocyclic nucleoside analogs led to abacavir and Jerome Deval (Prusoff Award) explained how his group chose to seek a nucleoside analog to treat RSV. ALS-8176 was active in a human RSV-challenge study and is being evaluated in children. The first keynote address, by Richard H. Scheuermann, reported on the remarkable progress made in viral genomics. The second keynote address, by Heinz Feldmann, gave an overview of Ebola virus disease. There were four mini-symposia, Structural Biology, Diagnostic Technologies, DNA viruses and Zika virus. Diagnostic assays are approaching an ideal aim, a compact instrument, simple to use with any type of sample, no sample preparation and a result within an hour. The diversity of HCMV is far greater than for other herpesviruses, typically, an individual having >20,000 single nucleotide polymorphisms (SNPs). During antiviral treatment, there is rapid CMV evolution which is presumed to be due to preferential selection of already present variants rather than by the creation of new variants. A selection of contributor presentations includes oral prodrugs for nucleoside triphosphate analogs, a new method for the synthesis of phosphoramidate prodrugs and the clinical evaluation of brincidofovir for treating transplant recipients with adenovirus infections. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Hodge, R. Anthony Vere] Vere Hodge Antivirals Ltd, Reigate, Surrey, England.
RP Hodge, RAV (corresponding author), Vere Hodge Antivirals Ltd, Reigate, Surrey, England.
EM info@isaricar.com
CR Bai C.-Q., 2016, INFECT DIS
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   DeVincenzo JP, 2015, NEW ENGL J MED, V373, P2048, DOI 10.1056/NEJMoa1413275
   Hodge RAV, 2015, ANTIVIR RES, V123, P172, DOI 10.1016/j.antiviral.2015.09.015
   LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383
   SCHAEFFER HJ, 1978, NATURE, V272, P583, DOI 10.1038/272583a0
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   VINCE R, 1983, SCIENCE, V221, P1405, DOI 10.1126/science.6684328
   YARCHOAN R, 1986, LANCET, V1, P575
NR 9
TC 5
Z9 6
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JAN
PY 2017
VL 137
BP 23
EP 40
DI 10.1016/j.antiviral.2016.10.014
PG 18
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EJ1YA
UT WOS:000393005300004
PM 27815125
OA Green Published
DA 2020-07-08
ER

PT J
AU Azevedo-Santos, VM
   Vitule, JRS
   Pelicice, FM
   Garcia-Berthou, E
   Simberloff, D
AF Azevedo-Santos, Valter M.
   Vitule, Jean R. S.
   Pelicice, Fernando M.
   Garcia-Berthou, Emili
   Simberloff, Daniel
TI Nonnative Fish to Control Aedes Mosquitoes: A Controversial, Harmful
   Tool
SO BIOSCIENCE
LA English
DT Article
DE Zika; public health; invasive species; mosquito control; Aedes aegypti
ID GAMBUSIA-AFFINIS; INTRODUCED MOSQUITOFISH; AEGYPTI; IMPACTS; DISEASE;
   OVIPOSITION; POPULATION; GUPPIES; RELEASE; BRAZIL
AB Zika, chikungunya, yellow fever, and dengue are mainly transmitted to humans through Aedes mosquitoes. In attempts to control these diseases, governments and the public have encouraged the use of fish predators to control mosquito populations. However, the efficacy of using these predators for mosquito-population control is largely unproven and dubious, particularly for container-breeding mosquitoes that reproduce in minute aquatic habitats, which are unsuitable for fish. Moreover, the use of nonnative fish for biological control entails a high potential risk of promoting escapes and invasions, which can impair ecosystem functioning and biodiversity. Although this risk is recognized, the practice may intensify in countries affected by recent epidemics transmitted by Aedes spp. Therefore, we argue that the use of nonnative fishes to control Aedes mosquitoes is ungrounded and ecologically damaging and point out that other approaches (e.g., habitat management, biotechnological tools, and more evidence-based integrated management) should be used to combat mosquito-borne human diseases.
C1 [Azevedo-Santos, Valter M.] Univ Estadual Paulista, Dept Zool, Lab Ictiol, Botucatu, SP, Brazil.
   [Vitule, Jean R. S.] Univ Fed Parana, Setor Tecnol, Dept Engn Ambiental, LEC, Curitiba, Parana, Brazil.
   [Pelicice, Fernando M.] Univ Fed Tocantins, Nucleo Estudos Ambientais, Porto Nacl, Brazil.
   [Garcia-Berthou, Emili] Univ Girona, Inst Aquat Ecol, GRECO, Catalonia, Spain.
   [Simberloff, Daniel] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA.
RP Azevedo-Santos, VM (corresponding author), Univ Estadual Paulista, Dept Zool, Lab Ictiol, Botucatu, SP, Brazil.
EM valter.ecologia@gmail.com
RI Vitule, Jean Ricardo Simoes/D-9822-2012; Garcia-Berthou,
   Emili/A-5392-2008
OI Vitule, Jean Ricardo Simoes/0000-0001-6543-7439; Garcia-Berthou,
   Emili/0000-0001-8412-741X; Azevedo-Santos, Valter M./0000-0001-8986-6406
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Spanish Ministry of Economy and Competitiveness
   [CGL2013-43822-R, CGL2015-69311-REDT]; Government of
   CataloniaGeneralitat de Catalunya [2014 SGR 484]; European Union (COST
   Action) [TD1209]
FX VMAS was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES); FMP and JRSV were supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq); and EGB was supported
   by the Spanish Ministry of Economy and Competitiveness (project nos.
   CGL2013-43822-R and CGL2015-69311-REDT), the Government of Catalonia
   (reference no. 2014 SGR 484), and the European Union (COST Action no.
   TD1209).
CR Angelon KA, 2002, J CHEM ECOL, V28, P797, DOI 10.1023/A:1015292827514
   Angulo E, 2008, NATURE, V454, P158, DOI 10.1038/454158a
   Araki M, 2014, TRENDS BIOTECHNOL, V32, P234, DOI 10.1016/j.tibtech.2014.03.005
   Arthington A. H., 1989, ASIAN FISH SCI, V2, P193
   Azevedo-Santos VM, 2016, SCIENCE, V351, P675, DOI 10.1126/science.351.6274.675
   Azevedo-Santos VM, 2015, NAT CONSERVACAO, V13, P123, DOI 10.1016/j.ncon.2015.06.002
   Baker C, 2004, WATER ATMOSPHERE, V12, P24
   BLAUSTEIN L, 1990, LIMNOL OCEANOGR, V35, P767, DOI 10.4319/lo.1990.35.3.0767
   Britton JR, 2012, REV FISH BIOL FISHER, V22, P555, DOI 10.1007/s11160-012-9254-x
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   Casal CMV, 2006, BIOL INVASIONS, V8, P3, DOI 10.1007/s10530-005-0231-3
   Cavalcanti LPG, 2007, REV SAUDE PUBL, V41, P1
   Pamplona LDC, 2009, TROP MED INT HEALTH, V14, P1347, DOI 10.1111/j.1365-3156.2009.02377.x
   Chandra G, 2008, INDIAN J MED RES, V127, P13
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   COY NJ, 1979, FRESHWATER FISHING S
   Cucherousset J, 2011, FISHERIES, V36, P215, DOI 10.1080/03632415.2011.574578
   Cunico AM, 2011, ECOL INDIC, V11, P1354, DOI 10.1016/j.ecolind.2011.02.009
   Deacon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024416
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dobson SL, 2016, SCIENCE, V352, P526, DOI 10.1126/science.352.6285.526-b
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678
   Enserink M, 2010, SCIENCE, V330, P1030, DOI 10.1126/science.330.6007.1030
   Espinoza-Gomez F, 2002, J EPIDEMIOL COMMUN H, V56, P148, DOI 10.1136/jech.56.2.148
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   FOCKS DA, 1981, AM J TROP MED HYG, V30, P1329, DOI 10.4269/ajtmh.1981.30.1329
   Francis RA, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P435
   Garcia-Berthou E, 1999, J FISH BIOL, V55, P135, DOI 10.1111/j.1095-8649.1999.tb00663.x
   Garcia-Berthou E, 2005, CAN J FISH AQUAT SCI, V62, P453, DOI 10.1139/F05-017
   Gkenas C, 2012, J BIOL RES-THESSALON, V17, P121
   Goodsell JA, 1999, CONSERV BIOL, V13, P921, DOI 10.1046/j.1523-1739.1999.98237.x
   Han WW, 2015, TROP MED INT HEALTH, V20, P1239, DOI 10.1111/tmi.12538
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Landeka N, 2015, PERIOD BIOL, V117, P415
   LANGEANI F, 2007, BIOTA NEOTROP, V7, P181, DOI DOI 10.1590/S1676-06032007000300020
   Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028
   Lindholm AK, 2005, MOL ECOL, V14, P3671, DOI 10.1111/j.1365-294X.2005.02697.x
   Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004
   Lucinda P.H.F., 2003, CHECK LIST FRESHWATE, P555
   Luna JED, 2004, REV SAUDE PUBL, V38, P1
   Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2
   Margaritora Fiorenza G., 2001, Journal of Limnology, V60, P189
   Martinez-Ibarra JA, 2002, BIOCONTROL, V47, P481, DOI 10.1023/A:1015691831489
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   O'Neill S, 2015, SCI AM, V312, P72, DOI 10.1038/scientificamerican0615-72
   O'Neill SL, 2016, SCIENCE, V352, P526, DOI 10.1126/science.352.6285.526-a
   Ortega JCG, 2015, HYDROBIOLOGIA, V746, P147, DOI 10.1007/s10750-014-2025-z
   Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2
   PINHEIRO Valéria Cristina Soares, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P245, DOI 10.1590/S0036-46652002000500002
   Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451
   Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x
   Rehage JS, 2005, ECOL FRESHW FISH, V14, P352, DOI 10.1111/j.1600-0633.2005.00109.x
   Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342
   Rupp HR, 1996, J AM MOSQUITO CONTR, V12, P155
   Saleeza SNR, 2014, SE ASIAN J TROP MED, V45, P299
   Sarwar M., 2015, INT J PREVENTIVE MED, V1, P232
   Loreto ELS, 2016, SCIENCE, V351, P1273, DOI 10.1126/science.351.6279.1273-b
   Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x
   Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619
   Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013
   Vitule JRS, 2009, FISH FISH, V10, P98, DOI 10.1111/j.1467-2979.2008.00312.x
   TABIBZADEH I, 1970, Bulletin of the World Health Organization, V43, P623
   US National Research Council, 2016, GEN DRIV HOR ADV SCI
   Vasconcelos P. F. C., 2015, REV PANAMAZ SAUDE, V2, P9
   Walshe DP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008090.pub2
   Welcomme RL, 1988, 294 FAO FISH
   [WHO] World Health Organization, 2003, US FISH MOSQ CONTR
NR 69
TC 20
Z9 20
U1 0
U2 31
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-3568
EI 1525-3244
J9 BIOSCIENCE
JI Bioscience
PD JAN
PY 2017
VL 67
IS 1
BP 83
EP 89
DI 10.1093/biosci/biw156
PG 7
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EL0VH
UT WOS:000394339400010
OA Bronze
DA 2020-07-08
ER

PT J
AU Xu, YQ
   Mahmood, I
   Zhong, LL
   Zhang, P
   Struble, EB
AF Xu, Yanqun
   Mahmood, Iftekhar
   Zhong, Lilin
   Zhang, Pei
   Struble, Evi B.
TI Passive Immunoprophylaxis for the Protection of the Mother and Her Baby:
   Insights from In Vivo Models of Antibody Transport
SO JOURNAL OF IMMUNOLOGY RESEARCH
LA English
DT Article
ID TO-CHILD TRANSMISSION; HEPATITIS-B-VIRUS; INTRAVENOUS IMMUNOGLOBULIN;
   HYPERIMMUNE GLOBULIN; HUMAN-PREGNANCY; CYTOMEGALOVIRUS; POPULATION;
   INFECTIONS; PREVENTION; SUBCLASSES
AB Pregnant women are at high risk for infection by pathogens. Vertical transmission of infectious agents, such as Zika, hepatitis B, and cytomegalovirus during pregnancy, remains a public health problem, associated with dire outcomes for the neonate. Thus, a safe prophylactic and therapeutic approach for protecting the mother and the neonate from infections remains a high priority. Our work is focused on better understanding the safety and efficacy determinants of IgG antibody preparations when used during pregnancy to benefit the mother and her baby. Using pregnant guinea pigs, we demonstrated that biodistribution of administered IgG to the fetus increases with gestation and results in lower maternal and higher fetal antibody concentrations as pregnancy progresses. Data suggests that partition of antibody immunotherapy to the fetal compartment may contribute to a lower maternal exposure (as measured by the AUC) and a shorter mean residence time of the IgG therapeutic at the end of pregnancy compared to nonpregnant age-matched controls, irrespective of the administered dose. Our studies provide insights on the importance of selecting an efficacious dose in pregnancy that takes into account IgG biodistribution to the fetus. The use of appropriate animal models of placental transfer and infectious disease during pregnancy would facilitate pharmacokinetic modeling to derive a starting dose in clinical trials.
C1 [Xu, Yanqun; Zhong, Lilin; Zhang, Pei; Struble, Evi B.] US FDA, Div Plasma Prot Therapeut, Off Tissues & Adv Therapies, CBER,Plasma Derivat Branch, Silver Spring, MD 20993 USA.
   [Mahmood, Iftekhar] US FDA, Div Clin Evaluat & Pharmacol Toxicol, Off Tissues & Adv Therapies, CBER, Silver Spring, MD USA.
RP Struble, EB (corresponding author), US FDA, Div Plasma Prot Therapeut, Off Tissues & Adv Therapies, CBER,Plasma Derivat Branch, Silver Spring, MD 20993 USA.
EM evi.struble@fda.hhs.gov
FU US FDA Office of Women's Health
FX The authors acknowledge the US FDA Office of Women's Health for funding
   this work. The authors thank Yun Lu, mathematical statistician, for
   helping with statistical analysis.
CR [Anonymous], 2012, HEPAGAM B PRESCRIBIN
   Arendt KW, 2016, INT J OBSTET ANESTH, V26, P59, DOI 10.1016/j.ijoa.2015.12.003
   Bialas KM, 2015, CLIN PERINATOL, V42, P61, DOI 10.1016/j.clp.2014.10.006
   Creanga AA, 2014, J WOMENS HEALTH, V23, P3, DOI 10.1089/jwh.2013.4617
   Dunkelberg JC, 2014, J PERINATOL, V34, P882, DOI 10.1038/jp.2014.167
   Einarsdottir H, 2014, TRANSFUSION, V54, P665, DOI 10.1111/trf.12334
   Ensom MHH, 2011, HUM REPROD, V26, P2283, DOI 10.1093/humrep/der227
   Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1
   Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993
   Hashira S, 2000, PEDIATR INT, V42, P337, DOI 10.1046/j.1442-200x.2000.01245.x
   Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5
   Lin XF, 2014, PEDIATR INFECT DIS J, V33, P897, DOI 10.1097/INF.0000000000000315
   Ma L, 2014, HEPAT RES TREAT, V2014
   Ma L, 2014, REV MED VIROL, V24, P396, DOI 10.1002/rmv.1801
   MALEK A, 1994, AM J REPROD IMMUNOL, V32, P8, DOI 10.1111/j.1600-0897.1994.tb00873.x
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1
   Orange JS, 2010, CLIN IMMUNOL, V137, P21, DOI 10.1016/j.clim.2010.06.012
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Sappenfield Elisabeth, 2013, Infect Dis Obstet Gynecol, V2013, P752852, DOI 10.1155/2013/752852
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shapiro R. S., 2014, J CLIN IMMUNOLOGY
   Shi ZJ, 2010, INT J INFECT DIS, V14, pE622, DOI 10.1016/j.ijid.2009.09.008
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7
   Thurmann PA, 1995, EUR J CLIN PHARMACOL, V49, P237
   van Leeuwen E, 2014, NEW ENGL J MED, V370, P2543, DOI 10.1056/NEJMc1405377
   Xu YQ, 2015, PLACENTA, V36, P1370, DOI 10.1016/j.placenta.2015.10.018
   Young MK, 2015, COCHRANE DB SYST REV, V9
NR 30
TC 1
Z9 1
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-8861
EI 2314-7156
J9 J IMMUNOL RES
JI J Immunol. Res.
PY 2017
AR 7373196
DI 10.1155/2017/7373196
PG 8
WC Immunology
SC Immunology
GA EK5NY
UT WOS:000393974300001
PM 28168206
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, J
   Qiao, LH
   Hou, ZH
   Luo, GX
AF Wang, Jing
   Qiao, Luhua
   Hou, Zhouhua
   Luo, Guangxiang
TI TIM-1 Promotes Hepatitis C Virus Cell Attachment and Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID ACTING RNA ELEMENTS; PHOSPHATIDYLSERINE RECEPTORS; VIRAL ENTRY;
   ZAIRE-EBOLAVIRUS; APOLIPOPROTEIN-E; REPLICATION; CULTURE; FAMILY; HCV;
   CLASSIFICATION
AB Human TIM and TAM family proteins were recently found to serve as phosphatidylserine (PS) receptors which promote infections by many different viruses, including dengue virus, West Nile virus, Ebola virus, Marburg virus, and Zika virus. In the present study, we provide substantial evidence demonstrating that TIM-1 is important for efficient infection by hepatitis C virus (HCV). The knockdown of TIM-1 expression significantly reduced HCV infection but not HCV RNA replication. Likewise, TIM-1 knockout in Huh-7.5 cells remarkably lowered HCV cell attachment and subsequent HCV infection. More significantly, the impairment of HCV infection in the TIM-1 knockout cells could be restored completely by ectopic expression of TIM-1 but not TIM-3 or TIM-4. Additionally, HCV infection and cell attachment were inhibited by PS but not by phosphatidylcholine (PC), demonstrating that TIM-1-mediated enhancement of HCV infection is PS dependent. The exposure of PS on the HCV envelope was confirmed by immunoprecipitation of HCV particles with a PS-specific monoclonal antibody. Collectively, these findings demonstrate that TIM-1 promotes HCV infection by serving as an attachment receptor for binding to PS exposed on the HCV envelope.
   IMPORTANCE TIM family proteins were recently found to enhance infections by many different viruses, including several members of the Flaviviridae family. However, their importance in HCV infection has not previously been examined experimentally. The TIM family proteins include three members in humans: TIM-1, TIM-3, and TIM-4. The findings derived from our studies demonstrate that TIM-1, but not TIM-3 or TIM-4, promotes HCV infection by functioning as an HCV attachment factor. Knockout of the TIM-1 gene resulted in a remarkable reduction of HCV cell attachment and infection. PS-containing liposomes blocked HCV cell attachment and subsequent HCV infection. HCV particles could also be precipitated with a PS-specific monoclonal antibody. These findings suggest that TIM-1 and its binding ligand, PS, may serve as novel targets for antiviral intervention.
C1 [Wang, Jing; Qiao, Luhua; Luo, Guangxiang] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing, Peoples R China.
   [Wang, Jing; Qiao, Luhua; Hou, Zhouhua; Luo, Guangxiang] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA.
RP Luo, GX (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing, Peoples R China.; Luo, GX (corresponding author), Univ Alabama Birmingham, Sch Med, Birmingham, AL 35294 USA.
EM gluo@uab.edu
FU Natural Science Foundation of China (NSFC)National Natural Science
   Foundation of China [81130082]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI097318,
   AI091953]; National Basic Research Program of China (973
   Program)National Basic Research Program of China [2012CB518900];
   University of Alabama at Birmingham (UAB) Center For AIDS Research
   (CFAR), an NIH program [P30 AI027767]
FX This work was supported by the Natural Science Foundation of China (NSFC
   grant 81130082), NIH grants AI097318 and AI091953, the National Basic
   Research Program of China (grant 2012CB518900 of the 973 Program), and
   the University of Alabama at Birmingham (UAB) Center For AIDS Research
   (CFAR), an NIH-funded program (grant P30 AI027767).
CR Abad-Molina C, 2012, CLIN VACCINE IMMUNOL, V19, P223, DOI 10.1128/CVI.05305-11
   Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766
   Baumert TF, 1998, J VIROL, V72, P3827, DOI 10.1128/JVI.72.5.3827-3836.1998
   Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002
   Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005
   Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x
   Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654
   Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x
   Frolov I, 1998, RNA, V4, P1418, DOI 10.1017/S1355838298981031
   Haberstroh A, 2008, GASTROENTEROLOGY, V135, P1719, DOI 10.1053/j.gastro.2008.07.018
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jiang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067982
   Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12
   Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11
   Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09
   Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06
   Kim HY, 2011, J CLIN INVEST, V121, P1111, DOI 10.1172/JCI44182
   Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011
   Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108
   Li MH, 2014, P NATL ACAD SCI USA, V111, pE3699, DOI 10.1073/pnas.1404851111
   Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08
   Liu Z, 2012, J BIOL CHEM, V287, P41922, DOI 10.1074/jbc.M112.414789
   Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110
   Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012
   Mosbruger TL, 2010, J INFECT DIS, V201, P1371, DOI 10.1086/651606
   Norman KL, 2010, J VIROL, V84, P666, DOI 10.1128/JVI.01156-09
   Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938
   Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223
   Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684
   Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104
   Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479
   Sagan SM, 2015, VIRUS RES, V206, P90, DOI 10.1016/j.virusres.2014.12.029
   Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581
   Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529
   Shi Q, 2013, J VIROL, V87, P6866, DOI 10.1128/JVI.03475-12
   Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06
   Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
   Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885
   Sourisseau M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003244
   Tellinghuisen TL, 2007, J VIROL, V81, P8853, DOI 10.1128/JVI.00753-07
   Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001
   Wu XF, 2014, J VIROL, V88, P8433, DOI 10.1128/JVI.00081-14
   Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06
   Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014
NR 55
TC 9
Z9 9
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2017
VL 91
IS 2
AR UNSP e01583
DI 10.1128/JVI.01583-16
PG 13
WC Virology
SC Virology
GA EJ4MX
UT WOS:000393192500013
PM 27807228
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wolf, B
   Diop, F
   Ferraris, P
   Wichit, S
   Busso, C
   Misse, D
   Gonczy, P
AF Wolf, Benita
   Diop, Fode
   Ferraris, Pauline
   Wichit, Sineewanlaya
   Busso, Coralie
   Misse, Dorothee
   Gonczy, Pierre
TI Zika virus causes supernumerary foci with centriolar proteins and
   impaired spindle positioning
SO OPEN BIOLOGY
LA English
DT Article
DE Zika virus; dengue virus; microcephaly; centrosome; spindle positioning
ID CENTROSOME DUPLICATION; NEURAL PROGENITORS; CELLS; PROCENTRIOLE;
   RECEPTORS
AB Zika virus (ZIKV) causes congenital microcephaly. Although ZIKV can impair cell cycle progression and provoke apoptosis, which probably contributes to disease aetiology through depletion of neural progenitor cells, additional cellular mechanisms may be important. Here, we investigated whether ZIKV infection alters centrosome number and spindle positioning, because such defects are thought to be at the root of inherited primary autosomal recessive microcephaly (MCPH). In addition to HeLa cells, in which centrosome number and spindle positioning can be well monitored, we analysed retinal epithelial cells (RPE-1), as well as brain-derived microglial (CHME-5) and neural progenitor (ReN) cells, using immunofluorescence. We established that ZIKV infection leads to supernumerary foci containing centriolar proteins that in some cases drive multipolar spindle assembly, as well as spindle positioning defects in HeLa, RPE-1 and CHME-5 cells, but not in ReN cells. We uncovered similar phenotypes in HeLa cells upon infection with dengue virus (DENV-2), another flavivirus that does not target brain cells and does not cause microcephaly. We conclude that infection with Flaviviridae can increase centrosome numbers and impair spindle positioning, thus potentially contributing to microcephaly in the case of Zika.
C1 [Wolf, Benita; Busso, Coralie; Gonczy, Pierre] Swiss Fed Inst Technol Lausanne EPFL, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.
   [Diop, Fode; Ferraris, Pauline; Wichit, Sineewanlaya; Misse, Dorothee] UMR 224 IRD CNRS UM1, Lab MIVEGEC, F-34394 Montpellier, France.
RP Gonczy, P (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.
EM pierre.gonczy@epfl.ch
RI Ferraris, Pauline/F-9077-2017
OI Ferraris, Pauline/0000-0002-8796-3074; Wolf, Benita/0000-0001-5673-4239
FU French Research Agency 'Agence Nationale de la Recherche'French National
   Research Agency (ANR) [ANR-14-CE14-0029]; European Union's Horizon
   research and innovation program under ZIKAlliance grant [734548]; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [3100A0-122500/1]
FX This research was supported in part by grants from the French Research
   Agency 'Agence Nationale de la Recherche' to D.M. (ANR-14-CE14-0029) and
   the European Union's Horizon 2020 research and innovation program under
   ZIKAlliance grant agreement No 734548 to D. M., as well as from the
   Swiss National Science Foundation to P.G. (3100A0-122500/1).
CR Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Arquint C, 2014, CURR BIOL, V24, P351, DOI 10.1016/j.cub.2013.12.016
   Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082
   BAKER SD, 1995, CYTOMETRY, V19, P134, DOI 10.1002/cyto.990190208
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Borawake K, 2011, INDIAN J CRIT CARE M, V15, P190, DOI 10.4103/0972-5229.84896
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7
   Diao MK, 2015, LIFE SCI, V127, P46, DOI 10.1016/j.lfs.2015.01.039
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Fu JY, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015800
   Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136
   Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   HENDARTO S K, 1992, Acta Paediatrica Japonica, V34, P350
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027
   JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H
   Kitagawa D, 2011, J CELL SCI, V124, P3884, DOI 10.1242/jcs.089888
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Milunovic-Jevtic A, 2016, CURR OPIN BIOTECH, V40, P113, DOI 10.1016/j.copbio.2016.03.011
   Nair AR, 2016, CELL REP, V14, P1100, DOI 10.1016/j.celrep.2015.12.097
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599
   Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435
   Webster WS, 1998, TERATOLOGY, V58, P13
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yen TTC, 2016, ONCOTARGET, V7, P23346, DOI 10.18632/oncotarget.8109
   Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026
NR 43
TC 18
Z9 18
U1 0
U2 7
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2046-2441
J9 OPEN BIOL
JI Open Biol
PD JAN
PY 2017
VL 7
IS 1
AR 160231
DI 10.1098/rsob.160231
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EJ7DR
UT WOS:000393382200003
PM 28100662
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Masi, M
   van der Westhuyzen, AE
   Tabanca, N
   Evidente, M
   Cimmino, A
   Green, IR
   Bernier, UR
   Becnel, JJ
   Bloomquist, JR
   van Otterlo, WAL
   Evidente, A
AF Masi, Marco
   van der Westhuyzen, Alet E.
   Tabanca, Nurhayat
   Evidente, Marco
   Cimmino, Alessio
   Green, Ivan R.
   Bernier, Ulrich R.
   Becnel, James J.
   Bloomquist, Jeffrey R.
   van Otterlo, Willem A. L.
   Evidente, Antonio
TI Sarniensine, a mesembrine-type alkaloid isolated from Nerine sarniensis,
   an indigenous South African Amaryllidaceae, with larvicidal and
   adulticidal activities against Aedes aegypti
SO FITOTERAPIA
LA English
DT Article
DE Nerine sarniensis; Amaryllidaceae alkaloids; Samiensine; Larvicide and
   adulticide activities; Natural pesticide; Aedes aegypti
AB A new mesembrine-type alkaloid, named sarniensine, was isolated together with tazettine, lycorine, the main alkaloid, and 3-epimacronine from Nerine sarniensis, with the last two produced for the first time by this plant. This Amaryllidaceae, which is indigenous of South Africa, was investigated for its alkaloid content, because the organic extract of its bulbs showed strong larvicidal activity with an LC50 value of 0.008 mu g mu L-1 against first instar Aedes aegypti larvae and with an LD50 value 4.6 mu g/mosquito against adult female Ac. aegypti, which is the major vector for dengue, yellow fever and the Zika virus. The extract did not show repellency at MED value of 0375 mg cm(2) against adult Ae. aegypti. Sarniensine was characterized using spectroscopic and chiroptical methods as (3aR,4Z,6S,7aS)-6-methoxy-3a-(2'-methoxymethyl-benzo [1,3]dioxol-1'-yl)-1-methyl-2,3,3a,6,7,7-hexahydro-1H-indole. It was less effective against larva at the lowest concentration of 0.1 mu g mu L-1, however it showed strong adulticidal activity with an LD50 value of 138 +/- 0.056 mu g mosquito(-1). (C) 2016 Elsevier B.V. All rights reserved.
C1 [Masi, Marco; Evidente, Marco; Cimmino, Alessio; Evidente, Antonio] Univ Naples Federico II, Dept Chem Sci, Complesso Univ Monte S Angelo,Via Cintia 4, I-80126 Naples, Italy.
   [van der Westhuyzen, Alet E.; Green, Ivan R.; van Otterlo, Willem A. L.] Univ Stellenbosch, Dept Chem & Polymer Sci, Private Bag X1, ZA-7602 Stellenbosch, South Africa.
   [Tabanca, Nurhayat; Bloomquist, Jeffrey R.] Univ Florida, Dept Entomol & Nematol, Emerging Pathogens Inst, Gainesville, FL 32610 USA.
   [Tabanca, Nurhayat; Bernier, Ulrich R.; Becnel, James J.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.
RP Evidente, A (corresponding author), Univ Naples Federico II, Dept Chem Sci, Complesso Univ Monte S Angelo,Via Cintia 4, I-80126 Naples, Italy.
EM evidente@unina.it
RI Cimmino, Alessio/I-2121-2012; Masi, Marco/J-7742-2016; Evidente,
   Antonio/N-9357-2013
OI Cimmino, Alessio/0000-0002-1551-4237; Masi, Marco/0000-0003-0609-8902;
   Evidente, Antonio/0000-0001-9110-1656; Bernier,
   Ulrich/0000-0002-4710-6801; Becnel, James/0000-0003-2464-0005
FU South-Africa Ministry of Foreign Affairs Area: South Africa, Medicine
   and Health Project [ZA14MO06]; Deployed War-Fighter Protection Research
   Program via U.S. Department of Defense through the Armed Forces Pest
   Management Board; Italian Ministry of Foreign Affairs Area: South
   Africa, Medicine and Health Project [ZA14MO06]
FX The work was supported in part by grants from a bilateral project of
   Italian and South-Africa Ministry of Foreign Affairs Area: South Africa,
   Medicine and Health Project number: ZA14MO06, titled: Bioactive
   metabolites from South-Africa plants with anticancer activity and in
   part by the Deployed War-Fighter Protection Research Program via grants
   from the U.S. Department of Defense through the Armed Forces Pest
   Management Board (to URB and to JRB). The authors thank Mrs. Dominique
   Melck, Istituto di Chimica Biomolecolare, CNR, Pozzuoli, Italy, for
   recording NMR spectra, and Miss Jessica Louton, Dr. Alden S. Estep, Mrs.
   Natasha M. Agramonte and Mr. Greg Allen (USDA-ARS, CMAVE, Gainesville
   FL) for mosquito bioassays. Prof. A Evidente is associated to Istituto
   di Chimica Biomolecolare, CNR, Pozzuoli, Italy.
CR Abd Kadir SL, 2013, J NAT MED-TOKYO, V67, P677, DOI 10.1007/s11418-013-0767-y
   Bastida J, 1998, STUD NAT PROD CHEM, V20, P323
   Berger S., 2004, 200 MORE BASIC NMR E
   BOIT HG, 1954, CHEM BER-RECL, V87, P1704, DOI 10.1002/cber.19540871115
   Breitmaier E., 1987, CARBON 13 NMR SPECTR, P183
   Chang F, 2014, J AGR FOOD CHEM, V62, P476, DOI 10.1021/jf4045843
   Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008
   EVIDENTE A, 1984, CHEM IND-LONDON, P348
   Evidente A, 2009, PHYTOCHEM REV, V8, P449, DOI 10.1007/s11101-008-9119-z
   Hayden EC, 2016, NATURE, V532, P16
   Hoel D, 2010, WINGBEATS, V21, P19
   Kishore N, 2014, PHYTOCHEM REV, V13, P587, DOI 10.1007/s11101-013-9316-2
   Kocyigit-Kaymakcioglu B, 2015, MED CHEM RES, V24, P3632, DOI 10.1007/s00044-015-1415-8
   Kornienko A, 2008, CHEM REV, V108, P1982, DOI 10.1021/cr078198u
   Kulhankova A, 2013, CHEM BIODIVERS, V10, P1120, DOI 10.1002/cbdv.201200144
   Lachance H, 2012, J MED CHEM, V55, P5989, DOI 10.1021/jm300288g
   Meepagala K. M., 2015, Agricultural Sciences, V6, P1195, DOI 10.4236/as.2015.610114
   Meerow A.W., 1998, FAMILIES GENERA VASC, V3, P83, DOI DOI 10.1007/978-3-662-03533-7_11
   Nair JJ, 2013, FOOD CHEM TOXICOL, V62, P262, DOI 10.1016/j.fct.2013.08.042
   Nair JJ, 2013, NAT PROD COMMUN, V8, P1335
   Patnala S, 2013, S AFR J SCI, V109, P29, DOI 10.1590/sajs.2013/882
   Pham LH, 1999, PHYTOCHEMISTRY, V51, P327, DOI 10.1016/S0031-9422(98)00743-2
   Poupon E., 2011, BIOMIMETIC ORGANIC S
   Pretsch E., 2000, STRUCTURE DETERMINAT, P161
   Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019
   WHO, 2009, WHO TECH REP SER, V958, P1
   World Health Organization, 2016, DENG VACC RES
NR 27
TC 20
Z9 20
U1 1
U2 29
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0367-326X
EI 1873-6971
J9 FITOTERAPIA
JI Fitoterapia
PD JAN
PY 2017
VL 116
BP 34
EP 38
DI 10.1016/j.fitote.2016.11.007
PG 5
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EI8SV
UT WOS:000392779200005
PM 27864138
OA Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Microcephaly and Zika Virus Infection
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Surin, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Niger.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Haikou, Hainan, Peoples R China.; Wiwanitkit, V (corresponding author), Surindra Rajabhat Univ, Surin, Thailand.; Wiwanitkit, V (corresponding author), Univ Nis, Fac Med, Nish, Serbia.; Wiwanitkit, V (corresponding author), Joseph Ayobabalola Univ, Ikeji Arakeji, Niger.; Wiwanitkit, V (corresponding author), Dr DY Patil Univ, Pune, Maharashtra, India.
EM wviroj@yahoo.com
CR [Anonymous], 2016, N Engl J Med, V375, P498, DOI 10.1056/NEJMx160025
   Collucci C, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4439
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003
   Raposo-Amaral CE, 2016, J CRANIOFAC SURG, V27, P1383, DOI 10.1097/SCS.0000000000002997
   Wiwanitkit V, 2016, SURG INFECT, V17, P498, DOI 10.1089/sur.2016.060
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
NR 8
TC 1
Z9 1
U1 0
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JAN
PY 2017
VL 28
IS 1
BP 299
EP 300
PG 3
WC Surgery
SC Surgery
GA EI2EJ
UT WOS:000392299200075
PM 27941545
DA 2020-07-08
ER

PT J
AU Benelli, G
   Canale, A
   Toniolo, C
   Higuchi, A
   Murugan, K
   Pavela, R
   Nicoletti, M
AF Benelli, Giovanni
   Canale, Angelo
   Toniolo, Chiara
   Higuchi, Akon
   Murugan, Kadarkarai
   Pavela, Roman
   Nicoletti, Marcello
TI Neem (Azadirachta indica): towards the ideal insecticide?
SO NATURAL PRODUCT RESEARCH
LA English
DT Review
DE Green nanosynthesis; malaria; Meliaceae; mosquito vectors; pesticides;
   Zika virus
ID CULEX-QUINQUEFASCIATUS DIPTERA; SEED EXTRACT MITESTOPA(R);
   ANOPHELES-STEPHENSI; ZIKA VIRUS; IN-VITRO; VETERINARY IMPORTANCE;
   CULICIFACIES DIPTERA; PLASMODIUM-BERGHEI; HPTLC FINGERPRINT;
   AEDES-AEGYPTI
AB Pesticide resistance is going to change rapidly our antibiotics and insecticides arsenal. In this scenario, plant-derived natural products are considered valuable candidates to reverse this negative trend. Growing research attention is focused on neem (Azadirachta indica, Meliaceae), exploring the utility of its products as insecticides and antibiotics. In this review, we summarised the knowledge on neem oil and neem cake by-products in arthropod pest control, with special reference to mosquito vectors of public health importance. To the best of our knowledge, neem-borne products currently showed effective and eco-friendly features, including little non-target effects, multiple mechanisms of action, low cost, easy production in countries with limited industrial facilities. In particular, the potentiality of neem cake as ideal and affordable source of mosquitocidal compounds in anopheline and aedine control programmes is outlined. Overall, we propose the employ of neem-based products as an advantageous alternative to build newer and safer arthropod control tools.
   [GRAPHICS]
   .
C1 [Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Pontedera, Italy.
   [Toniolo, Chiara; Nicoletti, Marcello] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy.
   [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, Jhongli, Taiwan.
   [Murugan, Kadarkarai] Bharathiar Univ, Sch Life Sci, Dept Zool, Coimbatore, Tamil Nadu, India.
   [Murugan, Kadarkarai] Thiruvalluvar Univ, Dept Biotechnol, Vellore, Tamil Nadu, India.
   [Pavela, Roman] Crop Res Inst, Prague, Czech Republic.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.; Benelli, G (corresponding author), St Anna Sch Adv Studies, BioRobot Inst, Pontedera, Italy.; Nicoletti, M (corresponding author), Sapienza Univ Rome, Dept Environm Biol, Rome, Italy.
EM benelli.giovanni@gmail.com; marcello.nicoletti@uniroma1.it
RI Pavela, Roman/Q-8647-2016; Higuchi, Akon/AAA-9711-2019; Murugan,
   Kadarkarai/AAP-3937-2020; Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010; Pavela, Roman/0000-0001-7866-4278
FU King Saud UniversityDeanship of Scientific Research at King Saud
   University
FX This work was supported by the King Saud University.
CR Abdel-Ghaffar F, 2008, PARASITOL RES, V104, P145, DOI 10.1007/s00436-008-1172-4
   Abdel-Ghaffar F, 2012, PARASITOL RES, V110, P277, DOI 10.1007/s00436-011-2484-3
   Abdel-Ghaffar F, 2009, PARASITOL RES, V105, P1469, DOI 10.1007/s00436-009-1590-y
   Akhila A, 1998, NAT PROD LETT, V11, P107, DOI 10.1080/10575639808041205
   Akihisa T, 2011, J OLEO SCI, V60, P53, DOI 10.5650/jos.60.53
   Akihisa T, 2009, J OLEO SCI, V58, P581, DOI 10.5650/jos.58.581
   Al-Quraishy S, 2012, PARASITOL RES, V110, P617, DOI 10.1007/s00436-011-2533-y
   Al-Quraishy S, 2012, PARASITOL RES, V110, P335, DOI 10.1007/s00436-011-2495-0
   Al-Samarrai G, 2012, ANN AGR ENV MED, V19, P673
   Ali MH, 2013, PROCEDIA ENGINEER, V56, P625, DOI 10.1016/j.proeng.2013.03.169
   Alzohairy MA, 2016, EVID-BASED COMPL ALT, DOI 10.1155/2016/7382506
   Anjali CH, 2012, PEST MANAG SCI, V68, P158, DOI 10.1002/ps.2233
   Ansari M. A., 1996, Indian Journal of Malariology, V33, P81
   BALANDRIN MF, 1988, J AGR FOOD CHEM, V36, P1048, DOI 10.1021/jf00083a035
   Banken JAO, 1997, J ECON ENTOMOL, V90, P1102, DOI 10.1093/jee/90.5.1102
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G, 2013, PHARM ONLINE, V47, P44
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Benelli G, 2014, PARASITOL RES, V113, P933, DOI 10.1007/s00436-013-3725-4
   Biswas K, 2002, CURR SCI INDIA, V82, P1336
   Brahmachari G, 2004, CHEMBIOCHEM, V5, P409, DOI 10.1002/cbic.200300749
   Chaisawangwong W, 2013, NAT PROD RES, V27, P394, DOI 10.1080/14786419.2012.706295
   Chandramohan B, 2016, ASIAN PAC J TROP BIO, V6, P472, DOI 10.1016/j.apjtb.2015.11.013
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chattopadhyay R. R., 1993, Indian Journal of Pharmacology, V25, P99
   Chauhan R.S., 2010, INDIAN COW SCI EC J, V7, P2
   Chava Venkateswara Rao, 2012, J Contemp Dent Pract, V13, P769
   CHOPRA I. C, 1952, INDIAN JOUR MED RES, V40, P511
   Coria C, 2008, BIORESOURCE TECHNOL, V99, P3066, DOI 10.1016/j.biortech.2007.06.012
   Debjit Bhowmik, 2010, Journal of Chemical and Pharmaceutical Research, V2, P62
   Del Serrone P, 2015, NAT PROD RES, V29, P985, DOI 10.1080/14786419.2014.964708
   Dhar R, 1996, J MED ENTOMOL, V33, P195, DOI 10.1093/jmedent/33.2.195
   Dua Virendra K., 1995, Indian Journal of Malariology, V32, P47
   Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6
   EPA, 2012, BIOP REG ACT DOC COL
   Farahna M, 2010, N AM J MED SCI, V2, P518, DOI 10.4297/najms.2010.2518
   Forim MR, 2011, INSECTICIDES - ADVANCES IN INTEGRATED PEST MANAGEMENT, P367
   Forster P., 2000, STATUS REPORT GLOBAL
   Girish K, 2008, J BIOL, V4, P102
   GOVINDACHARI TR, 1992, CURR SCI INDIA, V63, P117
   Habluetzel A, 2007, VET PARASITOL, V144, P328, DOI 10.1016/j.vetpar.2006.10.013
   Howard AFV, 2011, J MED PLANTS RES, V5, P1948
   Isman M. B., 1997, Pesticide Outlook, V8, P32
   Jarvis AP, 1997, NAT PROD LETT, V10, P95, DOI 10.1080/10575639708043721
   Jones P. S., 1989, Focus on phytochemical pesticides. Volume I. The neem tree., P19
   Koul O, 2007, NEEM TODAY NEW MILLE
   Kudom AA, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.14201
   Kumar S, 2012, PARASITOL RES, V110, P1795, DOI 10.1007/s00436-011-2701-0
   Kumar Venugopalan Santhosh, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P505, DOI 10.1016/S2221-1691(13)60105-7
   Lalitha A., 2013, INT J CUR MICRO APPL, V2, P228
   Lin N., 2015, ANNU REV ENTOMOL, V60, P34
   Lucantoni L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-66
   Luong K, 2012, J MED ENTOMOL, V49, P1361, DOI 10.1603/ME12075
   Maciel MV, 2010, REV BRAS PARASITOL V, V19, P7, DOI 10.1590/S1984-29612010000100003
   Mariani S., 2013, PHARMACOLOGYONLINE, V3, P122
   Mehlhorn H, 2012, PARASITOL RES, V110, P769, DOI 10.1007/s00436-011-2613-z
   Mehlhorn H, 2011, PARASITOL RES, V109, P1299, DOI 10.1007/s00436-011-2374-8
   Montezano DG, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu100
   Mulla MS, 1999, J AM MOSQUITO CONTR, V15, P133
   Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0
   Murugan K., 1996, Journal of Entomological Research (New Delhi), V20, P137
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2012, PARASITOL RES, V111, P1757, DOI 10.1007/s00436-012-3021-8
   NAS, 1992, NEEM TREE SOLV GLOB
   Nathan SS, 2005, ACTA TROP, V96, P47, DOI 10.1016/j.actatropica.2005.07.002
   Nathan SS, 2005, PESTIC BIOCHEM PHYS, V81, P113, DOI 10.1016/j.pestbp.2004.10.004
   Nicoletti M, 2013, PHARM ONLINE, V3, P115
   Nicoletti M., 2011, REV BRAS FARMACOGN, V21, P818, DOI DOI 10.1590/S0102-695X2011005000131
   Nicoletti M, 2016, INSECTICIDES RESISTANCE, P219, DOI 10.5772/61467
   Nicoletti M, 2016, CURR ORG CHEM, V20, P2681, DOI 10.2174/1385272820666160218233923
   Nicoletti M, 2011, INSECTICIDES - ADVANCES IN INTEGRATED PEST MANAGEMENT, P411
   Nicoletti M, 2013, JPC-J PLANAR CHROMAT, V26, P243, DOI 10.1556/JPC.26.2013.3.7
   Nicoletti M, 2012, STUD NAT PROD CHEM, V37, P217, DOI 10.1016/B978-0-444-59514-0.00008-0
   Nicoletti M, 2012, PARASITOL RES, V111, P205, DOI 10.1007/s00436-012-2819-8
   Nicoletti M, 2010, PARASITOL RES, V107, P89, DOI 10.1007/s00436-010-1838-6
   Nix S, 2007, NEEM TREE VILLAGE PH
   Oluwole FA, 2015, CONTINENTAL J ENG SC, V10, P1
   Pankaj S., 2011, INT RES J PHARM, V2, P97
   Pavela R, 2005, PHYTOPARASITICA, V33, P49, DOI 10.1007/BF02980924
   Pavela R, 2004, PHYTOPARASITICA, V32, P286, DOI 10.1007/BF02979823
   Pavela R, 2009, J PEST SCI, V82, P235, DOI 10.1007/s10340-009-0244-2
   Puri HS, 1999, NEEM DIVINE TREE AZA, P166
   Ragasa CY, 1997, PHYTOCHEMISTRY, V46, P555, DOI 10.1016/S0031-9422(97)87092-6
   Ramachandramohan M, 2015, J FISHERIES LIVEST P, V3, P2
   RAO DR, 1992, MED VET ENTOMOL, V6, P318, DOI 10.1111/j.1365-2915.1992.tb00627.x
   Rufrano D, 2015, SOJ MICROBIOL INFECT, V3, P01
   Ruskin F.R., 1992, NEEM TREE SOLVING GL
   Sara S.B., 2002, SUSTAINABLE IND UTIL, P45
   Schmahl G, 2010, PARASITOL RES, V107, P261, DOI 10.1007/s00436-010-1915-x
   Schmutterer H., 1995, P1
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   Shanmugapriyan R., 2015, J ENTOMOL ZOOL STU B, V3, P78
   SHARMA VP, 1993, J AM MOSQUITO CONTR, V9, P359
   Simmonds MS, 2004, PEST MANAG SCI, V60, P459, DOI 10.1002/ps.834
   Su TY, 1998, J VECTOR ECOL, V23, P114
   Su TY, 1998, J AM MOSQUITO CONTR, V14, P204
   Walldorf V, 2012, PARASITOL RES, V110, P623, DOI 10.1007/s00436-011-2535-9
   WHO, 2012, GLOB PLAN INS MAN MA
   Zoaka G., 2015, APPL RES J, V1, P252
NR 104
TC 27
Z9 29
U1 0
U2 46
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
PY 2017
VL 31
IS 4
BP 369
EP 386
DI 10.1080/14786419.2016.1214834
PG 18
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA EI6SI
UT WOS:000392626400002
PM 27687478
DA 2020-07-08
ER

PT J
AU Fan, YC
   Moon, JJ
AF Fan, Yuchen
   Moon, James J.
TI Particulate delivery systems for vaccination against bioterrorism agents
   and emerging infectious pathogens
SO WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY
LA English
DT Review
ID STAPHYLOCOCCAL-ENTEROTOXIN-B; INACTIVATED VIBRIO-CHOLERAE; PROTECTS
   NONHUMAN-PRIMATES; NANOPARTICLE-BASED VACCINE; ESCHERICHIA-COLI O157-H7;
   VIRUS-LIKE PARTICLES; FRANCISELLA-TULARENSIS; IMMUNE-RESPONSE;
   BURKHOLDERIA-PSEUDOMALLEI; BACILLUS-ANTHRACIS
AB Bioterrorism agents that can be easily transmitted with high mortality rates and cause debilitating diseases pose major threats to national security and public health. The recent Ebola virus outbreak in West Africa and ongoing Zika virus outbreak in Brazil, now spreading throughout Latin America, are case examples of emerging infectious pathogens that have incited widespread fear and economic and social disruption on a global scale. Prophylactic vaccines would provide effective countermeasures against infectious pathogens and biological warfare agents. However, traditional approaches relying on attenuated or inactivated vaccines have been hampered by their unacceptable levels of reactogenicity and safety issues, whereas subunit antigen-based vaccines suffer from suboptimal immunogenicity and efficacy. In contrast, particulate vaccine delivery systems offer key advantages, including efficient and stable delivery of subunit antigens, co-delivery of adjuvant molecules to bolster immune responses, low reactogenicity due to the use of biocompatible biomaterials, and robust efficiency to elicit humoral and cellular immunity in systemic and mucosal tissues. Thus, vaccine nanoparticles and microparticles are promising platforms for clinical development of biodefense vaccines. In this review, we summarize the current status of research efforts to develop particulate vaccine delivery systems against bioterrorism agents and emerging infectious pathogens. WIREs Nanomed Nanobiotechnol 2017, 9:e1403. doi: 10.1002/wnan.1403 For further resources related to this article, please visit the .
C1 [Fan, Yuchen; Moon, James J.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.
   [Fan, Yuchen; Moon, James J.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.
   [Moon, James J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Moon, JJ (corresponding author), Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.; Moon, JJ (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; Moon, JJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM moonjj@umich.edu
RI Moon, James/AAA-9905-2020; Moon, James C/F-1031-2014
OI Moon, James/0000-0001-8071-1491; Moon, James C/0000-0001-8071-1491
FU National Center for Advancing Translational Sciences of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR000433]; John S. and
   Suzanne C. Munn Cancer Fund of the University of Michigan Comprehensive
   Cancer Center; National Science Foundation CAREER awardNational Science
   Foundation (NSF); Melanoma Research Alliance Young Investigator Award;
   Broomfield International Student Fellowship
FX This work is supported in part by the National Center for Advancing
   Translational Sciences of the National Institutes of Health under Award
   Number UL1TR000433, the John S. and Suzanne C. Munn Cancer Fund of the
   University of Michigan Comprehensive Cancer Center, and National Science
   Foundation CAREER award. J.J.M. is supported by the Melanoma Research
   Alliance Young Investigator Award. Y.F. is supported by the Broomfield
   International Student Fellowship. We thank Joseph Bazzill and Cameron
   Louttit for critical review of the manuscript.
CR Afley P, 2015, APPL MICROBIOL BIOT, V99, P7625, DOI 10.1007/s00253-015-6787-7
   Anish C, 2012, BIOMATERIALS, V33, P6843, DOI 10.1016/j.biomaterials.2012.06.007
   Ano G, 2011, VACCINE, V29, P5758, DOI 10.1016/j.vaccine.2011.05.098
   Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342
   Ayithan N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118345
   Bach SJ, 2002, CAN J ANIM SCI, V82, P475, DOI 10.4141/A02-021
   Bavaro Mary F, 2012, Curr Gastroenterol Rep, V14, P317, DOI 10.1007/s11894-012-0264-6
   Bento D, 2015, VACCINE, V33, P3609, DOI 10.1016/j.vaccine.2015.06.037
   Bielinska AU, 2007, INFECT IMMUN, V75, P4020, DOI 10.1128/IAI.00070-07
   Bishop AL, 2011, EXPERT REV VACCINES, V10, P79, DOI [10.1586/erv.10.150, 10.1586/ERV.10.150]
   Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357
   Bramwell VW, 2005, ADV DRUG DELIVER REV, V57, P1247, DOI 10.1016/j.addr.2005.01.010
   Camacho AI, 2013, VACCINE, V31, P3288, DOI 10.1016/j.vaccine.2013.05.020
   Camacho AI, 2011, VACCINE, V29, P8222, DOI 10.1016/j.vaccine.2011.08.121
   Cannella AP, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00001
   Choi JH, 2013, BIODRUGS, V27, P565, DOI 10.1007/s40259-013-0046-1
   Christensen D, 2011, EXPERT REV VACCINES, V10, P513, DOI [10.1586/erv.11.17, 10.1586/ERV.11.17]
   Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004
   Clemens J, 2011, NAT REV GASTRO HEPAT, V8, P701, DOI 10.1038/nrgastro.2011.174
   Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346
   Martins RD, 2012, J CONTROL RELEASE, V162, P553, DOI 10.1016/j.jconrel.2012.07.030
   Avila-Calderon ED, 2013, BIOMED RES INT, DOI 10.1155/2013/743509
   Dasgupta G, 2011, VACCINE, V29, P5824, DOI 10.1016/j.vaccine.2011.06.083
   Davitt CJH, 2015, ADV DRUG DELIVER REV, V91, P52, DOI 10.1016/j.addr.2015.03.007
   Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   Desai MP, 2000, J MICROENCAPSUL, V17, P215
   desLa Vega MA, 2015, PLOS PATHOG, V11
   Di J, 2015, ACS NANO, V9, P9407, DOI 10.1021/acsnano.5b03975
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]
   Estevan M, 2006, VACCINE, V24, P4179, DOI 10.1016/j.vaccine.2006.01.038
   Eyles JE, 1998, VACCINE, V16, P2000, DOI 10.1016/S0264-410X(98)00089-9
   Fan YC, 2015, VACCINES-BASEL, V3, P662, DOI 10.3390/vaccines3030662
   Fan YC, 2015, J CONTROL RELEASE, V208, P121, DOI 10.1016/j.jconrel.2015.04.010
   Feodorova VA, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.34
   Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058
   Fischer NO, 2013, J AM CHEM SOC, V135, P2044, DOI 10.1021/ja3063293
   Flick-Smith HC, 2002, INFECT IMMUN, V70, P2022, DOI 10.1128/IAI.70.4.2022-2028.2002
   Fukuda T, 1998, INT ARCH ALLERGY IMM, V116, P313, DOI 10.1159/000023961
   Gao WW, 2015, NANO LETT, V15, P1403, DOI 10.1021/nl504798g
   Garcia-Angulo VA, 2013, VACCINE, V31, P3229, DOI 10.1016/j.vaccine.2013.05.013
   Geisbert TW, 2010, REV MED VIROL, V20, P344, DOI 10.1002/rmv.661
   Goel D, 2013, VACCINE, V31, P1231, DOI 10.1016/j.vaccine.2012.12.043
   Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08
   Greenway TE, 1998, VACCINE, V16, P1314, DOI 10.1016/S0264-410X(98)00008-5
   Gregory AE, 2012, VACCINE, V30, P6777, DOI 10.1016/j.vaccine.2012.09.021
   Gregory AE, 2015, NANOMED-NANOTECHNOL, V11, P447, DOI 10.1016/j.nano.2014.08.005
   Griffin JFT, 2002, ADV DRUG DELIVER REV, V54, P851, DOI 10.1016/S0169-409X(02)00072-8
   Griffiths GD, 1998, VACCINE, V16, P530, DOI 10.1016/S0264-410X(97)80007-2
   Griffiths GD, 1997, VACCINE, V15, P1933, DOI 10.1016/S0264-410X(97)00123-0
   Griffiths GD, 1999, VACCINE, V17, P2562, DOI 10.1016/S0264-410X(99)00054-7
   Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Haughney SL, 2014, NANOSCALE, V6, P13770, DOI 10.1039/c4nr03724c
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Henghold WB, 2004, DERMATOL CLIN, V22, P257, DOI 10.1016/j.det.2004.03.004
   Hickey AJ, 2011, VACCINE, V29, P6941, DOI 10.1016/j.vaccine.2011.07.075
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213
   Hopkins RJ, 2014, VACCINE, V32, P2217, DOI 10.1016/j.vaccine.2014.01.073
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/NNANO.2013.254, 10.1038/nnano.2013.254]
   Huang SS, 2014, INT J NANOMED, V9, P813, DOI 10.2147/IJN.S56260
   Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281
   Irvine DJ, 2015, CHEM REV, V115, P11109, DOI 10.1021/acs.chemrev.5b00109
   Camacho AI, 2013, EXPERT REV VACCINES, V12, P43, DOI [10.1586/ERV.12.135, 10.1586/erv.12.135]
   Isherwood KE, 2005, ADV DRUG DELIVER REV, V57, P1403, DOI 10.1016/j.addr.2005.01.030
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003
   Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258
   Karalewitz APA, 2012, CURR OPIN MICROBIOL, V15, P317, DOI 10.1016/j.mib.2012.05.009
   Kaur M, 2013, EXPERT REV VACCINES, V12, P955, DOI 10.1586/14760584.2013.814860
   Keitel WA, 2006, EXPERT REV VACCINES, V5, P417, DOI 10.1586/14760584.5.4.417
   Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005
   Krakauer T, 2013, VIRULENCE, V4, P759, DOI 10.4161/viru.23905
   Kuai R, 2015, BIOMEDICAL ENG FRONT, P177
   Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Li XR, 2014, J CONTROL RELEASE, V173, P148, DOI 10.1016/j.jconrel.2013.10.032
   Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0
   Lopez Anna Lena, 2014, Ther Adv Vaccines, V2, P123, DOI 10.1177/2051013614537819
   MacLennan CA, 2014, HUM VACC IMMUNOTHER, V10, P1478, DOI 10.4161/hv.29054
   Manish M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061885
   Mantis NJ, 2005, ADV DRUG DELIVER REV, V57, P1424, DOI 10.1016/j.addr.2005.01.017
   Marasini N, 2014, EXPERT REV VACCINES, V13, P1361, DOI 10.1586/14760584.2014.936852
   Martin S, 2014, B WORLD HEALTH ORGAN, V92, P881, DOI 10.2471/BLT.14.139949
   Martins K, 2015, VIRAL IMMUNOL, V28, P62, DOI 10.1089/vim.2014.0071
   Martins KAO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089735
   Marzi A, 2015, SCIENCE, V348, P439, DOI 10.1126/science.aaa4919
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mire CE, 2015, NATURE, V520, P688, DOI 10.1038/nature14428
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Moon JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031472
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nagata LP, 2013, FUTURE VIROL, V8, P661, DOI 10.2217/FVL.13.42
   Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777
   Niikura K, 2013, ACS NANO, V7, P3926, DOI 10.1021/nn3057005
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]
   Ochoa J, 2007, VACCINE, V25, P4410, DOI 10.1016/j.vaccine.2007.03.025
   Ochyl LJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52771
   Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003
   Parry CM, 2008, CURR OPIN INFECT DIS, V21, P531, DOI 10.1097/QCO.0b013e32830f453a
   Pastor M, 2013, VACCINE, V31, P4069, DOI 10.1016/j.vaccine.2013.06.096
   Pastor M, 2013, INT J PHARMACEUT, V448, P247, DOI 10.1016/j.ijpharm.2013.02.057
   Patel GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015574
   Paterson GK, 2010, HUM VACCINES, V6, P379, DOI 10.4161/hv.6.5.10755
   Peachman KK, 2012, CLIN VACCINE IMMUNOL, V19, P11, DOI 10.1128/CVI.05376-11
   Perkins SD, 2010, FEMS MICROBIOL REV, V34, P379, DOI 10.1111/j.1574-6976.2010.00211.x
   Pincus SH, 2011, TOXINS, V3, P1163, DOI 10.3390/toxins3091163
   Puangpetch A, 2012, CLIN VACCINE IMMUNOL, V19, P675, DOI 10.1128/CVI.05545-11
   Rao M, 1999, VACCINE, V17, P2991, DOI 10.1016/S0264-410X(99)00170-X
   Rao M, 2002, J VIROL, V76, P9176, DOI 10.1128/JVI.76.18.9176-9185.2002
   Richard K, 2014, CLIN VACCINE IMMUNOL, V21, P212, DOI 10.1128/CVI.00738-13
   Rosenzweig JA, 2011, APPL MICROBIOL BIOT, V91, P265, DOI 10.1007/s00253-011-3380-6
   Ross KA, 2014, ADV HEALTHC MATER, V3, P1071, DOI 10.1002/adhm.201300525
   Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164
   Sahdev P, 2014, PHARM RES-DORDR, V31, P2563, DOI 10.1007/s11095-014-1419-y
   Schier Joshua G, 2007, Am J Public Health, V97 Suppl 1, pS152, DOI 10.2105/AJPH.2006.099903
   Schully KL, 2013, PHARM RES-DORDR, V30, P1349, DOI 10.1007/s11095-013-0975-x
   Silva EB, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00010
   Simon R, 2012, HUM VACC IMMUNOTHER, V8, P494, DOI 10.4161/hv.19158
   Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554
   Singh D, 2015, VACCINE, V33, P2786, DOI 10.1016/j.vaccine.2015.04.030
   Smallshaw JE, 2012, CURR TOP MICROBIOL, V357, P259, DOI 10.1007/82_2011_156
   Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488
   Stahl JP, 2011, MED MALADIES INFECT, V41, P453, DOI 10.1016/j.medmal.2011.05.015
   Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182
   Suzaki Y, 2002, INT ARCH ALLERGY IMM, V127, P294, DOI 10.1159/000057746
   Tana, 2003, LETT APPL MICROBIOL, V36, P135, DOI 10.1046/j.1472-765X.2003.01278.x
   Torres AG, 2015, VACCINE, V33, P686, DOI 10.1016/j.vaccine.2014.11.057
   TSENG JN, 1995, INFECT IMMUN, V63, P2880, DOI 10.1128/IAI.63.8.2880-2885.1995
   Ulery BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017642
   Uppada JB, 2009, MED MICROBIOL IMMUN, V198, P247, DOI 10.1007/s00430-009-0124-7
   Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077
   van der Maaden K, 2012, J CONTROL RELEASE, V161, P645, DOI 10.1016/j.jconrel.2012.01.042
   Van Zandt KE, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-131
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Walker RI, 2015, VACCINE, V33, P954, DOI 10.1016/j.vaccine.2014.11.049
   Walle KV, 2013, VET IMMUNOL IMMUNOP, V152, P109, DOI 10.1016/j.vetimm.2012.09.028
   Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583
   Warfield KL, 2011, J INFECT DIS, V204, pS1053, DOI 10.1093/infdis/jir346
   Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100
   Webb RP, 2013, EXPERT REV VACCINES, V12, P481, DOI [10.1586/ERV.13.37, 10.1586/erv.13.37]
   Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385
   Williamson ED, 2013, CLIN EXP IMMUNOL, V172, P1, DOI 10.1111/cei.12044
   Wilson JT, 2013, ACS NANO, V7, P3912, DOI 10.1021/nn305466z
   Wongratanacheewin S, 2004, INFECT IMMUN, V72, P4494, DOI 10.1128/IAI.72.8.4494-4502.2004
   Yan CH, 1996, VACCINE, V14, P1031
   YAN CH, 1995, VACCINE, V13, P645
   Yeh MK, 2004, J MICROENCAPSUL, V21, P91, DOI 10.1080/02652040310001619794
   Yeh MK, 2002, J CONTROL RELEASE, V82, P237, DOI 10.1016/S0168-3659(02)00140-2
   Yue H, 2015, VACCINE, V33, P5927, DOI 10.1016/j.vaccine.2015.07.100
   Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023
NR 155
TC 7
Z9 8
U1 1
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1939-5116
EI 1939-0041
J9 WIRES NANOMED NANOBI
JI Wiley Interdiscip. Rev.-Nanomed. Nanobiotechnol.
PD JAN-FEB
PY 2017
VL 9
IS 1
AR e1403
DI 10.1002/wnan.1403
PG 26
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA EI5BQ
UT WOS:000392508900001
PM 27038091
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Molyneux, J
AF Molyneux, Jacob
TI Top Health Stories of 2016: ACA, Opioids, Zika-Representation and
   Misrepresentation in a Post-Fact Era It's easier to discover a villain
   than to solve a complex public health problem
SO AMERICAN JOURNAL OF NURSING
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0002-936X
EI 1538-7488
J9 AM J NURS
JI Am. J. Nurs.
PD JAN
PY 2017
VL 117
IS 1
BP 12
EP 13
DI 10.1097/01.NAJ.0000511548.54135.0d
PG 2
WC Nursing
SC Nursing
GA EH7OT
UT WOS:000391963000006
PM 28030386
DA 2020-07-08
ER

PT J
AU Wang, S
   Hong, S
   Deng, YQ
   Ye, Q
   Zhao, LZ
   Zhang, FC
   Qin, CF
   Xu, ZH
AF Wang, Shuo
   Hong, Shuai
   Deng, Yong-Qiang
   Ye, Qing
   Zhao, Ling-Zhai
   Zhang, Fu-Chun
   Qin, Cheng-Feng
   Xu, Zhiheng
TI Transfer of convalescent serum to pregnant mice prevents Zika virus
   infection and microcephaly in offspring
SO CELL RESEARCH
LA English
DT Letter
ID STRUCTURAL BASIS
C1 [Wang, Shuo; Hong, Shuai; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Wang, Shuo; Hong, Shuai] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Deng, Yong-Qiang; Ye, Qing; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zhao, Ling-Zhai; Zhang, Fu-Chun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
RP Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
EM qincf@bmi.ac.cn; zhxu@genetics.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Xu, Zhiheng/0000-0002-4809-2851
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31430037, 31271156, 81522025, 81621005]; National
   Basic Research Program ("973" program)National Basic Research Program of
   China [2014CB942801, 2013DFA31990, 2012YQ03026006]; National Key
   Research Program of China [2016YFD0500304]
FX This work was supported by the National Natural Science Foundation of
   China (31430037, 31271156, 81522025 and 81621005), the National Basic
   Research Program ("973" program; 2014CB942801, 2013DFA31990 and
   2012YQ03026006) and the National Key Research Program of China
   (2016YFD0500304).
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Winkler AM, 2015, CURR OPIN HEMATOL, V22, P521, DOI 10.1097/MOH.0000000000000191
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 11
TC 23
Z9 24
U1 0
U2 19
PU INST BIOCHEMISTRY & CELL BIOLOGY
PI SHANGHAI
PA SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD JAN
PY 2017
VL 27
IS 1
BP 158
EP 160
DI 10.1038/cr.2016.144
PG 3
WC Cell Biology
SC Cell Biology
GA EI1WU
UT WOS:000392277900017
PM 27922617
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Janahi, EM
   Dhasmana, A
   Srivastava, V
   Sarangi, AN
   Raza, S
   Arif, JM
   Bhatt, MLB
   Lohani, M
   Areeshi, MY
   Saxena, AM
   Haque, S
AF Janahi, Essam Mohammed
   Dhasmana, Anupam
   Srivastava, Vandana
   Sarangi, Aditya Narayan
   Raza, Sana
   Arif, Jamal M.
   Bhatt, Madan Lal Bramha
   Lohani, Mohtashim
   Areeshi, Mohammed Yahya
   Saxena, Anand Murari
   Haque, Shafiul
TI IN SILICO CD4+, CD8+T-CELL AND B-CELL IMMUNITY ASSOCIATED IMMUNOGENIC
   EPITOPE PREDICTION AND HLA DISTRIBUTION ANALYSIS OF ZIKA VIRUS
SO EXCLI JOURNAL
LA English
DT Article
DE Zika virus; HLA; vaccine; prophylactic; immunogens; B-/T-cell
ID PEPTIDE VACCINE; GENOME
AB Zika virus (ZIKV) is a mosquito-borne flavivirus distributed all over Africa, South America and Asia. The infection with the virus may cause acute febrile sickness that clinically resembles dengue fever, yet there is no vaccine, no satisfactory treatment, and no means of evaluating the risk of the disease or prognosis in the infected people. In the present study, the efficacy of the host's immune response in reducing the risk of infectious diseases was taken into account to carry out immuno-informatics driven epitope screening strategy of vaccine candidates against ZIKV. In this study, HLA distribution analysis was done to ensure the coverage of the vast majority of the population. Systematic screening of effective dominant immunogens was done with the help of Immune Epitope & ABCPred databases. The outcomes suggested that the predicted epitopes may be protective immunogens with highly conserved sequences and bear potential to induce both protective neutralizing antibodies, T & B cell responses. A total of 25 CD4+ and 16 CD8+ peptides were screened for T-cell mediated immunity. The predicted epitope "TGLDFSDLYYLTMNNKHWLV" was selected as a highly immunogenic epitope for humoral immunity. These peptides were further screened as non-toxic, immunogenic and non-mutated residues of envelop viral protein. The predicted epitope could work as suitable candidate(s) for peptide based vaccine development. Further, experimental validation of these epitopes is warranted to ensure the potential of B- and T-cells stimulation for their efficient use as vaccine candidates, and as diagnostic agents against ZIKV.
C1 [Janahi, Essam Mohammed] Univ Bahrain, Coll Sci, Dept Biol, POB 32038, Southern Governorate, Bahrain.
   [Dhasmana, Anupam] Amity Univ, Res Cell, Lucknow Campus, Lucknow 226028, Uttar Pradesh, India.
   [Dhasmana, Anupam; Raza, Sana; Bhatt, Madan Lal Bramha; Lohani, Mohtashim] King George Med Univ, Dept Radiotherapy, Lucknow 226003, Uttar Pradesh, India.
   [Srivastava, Vandana; Saxena, Anand Murari] Univ Lucknow, Dept Zool, Lucknow 226007, Uttar Pradesh, India.
   [Sarangi, Aditya Narayan] Sanjay Gandhi Postgrad Inst Med Sci, Biomed Informat Ctr, Lucknow 226014, Uttar Pradesh, India.
   [Raza, Sana] Integral Univ, Dept Biosci, Lucknow 226026, Uttar Pradesh, India.
   [Arif, Jamal M.] Univ Hail, Dept Biochem, Hail 2440, Saudi Arabia.
   [Lohani, Mohtashim; Areeshi, Mohammed Yahya; Haque, Shafiul] Jazan Univ, Coll Nursing & Allied Hlth Sci, Res & Sci Studies Unit, Jazan 45142, Saudi Arabia.
   [Haque, Shafiul] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India.
RP Janahi, EM (corresponding author), Univ Bahrain, Coll Sci, Dept Biol, POB 32038, Southern Governorate, Bahrain.; Haque, S (corresponding author), Jazan Univ, Coll Nursing & Allied Hlth Sci, Res & Sci Studies Unit, Jazan 45142, Saudi Arabia.
EM emohammed@uob.edu.bh; shafiul.haque@hotmail.com
RI Arif, Jamal/AAF-7517-2020; Dhasmana, Anupam/K-6043-2019; HAQUE,
   SHAFIUL/AAN-2946-2020
OI HAQUE, SHAFIUL/0000-0002-2989-121X; Janahi, Essam/0000-0001-7991-0151;
   Lohani, Mohtashim/0000-0001-9414-4539
CR Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Azizi A, 2008, J IMMUNOL, V180, P2174, DOI 10.4049/jimmunol.180.4.2174
   Badawi MM, 2016, AM J BIOMED RES, V4, P46
   Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966
   Davies MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/j.drudis.2007.03.010
   De Groot AS, 2002, IMMUNOL CELL BIOL, V80, P255, DOI 10.1046/j.1440-1711.2002.01092.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Salaam-Blyther T, 2016, CRS INSIGHT     0414
   Shi JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131461
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Yadav R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060785
NR 20
TC 3
Z9 5
U1 1
U2 11
PU EXCLI JOURNAL MANAGING OFFICE
PI DORTMUND
PA LEIBNIZ RESEARCH CENTRE WORKING ENVIRONMENT & HUMAN FACTORS EXCLI
   JOURNAL, ARDEYSTR 67, DORTMUND, D-44139, GERMANY
SN 1611-2156
J9 EXCLI J
JI EXCLI J.
PY 2017
VL 16
BP 63
EP 72
DI 10.17179/excli2016-719
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EI4EX
UT WOS:000392447000001
PM 28435428
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Reilly, M
   Rappaport, L
AF Reilly, Marie
   Rappaport, Leonard
TI Congenital Zika Virus Infection: A Developmental-Behavioral Perspective
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Editorial Material
C1 [Reilly, Marie; Rappaport, Leonard] Harvard Med Sch, Boston Childrens Hosp, Div Dev Med, Boston, MA USA.
RP Reilly, M (corresponding author), Boston Childrens Hosp, 300 Longwood Ave,Fegan 10, Boston, MA 02115 USA.
EM marie.reilly@childrens.harvard.edu
CR Berger BE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-340
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention (CDC), 2016, TRAV HLTH NOT
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Johansson MA, 2016, NEW ENGL J MED, V375
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Zavis A, LOS ANGELES TIMES
NR 9
TC 1
Z9 1
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD JAN
PY 2017
VL 38
IS 1
BP 65
EP 66
DI 10.1097/DBP.0000000000000382
PG 2
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA EI3AD
UT WOS:000392360700011
PM 27984418
DA 2020-07-08
ER

PT J
AU Dhawan, R
   Kumar, M
   Mohanty, AK
   Dey, G
   Advani, J
   Prasad, TSK
   Kumar, A
AF Dhawan, Rakhi
   Kumar, Manish
   Mohanty, Ajeet Kumar
   Dey, Gourav
   Advani, Jayshree
   Prasad, T. S. Keshava
   Kumar, Ashwani
TI Mosquito-Borne Diseases and Omics: Salivary Gland Proteome of the Female
   Aedes aegypti Mosquito
SO OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
LA English
DT Article
DE proteomics; global health; diagnostic medicine; neglected tropical
   diseases; personalized medicine
ID YELLOW-FEVER MOSQUITO; INNATE IMMUNITY; PROTEINS; EVOLUTION;
   MELANIZATION; MOLECULES; PROTEASES; FICOLINS; THAILAND; APYRASE
AB The female Aedes aegypti mosquito is an important vector for several tropical and subtropical diseases such as dengue, chikungunya, and Zika and yellow fever. The disease viruses infect the mosquito and subsequently spread to the salivary glands after which the viruses can be transmitted to humans with probing or feeding by the mosquito. Omics systems sciences offer the opportunity to characterize vectors and can inform disease surveillance, vector control and development of innovative diagnostics, personalized medicines, vaccines, and insecticide targets. Using high-resolution mass spectrometry, we performed an analysis of the A. aegypti salivary gland proteome. The A. aegypti proteome resulted in acquisition of 83,836 spectra. Upon searches against the protein database of the A. aegypti, these spectra were assigned to 5417 unique peptides, belonging to 1208 proteins. To the best of our knowledge, this is the largest set of proteins identified in the A. aegypti salivary gland. Of note, 29 proteins were involved in immunity-related pathways in salivary glands. A subset of these proteins is known to interact with disease viruses. Another 15 proteins with signal cleavage site were found to be secretory in nature, and thus possibly playing critical roles in blood meal ingestion. These findings provide a baseline to advance our understanding of vector-borne diseases and vector-pathogen interactions before virus transmission in global health, and might therefore enable future design and development of virus-blocking strategies and novel molecular targets in the mosquito vector A. aegypti.
C1 [Dhawan, Rakhi] Armed Forces Med Coll, Dept Community Med, Pune, Maharashtra, India.
   [Dhawan, Rakhi; Mohanty, Ajeet Kumar; Kumar, Ashwani] Natl Inst Malaria Res, Panaji, Goa, India.
   [Dhawan, Rakhi] Goa Univ, Dept Zool, Taleigao, Goa, India.
   [Kumar, Manish; Dey, Gourav; Advani, Jayshree; Prasad, T. S. Keshava] Int Technol Pk, Inst Bioinformat, Discoverer Bldg,7th Floor, Bangalore 560066, Karnataka, India.
   [Kumar, Manish; Dey, Gourav; Advani, Jayshree] Manipal Univ, Manipal, Karnataka, India.
   [Prasad, T. S. Keshava] Yenepoya Univ, YU IOB Ctr Syst Biol & Mol Med, Mangalore, India.
   [Prasad, T. S. Keshava] Natl Inst Mental Hlth & Neurosci, NIMHANS IOB Prote & Bioinformat Lab, Neurobiol Res Ctr, Bangalore, Karnataka, India.
RP Prasad, TSK (corresponding author), Int Technol Pk, Inst Bioinformat, Discoverer Bldg,7th Floor, Bangalore 560066, Karnataka, India.; Kumar, A (corresponding author), Natl Inst Malaria Res ICMR, Field Unit, DHS Bldg, Panaji 403001, Goa, India.
EM keshav@ibioinformatics.org; ashwani07@gmail.com
RI Prasad, Keshava/F-7631-2010
OI Prasad, Keshava/0000-0002-6206-2384; Dey, Gourav/0000-0002-2703-699X
FU Department of Biotechnology (DBT), Government of IndiaDepartment of
   Biotechnology (DBT) India; Infosys Foundation; Science and Engineering
   Research Board (SERB), Government of India [EMR/2014/000444]; Council of
   Scientific and Industrial Research, Government of IndiaCouncil of
   Scientific & Industrial Research (CSIR) - India; University Grants
   Commission, Government of IndiaUniversity Grants Commission, India; DBT
   Program Support on infrastructure for proteomic data analysis
   [BT/01/COE/08/05]
FX We thank the Indian Council of Medical Research, National Institute of
   Malaria Research, Institute of Bioinformatics, and Goa University for
   institutional support. This article bears the NIMR publication screening
   committee approval no. 028/2016. We are grateful to Dr. Neena Valecha,
   Director NIMR, for encouragement. We thank Ministry of Defence and Armed
   Forces Medical College (AFMC) for research approval to R.D. We thank the
   Department of Biotechnology (DBT), Government of India, and Infosys
   Foundation for research support to the Institute of Bioinformatics, the
   Department of Health and Family Welfare, for procuring mass spectrometer
   at NIMHANS-IOB laboratory, the Science and Engineering Research Board
   (SERB), Government of India, for funding (EMR/2014/000444) to NIMR and
   IOB to characterize proteome and transcriptome of mosquito vectors, the
   Council of Scientific and Industrial Research, Government of India, for
   research fellowships to M.K. and J.A, and the University Grants
   Commission, Government of India, for research fellowships to G.D. IOB is
   also supported by DBT Program Support on infrastructure for proteomic
   data analysis (BT/01/COE/08/05).
CR Barillas-Mury C, 2007, TRENDS PARASITOL, V23, P297, DOI 10.1016/j.pt.2007.05.001
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Cao-Lormeau VM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-35
   Chaerkady R, 2011, GENOME RES, V21, P1872, DOI 10.1101/gr.127951.111
   CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138
   CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694
   Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102
   Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200
   Fan CX, 2008, MOL IMMUNOL, V45, P3338, DOI 10.1016/j.molimm.2008.04.019
   Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059
   Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882
   Harsha HC, 2008, NAT PROTOC, V3, P505, DOI 10.1038/nprot.2008.2
   Higgs S, 2004, T ROY SOC TROP MED H, V98, P82, DOI 10.1016/S0035-9203(03)00004-X
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128
   Jang IH, 2008, BMB REP, V41, P102, DOI 10.5483/BMBRep.2008.41.2.102
   Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7
   Jirakanjanakit N, 2007, ENVIRON ENTOMOL, V36, P506, DOI 10.1603/0046-225X(2007)36[506:TOTRIA]2.0.CO;2
   Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2
   Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015
   Kalume DE, 2005, PROTEOMICS, V5, P3765, DOI 10.1002/pmic.200401210
   Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356
   Kenneth KR, 1998, J BIOL CHEM, V273, P20802, DOI 10.1074/jbc.273.33.20802
   Kuo TH, 2006, BIOCHEM J, V393, P757, DOI 10.1042/BJ20051108
   Lu JH, 2002, BBA-GEN SUBJECTS, V1572, P387, DOI 10.1016/S0304-4165(02)00320-3
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149
   Middha S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-260
   Oktarianti R, 2015, J INFECT PUBLIC HEAL, V8, P575, DOI 10.1016/j.jiph.2015.04.022
   Prasad TSK, 2016, GENOME RES
   Rawlins SC, 1998, J AM MOSQUITO CONTR, V14, P131
   Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032
   RIBEIRO JMC, 1984, COMP BIOCHEM PHYS B, V79, P81, DOI 10.1016/0305-0491(84)90081-6
   RIBEIRO JMC, 1992, J EXP BIOL, V165, P61
   Ribeiro JMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151400
   Rodriguez MM, 2005, J AM MOSQUITO CONTR, V21, P437, DOI 10.2987/8756-971X(2006)21[437:PISOAA]2.0.CO;2
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Sreenivasamurthy SK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-216
   Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x
   Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x
   Thangamani S, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-34
   Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4
   Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839
   Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798
   Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626
   Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x
   WHO, 2015, DENG SEV DENG
   Wong HV, 2016, METHODS MOL BIOL, V1426, P119, DOI 10.1007/978-1-4939-3618-2_11
   Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x
NR 58
TC 8
Z9 9
U1 1
U2 23
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1536-2310
EI 1557-8100
J9 OMICS
JI OMICS
PD JAN
PY 2017
VL 21
IS 1
BP 45
EP 54
DI 10.1089/omi.2016.0160
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA EI3YN
UT WOS:000392429200005
PM 28271980
DA 2020-07-08
ER

PT J
AU Muller, WJ
AF Muller, William J.
TI Treatment of perinatal viral infections to improve neurologic outcomes
SO PEDIATRIC RESEARCH
LA English
DT Review
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; CENTRAL-NERVOUS-SYSTEM; SIMPLEX
   VIRUS-INFECTION; SINGLE-DOSE PHARMACOKINETICS; JAPANESE
   ENCEPHALITIS-VIRUS; ENTEROVIRUS 71 INFECTION; WEST-NILE-VIRUS;
   HERPES-SIMPLEX; NEONATAL HERPES; CONTROLLED-TRIAL
AB Viral infections in the fetus or newborn often involve the central nervous system (CNS) and can lead to significant morbidity and mortality. Substantial progress has been made in identifying interventions decreasing adverse neurodevelopmental outcomes in this population. This review highlights progress in treatment of important viruses affecting the CNS in these susceptible hosts, focusing on herpes simplex virus (HSV), cytomegalovirus (CMV), human immunodeficiency virus (HIV), and enteroviruses. The observation that high-dose acyclovir improves mortality in neonatal HSV disease culminated decades of antiviral research for this disease. More recently, prolonged oral acyclovir was found to improve neurologic morbidity after neonatal HSV encephalitis. Ganciclovir, and more recently its oral prodrug valganciclovir, is effective in improving hearing and neurodevelopment after congenital CMV infection. Increasing evidence suggests early control of perinatal HIV infection has implications for neurocognitive functioning into school age. Lastly, the antiviral pleconaril has been studied for nearly two decades for treating severe enteroviral infections, with newer data supporting a role for this drug in neonates. Identifying common mechanisms for pathogenesis of viral CNS disease during this critical period of brain development is an important research goal, highlighted by the recent emergence of Zika virus as a potential cause of fetal neurodevelopmental abnormalities.
C1 [Muller, William J.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Muller, William J.] Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA.
RP Muller, WJ (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.; Muller, WJ (corresponding author), Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA.
EM wjmuller@northwestern.edu
OI Muller, William J/0000-0001-7690-0695
CR Abedi GR, 2015, MMWR-MORBID MORTAL W, V64, P940, DOI 10.15585/mmwr.mm6434a3
   Abzug MJ, 2016, J PEDIAT INF DIS SOC, V5, P53, DOI 10.1093/jpids/piv015
   ABZUG MJ, 1993, PEDIATR INFECT DIS J, V12, P820, DOI 10.1097/00006454-199310000-00005
   Abzug MJ, 2003, PEDIATR INFECT DIS J, V22, P335
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Berry JG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001158
   Birbeck GL, 2015, NATURE, V527, pS167, DOI 10.1038/nature16031
   BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007
   Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804
   Bradford RD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004774
   Burkala EJ, 2005, AIDS, V19, P675, DOI 10.1097/01.aids.0000166090.31693.aa
   Carlson Amanda, 2010, Rev Obstet Gynecol, V3, P172
   Cekinovic D, 2008, J VIROL, V82, P12172, DOI 10.1128/JVI.01214-08
   Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Crowell CS, 2015, AIDS, V29, P295, DOI 10.1097/QAD.0000000000000528
   Crowell CS, 2014, REV MED VIROL, V24, P316, DOI 10.1002/rmv.1793
   Depoortere E, 2004, TROP MED INT HEALTH, V9, P730, DOI 10.1111/j.1365-3156.2004.01253.x
   Feuer R, 2003, AM J PATHOL, V163, P1379, DOI 10.1016/S0002-9440(10)63496-7
   Feuer R, 2009, J VIROL, V83, P9356, DOI 10.1128/JVI.02382-07
   Fonseca-Aten M, 2005, PEDIATRICS, V115, P804, DOI 10.1542/peds.2004-0777
   Frenkel LM, 2005, PEDIATRICS, V115, P795, DOI 10.1542/peds.2004-1941
   Garon JR, 2015, INFECT DIS CLIN N AM, V29, P651, DOI 10.1016/j.idc.2015.07.003
   GAULD LW, 1979, J MENT DEFIC RES, V23, P63
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Griffiths P, 2013, VACCINE, V31, pB197, DOI 10.1016/j.vaccine.2012.10.074
   Gutierrez K, 2003, PEDIATR INFECT DIS J, V22, P371
   Hass GM, 1935, AM J PATHOL, V11, P127
   Havens PL, 2008, PEDIATRICS, V122, P1127, DOI 10.1542/peds.2008-2175
   Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302
   *I MED, 2000, VACC 21 CENT
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   KAUFMAN HE, 1962, ARCH OPHTHALMOL-CHIC, V68, P235
   Kawasaki H, 2002, LAB INVEST, V82, P1347, DOI 10.1097/01.LAB.0000032376.58688.D4
   Kearns GL, 2000, PEDIATR INFECT DIS J, V19, P833, DOI 10.1097/00006454-200009000-00005
   Kerdpanich Angkool, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P488
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2008, J INFECT DIS, V197, P836, DOI 10.1086/528376
   Kimberlin DW, 2011, NEW ENGL J MED, V365, P1284, DOI 10.1056/NEJMoa1003509
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230
   Kopp SJ, 2014, PEDIATR RES, V76, P528, DOI 10.1038/pr.2014.135
   Kopp SJ, 2013, J VIROL, V87, P474, DOI 10.1128/JVI.01849-12
   Laughton B, 2012, AIDS, V26, P1685, DOI 10.1097/QAD.0b013e328355d0ce
   Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63
   Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075
   MATHUR A, 1985, INDIAN J MED RES, V81, P9
   MATTHEWS T, 1988, REV INFECT DIS, V10, pS490
   McLean HQ, 2013, MMWR RECOMM REP, V62, P1
   Melvin AJ, 2015, J PEDIATR-US, V166, P827, DOI 10.1016/j.jpeds.2014.11.011
   Mendelson E, 2006, REPROD TOXICOL, V21, P350, DOI 10.1016/j.reprotox.2006.02.001
   Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0
   Modlin JF, 2016, J PEDIAT INF DIS SOC, V5, P63, DOI 10.1093/jpids/piv030
   Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8
   Nassetta L, 2009, J ANTIMICROB CHEMOTH, V63, P862, DOI 10.1093/jac/dkp083
   Nathanson N, 2010, AM J EPIDEMIOL, V172, P1213, DOI 10.1093/aje/kwq320
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012
   OVERALL JC, 1970, J PEDIATR-US, V77, P315, DOI 10.1016/S0022-3476(70)80346-8
   Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342
   Paramesparan Y, 2010, JAIDS-J ACQ IMM DEF, V55, P134, DOI 10.1097/QAI.0b013e3181d90e8c
   PASS RF, 1980, PEDIATRICS, V66, P758
   Petito CK, 1999, J NEUROVIROL, V5, P670, DOI 10.3109/13550289909021295
   Pevear DC, 1999, ANTIMICROB AGENTS CH, V43, P2109, DOI 10.1128/AAC.43.9.2109
   PEVEAR DC, 1989, J VIROL, V63, P2002, DOI 10.1128/JVI.63.5.2002-2007.1989
   Pfeiffer HC, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21062
   Phongsamart W, 2008, PEDIATR INFECT DIS J, V27, P500, DOI 10.1097/INF.0b013e318167917a
   POLAND SD, 1994, J INFECT DIS, V170, P1267, DOI 10.1093/infdis/170.5.1267
   POLI L, 1991, B SOC PATHOL EXOT, V84, P513
   Puccini JM, 2014, LAB INVEST, V94, P161, DOI 10.1038/labinvest.2013.138
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Rotbart HA, 2001, CLIN INFECT DIS, V32, P228, DOI 10.1086/318452
   SCOTT TFM, 1964, BACTERIOL REV, V28, P458, DOI 10.1128/MMBR.28.4.458-471.1964
   Shah SS, 2010, PEDIATR INFECT DIS J, V29, P199, DOI 10.1097/INF.0b013e3181bbf2a0
   Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866
   Silberberg D, 2015, NATURE, V527, pS151, DOI 10.1038/nature16028
   Smith R, 2006, PEDIATRICS, V117, P851, DOI 10.1542/peds.2005-0804
   Smith R, 2012, PEDIATR INFECT DIS J, V31, P592, DOI 10.1097/INF.0b013e318253844b
   Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8
   Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008
   TRANG JM, 1993, CLIN PHARMACOL THER, V53, P15, DOI 10.1038/clpt.1993.4
   van den Pol AN, 2002, J VIROL, V76, P8842, DOI 10.1128/JVI.76.17.8842-8854.2002
   Van Rie A, 2009, JAIDS-J ACQ IMM DEF, V52, P636, DOI 10.1097/QAI.0b013e3181b32646
   Venturi G, 2009, SCAND J INFECT DIS, V41, P898, DOI 10.3109/00365540903225179
   Wassilak SGF, 2014, J INFECT DIS, V210, pS5, DOI 10.1093/infdis/jiu456
   WHITLEY R, 1991, NEW ENGL J MED, V324, P444, DOI 10.1056/NEJM199102143240703
   Whitley RJ, 1997, J INFECT DIS, V175, P1080, DOI 10.1086/516445
   WHITLEY RJ, 1983, PEDIATRICS, V72, P778
   WHITLEY RJ, 1980, PEDIATRICS, V66, P495
   WHITLEY RJ, 1984, J ANTIMICROB CHEMOTH, V14, P57, DOI 10.1093/jac/14.suppl_A.57
   Wilcox DR, 2016, MBIO, V7, DOI 10.1128/mBio.00437-16
   Wilcox DR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004580
   WILLIAMSON WD, 1990, AM J DIS CHILD, V144, P1365, DOI 10.1001/archpedi.1990.02150360091031
   WILLIAMSON WD, 1992, PEDIATRICS, V90, P862
   Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493
   Ygberg S, 2012, ACTA PAEDIATR, V101, P120, DOI 10.1111/j.1651-2227.2011.02494.x
   Zhang XW, 2013, J VIROL, V87, P12407, DOI 10.1128/JVI.02090-13
   Zhou XJ, 1996, ANTIMICROB AGENTS CH, V40, P2202, DOI 10.1128/AAC.40.9.2202
NR 100
TC 9
Z9 9
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD JAN
PY 2017
VL 81
IS 1
BP 162
EP 169
DI 10.1038/pr.2016.191
PN 2
PG 8
WC Pediatrics
SC Pediatrics
GA EH6TO
UT WOS:000391907000007
PM 27673425
DA 2020-07-08
ER

PT J
AU Jimenez, A
   Shaz, BH
   Bloch, EM
AF Jimenez, Alexandra
   Shaz, Beth H.
   Bloch, Evan M.
TI Zika Virus and the Blood Supply: What Do We Know?
SO TRANSFUSION MEDICINE REVIEWS
LA English
DT Review
DE Zika virus; Blood transfusion; Blood safety; Arbovirus; Communicable
   diseases; Emerging; Transfusion-transmitted virus
ID MALE SEXUAL TRANSMISSION; WEST-NILE-VIRUS; CHIKUNGUNYA VIRUS; DENGUE
   VIRUS; EMERGING PATHOGENS; UNITED-STATES; PUERTO-RICO; TRANSFUSION;
   INFECTION; EPIDEMIC
AB Zika virus (ZIKV), a mosquito-borne Flavivirus and emerging infectious disease, is the focus of an international public health emergency after its rapid spread through the Americas and the Caribbean. Although most ZIKV infections are subclinical or characterized by mild febrile illness, ZIKV has been implicated in severe complications, most notably microcephaly in babies born to incident infected mothers during pregnancy. As yet, the extent to which ZIKV is transfusion transmissible remains undefined. Nonetheless, a high prevalence of asymptomatic infection during outbreaks, the demonstration of ZIKV in blood donors, and 4 possible cases of transfusion-transmitted ZIKV in Brazil have raised concern for risk to the blood supply. Consequently, a proactive response is underway by blood collection agencies, regulatory bodies, national funding agencies, and industry alike. Mitigation strategies differ between endemic and nonendemic areas. In the continental United States, the American Association of Blood Banks and Food and Drug Administration guidelines recommend travel-based deferral for those returning from affected areas, and nucleic acid testing is being initiated under an investigational new drug application in Puerto Rico and selected areas of the United States. Options are less clear for countries where autochthonous vector-borne transmission is active. The burden of Zika falls in low-resource countries where high cost and technical barriers associated with testing and pathogen reduction pose barriers to implementation. Additional strategies include maintaining selective inventory for high-risk recipients (eg, pregnant women). We review the available data as of July 2016 on ZIKV in relation to the blood supply including risk, mitigation strategies, and barriers to implementation in addition to the research that is needed to address current uncertainty. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Jimenez, Alexandra; Shaz, Beth H.] New York Blood Ctr, New York, NY 10021 USA.
   [Shaz, Beth H.] Columbia Univ, Med Ctr, New York, NY USA.
   [Bloch, Evan M.] Johns Hopkins Univ, Baltimore, MD USA.
RP Bloch, EM (corresponding author), Johns Hopkins Univ, Sch Med, 600 N Wolfe St,Carnegie 446 D1, Baltimore, MD 21287 USA.
EM ebloch2@jhmi.edu
RI amsalu, ribka/G-8780-2019; Bloch, Evan/G-7676-2018
OI Bloch, Evan/0000-0001-8181-9517
CR AABB, 2016, AABB ASS B
   Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005
   [Anonymous], 2016, AABB ZIK VIR S BLOOD
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bloch EM, 2016, ANN INTERN MED
   Bloch EM, 2015, TRANSFUSION, V55, P1675, DOI 10.1111/trf.13040
   Boadle A, 2016, REUTERS
   Brasil P, 2016, N ENGL J MED
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Center for Disease Control and Prevention, 2014, DENG VIR EP TRANSMJ
   Center for Disease Control and Prevention, 2015, CHIK VIR TRANSM
   Centers for Disease Control and Prevention, 2016, MEM REV DIAGN ZIK CH
   Centers for Disease Control and Prevention, 2016, INF SPEC GROUPS VECT
   Centers for Disease Control and Prevention, 2015, EM PREP RESP CDC HLT
   Centers for Disease Control and Prevention, 2013, W NOL VIR US GUID SU
   Centers for Disease Control and Prevention, 2016, ZIK VIR PREGN WOM AN
   Centers for Disease Control and Prevention, 2016, ZIK VIR ZIK VIR DIS
   Centers for Disease Control and Prevention, 2016, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention, 2015, W NOL VIR TRANSM 201
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System, 2016, ZIK VIR DIS ZIK VIR
   Chen L. H., 2005, Dengue Bulletin, V29, P18
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira AM, 2004, TRANSFUSION, V44, P1695, DOI 10.1111/j.0041-1132.2004.04130.x
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2016, ZIK VIR INF ZIK OUTB
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Food and Drug Administration (FDA) Guidance for Industry, 2009, US NUCL AC TESTS RED
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Herriman R, 2015, OUTBREAK NEWS TODAY
   Jenkins C, 2016, 1 BABY ZIKA RELATED
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Kuehnert MJ, 2016, MMWR MORB MORTAL WKL, V65
   Kuklina EV, 2009, OBSTET GYNECOL, V113, P293, DOI 10.1097/AOG.0b013e3181954e5b
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2012, TRANSFUSION, V52, P1634, DOI 10.1111/j.1537-2995.2012.03747.x
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lustig Y, 2016, EURO SURVEILL, V21
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Matos D, 2016, TRANSFUSION, V56, P215, DOI 10.1111/trf.13288
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Oehler E, 2014, EURO SURVEILL, V19
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, CUM ZIK SUSP CONF CA
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, ZIK VIR INF ZIK FEV
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, NUMB REP CAS CHIK FE
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Petersen LR, 2010, TRANSFUS MED REV, V24, P15, DOI 10.1016/j.tmrv.2009.09.002
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reuters, 2016, REUTERS
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Snyder EL, 2015, NEW ENGL J MED, V373, P882, DOI 10.1056/NEJMc1507761
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan LK, 2013, ADV INFECT DIS, V3, P1
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tucker Carlson, 2016, FOX NEWS
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Whitcomb D, 2016, REUTERS
   WHO, 2016, ZIK SIT REP NEUR SYN
   World Health Organization (WHO), 2015, EM PREP RESP ZIK VIR
   World Health Organization (WHO), 2016, WHOZIKVHS61
   World Health Organization. WHO statement on the first meeting of the International Health Regulations, 2005, EM COMM ZIK VIR OBS
NR 118
TC 18
Z9 19
U1 0
U2 30
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0887-7963
EI 1532-9496
J9 TRANSFUS MED REV
JI Transf. Med. Rev.
PD JAN
PY 2017
VL 31
IS 1
BP 1
EP 10
DI 10.1016/j.tmrv.2016.08.001
PG 10
WC Hematology
SC Hematology
GA EI4JS
UT WOS:000392460500001
PM 27569055
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika remains "significant public health challenge"
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 5
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD JAN
PY 2017
VL 95
IS 1
BP 4
EP 4
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EH8RR
UT WOS:000392040500003
DA 2020-07-08
ER

PT J
AU Craig, AT
   Butler, MT
   Pastore, R
   Paterson, BJ
   Durrheim, DN
AF Craig, Adam T.
   Butler, Michelle T.
   Pastore, Roberta
   Paterson, Beverley J.
   Durrheim, David N.
TI Acute flaccid paralysis incidence and Zika virus surveillance, Pacific
   Islands
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; OUTBREAK
AB Problem The emergence of Zika virus has challenged outbreak surveillance systems in many at-risk, low-resource countries.. As the virus has been linked with Guillain Barre syndrome, routine data on the incidence of acute flaccid paralysis (AFP) may provide a useful early warning system for the emergence of Zika virus.
   Approach We documented all Zika virus outbreaks and cases in 21 Pacific Islands and territories for the years 2007 to 2015. We extracted data from the Global Polio Eradication Initiative database on the reported and expected annual incidence of AFP in children younger than 15 years. Using a Poisson probability test, we tested the significance of unexpected increases in AFP in years correlating with Zika virus emergence. Data were analysed separately for each Pacific Island country and territory.
   Local setting In most Pacific Island countries, early warning surveillance for acute public health threats such as Zika virus is hampered by poor health infrastructure, insufficient human resources and geographical isolation.
   Relevant changes Only one example was found (Solomon Islands in 2015) of a significant increase in reported AFP cases correlating with Zika virus emergence.
   Lessons learnt We found no conclusive evidence that routinely reported AFP incidence data in children were useful for detecting emergence of Zika virus in this setting. More evidence may be needed from adult populations, who are more likely to be affected by Guillain Barre syndrome. Reporting of AFP may be deficient in regions certified as polio-free.
C1 [Craig, Adam T.; Paterson, Beverley J.] Univ Newcastle, Sch Med & Publ Hlth, Univ Dr, Callaghan, NSW 2308, Australia.
   [Butler, Michelle T.; Durrheim, David N.] Hunter New England Hlth, Populat Hlth, Wallsend, Tyne & Wear, Australia.
   [Pastore, Roberta] WHO, Reg Off Western Pacific, Expanded Programme Immunizat, Manila, Philippines.
RP Craig, AT (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Univ Dr, Callaghan, NSW 2308, Australia.
EM adam@adamcraig.com.au
RI Paterson, Beverley/G-8248-2013
OI Paterson, Beverley/0000-0001-5108-103X
FU World Health OrganizationWorld Health Organization [001]
CR [Anonymous], 2016, HLTH TOP POL
   [Anonymous], 2015, SIT ACT NOUV CAL
   [Anonymous], 2016, POL NOW
   [Anonymous], 2016, DIS OUTBREAK NE 0422
   [Anonymous], 2016, WEEKL PAC SYNDR SURV
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Kandel N, 2016, B WORLD HEALTH ORGAN, V94, P705, DOI 10.2471/BLT.16.171504
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10
   Pacific Public Health Surveillance Network, 2016, PACNET
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
NR 14
TC 10
Z9 10
U1 0
U2 10
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD JAN
PY 2017
VL 95
IS 1
BP 69
EP 75
DI 10.2471/BLT.16.171892
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EH8RR
UT WOS:000392040500016
PM 28053366
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Targeting Zika Virus Infection Through Drug Repurposing Screen
SO CLINICAL PHARMACOLOGY & THERAPEUTICS
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9236
EI 1532-6535
J9 CLIN PHARMACOL THER
JI Clin. Pharmacol. Ther.
PD JAN
PY 2017
VL 101
IS 1
BP 13
EP 13
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EH7BI
UT WOS:000391927400003
DA 2020-07-08
ER

PT J
AU Adlam, F
AF Adlam, Frances
TI Welcome to Volume 12 of the journal Future Virology
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE chikungunya; ebolavirus; filovirus; HPV; influenza; virology; Zika virus
AB "Future Virology's most read article of 2016 was an Editorial entitled 'Zika virus: an emerging arboviral disease' by authors Neelima Arora, Mangamoori Lakshmi Narasu and Amit K Banerjee..."
C1 [Adlam, Frances] FutureSci Grp, Unitec House,2 Albert Pl, London N3 1QB, England.
RP Adlam, F (corresponding author), FutureSci Grp, Unitec House,2 Albert Pl, London N3 1QB, England.
EM f.adlam@futuremedicine.com
CR Arora N, 2016, FUTURE VIROL, V11, P395, DOI 10.2217/fvl-2016-0048
   Jang YH, 2016, FUTURE VIROL, V11, P313, DOI 10.2217/fvl-2016-0022
   Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56
   Muhlberger E, 2007, FUTURE VIROL, V2, P205, DOI 10.2217/17460794.2.2.205
   Nakahara T, 2016, FUTURE VIROL, V11, P141, DOI 10.2217/fvl.16.2
   Roosenhoff R, 2016, FUTURE VIROL, V11, P61, DOI 10.2217/fvl.15.107
   Wang J, 2016, FUTURE VIROL, V11, P1, DOI 10.2217/fvl.15.95
NR 7
TC 0
Z9 0
U1 0
U2 3
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JAN
PY 2017
VL 12
IS 1
BP 1
EP 3
DI 10.2217/fvl-2016-0104
PG 3
WC Virology
SC Virology
GA EH7NS
UT WOS:000391960300001
OA Bronze
DA 2020-07-08
ER

PT J
AU Ngai, M
   McDowell, MA
AF Ngai, Michelle
   McDowell, Mary Ann
TI The search for novel insecticide targets in the post-genomics era, with
   a specific focus on G-protein coupled receptors
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Review
DE genomics; insecticides; G-protein-coupled receptors
ID AEDES-AEGYPTI; MOSQUITO; RESISTANCE; OCTOPAMINE; TRANSCRIPTOME; GENES
AB Insects are considered pests globally, implicated in the destruction of agricultural fields and transmission of pathogens that cause deadly human diseases, such as dengue, Zika and malaria. The diversity of the insecticide arsenal has remained stagnant for decades, but the recent rise of insecticide resistance fueled the discovery of novel modes of action, and the power of genomics has reinvigorated this search. This review discusses the importance of comparative and functional insect genomics in the identification of potential gene targets for an insecticidal mode of action with low off-target toxicity. Due to the global participation in the sequencing and annotation of insect genomes, the targeting of specific genes with molecular tools like RNAi and CRISPR/Cas9 for genome engineering and consequent functional identification and validation has become more efficient. While there are multiple avenues to explore for insecticidal candidates, this review identifies G-protein coupled receptors as attractive targets, and hones in on the octopamine and dopamine receptors due to their potential.
C1 [Ngai, Michelle; McDowell, Mary Ann] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
RP McDowell, MA (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
EM mcdowell.11@nd.edu
FU Telemedicine and Advanced Technology Research Center, United States
   Department of Defense [W81XWH-11-1-0415]
FX Telemedicine and Advanced Technology Research Center, United States
   Department of Defense (#W81XWH-11-1-0415).
CR Allemza P., 2007, INSECTICIDES DESIGN, P67
   Andersen JP, 2006, J INSECT PHYSIOL, V52, P1163, DOI 10.1016/j.jinsphys.2006.08.004
   Conley JM, 2015, J PHARMACOL EXP THER, V352, P53, DOI 10.1124/jpet.114.219717
   Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001
   Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x
   Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90
   Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231
   GRANT DF, 1991, INSECT BIOCHEM, V21, P421, DOI 10.1016/0020-1790(91)90009-4
   Gross AD, 2014, ACS SYM SER, V1172, P45
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Huang YP, 2016, INSECT BIOCHEM MOLEC, V75, P98, DOI 10.1016/j.ibmb.2016.06.004
   Itokawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24652
   Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56
   Kastner KW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-434
   Mansmann U, 2005, METHOD INFORM MED, V44, P454
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Nowling RJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-150
   Pang YP, 2012, CURR DRUG TARGETS, V13, P471, DOI 10.2174/138945012799499703
   Prapanthadara La-Aied, 1993, Biochemical Society Transactions, V21, p304S
   Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x
   Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781
   Regna K, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0115-z
   ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x
   Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Van Hiel MB, 2010, ADV EXP MED BIOL, V692, P211
   Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018
   Vleugels R., 2015, NEUROTRANSMITTER, V2, P1
   Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957
   Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   Zhang X, 2015, JOVE-J VIS EXP, DOI 10.3791/52523
   Zimmer CT, 2014, INSECT MOL BIOL, V23, P511, DOI 10.1111/imb.12099
NR 36
TC 7
Z9 7
U1 0
U2 22
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JAN
PY 2017
VL 112
IS 1
BP 1
EP 7
DI 10.1590/0074-02760160345
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EH6EZ
UT WOS:000391866900001
PM 28076467
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baez, CF
   Barel, VA
   de Souza, AMT
   Rodrigues, CR
   Varella, RB
   Cirauqui, N
AF Baez, C. F.
   Barel, V. A.
   de Souza, A. M. T.
   Rodrigues, C. R.
   Varella, R. B.
   Cirauqui, N.
TI Analysis of worldwide sequence mutations in Zika virus proteins E, NS1,
   NS3 and NS5 from a structural point of view
SO MOLECULAR BIOSYSTEMS
LA English
DT Article
ID EVOLUTIONARY ANALYSIS; NS2B-NS3 PROTEASE; LINKER REGION; FLEXIBILITY;
   DISCOVERY; INFECTION; BIOLOGY; REVEAL; DOMAIN
AB Zika virus (ZIKV) is an emergent arbovirus that has attracted attention in the last year as a possible causative agent of congenital malformation; it shows a remarkably increased microcephaly risk during otherwise healthy pregnancies. We present here an analysis of all ZIKV sequences available in Genbank up to April 2016, studying the mutations in the whole polyprotein and their possible structural implications for the proteins E, NS1, NS3 and NS5. This study suggests that microcephaly is not a consequence of any particular amino acid substitution but, conceivably, is a feature of ZIKV itself. Moreover, the structural analysis of ZIKV proteins, together with the mutational landscape of ZIKV and a structure-sequence comparison with other flaviviruses, allows the suggestion of regions that could be exploited as anti-ZIKV targets, including some allosteric sites found in the NS3 and NS5 proteins of DENV.
C1 [Baez, C. F.] Rio de Janeiro Fed Univ Hosp, Dept Prevent Med, Rio De Janeiro, RJ, Brazil.
   [Barel, V. A.; de Souza, A. M. T.; Rodrigues, C. R.; Cirauqui, N.] Univ Fed Rio de Janeiro, Fac Pharmaceut Sci, ModMolQSAR Lab, Rio De Janeiro, RJ, Brazil.
   [Varella, R. B.] Univ Fed Fluminense, Inst Biomed, Dept Microbiol & Parasitol, BR-24220000 Niteroi, RJ, Brazil.
RP Cirauqui, N (corresponding author), Univ Fed Rio de Janeiro, Fac Pharmaceut Sci, ModMolQSAR Lab, Rio De Janeiro, RJ, Brazil.
EM cirauquipharma@gmail.com
RI Rodrigues, Carlos Rangel/Q-2316-2019; Souza, Alessandra M.
   T./R-5628-2016; Diaz, Nuria Cirauqui/AAK-9574-2020; Varella,
   Rafael/Y-1194-2019
OI Rodrigues, Carlos Rangel/0000-0001-8453-7654; Souza, Alessandra M.
   T./0000-0001-9986-405X; Diaz, Nuria Cirauqui/0000-0003-4752-9916;
   Varella, Rafael/0000-0002-1698-5989
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso KM, 2015, J MED VIROL, V87, P1418, DOI 10.1002/jmv.24192
   Chambers TJ, 2005, J GEN VIROL, V86, P1403, DOI 10.1099/vir.0.80427-0
   Ciccozzi M, 2010, ARCH VIROL, V155, P1433, DOI 10.1007/s00705-010-0725-x
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gentles RG, 2014, J MED CHEM, V57, P1855, DOI 10.1021/jm4016894
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Jadav SS, 2015, BIOORG MED CHEM LETT, V25, P1747, DOI 10.1016/j.bmcl.2015.02.059
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Klema V. J., CRYSTAL STRUCTURE FU, DOI [10.2210/pdb5ccv/pdb, DOI 10.2210/PDB5CCV/PDB]
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Schmidt AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002627
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Ul Qamar MT, 2014, BIOINFORMATION, V10, P460, DOI 10.6026/97320630010460
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 55
TC 2
Z9 3
U1 0
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
EI 1742-2051
J9 MOL BIOSYST
JI Mol. Biosyst.
PD JAN 1
PY 2017
VL 13
IS 1
BP 122
EP 131
DI 10.1039/c6mb00645k
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EH3UM
UT WOS:000391697500010
PM 27805221
DA 2020-07-08
ER

PT J
AU Wikan, N
   Smith, DR
AF Wikan, Nitwara
   Smith, Duncan R.
TI Zika virus from a Southeast Asian perspective
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Review
DE Aedes; Flavivirus; Transmission; Urban; Sylvatic
ID CROSS-REACTIVITY; INFECTION; INDONESIA; FEVER; SPECIFICITY; PHILIPPINES;
   DENGUE
AB Phylogcnic evidence suggests that the strain of Zika virus causing an unprecedented outbreak of disease in the Americas had its origin in Southeast Asia, where reports of isolated cases of Zika virus infection have occurred since 2010. Why there has been no large outbreak of Zika infection in Southeast Asia remains unclear and whether such an outbreak will occur in the future is a question of significant concern. This review looks at Zika virus from a Southeast Asian perspective and highlights some of the possible scenarios with regards to Zika virus in this part of the world as well as highlighting some of the research questions that need to be urgently addressed.
C1 [Wikan, Nitwara; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya, Thailand.
   [Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Mol Pathol Lab, Salaya Campus,25-25 Phuttamonthon Sai 4, Salaya 73170, Nakhon Pathom, Thailand.
EM duncan_r_smith@hotmail.com
RI Smith, Duncan R/C-6891-2011
OI Smith, Duncan R/0000-0002-6592-9852
FU Thailand Research FundThailand Research Fund (TRF) [MRG5980168,
   RAP59K0006]; Mahidol University [IRG5780009, RTA5780009]; Office of the
   Higher Education Commission; Mahidol University under National Research
   Universities Initiative; National Science and Technology Development
   Agency [FDA-CO-2559-1569-TH, P-16-50685]
FX Duncan R. Smith is supported by Mahidol University, The Thailand
   Research Fund and Mahidol University (IRG5780009 and RTA5780009), the
   Office of the Higher Education Commission and Mahidol University under
   the National Research Universities Initiative and by the National
   Science and Technology Development Agency (FDA-CO-2559-1569-TH and
   P-16-50685). Nitwara Wikan is supported by The Thailand Research Fund
   (RAP59K0006) and the Office of the Higher Education Commission and the
   Thailand Research Fund (MRG5980168).
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Apiwathnasorn C., 1986, LIST MOSQUITO SPECIE
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Fajardo A, 2016, J MED VIROL, V88, P1672, DOI 10.1002/jmv.24596
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fuentes A, 2011, MONKEYS EDGE ECOLOGY
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462
   Hotez PJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003575
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Khamim K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003396
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 44
TC 14
Z9 14
U1 0
U2 10
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JAN
PY 2017
VL 10
IS 1
BP 1
EP 5
DI 10.1016/j.apjtm.2016.11.013
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EG9XZ
UT WOS:000391416300001
PM 28107856
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Goodnough, LT
   Marques, MB
AF Goodnough, Lawrence T.
   Marques, Marisa B.
TI Zika Virus and Patient Blood Management
SO ANESTHESIA AND ANALGESIA
LA English
DT Article
ID ACUTE NORMOVOLEMIC HEMODILUTION; UPDATE INTERIM GUIDANCE; CLINICAL
   DECISION-SUPPORT; UNITED-STATES; PREOPERATIVE ANEMIA; TRANSFUSION
   REQUIREMENTS; RESTRICTIVE TRANSFUSION; FRENCH-POLYNESIA;
   CARDIAC-SURGERY; TRANSMISSION
AB Sporadic Zika virus infections had only occurred in Africa and Asia until an outbreak in Micronesia (Oceania) in 2007. In 2013 to 2014, several outer Pacific Islands reported local outbreaks. Soon thereafter, the virus was likely introduced in Brazil from competing athletes from French Polynesia and other countries that participated in a competition there. Transmission is thought to have occurred through mosquito bites and spread to the immunologically naive population. Being also a flavivirus, the Zika virus is transmitted by the Aedes mosquito that is endemic in South and Central America that is also the vector of West Nile virus, dengue, and chikungunya. In less than a year, physicians in Brazil reported a many-fold increase in the number of babies born with microcephaly. Despite initial skepticism regarding the causal association of the Zika virus epidemic and birth defects, extensive basic and clinical research evidence has now confirmed this relationship. In the United States, more than 4000 travel-associated infections have been reported by the middle of 2016 to the Centers for Disease Control and Prevention. Furthermore, many local mosquito-borne infections have occurred in Puerto Rico and Florida. Considering that the virus causes a viremia in which 80% of infected individuals have no symptoms, the potential for transfusion transmission from an asymptomatic blood donor is high if utilizing donor screening alone without testing. Platelet units have been shown to infect 2 patients via transfusion in Brazil. Although there was an Investigational nucleic acid test available for testing donors, not all blood centers were initially required to participate. Subsequently, the US Food and Drug Administration issued a guidance in August 2016 that recommended universal nucleic acid testing for the Zika virus on blood donors.
   In this report, we review the potentially devastating effects of Zika virus infection during pregnancy and its implication in cases of Guillain Barre syndrome in adults. Furthermore, we urge hospital-based clinicians and transfusion medicine specialists to implement perisurgical patient blood management strategies to avoid blood component transfusions with their potential risks of emerging pathogens, illustrated here by the Zika virus. Ultimately, this current global threat, as described by the World Health Organization, will inevitably be followed by future outbreaks of other bloodborne pathogens; the principles and practices of perioperative patient blood management will reduce the risks from not only known, but also unknown risks of blood transfusion for our patients.
C1 [Goodnough, Lawrence T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.
   [Goodnough, Lawrence T.] Stanford Univ, Dept Med, Stanford, CA 94305 USA.
   [Marques, Marisa B.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.
RP Goodnough, LT (corresponding author), Stanford Univ, 300 Pasteur Dr,Room H-1402, Stanford, CA 94305 USA.
EM ltgoodno@stanford.edu
OI Marques, Marisa/0000-0002-6689-7856
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   [Anonymous], AABB HEM
   [Anonymous], CAS COUNTS US
   [Anonymous], 2016, PREGNANT WOMEN ANY L
   Barile L, 2016, ANESTH ANALG
   Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3
   Bennett-Guerrero E, 2010, JAMA-J AM MED ASSOC, V304, P1568, DOI 10.1001/jama.2010.1406
   Brasil P., 2016, LANCET INFECT DIS
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Bulger J, 2013, J HOSP MED, V8, P486, DOI 10.1002/jhm.2063
   Campos GC, 2016, BRAZ J INFECT DIS, V20, P227, DOI 10.1016/j.bjid.2016.05.001
   Carson JL, 2013, JAMA INTERN MED, V173, P139, DOI 10.1001/jamainternmed.2013.2855
   Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452
   Carson JL, 2016, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2016.9185, DOI 10.1001/JAMA.2016.9185.]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Despotis GJ, 1997, CLIN CHEM, V43, P1684
   Dos Santos T, 2016, NEW ENGL J MED, DOI [10.1056/NEJMc1609015, DOI 10.1056/NEJMC1609015.]
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gorlinger K, 2011, ANESTHESIOLOGY, V115, P1179, DOI 10.1097/ALN.0b013e31823497dd
   Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361
   Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9
   Goodnough LT, 2013, LANCET, V381, P1791, DOI 10.1016/S0140-6736(13)60673-X
   Goodnough LT, 2016, TRANSFUSION, V56, P2406, DOI 10.1111/trf.13767
   Goodnough LT, 2015, AM J HEMATOL, V90, P927, DOI 10.1002/ajh.24101
   Goodnough LT, 2013, ANESTH ANALG, V116, P15, DOI 10.1213/ANE.0b013e318273f4ae
   Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3
   Goodnough LT, 2011, BLOOD, V117, P6091, DOI 10.1182/blood-2010-11-316075
   Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260
   Goodnough LT, 1999, NEW ENGL J MED, V340, P525, DOI 10.1056/NEJM199902183400706
   Goodnough LT, 2005, ANESTH ANALG, V101, P1858, DOI 10.1213/01.ANE.0000184124.29397.EB
   Goodnough LT, 1996, J VASC SURG, V24, P213, DOI 10.1016/S0741-5214(96)70096-4
   GOODNOUGH LT, 1990, AM J SURG, V159, P602, DOI 10.1016/S0002-9610(06)80079-6
   GOODNOUGH LT, 1992, TRANSFUSION, V32, P648, DOI 10.1046/j.1537-2995.1992.32792391039.x
   GOODNOUGH LT, 1991, JAMA-J AM MED ASSOC, V265, P86, DOI 10.1001/jama.265.1.86
   GOODNOUGH LT, 1990, J LAB CLIN MED, V115, P28
   GOODNOUGH LT, 1994, ANESTH ANALG, V78, P932
   Guinn NR, 2016, TRANSFUSION, V56, P297, DOI 10.1111/trf.13426
   Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446
   Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601
   Holst LB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1354
   Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617
   Jimenez A., 2016, TRANSFUS MED REV
   Kelley T, 2016, ENVIRON HEALTH INSIG, V10, P173, DOI 10.4137/EHI.S40953
   Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054
   Koch CG, 2015, ANN THORAC SURG, V99, P779, DOI 10.1016/j.athoracsur.2014.09.062
   Kozek-Langenecker S, 2011, CRIT CARE, V15, DOI 10.1186/cc10488
   Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Monk TG, 1997, ANESTH ANALG, V85, P953, DOI 10.1097/00000539-199711000-00001
   Monk TG, 1999, ANESTHESIOLOGY, V91, P24, DOI 10.1097/00000542-199907000-00008
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   New York Times, 2016, NY TIMES
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Parra B, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1605564, DOI 10.1056/NEJMOA1605564.]
   Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X
   Rosencher N, 2003, TRANSFUSION, V43, P459, DOI 10.1046/j.1537-2995.2003.00348.x
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Saenz C, 2016, LANCET GLOB HEALTH, V4, pE686, DOI 10.1016/S2214-109X(16)30222-4
   Salisbury AC, 2011, ARCH INTERN MED, V171, P1646, DOI 10.1001/archinternmed.2011.361
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Segal JB, 2004, TRANSFUSION, V44, P632, DOI 10.1111/j.1537-2995.2004.03353.x
   Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991
   Soares de Souza A, 2016, CLIN INFECT DIS, DOI [10.1093/cid/ciw613, DOI 10.1093/CID/CIW613.]
   Spahn DR, 2013, LANCET, V381, P1855, DOI 10.1016/S0140-6736(13)60808-9
   Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801
   Virmani S, 2010, ANN CARD ANAESTH, V13, P34, DOI 10.4103/0971-9784.58832
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Wang GY, 2009, ANESTH ANALG, V109, P320, DOI 10.1213/ane.0b013e3181aa084c
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   ZUCK TF, 1990, ARCH PATHOL LAB MED, V114, P309
NR 86
TC 7
Z9 7
U1 0
U2 20
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD JAN
PY 2017
VL 124
IS 1
BP 282
EP 289
DI 10.1213/ANE.0000000000001770
PG 8
WC Anesthesiology
SC Anesthesiology
GA EF8WW
UT WOS:000390613500032
PM 27902502
DA 2020-07-08
ER

PT J
AU Li, R
   Simmons, KB
   Bertolli, J
   Rivera-Garcia, B
   Cox, S
   Romero, L
   Koonin, LM
   Valencia-Prado, M
   Bracero, N
   Jamieson, DJ
   Barfield, W
   Moore, CA
   Mai, CT
   Korhonen, LC
   Frey, MT
   Perez-Padilla, J
   Torres-Munoz, R
   Grosse, SD
AF Li, Rui
   Simmons, Katharine B.
   Bertolli, Jeanne
   Rivera-Garcia, Brenda
   Cox, Shanna
   Romero, Lisa
   Koonin, Lisa M.
   Valencia-Prado, Miguel
   Bracero, Nabal
   Jamieson, Denise J.
   Barfield, Wanda
   Moore, Cynthia A.
   Mai, Cara T.
   Korhonen, Lauren C.
   Frey, Meghan T.
   Perez-Padilla, Janice
   Torres-Munoz, Ricardo
   Grosse, Scott D.
TI Cost-effectiveness of Increasing Access to Contraception during the Zika
   Virus Outbreak, Puerto Rico, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UPDATE INTERIM GUIDELINES; UNITED-STATES; UNINTENDED PREGNANCY; CARE;
   WOMEN; PREVENTION; WORLDWIDE; INFECTION; DECLINES; SAVINGS
AB We modeled the potential cost-effectiveness of increasing access to contraception in Puerto Rico during a Zika virus outbreak. The intervention is projected to cost an additional $33.5 million in family planning services and is likely to be. cost-saving for the healthcare system overall. It could reduce Zika virus related costs by $65.2 million ($2.8 million from less Zika virus testing and monitoring and $62.3 million from avoided costs of Zika virus associated microcephaly [ZAM]). The estimates are influenced by the contraception methods used, the frequency of ZAM, and the lifetime incremental cost of ZAM. Accounting for unwanted pregnancies that are prevented, irrespective of Zika virus infection, an additional $40.4 million in medical costs would be avoided through the intervention. Increasing contraceptive access for women who want to delay or avoid pregnancy in Puerto Rico during a Zika virus outbreak can substantially reduce the number of cases of ZAM and healthcare costs.
C1 [Li, Rui; Simmons, Katharine B.; Bertolli, Jeanne; Cox, Shanna; Romero, Lisa; Koonin, Lisa M.; Jamieson, Denise J.; Barfield, Wanda; Moore, Cynthia A.; Mai, Cara T.; Korhonen, Lauren C.; Frey, Meghan T.; Perez-Padilla, Janice; Grosse, Scott D.] Ctr Dis Control & Prevent, 4770 Buford Hwy NE,Mailstop F-74, Atlanta, GA 30341 USA.
   [Rivera-Garcia, Brenda; Valencia-Prado, Miguel; Torres-Munoz, Ricardo] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Bracero, Nabal] Univ Puerto Rico & Puerto Rico, Sect Amer Coll Obstet & Gynecol, San Juan, PR USA.
RP Li, R (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Hwy NE,Mailstop F-74, Atlanta, GA 30341 USA.
EM ruili@cdc.gov
OI Grosse, Scott/0000-0003-1078-6855; Jamieson, Denise/0000-0003-2597-1201
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Arroyo MP, CONTRACEPTIVE ACCESS
   Bensyl Diana M., 2005, Morbidity and Mortality Weekly Report, V54, P1
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Biggio JR, 2004, AM J OBSTET GYNECOL, V190, P721, DOI 10.1016/j.ajog.2003.09.028
   Bishaw A, POVERTY 2012 2013
   Broyles RS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.3.e8
   Bureau of Economic Analysis. U.S. Department of Commerce, TABL 2 5 4 PRIC IND
   Bureau of Labor Statistics, MAY 2015 STAT OCC EM
   Burlone S, 2013, CONTRACEPTION, V87, P143, DOI 10.1016/j.contraception.2012.06.009
   Center for Work Force Studies, 2015, 2015 STAT PHYS WORKF
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US
   Centers for Disease Control and Prevention, 2016, OUTC PREGN LAB EV PO
   Cragan JD, 2009, BIRTH DEFECTS RES A, V85, P20, DOI 10.1002/bdra.20508
   Ellington SR, 2016, JAMA PEDIAT
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fowler C, 2015, TITLE X FAMILY PLANN
   Frost JJ, 2014, MILBANK Q, V92, P696, DOI 10.1111/1468-0009.12080
   Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165
   Grosse SD, 2008, AM J PREV MED, V35, P572, DOI 10.1016/j.amepre.2008.07.008
   Martin Joyce A, 2003, Natl Vital Stat Rep, V52, P1
   Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McGann PT, 2015, J PEDIATR-US, V167, P1314, DOI 10.1016/j.jpeds.2015.08.068
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Portela M, 2015, MILBANK Q, V93, P584, DOI 10.1111/1468-0009.12138
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Riehman KS, 1998, FAM PLANN PERSPECT, V30, P212, DOI 10.2307/2991606
   Santelli JS, 2007, AM J PUBLIC HEALTH, V97, P150, DOI 10.2105/AJPH.2006.089169
   Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017
   Sedgh G, 2011, INT PERSPECT SEX R H, V37, P84, DOI 10.1363/3708411
   Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Trussell J, 2008, EUR J CONTRACEP REPR, V13, P219, DOI 10.1080/13625180802359263
   Trussell J, 2015, CONTRACEPTION, V91, P49, DOI 10.1016/j.contraception.2014.08.011
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
   Trussell J, 2009, CONTRACEPTION, V79, P5, DOI 10.1016/j.contraception.2008.08.003
   Truven Health Analytics, COST HAV BAB US
NR 40
TC 23
Z9 23
U1 0
U2 13
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2017
VL 23
IS 1
BP 74
EP 82
DI 10.3201/eid2301.161322
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EG2AV
UT WOS:000390836400010
PM 27805547
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dirlikov, E
   Kniss, K
   Major, C
   Thomas, D
   Virgen, CA
   Mayshack, M
   Asher, J
   Mier-y-Teran-Romero, L
   Salinas, JL
   Pastula, DM
   Sharp, TM
   Sejvar, J
   Johansson, MA
   Rivera-Garcia, B
AF Dirlikov, Emilio
   Kniss, Krista
   Major, Chelsea
   Thomas, Dana
   Virgen, Cesar A.
   Mayshack, Marrielle
   Asher, Jason
   Mier-y-Teran-Romero, Luis
   Salinas, Jorge L.
   Pastula, Daniel M.
   Sharp, Tyler M.
   Sejvar, James
   Johansson, Michael A.
   Rivera-Garcia, Brenda
TI Guillain-Barre Syndrome and Healthcare Needs during Zika Virus
   Transmission, Puerto Rico, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID OUTBREAK; STATES
AB To assist with public health preparedness activities, we estimated the number of expected cases of Zika virus in Puerto Rico and associated healthcare needs. Estimated annual incidence is 3.2-5.1 times the baseline, and long-term care needs are predicted to be 3-5 times greater than in years with no Zika virus.
C1 [Dirlikov, Emilio; Kniss, Krista; Major, Chelsea; Thomas, Dana; Mayshack, Marrielle; Mier-y-Teran-Romero, Luis; Salinas, Jorge L.; Pastula, Daniel M.; Sharp, Tyler M.; Sejvar, James; Johansson, Michael A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Dirlikov, Emilio; Thomas, Dana; Mayshack, Marrielle; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Virgen, Cesar A.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Asher, Jason] Biomed Adv Res & Dev Author, Washington, DC USA.
   [Pastula, Daniel M.] Univ Colorado, Denver, CO 80202 USA.
RP Dirlikov, E (corresponding author), Dept Salud Oficina Epidemiol & Invest, POB 70184, San Juan, PR 00936 USA.
EM GBS@salud.pr.gov
RI Pastula, Daniel M./M-1325-2019
OI Pastula, Daniel M./0000-0001-9342-4459; Dirlikov,
   Emilio/0000-0003-4631-2643; Johansson, Michael/0000-0002-5090-7722
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [T32 GM007198]
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1
   HUND EF, 1993, CRIT CARE MED, V21, P433, DOI 10.1097/00003246-199303000-00023
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   US Census Bureau, PUERT RIC COMM TOT V
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 15
TC 13
Z9 13
U1 0
U2 20
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2017
VL 23
IS 1
BP 134
EP 136
DI 10.3201/eid2301.161290
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EG2AV
UT WOS:000390836400025
PM 27779466
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Whittemore, K
   Tate, A
   Illescas, A
   Saffa, A
   Collins, A
   Varma, JK
   Vora, NM
AF Whittemore, Kate
   Tate, Anna
   Illescas, Alex
   Saffa, Alhaji
   Collins, Austin
   Varma, Jay K.
   Vora, Neil M.
TI Zika Virus Knowledge among Pregnant Women Who Were in Areas with Active
   Transmission
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB We surveyed women in New York, New York, USA, who were in areas with active Zika virus transmission while pregnant. Of 99 women who were US residents, 30 were unaware of the government travel advisory to areas with active Zika virus transmission while pregnant, and 37 were unaware of their pregnancies during travel.
C1 [Whittemore, Kate; Tate, Anna; Illescas, Alex; Saffa, Alhaji; Collins, Austin; Varma, Jay K.; Vora, Neil M.] New York City Dept Hlth & Mental Hyg, New York, NY USA.
   [Varma, Jay K.; Vora, Neil M.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Vora, NM (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St, Long Isl City, NY 11101 USA.
EM nvora@cdc.gov
CR Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, WOM REPR AG
   Centers for Disease Control and Prevention, WOM TRYING BEC PREGN
   Centers for Disease Control and Prevention, ZIK TRAV INF
   Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3
   New York City Department of Health and Mental Hygiene, ZIK VIR
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 8
TC 22
Z9 22
U1 0
U2 11
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2017
VL 23
IS 1
BP 164
EP 166
DI 10.3201/eid2301.161614
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EG2AV
UT WOS:000390836400038
PM 27855041
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stamm, LV
   Noda, AA
AF Stamm, Lola V.
   Noda, Angel A.
TI Elimination of Mother-To-Child Transmission of Syphilis in the
   Americas-A Goal That Must Not Slip Away
SO SEXUALLY TRANSMITTED DISEASES
LA English
DT Editorial Material
ID ZIKA VIRUS
C1 [Stamm, Lola V.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   [Noda, Angel A.] Trop Med Inst Pedro Kouri, Km 6 1-2, Havana, Cuba.
RP Noda, AA (corresponding author), Trop Med Inst Pedro Kouri, Km 6 1-2, Havana, Cuba.
EM angelnoda25@gmail.com
OI Noda, Angel/0000-0001-9849-7091
CR Braccio S, 2016, CURR OPIN INFECT DIS, V29, P268, DOI 10.1097/QCO.0000000000000270
   Bristow CC, 2016, SEX TRANSM DIS, V43, P57, DOI 10.1097/OLQ.0000000000000387
   Centers for Disease Control and Prevention, SYPH 2014 STD SURV
   Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
   Jeffries WL, 2014, AM J PREV MED, V47, P320, DOI 10.1016/j.amepre.2014.05.002
   Kamb ML, 2015, DST J BRAS DOENCAS S, V27, P3
   Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396
   Pan American Health Organization, 2010, STRAT PLAN ACT EL MO
   Pan American Health Organization, 2015, EL MOTH CHILD TRANSM
   Shaw SY, 2016, INT J STD AIDS
   Stamm LV, 2016, JAMA DERMATOL, V152, P621, DOI 10.1001/jamadermatol.2016.1499
   Taylor MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159483
   WHO, 2014, REP GLOB SEX TRANSM
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   World Health Organization, 2007, GLOB EL CONG SYPH RA
   World Health Organization, 2016, WHO VAL COUNTR EL MO
NR 16
TC 0
Z9 0
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0148-5717
EI 1537-4521
J9 SEX TRANSM DIS
JI Sex. Transm. Dis.
PD JAN
PY 2017
VL 44
IS 1
BP 12
EP 13
DI 10.1097/OLQ.0000000000000538
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA EG0BB
UT WOS:000390694600003
DA 2020-07-08
ER

PT J
AU Pavela, R
   Maggi, F
   Kamte, SLN
   Rakotosaona, R
   Rasoanaivo, P
   Nicoletti, M
   Canale, A
   Benelli, G
AF Pavela, R.
   Maggi, F.
   Kamte, S. L. Ngahang
   Rakotosaona, R.
   Rasoanaivo, P.
   Nicoletti, M.
   Canale, A.
   Benelli, G.
TI Chemical composition of Cinnamosma madagascariensis (Cannelaceae)
   essential oil and its larvicidal potential against the filariasis vector
   Culex quinquefasciatus Say
SO SOUTH AFRICAN JOURNAL OF BOTANY
LA English
DT Article
DE Ethnobotanical knowledge; Culicidae; Eco-friendly insecticides;
   Mosquito-borne diseases; Vector control
ID ENCEPHALITIS MOSQUITO VECTORS; VITRO BIOLOGICAL-ACTIVITIES; ECO-FRIENDLY
   LARVICIDES; VETERINARY IMPORTANCE; ZIKA VIRUS; MALARIA; NANOPARTICLES;
   INSECTICIDE; DENGUE; PLANTS
AB Madagascar flora is diverse and unique. Cinnamosma madagascariensis is an endemic species widely present in the forests of Madagascar. This plant has important traditional uses ranging from management of dementia, epilepsy, headache to malaria. Few data have been reported about the chemical composition of the essential oil, and no studies have been published on its bioactivity against mosquitoes. Here, we focus on the chemical composition of essential oils extracted from C. madagascariensis stem bark and leaves, and their larvicidal potential against the filariasis vector Culex quinquefasciatus. GC-MS analysis revealed differences between the chemical volatile profiles of leaves and bark oils. In the former, linalool (30.1%), limonene (12.0%), myrcene (8.9%) and alpha-pinene (8.4%) were the major constituents, while in the latter beta-pinene (33.3%), alpha-pinene (19.3%) and limonene (12.0%) were the most representative compounds. Acute toxicity experiments conducted on larvae of the filariasis vector C. quinquefasciatus led to LC50 of 61.6 mu L L-1 and 80.1 mu L L-1 for the bark and the leaf essential oils, respectively. Overall, the chance to use compounds from the C. madagascariensis bark and leaf essential oils against filariasis vectors seems promising, since they are effective at moderate doses and could be an advantageous alternative to build newer and safer mosquito control tools. To the best of our knowledge, this is the first report about the chemical composition of C. madagascariensis essential oils. (C) 2016 SAAB. Published by Elsevier B.V. All rights reserved.
C1 [Pavela, R.] Crop Res Inst, Drnovska 507, Prague 16106 6, Czech Republic.
   [Maggi, F.; Kamte, S. L. Ngahang] Univ Camerino, Sch Pharm, Camerino, Italy.
   [Rakotosaona, R.; Rasoanaivo, P.] Rakoto Ratsimamanga Fdn, Malagasy Inst Appl Res, Lot AVB 77, Antananarivo, Madagascar.
   [Nicoletti, M.] Sapienza Univ, Dept Environm Biol, Rome, Italy.
   [Canale, A.; Benelli, G.] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
RI Pavela, Roman/Q-8647-2016; Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010; Pavela, Roman/0000-0001-7866-4278
FU PROAPI (PRAF) "Valutazione della qualita organolettica del polline d'api
   fresco sottoposto a differenti trattamenti di condizionamento";
   University of Pisa, Department of Agriculture, Food and Environment
   [COFIN2015_22]; Ministry of Agriculture of the Czech Republic (Project
   NAZV) [QJ1510160]
FX G. Benelli is supported by PROAPI (PRAF 2015) "Valutazione della qualita
   organolettica del polline d'api fresco sottoposto a differenti
   trattamenti di condizionamento" and University of Pisa, Department of
   Agriculture, Food and Environment (Grant ID: COFIN2015_22). The funders
   had no role in the study design, data collection and analysis, decision
   to publish, or preparation of the manuscript. R. Pavela would like to
   thank the Ministry of Agriculture of the Czech Republic for its
   financial support concerning botanical pesticide research (Project NAZV
   No. QJ1510160).
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   [Anonymous], 2008, 08 NIST
   BEAUJARD P, 1988, J ETHNOPHARMACOL, V23, P165, DOI 10.1016/0378-8741(88)90004-9
   Benelli G., 2016, ENZYME MICROBIAL TEC
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Chadee DD, 2002, ANN TROP MED PARASIT, V96, pS47, DOI 10.1179/000349802125002365
   DUPUY DJ, 1998, CHOROLOGY TAXONOMY E, P97
   FFNSC 2, 2012, FLAV FRAGR NAT SYNTH
   Finney D.T., 1971, PROBIT ANAL
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Harinantenaina L, 2008, J NAT PROD, V71, P123, DOI 10.1021/np070474c
   Hebeish A, 2008, CARBOHYD POLYM, V74, P268, DOI 10.1016/j.carbpol.2008.02.013
   Lopez MD, 2012, J AGR FOOD CHEM, V60, P1187, DOI 10.1021/jf204242x
   Maggi F, 2013, CHEM BIODIVERS, V10, P356, DOI 10.1002/cbdv.201200253
   Michaelakis A, 2009, PARASITOL RES, V105, P769, DOI 10.1007/s00436-009-1452-7
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nicoletti M., 2016, INTECH, P216
   Nicoletti M, 2012, NAT PROD RES, V26, P2291, DOI 10.1080/14786419.2012.665916
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Perrier De La Bathie H. A., 1954, FLORE MADAGASCAR COM, P46
   Perumalsamy H, 2009, J MED ENTOMOL, V46, P1420, DOI 10.1603/033.046.0624
   Rakotobe E., 1993, PHARMACOPEE AMBONGO
   Rakotosaona R., 2015, NATURAL PRODUCT RES, V30, P960
   Randrianarivelo R, 2010, J APPL MICROBIOL, V109, P642, DOI 10.1111/j.1365-2672.2010.04694.x
   Randrianarivelo R, 2009, FOOD CHEM, V114, P680, DOI 10.1016/j.foodchem.2008.10.007
   Randrianarivo E., 2016, ASIAN PACIFIC J TROP, V6, P930
   Razafindraibe M, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-73
   VECCHIETTI V, 1979, PHYTOCHEMISTRY, V18, P1847, DOI 10.1016/0031-9422(79)83067-8
   WHO, 1996, CTDWHOPESIC961
   WHO, 2014, LYMPH FIL
NR 42
TC 13
Z9 13
U1 4
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0254-6299
EI 1727-9321
J9 S AFR J BOT
JI S. Afr. J. Bot.
PD JAN
PY 2017
VL 108
BP 359
EP 363
DI 10.1016/j.sajb.2016.08.017
PG 5
WC Plant Sciences
SC Plant Sciences
GA EF9SU
UT WOS:000390671400050
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dehlendorf, C
   Gavin, L
   Moskosky, S
AF Dehlendorf, Christine
   Gavin, Loretta
   Moskosky, Susan
TI Providing family planning care in the context of Zika: a toolkit for
   providers from the US Office of Population Affairs
SO CONTRACEPTION
LA English
DT Editorial Material
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; VIRUS
C1 [Dehlendorf, Christine] Univ Calif San Francisco, Dept Family & Community Med, 995 Potrero Ave, San Francisco, CA 94110 USA.
   [Dehlendorf, Christine] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 995 Potrero Ave, San Francisco, CA 94110 USA.
   [Dehlendorf, Christine] Univ Calif San Francisco, Dept Epidemiol & Biostat, 995 Potrero Ave, San Francisco, CA 94110 USA.
   [Gavin, Loretta; Moskosky, Susan] US Dept HHS, Off Populat Affairs, Washington, DC 20201 USA.
RP Dehlendorf, C (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, 995 Potrero Ave, San Francisco, CA 94110 USA.; Dehlendorf, C (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 995 Potrero Ave, San Francisco, CA 94110 USA.; Dehlendorf, C (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 995 Potrero Ave, San Francisco, CA 94110 USA.
EM christine.dehlendorf@ucsf.edu
CR Chaillet N, 2006, OBSTET GYNECOL, V108, P1234, DOI 10.1097/01.AOG.0000236434.74160.8b
   Gavin L, 2014, MMWR RECOMM REP, V63, P1
   Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tavemise S, 2016, NY TIMES
   WHO, 2016, PREV SEX TRANSM ZIK
NR 9
TC 5
Z9 5
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0010-7824
EI 1879-0518
J9 CONTRACEPTION
JI Contraception
PD JAN
PY 2017
VL 95
IS 1
BP 1
EP 4
DI 10.1016/j.contraception.2016.08.013
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EF1KB
UT WOS:000390082600001
PM 27589884
DA 2020-07-08
ER

PT J
AU Ho, SH
   Speldewinde, P
   Cook, A
AF Ho, S. H.
   Speldewinde, P.
   Cook, A.
TI Predicting arboviral disease emergence using Bayesian networks: a case
   study of dengue virus in Western Australia
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Bayesian Belief Network; dengue virus;
   risk mapping; risk modelling
ID BELIEF NETWORKS; AEDES-AEGYPTI; RISK; POPULATIONS; ALBOPICTUS; KNOWLEDGE
AB A Bayesian Belief Network (BBN) for assessing the potential risk of dengue virus emergence and distribution in Western Australia (WA) is presented and used to identify possible hotspots of dengue outbreaks in summer and winter. The model assesses the probabilities of two kinds of events which must take place before an outbreak can occur: (1) introduction of the virus and mosquito vectors to places where human population densities are high; and (2) vector population growth rates as influenced by climatic factors. The results showed that if either Aedes aegypti or Ae. albopictus were to become established in WA, three centres in the northern part of the State (Kununurra, Fitzroy Crossing, Broome) would be at particular risk of experiencing an outbreak. The model can also be readily extended to predict the risk of introduction of other viruses carried by Aedes mosquitoes, such as yellow fever, chikungunya and Zika viruses.
C1 [Ho, S. H.; Cook, A.] Univ Western Australia, Sch Populat Hlth M431, 35 Stirling Highway, Perth, WA 6009, Australia.
   [Speldewinde, P.] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia.
RP Ho, SH (corresponding author), Univ Western Australia, Sch Populat Hlth M431, 35 Stirling Highway, Perth, WA 6009, Australia.
EM hosoonhoe@gmail.com
RI Speldewinde, Peter C/H-5871-2014
OI Speldewinde, Peter C/0000-0002-1671-3633; Cook,
   Angus/0000-0002-1758-6496
CR Australian Bureau of Statistics, 2011, DIG BOUND ESRI SHAP
   Ayre KK, 2014, RISK ANAL, V34, P1589, DOI 10.1111/risa.12189
   Azil AH, 2010, TROP MED INT HEALTH, V15, P1190, DOI 10.1111/j.1365-3156.2010.02592.x
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Centers for Disease Control and Prevention, ZIK VIR TRANSM RISKS
   CHARNIAK E, 1991, AI MAG, V12, P50
   Duncombe J, 2013, TROP MED INT HEALTH, V18, P839, DOI 10.1111/tmi.12115
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Ho SH, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0036-x
   Kilpatrick AM, 2006, CONSERV BIOL, V20, P1224, DOI 10.1111/j.1523-1739.2006.00423.x
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x
   Lindsay MDA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004114
   Liu KFR, 2012, STOCH ENV RES RISK A, V26, P451, DOI 10.1007/s00477-011-0470-z
   Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004
   MacKenzie JS, 1996, J MED MICROBIOL, V45, P159, DOI 10.1099/00222615-45-3-159
   Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135
   McCann RK, 2006, CAN J FOREST RES, V36, P3053, DOI 10.1139/X06-238
   Nguyen H, 2010, NO TERRITORY DIS CON, V17, P29
   Nyberg JB, 2006, CAN J FOREST RES, V36, P3104, DOI 10.1139/X06-108
   Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35
   Russell RC, 2005, COMMUN DIS INTELL, V29, P296
   Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x
   Stephenson TA, 2000, 0003 IDIAPRR
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033
   Whelan P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001619
   Whelan Peter I, 2003, Commun Dis Intell Q Rep, V27, P110
   WHO/TDR, 2009, DENG GUID DIAGN TREA
NR 31
TC 3
Z9 3
U1 0
U2 30
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JAN
PY 2017
VL 145
IS 1
BP 54
EP 66
DI 10.1017/S0950268816002090
PG 13
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EF1RD
UT WOS:000390101500007
PM 27620510
OA Bronze
DA 2020-07-08
ER

PT J
AU Porter, S
   Mimm, N
AF Porter, Sallie
   Mimm, Nancy
TI Infants With Congenital Zika Virus Infection A New Challenge for Early
   Intervention Professionals
SO INFANTS & YOUNG CHILDREN
LA English
DT Article
DE brain calcification; congenital infection; early intervention;
   microcephaly; Zika virus
ID PREGNANT-WOMEN; UNITED-STATES
AB Zika virus infection-associated microcephaly has generated public health and media concern. Unsettling images emerging from Brazil of infants with abnormally small heads have raised concern among women of childbearing age, international travelers, government officials, and health care professionals. The World Health Organization declared the most recent, ongoing Zika virus infection outbreak a "public health emergency of international concern." The Centers for Disease Control and Prevention is working to understand the impact of Zika virus infection in the United States and elsewhere. Zika virus is a mosquito-transmitted Flavivirus that can also be transmitted through sexual contact. Congenital Zika virus infection is a cause of microcephaly and other serious neurological harm to the fetus. The early intervention professional should understand Zika virus infection including the geographical risk, etiology, epidemiology, and potential developmental impact. Still evolving clinical, policy, and research implications for early intervention professionals need to be based on the context of emerging scientific information. It is important for early intervention professionals to remain attentive, as scientific knowledge concerning the impact of congenital Zika virus infection in infants and families will be evolving for years to come.
C1 [Porter, Sallie] Rutgers Sch Nursing, Div Adv Nursing Practice, 180 Univ Ave, Newark, NJ 07102 USA.
   [Mimm, Nancy] New Jersey Dept Hlth, Div Family Hlth Serv Reprod & Perinatal Hlth Serv, Trenton, NJ USA.
RP Porter, S (corresponding author), Rutgers Sch Nursing, Div Adv Nursing Practice, 180 Univ Ave, Newark, NJ 07102 USA.
EM portersa@rutgers.edu
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Baptista T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2194
   Bell BP, 2016, AM J PUBLIC HEALTH, V106, P589, DOI 10.2105/AJPH.2016.303124
   Berkrot B., 2016, WHO EXPERTS SAY ZIKA
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, EST RANG AED ALB AED
   Centers for Disease Control and Prevention, 2016, PLANN TIPS
   Centers for Disease Control and Prevention, 2016, PAR POS ZIK TEST WHA
   Costello A., 2016, B WHO
   Doce N, 2016, BRAZIL SCI SEEK UNRA
   dos Santos C. N., 2016, TRENDS PARASITOLOGY
   Ellis E.G., 2016, WIRED
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Jamieson D. J., 2016, CDC ZIKA UPDATE MAY
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Litt JS, 2014, J EARLY INTERVENTION, V36, P37, DOI 10.1177/1053815114555575
   Malo S., 2016, OFFICIAL MAP FINDS Z
   McKay B., 2016, THE WALL STREET JOUR, pA1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   National Institute for Child Health and Human Development, 2016, LAUNCH ZIK INF PREGN
   Pacheco O, 2016, NEW ENGLAND J MED
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rathore MH, 2016, PEDIATR REV, V37, P133, DOI 10.1542/pir.2016-0003
   Ruble K., 2016, VICE NEWS
   Russell K., 2016, MMWR MORBIDITY MORTA
   Santora M., 2016, NY TIMES
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Sun L., 2016, WASHINGTON POST
   Tavernise S, 2016, NY TIMES
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, EM ZIK SIT REP SEPT
   Zavis A., 2016, LOS ANGELES TIMES
NR 37
TC 3
Z9 3
U1 0
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0896-3746
EI 1550-5081
J9 INFANT YOUNG CHILD
JI Infants Young Child.
PD JAN-MAR
PY 2017
VL 30
IS 1
BP 17
EP 27
DI 10.1097/IYC.0000000000000084
PG 11
WC Education, Special; Psychology, Developmental; Rehabilitation
SC Education & Educational Research; Psychology; Rehabilitation
GA EF3TE
UT WOS:000390246500002
DA 2020-07-08
ER

PT J
AU Kaffenberger, BH
   Shetlar, D
   Norton, SA
   Rosenbach, M
AF Kaffenberger, Benjamin H.
   Shetlar, David
   Norton, Scott A.
   Rosenbach, Misha
TI The effect of climate change on skin disease in North America
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Review
DE cercarial dermatitis; chikungunya; climate change; coccidioidomycosis;
   dengue; environmental change; global warming; hand-foot-and-mouth
   syndrome; herpangina; jellyfish; leishmaniasis; Lyme disease; seabather
   eruption; skin cancer; skin disease; swimmer itch; Zika
ID ECOLOGICAL NICHE MODELS; ZIKA VIRUS; CERCARIAL DERMATITIS; OZONE
   DEPLETION; SWIMMERS ITCH; UNITED-STATES; RISK-FACTORS; IMPACT; VECTOR;
   LEISHMANIASIS
AB Global temperatures continue to rise, reaching new records almost every year this decade. Although the causes are debated, climate change is a reality. Consequences of climate change include melting of the arctic ice cap, rising of sea levels, changes in precipitation patterns, and increased severe weather events. This article updates dermatologists about the effects of climate change on the epidemiology and geographic ranges of selected skin diseases in North America. Although globalization, travel, and trade are also important to changing disease and vector patterns, climate change creates favorable habitats and expanded access to immunologically naive hosts. Endemic North American illnesses such as Lyme disease, leishmaniasis, and dimorphic fungal infections have recently expanded the geographic areas of risk. As temperatures increase, epidemic viral diseases such as hand-foot-and-mouth disease may develop transmission seasons that are longer and more intense. Chikungunya and dengue are now reported within the southern United States, with Zika on the horizon. Cutaneous injuries from aquatic and marine organisms that have expanding habitats and longer durations of peak activity include jellyfish envenomation, cercarial dermatitis, and seabather eruption, among others. Skin cancer rates may also be affected indirectly by changes in temperature and associated behaviors.
C1 [Kaffenberger, Benjamin H.] Ohio State Univ, Dermatol, Columbus, OH 43210 USA.
   [Shetlar, David] Ohio State Univ, Entomol, Columbus, OH 43210 USA.
   [Norton, Scott A.] Childrens Natl Med Ctr, Dermatol, Washington, DC 20010 USA.
   [Rosenbach, Misha] Hosp Univ Penn, Dermatol, Philadelphia, PA 19104 USA.
RP Rosenbach, M (corresponding author), Perelman Ctr Adv Med, South Pavil,First Floor,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM Misha.Rosenbach@uphs.upenn.edu
RI Kaffenberger, Benjamin H/N-2732-2014
OI Kaffenberger, Benjamin H/0000-0001-8079-0011
CR Ampel Neil M, 2010, Curr Infect Dis Rep, V12, P211, DOI 10.1007/s11908-010-0094-3
   Armed Forces Health Surveillance Center, 2011, MSMR, V18, P2
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Benedict K, 2014, EMERG INFECT DIS, V20, P349, DOI 10.3201/eid2003.131230
   Benoit TJ, 2015, MMWR SURVEILL SUMM, V64, P1
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brant SV, 2009, J HELMINTHOL, V83, P191, DOI 10.1017/S0022149X09308020
   Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cardenas R, 2006, AM J TROP MED HYG, V75, P273, DOI 10.4269/ajtmh.2006.75.273
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Center of Disease Control and Prevention, LYM DIS DAT
   Centers for Disease Control and Prevention, 2016, EST RANG AED ALB AED
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P961
   Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005
   Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024
   Cross ER, 1996, ENVIRON HEALTH PERSP, V104, P724, DOI 10.2307/3433217
   An DTM, 2014, GLOBAL HEALTH ACTION, V7, P15, DOI 10.3402/gha.v7.23074
   Diffey B, 2004, PHYS MED BIOL, V49, pR1, DOI 10.1088/0031-9155/49/1/R01
   Dobbinson S, 2008, J AM ACAD DERMATOL, V59, P602, DOI 10.1016/j.jaad.2008.06.011
   Doker TJ, 2014, AM J TROP MED HYG, V91, P743, DOI 10.4269/ajtmh.14-0172
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eissa AE, 2011, PROCEDIA ENVIRON SCI, V4, P251, DOI 10.1016/j.proenv.2011.03.030
   Farahnik B, 2016, J AM ACAD DERMATOL, V74, P1286, DOI 10.1016/j.jaad.2016.02.1232
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FREUDENTHAL AR, 1993, NEW ENGL J MED, V329, P542, DOI 10.1056/NEJM199308193290805
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Haddad V, 2013, REV SOC BRAS MED TRO, V46, P641, DOI 10.1590/0037-8682-1518-2013
   Haines A, 2014, LANCET, V384, P1073, DOI 10.1016/S0140-6736(14)61659-7
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Inglis TJJ, 2011, AM J TROP MED HYG, V84, P851, DOI 10.4269/ajtmh.2011.10-0480
   Inglis TJJ, 2009, BRAZ J INFECT DIS, V13, P59, DOI 10.1590/S1413-86702009000100013
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320
   Kumar S, 1997, PUBLIC HEALTH REP, V112, P59
   LEE CCD, 2015, BIOMED RES INT, DOI DOI 10.1155/2015/805039
   Levy S, 2014, ENVIRON HEALTH PERSP, V122, pA168, DOI 10.1289/ehp.122-A168
   Lindblade KA, 1998, J PARASITOL, V84, P19, DOI 10.2307/3284521
   Liu WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131311
   Marsden-Haug N, 2013, CLIN INFECT DIS, V56, P847, DOI 10.1093/cid/cis1028
   Martinez-Urtaza J, 2010, FOOD RES INT, V43, P1780, DOI 10.1016/j.foodres.2010.04.001
   McCoy D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5178
   Mohan JE, 2006, P NATL ACAD SCI USA, V103, P9086, DOI 10.1073/pnas.0602392103
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148
   Oiso N, 2005, CONTACT DERMATITIS, V52, P232, DOI 10.1111/j.0105-1873.2005.0566f.x
   Pachauri R. K., 2014, CLIMATE CHANGE 2014
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Park BJ, 2005, J INFECT DIS, V191, P1981, DOI 10.1086/430092
   Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7
   Patz JA, 2008, AM J PREV MED, V35, P451, DOI 10.1016/j.amepre.2008.08.026
   Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8
   Przeslawski R, 2015, GLOBAL CHANGE BIOL, V21, P2122, DOI 10.1111/gcb.12833
   Reitzel AM, 2007, J PARASITOL, V93, P1392, DOI 10.1645/GE-1250.1
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Sanchez-Lugo A, 2015, B AM METEOROL SOC, V96, pS9
   Slaper H, 1998, J HAZARD MATER, V61, P77, DOI 10.1016/S0304-3894(98)00110-1
   Soldanova M, 2013, TRENDS PARASITOL, V29, P65, DOI 10.1016/j.pt.2012.12.002
   Solomon S., 2007, CLIMATE CHANGE 2007, P1, DOI DOI 10.1017/CBO9780511546013
   Stone R, 2002, SCIENCE, V295, P2002, DOI 10.1126/science.295.5562.2002
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Suk JE, 2014, EUR J PUBLIC HEALTH, V24, P531, DOI 10.1093/eurpub/cku041
   Sullivan BK, 2001, HYDROBIOLOGIA, V451, P113, DOI 10.1023/A:1011848327684
   Urashima M, 2003, JPN J INFECT DIS, V56, P48
   Urbach F, 1997, J PHOTOCH PHOTOBIO B, V40, P3, DOI 10.1016/S1011-1344(97)00029-8
   Urquhart EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098256
   US Department of Agriculture Forest Service Rocky Mountain Research Station, HER MANT FIR EFF INF, Vhttp:// www.fs.fed.us/database/feis/
   US Fish and Wildlife Service, INV PLANT SPEC RESP
   van der Leun JC, 2002, PHOTOCH PHOTOBIO SCI, V1, P324, DOI 10.1039/b201025a
   Verbrugge LM, 2004, AM J PUBLIC HEALTH, V94, P738, DOI 10.2105/AJPH.94.5.738
   Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6
   Zender CS, 2006, INT J BIOMETEOROL, V50, P174, DOI 10.1007/s00484-005-0007-6
NR 75
TC 23
Z9 23
U1 2
U2 89
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD JAN
PY 2017
VL 76
IS 1
BP 140
EP 147
DI 10.1016/j.jaad.2016.08.014
PG 8
WC Dermatology
SC Dermatology
GA EF0TC
UT WOS:000390037900038
PM 27742170
DA 2020-07-08
ER

PT J
AU Leao, JC
   Gueiros, LA
   Lodi, G
   Robinson, NA
   Scully, C
AF Leao, J. C.
   Gueiros, L. A.
   Lodi, G.
   Robinson, N. A.
   Scully, C.
TI Zika virus: oral healthcare implications
SO ORAL DISEASES
LA English
DT Review
DE Arboviruses; Zika virus; epidemiology; oral; dental
ID FRENCH-POLYNESIA; DECEMBER 2013; TRANSMISSION
AB Zika virus (ZIKV) infection has been recognised since 1947, but just recently it became a worldwide major public health problem. The most common features of ZIKV infection are fever, cutaneous rash, arthralgia and conjunctivitis but most affected patients with the clinical disease present with only mild symptoms. However, severe neurological complications have been described: there is an occasional association with Guillain-Barre syndrome, and emerging data indicate an association between vertical transmission of ZIKV infection and microcephaly, but no specific orofacial manifestations have yet been reported. ZIKV is present in body fluids and has also been demonstrated in the saliva, but there is as yet no reliable evidence to support ZIKV transmission via this pathway. Transmission in oral health care should be effectively prevented using standard infection control measures. There are currently no specific treatments for Zika virus disease and no vaccines available, so prevention of ZIKV is based on vector control.
C1 [Leao, J. C.; Gueiros, L. A.] Univ Fed Pernamuco, Oral Med Unit, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Lodi, G.] Univ Milan, Dipartimento Sci Biomed Chirurg & Odontoiatr, Milan, Italy.
   [Robinson, N. A.] Natl Univ Singapore, Discipline Oral & Maxillofacial Surg, Fac Dent, Singapore, Singapore.
   [Scully, C.] UCL, WHO Collaborating Ctr Oral Hlth Gen Hlth, London, England.
RP Leao, JC (corresponding author), Programa Posgrad Odontol, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Lodi, Giovanni/C-1049-2013; Leao, Jair Carneiro/AAL-6154-2020; Gueiros,
   Luiz Alcino/F-7171-2012
OI Lodi, Giovanni/0000-0002-0218-8292; Leao, Jair
   Carneiro/0000-0001-8303-2291; Gueiros, Luiz Alcino/0000-0003-4979-4318
CR [Anonymous], 2017, ORAL DIS, V23, P12
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2015, NATURE, V524, P13, DOI 10.1038/524013a
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Musso D., 2014, POTENTIAL ZIKA VIRUS
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Scully C, 2016, BRIT DENT J, V220, P265, DOI 10.1038/sj.bdj.2016.182
   Shakib K, 2016, BRIT J ORAL MAX SURG, V54, P355, DOI 10.1016/j.bjoms.2016.02.001
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, 2016, ZIK SIT REP
NR 30
TC 9
Z9 9
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD JAN
PY 2017
VL 23
IS 1
BP 12
EP 17
DI 10.1111/odi.12512
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EF4BB
UT WOS:000390268200004
PM 27232461
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus: oral health care and oral disease
SO ORAL DISEASES
LA English
DT Letter
EM wviroj@yahoo.com
CR Leao JC, 2017, ORAL DIS, V23, P12, DOI 10.1111/odi.12512
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Wiwanitkit V, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0076
NR 3
TC 1
Z9 1
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD JAN
PY 2017
VL 23
IS 1
BP 134
EP 134
DI 10.1111/odi.12517
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EF4BB
UT WOS:000390268200022
PM 27255682
DA 2020-07-08
ER

PT J
AU Dogan, AC
   Wayne, S
   Bauer, S
   Ogunyemi, D
   Kulkharni, SK
   Maulik, D
   Carpenter, CF
   Bahado-Singh, RO
AF Dogan, Ayse Citil
   Wayne, Sandra
   Bauer, Samuel
   Ogunyemi, Dotun
   Kulkharni, Santosh K.
   Maulik, Devika
   Carpenter, Christopher F.
   Bahado-Singh, Ray O.
TI The Zika virus and pregnancy: evidence, management, and prevention
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Management of Zika virus; pregnancy; Zika virus infection
ID UNITED-STATES; INTERIM GUIDELINES; SEXUAL CONTACT; TRANSMISSION;
   INFECTION; TRAVELERS; AREAS
AB Objective: To comprehensively review the available evidence and existing consensus reports and guidelines regarding the pregnancy and reproductive implications of the mosquito-transmitted Zika virus (ZIKV) infection. A primary focus was to provide pertinent information to aid clinicians in the management of pregnancies at risk for, exposed to, or with confirmed ZIKV infection.
   Method: An extensive literature review was performed using Pubmed. Practice guidelines and consensus reports were accessed from international, national, and professional organizations' websites. The clinical articles for ZIKV infection testing varied from case reports to small epidemiologic studies.
   Results: A ZIKV epidemic has been declared in several countries in the Americas. Fifty-two travel-associated ZIKV infection cases have been reported throughout the USA (as of February 10, 2016). The consequences of congenital fetal/newborn ZIKV infection could potentially have devastating consequences including miscarriage, fetal death, and major anomalies such as microcephaly, brain and brain-stem defects, and long-term neurologic sequelae. While not definitive, current evidence suggests the existence of nonvector-borne transmission through sexual activity with an infected male partner. For women at risk for sexual transmission, condom use is advised, especially during pregnancy.
   Conclusion: While ZIKV infection appears to be a mild disease in the general population the potential consequences to the fetus and newborn could be profound. Management guidelines are currently evolving and will be significantly impacted as new evidence develops. It is therefore imperative that obstetric health-care providers keep abreast of this rapidly evolving information landscape that has so far characterized this outbreak.
C1 [Dogan, Ayse Citil] William Beaumont Hosp, Dept Obstet & Gynecol, Royal Oak, MI 48072 USA.
   [Wayne, Sandra] William Beaumont Hosp, Grosse Pointe Shores, Royal Oak, MI 48072 USA.
   [Bauer, Samuel; Ogunyemi, Dotun; Bahado-Singh, Ray O.] Oakland Univ, William Beaumont Hosp, Sch Med, Dept Obstet & Gynecol, Royal Oak, MI USA.
   [Kulkharni, Santosh K.] Univ West Indies, Fac Med, Dept Obstet & Gynecol, Kingston, Jamaica.
   [Maulik, Devika] UMKC Sch Med, Dept Obstet & Gynecol, Kansas City, MO USA.
   [Carpenter, Christopher F.] Oakland Univ, William Beaumont Hosp, Sch Med, Dept Internal Med, Royal Oak, MI USA.
RP Bahado-Singh, RO (corresponding author), Med Off Bldg,3535 West 13 Mile Rd,Suite 233, Royal Oak, MI 48073 USA.
EM Ray.Bahado-Singh@beaumont.edu
OI Carpenter, Christopher/0000-0001-5708-5381
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bahado-Singh RO, 2013, SEMIN PERINATOL, V37, P334, DOI 10.1053/j.semperi.2013.06.010
   BAHADOSINGH RO, 1992, AM J OBSTET GYNECOL, V167, P1009, DOI 10.1016/S0002-9378(12)80029-9
   Barbu D, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.029
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hobbins J., 2008, OBSTET ULTRASOUND AR, P44
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, ZIKA VIRUS ASS MICRO
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P552
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2013, EUROSURVEILLANCE, V19, P1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization World Health Organization, 2015, NEUR SYNDR CONG MALF
   Pan American Health Organization/World Health Organization, 2015, INCR MICR NE BRAZ
   Pan American Health Organization/World Health Organization (PAHO/WHO), 2016, PROV REM ZIK VIR INF, P1
   Portal da Saude (Brazil), 2016, MIN HLTH INV 3448 SU
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Rossi AC, 2014, ULTRASOUND OBST GYN, V44, P388, DOI 10.1002/uog.13429
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zika Lang P., 2015, CHIKUNGUNYA DENGUE U
NR 44
TC 15
Z9 15
U1 0
U2 42
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PY 2017
VL 30
IS 4
BP 386
EP 396
DI 10.3109/14767058.2016.1174210
PG 11
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EE5RZ
UT WOS:000389666700003
PM 27052666
OA Other Gold
DA 2020-07-08
ER

PT J
AU Banwell, B
AF Banwell, Brenda
TI Paediatric neurology in 2016: a year in review
SO LANCET NEUROLOGY
LA English
DT Editorial Material
ID ZIKA VIRUS
C1 [Banwell, Brenda] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Philadelphia, PA 19010 USA.
RP Banwell, B (corresponding author), Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Philadelphia, PA 19010 USA.
EM banwellb@email.chop.edu
CR Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445
   Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   FIGI C, SCI AM TIMES
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Messacar K, 2016, ANN NEUROL, V80, P326, DOI 10.1002/ana.24730
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 8
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD JAN
PY 2017
VL 16
IS 1
BP 14
EP 15
DI 10.1016/S1474-4422(16)30348-9
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EE8IP
UT WOS:000389869200009
PM 27979340
DA 2020-07-08
ER

PT J
AU van de Beek, D
   Brouwer, MC
AF van de Beek, Diederik
   Brouwer, Matthijs C.
TI Neurological infections in 2016: Zika and the rest
SO LANCET NEUROLOGY
LA English
DT Editorial Material
ID MENINGITIS; ADULTS
C1 [van de Beek, Diederik; Brouwer, Matthijs C.] Acad Med Ctr, Amsterdam Neurosci, Dept Neurol, Amsterdam, Netherlands.
RP van de Beek, D (corresponding author), Acad Med Ctr, Amsterdam Neurosci, Dept Neurol, Amsterdam, Netherlands.
EM d.vandebeek@amc.uva.nl
RI van de Beek, Diederik/Y-2713-2019
OI van de Beek, Diederik/0000-0002-4571-044X
CR Beardsley J, 2016, NEW ENGL J MED, V374, P542, DOI 10.1056/NEJMoa1509024
   Bijlsma MW, 2016, LANCET INFECT DIS, V16, P339, DOI 10.1016/S1473-3099(15)00430-2
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Heemskerk AD, 2016, NEW ENGL J MED, V374, P124, DOI 10.1056/NEJMoa1507062
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   van de Beek D, 2016, MICROBIOL INFECT S3, V22, pS37
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 8
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD JAN
PY 2017
VL 16
IS 1
BP 17
EP 18
DI 10.1016/S1474-4422(16)30344-1
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EE8IP
UT WOS:000389869200011
PM 27979342
OA Bronze
DA 2020-07-08
ER

PT J
AU Graber, C
AF Graber, Cynthia
TI The Disease Detectives Can Silicon Valley help government find a better
   way to fight viruses like Zika?
SO NEW REPUBLIC
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NEW REPUBLIC INC
PI WASHINGTON
PA 1331 H STREET, NW STE 700, WASHINGTON, DC 20005 USA
SN 0028-6583
J9 NEW REPUBLIC
JI New Repub.
PD JAN-FEB
PY 2017
VL 248
IS 1-2
BP 10
EP +
PG 3
WC Political Science
SC Government & Law
GA EE5AZ
UT WOS:000389618400003
DA 2020-07-08
ER

PT J
AU Almeida, LCP
   de Souza, TM
   Tabosa, PMS
   Soares, NG
   Rocha-Bezerra, LCB
   Vasconcelos, IM
   Carvalho, AFU
AF Almeida Filho, Luiz C. P.
   de Souza, Terezinha M.
   Tabosa, Pedro M. S.
   Soares, Nayana G.
   Rocha-Bezerra, Lady C. B.
   Vasconcelos, Ilka M.
   Carvalho, Ana F. U.
TI Trypsin inhibitor from Leucaena leucocephala seeds delays and disrupts
   the development of Aedes aegypti, a multiple-disease vector
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE protease inhibitors; Leucaena; legume seeds; dengue; zika; midgut
   enzymes
ID SERINE PROTEINASE-INHIBITOR; LARVAL DEVELOPMENT; BIOINSECTICIDAL
   ACTIVITY; DIPTERA-CULICIDAE; DIGESTIVE ENZYMES; SUSCEPTIBILITY;
   ALBOPICTUS; SURVIVAL; EXTRACTS; MOSQUITO
AB BACKGROUNDNowadays, the Aedes aegypti mosquito represents a serious public health issue in view of the large outbreaks of the arboviral diseases zika, dengue, chikungunya and yellow fever. This holometabolous insect has midgut digestive enzymes that are trypsin- and chymotrypsin-like proteins. Protease inhibitors are able to bind to proteolytic enzymes and promote a blockage in digestion and nutrition, leading to death. Thus, we investigated the effect of trypsin inhibitor of Leucaena leucocephala (LTI) seeds on egg hatching, larval development and digestive midgut proteases.
   RESULTSLTI was obtained by trichloroacetic acid precipitation followed by a single chromatography step on anhydrous trypsin sepharose. Polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate showed a single protein band with a molecular mass close to 20 kDa. After exposure of Ae. aegypti eggs to LTI (0.3mg mL(-1)), egg hatching was reduced (50%). LTI did not show acute toxicity on newly hatched larvae incubated under the same conditions, but after 10 days of exposure a high mortality rate (86%) was observed and the surviving larvae had a 25% delay in development. LTI was able to inhibit in vitro the midgut enzymatic activity (70%), and when larvae were incubated with LTI solution we observed an inhibition of 56%.
   CONCLUSIONSLTI is a promising new tool to control critical points of Ae. aegypti development. (c) 2016 Society of Chemical Industry
C1 [Tabosa, Pedro M. S.; Soares, Nayana G.; Carvalho, Ana F. U.] Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, Ceara, Brazil.
   [Almeida Filho, Luiz C. P.; de Souza, Terezinha M.; Rocha-Bezerra, Lady C. B.; Vasconcelos, Ilka M.] Univ Fed Ceara, Biochem & Mol Biol Dept, Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Dept Biol, BR-60440900 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Almeida Filho, Luiz/K-7313-2018; de Souza, Terezinha/L-8727-2015;
   Carvalho, Ana/K-7344-2018
OI Almeida Filho, Luiz/0000-0001-6234-2418; de Souza,
   Terezinha/0000-0002-9580-3310; Carvalho, Ana/0000-0001-5293-9317
FU MCT-INSA/CNPq/CT, through Hidro/AcAo Tranversal [35/2010]; CoordenacAo
   de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)CAPES
FX The authors thank MCT-INSA/CNPq/CT, through Hidro/AcAo Tranversal No.
   35/2010 - Desenvolvimento Sustentavel do Semiarido Brasileiro and
   CoordenacAo de Aperfeicoamento de Pessoal do Ensino Superior (CAPES),
   for financial support of this research.
CR Agra-Neto AC, 2014, PARASITOL RES, V113, P175, DOI 10.1007/s00436-013-3640-8
   Barbosa PBBM, 2014, PARASITOL RES, V113, P3565, DOI 10.1007/s00436-014-4022-6
   Barros LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039138
   Bhattacharyya A, 2007, COMP BIOCHEM PHYS C, V145, P669, DOI 10.1016/j.cbpc.2007.03.003
   Bhavani P, 2007, ARTHROPOD-PLANT INTE, V1, P255, DOI 10.1007/s11829-007-9020-5
   Bosire CM, 2014, J ASIA-PAC ENTOMOL, V17, P531, DOI 10.1016/j.aspen.2014.05.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4
   Chen TH, 2015, J FORMOS MED ASSOC, V114, P546, DOI 10.1016/j.jfma.2014.12.002
   Cruz ACB, 2013, PLANT PHYSIOL BIOCH, V70, P61, DOI 10.1016/j.plaphy.2013.04.023
   Dantzger M, 2015, PHYTOCHEMISTRY, V118, P224, DOI 10.1016/j.phytochem.2015.08.013
   de Arruda EJ, 2011, BRAZ ARCH BIOL TECHN, V54, P503, DOI 10.1590/S1516-89132011000300010
   Gatehouse LN, 1997, INSECT BIOCHEM MOLEC, V27, P929, DOI 10.1016/S0965-1748(97)00074-X
   Hernandez-Morales A, 2015, J ASIA-PAC ENTOMOL, V18, P227, DOI 10.1016/j.aspen.2014.09.004
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kim Lien PT, 2015, ASIAN PAC J TROP MED, V8, P543
   KUNZ PA, 1978, INSECT BIOCHEM, V8, P43, DOI 10.1016/0020-1790(78)90009-4
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Macedo MLR, 2009, PROTEIN PEPTIDE LETT, V16, P1459, DOI 10.2174/092986609789839395
   Maestre-Serrano R, 2014, PESTIC BIOCHEM PHYS, V116, P63, DOI 10.1016/j.pestbp.2014.09.014
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Oddepally R, 2013, PHYTOCHEMISTRY, V96, P26, DOI 10.1016/j.phytochem.2013.09.010
   Oliva MLV, 2000, BBA-PROTEIN STRUCT M, V1477, P64, DOI 10.1016/S0167-4838(99)00285-X
   Paiva PMG, 2013, LECTINS TRYPSIN INHI, P29
   Pardo-Lopez L, 2009, PEPTIDES, V30, P589, DOI 10.1016/j.peptides.2008.07.027
   Pilon AM, 2006, PESTIC BIOCHEM PHYS, V86, P23, DOI 10.1016/j.pestbp.2005.11.005
   Pontual EV, 2014, PARASITOL RES, V113, P727, DOI 10.1007/s00436-013-3702-y
   Pontual EV, 2012, ARCH INSECT BIOCHEM, V79, P135, DOI 10.1002/arch.21012
   Pradeep FS, 2015, PROCESS BIOCHEM, V50, P1479, DOI 10.1016/j.procbio.2015.05.022
   Prasad ER, 2010, PESTIC BIOCHEM PHYS, V98, P80, DOI 10.1016/j.pestbp.2010.05.003
   de Oliveira CFR, 2012, PROCESS BIOCHEM, V47, P929, DOI 10.1016/j.procbio.2012.02.022
   Ramos MV, 2009, MEM I OSWALDO CRUZ, V104, P805, DOI 10.1590/S0074-02762009000600001
   Ramos VD, 2009, COMP BIOCHEM PHYS A, V152, P255, DOI 10.1016/j.cbpa.2008.10.013
   Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013
   Rufino FPS, 2013, PLANT PHYSIOL BIOCH, V63, P70, DOI 10.1016/j.plaphy.2012.11.013
   Saboia-Vahia L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-50
   Sasaki NY, 2015, BIOCHIMIE, V112, P172, DOI 10.1016/j.biochi.2015.03.011
   Silva RGG, 2015, IND CROP PROD, V70, P48, DOI 10.1016/j.indcrop.2015.02.058
   Simoy MI, 2015, ECOL MODEL, V314, P100, DOI 10.1016/j.ecolmodel.2015.07.007
   Singh MK, 2014, J MOL CATAL B-ENZYM, V110, P92, DOI 10.1016/j.molcatb.2014.10.010
   Soares TS, 2013, INSECT BIOCHEM MOLEC, V43, P9, DOI 10.1016/j.ibmb.2012.10.007
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   SouzaPinto JC, 1996, IMMUNOPHARMACOLOGY, V33, P330, DOI 10.1016/0162-3109(96)00056-2
   Suman DS, 2011, ARTHROPOD STRUCT DEV, V40, P479, DOI 10.1016/j.asd.2011.04.003
   Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x
   Wu YR, 1997, MOL BREEDING, V3, P371, DOI 10.1023/A:1009681323131
NR 48
TC 3
Z9 3
U1 0
U2 11
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JAN
PY 2017
VL 73
IS 1
BP 181
EP 187
DI 10.1002/ps.4284
PG 7
WC Agronomy; Entomology
SC Agriculture; Entomology
GA EE2IT
UT WOS:000389408100024
PM 27040615
DA 2020-07-08
ER

PT S
AU Lu, A
   Lin, W
   Yu, CM
AF Lu, An
   Lin, Wu
   Yu, Chuanming
GP ISSI
BE Atanassova, I
   Bertin, M
   Mayr, P
TI An Integrated Analysis of Topical and Emotional Evolution of Microblog
   Public Opinions on Public Emergencies
SO 16TH INTERNATIONAL CONFERENCE ON SCIENTOMETRICS & INFORMETRICS (ISSI
   2017)
SE Proceedings of the International Conference on Scientometrics and
   Informetrics
LA English
DT Proceedings Paper
CT 16th International Conference on Scientometrics and Informetrics (ISSI)
CY OCT 16-20, 2017
CL Wuhan Univ, Wuhan, PEOPLES R CHINA
HO Wuhan Univ
AB Microblog is an important medium of communicating public opinions toward public emergencies. Excavating topics and sentiment of microblogs on public emergencies has important practical significance in grasping online public opinions, identifying and predicting potential problems and risks during public emergencies. In this study, we propose an approach to analyse the topical and emotional evolution of microblog public opinions on public emergencies. The Zika outbreak is taken as an example and the life cycle of related microblog public opinions is divided into several phases. Topics are extracted from microblogs by the word2vec technique. The sentiment analysis has been conducted based on dictionaries containing sentiment words and emoticons to categorize the sentiment of microblogs at a fine-grained level. The emotional intensity of microblogs for each topic is also calculated to achieve synergetic analysis of topics and sentiment of microblogs. The proposed method can reveal the topical and emotional features and emotional intensity of microblogs on public emergencies and summarize the synergetic evolution patterns of topics and sentiment of online public opinions.
C1 [Lu, An; Lin, Wu] Wuhan Univ, Wuhan, Peoples R China.
   [Yu, Chuanming] Zhongnan Univ Econ & Law, Wuhan, Peoples R China.
RP Yu, CM (corresponding author), Zhongnan Univ Econ & Law, Wuhan, Peoples R China.
EM anlu97@163.com; 2016201040013@whu.edu.cn; yucm@zuel.edu.cn
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [71603189, 71373286]; Youth Innovation Corps Fund of Humanities
   and Social Sciences, Wuhan University
FX This study is funded by the Natural Science Foundation of China (No.
   71603189 and 71373286) and Youth Innovation Corps Fund of Humanities and
   Social Sciences, Wuhan University.
CR Chen Y., 2015, J HEBEI UNIV NAT SCI, V35, P651, DOI DOI 10.3969/j.issn.1000-1565.2015.06.016
   Du Z. L., 2013, SENTIMENT ANAL MICRO
   Fan B., 2017, 2016 MICROBLOG USER
   Han Z.M., 2012, COMPUTER APPL SOFTWA, P89
   JIA D, 2015, J INFORM, P91
   Li L.X., 2016, J INTELLIGENT SYSTEM, P546
   Li Y. P., 2015, RES APPL INFORM TECH
   Ma Bing-nan, 2016, Computer Engineering and Design, V37, P1129, DOI 10.16208/j.issn1000-7024.2016.05.003
   Ma J., 2016, COMPUTER APPL RES, V33, P2914
   Mikolov Tomas, 2013, ADV NEURAL INFORM PR, V26, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951
   Rehurek R., 2011, GENSIM STAT SEMANTIC
   Robert H., 2004, EMERGENCY MANAGEMENT
   Tang X.B., 2016, LIB INFORM WORK, P121
   Xu Linhong, 2008, Journal of the China Society for Scientific and Technical Information, V27, P180
   Zhu X.M., 2014, BASED WORD2VEC THEME
NR 15
TC 0
Z9 0
U1 1
U2 1
PU INT SOC SCIENTOMETRICS & INFORMETRICS-ISSI
PI LEUVEN
PA KATHOLIEKE UNIV LEUVEN, FACULTEIT E T E W, DEKENSTRAAT 2, LEUVEN,
   B-3000, BELGIUM
SN 2175-1935
J9 PRO INT CONF SCI INF
PY 2017
BP 431
EP 441
PG 11
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA BO2SP
UT WOS:000508234900043
DA 2020-07-08
ER

PT S
AU Chen, JS
   Lin, H
   Liang, WH
   Yu, Y
   Han, WT
   An, H
   Chen, Y
   Liu, X
AF Chen, Junshi
   Lin, Han
   Liang, Weihao
   Yu, Yang
   Han, Wenting
   An, Hong
   Chen, Yong
   Liu, Xin
BE Wang, G
   Fox, G
   Martinez, G
   Hill, R
   Mueller, P
TI Refactoring the Molecular Docking Simulation for Heterogeneous, Manycore
   Processors Systems
SO 2017 15TH IEEE INTERNATIONAL SYMPOSIUM ON PARALLEL AND DISTRIBUTED
   PROCESSING WITH APPLICATIONS AND 2017 16TH IEEE INTERNATIONAL CONFERENCE
   ON UBIQUITOUS COMPUTING AND COMMUNICATIONS (ISPA/IUCC 2017)
SE IEEE International Symposium on Parallel and Distributed Processing with
   Applications
LA English
DT Proceedings Paper
CT 15th IEEE International Symposium on Parallel and Distributed Processing
   with Applications (ISPA) / 16th IEEE International Conference on
   Ubiquitous Computing and Communications (IUCC)
CY DEC 12-15, 2017
CL Guangzhou, PEOPLES R CHINA
SP IEEE, IEEE Comp Soc, Guangzhou Univ, Cent S Univ
DE molecular docking; Sunway TaihuLight Supercomputer; heterogeneous;
   manycore; optimization
ID VALIDATION
AB This paper presents a scalable design and implementation of the molecular docking application DOCK for a large-scale high performance computing system, the Sunway TaihuLight supercomputer, which provisions a heterogeneous, manycore processor architecture that consists of management processing elements (MPEs) and clusters of computing processing elements (CPEs). The key innovation is a novel refactoring of DOCK on the CPEs. Optimization techniques for data redundancy minimization to fit data in cache, software-controlled prefetching into scratchpads, memory access coalescing, software caches, vectorization and loop unrolling are employed to improve the exploitation of the computational resources. For a single docking process, the refactored version using both the MPE and CPE cluster achieved 260x to 402x speedup compared against the original ported version using MPE only. To scale the DOCK to the full Sunway Taihulight system with 10,649,600 cores (including all MPE and CPE cores), we present an MPI communication domain partition scheme as well. For docking 9 million small compounds to a Zika virus target protein, we manage to scale to 131,072 MPEs, and 8,388,608 CPEs, with a total of 8,519,680 cores.
C1 [Chen, Junshi; Lin, Han; Liang, Weihao; Yu, Yang; Han, Wenting; An, Hong] Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei, Anhui, Peoples R China.
   [Chen, Yong] Texas Tech Univ, Dept Comp Sci, Lubbock, TX 79409 USA.
   [Liu, Xin] Natl Res Ctr Parallel Comp Engn & Technol, Beijing, Peoples R China.
RP Chen, JS (corresponding author), Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei, Anhui, Peoples R China.
EM cjuns@mail.ustc.edu.cn; han@ustc.edu.cn; yong.chen@ttu.edu
OI Chen, Yong/0000-0002-9961-9051
FU National Key Research and Development Program of China [2016YFB0201902]
FX The authors would like to acknowledge Chenzhi Liao and Wenjun Yao for
   the valuable comments and discussions, professor Wei Zhao of the First
   Institute of Oceanography for the suggestions of performance
   optimizations, and the anonymous reviewers of this paper. Special thanks
   go to NSCC-Wuxi for providing the computational resources on the Sunway
   TaihuLight. The work is supported by the National Key Research and
   Development Program of China (GrantsNo. 2016YFB0201902).
CR Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905
   Altuntas S., 2016, GPU ACCELERATED MOL
   Cheng Q, 2015, IEEE ACM INT SYMP, P725, DOI 10.1109/CCGrid.2015.64
   Collignon B., 2010, J COMPUT CHEM, V32, P1202
   Dongarra J., 2016, TECH REP
   Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450
   Fu HH, 2016, SCI CHINA INFORM SCI, V59, DOI 10.1007/s11432-016-5588-7
   Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277
   Kannan S, 2010, IEEE C EVOL COMPUTAT
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4
   Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982
   Olson A. J., 2010, J COMPUTATIONAL CHEM
   Peters A., 2008, HIGH THROUGHPUT COMP
   Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197
   Zhang XH, 2013, J COMPUT CHEM, V34, P915, DOI 10.1002/jcc.23214
NR 16
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2158-9178
BN 978-1-5386-3790-6
J9 IEEE INT SYMP PARAL
PY 2017
BP 1031
EP 1038
DI 10.1109/ISPA/IUCC.2017.00157
PG 8
WC Computer Science, Hardware & Architecture; Computer Science, Information
   Systems; Computer Science, Interdisciplinary Applications;
   Telecommunications
SC Computer Science; Telecommunications
GA BM4YH
UT WOS:000464435000147
DA 2020-07-08
ER

PT S
AU Lima, T
   Barbosa, B
   Niquini, C
   Araujo, C
   Lana, R
AF Lima, Tiago
   Barbosa, Breno
   Niquini, Carlos
   Araujo, Camila
   Lana, Raquel
BE Dias, N
   DeFreitas, S
   Duque, D
   Rodrigues, N
   Wong, K
   Vilaca, JL
TI Playing against dengue Design and development of a serious game to help
   tackling dengue
SO 2017 IEEE 5TH INTERNATIONAL CONFERENCE ON SERIOUS GAMES AND APPLICATIONS
   FOR HEALTH (SEGAH)
SE IEEE International Conference on Serious Games and Applications for
   Health
LA English
DT Proceedings Paper
CT 5th IEEE International Conference on Serious Games and Applications for
   Health (SeGAH)
CY APR 02-04, 2017
CL Perth, AUSTRALIA
SP IEEE
DE Serious game; dengue; Aedes aegypti; public health
ID GLOBAL DISTRIBUTION; HEALTH-EDUCATION; COMMUNITY; FEVER; KNOWLEDGE;
   PREVENTION; AWARENESS; IMPACT; EXPERIENCES; VECTORS
AB Dengue is a global public health challenge. The dengue virus is transmitted mainly by the Aedes aegypti mosquito, which is also a vector of other diseases such as zika, chikungunya and urban yellow fever. Its transmission dynamics is complex, involving several actors, factors and processes. Acting against vectors is still an important strategy, mainly due to limitations in efficacy and accessibility of vaccines. We believe that including and awareness of population is an important factor to address the problem. This project aims to design and develop a serious game to support actions and strategies based on prevention and epidemiological surveillance. In order to raise awareness about vector ecology and disease transmission dynamics, the game design presents information and seeks to encourage behavior changes in a playful environment. Moreover, gamification strategies are being used to stimulate concrete actions in real world. A mix of 2D-based game, augmented reality, virtual reality and the real world itself, will provide the proper environment to offer fun with the purpose of helping to deal with this complex problem. This paper presents the game design and current development stage. The artifacts are being developed in an iterative and incremental way, involving activities of conception, design, construction/prototyping and evaluation. Results include the game design, prototypes and the release of a demo version.
C1 [Lima, Tiago; Barbosa, Breno; Niquini, Carlos; Araujo, Camila] UFOP, ICEA, BR-35931008 Joao Monlevade, MG, Brazil.
   [Lana, Raquel] Fundacao Oswaldo Cruz, FIOCRUZ, Escola Nacl Saude Publ Sergio Arouca ENSP, Programa Posgrad Epidemiol Saude Publ, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Lima, T (corresponding author), UFOP, ICEA, BR-35931008 Joao Monlevade, MG, Brazil.
EM tiagolima@decsi.ufop.br; brenonix@gmail.com; niquini.carlos@gmail.com;
   kmilazd@gmail.com; raquelmlana@gmail.com
FU UFOP
FX The authors would like to thank UFOP for the support and all those who
   are helping in the tests.
CR Aguiar M., 2016, EXPERT REV VACCINES
   Al-Dubai SAR, 2013, SE ASIAN J TROP MED, V44, P37
   Al-Muhandis N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001278
   Badurdeen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-607
   Barbosa B. G., 2016, P 1 S LAT JOG, P21
   Beinner M. A., 2015, J NURSING UFPE LINE, V9, P7304, DOI DOI 10.5205/REUOL.7275-62744-1-SM.0904201516
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bouzid M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005176
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Boyle EA, 2012, COMPUT HUM BEHAV, V28, P771, DOI 10.1016/j.chb.2011.11.020
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Buchinger D., 2014, P 13 S BRAS JOG ENTR, P400
   Buchinger D., INFORM EDUCACAO TEOR, V18
   Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012
   Cheng MT, 2015, J COMPUT EDUC, V2, P353, DOI 10.1007/s40692-015-0039-9
   Chinnakali P, 2012, N AM J MED SCI, V4, P278, DOI 10.4103/1947-2714.97210
   Claro Lenita Barreto Lorena, 2004, Cad. Saúde Pública, V20, P1447, DOI 10.1590/S0102-311X2004000600002
   Connolly TM, 2012, COMPUT EDUC, V59, P661, DOI 10.1016/j.compedu.2012.03.004
   da Silva V., 2011, P 10 SBGAMES, P1
   Deen J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002182
   Degallier N, 2000, J AM MOSQUITO CONTR, V16, P114
   Denis G., 2005, P 2005 ACM SIGCHI IN, P462, DOI DOI 10.1145/1178477.1178581
   Deterding S., 2012, INTERACTIONS, V16, P14, DOI [DOI 10.1145/2212877.2212883, 10.1145/2212877.2212883]
   Deterding S, 2011, P 15 INT AC MINDTREK, V15, P9, DOI DOI 10.1145/2181037.2181040
   Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028
   Dominguez A, 2013, COMPUT EDUC, V63, P380, DOI 10.1016/j.compedu.2012.12.020
   Dondlinger M. J., 2007, J APPL ED TECHNOL, V4, P21, DOI DOI 10.1108/10748120410540463
   Erhel S, 2013, COMPUT EDUC, V67, P156, DOI 10.1016/j.compedu.2013.02.019
   Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x
   Giannakos MN, 2013, COMPUT EDUC, V68, P429, DOI 10.1016/j.compedu.2013.06.005
   Godoi I. P., 2017, J COMP EFFECTIVENESS
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2016, J INFECT DIS
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2016, J INFECT DIS, V214, P1793, DOI 10.1093/infdis/jiw340
   Hamari J, 2014, P ANN HICSS, P3025, DOI 10.1109/HICSS.2014.377
   Hamari J, 2013, ELECTRON COMMER R A, V12, P236, DOI 10.1016/j.elerap.2013.01.004
   HAMARI Juho, 2013, ECIS, P105
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620
   Johnson Daniel, 2016, Internet Interv, V6, P89, DOI 10.1016/j.invent.2016.10.002
   Juul Jesper, 2011, HALF REAL VIDEO GAME
   Khun S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000143
   Kiili K., 2005, Internet and Higher Education, V8, P13, DOI 10.1016/j.iheduc.2004.12.001
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lennon JL, 2007, HEALTH EDUC, V107, P290, DOI 10.1108/09654280710742582
   Lennon JL, 2006, SIMULAT GAMING, V37, P88, DOI 10.1177/1046878105285550
   LIVDAHL TP, 1987, ECOL ENTOMOL, V12, P395, DOI 10.1111/j.1365-2311.1987.tb01020.x
   Luz S, 2016, ENTERTAIN COMPUT, V15, P43, DOI 10.1016/j.entcom.2015.11.001
   Madeira Newton G., 2002, Rev. Soc. Bras. Med. Trop., V35, P221, DOI 10.1590/S0037-86822002000300004
   Michael D. R., 2005, SERIOUS GAMES GAMES
   Mitchell-Fostera K, 2015, T ROY SOC TROP MED H, V109, P126, DOI 10.1093/trstmh/tru209
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Moreno-Ger P, 2008, COMPUT HUM BEHAV, V24, P2530, DOI 10.1016/j.chb.2008.03.012
   Naing C, 2011, J COMMUN HEALTH, V36, P1044, DOI 10.1007/s10900-011-9407-1
   Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6
   Pai HH, 2006, J ENVIRON HEALTH, V68, P35
   PAPASTERGIOU M, 2009, COMPUT EDUC, V2009, P1, DOI DOI 10.1016/J.C0MPEDU.2008.06.004
   Pereira P, 2014, LECT NOTES COMPUT SC, V8518, P742, DOI 10.1007/978-3-319-07626-3_70
   Pilger D., 2010, TROPIKA NET, V1
   Porcino T.M., 2014, 2014 IEEE 3 INT C SE, P1
   Prensky M., 2006, DONT BOTHER ME MOM I
   Primack BA, 2012, AM J PREV MED, V42, P630, DOI 10.1016/j.amepre.2012.02.023
   Quintao M. S., 2016, X DENGUE GAME DESIGN
   Rogers Y., 2013, DESIGN DE INTERACAO
   Rothman AL, 2016, J INFECT DIS, V214, P825, DOI 10.1093/infdis/jiw068
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Silva TD, 2008, REV BRAS ENS CIENC T, V1, P58
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Squire K. D., 2003, INT J INTELLIGENT GA, V2, P49, DOI DOI 10.1145/950566.950583
   Stifter C., 2016, GAM VIRT WORLDS SER, P1
   Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004
   Swaddiwudhipong W., 1992, SHOCK, V5, P1
   Van Eck R., 2006, EDUCAUSE REV, V41, P16, DOI DOI 10.1145/950566.950596
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Vivas Edison, 2003, Rev Panam Salud Publica, V14, P394, DOI 10.1590/S1020-49892003001100004
   W.H.O, CHIK
   WHO, ON YEAR ZIK OUTBR OB
   Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363
   Wong LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122890
   Zamora Antón, 2015, Rev. perú. med. exp. salud publica, V32, P397
   Zhu GH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004633
NR 85
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2330-5649
BN 978-1-5090-5482-4
J9 IEEE INT CONF SERIOU
PY 2017
PG 8
WC Health Care Sciences & Services; Engineering, Electrical & Electronic
SC Health Care Sciences & Services; Engineering
GA BH8JC
UT WOS:000403392400042
DA 2020-07-08
ER

PT S
AU Sheth, S
AF Sheth, Suraj (Neil)
GP IEEE
TI The TripleRM Global Health Management Model (GHMM): Strategic Risk
   Management of Vector Borne Infectious Diseases to Build Healthy,
   Sustainable, Adaptable and Resilient Communities (Strategic Global
   Health Security Risk Assessment, Resilience Planning And Resource
   Management in Urban and Rural Environments)
SO 2017 IEEE CONFERENCE ON TECHNOLOGIES FOR SUSTAINABILITY (SUSTECH 2017)
SE IEEE Conference on Technologies for Sustainability SusTech
LA English
DT Proceedings Paper
CT 5th Annual IEEE Conference on Technologies for Sustainability (SusTech)
CY NOV 12-14, 2017
CL Phoenix, AZ
SP IEEE, IEEE Phoenix Sect, IEEE Reg 6, IEEE Oregon Sect, IEEE USA, IEEE Environm Engn Tech Community, IEEE Consumer Elect Soc, IEEE, Soc Social Implicat Technol, Renavitas Technologies, Sphera, So States
DE Public Health; Global Health; Vector Borne Disease; Medicine; Risk;
   Resilience; Resource; Assessment; Management; TripleRM Strategic Model;
   World Health Organization; Security; Paul Epstein; Urban; Rural;
   Technologies; Remedies; Climate Change; United Nations Sustainable
   Development Goals
AB Over the last 30 years, rising global temperatures due to climate change have led to changes in, and proximal to, urban and rural ecosystems. These changes have caused the patterns of transmission of infectious diseases by vectors, such as mosquitoes, to vary considerably. Diseases such as Dengue Fever, Malaria and Zika (caused by the Zika Virus) have re-emerged where they had disappeared, have become more pervasive in the areas they already existed, and have now emerged in cities where they were previously not seen. In order to combat this dangerous trend while meeting the targets set by the United Nations Sustainable Development Goals, public health officials in charge of urban and rural environments constantly have sought ways to reduce the risk from a disease outbreak.
   The TripleRM Global Health Management Model (GHMM) can be used for Disease Outbreak and Response in Urban and Rural Environments. It is designed for risk assessment, resilience building and resource management, and can be utilized to research the effectiveness of processes implemented in disease detection and response. The TripleRM Global Health Management Model (GHMM) can be used for reduction or elimination of risk to populations by identifying situational and process vulnerabilities and their impending effects, evaluating current public health controls in place, identifying effective solutions and remedial measures, and recommending a methodology for optimal resource allocation. The TripleRM Global Health Management Model (GHMM) incorporates remedial measures, strategic initiatives designed to integrate adaptability and resiliency, implement policy changes and update emergency response protocols.
C1 [Sheth, Suraj (Neil)] Magnova Global, Chicago, IL 60603 USA.
RP Sheth, S (corresponding author), Magnova Global, Chicago, IL 60603 USA.
EM neilprojectnotes@gmail.com
CR [Anonymous], 2016, NPR             0807
   Epstein PR, 1999, SCIENCE, V285, P347, DOI 10.1126/science.285.5426.347
   Krishnaswamy A, 2015, IEEE CONF TECH SUST, P117, DOI 10.1109/SusTech.2015.7314333
   Nelson B, 2016, PLOS CURRENTS OUTBRE, DOI [10.1371/cun-ents.outbreaks.ac6d0f8c9c35e88825clal147697531c, DOI 10.1371/CURRENTS.OUTBREAKS.AC6D0F8C9C35E88825CLAL147697531C]
   Reisen William K, 2015, CLIMATE CHANGE PUBLI, P129
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741
NR 7
TC 0
Z9 0
U1 3
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2640-6829
EI 2640-6810
BN 978-1-5386-0452-6
J9 IEEE CONF TECH SUST
PY 2017
BP 310
EP 316
PG 7
WC Green & Sustainable Science & Technology; Engineering, Electrical &
   Electronic
SC Science & Technology - Other Topics; Engineering
GA BL5MO
UT WOS:000452178500050
DA 2020-07-08
ER

PT B
AU Prakash, R
   Wong, A
   Pabbaraju, K
   Tellier, R
   Kaler, KVIS
AF Prakash, Ravi
   Wong, Anita
   Pabbaraju, Kanti
   Tellier, Raymond
   Kaler, Karan V. I. S.
GP IEEE
TI Detection of Arboviruses in Blood and Mosquito Slurry Samples using
   Polymer Microchip
SO 2017 IEEE-NIH HEALTHCARE INNOVATIONS AND POINT OF CARE TECHNOLOGIES
   (HI-POCT)
LA English
DT Proceedings Paper
CT NIH-IEEE Strategic Conference on Healthcare Innovations and
   Point-of-Care Technologies (HI-POCT)
CY NOV 06-08, 2017
CL Natl Inst Hlth Bethesda Campus, MD
SP IEEE, IEEE EMB, Natl Inst Hlth, Consortia Improving Med Innovat & Technol, Zimmer & Peacock, APDM
HO Natl Inst Hlth Bethesda Campus
ID CHIKUNGUNYA; EXTRACTION; VIRUSES; DEVICE; RNA
AB Molecular detection of arboviruses has several potential public health benefits. Worldwide increase in Dengue virus activity as well as the emergence of Zika and Chikungunya viruses underline the usefulness of a portable, small foot-print platforms for the molecular detection of viruses in diagnostic laboratories, point of care applications and field work. In this study, we have demonstrated a polymer based diagnostic microchip technology capable of extracting and purifying nucleic acid from highly complex sample matrices including mosquito slurry. We have furthermore reported a multilayered chip design on the polymer surface for nucleic acid based sample-to-answer tests while lowering the voltage and power requirements to make it suitable for in-field deployment. Several panels of human and mosquito samples containing different levels of arboviruses were successfully tested to establish the sensitivity and accuracy of this low-cost disposable diagnostic technology.
C1 [Prakash, Ravi] ProvLab Calgary, Calgary, AB, Canada.
   [Prakash, Ravi] Queens Univ, ECE Dept, Kingston, ON, Canada.
   [Tellier, Raymond] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada.
   [Kaler, Karan V. I. S.] Univ Calgary, ECE Dept, Calgary, AB, Canada.
RP Prakash, R (corresponding author), ProvLab Calgary, Calgary, AB, Canada.
EM ravi.prakash@queensu.ca; Raymond.Tellier@ahs.ca; kaler@ucalgary.ca
FU NSERC Postdoctoral FellowshipNatural Sciences and Engineering Research
   Council of Canada; CMC Microsystems MNT support grant
FX Research supported in part by NSERC Postdoctoral Fellowship and CMC
   Microsystems MNT support grant.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chen  D., 2016, BIOMEDICAL MICRODEVI, V14, P705
   Choi K, 2012, ANNU REV ANAL CHEM, V5, P413, DOI 10.1146/annurev-anchem-062011-143028
   Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411
   de la Rosa C, 2008, IEEE T BIO-MED ENG, V55, P2426, DOI 10.1109/TBME.2008.923148
   Dineva MA, 2007, ANALYST, V132, P1193, DOI 10.1039/b705672a
   Easley CJ, 2006, P NATL ACAD SCI USA, V103, P19272, DOI 10.1073/pnas.0604663103
   Fair RB, 2007, IEEE DES TEST COMPUT, V24, P10, DOI 10.1109/MDT.2007.8
   Gijs MAM, 2004, MICROFLUID NANOFLUID, V1, P22, DOI 10.1007/s10404-004-0010-y
   Henessy  M., 2016, MMWR-MORBID MORTAL W, V65, P55
   Honegger T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3583441
   Kim TH, 2014, ANAL CHEM, V86, P3841, DOI 10.1021/ac403971h
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pabbarak K, 2009, J MED ENTOMOL, V46, P640, DOI 10.1603/033.046.0332
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Prakash R, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0069-8
   Prakash R, 2015, MICROMACHINES-BASEL, V6, P63, DOI 10.3390/mi6010063
   Prince HE, 2015, CLIN VACCINE IMMUNOL, V22, P291, DOI 10.1128/CVI.00720-14
   Rodriguez NM, 2016, LAB CHIP, V16, P753, DOI 10.1039/c5lc01392e
   Tang RH, 2017, LAB CHIP, V17, P1270, DOI 10.1039/c6lc01586g
   Zhang BH, 2015, J VIROL METHODS, V212, P44, DOI 10.1016/j.jviromet.2014.11.004
NR 22
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5386-1392-4
PY 2017
BP 168
EP 171
PG 4
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA BM4MG
UT WOS:000463495800041
DA 2020-07-08
ER

PT J
AU Sirohi, D
   Chen, ZG
   Sun, L
   Klose, T
   Pierson, TC
   Rossmann, MG
   Kuhn, RJ
   Prasad, VM
   Miller, A
   Klose, T
   Sirohi, D
   Buda, G
   Kuhn, RJ
   Rossmann, MG
   Hasan, SS
   Miller, A
   Sapparapu, G
   Fernandez, E
   Klose, T
   Long, F
   Fokine, A
   Porta, JC
   Jiang, W
   Diamond, MS
   Crowe, JE
   Kuhn, RJ
   Rossmann, MG
AF Sirohi, Devika
   Chen, Zhenguo
   Sun, Lei
   Klose, Thomas
   Pierson, Theodore C.
   Rossmann, Michael G.
   Kuhn, Richard J.
   Prasad, Vidya Mangala
   Miller, Andrew
   Klose, Thomas
   Sirohi, Devika
   Buda, Geeta
   Kuhn, Richard J.
   Rossmann, Michael G.
   Hasan, S. Saif
   Miller, Andrew
   Sapparapu, Gopal
   Fernandez, Estefania
   Klose, Thomas
   Long, Feng
   Fokine, Andrey
   Porta, Jason C.
   Jiang, Wen
   Diamond, Michael S.
   Crowe, James E., Jr.
   Kuhn, Richard J.
   Rossmann, Michael G.
TI The cryoEM structures of immature and mature Zika virus and of mature
   Zika virus complexed with a human monoclonal antibody
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
C1 [Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
RI Diamond, Michael/AAH-1733-2019; Crowe, James E./B-5549-2009
OI Diamond, Michael/0000-0002-8791-3165; Crowe, James
   E./0000-0002-0049-1079
NR 0
TC 0
Z9 0
U1 0
U2 2
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2017
VL 73
SU S
BP A347
EP A347
DI 10.1107/S0108767317096611
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3TU
UT WOS:000477683800337
OA Bronze
DA 2020-07-08
ER

PT J
AU Sharma, A
   Rey, F
AF Sharma, Arvind
   Rey, Felix
TI Structural basis of Zika virus neutralization by highly potent antibody
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE Zika virus; neutralization; FabC10
C1 [Sharma, Arvind; Rey, Felix] Inst Pasteur, Struct Virol, Paris, France.
EM arvind.sharma@pasteur.fr
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
NR 3
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2017
VL 73
SU S
MA MS036.O06
BP C388
EP C388
DI 10.1107/S2053273317091859
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3XK
UT WOS:000481522000387
OA Bronze
DA 2020-07-08
ER

PT J
AU Zhang, H
   He, ZY
   Zeng, WT
   Peng, HJ
AF Zhang, Hao
   He, Zhiyi
   Zeng, Wenting
   Peng, Hong-Juan
TI Roles of Interferons in Pregnant Women with Dengue Infection: Protective
   or Dangerous Factors
SO CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY
LA English
DT Review
ID ZIKA VIRUS; IFN-GAMMA; HEMORRHAGIC-FEVER; SERUM-LEVELS; VIRAL LOAD;
   BETA; EXPRESSION; SEROPREVALENCE; P110-DELTA; APOPTOSIS
AB Dengue infection is a serious public health problemin tropical and subtropical areas. With the recent outbreaks of Zika disease and its reported correlation with microcephaly, the large number of pregnancies with dengue infection has become a serious concern. This review describes the epidemiological characteristics of pregnancy with dengue and the initial immune response to dengue infection, especially in IFNs production in this group of patients. Dengue is much more prevalent in pregnant women compared with other populations. The severity of dengue is correlated with the level of IFNs, while the serum IFN level must be sufficiently high to maintain the pregnancy and to inhibit virus replication.
C1 [Zhang, Hao; Zeng, Wenting] Guangzhou Med Univ, Dept Infect Dis, Key Discipline Guangdong Prov, Affiliated Hosp 1, 151 Yanjiang Rd, Guangzhou 510120, Guangdong, Peoples R China.
   [He, Zhiyi] Guangzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, 151 Yanjiang Rd, Guangzhou 510120, Guangdong, Peoples R China.
   [Peng, Hong-Juan] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
   [Peng, Hong-Juan] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Higher Inst, Key Lab Prevent & Control Emerging Infect Dis, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
RP Zeng, WT (corresponding author), Guangzhou Med Univ, Dept Infect Dis, Key Discipline Guangdong Prov, Affiliated Hosp 1, 151 Yanjiang Rd, Guangzhou 510120, Guangdong, Peoples R China.; Peng, HJ (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Dis Res, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.; Peng, HJ (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Higher Inst, Key Lab Prevent & Control Emerging Infect Dis, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.
EM 13609645855@163.com; hongjuan@smu.edu.cn
RI amsalu, ribka/G-8780-2019
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81271866, 81572012]; Guangdong Province
   Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong
   Provincial Natural Science FoundationNational Natural Science Foundation
   of Guangdong Province [2016A030311025]; Guangzhou Health and Medical
   Collaborative Innovation Major Special Project [201604020011]
FX This study was partly supported by the grant from the National Natural
   Science Foundation of China (nos. 81271866 and 81572012), the Guangdong
   Province Universities and Colleges Pearl River Scholar Funded Scheme
   (2014), the Guangdong Provincial Natural Science Foundation Key Project
   (2016A030311025), and Guangzhou Health and Medical Collaborative
   Innovation Major Special Project (201604020011) to Hong-Juan Peng.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   ALLEN G, 1980, NATURE, V287, P408, DOI 10.1038/287408a0
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bazer FW, 2009, REPRODUCTION, V138, P195, DOI 10.1530/REP-09-0158
   Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356
   BERKOWITZ RS, 1988, AM J OBSTET GYNECOL, V158, P199, DOI 10.1016/0002-9378(88)90810-1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Borbely AU, 2012, AM J REPROD IMMUNOL, V67, P73, DOI 10.1111/j.1600-0897.2011.01060.x
   Boskovic R, 2005, NEUROLOGY, V65, P807, DOI 10.1212/01.wnl.0000180575.77021.c4
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   CHAOUAT G, 1990, J REPROD FERTIL, V89, P447
   Chistyakova G, 2016, GYNECOL ENDOCRINOL, V32, P56, DOI 10.1080/09513590.2016.1232543
   Comba C, 2015, FERTIL STERIL, V104, P1467, DOI 10.1016/j.fertnstert.2015.08.011
   Cui L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004607
   Hernandez SID, 2014, J CLIN VIROL, V60, P196, DOI 10.1016/j.jcv.2014.04.002
   Oliveira RAD, 2016, MEM I OSWALDO CRUZ, V111, P378, DOI 10.1590/0074-02760150453
   EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591
   Giles M, 2011, ANTIVIR THER, V16, P621, DOI 10.3851/IMP1813
   Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327
   Hsu YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24530
   Jaiswal M. K., 2015, SCI REPORTS, V5
   Joyce MM, 2008, J IMMUNOL, V181, P2494, DOI 10.4049/jimmunol.181.4.2494
   Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813
   Kieckbusch J., 2015, CELL REPORTS
   Kim M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094011
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Li L, 2017, MUCOSAL IMMUNOL, V10, P613, DOI 10.1038/mi.2016.84
   Li Z., 2016, SCI REPORTS, V5
   Liu Z, 2002, CONTRACEPTION, V65, P177, DOI 10.1016/S0010-7824(01)00277-3
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Feitosa RNM, 2016, VIRAL IMMUNOL, V29, P379, DOI 10.1089/vim.2016.0026
   Mohamed Ismail NA, 2014, SCI WORLD J, V2014
   Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pal T, 2014, J CLIN VIROL, V61, P365, DOI 10.1016/j.jcv.2014.09.003
   Palma-Ocampo HK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0383-4
   Paludan SR, 2016, TRENDS IMMUNOL, V37, P588, DOI 10.1016/j.it.2016.06.003
   Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6
   Pozo-Aguilar JO, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0590-7
   Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709
   Saudemont A, 2009, P NATL ACAD SCI USA, V106, P5795, DOI 10.1073/pnas.0808594106
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327
   St John A. L., 2013, ELIFE, V2013
   Ucar I, 2016, FOLIA MORPHOL, V75, P257, DOI 10.5603/FM.a2015.0099
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   World H. O., 2009, DENG GUID DIAGN TREA
   Yen TY, 2016, ACTA TROP, V155, P58, DOI 10.1016/j.actatropica.2015.12.012
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   YUI J, 1994, PLACENTA, V15, P819, DOI 10.1016/S0143-4004(05)80184-5
   Zavattoni M., 2016, EURO SURVEILLANCE B, V21
   Zhang L, 2015, INT J INFECT DIS, V30, P10, DOI 10.1016/j.ijid.2014.10.027
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
   Zhao WX, 2012, INT J MED SCI, V9, P447, DOI 10.7150/ijms.4593
NR 57
TC 4
Z9 4
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1712-9532
EI 1918-1493
J9 CAN J INFECT DIS MED
JI Can. J. Infect. Dis. Med. Microbiol.
PY 2017
VL 2017
AR 1671607
DI 10.1155/2017/1671607
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA FG0WB
UT WOS:000409504100001
PM 29081814
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sorensen, AE
   Jordan, RC
   LaDeau, S
AF Sorensen, Amanda E.
   Jordan, Rebecca C.
   LaDeau, Shannon
TI Reframing communication about Zika and mosquitoes to increase disease
   prevention behavior
SO COGENT ENVIRONMENTAL SCIENCE
LA English
DT Article
DE mosquitoes; Zika virus; framing; public action
AB Emergence of invasive vector species and the diseases they carry present a clear danger to the public as well as a challenge for scientists and experts to control effectively. Given the urgent need to address this phenomenon, we suggest that desired public action toward these invasive vectors can be motivated through intentional framing in science communication. In this paper, we sought to evaluate the effect of framing about ZIKV (Zika virus) on reported willingness to comply with mosquito prevention action. Post framing intervention, we found a significant increase (N = 26, p < 0.001) in individuals willing to take preventative action against mosquitoes. By methodically investigating best communication practices, this study and others can help practitioners mobilize communities to address large-scale ecological problems. Additionally, the principles outlined here may be transferrable to other communication efforts about ecological issues outside of ZIKV and mosquitoes.
C1 [Sorensen, Amanda E.; Jordan, Rebecca C.] Rutgers State Univ, Dept Human Ecol, 59 Lipman Dr Room 104, New Brunswick, NJ 08901 USA.
   [LaDeau, Shannon] Cary Inst Ecosyst Studies, 2801 Sharon Turnpike, Millbrook, NY 12545 USA.
RP Sorensen, AE (corresponding author), Rutgers State Univ, Dept Human Ecol, 59 Lipman Dr Room 104, New Brunswick, NJ 08901 USA.
EM amandaesorensen@gmail.com; rcjordan@rci.rutgers.edu;
   ladeaus@caryinstitute.org
FU National Science Foundation (NSF) Coupled Natural Human Systems
   [CNH-1211797]
FX This research was funded by the National Science Foundation (NSF)
   Coupled Natural Human Systems [grant number CNH-1211797].
CR Acemoglu D, 2010, GAME ECON BEHAV, V70, P194, DOI 10.1016/j.geb.2010.01.005
   Allen JD, 2010, VACCINE, V28, P4027, DOI 10.1016/j.vaccine.2010.03.063
   [Anonymous], SYMPT ZIK VIR
   ARMOR DA, 2002, HEURISTICS BIASES PS, P334, DOI DOI 10.1017/CBO9780511808098.021
   Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907., DOI 10.1145/2187836.2187907]
   Barr S, 2004, GEOFORUM, V35, P231, DOI 10.1016/j.geoforum.2003.08.009
   Betsch C, 2013, HEALTH PSYCHOL, V32, P978, DOI 10.1037/a0031590
   Bond L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-943
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chi MTH, 1997, J LEARN SCI, V6, P271, DOI 10.1207/s15327809jls0603_1
   Devereux E., 2007, MEDIA STUDIES KEY IS
   Donlan CJ, 2003, CONSERV BIOL, V17, P1850, DOI 10.1111/j.1523-1739.2003.00012.x
   Engel P., 2013, BUSINESS INSIDER, DOI [10.1037/0278-6133.26.6.745, DOI 10.1037/0278-6133.26.6.745]
   Ferguson E, 2007, BRIT J PSYCHOL, V98, P667, DOI 10.1348/000712607X190692
   Flaherty DK, 2011, ANN PHARMACOTHER, V45, P1302, DOI 10.1345/aph.1Q318
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Freed GL, 2010, PEDIATRICS, V125, P654, DOI 10.1542/peds.2009-1962
   Gerend MA, 2007, HEALTH PSYCHOL, V26, P745, DOI 10.1037/0278-6133.26.6.745
   Goffman E., 1974, FRAME ANAL ESSAY ORG
   Jordan R. C., ECOLOGY SOC
   LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505
   Little E, 2017, J MED ENTOMOL, V54, P1183, DOI 10.1093/jme/tjx103
   Matthes J, 2008, J COMMUN, V58, P258, DOI 10.1111/j.1460-2466.2008.00384.x
   McNutt M, 2013, SCIENCE, V342, P13, DOI 10.1126/science.1246449
   McRee AL, 2010, CANCER EPIDEM BIOMAR, V19, P1937, DOI 10.1158/1055-9965.EPI-09-1287
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Nisbet MC, 2007, SCIENCE, V316, P56, DOI 10.1126/science.1142030
   Nisbet MC, 2009, AM J BOT, V96, P1767, DOI 10.3732/ajb.0900041
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pielke RA, 2002, NATURE, V416, P367, DOI 10.1038/416367a
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rohde R. E., 2016, ZIKA CASES CONFIRMED
   Sorensen AE, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00036
   U. S. Census Bureau, 2013, AM COMM SURV EST CIT
   Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140
   Vietri JT, 2012, MED DECIS MAKING, V32, P447, DOI 10.1177/0272989X11427762
   Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0
   Wang C, 2009, PREV MED, V48, P197, DOI 10.1016/j.ypmed.2008.11.008
   WEINSTEIN ND, 1987, J BEHAV MED, V10, P481, DOI 10.1007/BF00846146
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zehr SC, 2000, PUBLIC UNDERST SCI, V9, P85, DOI 10.1088/0963-6625/9/2/301
NR 41
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 2331-1843
J9 COGENT ENVIRON SCI
JI Cogent Environ. Sci.
PY 2017
VL 3
IS 1
AR 1402498
DI 10.1080/23311843.2017.1402498
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA VH8CZ
UT WOS:000455331900031
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gaskell, KM
   Houlihan, C
   Nastouli, E
   Checkley, AM
AF Gaskell, Katherine M.
   Houlihan, Catherine
   Nastouli, Eleni
   Checkley, Anna M.
TI Persistent Zika Virus Detection in Semen in a Traveler Returning to the
   United Kingdom from Brazil, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID SEXUAL TRANSMISSION; STATES
AB Zika virus is normally transmitted by mosquitos, but cases of sexual transmission have been reported. We describe a patient with symptomatic Zika virus infection in whom the virus was detected in semen for 92 days. Our findings support recommendations for 6 months of barrier contraceptive use after symptomatic Zika virus infection.
C1 [Gaskell, Katherine M.; Checkley, Anna M.] UCL, Hosp Trop Dis, London, England.
   [Gaskell, Katherine M.] London Sch Hyg & Trop Med, London, England.
   [Houlihan, Catherine; Nastouli, Eleni] Univ Coll London Hosp, Dept Clin Virol, London, England.
   [Nastouli, Eleni] UCL, Great Ormond St Inst Child Hlth, Dept Populat Policy & Practice, London, England.
RP Gaskell, KM (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Infect Div, 235 Euston Rd, Fitzrovia London NW1 2BU, England.
EM kmgaskell@doctors.org.uk
OI Gaskell, Katherine/0000-0003-4691-6359
FU National Institute for Health ResearchNational Institute for Health
   Research (NIHR) [2755]
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EUROIMMUN, ZIK SER DIAGN TESTS
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Public Health England, ZIK VIR ZIKV CLIN TR
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   WHO, PREV SEX TRANSM ZIK
NR 15
TC 28
Z9 28
U1 0
U2 15
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2017
VL 23
IS 1
BP 137
EP 139
DI 10.3201/eid2301.161300
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EG2AV
UT WOS:000390836400026
PM 27748650
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT S
AU Kirk, RA
   Kirk, DA
AF Kirk, Ryan A.
   Kirk, Dave A.
BE Yamamoto, S
TI Introducing a Decision Making Framework to Help Users Detect, Evaluate,
   Assess, and Recommend (DEAR) Action Within Complex Sociotechnical
   Environments
SO HUMAN INTERFACE AND THE MANAGEMENT OF INFORMATION: SUPPORTING LEARNING,
   DECISION-MAKING AND COLLABORATION, HCI INTERNATIONAL 2017, PT II
SE Lecture Notes in Computer Science
LA English
DT Proceedings Paper
CT 19th International Conference on Human-Computer Interaction (HCI
   International)
CY JUL 09-14, 2017
CL Vancouver, CANADA
DE Causality; Decision-making; Decision support systems; DSS; Complex
   systems; Causal inference; Vector-based transmission; Disease; Viruses;
   Zika; West nile virus; Mosquitoes
AB As causality becomes non-linear, data-driven decision making becomes challenging because traditional Decision Support Systems (DSSs) do not support these environments. Existing analytical methods struggle in complex environments where variables that interact with each other as well as themselves. DEAR is a new framework that supports complex decision making. This framework performs change detection, evaluates causal relationships and interactions, assesses the risk of known interventions, and recommends action using a guided exploration strategy that blends historically successful solutions with possible alternatives.
   Fear of viral outbreaks drove the need for public policy to mitigate mosquito populations in Columbus, OH. Through monitoring environmental variables, this approach detected changes in precipitation and temperature. Using CCM to assess causality, this approach determined that temperature was the primary driver of the complex mosquito population ecosystem. It determined the probability that mosquito populations would also rise. Through forming a risk assessment based upon the historic success of mosquito control systems, this approach is able to offer real-time guidance as to which vector-based mitigation strategy to pursue.
C1 [Kirk, Ryan A.] Kirk Enterprises LLC, Seattle, WA 98021 USA.
   [Kirk, Dave A.] Consul Pack Inc, Minneapolis, MN USA.
RP Kirk, RA (corresponding author), Kirk Enterprises LLC, Seattle, WA 98021 USA.
EM info@ryankirk.info; dave.kirk1@comcast.net
CR [Anonymous], 2015, FOX 8 NEWS CLEVELAND
   [Anonymous], 2014, GLOB BRIEF VECT BORN
   [Anonymous], 2015, WEATH HIST COL
   [Anonymous], 2016, MOSQ BORN DIS
   Boyd J., 1987, 43947 MU WORK AIR U
   Frieden T. R., 2016, THE JAMA NETWORK
   Hargens L., 2008, 67R CSSS
   Jaderberg M., 2016, COMPUTING RES REPOSI, V1611
   Kirk R. M., 2015, THESIS
   Kirk RA, 2016, COMM COM INF SC, V617, P110, DOI 10.1007/978-3-319-40548-3_18
   Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1
   PEARL J, 2000, CAUSALITY
   Pesheck P. S., 2016, TRANSFORMATIVE FOOD
   Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079
   Takens F., 1981, LECT NOTES MATH, V1980, P366, DOI DOI 10.1007/BFB0091924
   Thompson DR, 2013, IEEE GEOSCI REMOTE S, V10, P1021, DOI 10.1109/LGRS.2012.2227932
   Veeramachaneni K, 2016, 2016 IEEE 2ND INTERNATIONAL CONFERENCE ON BIG DATA SECURITY ON CLOUD (BIGDATASECURITY), IEEE INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE AND SMART COMPUTING (HPSC), AND IEEE INTERNATIONAL CONFERENCE ON INTELLIGENT DATA AND SECURITY (IDS), P49, DOI 10.1109/BigDataSecurity-HPSC-IDS.2016.79
   Ye H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14750
   Zeckhauser Richard, 2006, CAPITALISM SOC, V1, P1
NR 19
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0302-9743
EI 1611-3349
BN 978-3-319-58524-6; 978-3-319-58523-9
J9 LECT NOTES COMPUT SC
PY 2017
VL 10274
BP 223
EP 239
DI 10.1007/978-3-319-58524-6_20
PN II
PG 17
WC Computer Science, Information Systems; Computer Science, Software
   Engineering; Computer Science, Theory & Methods
SC Computer Science
GA BL6NA
UT WOS:000454446400020
DA 2020-07-08
ER

PT B
AU Ovadia, Y
   Halpern, Y
   Krishnan, D
   Livni, J
   Newburger, D
   Poplin, R
   Zha, TT
   Sculley, D
AF Ovadia, Yaniv
   Halpern, Yoni
   Krishnan, Dilip
   Livni, Josh
   Newburger, Daniel
   Poplin, Ryan
   Zha, Tiantian
   Sculley, D.
GP ACM
TI Learning to Count Mosquitoes for the Sterile Insect Technique
SO KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON
   KNOWLEDGE DISCOVERY AND DATA MINING
LA English
DT Proceedings Paper
CT 23rd ACM SIGKDD International Conference on Knowledge Discovery and Data
   Mining (KDD)
CY AUG 13-17, 2017
CL Halifax, CANADA
SP Assoc Comp Machinery, Assoc Comp Machinery SIGMOD, Assoc Comp Machinery SIGKDD
DE image modeling; quality assurance; counting from images
AB Mosquito-borne illnesses such as dengue, chikungunya, and Zika are major global health problems, which are not yet addressable with vaccines and must be countered by reducing mosquito populations. The Sterile Insect Technique (SIT) is a promising alternative to pesticides; however, effective SIT relies on minimal releases of female insects. This paper describes a multi-objective convolutional neural net to significantly streamline the process of counting male and female mosquitoes released from a SIT factory and provides a statistical basis for verifying strict contamination rate limits from these counts despite measurement noise. These results are a promising indication that such methods may dramatically reduce the cost of effective SIT methods in practice.
C1 [Ovadia, Yaniv; Halpern, Yoni; Krishnan, Dilip; Sculley, D.] Google Inc, Mountain View, CA 94043 USA.
   [Livni, Josh; Newburger, Daniel; Poplin, Ryan; Zha, Tiantian] Verily Inc, San Francisco, CA USA.
RP Ovadia, Y (corresponding author), Google Inc, Mountain View, CA 94043 USA.
EM yovadia@google.com; yhalpern@google.com; dilipkay@google.com;
   jlivni@google.com; dnewb@google.com; rpoplin@google.com; zha@google.com;
   dsculley@google.com
CR Abadi M., 2016, ARXIV160304467
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Arteta C, 2016, LECT NOTES COMPUT SC, V9911, P483, DOI 10.1007/978-3-319-46478-7_30
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   Chattopadhyay Prithvijit, 2016, CORR
   Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177
   Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2
   Dyck VA, 2005, STERILE INSECT TECHN
   French G., 2015, CONVOLUTIONAL NEURAL
   Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223
   Kingma D., 2014, 14126980 ARXIV, DOI [10.1063/1.4902458, DOI 10.1145/1830483.1830503]
   KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902
   Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386
   Lempitsky V.S., 2010, ADV NEURAL INFORM PR, P1324, DOI DOI 10.1111/1467-9280.03439
   Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94
   Moranduzzo T, 2014, IEEE T GEOSCI REMOTE, V52, P1635, DOI 10.1109/TGRS.2013.2253108
   Mundhenk TN, 2016, LECT NOTES COMPUT SC, V9907, P785, DOI 10.1007/978-3-319-46487-9_48
   Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5
   Sermanet P., 2013, COMPUT VIS PATTERN R, V1312, P6229, DOI DOI 10.1109/CVPR.2015.7299176
   Shelhamer E, 2017, IEEE T PATTERN ANAL, V39, P640, DOI [10.1109/CVPR.2015.7298965, 10.1109/TPAMI.2016.2572683]
   Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308
   World Health Organization, 2015, 10 FACTS ON MAL
   ZHANG C, 2015, PROC CVPR IEEE, P833, DOI DOI 10.1109/CVPR.2015.7298684
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-4887-4
PY 2017
BP 1943
EP 1949
DI 10.1145/3097983.3098204
PG 7
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Theory & Methods
SC Computer Science
GA BL7XZ
UT WOS:000455787300207
OA Bronze
DA 2020-07-08
ER

PT J
AU Kucharski, A
   Riley, S
AF Kucharski, Adam
   Riley, Steven
TI Reducing uncertainty about flavivirus infections
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID ZIKA VIRUS; DENGUE VIRUS; TRANSMISSION
C1 [Kucharski, Adam] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
   [Riley, Steven] Imperial Coll London, MRC, Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England.
RP Kucharski, A (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
EM adam.kucharski@lshtm.ac.uk
OI Riley, Steven/0000-0001-7904-4804
FU Medical Research CouncilMedical Research Council UK (MRC) [1109359];
   Medical Research CouncilMedical Research Council UK (MRC) [MR/K021524/1,
   MR/J008761/1]
CR Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Kucharski AJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002082
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   MAKINO Y, 1994, MICROBIOL IMMUNOL, V38, P951, DOI 10.1111/j.1348-0421.1994.tb02152.x
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   White MT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0117-2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 3
Z9 3
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2017
VL 17
IS 1
BP 13
EP 15
DI 10.1016/S1473-3099(16)30524-2
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EE8GW
UT WOS:000389864700010
PM 27998552
DA 2020-07-08
ER

PT S
AU Ciafarone, A
   D'Amico, A
   Bologna, M
AF Ciafarone, Alessia
   D'Amico, Argilia
   Bologna, Mauro
BE Banoub, JH
   Caprioli, RM
TI Vaccines, Sera and "New" Viruses: Ebola, Zika and Other Infectious
   Challenges for Human Health
SO MOLECULAR TECHNOLOGIES FOR DETECTION OF CHEMICAL AND BIOLOGICAL AGENTS
SE NATO Science for Peace and Security Series A-Chemistry and Biology
LA English
DT Proceedings Paper
CT NATO-Advanced-Study-Institute (ASI) Conference on Molecular Technologies
   for Detection of Chemical and Biological Agents
CY APR 09-16, 2016
CL Calabria, ITALY
SP NATO, Adv Study Inst
DE Immunology; Virus; New infectious diseases; Bioterrorism
ID BIOLOGICAL WEAPON; ANTHRAX
AB Following the basic description of the immunological science, we may now go in more detail into the practical applications involving immunological prevention against infectious diseases (vaccine use, requiring availability of suitable antigenic preparations, safe and effective immunization schedules and time to allow for immunity to develop) and immunotherapy of dangerous infective conditions (serotherapy, involving availability of immune sera and their use for injection in subjects needing protection against infectious agents).
   All this is discussed with special regard of the many new micro-organisms described in human pathology and also in situations in which the deliberate use of them for biological warfare or related menace (bioterrorism) is realized.
C1 [Ciafarone, Alessia; D'Amico, Argilia] Chair Gen Pathol, Laquila, Italy.
   [Bologna, Mauro] Univ Aquila, Dept Life Hlth & Environm Sci, Chair Gen Pathol, Gen Pathol, I-67100 Laquila, Italy.
RP Bologna, M (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Chair Gen Pathol, Gen Pathol, I-67100 Laquila, Italy.
EM mauro.bologna@univaq.it
CR Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Bologna M, 2010, PANDEMIE VIROLOGIA P
   Cudahy P, 2016, POSTGRAD MED J, V92, P187, DOI 10.1136/postgradmedj-2015-133278
   Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763
   Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127
   Hendricks Katherine A, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2002.130687
   Herremans T, 2000, CLIN DIAGN LAB IMMUN, V7, P40, DOI 10.1128/CDLI.7.1.40-44.2000
   Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236
   Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281
   Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735
   Johnson KM, 2001, CURR TOP MICROBIOL, V256, P1
   Lovinger S, 2002, JAMA-J AM MED ASSOC, V288, P2530, DOI 10.1001/jama.288.20.2530
   Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P569, DOI 10.1001/jama.2013.251229
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poliomyelitis, 2012, POL
   Porter R.S., 2011, MERCK MANUAL DIAGNOS
   Ryan KJ, 2004, SHERRIS MED MICROBIO, P488
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Turnbull P, 2008, ANTHRAX HUMANS ANIMA, P20
   Wallace GS, 2013, TRAVELERS HLTH POLIO
   William A, 2012, TETANUS EPIDEMIOLOGY, P291
   World Health Organization, 2014, WHOHSEPEDCED201405, P123
   Yun NE, 2012, VIRUSES-BASEL, V4, P2031, DOI 10.3390/v4102031
NR 25
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1874-6489
BN 978-94-024-1114-0; 978-94-024-1113-3; 978-94-024-1112-6
J9 NATO SCI PEACE SEC A
JI NATO Sci. Peace Secur. Ser. A-Chem. Biol.
PY 2017
BP 10
EP 20
DI 10.1007/978-94-024-1113-3_2
PG 11
WC Public, Environmental & Occupational Health; Toxicology
SC Public, Environmental & Occupational Health; Toxicology
GA BM0KI
UT WOS:000458814100002
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika Virus Infection: Some Facts
SO NEUROHOSPITALIST
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Osun, Nigeria.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Pastula DM, 2016, NEUROHOSPITALIST, V6, P93, DOI 10.1177/1941874416637409
   Wiwanitkit S, 2016, J FORMOS MED ASSOC, V115, P822, DOI 10.1016/j.jfma.2016.06.003
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 4
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1941-8744
EI 1941-8752
J9 NEUROHOSPITALIST
JI Neurohospitalist
PD JAN
PY 2017
VL 7
IS 1
BP 5
EP 5
DI 10.1177/1941874416665525
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA VH9DJ
UT WOS:000457810100001
PM 28042362
OA Green Published
DA 2020-07-08
ER

PT S
AU Chen, X
   Zhang, LL
   Cui, DF
   Yin, H
AF Chen, Xing
   Zhang, Lu-lu
   Cui, Da-fu
   Yin, Hong
BE AbdelHafez, AA
   Sheng, J
TI Miniaturized System with a Facile Isothermal Amplification Microfluidic
   Chip for Rapid Detection of Zika Viruses
SO PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON BIOMEDICAL AND
   BIOLOGICAL ENGINEERING 2017 (BBE 2017)
SE Advances in Biological Sciences Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Biomedical and Biological Engineering
   (BBE)
CY MAY 26-28, 2017
CL Guilin, PEOPLES R CHINA
DE Microfluidic chips; Loop-mediated is other mal amplification (LAMP);
   Formatting; Miniaturized System
AB A real-time fluorescence detection biomedical miniaturized system with a disposable microfluidic chip was developed for loop-mediated isothermal amplification (LAMP) reactions. The miniaturized system was developed consisting of a mini heating plate, a temperature sensor, a temperature controller and an adjustable mechanical stage. Based on experimental result, the temperature of the heating plate is evenly distributed, and the error of the temperature is less than 1.3%. The microfluidic chip was designed and fabricated by MEMS technology and thin-casting method. The volume of the LAMP reaction was changed from 25 mu L to 2 mu L. The volume of the LAMP reaction was optimized. The nucleic acid of Zika viruses was amplified and detected in real-time mode with our miniatureized system by using above microfluidic chip. From the experiment results, the detection range was from 100 copies to 10(6) copies. This biomedical system has the potential for point-of-care diagnostics (POCT) with the many advantages, such as not high cost, short analysis and detection time, not much reagent and sample consumption and so on.
C1 [Chen, Xing; Zhang, Lu-lu; Cui, Da-fu] Chinese Acad Sci, Inst Elect, State Key Lab Transducer Tech, Beijing 100190, Peoples R China.
   [Yin, Hong] Chinese Acad Inspect & Quarantine, Beijing 100123, Peoples R China.
RP Chen, X (corresponding author), Chinese Acad Sci, Inst Elect, State Key Lab Transducer Tech, Beijing 100190, Peoples R China.
EM xchen@mail.ie.ac.cn
FU National Science Foundation of ChinaNational Natural Science Foundation
   of China [61372055, 31571007, 61571420, 8137171]; National Key
   Scientific Instrument and Equipment Development Project [2012YQ090197]
FX This research was financially supported by the National Science
   Foundation of China (61372055, 31571007, 61571420 and 8137171) and the
   National Key Scientific Instrument and Equipment Development Project
   (2012YQ090197).
CR Arora A, 2010, ANAL CHEM, V82, P4830, DOI 10.1021/ac100969k
   Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011
   Fang XE, 2010, ANAL CHEM, V82, P3002, DOI 10.1021/ac1000652
   Ferguson BS, 2011, J AM CHEM SOC, V133, P9129, DOI 10.1021/ja203981w
   Lingam Swathi, 2014, Microrna, V3, P18
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Uddin SM, 2015, SENSORS-BASEL, V15, P5376, DOI 10.3390/s150305376
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2468-5747
BN 978-94-6252-362-3
J9 ADV BIO SCI RES
PY 2017
VL 4
BP 404
EP 409
PG 6
WC Chemistry, Medicinal; Engineering, Biomedical
SC Pharmacology & Pharmacy; Engineering
GA BM4OC
UT WOS:000463699800064
DA 2020-07-08
ER

PT J
AU Singer, M
AF Singer, Merrill
TI The spread of Zika and the potential for global arbovirus syndemics
SO GLOBAL PUBLIC HEALTH
LA English
DT Article
DE Syndemic; arbovirus; vectors; Zika; dengue; chikungunya; Aedes
   mosquitoes; Planetary Health
ID AEDES-ALBOPICTUS DIPTERA; CHIKUNGUNYA VIRUS; DENGUE VIRUS; INCREASED
   DISSEMINATION; PLANETARY HEALTH; CLIMATE-CHANGE; RISK-FACTORS; DALY
   LOST; AEGYPTI; DISEASE
AB It is estimated that over a million people die each year from infectious diseases of zoonotic origin and hundreds of millions suffer from these pervasive threats to human well-being. In light of the emergent global concern over the Zika virus, evidence that it has not one but two competent mosquito vector species in the Aedes family, and that both can be co-infected with other pathogens including dengue and chikungunya, this paper examines research suggesting the prospect of significant twenty-first-century outbreaks of arbovirus syndemics. Uniting the concepts 'synergy' with 'epidemic', a syndemics approach recognises that diseases in a population occur neither independent of social and ecological conditions, nor in isolation from other diseases. Assessment of the potential for arbovirus syndemics entails a review of the human role in the global spread of Aedes mosquitoes, the socio-environmental conditions of Aedes diffusion, the increasing likelihood of co-transmission of arbovirus diseases, evidence of co-infection and concern about the adverse health effects of arbovirus syndemic interaction, and the need for an appropriate environment-sensitive framework for effective public health responses. Called Planetary Health, this emergent framework confronts conceptual, knowledge, and governance challenges created by the dramatic shifts in environments, climates, people, vectors, and pathogens in the world.
C1 [Singer, Merrill] Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA.
   [Singer, Merrill] Univ Connecticut, Dept Community Med, Storrs, CT 06269 USA.
RP Singer, M (corresponding author), Univ Connecticut, Dept Anthropol, Storrs, CT 06269 USA.; Singer, M (corresponding author), Univ Connecticut, Dept Community Med, Storrs, CT 06269 USA.
EM merrill.singer@uconn.edu
CR Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338
   Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Baer HA, 2009, GLOBAL WARMING POLIT
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bousfield B., 2011, ONE WORLD ONE HLTH, V1, P1
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Centers for Disease Control and Prevention, 2016, ZIK CAS COUNTS US
   Centre for Health and Population Research, 2005, LITTL SWED LIF SAV E
   Cha A., 2016, WASHINGTON POST
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chan M., 2016, BRIEFING EXECUTIVE B
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chen Chee Dhang, 2005, Trop Biomed, V22, P39
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868
   Devaux Christian A, 2012, World J Virol, V1, P11, DOI 10.5501/wjv.v1.i1.11
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dingwall R, 2013, PANDEMICS EMERGING I
   Drucker PF, 2007, INNOVATION ENTREPREN
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faure E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00441
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Flegel TW, 2011, MAR BIOTECHNOL, V13, P587, DOI 10.1007/s10126-010-9287-x
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Griffiths EC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2286
   Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Hapuarachchi H. A. C., 2008, CEYLON MEDICAL JOURNAL, V53, P104
   Horton R, 2015, LANCET, V386, P1921, DOI 10.1016/S0140-6736(15)61038-8
   Horton R, 2014, LANCET, V384, P218, DOI 10.1016/S0140-6736(14)61178-8
   Horton R, 2014, LANCET, V383, P847, DOI 10.1016/S0140-6736(14)60409-8
   Jean CM, 2007, EMERG INFECT DIS, V13, P1918, DOI 10.3201/eid1312.061265
   Kalantri SP, 2006, NATL MED J INDIA, V19, P315
   Kanthong N, 2008, DEV COMP IMMUNOL, V32, P1063, DOI 10.1016/j.dci.2008.02.008
   Kanthong N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-14
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Knobler S., 2006, IMPACT GLOBALIZATION
   Kolbert E., 2011, NATL GEOGRAPHIC
   Krishnamoorthy K, 2009, J VECTOR DIS, V46, P26
   LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247
   Lee H.L., 1990, Tropical Biomedicine, V7, P185
   Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3
   Mendenhall E., 2012, SYNDEMIC SUFFERING S
   Mishra B, 2006, LANCET, V368, P918, DOI 10.1016/S0140-6736(06)69370-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307
   Navarro DMAF, 2003, J APPL ENTOMOL, V127, P46, DOI 10.1046/j.1439-0418.2003.00690.x
   Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060
   Neteler M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-49
   Nichter M., 2008, GLOBAL HLTH WHY CULT
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   PADBIDRI VS, 1979, J HYG EPID MICROB IM, V23, P445
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rock M, 2009, SOC SCI MED, V68, P991, DOI 10.1016/j.socscimed.2008.12.047
   Rodriguez-Barraquer I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003906
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423
   Singer M., 2014, CLIMATE CHANGE PLANE
   Singer M., 2011, COMPANION MED ANTHR, P219
   Singer M, 2016, MED ANTHROPOL Q, V30, P442, DOI 10.1111/maq.12163
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2
   Sudeep AB, 2014, J VECTOR DIS, V51, P251
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tavernise S, 2016, NY TIMES
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   TURELL MJ, 1987, AM J TROP MED HYG, V37, P197, DOI 10.4269/ajtmh.1987.37.197
   Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Vittor A, 2016, NY TIMES
   WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121
   Wang Y., 2016, LOS ANGELES TIMES
   Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1
   Wolf M, 2015, SOC SCI MED, V129, P5, DOI 10.1016/j.socscimed.2014.06.018
   World Health Organization, 2015, FAST MOV EB EP FULL
   Yusoff K, 2013, ENVIRON PLANN D, V31, P779, DOI 10.1068/d11512
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   ZYTOON EM, 1993, AM J TROP MED HYG, V49, P201, DOI 10.4269/ajtmh.1993.49.201
NR 108
TC 13
Z9 13
U1 0
U2 96
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1744-1692
EI 1744-1706
J9 GLOB PUBLIC HEALTH
JI Glob. Public Health
PY 2017
VL 12
IS 1
BP 1
EP 18
DI 10.1080/17441692.2016.1225112
PG 18
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ED2YH
UT WOS:000388715600001
PM 27590737
DA 2020-07-08
ER

EF